Citrus Sinensis ID: 011819
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 477 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | yes | no | 0.937 | 0.993 | 0.759 | 0.0 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | yes | no | 0.712 | 0.817 | 0.673 | 1e-147 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | yes | no | 0.683 | 0.783 | 0.687 | 1e-146 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.624 | 0.718 | 0.775 | 1e-146 | |
| Q06486 | 415 | Casein kinase I isoform d | yes | no | 0.624 | 0.718 | 0.778 | 1e-146 | |
| Q9DC28 | 415 | Casein kinase I isoform d | no | no | 0.624 | 0.718 | 0.778 | 1e-146 | |
| P48730 | 415 | Casein kinase I isoform d | yes | no | 0.624 | 0.718 | 0.778 | 1e-146 | |
| P35508 | 415 | Casein kinase I isoform d | yes | no | 0.624 | 0.718 | 0.778 | 1e-146 | |
| P49674 | 416 | Casein kinase I isoform e | no | no | 0.683 | 0.783 | 0.687 | 1e-145 | |
| Q6P3K7 | 409 | Casein kinase I isoform d | yes | no | 0.723 | 0.843 | 0.659 | 1e-145 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 720 bits (1858), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/479 (75%), Positives = 400/479 (83%), Gaps = 32/479 (6%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PNV+WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAKKYRD++THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKYE+ISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGTSGA-PPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
PP+RAL P GTS A PP I++ DR T G EEGRP M+SSRRR+SG + NSG+
Sbjct: 301 TAPPSRALNPAVGTSAALPPGISNIDRYT-GEEEGRP----HMESSRRRVSGALDNSGNI 355
Query: 360 SKQKSPVVNEPTMT--KDTMLSSSNFLGRSGGGSSRRAAAVSSSRDAFVGSETEPQRSRT 417
S N+PT + +D+M+ SS+ +S GSSRR AVS SRD F GSE QRSRT
Sbjct: 356 S-------NQPTSSSARDSMIPSSSLFAQS-AGSSRRVTAVSGSRDNFPGSEELLQRSRT 407
Query: 418 TEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYETTLKGIESLHFDTDERVH 476
+ S G + PR SP +G++T + YE+ +KGI++L + H
Sbjct: 408 GDVSRGVI------PRNSP--------GEAGKSTR--RHYESVVKGIDNLQVSDEHHPH 450
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 521 bits (1342), Expect = e-147, Method: Compositional matrix adjust.
Identities = 250/371 (67%), Positives = 296/371 (79%), Gaps = 31/371 (8%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGNK+RLGRKIGSGSFG+IYLG NI T EEVAIKLE VKTKHPQL ESK Y+++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP+++W G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY----- 295
C+GYP+EF++Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300
Query: 296 ---------------QQSQLATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAGLS 340
+ QL RAL PG PPA A+G+R E ++
Sbjct: 301 PEDMDRERREHEREERMGQLRGSATRALPPG------PPAGATGNRLRNVAEP-----MA 349
Query: 341 SMDSSRRRMSG 351
S +SR + SG
Sbjct: 350 STPTSRIQQSG 360
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 517 bits (1332), Expect = e-146, Method: Compositional matrix adjust.
Identities = 242/352 (68%), Positives = 285/352 (80%), Gaps = 26/352 (7%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGNK+RLGRKIGSGSFG+IYLG NI + EEVAIKLE VKTKHPQL ESK Y+++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP+++W G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY----- 295
C+GYP+EF++Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300
Query: 296 ---------------QQSQLATPPARALVPGAGTSGAPPAIASGDRQTGGGE 332
+ QL RAL PG PP A+ +R E
Sbjct: 301 PEDVDRERREHEREERMGQLRGSATRALPPG------PPTGATANRLRSAAE 346
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 517 bits (1331), Expect = e-146, Method: Compositional matrix adjust.
Identities = 231/298 (77%), Positives = 272/298 (91%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I +EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP ++W G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 517 bits (1331), Expect = e-146, Method: Compositional matrix adjust.
Identities = 232/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 517 bits (1331), Expect = e-146, Method: Compositional matrix adjust.
Identities = 232/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 517 bits (1331), Expect = e-146, Method: Compositional matrix adjust.
Identities = 232/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2 | Back alignment and function description |
|---|
Score = 517 bits (1331), Expect = e-146, Method: Compositional matrix adjust.
Identities = 232/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P49674|KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 516 bits (1329), Expect = e-145, Method: Compositional matrix adjust.
Identities = 242/352 (68%), Positives = 285/352 (80%), Gaps = 26/352 (7%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGNK+RLGRKIGSGSFG+IYLG NI + EEVAIKLE VKTKHPQL ESK Y+++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP+++W G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY----- 295
C+GYP+EF++Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAARN 300
Query: 296 ---------------QQSQLATPPARALVPGAGTSGAPPAIASGDRQTGGGE 332
+ QL RAL PG PP A+ +R E
Sbjct: 301 PEDVDRERREHEREERMGQLRGSATRALPPG------PPTGATANRLRSAAE 346
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P3K7|KC1DB_DANRE Casein kinase I isoform delta-B OS=Danio rerio GN=csnk1db PE=2 SV=1 | Back alignment and function description |
|---|
Score = 516 bits (1328), Expect = e-145, Method: Compositional matrix adjust.
Identities = 244/370 (65%), Positives = 293/370 (79%), Gaps = 25/370 (6%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDISVGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP ++W G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ ++
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGANRT 300
Query: 301 A------------------TPPARALVPGAG-----TSGAPPAIASGDRQTGGGEEGRPA 337
A P AR + +G GAPP + T RP
Sbjct: 301 AEEADRERRERDERMRHSRNPAARGIPAASGRPRPTQDGAPPTPLTPTSHTANTSSPRP- 359
Query: 338 GLSSMDSSRR 347
++ M+ R+
Sbjct: 360 -VTGMERERK 368
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 477 | ||||||
| 224122454 | 475 | predicted protein [Populus trichocarpa] | 0.993 | 0.997 | 0.876 | 0.0 | |
| 224091248 | 475 | predicted protein [Populus trichocarpa] | 0.993 | 0.997 | 0.878 | 0.0 | |
| 359484471 | 474 | PREDICTED: casein kinase I isoform delta | 0.987 | 0.993 | 0.854 | 0.0 | |
| 255560729 | 472 | casein kinase, putative [Ricinus communi | 0.985 | 0.995 | 0.843 | 0.0 | |
| 359482807 | 471 | PREDICTED: casein kinase I isoform delta | 0.981 | 0.993 | 0.841 | 0.0 | |
| 356547889 | 483 | PREDICTED: casein kinase I isoform delta | 0.991 | 0.979 | 0.831 | 0.0 | |
| 121501708 | 473 | casein kinase [Beta vulgaris] | 0.985 | 0.993 | 0.839 | 0.0 | |
| 449446600 | 479 | PREDICTED: casein kinase I isoform delta | 0.993 | 0.989 | 0.840 | 0.0 | |
| 413915514 | 479 | Caesin kinase I isoform delta like prote | 0.993 | 0.989 | 0.838 | 0.0 | |
| 449488044 | 480 | PREDICTED: casein kinase I isoform delta | 0.993 | 0.987 | 0.840 | 0.0 |
| >gi|224122454|ref|XP_002330485.1| predicted protein [Populus trichocarpa] gi|222872419|gb|EEF09550.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/478 (87%), Positives = 444/478 (92%), Gaps = 4/478 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN+KTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENIKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSFS 360
A PP R + PG GTS P I S DRQTG GEEGR G SMDSSR R+SGP++N+GS+S
Sbjct: 301 ANPPTRGIGPGVGTSSGMPPIVSADRQTGSGEEGRAVG-QSMDSSRHRLSGPILNAGSYS 359
Query: 361 KQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRDAF-VGSETEPQRSRTTE 419
KQKSPV N+ +TKD +L SS FLGRS GS+RRAA VSSSRD F SE++PQ SR T+
Sbjct: 360 KQKSPVANDYPITKDAVLPSSTFLGRS-SGSARRAAGVSSSRDVFAAASESDPQWSRITD 418
Query: 420 ASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYETTLKGIESLHFDTDERVHY 477
ASPGA+H+ISSGPR SP+GSSDP+R+SS RNTTH+KTYETTLKGIESL+FD+DE+VHY
Sbjct: 419 ASPGAIHKISSGPR-SPLGSSDPRRTSSSRNTTHMKTYETTLKGIESLNFDSDEKVHY 475
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224091248|ref|XP_002309212.1| predicted protein [Populus trichocarpa] gi|222855188|gb|EEE92735.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2210), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/478 (87%), Positives = 442/478 (92%), Gaps = 4/478 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 SRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
A PP R L G GT SG PP I S DRQT GGEE R AG +M+SSRRR+SG +IN+GS
Sbjct: 301 ANPPTRGLGLGVGTSSGMPPPIVSADRQT-GGEEVRAAG-QTMESSRRRLSGQIINAGSS 358
Query: 360 SKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRDAFVGSETEPQRSRTTE 419
SKQKS V NE +TKD ML +S FLGRS GSSRRAAAVSSSRD FVGSE++PQRS TTE
Sbjct: 359 SKQKSLVANESPITKDAMLPNSTFLGRS-SGSSRRAAAVSSSRDVFVGSESDPQRSCTTE 417
Query: 420 ASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYETTLKGIESLHFDTDERVHY 477
ASPGA+H+ISSG R P+GSSDP+R+SS RNT+H+KTYETTLKG ESL+FD+DE+ H+
Sbjct: 418 ASPGAIHKISSGQRSPPLGSSDPRRTSSSRNTSHMKTYETTLKGFESLNFDSDEKAHH 475
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484471|ref|XP_002281345.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|147859066|emb|CAN80417.1| hypothetical protein VITISV_024542 [Vitis vinifera] gi|297738643|emb|CBI27888.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 829 bits (2142), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/480 (85%), Positives = 439/480 (91%), Gaps = 9/480 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEG+YNVLVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTATHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE+KVSTSIE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISERKVSTSIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGTSGA--PPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGS 358
ATPP+R L PGAGTS PPA+A+ DRQ+ GEEGRPAGLSSMD SRRR+SG + G
Sbjct: 301 ATPPSRVLGPGAGTSSGLPPPAVANADRQS--GEEGRPAGLSSMDPSRRRISG---DGGG 355
Query: 359 FSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRDAFVGSETEPQRSRTT 418
SKQKSPV ++ ++KD MLSSS+FLGRS G S R A + S A +GSE++P R+ TT
Sbjct: 356 LSKQKSPVASDLAVSKDAMLSSSHFLGRSSGSSRRAAVSSSRDA-AIMGSESDPSRAHTT 414
Query: 419 EASPG-AMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYETTLKGIESLHFDTDERVHY 477
EASPG A+ RISSG R SP+GSSDPKR+SSGRN T+IK YE+T++GIE+L+FD DERVHY
Sbjct: 415 EASPGAAVRRISSGQRSSPVGSSDPKRTSSGRNITNIKNYESTIRGIENLNFDNDERVHY 474
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255560729|ref|XP_002521378.1| casein kinase, putative [Ricinus communis] gi|223539456|gb|EEF41046.1| casein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2086), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/479 (84%), Positives = 432/479 (90%), Gaps = 9/479 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 ATPPARALVPGAG-TSGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
A PP RAL PGAG +SG PP+ A+ DRQ GGEEGRP SMD +RRR SGP+ +S +F
Sbjct: 301 ANPPTRALGPGAGPSSGMPPSGANIDRQP-GGEEGRPT-WPSMDPTRRRNSGPITSSVNF 358
Query: 360 SKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRD-AFVGSETEPQRSRTT 418
SKQK PV N+ ++KD LSS+NFL S G+SRR A+SSSRD A G+E++P SRTT
Sbjct: 359 SKQKGPVANDLPLSKDAKLSSTNFLRSS--GTSRR-PAISSSRDAALTGNESDPTWSRTT 415
Query: 419 EASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYETTLKGIESLHFDTDERVHY 477
+ASP +IS G R SPI S++ K SSGRNTT+IKT+E+TL+GIESLHF+ DERV Y
Sbjct: 416 DASPAV--KISGGQRSSPIVSAEQKHLSSGRNTTNIKTFESTLRGIESLHFNNDERVQY 472
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482807|ref|XP_002277513.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297743045|emb|CBI35912.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2085), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/480 (84%), Positives = 435/480 (90%), Gaps = 12/480 (2%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNV+WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 ATPPARALVPGAGTS-GAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
+ PP+RAL PGAG S G PPA+A+ DRQ+ GGE+GRP+G SS D SRRR + P +N GS
Sbjct: 301 SGPPSRALGPGAGPSHGIPPAVANMDRQS-GGEDGRPSGWSSADPSRRRTTVPALNLGSL 359
Query: 360 SKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRDA-FVGSETEPQRSRTT 418
KQKSPV N+ TM KD++ S+N GSSRR AVSSSRDA VG E++P RSR
Sbjct: 360 -KQKSPVANDSTMAKDSL--SANV---RASGSSRR-GAVSSSRDAVIVGGESDPSRSR-A 411
Query: 419 EASPGAMHRISSGPRGSPIGSSDPKRSSSGRNT-THIKTYETTLKGIESLHFDTDERVHY 477
+ASPGA+ +ISSG RGSP+ SS+ KR SSGRNT ++IK +E+TLKGIESLHF+ +ERV Y
Sbjct: 412 DASPGALRKISSGQRGSPVHSSEHKRISSGRNTSSNIKNFESTLKGIESLHFNNEERVQY 471
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547889|ref|XP_003542337.1| PREDICTED: casein kinase I isoform delta-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 806 bits (2082), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/487 (83%), Positives = 429/487 (88%), Gaps = 14/487 (2%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF+H
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
ATPP RA+ P AGT SG PPA+ + DR T GGEEGRP L S+DSSRRRMSGP++N+ SF
Sbjct: 301 ATPPTRAIGPSAGTSSGMPPAVTNADRHT-GGEEGRPPALVSVDSSRRRMSGPILNTVSF 359
Query: 360 SKQKSPVVNEPTMTKDTMLSSS--------NFLGRSGGGSSRRAAAVSSSRDAFVGSETE 411
SK K + N D+++SSS N LG+S G S AVSSSRDAFVG+E++
Sbjct: 360 SKPKKLITNFSFTFSDSIISSSMNMQLSSANALGQSSGSSR--RVAVSSSRDAFVGAESD 417
Query: 412 PQRSRTTEASPGAMHRISSGPRGSPIGSSDPKR-SSSGRNTTHIKTYETTLKGIESLHFD 470
R+RT EASPGA HR SG R SPIGSSDPKR SSGRN +H+K Y+T L+G+E L +
Sbjct: 418 I-RTRTAEASPGAAHRALSGQRSSPIGSSDPKRVVSSGRNASHVKNYDTALRGMEGLQLE 476
Query: 471 TDERVHY 477
DER HY
Sbjct: 477 NDERTHY 483
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|121501708|gb|ABM55249.1| casein kinase [Beta vulgaris] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/479 (83%), Positives = 427/479 (89%), Gaps = 9/479 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNK+RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK SLKTVLMLADQMINR+EFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKFSLKTVLMLADQMINRIEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAKKYRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDTTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI+RDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIYRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGTS-GAP-PAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGS 358
A PPAR GAGTS G P P +A+ +R+ G EEGR GLS+ D RRRMSG ++NSGS
Sbjct: 301 AAPPARTGA-GAGTSAGVPTPPVANPERKL-GEEEGRAGGLSTGDGLRRRMSGSLLNSGS 358
Query: 359 FSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRDAFV-GSETEPQRSRT 417
KQKSP+ N+PT++KD LSS+N GRS G R AA+ SSR+A G+E++P RSRT
Sbjct: 359 LLKQKSPLANDPTVSKDPTLSSTNLTGRSSGFLKR--AAIPSSREAVTGGNESDPSRSRT 416
Query: 418 TEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYETTLKGIESLHFDTDERVH 476
EASP M R SSG R SP+GSSD K+ SSGR T IK YE+TLKGIESLHFD DERVH
Sbjct: 417 AEASPSTMQRFSSGQRSSPVGSSDAKQQSSGR-ITSIKNYESTLKGIESLHFD-DERVH 473
|
Source: Beta vulgaris Species: Beta vulgaris Genus: Beta Family: Amaranthaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446600|ref|XP_004141059.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 804 bits (2076), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/482 (84%), Positives = 431/482 (89%), Gaps = 8/482 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
ATPP RAL GAGT SG PP IA+ DRQT GGEE + AG+S MDSSRRR SG +NSG+F
Sbjct: 301 ATPPTRALGAGAGTSSGIPPGIANPDRQT-GGEEAQLAGMSLMDSSRRRASGLTMNSGTF 359
Query: 360 SKQKSPVVNE-PTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRDAFVGSETEPQR-SRT 417
+KQKSP+ N+ + KD + S N +GRS G S AAVSSSRD +VGSE +P R SRT
Sbjct: 360 AKQKSPIANDTAAVPKDGVFSGPNIVGRSSGSSR--RAAVSSSRDPYVGSEADPHRSSRT 417
Query: 418 TEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNT--THIKTYETTLKGIESLHFDTDERV 475
+ASPGA+H+ S R P+G +DPKRS+SGR+T H+K Y++ LKGIE L + DERV
Sbjct: 418 RDASPGALHKSMSAQRSPPVGPADPKRSASGRHTGHGHVKNYDSALKGIEGLQLENDERV 477
Query: 476 HY 477
HY
Sbjct: 478 HY 479
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|413915514|emb|CCM43976.1| Caesin kinase I isoform delta like protein [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2075), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/482 (83%), Positives = 431/482 (89%), Gaps = 8/482 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLE+LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLETLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSF 359
ATPP RAL GAGT SG PP IA+ DRQT GGEE + AG+S MDSSRRR SG +NSG+F
Sbjct: 301 ATPPTRALGAGAGTSSGIPPGIANPDRQT-GGEEAQLAGMSLMDSSRRRASGLTMNSGTF 359
Query: 360 SKQKSPVVNE-PTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRDAFVGSETEPQR-SRT 417
+KQKSP+ N+ + KD + S N +GRS G S AAVSSSRD +VGSE +P R SRT
Sbjct: 360 AKQKSPIANDTAAVPKDGVFSGPNIVGRSSGSSR--RAAVSSSRDPYVGSEADPHRSSRT 417
Query: 418 TEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNT--THIKTYETTLKGIESLHFDTDERV 475
+ASPGA+H+ S R P+G +DPKRS+SGR+T H+K Y++ LKGIE L + DERV
Sbjct: 418 RDASPGALHKSMSAQRSPPVGPADPKRSASGRHTGHGHVKNYDSALKGIEGLQLENDERV 477
Query: 476 HY 477
HY
Sbjct: 478 HY 479
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449488044|ref|XP_004157925.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 803 bits (2074), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/483 (84%), Positives = 432/483 (89%), Gaps = 9/483 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD+STHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALV-PGAGT-SGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGS 358
ATPP RALV GAGT SG PP IA+ DRQT GGEE + AG+S MDSSRRR SG +NSG+
Sbjct: 301 ATPPTRALVRAGAGTSSGIPPGIANPDRQT-GGEEAQLAGMSLMDSSRRRASGLTMNSGT 359
Query: 359 FSKQKSPVVNE-PTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRDAFVGSETEPQR-SR 416
F+KQKSP+ N+ + KD + S N +GRS G S AAVSSSRD +VGSE +P R SR
Sbjct: 360 FAKQKSPIANDTAAVPKDGVFSGPNIVGRSSGSSR--RAAVSSSRDPYVGSEADPHRSSR 417
Query: 417 TTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNT--THIKTYETTLKGIESLHFDTDER 474
T +ASPGA+H+ S R P+G +DPKRS+SGR+T H+K Y++ LKGIE L + DER
Sbjct: 418 TRDASPGALHKSMSAQRSPPVGPADPKRSASGRHTGHGHVKNYDSALKGIEGLQLENDER 477
Query: 475 VHY 477
VHY
Sbjct: 478 VHY 480
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 477 | ||||||
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.970 | 0.995 | 0.696 | 1e-171 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.863 | 0.915 | 0.745 | 2.7e-167 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.758 | 0.832 | 0.802 | 2e-162 | |
| TAIR|locus:2050409 | 433 | ckl5 "casein kinase I-like 5" | 0.685 | 0.755 | 0.789 | 1.8e-146 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.622 | 0.623 | 0.791 | 1.4e-133 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.622 | 0.630 | 0.787 | 1.3e-132 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.649 | 0.701 | 0.748 | 2.4e-131 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.624 | 0.622 | 0.755 | 1.8e-129 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.610 | 0.628 | 0.780 | 4e-129 | |
| TAIR|locus:2129640 | 457 | CKI1 "casein kinase I" [Arabid | 0.706 | 0.737 | 0.695 | 2.8e-128 |
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1669 (592.6 bits), Expect = 1.0e-171, P = 1.0e-171
Identities = 328/471 (69%), Positives = 361/471 (76%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIG GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY++LQ
Sbjct: 1 MEPRVGNKFRLGRKIGGGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKVLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PNV+W+GVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR+EFVH
Sbjct: 61 GGTGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
KSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAKKYRD S HQHIPYRENKNLTGTARYA
Sbjct: 121 QKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRD-SNHQHIPYRENKNLTGTARYA 179
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
SMNTHLGIEQSRRDDLESLG+VLMYFL+GSLPWQGLKAG VSTSIEAL
Sbjct: 180 SMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEAL 239
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 240 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 299
Query: 301 ATPPARALVPGAGTSGA-PPAIASGDRQTGGGEEGRPAGLXXXXXXXXXXXGPVINSGSF 359
+TPP R P G S A PPAI S +R +GG +E RP+G G + NSGS
Sbjct: 300 STPPPRHHGPVVGPSSALPPAITSAERPSGG-DEARPSGWSSGIPRRNS--GQIFNSGSL 356
Query: 360 SKQKSPVVNEPTMTKDTMLXXXXXXXXXXXXXXXXXXXXXXXXXXFVGSETEPQRSRTTE 419
+KQK+PV ++P ++KD +L +G+++EP + E
Sbjct: 357 AKQKAPVSSDPAISKDVVLSSSSFLRATGSSRRAAVSSSREAAV--LGTDSEPSNPQIVE 414
Query: 420 ASPGAMHXXXXXXXXXXXXXXDPKRSSSGRNTTHI-KTYETTLKGIESLHF 469
A G+ K SS R TT + K YE LKGIESLHF
Sbjct: 415 AGSGSNSKIPVSRNSPIVSSEINKLSSPSRATTSVMKNYEANLKGIESLHF 465
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1596 (566.9 bits), Expect = 2.7e-167, Sum P(2) = 2.7e-167
Identities = 319/428 (74%), Positives = 341/428 (79%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PNV+WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAKKYRD++THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALVPGAGTSGA-PPAIASGDRQTGGGEEGRPAGLXXXXXXXXXXXGPVINSGSF 359
PP+RAL P GTS A PP I++ DR TG EEGRP G + NSG+
Sbjct: 301 TAPPSRALNPAVGTSAALPPGISNIDRYTGE-EEGRP----HMESSRRRVSGALDNSGNI 355
Query: 360 SKQKSPVVNEPTMT--KDTMLXXXXXXXXXXXXXXXXXXXXXXXXXXFVGSETEPQRSRT 417
S N+PT + +D+M+ F GSE QRSRT
Sbjct: 356 S-------NQPTSSSARDSMIPSSSLFAQSAGSSRRVTAVSGSRDN-FPGSEELLQRSRT 407
Query: 418 TEASPGAM 425
+ S G +
Sbjct: 408 GDVSRGVI 415
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1539 (546.8 bits), Expect = 2.0e-162, Sum P(2) = 2.0e-162
Identities = 296/369 (80%), Positives = 317/369 (85%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNK+RLGRKIGSGSFGEIYLGT+IQTNEEVAIKLENVKTKHPQLLYESKLYRILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTHIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PN++WFGVEGDYN LVMDLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVE+ H
Sbjct: 61 GGTGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRD+KPDNFLMGLGRRANQV+IIDFGLAKKYRD +THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYP+EFASYFHYCRSLRFDDKPDY YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ATPPARALV-PGAGTS-GAPPAIASGDRQTGGGEEGRPAGLXXXXXXXXXXXGPVINSGS 358
PP+R LV P GTS G PP + S DR G E GRP G + NSG+
Sbjct: 301 TAPPSRGLVSPAVGTSAGLPPGLTSIDRYGGEEEGGRPP----MDSSRRRMSGALENSGN 356
Query: 359 FSKQKSPVV 367
S + P++
Sbjct: 357 LSS-RGPMM 364
|
|
| TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1408 (500.7 bits), Expect = 1.8e-146, Sum P(2) = 1.8e-146
Identities = 259/328 (78%), Positives = 292/328 (89%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGT++QTNEEVAIKLE+VKT HPQL YES++YR+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTDVQTNEEVAIKLESVKTAHPQLSYESRIYRVLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN++W+GVEGDYNVLVMDLLGPSLEDLF++C R+ SLKTVLMLADQMINR+EF+H
Sbjct: 61 GGTGIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKS+LHRDIKPDNFLMGLGRRANQVYIID+GLAKKYRD+STH+HIPYRENK+L GT RYA
Sbjct: 121 SKSYLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLGIEQSRRDD+ESLGY+LMYFL+GSLPWQGLKAG VSTSIE L
Sbjct: 181 SLNTHLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIETL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRG+PTEFASYFHYCRSLRFDDKPDYAYLKR+FR+LFIREGFQFD+VFDWT+ KYQQSQ
Sbjct: 241 CRGHPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQS 300
Query: 301 ATPPARALVPGAGTS-GAPPAIASGDRQ 327
P R G GTS G PA+ + +++
Sbjct: 301 GNPQPRPHDGGVGTSSGLNPAVGNSEKR 328
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1309 (465.8 bits), Expect = 1.4e-133, P = 1.4e-133
Identities = 235/297 (79%), Positives = 268/297 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
M+ +G KF+LG+KIGSGSFGE+YLG N+QT EEVA+KLENVKTKHPQL YESKLY +LQ
Sbjct: 1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG+GIPN++WFGVEGDY+V+V+DLLGPSLEDLFN+C+RKL+LKTVLMLADQ++NRVEF+H
Sbjct: 61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL KKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLESLGYVLMYFL+GSLPWQGLKAGT VST IE L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297
C+ P+EF SYFHYCRSLRFDDKPDY+YLKR+FRDLFIREG+QFDYVFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQ 297
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1300 (462.7 bits), Expect = 1.3e-132, P = 1.3e-132
Identities = 234/297 (78%), Positives = 267/297 (89%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
M+ +G KF+LGRKIGSGSFGE+YLG N+QT EEVA+KLE+VKTKHPQL YESKLY +LQ
Sbjct: 1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PN++W+GVEGDYNV+V+DLLGPSLEDLFN+C+RKLSLKTVLMLADQ+INRVEF+H
Sbjct: 61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL KKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLE+LGYVLMYFL+GSLPWQGLKAGT V+T IE L
Sbjct: 181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297
C+ P+EF SYF YCRSLRFDDKPDY+YLKR+FRDLFIREG+QFDYVFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQ 297
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1288 (458.5 bits), Expect = 2.4e-131, P = 2.4e-131
Identities = 235/314 (74%), Positives = 272/314 (86%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
M+ +G KF+LGRKIGSGSFGE+Y+G N+QT EEVA+KLE VKTKHPQL YESK+Y +LQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+P+++WFGVEG+YN + +DLLGPSLEDLFN+C+R SLKTVLMLADQ+INRVE++H
Sbjct: 61 GGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGR+ANQVYIID+GLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF+RGSLPWQGLKAGT + T +E L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS-Q 299
C+ YP+EF SYFHYCRSLRF+DKPDY+YLKR+FRDLFIREG+QFDYVFDWTILKY QS
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQSGS 300
Query: 300 LATP---PARALVP 310
++ P P AL P
Sbjct: 301 ISKPRPNPKPALDP 314
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1251 (445.4 bits), Expect = 1.8e-129, Sum P(2) = 1.8e-129
Identities = 225/298 (75%), Positives = 261/298 (87%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
M+ +G KF+LGRKIG GSFGE++L ++QT EE A+KLE KTKHPQL YESK+Y +LQ
Sbjct: 5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG+GIP+++WFGV+GDYN +V+DLLGPSLEDLFN+C+R+L+LK VLMLADQ+I+RVE++H
Sbjct: 65 GGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMH 124
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 125 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYA 184
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT VST IE L
Sbjct: 185 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 244
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298
C+ YP EF SYF YCRSLRF+DKPDY+YLKR+FRDLFIREG+QFDYVFDWT LK+ QS
Sbjct: 245 CKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1267 (451.1 bits), Expect = 4.0e-129, P = 4.0e-129
Identities = 227/291 (78%), Positives = 263/291 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME +G KF+LGRKIGSGSFGE+YLG NIQ++EEVAIKLE+VK++HPQL YESKLY +LQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIP+++WFGVEG+YNV+V+DLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++H
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
++ FLHRDIKPDNFLMGLGR+A+QVY+ID+GLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + T +E L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291
C+ YPTEF SYFHYCRSLRF+DKPDY+YLKR+FRDLFIREG+Q DY+FDWT
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT 291
|
|
| TAIR|locus:2129640 CKI1 "casein kinase I" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1259 (448.2 bits), Expect = 2.8e-128, P = 2.8e-128
Identities = 235/338 (69%), Positives = 273/338 (80%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
M+ +G KF+LGRK+GSGSFGE+YLG NIQT EEVA+KLE VKT+HPQL YESK+Y LQ
Sbjct: 7 MDHVIGGKFKLGRKLGSGSFGELYLGINIQTGEEVAVKLEPVKTRHPQLQYESKIYMFLQ 66
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+P+++WFGVEG+Y+ +V+DLLGPSLEDLFN+C R SLK+VLMLADQ+I RVE++H
Sbjct: 67 GGTGVPHLKWFGVEGEYSCMVIDLLGPSLEDLFNYCKRIFSLKSVLMLADQLICRVEYMH 126
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGRRANQVYIID+GLAKKY+D T +HIPYRENKNLTGTARYA
Sbjct: 127 SRGFLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYKDLQTQKHIPYRENKNLTGTARYA 186
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + TS+E L
Sbjct: 187 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTSVETL 246
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
C+ YP+EF SYFHYCRSLRF+DKPDY+YL+R+FRDLFIREG+Q DYVFDWTI KY Q
Sbjct: 247 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLRRLFRDLFIREGYQLDYVFDWTISKYPQIGS 306
Query: 301 ATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAG 338
++ P P G PPA + G GR G
Sbjct: 307 SSRPRPTPRPALDPPG-PPAERAEKPTVGQDLRGRFTG 343
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| P42158 | KC1D_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7599 | 0.9371 | 0.9933 | yes | no |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7108 | 0.6163 | 0.6901 | yes | no |
| P48730 | KC1D_HUMAN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7785 | 0.6247 | 0.7180 | yes | no |
| Q6QNM1 | KC1_TOXGO | 2, ., 7, ., 1, 1, ., 1 | 0.7458 | 0.6268 | 0.9228 | N/A | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7785 | 0.6247 | 0.7180 | yes | no |
| Q6P3K7 | KC1DB_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.6594 | 0.7232 | 0.8435 | yes | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7718 | 0.6247 | 0.7180 | yes | no |
| P29295 | HRR25_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6666 | 0.6289 | 0.6072 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7773 | 0.6121 | 0.8 | yes | no |
| Q06486 | KC1D_RAT | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7785 | 0.6247 | 0.7180 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7254 | 0.6184 | 0.6704 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.6962 | 0.6142 | 0.9071 | yes | no |
| Q5ZLL1 | KC1E_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.6738 | 0.7127 | 0.8173 | yes | no |
| Q20471 | KIN20_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7366 | 0.6268 | 0.6016 | yes | no |
| Q6QNL9 | KC1_EIMTE | 2, ., 7, ., 1, 1, ., 1 | 0.7372 | 0.6142 | 0.8746 | N/A | no |
| Q5BP74 | KC1D_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7751 | 0.6247 | 0.7180 | N/A | no |
| Q9JMK2 | KC1E_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6875 | 0.6834 | 0.7836 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 477 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-21 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-21 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-12 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-12 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-11 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 1e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-04 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.001 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.001 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.001 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 0.001 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 0.001 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.001 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.002 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.003 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-47
Identities = 71/260 (27%), Positives = 109/260 (41%), Gaps = 23/260 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKLYRILQGGTG 64
+ L RK+GSGSFG +Y + T + VA+K+ +++ + E ++ R L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSK 122
+ + F + D+ LVM+ DLF++ SR LS +A Q++ +E++HS
Sbjct: 61 VRLIDAF-EDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
+HRD+KP+N L+ V I DFGLAKK GT Y +
Sbjct: 118 GIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAP 167
Query: 183 NTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
L G + D+ SLG +L L G P+ G + Q +I +
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227
Query: 242 RGYPTEFASYFHYCRSLRFD 261
G E C L D
Sbjct: 228 SGSE-EAKDLIKKC--LNKD 244
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 22/201 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGIPN-VRW 70
+G G FG +YL + +T ++VAIK E+ + +LL E ++ + L PN V+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH----PNIVKL 56
Query: 71 FGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
+GV + ++ LVM+ G SL+DL KLS +L + Q++ +E++HS +HR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 187
D+KP+N L L +V + DFGL+K K + GT Y + LG
Sbjct: 117 DLKPENIL--LDSDNGKVKLADFGLSKLLTSDK-------SLLKTIVGTPAYMAPEVLLG 167
Query: 188 I-EQSRRDDLESLGYVLMYFL 207
S + D+ SLG V++Y L
Sbjct: 168 KGYYSEKSDIWSLG-VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (336), Expect = 5e-35
Identities = 78/238 (32%), Positives = 119/238 (50%), Gaps = 11/238 (4%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKTKHPQLLYESKLYRILQGGTGI 65
+R+ RK+G GSFGE+YL + + + +A KLE+ + + L E ++ L I
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK 122
+ F + LVM+ + G SLEDL R LS L + Q+++ +E++HSK
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
+HRDIKP+N L L R V +IDFGLAK D + IP + ++ GT Y +
Sbjct: 121 GIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGYMAP 177
Query: 183 NTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
LG+ S D+ SLG L L G P++G K + + KI + + S+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
|
Length = 384 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 69/234 (29%), Positives = 111/234 (47%), Gaps = 27/234 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGI 65
+ + K+G GSFG++YL + +T + VAIK + +K ++L E K+ + L+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH---- 56
Query: 66 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN VR + V + D LVM+ G L DL +LS Q+++ +E++HS
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLHS 115
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
K +HRD+KP+N L+ V + DFGLA++ GT Y +
Sbjct: 116 KGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKL--------TTFVGTPEYMA 164
Query: 182 MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
LG + D+ SLG V++Y L G P+ G + ++KI + K
Sbjct: 165 PEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPP 215
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 63/221 (28%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTK-HPQLLYESKLYRILQGGT 63
+++ G KIG G+FG++Y N+ T E +A I++++ K ++ E K+ +L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58
Query: 64 GIPN-VRWFGVE-GDYNVLV-MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN V+++GVE V + M+ G +LE+L R L + + Q++ + ++
Sbjct: 59 --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN-KNLTGTAR 178
HS +HRDIKP N + + + DFG A K ++ +T E ++L GT
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTPA 168
Query: 179 YASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGL 216
Y + G + R D+ SLG V++ G PW L
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 50/289 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY------RILQ 60
+ F+ G+ IG GSF + L +TN+E AIK+ + + QL+ E K+ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR----QLIKEKKVKYVKIEKEVLT 56
Query: 61 GGTGIPN-VRWFGVEGD----YNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
G P ++ + D Y V++ G L+ + + S L K A +++
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLY--FVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEIL 112
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-------------KYRDTS 160
+E++HSK +HRD+KP+N L+ + + I DFG AK +
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
+ R + GTA Y S + DL +LG ++ L G P++G
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG---SN 226
Query: 221 KKQKYEKISE----------KKVSTSIEALCRGYPTEFASYFHYCRSLR 259
+ ++KI + IE L P + L+
Sbjct: 227 EYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 79/298 (26%), Positives = 138/298 (46%), Gaps = 45/298 (15%)
Query: 6 GNKFRLGRKIGSGSFGEIY---LGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRI-- 58
G ++++ + IG G FG +Y ++ N + K+EN++ T + L + +Y I
Sbjct: 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDK 70
Query: 59 LQGGTGIPNVRWFGVEGDYNV------------LVMDLLGPSLEDLFN--FCSRKLSLKT 104
+ I N+ G+ Y ++++ L + +++F C K +K
Sbjct: 71 IALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKN 130
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
++ M+ +E++H H DIKP+N ++ R YIID+G+A + +H
Sbjct: 131 IMK---DMLTTLEYIHEHGISHGDIKPENIMVDGNNRG---YIIDYGIASHF--IIHGKH 182
Query: 165 IPY-RENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-- 220
I Y +E K+L GT YA ++ H G +RR DLESLGY ++ + LPW+G
Sbjct: 183 IEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242
Query: 221 ----KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRS-LRFDDKPDYAYLKRIF 273
K +++ E K+ +F F C + L +++KPDY L +IF
Sbjct: 243 IHAAKCDFIKRLHEGKIKIK-------NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293
|
Length = 294 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 8e-20
Identities = 51/180 (28%), Positives = 93/180 (51%), Gaps = 21/180 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQGGTGI 65
F + KIG G FGE+Y + +T +EVAIK+ K K +++ E ++ + +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH---- 56
Query: 66 PN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN V+++G ++ D +VM+ G SL+DL ++ L+ + + +++ +E++HS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+HRDIK N L+ +V +IDFGL+ + DT + + GT + +
Sbjct: 117 NGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 2e-19
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGT 63
++ G +G GSFG +YL + T E +A+K + L E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58
Query: 64 GIPN-VRWFGVEGD-----YNVLVMDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINR 115
PN VR++G E D N + ++ + G SL L F KL + Q++
Sbjct: 59 --PNIVRYYGSERDEEKNTLN-IFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEG 113
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+ ++HS +HRDIK N L+ + DFG AK+ D T + ++ G
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDGVVK---LADFGCAKRLGDIETGE-----GTGSVRG 165
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
T + + G E R D+ SLG ++ G PW
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 31/216 (14%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGT 63
++++ +IG G+ G ++ + +T E VA+K ++ Q L E K + Q
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-- 58
Query: 64 GIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
P V+ V G VLVM+ + L ++ R L V ++ V ++H
Sbjct: 59 --PYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIP--YRENKNLT 174
+ +HRD+KP N L+ + I DFGLA+ + +HQ YR + L
Sbjct: 117 ANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
G +Y G+ DL ++G + L GS
Sbjct: 174 GARKYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (204), Expect = 2e-17
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 17/164 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-LLYESKLYRILQGGTG 64
+ K+G G++G +Y + +T E VA+K L+N + P L E L + L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH--- 57
Query: 65 IPN-VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN V+ V LV + L+ + LS + + Q++ + + HS
Sbjct: 58 -PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTH 162
LHRD+KP N L+ R + + DFGLA+ + T TH
Sbjct: 117 HRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIPLRTYTH 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 9e-17
Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 44/181 (24%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLLYESKLY 56
++ G+K+G G++ +Y + +T VAIK K K + L E KL
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK----KIKLGERKEAKDGINFTALREIKLL 56
Query: 57 RILQGGTGIPNV----RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD-- 110
+ L+ PN+ FG + + N LV + + LE + VL AD
Sbjct: 57 QELKH----PNIIGLLDVFGHKSNIN-LVFEFMETDLEKVIK------DKSIVLTPADIK 105
Query: 111 ----QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTS---TH 162
+ +E++HS LHRD+KP+N L+ ++ + + DFGLA+ + + TH
Sbjct: 106 SYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLARSFGSPNRKMTH 161
Query: 163 Q 163
Q
Sbjct: 162 Q 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 30/154 (19%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKLYRILQGGTGIPN-VRWF 71
KIG G+ GE+Y T+ T +EVAIK ++ ++ +L+ E + + + PN V ++
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH----PNIVDYY 81
Query: 72 G--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV--------EFVH 120
+ GD +VM+ + G SL D+ +++ + I V E++H
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMN--------EPQIAYVCREVLQGLEYLH 133
Query: 121 SKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLA 153
S++ +HRDIK DN L+ G V + DFG A
Sbjct: 134 SQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 39/169 (23%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------LENVK-----TKHPQL 49
+++ +++G G+FG +YL N +T E VAIK L VK +HP +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 50 LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCSRKLSLKTVLML 108
+ KL + E D V + + +L L + + S + +
Sbjct: 61 V---KLKEVF-------------RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSI 104
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
Q++ + +H F HRD+KP+N L+ V I DFGLA++ R
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 2e-14
Identities = 65/254 (25%), Positives = 104/254 (40%), Gaps = 77/254 (30%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP---QLLY 51
+G GSFG++ L T + A+K +E+ T HP +L Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 52 ----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR--KLSLK 103
E KLY LV++ G +LF+ S+ + S +
Sbjct: 61 AFQTEEKLY-----------------------LVLEYAPGG----ELFSHLSKEGRFSEE 93
Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--YRDTST 161
A +++ +E++HS ++RD+KP+N L L + + + DFGLAK+ + T
Sbjct: 94 RARFYAAEIVLALEYLHSLGIIYRDLKPENIL--LDADGH-IKLTDFGLAKELSSEGSRT 150
Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGT 220
+ GT Y + LG + D SLG VL+Y L G P+ A
Sbjct: 151 NT---------FCGTPEYLAPEVLLGKGYGKAVDWWSLG-VLLYEMLTGKPPFY---AED 197
Query: 221 KKQKYEKISEKKVS 234
+K+ YEKI + +
Sbjct: 198 RKEIYEKILKDPLR 211
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 54/174 (31%), Positives = 82/174 (47%), Gaps = 22/174 (12%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTN----EEVAIK--LENVKTKHPQLLY-ESKLYRILQGG 62
LG+K+G G+FGE+Y G EVA+K E+ + + E+++ R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
PN V+ GV E + +VM+ + G L KLSL +L A Q+ +E+
Sbjct: 61 ---PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT----STHQHIPYR 168
+ SK+F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 118 LESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 68/255 (26%), Positives = 99/255 (38%), Gaps = 58/255 (22%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLL------YESK 54
+ I G+FG +YL T + AIK + NVK + ++ Y +K
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
LY Q DY LVM+ L G L L +++
Sbjct: 62 LYYSFQ-------------SKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVV 107
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
VE +H + +HRDIKP+N L+ + + + DFGL++ ENK
Sbjct: 108 LGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKKF 153
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----- 228
GT Y + T LG+ + D SLG V+ FL G P+ A T ++ I
Sbjct: 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRI 210
Query: 229 ---SEKKVSTSIEAL 240
E K S EA+
Sbjct: 211 NWPEEVKEFCSPEAV 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 19/162 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---ILQ-----GGTG 64
KIG G++G +Y + T E VAIK +K + R +L+
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIK--KIKLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
+ +V F +GD LV + + L L R L + Q++ + F HS
Sbjct: 63 LLDV--FRHKGDL-YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQ 163
LHRD+KP+N L+ + + DFGLA+ + TH
Sbjct: 120 LHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHY 158
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (173), Expect = 2e-13
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 27/186 (14%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLYRILQGGT 63
K+ + ++IG GSFG++YL + +K L N+ K L E K+ + L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-- 58
Query: 64 GIPN-VRWFG--VEGDYNVLVMDLL-GPSLEDLF---NFCSRKLSLKTVLMLADQMINRV 116
PN ++++ E +VM+ G L + + +L Q+ +
Sbjct: 59 --PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 117 EFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+++HS+ LHRDIKP N FL V + DFG++K T K + G
Sbjct: 117 KYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSSTVDL-------AKTVVG 165
Query: 176 TARYAS 181
T Y S
Sbjct: 166 TPYYLS 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-13
Identities = 75/270 (27%), Positives = 111/270 (41%), Gaps = 54/270 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQGGTGIPN 67
R IG G GE+YL + + VA+K L + L E+K+ L GI
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVP 66
Query: 68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL----------KTVLMLADQMINRV 116
V +GD M + G +L+ L +K SL L + ++ +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK------------KYRDTSTHQH 164
E+VHSK LHRD+KPDN L+GL +V I+D+G A + +
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 165 ---IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
IP + + GT Y + LG+ S D+ +LG +L L S P+ +
Sbjct: 184 SMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-------R 232
Query: 222 KQKYEKISEKKVSTSIEALCRGYPTEFASY 251
++K KIS + V S P E A Y
Sbjct: 233 RKKGRKISYRDVILS--------PIEVAPY 254
|
Length = 932 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 51/282 (18%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQL-LYESKLYRILQGGTGIPNV 68
+IG G++G++Y N +T E VA+K +EN K P + E KL + L+ PN+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR----HPNI 60
Query: 69 -RWFGV---EGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
R + +G ++ +V + + L L + K + + Q++ ++++HS
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP------YRENKNLTGTA 177
LHRDIK N L+ + + DFGLA+ Y ++ + YR + L G
Sbjct: 121 ILHRDIKGSNILIN---NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
RY + D+ S+G +L G +QG T+ ++ EKI E
Sbjct: 178 RYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEKIFE------- 216
Query: 238 EALCRGYPTEFASYFHYCRSLRF--DDKPDYAYLKRIFRDLF 277
LC G PT+ + L + + KP Y KR R+ F
Sbjct: 217 --LC-GSPTD--ENWPGVSKLPWFENLKPKKPY-KRRLREFF 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 52/170 (30%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 9 FRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ---LLYESKLYRILQG 61
LG+K+G G+FGE+Y GT T +VA+K + L E+ + + L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 62 GTGIPN-VRWFGV--EGDYNVLVMDL--LGPSLEDLFNF---CSRKLSLKTVLMLADQMI 113
PN VR GV +G+ +V + G DL +F KL+LK +L +A Q+
Sbjct: 61 ----PNIVRLLGVCTQGEPLYIVTEYMPGG----DLLDFLRKHGEKLTLKDLLQMALQIA 112
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
+E++ SK+F+HRD+ N L+ V I DFGL++ + ++
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVT---ENLVVKISDFGLSRDIYEDDYYR 159
|
Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 13/156 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN- 67
F + K+G GS+G +Y + +T + VAIK+ V+ ++ K IL+ P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEI---IKEISILK-QCDSPYI 60
Query: 68 VRWFG---VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
V+++G D +VM+ G S+ D+ ++ L+ + + + Q + +E++HS
Sbjct: 61 VKYYGSYFKNTDL-WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIK N L+ Q + DFG++ + DT
Sbjct: 120 KIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDT 152
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 5e-13
Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 27/177 (15%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTN----EEVAIK--LENVKTKHPQLLY-ESKLYRILQGG 62
LG+K+G G+FGE+Y GT EVA+K E+ + + E+++ R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINR 115
PN V+ GV E + ++VM+ + DL ++ ++LSL +L A Q+
Sbjct: 61 ---PNIVKLLGVCTEEEPLMIVMEYM--PGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
+E++ SK+F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKLYRIL 59
+R G+ +G G+FG +YL ++ T E+A+K P L E +L + L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 60 QGGTGIPNVRWFGVEGDYNVL--VMDLL-GPSLED-------LFNFCSRKLSLKTVLMLA 109
Q V+++G D L M+ + G S++D L +RK +
Sbjct: 62 QHER---IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------- 111
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Q++ VE++HS +HRDIK N L A V + DFG +K+ + +
Sbjct: 112 -QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTICSSG----TG 163
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 4e-12
Identities = 71/246 (28%), Positives = 104/246 (42%), Gaps = 55/246 (22%)
Query: 13 RKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHP-----QLLYESKLYRILQGGTG 64
+K+G G+FGE+Y G EVA+K +K L E+++ + L G
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKKL----G 54
Query: 65 IPN-VRWFGV--EGDYNVLVM------DLLG---PSLEDLFNFCSRKLSLKTVLMLADQM 112
PN VR GV E + LV+ DLL S + LSLK +L A Q+
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK-----YRDTSTHQHIPY 167
+E++ SK F+HRD+ N L+G V I DFGL++ Y T +P
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 168 R----ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTK 221
R E S+ + +S D+ S G VL++ F G+ P+ GL
Sbjct: 172 RWMAPE-----------SLKDGIFTSKS---DVWSFG-VLLWEIFTLGATPYPGLSNEEV 216
Query: 222 KQKYEK 227
+ K
Sbjct: 217 LEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLLYESKLYRILQGGTGI 65
+ +G GS G +Y + T + A+K +V QLL E K R
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS----CES 58
Query: 66 PN-VRWFGV---EGDYNVLV--MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P V+ +G EG+ ++++ MD G SL DL K+ + +A Q++ ++++
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMD--GGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL 115
Query: 120 HSKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
H+K +HRDIKP N L+ +V I DFG++K +T + GT
Sbjct: 116 HTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENTLD-------QCNTFVGTVT 165
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
Y S G S D+ SLG L+ G P+ +
Sbjct: 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTKH--PQLLYESKLYRILQ 60
++R G +GSGSFG +Y G N+ + EV++ + + QL E L LQ
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 61 GGTGIPN-VRWFGV---EGDYNVLVMDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINR 115
PN V++ G E + + + + G SL L + S + + + Q++
Sbjct: 61 H----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV--IRLYTRQILLG 114
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
+E++H ++ +HRDIK N L+ V + DFG+AK+
Sbjct: 115 LEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQ 151
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 21/229 (9%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKH--PQLLYESKLYRILQGGTGIPNVR 69
I G++G ++L T + AIK+ ++ K+ Q+L E IL V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERD---ILSQAQSPYVVK 57
Query: 70 WF-GVEGDYNV-LVMDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
+ +G N+ LVM+ L G L L N S L + +++ +E++HS +
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGS--LDEDVARIYIAEIVLALEYLHSNGII 115
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKK-YRDTSTHQHIPYRENKNLTGTARYASMNT 184
HRD+KPDN L+ + + DFGL+K + + +E+K + GT Y +
Sbjct: 116 HRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
LG S+ D SLG +L FL G P+ G T ++ ++ I K+
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNGKI 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK-HPQLLYESKLYRILQGGT 63
++LG IG G+FG +Y G N++T + VAIK LE +K + ++ E L + L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58
Query: 64 GIPN-VRWFGV--EGDYNVLVMDL-LGPSLEDL---FNFCSRKLSLKTVLMLADQMINRV 116
PN V++ G D ++++ SL + F L V Q++ +
Sbjct: 59 --PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY----QVLQGL 112
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
++H + +HRDIK N L + V + DFG+A K D S
Sbjct: 113 AYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDA 157
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 51/190 (26%), Positives = 82/190 (43%), Gaps = 43/190 (22%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI----- 65
G +G G++G++ + T + VAIK K K ++ + R L G GI
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIK----KVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 66 -----------PNV---RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL----KTVLM 107
N+ VEGD+ LVMD++ L+ + + RK+ L ++
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD---RKIRLTESQVKCIL 125
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKY------RDTS 160
L Q++N + +H F+HRD+ P N F+ G I DFGLA++Y S
Sbjct: 126 L--QILNGLNVLHKWYFMHRDLSPANIFINSKG----ICKIADFGLARRYGYPPYSDTLS 179
Query: 161 THQHIPYREN 170
+ + RE
Sbjct: 180 KDETMQRREE 189
|
Length = 335 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 48/159 (30%), Positives = 70/159 (44%), Gaps = 17/159 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQ-LLYESKLYRILQGGTGIPN-VR 69
IG G++G +Y ++ T VA+K V P L E L + L+ PN VR
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES-FEHPNIVR 65
Query: 70 WFGVEGDYNV-------LVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHS 121
V LV + + L + C + L +T+ L Q++ V+F+HS
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS 125
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
+HRD+KP N L+ QV I DFGLA+ Y
Sbjct: 126 HRIVHRDLKPQNILVT---SDGQVKIADFGLARIYSFEM 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 63/264 (23%), Positives = 100/264 (37%), Gaps = 52/264 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGG 62
+ F + + IG G+FGE++L + T + A+K+ +K + + IL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERD--ILA-- 56
Query: 63 TGIPNVRW-------FGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMI 113
+ W F E ++ LVM+ + DL N RK +T +++
Sbjct: 57 --DADSPWIVKLYYSFQDE-EHLYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELV 111
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD--------------- 158
++ VH F+HRDIKPDN L+ + + DFGL KK
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 159 --TSTHQHIPYRENKN-----LTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGS 210
+ + + GT Y + G D SLG V++Y L G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILYEMLYGF 227
Query: 211 LPWQGLKAGTKKQKYEKISEKKVS 234
P + T ++ Y KI K S
Sbjct: 228 PP---FYSDTLQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQL--LYESKLYRILQGGT 63
K+ R +G G+FG ++L + V IK V+ TK +L E ++ ++L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS 121
I F +E ++VM+ G +L + C+ L T+L Q++ + VH+
Sbjct: 61 IIEYYENF-LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
K LHRD+K N L+ + V I DFG++K S + + GT Y S
Sbjct: 120 KLILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSKS--------KAYTVVGTPCYIS 169
Query: 182 MNTHLGIEQSRRDDLESLGYVL 203
G +++ D+ +LG VL
Sbjct: 170 PELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI-- 65
+ L ++IGSG++G++Y +I T E VAIK+ +K L + I+Q +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKV--IK------LEPGDDFEIIQQEISMLK 55
Query: 66 ----PN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
PN V +FG + D +VM+ G SL+D++ LS + + + + +
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
++H +HRDIK N L+ V + DFG++
Sbjct: 116 YLHETGKIHRDIKGANILL---TEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
K+ KIG G+ G +Y ++ T +EVAIK N++ + + L +++ + + PN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH--PN 77
Query: 68 VRWF---GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + + GD +VM+ L G SL D+ + + + + + +EF+HS
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQ 135
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFG----LAKKYRDTSTHQHIPY 167
+HRDIK DN L+G+ V + DFG + + ST PY
Sbjct: 136 VIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 50/194 (25%), Positives = 78/194 (40%), Gaps = 37/194 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYESKLYRILQGGTG 64
+ + K+G G+FGE+Y I+T VA+K + N K P L E K+ + L+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 65 IPNVRWFGVEGD---------YNVL---VMDLLG----PSLEDLFNFCSRKLSLKTVLML 108
+P + D Y V DL G PS++ K +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYML----- 122
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
Q++ + ++H LHRDIK N L+ + I DFGLA+ Y P
Sbjct: 123 --QLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNP 172
Query: 169 ENKNLTGTARYASM 182
+ GT +Y ++
Sbjct: 173 KGGGGGGTRKYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGGTG 64
F L R IG G+FG++ + T + A+K N V+ + + + RILQ
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNER--RILQELNH 59
Query: 65 --IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVH 120
+ N+ + + + LV+DLL DL S+K+ V +++ +E++H
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT---GTA 177
SK +HRDIKPDN L+ V+I DF +A K + T GT
Sbjct: 118 SKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTP-----------DTLTTSTSGTP 163
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
Y + S D SLG V Y LRG P++G
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLG-VTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 20/162 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTG 64
F L IG G++G++Y + +T + VAIK ++ ++ + ++ E Y IL+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE---YNILRKYSN 61
Query: 65 IPNV-RWFGV--------EGDYNVLVMDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQ 111
PN+ ++G D LVM+L G S+ DL ++L + + + +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ + ++H +HRDIK N L L + A +V ++DFG++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNIL--LTKNA-EVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 38/151 (25%), Positives = 59/151 (39%), Gaps = 28/151 (18%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAKK-YRDTSTHQHIPYR 168
++ E++H++ ++RD+KP+N L+ G V ++DFG AKK T
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQKTW------ 150
Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA--------- 218
GT Y + L D SLG +L+Y L G P+
Sbjct: 151 ---TFCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYNDI 206
Query: 219 --GTKKQKYEKISEKKVSTSIEALCRGYPTE 247
G K ++ +K I+ L R P E
Sbjct: 207 LKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 26/232 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGGTG 64
+ +G+G+FG ++L + + A+K+ ++ K Q ++ K R+L+ +
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK--RVLKEVSH 60
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSK 122
+R F E D L M + +LF++ S + S T L A +++ +E++HSK
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENKNLTGTARYAS 181
++RD+KP+N L+ + + + DFG AKK RD T T L GT Y +
Sbjct: 121 EIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRDRTWT-----------LCGTPEYLA 166
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
++ D +LG ++ L G P+ YEKI K+
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 41/171 (23%), Positives = 74/171 (43%), Gaps = 44/171 (25%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--------KT----------KHPQ 48
++ L + IGSG++G + + +T +VAIK + NV + +H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVL--VMDLLGPSLEDLFNFCSRKLSLKTVL 106
++ L IL P D+N + V +L+ L + + L+ +
Sbjct: 61 II---GLLDIL-----RPPSP-----EDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQ 106
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK 154
Q++ ++++HS + +HRD+KP N L N + I DFGLA+
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNIL------VNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 26/167 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP----------QLLYES 53
+K+ KIG G+FGE++ + +T + VA+K +EN K P QLL
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 54 KLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
+ +++ T + G + LV + L L + + K +L + +
Sbjct: 72 NVVNLIEICRTKATPYNRYK-----GSF-YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
++N + ++H LHRD+K N L+ + + + DFGLA+ +
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQL-LYESKLYRILQGGTGIPNVR 69
KIG G++G +Y + TNE +A I+LE P + E L + +Q G VR
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN---IVR 65
Query: 70 WFGV-EGDYNV-LVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSF 124
V + + LV + L L+ + ++ L + Q++ + + HS
Sbjct: 66 LQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY--QILRGIAYCHSHRV 123
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQHIP--YRENKNLTGTARY 179
LHRD+KP N L + RR N + + DFGLA+ + T TH+ + YR + L G+ Y
Sbjct: 124 LHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181
Query: 180 AS 181
++
Sbjct: 182 ST 183
|
Length = 294 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL--LYESKLYRILQGGTGI 65
+++ KIG G+F E+ + +T + AIK ++ Q+ L E + R L +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL---SPH 57
Query: 66 PNVRWFGVEGDYN------VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN+ +E ++ LV +L+ +L +L R L K V Q++ ++ +
Sbjct: 58 PNILRL-IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
H HRDIKP+N L+ + + + + DFG + + PY E
Sbjct: 117 HRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIYSKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKLYRI----LQGG 62
++LG IG+GSFG +Y I T+E+VAIK L++ + K+ +LL L I L+
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 63 TGIPNVRWFGVEGDYNV---LVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
+ + + N+ +VM+ + ++ +R L L V + + Q+ +
Sbjct: 128 YYTECFK----KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIPYRENKN 172
++HSK HRD+KP N L + + + + DFG AK R S YR +
Sbjct: 184 AYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPEL 241
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209
+ G Y TH+ DL SLG ++ + G
Sbjct: 242 MLGATNYT---THI--------DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 66/240 (27%), Positives = 108/240 (45%), Gaps = 37/240 (15%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLL----YESKLYRILQ 60
G IGSGSFG +YLG N + E +A+K + K + +L E L + LQ
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 61 GGTGIPN-VRWFGVEGDYNVLVMDLL---GPSLEDLFN-FCSRKLSLKTVLMLADQMINR 115
N V++ G D + L + L G S+ L N + + + +L V Q++
Sbjct: 65 H----ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL--VRNFVRQILKG 118
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR----DTSTHQHIPYRENK 171
+ ++H++ +HRDIK N L+ + I DFG++KK T T+ P
Sbjct: 119 LNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP----- 170
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231
+L G+ + + +R+ D+ SLG +++ L G P+ T+ Q KI E
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIFKIGEN 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQ 60
PR +L RK+G+G FGE+++GT N T +VA+K T P+ L E+++ + L+
Sbjct: 4 PR--ESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQEAQIMKKLR 59
Query: 61 GGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
V+ + V E + +V + + G L+ L + +KL L ++ +A Q+
Sbjct: 60 H----DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ ++ S++++HRD+ N L+G I DFGLA+ D
Sbjct: 116 MAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 15/162 (9%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKLYRILQGGTGIPN- 67
+IG GSFG +Y TN TNE VA+K + K ++ E K + L+ PN
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH----PNT 83
Query: 68 VRWFG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
+ + G ++ LVM+ S DL + L + + + + ++HS + +
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
HRDIK N L+ QV + DFG A K ++ PY
Sbjct: 144 HRDIKAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 52/281 (18%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQGGTGIP 66
F L RK+GSG FGE++ G + VAIK+ + K E + + L+ I
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI- 65
Query: 67 NVRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
F V G+ ++ +L+ G L L + + L + +++ +A Q+ + ++ +
Sbjct: 66 --SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT--STHQH-IPYRENKNLTGTARY 179
+ +HRD+ N L+G + DFGLA+ ++ + IPY+ TA
Sbjct: 124 NSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTAPE 174
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
A+ + S + D+ S G +L+Y F G +P+ G+ + Y++I+
Sbjct: 175 AASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPGM---NNHEVYDQIT-------- 218
Query: 238 EALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLK 270
GY P E C + +D+P + L+
Sbjct: 219 ----AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQG 61
PR RL K+G G FGE+++GT T + VAIK T P+ L E+++ + L+
Sbjct: 4 PR--ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRH 60
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+P E Y V G L+ L + L L ++ +A Q+ + + ++
Sbjct: 61 DKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 122 KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
+++HRD++ N L+G N V I DFGLA+ D Y + ++
Sbjct: 121 MNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNE------YTARQGAKFPIKWT 170
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ L + + D+ S G +L + +G +P+ G+ ++ E +V
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLE-----QVERGYRM 222
Query: 240 LC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275
C +G P C D++P + Y++ D
Sbjct: 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGT 63
F L IG GSFGE+Y + +TN+ VAIK LE + + + E + +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR--- 57
Query: 64 GIPNV-RWFG-VEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P + +++G + ++M+ G S DL KL + + +++ +E++
Sbjct: 58 -SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYL 114
Query: 120 HSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKKYRDTST 161
H + +HRDIK N L+ G V + DFG++ + T +
Sbjct: 115 HEEGKIHRDIKAANILLSEEG------DVKLADFGVSGQLTSTMS 153
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 10/149 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHP-QLLYESKLYRILQGGTGIPNVR 69
+I G++G +Y + +T E VA +K+E K P L E + LQ I V+
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PNIVTVK 70
Query: 70 --WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
G D +VM+ + L+ L + V L Q+++ V +H LHR
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR 130
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
D+K N L+ + I DFGLA++Y
Sbjct: 131 DLKTSNLLL---NNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-------LLYESKLYRILQGGT 63
KIG G++G ++ N +T+E VA+K L++ P LL E K I
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI----- 61
Query: 64 GIPNVRWFGV-EGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
VR + V D + LV + L+ F+ C+ + + V Q++ + F HS
Sbjct: 62 ----VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
+ LHRD+KP N L+ + ++ + DFGLA+ +
Sbjct: 118 HNVLHRDLKPQNLLI---NKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 8e-09
Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
K+ KIG G+ G +Y ++ T +EVAI+ N++ + + L +++ + + PN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN--PN 78
Query: 68 VRWF---GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + + GD +VM+ L G SL D+ + + + + + +EF+HS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN-LTGTARYASM 182
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 137 VIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAP 185
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 8e-09
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ---LLYESKLYRILQGGTG 64
K+ KIG G+ G ++ ++ T +EVAIK N++ K P+ ++ E + + L+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKN--- 75
Query: 65 IPNVRWF---GVEGDYNVLVMDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFV 119
PN+ F + GD +VM+ L G SL D+ C + + V + + +EF+
Sbjct: 76 -PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFL 131
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN-LTGTAR 178
H+ +HRDIK DN L+G+ V + DFG Q P + ++ + GT
Sbjct: 132 HANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCA--------QITPEQSKRSTMVGTPY 180
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ + + D+ SLG + + + G P+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 53/211 (25%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
K+ KIG G+ G +Y +I T +EVAIK N++ + + L +++ + + PN
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN--PN 77
Query: 68 VRWF---GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + + GD +VM+ L G SL D+ + + + + + ++F+HS
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN-LTGTARYASM 182
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 136 VIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAP 184
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 44/203 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYESKLYRILQGG 62
+KF + +IG G++G++Y + T E VA+K L+N K P + E K+ R L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH- 65
Query: 63 TGIPNV--------------------RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL 102
N+ F + +Y + DL+G L +F S
Sbjct: 66 ---RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEY--MDHDLMGLLESGLVHF-----SE 115
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS-- 160
+ Q++ + + H K+FLHRDIK N L+ Q+ + DFGLA+ Y
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESR 172
Query: 161 --THQHIP--YRENKNLTGTARY 179
T++ I YR + L G RY
Sbjct: 173 PYTNKVITLWYRPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 69/281 (24%), Positives = 116/281 (41%), Gaps = 28/281 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQ-LLYESKLYRILQGGT 63
F++ +KIG G F E+Y T + + VA+K E + K Q + E L + L
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVH 120
I + F + + N+++ L + + ++ L +TV Q+ + VE +H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 121 SKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
S+ +HRDIKP N F+ G V + D GL + + +T H +L GT Y
Sbjct: 124 SRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPYY 172
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEKKVSTSI 237
S + + D+ SLG +L P+ G K + QK E+ + T
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT-- 230
Query: 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278
Y + C D +PD Y+ +I + + +
Sbjct: 231 ----EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 23/160 (14%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK-----------LYRILQGGT 63
+GSG+FG +Y + N + + L+ + +P + + I++
Sbjct: 8 LGSGAFGCVY-KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 64 GIPN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
PN VR++ +E D +VMDL+ G L + FN K + + + + QM+ +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 117 EFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
++H K +HRD+ P+N ++G ++V I DFGLAK+
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG- 72
+IG GSFGE+Y G + +T E VAIK+ +++ ++ + +L R++G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 73 -VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
++G ++M+ L G S DL L + + +++ ++++HS+ +HRDIK
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
N L+ V + DFG+A + DT ++ GT + + I+Q
Sbjct: 129 AANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---IKQ 175
Query: 191 SRRD---DLESLGYVLMYFLRGSLPWQGL 216
S D D+ SLG + +G P L
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 74/281 (26%), Positives = 123/281 (43%), Gaps = 45/281 (16%)
Query: 13 RKIGSGSFGEIYLGTNIQTNE---EVAIKL---ENVKTKHPQLLYESKLYRILQGGTGIP 66
+++G G+FG + G + + EVA+K E++ + L E+ + L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56
Query: 67 N-VRWFGV-EGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
VR GV +G+ +LVM+L LGP L+ L R++ + + LA Q+ + ++ SK
Sbjct: 57 CIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK 114
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK------KYRDTSTHQHIPYRENKNLTGT 176
F+HRD+ N L L R +Q I DFG+++ Y +T P +
Sbjct: 115 HFVHRDLAARNVL--LVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLK-------- 163
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
YA + G S + D+ S G V ++ F G+ P+ +K + + E
Sbjct: 164 -WYAPECINYGK-FSSKSDVWSYG-VTLWEAFSYGAKPYGEMKG----AEVIAMLESGER 216
Query: 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275
C P E S C R +D+P ++ L+ FR
Sbjct: 217 LPRPEEC---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 22/156 (14%)
Query: 13 RKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ---LLYESKLYRILQGGTGI 65
+++G G FG++ L T E+VA+K N + E ++ R L
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH---- 65
Query: 66 PN-VRWFGV-EGDYNV---LVMDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
N V++ GV E L+M+ L P SL D +++LK +L+ + Q+ +++
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYL-PSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ S+ ++HRD+ N L+ + V I DFGLAK
Sbjct: 125 LGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKLYRILQGGTGIPN- 67
R +G G+FGE L + + V K N+ + E + +LQ PN
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH----PNI 61
Query: 68 VRWFGVEGDYNVLVMDLL---GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKS 123
+ ++ D N L++++ G +L D +L + VL Q+++ V ++H
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
LHRDIK N + +A + + DFG++K + + + GT Y S
Sbjct: 122 ILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMA-------ETVVGTPYYMSPE 171
Query: 184 THLGIEQSRRDDLESLGYVL 203
G++ + + D+ +LG VL
Sbjct: 172 LCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 55/198 (27%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLEN----------------VKTKHPQ------ 48
KIG G++G +Y G N +T + VA I+LE+ + +HP
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 49 -LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
L+ ES+LY I + L MDL L+ L + + + V
Sbjct: 67 VLMQESRLYLI------------------FEFLSMDL-KKYLDSLPK--GQYMDAELVKS 105
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQH 164
Q++ + F HS+ LHRD+KP N L+ + + DFGLA+ + TH+
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 165 IP--YRENKNLTGTARYA 180
+ YR + L G+ RY+
Sbjct: 163 VTLWYRAPEVLLGSPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 22/159 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLLYESKLYRIL 59
NK+ + +G G++G + N T E VAIK E+VK L E K+ R L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT---ALREVKVLRQL 57
Query: 60 QGGTGIPNV----RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
+ N+ F +G LV + + +L +L L V Q++
Sbjct: 58 RH----ENIVNLKEAFRRKGRL-YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQA 112
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ + HS + +HRDIKP+N L+ + + + DFG A+
Sbjct: 113 IAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 22/182 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQL-LYESKLYRILQGGTGIPN-V 68
KIG G++G +Y + T E VA I+LE P + E L + L PN V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH----PNIV 61
Query: 69 RWFGV-EGDYNV-LVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFL 125
R V + + LV + L L+ + L + Q++ + + HS L
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKY----RDTSTHQHIP--YRENKNLTGTARY 179
HRD+KP N L+ R + + DFGLA+ + R T TH+ + YR + L G+ +Y
Sbjct: 122 HRDLKPQNLLID---REGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQY 177
Query: 180 AS 181
++
Sbjct: 178 ST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 48/236 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI-----PN 67
KIG G+FG++Y G ++ N EVA+K ++ P L + LQ + PN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK--TCRSTLPPDLKR----KFLQEAEILKQYDHPN 53
Query: 68 -VRWFGVEGDYN--VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
V+ GV +VM+L+ G SL +L++K +L ++ +E++ SK+
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK-----YRDTSTHQHIPYR----ENKNLT 174
+HRD+ N L+G N + I DFG++++ Y + + IP + E N
Sbjct: 114 CIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN-- 168
Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKI 228
RY S + D+ S G +L++ F G P+ G+ + +Q E+I
Sbjct: 169 -YGRYTSES-----------DVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGIPN-V 68
LG IG G FG++ LG ++VA+K L++ T L E+ + L+ PN V
Sbjct: 10 LGATIGKGEFGDVMLGD--YRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH----PNLV 63
Query: 69 RWFGV--EGDYNVLVMDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
+ GV +G+ +V + + SL D R ++L L A + +E++ K+F
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
+HRD+ N L+ + DFGLAK+
Sbjct: 124 VHRDLAARNVLVS---EDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 43/162 (26%), Positives = 80/162 (49%), Gaps = 22/162 (13%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKLYRIL--------QGG 62
+GSG++G + + + ++VA+K K P L++ + YR L +
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 63 TGIPNVRWFGVEG-DYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
G+ +V ++N LV +L+G L ++ +KLS + V L Q++ ++++
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYI 134
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
HS +HRD+KP N + ++ I+DFGLA++ D T
Sbjct: 135 HSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 53/182 (29%), Positives = 79/182 (43%), Gaps = 25/182 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGT 63
+ + L IG G+ +Y + NE+VAIK LE +T +L E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-- 58
Query: 64 GIPN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMIN 114
PN V+++ V GD LVM L G SL D+ + + TVL +++
Sbjct: 59 --PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLK 113
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
+E++HS +HRDIK N L+G V I DFG++ D + K
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTFV 167
Query: 175 GT 176
GT
Sbjct: 168 GT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 57/288 (19%)
Query: 14 KIGSGSFGEIYLG--TNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPN 67
++GSG+FG + G ++ + VA+K+ P +LL E+ + + L P
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN----PY 57
Query: 68 -VRWFGV-EGDYNVLVMDL--LGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS 121
VR G+ E + +LVM+L LGP L F ++ ++ K + L Q+ ++++
Sbjct: 58 IVRMIGICEAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------KYRDTSTHQHIPYRENKNL 173
+F+HRD+ N L+ Q Y I DFGL+K Y TH P +
Sbjct: 114 TNFVHRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----- 163
Query: 174 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKIS 229
YA MN + + S + D+ S G VLM+ F G P++G+K Q E
Sbjct: 164 ----WYAPECMNYY---KFSSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES-- 213
Query: 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
+++ + P E C + D++P +A ++ R+ +
Sbjct: 214 GERMECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 5e-08
Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 60/268 (22%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGGTG 64
F + +G+GSFG + L + + + A+K+ + VK K + + K RILQ
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEK--RILQ---- 56
Query: 65 IPNVR-------WFGVEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
++R + + D N+ LVM+ + G L + A Q++
Sbjct: 57 --SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLA 113
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENKNLT 174
+E++HS ++RD+KP+N L+ + I DFG AK+ + T T L
Sbjct: 114 LEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRTYT-----------LC 159
Query: 175 GTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEK 231
GT Y + + G ++ D +LG +L+Y L G P+ Q YEKI E
Sbjct: 160 GTPEYLAPEIILSKGYGKAV--DWWALG-ILIYEMLAGYPPF---FDDNPIQIYEKILEG 213
Query: 232 KVSTSIEALCRGYPTEFASYFHY-CRSL 258
KV F S+F + L
Sbjct: 214 KV-------------RFPSFFSPDAKDL 228
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-08
Identities = 29/149 (19%), Positives = 60/149 (40%), Gaps = 18/149 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG-GTGIPNVRWF 71
+ + G +YL +E+ +K+ + K E + ++L G +P V
Sbjct: 4 KLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 72 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127
G ++ L+M+ + G +L+ ++S + +A+Q+ + +H H
Sbjct: 62 GESDGWSYLLMEWIEGETLD--------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
D+ P N L+ + IID+ A
Sbjct: 114 DLHPGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 39/286 (13%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQG 61
PR RL K+G G FGE+++GT T VAIK T P+ L E+++ + L+
Sbjct: 4 PR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH 60
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ E Y V G L+ L + L L ++ +A Q+ + + +V
Sbjct: 61 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 122 KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
+++HRD++ N L+G N V + DFGLA+ D Y + ++
Sbjct: 121 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWT 170
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ L + + D+ S G +L +G +P+ G+ ++V +E
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE- 217
Query: 240 LCRGY----PTEFASYFH----YCRSLRFDDKPDYAYLKRIFRDLF 277
RGY P E H C +++P + YL+ D F
Sbjct: 218 --RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 7/159 (4%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES--KLYRILQGGTGIPNVRW 70
R+IG GSFG +Y +++TNE VAIK + K ++ K + LQ ++ +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 71 FG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
G + LVM+ S DL + L + + + + ++HS + +HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
IK N L+ QV + DFG A ++ PY
Sbjct: 151 IKAGNILL---TEPGQVKLADFGSASIASPANSFVGTPY 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 47/218 (21%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------KHPQLLYESKLYRILQGGTGI 65
IG G++G +Y G ++ T VA+K+ N+ T + LL + + +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ-------SQP 61
Query: 66 PNV-RWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN+ +++G ++G ++M+ G S+ L + ++ K + ++ +++ ++++H
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISVIIREVLVALKYIHK 119
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+HRDIK N L+ V + DFG+A S + GT + +
Sbjct: 120 VGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS-------SKRSTFVGTPYWMA 169
Query: 182 MNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
G + D+ SLG + G+ P+ + A
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 56/230 (24%), Positives = 96/230 (41%), Gaps = 41/230 (17%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI------ 65
G IG G++G +YL N+ T E +A+K + + P + R +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVK----QVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 66 ------PN-VRWFGVEG---DYNVLVMDLLGPSLEDLFNFCSR---KLSLKTVLMLADQM 112
N V++ G E ++ + + G S+ C R + + V +Q+
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGS----CLRTYGRFEEQLVRFFTEQV 117
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
+ + ++HSK LHRD+K DN L+ I DFG++KK D + +N +
Sbjct: 118 LEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDND-----QNMS 169
Query: 173 LTGT----ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+ G+ A + G S + D+ SLG V++ G PW +A
Sbjct: 170 MQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 20/181 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----LYESKLYRILQGGTGIPN-V 68
KIG G++G +Y N T E VA+K + T+ + + E L + L PN V
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH----PNIV 62
Query: 69 RWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFL 125
+ V N LV + L L+ + + L + Q++ + F HS L
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKY---RDTSTHQHIP--YRENKNLTGTARYA 180
HRD+KP N L+ + + DFGLA+ + T TH+ + YR + L G Y+
Sbjct: 123 HRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179
Query: 181 S 181
+
Sbjct: 180 T 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 17/219 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY----RILQGGTG 64
+RLG+ +G G+FG +YL + T E+A+K + P+ E ++L+
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 65 IPNVRWFGV-----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
V+++G E ++ + + G S++D L+ Q++ V ++
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGVSYL 122
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
HS +HRDIK N L V + DFG +K+ + + K++TGT +
Sbjct: 123 HSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGMKSVTGTPYW 175
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
S G R+ D+ S+G ++ L PW +A
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG- 72
+IG GSFGE++ G + +T + VAIK+ +++ ++ + +L +++G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 73 -VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
++G ++M+ L G +L+ L + + T+L +++ ++++HS+ +HRDI
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRDI 127
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE 189
K N L+ V + DFG+A + DT + GT + + I+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEV---IQ 174
Query: 190 QSRRD---DLESLGYVLMYFLRGSLP 212
QS D D+ SLG + +G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----LYESKLYRILQGGTGIPN-V 68
+IG G++G +Y + + VA+K V+T L + E L + L+ PN V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH-PNIV 65
Query: 69 RWFGV----EGDYNVLVMDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVH 120
R V D V + +DL + + L +T+ L Q + ++F+H
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
+ +HRD+KP+N L+ G QV + DFGLA+ Y
Sbjct: 126 ANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 44/175 (25%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKLYRIL 59
VG++++ IGSG++G + + ++ ++VAIK +V T + L E K+ R
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 60 QGGTGIPNV-------RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 112
+ N+ R G + +VMDL+ L + + L+ + + Q+
Sbjct: 62 KH----DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQL 116
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLAKKYRDTSTHQH 164
+ ++++HS + +HRD+KP N L+ N+ + I DFG+A+ +S +H
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMARGL-SSSPTEH 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 18/153 (11%)
Query: 13 RKIGSGSFGEI----YLGTNIQTNEEVAIKLENVKTKHPQLLYES--KLYRILQGGTGIP 66
R +G G FG++ Y N T E VA+K +K + Q K IL+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVK--TLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 67 NVRWFGV---EGDYNV-LVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHS 121
V++ G +G + L+M+ + L L ++ + KL+L +L+ A Q+ + ++HS
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYV--PLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++HRD+ N L+ V I DFGLAK
Sbjct: 126 QHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 50/167 (29%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQGGTGIPNVR 69
IG G++G + N +TNE+VAIK +N + + L E KL R L NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDH----ENV- 66
Query: 70 WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD------------------- 110
+ + D++ P + FN + + LM D
Sbjct: 67 ---------IAIKDIMPPPHREAFN----DVYIVYELMDTDLHQIIRSSQTLSDDHCQYF 113
Query: 111 --QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 154
Q++ ++++HS + LHRD+KP N L+ AN + I DFGLA+
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG- 72
KIG GSFGE++ G + +T + VAIK+ +++ ++ + +L +++G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 73 -VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
++ ++M+ L G S DL L + + +++ ++++HS+ +HRDIK
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
N L+ +V + DFG+A + DT ++ GT + + I+Q
Sbjct: 129 AANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---IKQ 175
Query: 191 SRRD---DLESLGYVLMYFLRGSLP 212
S D D+ SLG + +G P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLY-ESKLYRILQGGTGIPN-VRW 70
KIG GS G + + T+ T +VA+K ++ K + +LL+ E + R Q PN V
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH----PNIVEM 81
Query: 71 FG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
+ + GD +VM+ L G +L D+ +++ + + + ++ + F+H++ +HR
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 187
DIK D+ L+ +V + DFG + + +P R K+L GT + +
Sbjct: 140 DIKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPEVISR 189
Query: 188 IEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG +++ + G P+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 42/155 (27%), Positives = 80/155 (51%), Gaps = 10/155 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN- 67
F L ++IGSG++G++Y N+ T E AIK+ ++ + + ++ I+ N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI--IMMKDCKHSNI 68
Query: 68 VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
V +FG + D + M+ G SL+D+++ + LS + ++ + + + ++HSK
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIK N L+ V + DFG++ + T
Sbjct: 128 MHRDIKGANILL---TDNGHVKLADFGVSAQITAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 25/80 (31%), Positives = 42/80 (52%), Gaps = 8/80 (10%)
Query: 78 NVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 134
+VL+MD + DLF+ KLS V + Q++ + +H + +H DIK +N
Sbjct: 84 HVLIMDYIKDG---DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENV 140
Query: 135 LMGLGRRANQVYIIDFGLAK 154
L R +++Y+ D+GL K
Sbjct: 141 L--YDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 42/151 (27%), Positives = 67/151 (44%), Gaps = 19/151 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKLYRILQGGTGIPN 67
R+IG GSFG +Y +++TNE VAIK + K ++ E + + L+ PN
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH----PN 76
Query: 68 VRWFGVEGDY-----NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ +G Y LVM+ S D+ + L + + + + ++HS
Sbjct: 77 TIEY--KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+HRDIK N L+ V + DFG A
Sbjct: 135 ERIHRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 71/288 (24%), Positives = 121/288 (42%), Gaps = 47/288 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQG 61
PR +L +K+G+G FGE+++G + +VAIK + P+ L E+ L + LQ
Sbjct: 4 PR--ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 62 GTGIPNVRWFGV---EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
VR + V E Y + G ++ L KL++ ++ +A Q+ + F
Sbjct: 61 PR---LVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN--LTGT 176
+ K+++HRD++ N L+ I DFGLA+ D RE + T
Sbjct: 118 IERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTA----REGAKFPIKWT 170
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235
A A I + D+ S G +L + G +P+ G+ + +V
Sbjct: 171 APEAINYGTFTI----KSDVWSFGILLTEIVTYGRIPYPGM------------TNPEV-- 212
Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275
I+ L RGY P E C + +++P + YL+ + D
Sbjct: 213 -IQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 7/159 (4%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES--KLYRILQGGTGIPNVRW 70
R+IG GSFG +Y +++ +E VAIK + K ++ K R LQ +++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 71 FG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
G + LVM+ S DL + L + + + + ++HS + +HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
+K N L+ V + DFG A + PY
Sbjct: 141 VKAGNILL---SEPGLVKLGDFGSASIMAPANXFVGTPY 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 35/228 (15%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHP-----QLLYESKL 55
+RLG+ +G G+FGE+YL + T E+A+K E K + QLL +
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 56 YRILQGGTGIPNVRWFGV-----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
RI+Q ++G E ++ V + G S++D L+
Sbjct: 64 DRIVQ---------YYGCLRDPEEKKLSIFVEYMPGGSIKDQLK-AYGALTENVTRRYTR 113
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q++ V ++HS +HRDIK N L A V + DFG +K+ + +
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQTI----CMSGTGI 166
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
K++TGT + S G R+ D+ S+ ++ L PW +A
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 65/283 (22%), Positives = 119/283 (42%), Gaps = 37/283 (13%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQG 61
PR +L +K+G+G FGE+++GT N +VA+K T P+ L E+++ + L+
Sbjct: 4 PR--ESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRH 60
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ E Y V G L+ L + R L L ++ +A Q+ + ++
Sbjct: 61 DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+++HRD++ N L+G G I DFGLA+ D Y + ++ +
Sbjct: 121 MNYIHRDLRSANILVGDGLVCK---IADFGLARLIEDNE------YTARQGAKFPIKWTA 171
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
L + + D+ S G +L + +G +P+ G+ + ++V +E
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM------------NNREVLEQVE-- 217
Query: 241 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275
RGY P C +++P + YL+ D
Sbjct: 218 -RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 26/161 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQ--LLYESKLYRILQGG 62
K+ +G GS+G + + +T + VAIK LE+ K + + E ++ + L+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH- 59
Query: 63 TGIPNV--------RWFGVEGDYNVLVMDLLGPS-LEDLFNFCSRKLSLKTVLMLADQMI 113
+ N+ R + LV + + + L+DL + + L V Q++
Sbjct: 60 ENLVNLIEVFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQIL 110
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+EF HS + +HRDIKP+N L+ ++ V + DFG A+
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEE---VAIKL---ENVKTKHPQLLYESKLYRILQGGTG 64
LGR IG G FG++Y G + E VA+K + + L E+ + R
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH--- 66
Query: 65 IPN-VRWFGVEGDYNV-LVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFV 119
P+ V+ GV + V +VM+L L +L ++ L L ++++ + Q+ + ++
Sbjct: 67 -PHIVKLIGVITENPVWIVMELA--PLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
SK F+HRDI N L+ + V + DFGL++ D S
Sbjct: 124 ESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYLEDES 161
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 16/155 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTG 64
+L RK+G+G FGE++ G N T VA+K T P+ L E+++ + L+
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPKDFLAEAQIMKKLRH--- 60
Query: 65 IPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P ++ + V + +V +L+ G LE L R L L ++ +A Q+ + + ++
Sbjct: 61 -PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+++++HRD+ N L+G N + DFGLA+
Sbjct: 120 EAQNYIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 56/202 (27%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESK-LYRILQGGTGIPNVRW 70
R IG G+FG ++ T+ + + VA+K + NV Q L K ++R L+ + +
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF----QNLVSCKRVFRELK------MLCF 55
Query: 71 FGVEGDYNVL-VMDLLGPSLEDLFNFCSRKLSLKTVLMLAD------------------- 110
F + NVL +D+L P D F ++ + T LM +D
Sbjct: 56 FKHD---NVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVF 108
Query: 111 --QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYR-DTSTH---- 162
Q++ ++++HS LHRDIKP N L+ +N + I DFGLA+ D S H
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLARVEEPDESKHMTQE 164
Query: 163 ---QHIPYRENKNLTGTARYAS 181
Q+ YR + L G+ Y S
Sbjct: 165 VVTQY--YRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 22/219 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRILQGG 62
FR+ +KIG G F E+Y T + VA+K L + K + + E L + L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLNHP 62
Query: 63 TGIPNVRWFGVEGDYNVLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFV 119
I F + + N+++ L + F R + KTV Q+ + +E +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 120 HSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
HS+ +HRDIKP N F+ G V + D GL + + +T H +L GT
Sbjct: 123 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 171
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
Y S + + D+ SLG +L P+ G K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 39/154 (25%), Positives = 80/154 (51%), Gaps = 8/154 (5%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNV 68
+ L +++GSG++G++Y N+ T E A+K+ ++ L + +++ +++ V
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF-MVKECKHCNIV 69
Query: 69 RWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
+FG + + + M+ G SL+D+++ + LS + + + + + ++HSK +
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSKGKM 128
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
HRDIK N L+ V + DFG+A K T
Sbjct: 129 HRDIKGANILL---TDNGDVKLADFGVAAKITAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 50/202 (24%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLY-ESKLYRILQGGTGIPNVRWF 71
KIG GS G + + + +VA+K+ ++ K + +LL+ E + R Q + + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 72 GVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
V + VL+ L G +L D+ + +L+ + + + + ++ + ++HS+ +HRDIK
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 191
D+ L+ L R V + DFG + + +P R K+L GT + +
Sbjct: 146 DSILLTLDGR---VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPYG 195
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 47/274 (17%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LLYESKLYRILQGGTGIPN-V 68
+G G+FGE++ GT ++ VA+K K PQ L E+++ + PN V
Sbjct: 3 LGKGNFGEVFKGT-LKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDH----PNIV 55
Query: 69 RWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKS 123
+ GV + +VM+L+ D +F +K L K ++ A + ++ SK+
Sbjct: 56 KLIGVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR-ENKNLTGTAR 178
+HRD+ N L+G N + I DFG++++ D +S + IP + R
Sbjct: 114 CIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
Y+S D+ S G +L F G P+ G+ T +Q E++ EK S
Sbjct: 171 YSS-----------ESDVWSYGILLWETFSLGVCPYPGM---TNQQAREQV-EKGYRMSC 215
Query: 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271
C P + C + +++P ++ L++
Sbjct: 216 PQKC---PDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 21/170 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE---VAIKL---ENVKTKHPQLLYESKLYRILQGGTGIPN 67
K+G GSFG + G + + VA+K + + L E+ + L N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH----EN 57
Query: 68 -VRWFGVEGDYNV-LVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+R +GV + + +V +L LG L+ L + T+ A Q+ N + ++ SK
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
F+HRD+ N L+ ++V I DFGL + H Y ++L
Sbjct: 118 FIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH----YVMEEHL 160
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 60/248 (24%), Positives = 89/248 (35%), Gaps = 53/248 (21%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYESKLYRILQGGTGIPN-V 68
IG GSFG + + + K N+ K QL+ E + R L+ PN V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH----PNIV 62
Query: 69 RWFGVEGD------YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF---- 118
R++ D Y +VM+ DL + + + ++ I R+
Sbjct: 63 RYYDRIIDRSNQTLY--IVMEYCEGG--DLAQLIQKCKKERK--YIEEEFIWRILTQLLL 116
Query: 119 ---------VHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTS--THQHIP 166
+ LHRD+KP N FL N V + DFGLAK S ++
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSSFAKTYV- 171
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226
GT Y S + + D+ SLG ++ S P+ A + Q
Sbjct: 172 --------GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLAS 220
Query: 227 KISEKKVS 234
KI E K
Sbjct: 221 KIKEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKLYRILQG 61
NKF + +G G++G + + +T E VAIK EN + K L E K+ R L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTL-RELKMLRTLKQ 59
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ F G LV + + ++ +L + + V Q+I + + H
Sbjct: 60 ENIVELKEAFRRRGKL-YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
+HRDIKP+N L+ N V + DFG A+ + S + Y T Y
Sbjct: 119 NDIVHRDIKPENLLIS----HNDVLKLCDFGFARNLSEGSNANYTEY------VATRWYR 168
Query: 181 SMNTHLGIEQSRRDDLESLGYVL 203
S LG + D+ S+G +L
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 43/169 (25%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK----------------TKHPQLL 50
+L R IG G++G +Y + + E VA+K ++N + +HP ++
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
+L ++ G D LVM+ L L + S V L
Sbjct: 70 ---ELKEVVVGK-----------HLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKKY 156
Q++ ++++H +HRD+K N L+ G + I DFGLA+ Y
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGC------LKIADFGLARTY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 33/221 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKLYRILQG 61
F++ ++G G +G+++L T E VA+K +L E IL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERD---ILTT 57
Query: 62 GTGIPNVRW-----FGVEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
W + + D + L M+ + G L N LS +M
Sbjct: 58 T----KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLSEDHARFYMAEMFE 112
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
V+ +H ++HRD+KP+NFL+ + + + DFGL+K T+ + ++
Sbjct: 113 AVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSK---GIVTYAN-------SVV 159
Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
G+ Y + G D SLG +L FL G P+ G
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 28/210 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQ-LLYESKLYRILQG 61
F++ +KIG G F +Y + VA+K E + K Q L E L + L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 62 GTGIPNV-RWFGVEGDYNVLVMDLLGPSLEDL------FNFCSRKLSLKTVLMLADQMIN 114
PNV ++ + N L + L DL F R + +T+ Q+ +
Sbjct: 62 ----PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
+E +HSK +HRDIKP N + A V + D GL + + +T H +L
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH-------SL 166
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVL 203
GT Y S + + D+ SLG +L
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 28/167 (16%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKLYRILQGG 62
V +++R +++GSG++G + + +T +VAIK K P L+ + YR L+
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK----KLYRPFQSELFAKRAYRELR-- 66
Query: 63 TGIPNVRWFGVEGDYNV--------------LVMDLLGPSLEDLFNFCSRKLSLKTVLML 108
+ +++ V G +V LVM +G L L KLS + L
Sbjct: 67 -LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFL 123
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
QM+ ++++H+ +HRD+KP N + ++ I+DFGLA++
Sbjct: 124 VYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRD 158
Q++N V ++HS LHRD+KP N +MG G V I D GLA+ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 43/157 (27%), Positives = 82/157 (52%), Gaps = 14/157 (8%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGIPN-VRWF 71
K+G G +GE+Y G + + VA+K L+ + + L E+ + + ++ PN V+
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNLVQLL 68
Query: 72 GV---EGDYNVLVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHR 127
GV E + ++ + +L D C+R+ ++ +L +A Q+ + +E++ K+F+HR
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYR-DTSTHQ 163
D+ N L+G + V + DFGL++ DT T
Sbjct: 129 DLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 38/169 (22%), Positives = 71/169 (42%), Gaps = 49/169 (28%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----------------KHPQLL------- 50
+G G+FG++Y + +T A K+ +++ KHP ++
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
YE+KL+ +++ G G + ++++L E + R
Sbjct: 73 YENKLWILIEFCDG----------GALDSIMLELERGLTEPQIRYVCR------------ 110
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
QM+ + F+HS +HRD+K N L+ L V + DFG++ K + T
Sbjct: 111 QMLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKST 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 45/160 (28%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEE--VAIK-LENVKTKH---PQLLYESKLYRILQGG 62
+ L +++G G++G + N +T+EE VAIK + NV +K + L E KL R +G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 63 TGIPN------VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
I V Y L +L+ L + + L+ Q++ +
Sbjct: 62 KNITCLYDMDIVFPGNFNELY--LYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGL 118
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
+++HS + LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 12/176 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLYESKLYRILQGGTGIPNVRW 70
K+G G++ +Y G + T+ VA I+LE+ + + E L + L+ +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 71 FGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
E LV + L L+ + C +++ V + Q++ + + H + LHRD+K
Sbjct: 73 IHTEKSLT-LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 131 PDNFLMGLGRRANQVYIIDFGLAK-KYRDTSTHQH----IPYRENKNLTGTARYAS 181
P N L+ ++ + DFGLA+ K T T+ + + YR L G+ Y++
Sbjct: 132 PQNLLIN---ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 75/288 (26%), Positives = 127/288 (44%), Gaps = 63/288 (21%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE--VAIKL---ENVKTKHPQLLYESKLYRILQGGTGIPN- 67
++GSG+FG + G ++ VAIK+ EN K+ +++ E+++ L P
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN----PYI 57
Query: 68 VRWFGV-EGDYNVLVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
VR GV E + +LVM++ GP L F S K +++ V+ L Q+ ++++
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------KYRDTSTHQHIPYRENKNL 173
K+F+HRD+ N L+ NQ Y I DFGL+K Y + P +
Sbjct: 114 KNFVHRDLAARNVLL-----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK----- 163
Query: 174 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231
YA +N + S R D+ S G + W+ G K Y+K+
Sbjct: 164 ----WYAPECINFR---KFSSRSDVWSYGITM---------WEAFSYGQK--PYKKMKGP 205
Query: 232 KVSTSIEALCR-----GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274
+V + IE R P E + C +++D+P++A ++ R
Sbjct: 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 27/169 (15%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKLYRILQ-- 60
+G+++ R +G GS G ++ + ++ VA+K + L E K+ R L
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHD 62
Query: 61 ---------GGTGIPNVRWFGVEGDYNVL--VMDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
G +G G + N + V + + L ++ LS + +
Sbjct: 63 NIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFM 120
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ----VYIIDFGLAK 154
Q++ ++++HS + LHRD+KP N + N + I DFGLA+
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 47/180 (26%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQGG 62
++++ IG GS+G + + T E+VAIK E+V ++L E KL R+L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDAT-RILREIKLLRLLRH- 58
Query: 63 TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFN-----FCSRKLSLKTVLMLAD------- 110
P++ V + ++ P F F + L V+ D
Sbjct: 59 ---PDI----------VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH 105
Query: 111 -----QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK-KYRDTST 161
Q++ ++++H+ + HRD+KP N L AN ++ I DFGLA+ + DT T
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLARVAFNDTPT 159
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 41/155 (26%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLY-ESKLYRILQGGTGIP 66
+GSG++G++ + +T +VAIK ++ H + Y E +L + + I
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIG 78
Query: 67 NVRWF----GVEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ F +E +V LV L+G L ++ +KLS + L Q++ ++++HS
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHS 136
Query: 122 KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKK 155
+HRD+KP N + + ++ I+DFGLA+
Sbjct: 137 AGIIHRDLKPSN----IAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 46/179 (25%), Positives = 85/179 (47%), Gaps = 18/179 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLYESKLYRILQGGTGIPNVRW 70
K+G G++ ++ G + T VA I+LE+ + + E L + L+ N+
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA----NIVT 68
Query: 71 FG--VEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
V D ++ LV + L L+ + C +S+ V + Q++ + + H + LHR
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK-KYRDTSTHQH----IPYRENKNLTGTARYAS 181
D+KP N L+ ++ + DFGLA+ K T T+ + + YR L G++ Y++
Sbjct: 129 DLKPQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 23/153 (15%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKLYRIL--------QGGTG 64
+GSG++G + + +T E+VAIK K P ++ + YR L + G
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 65 IPNVRWFGVEGD--YNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ +V V GD + LVM + DL LS V L QM+ ++++HS
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYM---QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+HRD+KP N + ++ I+DFGLA+
Sbjct: 136 AGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 47/172 (27%), Positives = 74/172 (43%), Gaps = 35/172 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVK---TKHPQLLYESK 54
PR N G+ +G+G+FG++ T +VA+K+ ++ L+ E K
Sbjct: 33 PR--NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSL--------EDLFNFCSRK----LSL 102
+ L I N+ G GP L DL NF RK L+L
Sbjct: 91 IMSHLGNHENIVNLLGACTIG----------GPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ +L + Q+ + F+ SK+ +HRD+ N L+ G+ I DFGLA+
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK---ICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 5e-06
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 23/222 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-------LLYESKLYRILQG 61
+R G+ +G G+FG +YL ++ T E+A K + P+ L E +L + LQ
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 62 GTGIPNVRWFGVEGDY-----NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
V+++G D + + + G S++D L+ Q++ +
Sbjct: 64 ER---IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK-AYGALTESVTRKYTRQILEGM 119
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
++HS +HRDIK N L A V + DFG +K+ + + +++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTIC----MSGTGIRSVTGT 172
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+ S G R+ D+ SLG ++ L PW +A
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 26/219 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
++ + +KIG GSFG+IYL +E IK ++ + SK IL PN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 68 VRWFGVEGDYN---VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN-------RVE 117
+ F N +VM+ DL +R+ + VL DQ+++ ++
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGG--DLMKRINRQ---RGVLFSEDQILSWFVQISLGLK 115
Query: 118 FVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
+H + LHRDIK N FL G A + DFG+A++ D+ GT
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQLNDSMELA-------YTCVGT 165
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
Y S + + D+ SLG VL P++G
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 64/247 (25%), Positives = 100/247 (40%), Gaps = 40/247 (16%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
K LG IG G FG + G T ++VA+K L E+ + L
Sbjct: 7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKN---L 61
Query: 68 VRWFGV---EGDYNVLVMDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVH 120
VR GV G Y +VM+L+ S +L NF + +S+ +L + + +E++
Sbjct: 62 VRLLGVILHNGLY--IVMELM--SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK +HRD+ N L+ + DFGLA+ + +P + TA A
Sbjct: 118 SKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEA 168
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
+ S + D+ S G +L W+ G + Y K+S K+V +E
Sbjct: 169 LKHKKF----SSKSDVWSYGVLL---------WEVFSYG--RAPYPKMSLKEVKECVEKG 213
Query: 241 CRGYPTE 247
R P E
Sbjct: 214 YRMEPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139
LVM+L+ +L + + +L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 103 LVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 156
Query: 140 RRANQVYIIDFGLAKKYRDTSTH-QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLES 198
+ + I+DFGLA R T+ PY T Y + LG+ D+ S
Sbjct: 157 KSDCTLKILDFGLA---RTACTNFMMTPY------VVTRYYRAPEVILGMGYKENVDIWS 207
Query: 199 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246
+G ++ ++GS+ +QG ++ K+ E+ + S E + R PT
Sbjct: 208 VGCIMGELVKGSVIFQGTD---HIDQWNKVIEQLGTPSAEFMNRLQPT 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 69/292 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LEN----VKTKHPQLL 50
++ L ++IGSG FG ++LG +VAIK +E +K HP+L+
Sbjct: 4 SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLV 62
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
+LY + + I V F G L D K S +T+L +
Sbjct: 63 ---QLYGVCTERSPICLVFEFMEHG------------CLSDYLRAQRGKFSQETLLGMCL 107
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRD----TSTHQHI 165
+ + ++ S + +HRD+ N L+G NQV + DFG+ + D +ST
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163
Query: 166 PYR-ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
P + + + ++Y+S + D+ S G VLM W+ G K
Sbjct: 164 PVKWSSPEVFSFSKYSS-----------KSDVWSFG-VLM--------WEVFSEG--KTP 201
Query: 225 YEKISEKKVSTSIEALCRGYPTEFAS-----YFHYCRSLRFDDKPDYAYLKR 271
YE S +V +I A R Y AS +C R +D+P ++ L
Sbjct: 202 YENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES-KLYRILQGGTGIPN 67
F++ +K+G GS+G +Y + N+ A+K ++ + + ++ RIL PN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PN 60
Query: 68 VRWFG---VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL------MLADQMINRVEF 118
+ + ++G+ +VM+ DL S++ + ++ + Q++ ++
Sbjct: 61 IISYKEAFLDGNKLCIVMEY--APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
+H + LHRD+K N L AN + I D G++K + K GT
Sbjct: 119 LHEQKILHRDLKSANIL----LVANDLVKIGDLGISKVLKKNMA---------KTQIGTP 165
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
Y + G S + D+ SLG +L + P++
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 35/228 (15%)
Query: 11 LGRKIGSGSFGEIYLGT--NIQ-TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
L R++G G+FG+++L N+ T +++ + ++ +K P L R + T + +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQH 66
Query: 68 ---VRWFGVEGDYNVLVM--------DL------LGPSLEDLFNFCSRK----LSLKTVL 106
V+++GV GD + L+M DL GP L + R+ L L +L
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
+A Q+ + + ++ S+ F+HRD+ N L+G V I DFG++ RD + +
Sbjct: 127 HIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYSTDY-- 178
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
YR + R+ + + + + D+ S G +L F G PW
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 56/234 (23%), Positives = 95/234 (40%), Gaps = 22/234 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN---VKTKHPQLLYESKLYRILQGGTGI 65
F + + IG G+FGE+ + ++ A+K+ N + + + + ++ G
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 66 PNVRWFGVEGDYNV-LVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + + N+ LVMD +G L L + +L +M+ ++ VH
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
++HRDIKPDN LM + + + DFG K + T Q + GT Y S
Sbjct: 123 YVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYISPE 173
Query: 184 THLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+E + D SLG + L G P+ A + + Y KI K
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 44/179 (24%), Positives = 83/179 (46%), Gaps = 18/179 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLYESKLYRILQGGTGIPNVRW 70
K+G G++ ++ G + T VA I+LE+ + + E L + L+ N+
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA----NIVT 67
Query: 71 FG--VEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
+ + + LV + L L+ + C +S+ V + Q++ + + H + LHR
Sbjct: 68 LHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK-KYRDTSTHQH----IPYRENKNLTGTARYAS 181
D+KP N L+ ++ + DFGLA+ K T T+ + + YR L G+ Y++
Sbjct: 128 DLKPQNLLIN---EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGIPN-V 68
++G+G+ G + + T + +A+K LE + Q+L E IL P V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRE---LDILHKCNS-PYIV 62
Query: 69 RWFG---VEGDYNVLV--MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK- 122
++G GD ++ + MD G SL+ + ++ + + +A ++ + ++H K
Sbjct: 63 GFYGAFYNNGDISICMEYMD--GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
+HRD+KP N L+ Q+ + DFG++ + ++ K GT+ Y +
Sbjct: 121 KIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAP 168
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
G + S + D+ SLG L+ G P+
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 9e-06
Identities = 48/213 (22%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKLYRI-LQGGTGIP 66
G+++G+G+F Y +++T +A+K + N ++ ++ E+ I L P
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEV-VEALRKEIRLMARLNHP 63
Query: 67 N-VRWFGV---EGDYNVLVMDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ +R G + +N+ V + G S+ L + + K ++ ++ +Q++ + ++H
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV--IINYTEQLLRGLSYLHE 121
Query: 122 KSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
+HRD+K N L+ G+R + I DFG A + T L GT +
Sbjct: 122 NQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EFQGQLLGTIAFM 175
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ G + R D+ S+G V++ PW
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 52/192 (27%), Positives = 83/192 (43%), Gaps = 32/192 (16%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVR 69
KIG G++G++Y + T + VA+K ++ P L E L ++L I VR
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI--VR 65
Query: 70 WFGVE------GDYNV-LVMDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEF 118
VE G ++ LV + L L+ + R L KT+ Q++ V
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA-------KKYRDTSTHQHIP--YRE 169
H +HRD+KP N L + ++ + I D GL K Y TH+ + YR
Sbjct: 126 CHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVKSY----THEIVTLWYRA 179
Query: 170 NKNLTGTARYAS 181
+ L G+ Y++
Sbjct: 180 PEVLLGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 28/163 (17%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--QLLYESKLYRILQGGTGIPNVRWFG 72
+GSG++G + + +T VA+K K P +++ + YR L+ + +++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRL---LKHMKHEN 77
Query: 73 VEGDYNV--------------LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
V G +V LV L+G L ++ +KL+ V L Q++ +++
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKY 135
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
+HS +HRD+KP N + ++ I+DFGLA+ D T
Sbjct: 136 IHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 175
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 37/159 (23%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQ----LLYES------KLYR 57
IG G+FGE+ L T A+K LE + H + +L E+ KLY
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY 68
Query: 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINR 115
Q + +Y L+M+ L P D+ +K + + + I
Sbjct: 69 SFQ-------------DENYLYLIMEYL-PG-GDMMTLLMKKDTFTEEETRFYIAETILA 113
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++ +H ++HRDIKPDN L+ + + DFGL
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 41/218 (18%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKL------ENVKTKHPQLLYESKLYRILQGGTGI 65
+IGSG+ G +Y + T A+K+ + V+ Q+ E ++ R
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR---QICREIEILR----DVNH 131
Query: 66 PNV----RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PNV F G+ VL+ + G SLE + L+ +A Q+++ + ++H
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHR 186
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+ +HRDIKP N L+ + V I DFG+++ T P + GT Y S
Sbjct: 187 RHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMD----PCNSS---VGTIAYMS 236
Query: 182 ---MNTHLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
+NT L D D+ SLG ++ F G P
Sbjct: 237 PERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 55/238 (23%), Positives = 88/238 (36%), Gaps = 33/238 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY------RILQ 60
F + +G G FGE+ + T + A+K K LL + + IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMK----VMKKSVLLAQETVSFFEEERDILS 56
Query: 61 GGTG--IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
IP +++ + D LVM+ G L L N + +++ +
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGT 176
VH ++HRDIKP+N L+ R + + DFG A + + + +P GT
Sbjct: 117 SVHQMGYVHRDIKPENVLID---RTGHIKLADFGSAARLTANKMVNSKLP-------VGT 166
Query: 177 ARY------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
Y +MN D SLG + + G P+ GT + Y I
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH---EGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 56/191 (29%), Positives = 78/191 (40%), Gaps = 47/191 (24%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLLYES------K 54
+ IG G+FGE+ L + TN A+K +VK + +L E+ K
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAER-DILAEADNEWVVK 65
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL---GPSLEDLFNFCSRKLSLKTVLMLADQ 111
LY Q + V + GD +M LL G EDL F +L+
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGD----MMSLLIRLGIFEEDLARFYIAELTCA-------- 113
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
+E VH F+HRDIKPDN L+ R + + DFGL +R TH Y++
Sbjct: 114 ----IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR--WTHDSKYYQKG- 163
Query: 172 NLTGTARYASM 182
R SM
Sbjct: 164 ---DHHRQDSM 171
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 57/227 (25%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-------LEN--------------VKTKHPQLLYES 53
+G GSFG++ L TNE AIK LE+ + +HP L +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL---T 59
Query: 54 KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQ 111
L+ Q ++ VM+ L G L +F+ S + A +
Sbjct: 60 HLFCTFQ-------------TKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAE 104
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
+I ++F+H K ++RD+K DN L+ + + I DFG+ K +++ E K
Sbjct: 105 IICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCK--------ENM-NGEGK 152
Query: 172 NLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
T GT Y + G + + D S G VL+Y L G P+ G
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 39/148 (26%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYES-KLYRILQGGTGIPNVRWFG 72
+G G++G +Y ++ T +AIK + +++ Q L+E L+ L+ V++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN---IVQYLG 72
Query: 73 --VEGDYNVLVMDLL-GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
E + + M+ + G SL L + K + +T++ Q++ ++++H +HR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKK 155
DIK DN L + + V I DFG +K+
Sbjct: 133 DIKGDNVL--VNTYSGVVKISDFGTSKR 158
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 13 RKIGSGSFGEIYL------GTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
R +G G FG++ L G N T E+VA+K ++ + K IL+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 67 NVRWFGV---EGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V++ G+ +G + L+M+ L SL++ K++LK L A Q+ ++++ S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ ++HRD+ N L+ +QV I DFGL K
Sbjct: 128 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 63/242 (26%), Positives = 98/242 (40%), Gaps = 46/242 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQ-LLYESKLYRILQGGT 63
F +G +G+GSFG + + + T E AIK E +K K Q + E + L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 64 GIPNVRWFGVEGDYNVLVMDLLGPSL-----------EDLFNFCSRKLSLKTVLMLADQM 112
+ + F E L+ ++G L D+ F +L L
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--------- 130
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENK 171
E++HSK ++RD+KP+N L L + + V + DFG AKK D T T
Sbjct: 131 ---FEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTFT---------- 174
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231
L GT Y + + D ++G +L F+ G P+ T + YEKI
Sbjct: 175 -LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAG 230
Query: 232 KV 233
++
Sbjct: 231 RL 232
|
Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 9/146 (6%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK--HPQLLYESKLYRILQGGTGIPNV 68
+ +G G+FG + + T + VAIK ++ T + E KL + L+ I
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 69 RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
F + V +LLG L L SR L + + Q++ +++VHS +HRD
Sbjct: 76 DIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
+KP N L+ + I DFGLA+
Sbjct: 134 LKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 40/163 (24%), Positives = 65/163 (39%), Gaps = 44/163 (26%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---------------LENVKT----KHPQL--LYE 52
KIG GS+G ++ N +T + VAIK L ++ KHP L L E
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 53 S-KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
+ R L LV + ++ + R + + + Q
Sbjct: 68 VFRRKRKLH-------------------LVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ 108
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ V F H + +HRD+KP+N L+ + Q+ + DFG A+
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 69/284 (24%), Positives = 118/284 (41%), Gaps = 48/284 (16%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGIPNV 68
+L +K+G+G FGE+++G + +VA+K T Q L E+ L + LQ V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDK---LV 64
Query: 69 RWFGV----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
R + V E Y + G L+ L + K+ L ++ + Q+ + ++ K++
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN--LTGTARYASM 182
+HRD++ N L+ + I DFGLA+ D RE + TA A
Sbjct: 125 IHRDLRAANVLVS---ESLMCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAIN 177
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
I + D+ S G +L+Y + G +P+ G+ S + AL
Sbjct: 178 FGSFTI----KSDVWSFG-ILLYEIVTYGKIPYPGMSN---------------SDVMSAL 217
Query: 241 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
RGY P E C + +++P + YL+ + D
Sbjct: 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 46/165 (27%), Positives = 70/165 (42%), Gaps = 35/165 (21%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLLYES------K 54
+ +G G+FGE+ L + T A+K + +VK + +L E+ +
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAER-DILAEADNEWVVR 65
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
LY Q + V + GD L++ + G EDL F ++
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARF------------YIAELTC 112
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
VE VH F+HRDIKPDN L+ R + + DFGL +R T
Sbjct: 113 AVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 54/219 (24%), Positives = 85/219 (38%), Gaps = 27/219 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGGTG 64
F + + IG G+FGE+ + T A+K+ N +K E + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 65 IPNVRWFGVEGDYNVLVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I + + + +Y LVMD +G L L + +L +M+ + +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
++HRDIKPDN L+ + + + DFG K T Q + GT Y S
Sbjct: 123 YVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGTVQ------SSVAVGTPDYISPE 173
Query: 184 THLGIEQSRRD---------DLESLGYVLMYFLRGSLPW 213
I Q+ D D SLG + L G P+
Sbjct: 174 ----ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 40/168 (23%), Positives = 63/168 (37%), Gaps = 49/168 (29%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------ENVKTKHPQ 48
K+G G++ +Y G N T E VA+K EN+ H
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLML 108
+ E+KL + + ++ D MD G L TV
Sbjct: 67 IHTENKLMLVFEY-----------MDKDLKKY-MDTHGVR---------GALDPNTVKSF 105
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
Q++ + F H LHRD+KP N L+ + ++ + DFGLA+ +
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 46/202 (22%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKLYRILQGGTGIPNVRWFG 72
KIG GS G + + T T ++VA+K ++ K + +LL+ + + ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
+ GD +VM+ L G +L D+ +++ + + + ++ + ++H++ +HRDIK
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS 191
D+ L+ R + + DFG + + +P R K+L GT + + +
Sbjct: 147 DSILLTSDGR---IKLSDFGFCAQ-----VSKEVPKR--KSLVGTPYWMAPEVISRLPYG 196
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 34/145 (23%), Positives = 70/145 (48%), Gaps = 7/145 (4%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV 73
++G G+FG++Y N +T A K+ K++ Y ++ IL V+ G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI-EILATCNHPYIVKLLGA 77
Query: 74 ---EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
+G +++ G +++ + R L+ + ++ QM+ ++++HS +HRD+K
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKK 155
N L+ L + + DFG++ K
Sbjct: 138 AGNVLLTLD---GDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 37/152 (24%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGTG 64
+ + + IG G+FGE+ L + T + A+KL E +K +E +
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS 123
+ + + + Y +VM+ + DL N S + K +++ ++ +HS
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
F+HRD+KPDN L+ ++ + + DFG K
Sbjct: 163 FIHRDVKPDNMLLD---KSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 116 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAK------------KYRDTSTH 162
+E++H+ +HRD+KPDN L+ +G + + DFGL+K + + T
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ + +K + GT Y + L + D ++G +L FL G +P+ G
Sbjct: 170 EFL----DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 40/170 (23%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQG 61
P + + + IG G++G+++ N + + A+K L+ + ++ E Y IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAE---YNILKA 70
Query: 62 GTGIPNV-RWFG-------VEGDYNVLVMDLL-GPSLEDLFN-FCSR--KLSLKTVLMLA 109
+ PNV +++G GD LV++L G S+ DL F R ++ + +
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ + ++ +H +HRD+K +N L+ V ++DFG++ + T
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTST 177
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 39/280 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGIPN 67
+L +K+G+G FGE+++ T + +VA+K + + L E+ + + LQ +
Sbjct: 8 LKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 68 VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
E Y + G L+ L + K L ++ + Q+ + F+ ++++HR
Sbjct: 67 HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN--LTGTARYASMNTH 185
D++ N L+ + I DFGLA+ D RE + TA A
Sbjct: 127 DLRAANILVS---ASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAINFGS 179
Query: 186 LGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244
I + D+ S G +LM + G +P+ G+ I AL RGY
Sbjct: 180 FTI----KSDVWSFGILLMEIVTYGRIPYPGMSN---------------PEVIRALERGY 220
Query: 245 --------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
P E + C R +++P + Y++ + D
Sbjct: 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 61/284 (21%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPN-V 68
+++GSG FG ++LG + +VAIK+ + E+K+ L PN V
Sbjct: 8 FLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH----PNLV 62
Query: 69 RWFGVEGDYN--VLVMDLLGPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS 123
+ +GV +V + + + L N+ KL + +L + + +E++ S
Sbjct: 63 QLYGVCTKQRPIFIVTEYM--ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQHIPYRENKNLTGT---A 177
F+HRD+ N L+G N V + DFGLA+ D TS+ GT
Sbjct: 121 FIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSS------------QGTKFPV 165
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
++A S + D+ S G VLM+ F G +P YE+ S +V
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFG-VLMWEVFSEGKMP------------YERFSNSEV-- 210
Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKR 271
+E++ GY PTE + + C + +D+P + L
Sbjct: 211 -VESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 39/268 (14%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----LYESKLYRILQGGTGIPNVR 69
+IG G+FGE++ G N VA+K +T P L L E+ RIL+ + VR
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK-SCRETLPPDLKAKFLQEA---RILKQYSHPNIVR 57
Query: 70 WFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
GV + +VM+L+ G +L +K ++ + + +E++ SK +H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKK-----YRDTSTHQHIPYR-ENKNLTGTARYA 180
RD+ N L+ N + I DFG++++ Y T + IP + RY+
Sbjct: 118 RDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 181 SMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
S D+ S G +L F G++P+ L + +Q E I E+ V
Sbjct: 175 S-----------ESDVWSFGILLWEAFSLGAVPYANL---SNQQTREAI-EQGVRLPCPE 219
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYA 267
LC P C +P ++
Sbjct: 220 LC---PDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 61/246 (24%), Positives = 94/246 (38%), Gaps = 62/246 (25%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT--NIQTNE---EVAIKLENVK---TKHPQLLYESKLYRI 58
K L R++G GSFG +Y G + E VAIK N + + L E+ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS---V 62
Query: 59 LQGGTGIPNVRWFGV--EGDYNVLVMDLLG-----------------------PSLEDLF 93
++ VR GV G ++VM+L+ P+L+
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ +AD M ++ +K F+HRD+ N ++ V I DFG+
Sbjct: 123 QMAAE---------IADGM----AYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT 166
Query: 154 KKYRDTSTHQHIPYR-ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL--MYFLRGS 210
RD + YR K L A + G+ + + D+ S G VL M L
Sbjct: 167 ---RDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATL-AE 219
Query: 211 LPWQGL 216
P+QGL
Sbjct: 220 QPYQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 37/173 (21%)
Query: 9 FRLGRKIGSGSFG---EIYLGTNIQTNEEVAIKL----------------ENVKTK---H 46
F LGR +G G FG E L + + ++VA+K+ E K H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 47 PQL--LYESKLYRILQGGTGIPNVRW-FGVEGD-YNVLVMDLLGPSLEDLFNFCSRKLSL 102
P + L L +G IP V F GD + L+M +G E+ F L L
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG---EEPFT-----LPL 112
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
+T++ + + +E++ SK+F+HRD+ N ++ V + DFGL+KK
Sbjct: 113 QTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 23/222 (10%)
Query: 2 EPRVGNK-----FRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK-LENVKT-KHPQLLYES 53
EP+ NK F R +G+GSFG + L T + VAIK E K K Q+ +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF 79
Query: 54 KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL--MLADQ 111
+IL V +G D + L + L + F F R + A Q
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
++ E++ S + ++RD+KP+N L+ + + + DFG AK DT T+
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVV-DTRTY--------- 186
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
L GT Y + L + + D +LG + L G P+
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 42/193 (21%), Positives = 65/193 (33%), Gaps = 40/193 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG 72
+++ G+ +YLG EVA+K+ + L E+K+ IL G P V ++G
Sbjct: 28 KELAKGTTSVVYLGE--WRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG 85
Query: 73 VEGDYNVLVMD-LLGPSLEDLFNFCSRKLSLKTV---LMLADQMINRVEFVHSKSFLHRD 128
+ + M+ + G L L RK L+ + L I E +
Sbjct: 86 ----EDFIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNV--- 138
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI 188
+ D VYIIDF A + N+T L
Sbjct: 139 LVND----------RDVYIIDFDSATFKKKPR-----------NVTQALSL------LFR 171
Query: 189 EQSRRDDLESLGY 201
E R + GY
Sbjct: 172 EGLRIEKTILRGY 184
|
Length = 201 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 48/181 (26%), Positives = 82/181 (45%), Gaps = 42/181 (23%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLY--RILQG 61
VG +++ IG G++G + T+ T +VAIK K P +E + + R L+
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK------KISP---FEHQTFCQRTLRE 53
Query: 62 GTGIPNVRWFGVEGDYNVL-VMDLLGPSLEDLFN----------------FCSRKLSLKT 104
I +R F E N++ ++D++ P + FN ++ LS
Sbjct: 54 ---IKILRRFKHE---NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH 107
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQ 163
+ Q++ ++++HS + LHRD+KP N L+ N + I DFGLA+ H
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDFGLARI--ADPEHD 161
Query: 164 H 164
H
Sbjct: 162 H 162
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 46/172 (26%), Positives = 76/172 (44%), Gaps = 33/172 (19%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-LENVKTKHPQL--LYESKLYRILQG 61
L R +G G+FGE+Y G + + VA+K L ++ + L E+ ++
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA----LIMS 64
Query: 62 GTGIPN-VRWFGVEGDYN--VLVMDLLGPSLEDLFNFC---------SRKLSLKTVLMLA 109
N VR GV + ++++L+ DL +F L++K +L A
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGG--DLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKK-YR 157
+ +++ F+HRDI N L+ G GR A I DFG+A+ YR
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 50/154 (32%), Positives = 78/154 (50%), Gaps = 23/154 (14%)
Query: 15 IGSGSFGEI----Y--LGTNIQTNEEVAIK-LENVKTKHPQ-LLYESKLYRILQGGTGIP 66
+G G+FG + Y L N T E VA+K L++ +H + E ++ + LQ
Sbjct: 12 LGKGNFGSVELCRYDPLQDN--TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN--- 66
Query: 67 NVRWFGV---EGDYNV-LVMDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
V++ GV G N+ LVM+ L P SL D +L + +L+ A Q+ +E++
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
SK ++HRD+ N L+ N+V I DFGL K
Sbjct: 126 SKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 35/170 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLLYES------K 54
+ +G G+FGE+ L + T+ A+K + +VK + +L E+ K
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAER-DILAEADNEWVVK 65
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
LY Q + V + GD L++ + E L F +L+L
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLA----------- 113
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
+E VH F+HRDIKPDN L+ L + + DFGL +R T ++
Sbjct: 114 -IESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFRWTHNSKY 159
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 35/159 (22%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGIPNVRWF 71
IG G+FG + + + +A+K + + +LL + L +++ V+++
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMD--LDVVMRSSDCPYIVKFY 69
Query: 72 GV---EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR-------VEFVHS 121
G EGD + M+L+ SL+ + K V + +I V V +
Sbjct: 70 GALFREGDCWI-CMELMDISLDKFY---------KYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 122 KSFL-------HRDIKPDNFLMGLGRRANQVYIIDFGLA 153
++L HRD+KP N L L R N + + DFG++
Sbjct: 120 LNYLKEELKIIHRDVKPSNIL--LDRNGN-IKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 56/225 (24%), Positives = 88/225 (39%), Gaps = 49/225 (21%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKL---------ENVKT------------KHPQLLY 51
+ +G GSFG+++L TN+ AIK ++V+ +HP L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-- 58
Query: 52 ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 110
+ LY Q + VM+ L G L C K L A
Sbjct: 59 -THLYCTFQTKENL-------------FFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAA 103
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
++I ++F+HSK ++RD+K DN L+ + I DFG+ K+ + +
Sbjct: 104 EIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKE-------NMLGDAKT 153
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
GT Y + LG + + D S G +L L G P+ G
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 8/160 (5%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLLYESKLYRILQGGTG 64
F + + IG G+FGE+ + T + A+K+ N +K E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 65 IPNVRWFGVEGDYNVLVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I N+ + + + LVMD +G L L + +L +M+ ++ VH
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
++HRDIKPDN L+ + + + DFG + T Q
Sbjct: 123 YVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLADGTVQ 159
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 14/109 (12%)
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
A +++ ++F+HSK ++RD+K DN ++ R + I DFG+ K+ +
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCKEN---------VFG 149
Query: 169 ENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+N+ T GT Y + G++ + D S G +L L G P+ G
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 38/156 (24%), Positives = 73/156 (46%), Gaps = 16/156 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE-VAIKLENVKTKHPQL----LYESKLYRILQGGTGIPNV 68
+IG G++G+++ +++ VA+K V+T + + E + R L+ V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 69 RWFGV----EGDYNVLVMDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVH 120
R F V D + + +DL + + + +T+ + Q++ ++F+H
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
S +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 128 SHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 50/191 (26%), Positives = 74/191 (38%), Gaps = 43/191 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLLYES- 53
F + IG G+FGE+ L T + A+K L +VK + +L ES
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAER-DVLAESD 59
Query: 54 -----KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVL 106
LY Q + Y L+M+ L G + L + S
Sbjct: 60 SPWVVSLYYSFQ-------------DAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTR 104
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
+ + +E VH F+HRDIKPDN L+ R + + DFGL+ + H
Sbjct: 105 FYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFH--KQHDSAY 159
Query: 167 YRENKNLTGTA 177
Y+ K L G +
Sbjct: 160 YQ--KLLQGKS 168
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLY---------ESK-LYRILQGGT 63
I G+ EIYLG + + IK K +HP+L E++ + R + G
Sbjct: 4 IKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61
Query: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+P V + E ++VM+ + G L+DL N S + + +++ ++ HS
Sbjct: 62 NVPAVYFVDPENF--IIVMEYIEGEPLKDLIN--SNGMEELELSREIGRLVGKL---HSA 114
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+H D+ N ++ ++Y+IDFGLA+ +D
Sbjct: 115 GIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKD 146
|
Length = 211 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 24/217 (11%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQGGTG----IPN 67
IG G FGE+Y T + A+K + +K K + L ++ + TG I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 68 VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 125
+ + D ++DL+ DL S+ S + A ++I +E +H++ +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASMNT 184
+RD+KP N L+ V I D GLA + H + GT Y A
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
G+ D SLG +L LRG P++ K K
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 45/207 (21%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV 73
K+G GS+ +Y G + + VA+K+ ++ + + +L+G V +
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 74 --EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
+ LV + + L + L + V + Q++ + ++H + LHRD+KP
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKP 131
Query: 132 DNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQ 190
N L+ ++ + DFGLA+ + +P N T Y + LG E
Sbjct: 132 QNLLIS---DTGELKLADFGLARA-------KSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 191 SRRDDLESLGYVLMYFLRGSLPWQGLK 217
S D+ +G + + ++G + G+K
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 41/158 (25%), Positives = 78/158 (49%), Gaps = 19/158 (12%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGIPN-VRWFG 72
IG G++G++Y TN + A+K L+ + ++ E Y ILQ PN V+++G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAE---YNILQSLPNHPNVVKFYG 86
Query: 73 V--EGDYNV-----LVMDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHS 121
+ + D V LV++L G S+ +L C ++L + + + ++ +H+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRD+K +N L+ V ++DFG++ + T
Sbjct: 147 NRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTST 181
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 48/227 (21%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN---- 67
G +G G++G +Y G TN+ I ++ V+ +L K Y LQ +
Sbjct: 5 GEVLGKGAYGTVYCGL---TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 68 ---VRWFGVEGDYNVL--------------VMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
V++ G D N + +++ GP E +F ++
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK------------ 109
Query: 111 QMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTS---THQHIP 166
Q+++ V ++H+ +HRDIK +N LM G + +IDFG A++ TH ++
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
K++ GT + + R+ D+ S+G + G P
Sbjct: 166 ----KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 39/169 (23%), Positives = 76/169 (44%), Gaps = 30/169 (17%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-------LLYESKLYR---- 57
F L +G+G++G++Y G +++T + AIK+ +V + +L + +R
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 58 -----ILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLEDLF-NFCSRKLSLKTVLMLAD 110
I + G+ + W LVM+ G S+ DL N L + + +
Sbjct: 68 YYGAFIKKNPPGMDDQLW---------LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+++ + +H +HRDIK N L+ +V ++DFG++ + T
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 164
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 36/154 (23%), Positives = 71/154 (46%), Gaps = 11/154 (7%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNV----R 69
++G G+FG++Y N +T A K+ + TK + L + + + PN+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKV--IDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 70 WFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
F E + +L+ G +++ + R L+ + ++ Q + + ++H +HRD+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
K N L L + + DFG++ K +T T Q
Sbjct: 130 KAGNILFTLD---GDIKLADFGVSAK--NTRTIQ 158
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 37/165 (22%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQL-LYESK- 54
F + + I G+FG++YLG ++ A+K+ V+ + L L +S
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 55 ---LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
LY LQ + V + + GD SL ++ + ++++K + +
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVK---------SLLHIYGYFDEEMAVKYI----SE 112
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI--IDFGLAK 154
+ ++++H +HRD+KPDN L+ +N+ +I DFGL+K
Sbjct: 113 VALALDYLHRHGIIHRDLKPDNMLI-----SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 59/258 (22%), Positives = 98/258 (37%), Gaps = 79/258 (30%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-----------------LENVKT- 44
+ LG+ +G G+FG++ + + VA+K +E +K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 45 -KHPQLL-------YESKLYRIL----QGGTGIPNVRWF-----GVEGDYNVLVMDLLGP 87
KH ++ E LY ++ G N+R F +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHG-----NLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147
L+ K ++ A Q+ +EF+ SK +HRD+ N L+ + + I
Sbjct: 128 -----------TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKI 173
Query: 148 IDFGLAKK------YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 201
DFGLA+ YR T T+ +P K + A + + TH QS D+ S G
Sbjct: 174 ADFGLARDIHHIDYYRKT-TNGRLPV---KWMAPEALFDRVYTH----QS---DVWSFG- 221
Query: 202 VLMY--FLRGSLPWQGLK 217
VL++ F G P+ G+
Sbjct: 222 VLLWEIFTLGGSPYPGIP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 14 KIGSGSFGEIYLG--TNIQTNEE---VAIKLENVKTKHPQLLY--ESKLYRILQGGTGIP 66
++G G+FG+++L N+ ++ VA+K ++ + + E++L +LQ
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH--- 68
Query: 67 NVRWFGV--EGDYNVLVMDLL------------GPS---LEDLFNFCSRKLSLKTVLMLA 109
VR++GV EG ++V + + GP L + +L+L +L +A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Q+ + + ++ S F+HRD+ N L+G G V I DFG+++ T YR
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDY-----YRV 180
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 216
R+ + L + + D+ S G VL F G PW L
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
K + +A+ ++ + ++HS+ +HRDIKP N L+ R QV + DFG++ + ++
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA- 160
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
TGT+ Y + G S D+ SLG L+ + P
Sbjct: 161 --------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 22/116 (18%)
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDT------ 159
+L Q++ ++ VHS+ +HRD+K N FLM G + + DFG +K+Y D+
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDSVSLDVA 228
Query: 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
S+ PY L RY S++ D+ SLG +L L P++G
Sbjct: 229 SSFCGTPYYLAPELWERKRY-----------SKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 32/196 (16%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQ----LLYESKLYRILQGGT 63
IG G+FGE+ L T A+K LE + H + +L E+ +++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVK--- 65
Query: 64 GIPNVRWFGVEGDYNV-LVMDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFV 119
++ + N+ L+M+ L D+ +K +L +T +A+ ++ ++ +
Sbjct: 66 -----MFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETVL-AIDSI 117
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE-NKNLTGTAR 178
H F+HRDIKPDN L+ V + DFGL + H+ YR N +L
Sbjct: 118 HQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSLPSDFT 172
Query: 179 YASMNTHLGIEQSRRD 194
+ +MN+ E +R+
Sbjct: 173 FQNMNSKRKAETWKRN 188
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 51/221 (23%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVK-TKHPQLLYESK 54
++ L +++G GSFG +YL + + E +K+ E V+ + QLL SK
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLL--SK 58
Query: 55 LYRILQGGTGIPNVRWFG---VEGDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLM 107
L P + F +E D ++ + G L+ + LS V
Sbjct: 59 LDH--------PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQH 164
Q++ V ++H + LHRD+K N + + N + I DFG+++ D +T
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT--- 163
Query: 165 IPYRENKNLTGTARYASMN--THLGIEQSRRDDLESLGYVL 203
TGT Y S H G + + D+ SLG +L
Sbjct: 164 -------TFTGTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 23/159 (14%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKHPQ-----LLYESKLYRIL 59
+ +GSG+FG +Y G I E VAIK+ ++ + +L E+ +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAY----V 62
Query: 60 QGGTGIPN-VRWFGV-EGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
P+ VR G+ L+ L LG L+ + N + + +L Q+
Sbjct: 63 MASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKG 121
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ K +HRD+ N L+ + V I DFGLAK
Sbjct: 122 MSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 24/219 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQGGTG----IPN 67
IG G FGE+Y T + A+K + +K K + L ++ + TG I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 68 VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 125
+ + D ++DL+ DL S+ S K + A ++I +E +H++ +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT- 184
+RD+KP N L+ V I D GLA + H + GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
G D SLG +L LRG P++ K K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 38/162 (23%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKLYRILQGGTGIPN 67
F L +G+G++G++Y G +++T + AIK+ +V + + ++ E + + I
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 68 VRWFGV--------EGDYNVLVMDLLGP-SLEDLF-NFCSRKLSLKTVLMLADQMINRVE 117
++G D LVM+ G S+ DL N L + + +++ +
Sbjct: 78 --YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+H+ +HRDIK N L+ +V ++DFG++ + T
Sbjct: 136 HLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 12/157 (7%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL--LYESKLYRILQGGTGIPNVR 69
G K+G G++G +Y +E L+ ++ + E L R L+ I +
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 70 WFGVEGDYNV-LVMDLLGPSLEDLFNF--CSR------KLSLKTVLMLADQMINRVEFVH 120
F D V L+ D L + F S+ +L V L Q+++ + ++H
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 121 SKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKY 156
+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 62/268 (23%), Positives = 97/268 (36%), Gaps = 22/268 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK-HPQLLYESKLYRILQGGTG 64
F + KIG GSFG ++ A+K L + + + + E+++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I F +G N+++ L L R L V Q++ + +HSK
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
LHRDIK N + + V I D G+AK D + + GT Y S
Sbjct: 122 ILHRDIKSLNLFLDAY---DNVKIGDLGVAKLLSDNTNFA-------NTIVGTPYYLSPE 171
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
+ + D+ +LG VL G P+ G K + VS +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-------QM 224
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKR 271
Y + A C + + +PD L R
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 41/184 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYL------------GTNIQTNEE--VAIKL---ENVKTK 45
PR + RL K+G G FGE++L G + VA+K+ + KT
Sbjct: 3 PR--QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 46 HPQLLYESKLYRILQGGTGIPNV-RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK----- 99
L E K+ L+ PN+ R GV + L M DL F S++
Sbjct: 61 RNDFLKEIKIMSRLKN----PNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116
Query: 100 ---------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
+S+ +L +A Q+ + ++++ S +F+HRD+ N L+G + I DF
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG---NHYTIKIADF 173
Query: 151 GLAK 154
G+++
Sbjct: 174 GMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLY-ESKLYRILQGGTGIP 66
+ IGSG+ G + + T + VAIK +NV H + Y E L +++ I
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT--HAKRAYRELVLMKLVNHKNIIG 79
Query: 67 NVRWFGVEGDYN-----VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ F + LVM+L+ +L + L + + L QM+ ++ +HS
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHS 136
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
+HRD+KP N ++ + + I+DFGLA+
Sbjct: 137 AGIIHRDLKPSNIVV---KSDCTLKILDFGLART 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 50/203 (24%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLY-ESKLYRILQGGTGIPNVRWF 71
KIG GS G + + T + + VA+K ++ K + +LL+ E + R Q + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 72 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
V GD +VM+ L G +L D+ +++ + + + ++ + +H++ +HRDIK
Sbjct: 87 LV-GDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
D+ L+ R V + DFG + + +P R K+L GT + + +
Sbjct: 144 SDSILLTHDGR---VKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPELISRLPY 193
Query: 191 SRRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Q++ V VHSK +HRDIK N L+ GL V + DFG +K Y T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSDD---- 200
Query: 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207
+ GT Y + S++ D+ SLG VL+Y L
Sbjct: 201 -VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 39/150 (26%), Positives = 65/150 (43%), Gaps = 10/150 (6%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGTGIPNVRW 70
IG G+FGE+ L + + + A+KL E +K +E + I+ V+
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER--DIMAFANSPWVVQL 108
Query: 71 FGVEGDYNVLVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
F D L M + DL N S + K +++ ++ +HS +HRD+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
KPDN L+ + + + DFG K +T
Sbjct: 169 KPDNMLLD---KHGHLKLADFGTCMKMDET 195
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 17/152 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEE----VAIKL--ENVKTK-HPQLLYESKLYRILQGGTGI 65
+ +GSG+FG +Y G I E VAIK+ EN K + ++L E+ + G G
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEA----YVMAGVGS 68
Query: 66 PNV-RWFGVEGDYNVLVMDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
P V R G+ V ++ L P L D ++ + +L Q+ + ++
Sbjct: 69 PYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+HRD+ N L+ + N V I DFGLA+
Sbjct: 129 RLVHRDLAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG 72
+KIG GSFG+ L + + ++ IK N+ P+ ES+ + PN+ +
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 73 VEGDYN---VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN-------RVEFVHSK 122
+ N +VMD DL+ + + + VL DQ+++ ++ VH +
Sbjct: 66 ESFEENGNLYIVMDYCEGG--DLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 123 SFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDT 159
LHRDIK N FL + + + DFG+A+ T
Sbjct: 121 KILHRDIKSQNIFLT----KDGTIKLGDFGIARVLNST 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
++ + R +G GSFG L ++ ++++ A+K E K + +S+ +L PN
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK-EIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 68 VRWF--GVEGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ F E D ++ +VM+ G ++ + + T+L QM V+ +H K
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
LHRDIK N + + +V + DFG A+
Sbjct: 120 RVLHRDIKSKNIFL---TQNGKVKLGDFGSAR 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 51/183 (27%), Positives = 73/183 (39%), Gaps = 55/183 (30%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVR 69
R IG G FG +Y GT I ++ + A+K L RI T + V
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVK---------------SLNRI----TDLEEVE 41
Query: 70 WFGVEG-------DYNVLVMDLLGPSLE---------------DLFNFC---SRKLSLKT 104
F EG NVL LLG L DL NF + ++K
Sbjct: 42 QFLKEGIIMKDFSHPNVL--SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD 99
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT---ST 161
++ Q+ +E++ SK F+HRD+ N ++ + V + DFGLA+ D S
Sbjct: 100 LIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEYYSV 156
Query: 162 HQH 164
H H
Sbjct: 157 HNH 159
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 35/140 (25%), Positives = 61/140 (43%), Gaps = 17/140 (12%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q+I+ +E +H + ++RD+KP+N L+ V I D GLA + +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQGLKAGTKKQKYEKI 228
K GT + + G E D +LG L + RG +G K K+ K +
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRIL 214
Query: 229 SE-----KKVSTSIEALCRG 243
++ K S + ++ C
Sbjct: 215 NDSVTYPDKFSPASKSFCEA 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.001
Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
Q++ ++++HS + +HRD+KP N L+ +V + DFGLA+
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 40/173 (23%), Positives = 70/173 (40%), Gaps = 23/173 (13%)
Query: 80 LVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137
LVM L+ G L+ ++N + A Q+I +E +H + ++RD+KP+N L+
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD 129
Query: 138 LGRRANQVYIIDFGLAKKYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDL 196
V I D GLA + + GT Y + G D
Sbjct: 130 ---DHGNVRISDLGLAVELKGGKKIKGRA---------GTPGYMAPEVLQGEVYDFSVDW 177
Query: 197 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 249
+LG L + G P++ Q+ EK+ ++++ + YP +F+
Sbjct: 178 FALGCTLYEMIAGRSPFR--------QRKEKVEKEELKRRTLEMAVEYPDKFS 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 32/228 (14%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPN-- 67
L R++G G+FG+++L E L VKT K +R + T + +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 68 -VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCS---------------RKLSLKTVLMLA 109
V+++GV EGD ++V + + DL F +L+ +L +A
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
Q+ + ++ S+ F+HRD+ N L+G V I DFG+++ T YR
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYSTDY-----YRV 178
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 216
+ R+ + + + + D+ SLG VL F G PW L
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 12/157 (7%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL--LYESKLYRILQGGTGIPNVR 69
G K+G G++G +Y ++ L+ ++ + E L R L+ I +
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65
Query: 70 WFGVEGDYNV-LVMDLLGPSLEDLFNFC-SRKLSLKTVLM-------LADQMINRVEFVH 120
F D V L+ D L + F + K + K V + L Q+++ + ++H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 121 SKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKY 156
+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 12/101 (11%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
++ +HS ++RD+KP+N L+ + + DFGL+K+ D H+ Y + G
Sbjct: 111 LDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY----SFCG 160
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
T Y + ++ D S G VLM+ L GSLP+QG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI----- 65
LG+ +G G FG + G Q N++ +I VKT + S++ L +
Sbjct: 3 LGKTLGEGEFGSVMEG---QLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 66 PNV-RWFGV-------EGDYNVLVMDLLGPSLEDLFNF--------CSRKLSLKTVLMLA 109
PNV R GV EG Y V+ L DL +F C + L + ++
Sbjct: 60 PNVMRLIGVCLQTVESEG-YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
+ + +E++ SKSF+HRD+ N ++ V + DFGL+KK + YR+
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVADFGLSKKIYNGDY-----YRQ 170
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQGLK 217
+ ++ ++ + + + D+ S G V M+ + RG P+ G++
Sbjct: 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFG-VTMWEIATRGQTPYPGVE 219
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 15/49 (30%), Positives = 30/49 (61%), Gaps = 3/49 (6%)
Query: 91 DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
DL+ + + L L V +A Q+++ ++++H + +HRDIK +N L+
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293
|
Length = 461 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 34/136 (25%), Positives = 64/136 (47%), Gaps = 14/136 (10%)
Query: 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139
LVM+L+ +L + +L + + L QM+ ++ +HS +HRD+KP N ++
Sbjct: 99 LVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV--- 152
Query: 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESL 199
+ + I+DFGLA+ ++ PY T Y + LG+ D+ S+
Sbjct: 153 KSDCTLKILDFGLART--AGTSFMMTPY------VVTRYYRAPEVILGMGYKENVDIWSV 204
Query: 200 GYVLMYFLRGSLPWQG 215
G ++ +R + + G
Sbjct: 205 GCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGTG 64
F + + IG G+FGE+ L + + + A+KL E +K +E +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS 123
I + + + Y +VM+ + P DL N S + K +++ ++ +HS
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYM-PG-GDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFG 151
F+HRD+KPDN L+ ++ + + DFG
Sbjct: 163 FIHRDVKPDNMLLD---KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 477 | |||
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.86 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.56 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.39 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.3 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.96 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.95 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.94 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.89 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.82 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.82 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.74 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.57 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.5 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.44 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.42 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.4 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.38 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.29 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.14 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.0 | |
| PLN02236 | 344 | choline kinase | 96.82 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.74 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.66 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.56 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.46 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.0 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.38 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.3 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.2 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.99 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.85 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.85 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.67 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.38 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.54 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.2 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 91.45 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 89.9 |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-59 Score=431.96 Aligned_cols=299 Identities=72% Similarity=1.239 Sum_probs=291.0
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
-+++++|+++++||+|+||.+|+|.+..+|++||||++..+..++++.+|.+++..|+++.++|.+.+|+.+..+++|||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|++|++|+++++.|.+.|+.++++.++.|++..|+|+|.+++|||||||+|||++.+.....+.|+|||+|+.+.+..+.
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
.++||++...++||.+|++-..+.|.++++++|+.|+|++|+++..|.+||+++.+.+.+|+|++|.+++..++++.+|+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccccC
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 301 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (477)
++|.||.-++.+|..+.+++.|++.+|.++|+-+|...+++.|+.+||+.++.+..+..
T Consensus 251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q~~ 309 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQSG 309 (341)
T ss_pred CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHhhccc
Confidence 99999999999999999999999999999999999999999999999999886655533
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-56 Score=426.99 Aligned_cols=291 Identities=60% Similarity=1.040 Sum_probs=283.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|+-+|+++++||+|+||++|+|++.-++++||||.+..+...+++..|...++.|.++++|+.+++|+.++.++.||||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec--CCCCCcEEEeecCceeecccCCC
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~--~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
++|++|+||++.|+++|+.+++++++.||+.-|+|+|++.+|+|||||+||||+. ..+.+.|.|+|||+|+.+.++.+
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 9999999999999999999999999999999999999999999999999999975 23456889999999999999999
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.+++||++.+.+.||.+||+-..|+|.++++++|+.|||-+++++|.|.+||+++++.+.+++|++|.+++..++++.||
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc 264 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC 264 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
.++|.+|..++.+...+++++-|+|+.+..+|.+++.+.|..+|..+||..+.
T Consensus 265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 99999999999999999999999999999999999999999999999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=404.65 Aligned_cols=273 Identities=23% Similarity=0.364 Sum_probs=237.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.-..+|.+++.||+|+|++|++|+.+.++++||||++.++ .+.+-+..|..+|..|.+|++|..+.+-+.+....
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3457899999999999999999999999999999987654 23344678999999999999999999999999999
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|+|+||+ +|.|.++|+. -+.|++..+++|+.||+.||+|||++|||||||||+|||| |++|++||+|||.|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCC
Confidence 9999999 9999999986 4679999999999999999999999999999999999999 899999999999999886
Q ss_pred cCCCCccc----cccc--CCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh
Q 011819 158 DTSTHQHI----PYRE--NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (477)
Q Consensus 158 ~~~~~~~~----p~~~--~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (477)
.....+.. .+.. ...++||..|.+||++.....++.+|||+||||||+|+.|.+||.+ ..+...+.+|+..
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra---~NeyliFqkI~~l 302 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA---ANEYLIFQKIQAL 302 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc---ccHHHHHHHHHHh
Confidence 65433111 1112 2669999999999999999999999999999999999999999965 5567788888776
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 011819 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (477)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~ 298 (477)
.+. +++++|+.+.+||.++|..||.+|++.++|++ ++|+..+||+.+..+..
T Consensus 303 ~y~-----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~----------HpFF~~Vdw~nlw~~~P 354 (604)
T KOG0592|consen 303 DYE-----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA----------HPFFEGVDWENLWQQTP 354 (604)
T ss_pred ccc-----CCCCCCHHHHHHHHHHHccCccccccHHHHhh----------CcccccCChhhhhhcCC
Confidence 654 56789999999999999999999999877754 68899999998665443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=387.68 Aligned_cols=271 Identities=21% Similarity=0.275 Sum_probs=231.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
-.++|++++.||+|+||+||+++.+.+++.||+|+++++. .......|..|+..++| |.|+.+.+.+++.+..|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~h-PFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKH-PFIVKLIYSFQTEEKLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCC-CcEeeeEEecccCCeEE
Confidence 3578999999999999999999999999999999987643 23457789999999776 77888888888889999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
||+||+ ||.|...+++ ++.|++..+..|+.+|+.||.|||++|||||||||+|||| +.+|+|+|+|||||+....
T Consensus 102 lVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhccc
Confidence 999999 9999999985 6779999999999999999999999999999999999999 8999999999999986544
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
... ...++|||+.|||||++.+..|+..+|+|||||++|||++|..||.+ .+..+.+++|...+...
T Consensus 178 ~~~-------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~---~~~~~~~~~I~~~k~~~--- 244 (357)
T KOG0598|consen 178 DGD-------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA---EDVKKMYDKILKGKLPL--- 244 (357)
T ss_pred CCC-------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC---ccHHHHHHHHhcCcCCC---
Confidence 432 23568999999999999999999999999999999999999999966 45577788887776321
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCC----HHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPD----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
....++.+.++++..+|..+|++|.. +.+ -..++++..+||+.+......++..|
T Consensus 245 -~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~----------ik~HpfF~~inW~~l~~k~l~PpF~P 303 (357)
T KOG0598|consen 245 -PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEE----------IKRHPFFKGINWEKLLAKKLSPPFKP 303 (357)
T ss_pred -CCccCCHHHHHHHHHHhccCHHHhcCCCCChHH----------hhcCcccccCCHHHHHhcCCCCCeec
Confidence 22337889999999999999999963 333 25678999999999877766665544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=377.37 Aligned_cols=251 Identities=26% Similarity=0.362 Sum_probs=210.2
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
....++|.+.++||.|+|++||+|+++.++.+||||.+..+. ..+.+..|+++++.|+| ++|+.+..+...+++.
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H-~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKH-PNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCC-cceeeEEEEEecCCeE
Confidence 345678999999999999999999999999999999887764 23457899999999996 7888888888899999
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC---CcEEEeecCcee
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA---NQVYIIDFGLAK 154 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~---~~vkL~DFGla~ 154 (477)
||||||| ||+|.++++. .+.+++.+++.++.||+.||++||+++||||||||+||||+..... -.+||+|||+|+
T Consensus 85 ~lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999 9999999986 4579999999999999999999999999999999999999754223 578999999999
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
.+..... ..++||++.|||||++..+.|+.|+|+||+|+|||+|++|+.||... +..+.+..+......
T Consensus 164 ~L~~~~~--------a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~---t~~eL~~~~~k~~~~ 232 (429)
T KOG0595|consen 164 FLQPGSM--------AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE---TPKELLLYIKKGNEI 232 (429)
T ss_pred hCCchhH--------HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc---CHHHHHHHHhccccc
Confidence 8875443 45789999999999999999999999999999999999999999764 444555444333221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 268 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~ 268 (477)
+..+...+..++.+++...+..++.+|-++.+
T Consensus 233 --~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 233 --VPVLPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred --cCchhhhccCchhhhhhHHHhcCccccCchHH
Confidence 12223334566778898999999999988644
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=388.72 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=224.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.+|+.++.||+|||+.||.+++..+|+.||+|++.++. ....+..|++|.+.|+| ++|+.+..|+++.++.|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~H-pnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKH-PNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCC-CcEEeeeeEeecCCceEEE
Confidence 56999999999999999999999999999999987632 33468899999999998 7788888888899999999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
+|+| .++|..++++ .+++++.+++.++.||+.||.|||+++|||||||..|+|| +++.+|||+|||||..+....
T Consensus 97 LELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence 9999 9999999984 6789999999999999999999999999999999999999 788999999999999887654
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. ...++||||.|.|||++.....+..+||||+|||||.||.|++||+. .+.++.|.+|.......
T Consensus 173 E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet---k~vkety~~Ik~~~Y~~----- 237 (592)
T KOG0575|consen 173 E-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET---KTVKETYNKIKLNEYSM----- 237 (592)
T ss_pred c-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc---chHHHHHHHHHhcCccc-----
Confidence 3 34678999999999999999999999999999999999999999965 55678888888776653
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQ 283 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~ 283 (477)
+..++.+.++||..+|+.+|.+||++++ +|.+-|...|+.
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~---vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDE---VLDHPFFKSGFT 277 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHH---HhcCHhhhCCCc
Confidence 3467899999999999999999999554 466666666654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=379.34 Aligned_cols=254 Identities=24% Similarity=0.325 Sum_probs=212.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---------CchhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------KHPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
.+.+.|.+.+.||+|+||.|-+|..+.+|+.||||+++... ......+|+++|+.|+| |+|+.+..+++.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H-P~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH-PNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC-CCEEEEeeeeec
Confidence 35678999999999999999999999999999999987542 12235699999999998 667777777778
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.++.||||||+ ||.|.+.+-. ++.+.+.....++.||+.||.|||++||+||||||+|||++.++.+..+||+|||+|
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred CCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 88889999999 9999998864 566888888999999999999999999999999999999987777899999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCCC--C-CcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ--S-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~--s-~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
+....... .+++|||+.|.|||++.+..+ . .++|||||||+||-+|+|.+||.+..... ...+.|..
T Consensus 327 K~~g~~sf--------m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~ 396 (475)
T KOG0615|consen 327 KVSGEGSF--------MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILK 396 (475)
T ss_pred hcccccee--------hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhc
Confidence 98765432 568999999999999987653 3 48899999999999999999998754432 24455555
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..+.. ....+..++++..+||.+||..||+.||+++++.
T Consensus 397 G~y~f-~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 397 GRYAF-GPLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred Ccccc-cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 55532 2345677899999999999999999999976653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=361.43 Aligned_cols=279 Identities=20% Similarity=0.283 Sum_probs=237.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.-.++|++++.||.|+||+|.+++++.+|..+|+|+++..... +....|..+++.+.| +.+..+.+-+.+..+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~-PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH-PFLVKLYGTFKDNSNL 119 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC-ceeEEEEEeeccCCeE
Confidence 3457899999999999999999999999999999998765322 235678899999885 7777777778889999
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||||||+ ||.|..++..+ ++|++..++.|+.||+.||+|||+++|++|||||+|||| |..|.+||+|||+|+...
T Consensus 120 ymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEec
Confidence 9999999 99999999864 569999999999999999999999999999999999999 899999999999999876
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.. .-++||||.|+|||++...+|+..+|+|||||++|||+.|..||... ...+.|++|.+.++.
T Consensus 196 ~r----------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~---~~~~iY~KI~~~~v~--- 259 (355)
T KOG0616|consen 196 GR----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD---NPIQIYEKILEGKVK--- 259 (355)
T ss_pred Cc----------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC---ChHHHHHHHHhCccc---
Confidence 54 24789999999999999999999999999999999999999999764 447899999988775
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCCCccCCC
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARALVP 310 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~~~~~~ 310 (477)
.+..+++++++|+..+|+.|-.+|- ..++.-.+++ .+++|+..++|..+..+..+++..|+....+
T Consensus 260 --fP~~fs~~~kdLl~~LL~vD~t~R~--gnlknG~~dI---k~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~ 325 (355)
T KOG0616|consen 260 --FPSYFSSDAKDLLKKLLQVDLTKRF--GNLKNGVEDI---KNHPWFKGVDWEAILQRKIEPPFEPPNIHGP 325 (355)
T ss_pred --CCcccCHHHHHHHHHHHhhhhHhhh--cCcCCCcccc---ccCcccccccHHHHhhccccCCCCCccccCC
Confidence 4566889999999999999999883 1222112222 5689999999999988888877766444333
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=369.99 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=214.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc-EEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~-~~~lVm 82 (477)
.+.+.++.||+|..|+||++.|+.+++.+|+|++.... ...++.+|+++++.+++ ++|+.++..+...+ ..+|+|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~s-pyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQS-PYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCC-CCeeeEeEEEEeCCceEEeeh
Confidence 36778899999999999999999999999999884432 34578999999999966 55555555555555 589999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||| ||+|.+++.. .+++++.....++.+|++||.|||+ ++||||||||.|||+ +..|.|||||||.++.+.+..
T Consensus 158 EYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS~ 233 (364)
T KOG0581|consen 158 EYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNSI 233 (364)
T ss_pred hhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhhh
Confidence 999 9999999986 4679999999999999999999995 999999999999999 689999999999999877652
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCC--CcccHHHHHHHHhhhcccccHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL--KAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~--~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
..+++||..|||||.+.+..|+.++||||||++++||++|+.||... ......+.+..|.....+.
T Consensus 234 ---------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~--- 301 (364)
T KOG0581|consen 234 ---------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR--- 301 (364)
T ss_pred ---------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC---
Confidence 36789999999999999999999999999999999999999999763 2345667777777755443
Q ss_pred HHhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 239 ALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 239 ~l~~~-~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
++.+ ++++|.+||..||.+||.+||++.+| +++.|++.
T Consensus 302 -lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qL---l~Hpfi~~ 340 (364)
T KOG0581|consen 302 -LPEGEFSPEFRSFVSCCLRKDPSERPSAKQL---LQHPFIKK 340 (364)
T ss_pred -CCcccCCHHHHHHHHHHhcCCcccCCCHHHH---hcCHHHhh
Confidence 4444 89999999999999999999996555 56666553
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=375.59 Aligned_cols=270 Identities=21% Similarity=0.309 Sum_probs=219.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|++++.||+|+||.||+|+.+.||..+|+|++++.. ....+..|..+|.. ...+.++.+.+.+++.++.||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCeeEE
Confidence 478999999999999999999999999999999987653 22346789999988 556888999999999999999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ ||++..|+.. ...|++..++.|+.+++.||+.+|+.|+|||||||+|+|| |..|++||+|||||..+...
T Consensus 219 iMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence 99999 9999999985 5679999999999999999999999999999999999999 89999999999999644221
Q ss_pred CC------------------Ccccc----------------------cccCCCCccCccccccchhcCCCCCCcchHHHH
Q 011819 160 ST------------------HQHIP----------------------YRENKNLTGTARYASMNTHLGIEQSRRDDLESL 199 (477)
Q Consensus 160 ~~------------------~~~~p----------------------~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSl 199 (477)
.. ....+ .......+|||.|||||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 00 00000 001234689999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHH
Q 011819 200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRIFRDL 276 (477)
Q Consensus 200 GviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt---~~~l~~~l~~~ 276 (477)
|||+||||.|.+||.+ .+..+.+.+|..-......+ -...+.++..+||.+|+. ||++|.. +++|
T Consensus 375 G~ImyEmLvGyPPF~s---~tp~~T~rkI~nwr~~l~fP-~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI------- 442 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCS---ETPQETYRKIVNWRETLKFP-EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI------- 442 (550)
T ss_pred HHHHHHHHhCCCCCCC---CCHHHHHHHHHHHhhhccCC-CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH-------
Confidence 9999999999999976 44566666665443211111 112356899999999999 9999975 3444
Q ss_pred HHHcCCCCCCccccccchh
Q 011819 277 FIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 277 ~~~~~~~~~~~~dw~~~~~ 295 (477)
..++|+..+||+.+..
T Consensus 443 ---K~HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 443 ---KKHPFFKGVDWDHLRE 458 (550)
T ss_pred ---hcCCccccCCcchhhc
Confidence 4579999999997643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=379.47 Aligned_cols=272 Identities=22% Similarity=0.298 Sum_probs=235.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.-.++|.++++||+|+||+|+++..+.+++.||||++++.. ..+....|..|+.....||.+..+...++..++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 44578999999999999999999999999999999987653 3346788999999999889999999999999999
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|+||||+ ||++..+.+ ...|++..+..|+..|+.||.|||++||||||||.+|||| |..|.+||+|||+|+..-
T Consensus 445 ~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccC
Confidence 9999999 888544433 5679999999999999999999999999999999999999 899999999999998543
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
... ....++|||+.|||||++.+..|+..+|+|||||+|||||.|..||.+ +++.+.++.|....+.
T Consensus 520 ~~g-------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g---ddEee~FdsI~~d~~~--- 586 (694)
T KOG0694|consen 520 GQG-------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG---DDEEEVFDSIVNDEVR--- 586 (694)
T ss_pred CCC-------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCCCC---
Confidence 222 135689999999999999999999999999999999999999999977 4556777777776554
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCH-----HHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCCC
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDY-----AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPA 305 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~-----~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~ 305 (477)
.+..++.+..++++.+|..+|++|..+ ++| ..++|+..+||+.+...+.+++..|.
T Consensus 587 --yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i----------~~hpFFr~i~w~~L~~r~i~PPf~P~ 647 (694)
T KOG0694|consen 587 --YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDI----------KKHPFFRSIDWDDLLNRRIKPPFVPT 647 (694)
T ss_pred --CCCcccHHHHHHHHHHhccCcccccCCCCCCchhh----------hhCCccccCCHHHHhhccCCCCCCcc
Confidence 334578999999999999999999865 222 34688999999999999888877764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=351.60 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=211.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEE-eeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRW-FGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~-~~~~~~~~~lV 81 (477)
.+|+|.++||.|.||+||++++..+|+.||.|-++-.. ....+..|+.++++|+|+|+|..+.+ |..+....+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 46999999999999999999999999999999765432 23457899999999999887777774 44455558999
Q ss_pred EecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 82 MDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS--KS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 82 mE~~-g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs--~g--iiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
|||| +|+|.++++. ..+.+++.++++++.|++.||..+|. .. |+||||||.||+| +.+|.|||.||||+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLG 175 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccchhH
Confidence 9999 9999999863 34569999999999999999999998 45 9999999999999 78999999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
+.+....+ ...+++|||.||+||.+.+.+|+.++||||+||++|||+.=+.||.+. ...+...+|..+..
T Consensus 176 r~l~s~~t-------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 176 RFLSSKTT-------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDY 245 (375)
T ss_pred hHhcchhH-------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCC
Confidence 98876544 245789999999999999999999999999999999999999999884 45666677777765
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHHHH
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRI 272 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt-~~~l~~~ 272 (477)
+.... ..++.++..+|..|+..|++.||+ ...+.++
T Consensus 246 ~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 246 PPLPD---EHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CCCcH---HHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 43322 347889999999999999999998 4444433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=362.39 Aligned_cols=247 Identities=26% Similarity=0.334 Sum_probs=211.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-------~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
...++|++++.||+|+||.|++|.+..+++.||+|+++.+ .....+.+|+.+++.+.+|++|..+..+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999999999999999987764 123456689999999996778888887777777
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC-CcEEEeecCcee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAK 154 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~-~~vkL~DFGla~ 154 (477)
..||||||+ ||.|.+++.. .+++.+.++..++.||+.||+|||++||+||||||+|||+ +.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccc
Confidence 799999999 8899999987 7789999999999999999999999999999999999999 566 999999999998
Q ss_pred ecc-cCCCCcccccccCCCCccCccccccchhcCCC-CC-CcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh
Q 011819 155 KYR-DTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (477)
Q Consensus 155 ~~~-~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s-~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (477)
... ... ...+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.. .+....+.+|...
T Consensus 170 ~~~~~~~--------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 170 ISPGEDG--------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRKIRKG 238 (370)
T ss_pred ccCCCCC--------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHHHhcC
Confidence 773 211 346789999999999999988 85 899999999999999999999976 3344555666555
Q ss_pred cccccHHHHhcCC-cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 232 KVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 232 ~~~~~~~~l~~~~-p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.+. ++..+ ++++.+++.+||..+|..|+++.++.
T Consensus 239 ~~~-----~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EFK-----IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Ccc-----CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 443 33445 89999999999999999999976664
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=341.85 Aligned_cols=253 Identities=21% Similarity=0.278 Sum_probs=203.4
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~----~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+.|+.+.++|+|+||.||+|+++.||+.||||.+......+ -.++|++++++|+| ++++.+..++-.....+||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH-~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKH-ENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhccc-chHHHHHHHHHhcceeEEEe
Confidence 47999999999999999999999999999999876544433 35789999999998 45555555555667789999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|||..++.+.+.+....++.+.+..|+.|++.|+.|+|++++|||||||+|||+ ..++.+||||||+|+.+..+..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---ecCCcEEeccchhhHhhcCCcc-
Confidence 999888888887666679999999999999999999999999999999999999 6889999999999998875332
Q ss_pred cccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc---------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (477)
.++..+.|..|.|||.+.| .+|+..+||||+||++.||++|.+-|.+..+-+..-.+.+.....
T Consensus 157 ------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 157 ------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred ------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 2355688999999999998 789999999999999999999999998855432222221111111
Q ss_pred --------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 --------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 --------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
-..+++.-.+++..-+.+|+..||..||++|++.+++.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 01112222233455689999999999999999977764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=357.79 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=207.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcE-EEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc-EEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-VAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVL 80 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~-vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~-~~~l 80 (477)
....+.+.||.|+||+||+|.+ .|.. ||||++..... ...+..|+.++..|+|++++. +..++.... ..+|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~-f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQ-FYGACTSPPGSLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeee-EEEEEcCCCCceEE
Confidence 3456677899999999999995 4555 99998765431 347899999999999865555 444444444 6899
Q ss_pred EEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeCCCCCCceEeecCCCCC-cEEEeecCceeec
Q 011819 81 VMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKY 156 (477)
Q Consensus 81 VmE~~-g~sL~~li~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~g-iiHRDLKP~NILl~~~~~~~-~vkL~DFGla~~~ 156 (477)
||||+ +|+|.+++.. ....+++..++.++.||+.||+|||+++ ||||||||+|||+ +... ++||+|||+++..
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceee
Confidence 99999 9999999986 3678999999999999999999999999 9999999999999 6776 9999999999877
Q ss_pred ccCCCCcccccccCCCCccCccccccchhc--CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~--g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
..... ......||+.|||||++. ...|+.|+||||||++||||+||..||.++.. .+....+......
T Consensus 195 ~~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 195 VISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLR 264 (362)
T ss_pred ccccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCC
Confidence 65321 123468999999999999 56899999999999999999999999988665 2333333322222
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
. .++..+|+.+..+++.||..+|..||++.++...|+.+....
T Consensus 265 p---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 265 P---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred C---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 2 233458999999999999999999999999999999886443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.75 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=213.7
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeEEeeEe-CcE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWFGVE-GDY 77 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~----~~~~E~~il~~L~~~~~i~~~~~~~~~-~~~ 77 (477)
++-.+.|+.+++||+|+||.||+|++..+|+.||+|.+......+ ...+|+.||+.|.|+++|.....+... ...
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 344568999999999999999999999999999999877665443 357999999999997777666666554 678
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
.|||+|||..+|.-|+....-+|++.++..|+.||+.||+|||.+||+|||||..|||| |.+|.+||+|||||+.+.
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence 99999999999999998666789999999999999999999999999999999999999 789999999999999887
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc----
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---- 232 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~---- 232 (477)
..... ..+..+-|..|.|||.++|. .|+..+|+||.||||.||+.|++.|++...-....++.+++-..
T Consensus 270 ~~~~~------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 270 PSGSA------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred CCCCc------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 65532 24566789999999999985 59999999999999999999999998854433233333322111
Q ss_pred -----------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 -----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 -----------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....+.+.++.+|+...+|+..+|.+||++|.|+.+++.
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 011222335567889999999999999999999876643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=343.03 Aligned_cols=271 Identities=18% Similarity=0.232 Sum_probs=213.6
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.|+ ++..+...+.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~-~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCC-cEEEEEEEEccCCeEEEEE
Confidence 4899999999999999999999999999999875432 122467899999999874 5555555666777899999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 999 89998887543 3468999999999999999999999999999999999999 678899999999998754322
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. .....||..|||||++.+..++.++|||||||+||+|++|..||...........+..... .....+
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~ 224 (285)
T cd05631 157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----EDQEEY 224 (285)
T ss_pred e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh----cccccC
Confidence 1 1245789999999999999999999999999999999999999987544322222221111 111224
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
...+++++.+|+..||..+|.+||+ ++++. + ++|....+|..+...+.+++..|
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~---~-------h~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVK---Q-------HPIFKNINFKRLEANMLEPPFCP 283 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHh---c-------CHhhcCCCHHHHHhCcCCcCCCC
Confidence 4568899999999999999999997 44443 2 45566678998877766655554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=361.85 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=216.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.+-|++++.||.|+-|.|-+|+|..||+.+|||++..... ...+.+|+.+|+.|.|+ ++..++.+.....+.|+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~Hp-nVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHP-NVLRLYDVWENKQHLYL 89 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCC-CeeeeeeeeccCceEEE
Confidence 4679999999999999999999999999999999876532 23578999999999885 55555566667788899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|.||+ ||-|.+++-. .+++++.++.+++.||+.||.|+|..+|+||||||+|+|| |..++|||+|||+|......
T Consensus 90 vlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCC
Confidence 99999 9999999875 6679999999999999999999999999999999999999 67788999999999765543
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
.. ..+.||++.|+|||++.|.+| +.++||||+|||||.||+|++||. +++....+.+++...+.
T Consensus 166 kl--------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G~f~---- 230 (786)
T KOG0588|consen 166 KL--------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRGVFE---- 230 (786)
T ss_pred cc--------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcCccc----
Confidence 32 457799999999999999999 489999999999999999999996 46677888888887765
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
++.++++++++|+.+||..||..|.+.++ +|++.|...
T Consensus 231 -MPs~Is~eaQdLLr~ml~VDp~~RiT~~e---I~kHP~l~g 268 (786)
T KOG0588|consen 231 -MPSNISSEAQDLLRRMLDVDPSTRITTEE---ILKHPFLSG 268 (786)
T ss_pred -CCCcCCHHHHHHHHHHhccCccccccHHH---HhhCchhhc
Confidence 45789999999999999999999999554 466666543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=348.84 Aligned_cols=258 Identities=25% Similarity=0.394 Sum_probs=205.1
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEe-eEeCc-EEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWF-GVEGD-YNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~-~~~~~-~~~lVm 82 (477)
.+|..++.||+|+||.||++.+..+|+.+|||....... ...+..|+.++..|+| ++|+.+... ....+ .++|+|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~-p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNH-PNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCC-CCEEeeCCccccccCeeeEeee
Confidence 468899999999999999999999999999998665421 3458999999999995 555555443 33333 689999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC-CCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~-~~~vkL~DFGla~~~~~~~ 160 (477)
||+ +++|.+++...+.++++..+..+..||++||+|||++|||||||||+|||+ +. ++.+||+|||+++......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCcccccccccc
Confidence 999 999999998765589999999999999999999999999999999999999 56 6899999999998776411
Q ss_pred CCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. ......+.||+.|||||++.. ...++++|||||||++.||+||..||... ......+.++..... .+.
T Consensus 173 ~~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~---~P~ 243 (313)
T KOG0198|consen 173 TK----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDS---LPE 243 (313)
T ss_pred cc----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCC---CCC
Confidence 11 122345789999999999994 34456999999999999999999999874 222333334443331 124
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
++..++++..+|+.+|+..+|+.|||+++| |++.|.+.
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL---L~hpf~~~ 281 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEEL---LEHPFLKQ 281 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHH---hhChhhhc
Confidence 667789999999999999999999997665 55565444
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=345.54 Aligned_cols=269 Identities=21% Similarity=0.325 Sum_probs=222.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++++.||.|.-|.||+|+...++..+|+|++.+.. +......|.+||..+.| |.++.++..++..++.|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH-PFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH-PFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC-CccchhhheeeccceeEEE
Confidence 47889999999999999999999999999999987643 33456789999999987 8899999999999999999
Q ss_pred EecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 82 MDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 82 mE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|||| ||+|..+.++. ++.|++..+++|+.+|+.||+|||-.|||+|||||+|||| .++|+|.|+||.|+......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999 99999999754 4569999999999999999999999999999999999999 79999999999998643110
Q ss_pred CCC-------------------------------cc-----------------ccc-ccCCCCccCccccccchhcCCCC
Q 011819 160 STH-------------------------------QH-----------------IPY-RENKNLTGTARYASMNTHLGIEQ 190 (477)
Q Consensus 160 ~~~-------------------------------~~-----------------~p~-~~~~~~~Gt~~Y~APE~~~g~~~ 190 (477)
.+. .. .|- .....++||-.|.|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 00 000 12345789999999999999999
Q ss_pred CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC----H
Q 011819 191 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD----Y 266 (477)
Q Consensus 191 s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt----~ 266 (477)
+.++|+|+|||+|||||+|..||.+. ...+.+..|..+....+-. ..++..+++||.++|.+||.+|.. +
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~---~~~~Tl~NIv~~~l~Fp~~---~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGS---NNKETLRNIVGQPLKFPEE---PEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCC---CchhhHHHHhcCCCcCCCC---CcchhHHHHHHHHHhccChhhhhccccch
Confidence 99999999999999999999999774 4466777776655432221 245689999999999999999987 5
Q ss_pred HHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 267 AYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 267 ~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
++|+ .++|+..++|..+..
T Consensus 387 ~eIK----------~HpFF~gVnWaLir~ 405 (459)
T KOG0610|consen 387 AEIK----------RHPFFEGVNWALIRC 405 (459)
T ss_pred HHhh----------cCccccCCChhheec
Confidence 5554 478999999996543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=350.55 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=209.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-ch--hHHHHHHHHHHHcCCCCCCeeEEeeEeCc-EEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HP--QLLYESKLYRILQGGTGIPNVRWFGVEGD-YNV 79 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~--~~~~E~~il~~L~~~~~i~~~~~~~~~~~-~~~ 79 (477)
.+-++|.++++||.|+||.||+|+.+.+++.||||.++.+-. ++ .-++|++.+++|..|++|..+..+..+.+ ..|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 355789999999999999999999999999999998766532 22 34689999999995566666655544444 889
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
+|||||..+|.++++..++.|++..+..|+.||+.||+|+|++|+.||||||+|||+ .....|||+|||+|+.....
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---SGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---cccceeEecccccccccccC
Confidence 999999999999998778889999999999999999999999999999999999999 45789999999999977654
Q ss_pred CCCcccccccCCCCccCccccccchhc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc------
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 232 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~-g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~------ 232 (477)
.. | +..+.|..|.|||+++ ..-|+.+.||||+|||++|+.+=++-|.|.+. .+.+.+|.+..
T Consensus 164 pP-----Y---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE---~Dqi~KIc~VLGtP~~~ 232 (538)
T KOG0661|consen 164 PP-----Y---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE---IDQIYKICEVLGTPDKD 232 (538)
T ss_pred CC-----c---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH---HHHHHHHHHHhCCCccc
Confidence 43 3 4568899999999876 45689999999999999999999999988544 23333333221
Q ss_pred -------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 -------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 -------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....+..+.+.++.++.++|..|+.+||++|||++++++
T Consensus 233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 233445566678899999999999999999999877644
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=347.38 Aligned_cols=260 Identities=20% Similarity=0.293 Sum_probs=210.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..++|+ +|..+..++...+..|+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP-FIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCC-CCCcEEEEEEcCCEEEE
Confidence 478999999999999999999999999999999876431 223577899999999875 55555556667788999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC
Confidence 99999 8999999875 4568999999999999999999999999999999999999 67899999999999866432
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
. ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+......
T Consensus 172 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~----- 233 (329)
T PTZ00263 172 T----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD---TPFRIYEKILAGRLK----- 233 (329)
T ss_pred c----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCcC-----
Confidence 2 2457999999999999999999999999999999999999999763 334555555544322
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~--~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
++..++.++.++|..||..||.+||+. ..+.++ ..++|....+|..+..
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l-------l~hp~f~~~~~~~~~~ 284 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADV-------KNHPYFHGANWDKLYA 284 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH-------hcCCccCCCCHHHHHh
Confidence 234578899999999999999999973 112222 2345666668886544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=354.54 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=213.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|.+.+.||+|+||.||+|+.+.+.+.||||++.+.... ..+.+|++|++.|+|++++..+.+|. .....|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-t~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-TSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-ccceEEEEe
Confidence 5799999999999999999999999999999998764432 34889999999999977777777765 455679999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||+-++|..++.+ ..+++++.+..++.|++.||.|||+.+|+|||+||.|||+ ++.+.+|+||||+|+.+.....
T Consensus 81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce-
Confidence 9996699999985 6779999999999999999999999999999999999999 7899999999999997765322
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
....+.|||.|||||...+.+|+..+|+|||||||||+++|++||.. ....+....|.......+ .
T Consensus 156 ------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p-----~ 221 (808)
T KOG0597|consen 156 ------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPP-----S 221 (808)
T ss_pred ------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCc-----c
Confidence 23567899999999999999999999999999999999999999964 445566666666555433 3
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
..+.+|..|++.+|.+||..|.+-. +++.+.|.+.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~---~Ll~HpF~k~ 256 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWT---DLLGHPFWKG 256 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHH---HHhcChHHhh
Confidence 5788999999999999999999944 4456666544
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=344.47 Aligned_cols=265 Identities=21% Similarity=0.263 Sum_probs=214.1
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+|++.+.||+|+||.||+|.+..+++.||||++... .....+..|..++..+.|+++++.+..++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999987642 122346778889999988888888888888888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCC
Confidence 999 8999999874 4568999999999999999999999999999999999999 6788999999999875322111
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+..... .++
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~-----~~~ 221 (324)
T cd05587 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHNV-----SYP 221 (324)
T ss_pred -------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC-----CCC
Confidence 1234579999999999999999999999999999999999999997643 3444444444332 134
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 296 (477)
..+++++.+++..||..+|.+|++.... ..+++ ..++|....+|......
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~--~~~~~---~~hp~~~~~~~~~~~~~ 271 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGPT--GERDI---REHAFFRRIDWEKLERR 271 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCC--CHHHH---hcCCCcCCCCHHHHHhC
Confidence 5678999999999999999999975210 00111 24567777899876543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=346.38 Aligned_cols=261 Identities=19% Similarity=0.322 Sum_probs=203.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEE-eeEe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRW-FGVE 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~-~~~~ 74 (477)
+-.++|+++++||+|+||.||+|.+. .+++.||||++..... ...+..|+.++..+.+|++|..+.. +...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34578999999999999999999752 3457899998765332 2357789999999955566665554 4444
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcC--------------------------------------------------------
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCS-------------------------------------------------------- 97 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~-------------------------------------------------------- 97 (477)
....+++|||+ +++|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 55689999999 999999986421
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCC
Q 011819 98 -----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172 (477)
Q Consensus 98 -----~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~ 172 (477)
..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... +.....
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~ 235 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPD-----YVRKGS 235 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcc-----hhcccC
Confidence 247788999999999999999999999999999999999 6788999999999986543221 111233
Q ss_pred CccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHH
Q 011819 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASY 251 (477)
Q Consensus 173 ~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~l 251 (477)
..++..|||||++.+..++.++|||||||+||||++ |..||.+..... .....+..... ...+..+++++.++
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~l~~l 309 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGTR----MRAPENATPEIYRI 309 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCCC----CCCCCCCCHHHHHH
Confidence 456788999999999999999999999999999997 999997644321 11222222111 11235678999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 252 FHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 252 i~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
+..||..+|++||++.++.+.|++++.
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=341.07 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=209.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.| ++|..+..+..+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH-PFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCC-CcHhhhHhhhccCCeEEEE
Confidence 47999999999999999999999999999999875432 12346789999999988 4555555666677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCCc
Confidence 9999 8999999975 4569999999999999999999999999999999999999 678899999999998654321
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+...... +
T Consensus 156 ----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~-----~ 217 (291)
T cd05612 156 ----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKILAGKLE-----F 217 (291)
T ss_pred ----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcC-----C
Confidence 24579999999999999999999999999999999999999997643 34445544443321 3
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
...+++.+.++|.+||..||.+||+ ++++. .++|...++|....
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l----------~h~~~~~~~~~~~~ 266 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK----------NHRWFKSVDWDDVP 266 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh----------cCccccCCCHHHHh
Confidence 3457889999999999999999995 44443 45666777887543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.74 Aligned_cols=268 Identities=21% Similarity=0.269 Sum_probs=214.8
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.+++++..+..++...+..||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999876532 11235567778888888888888888888888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCC
Confidence 999 8999988874 4569999999999999999999999999999999999999 6789999999999975432211
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+...... ++
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~-----~p 221 (323)
T cd05616 157 -------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEHNVA-----YP 221 (323)
T ss_pred -------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC-----CC
Confidence 1235679999999999999999999999999999999999999997643 33445555443322 34
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccc
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~ 299 (477)
..+++++.+++..||..+|++|++.... ...++ ..++|....||........+
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~~--~~~~i---~~h~~~~~~~~~~~~~~~~~ 274 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGPE--GERDI---KEHAFFRYIDWEKLERKEVQ 274 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCCC--CHHHH---hcCCCcCCCCHHHHHhCCCC
Confidence 5678999999999999999999985210 01111 24566677899876654443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.29 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=208.2
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
++++++||+|-||+||+|... ....||+|.+..... ...+..|+++|+.|+| ++|+.++.++..++..||||||| .
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H-~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRH-EKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcc-cCeEEEEEEEecCCceEEEEEeccc
Confidence 456788999999999999963 334799998877544 4678899999999998 66777777777777899999999 9
Q ss_pred CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 87 PSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 87 ~sL~~li~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
|+|.+++.. ....+...+.+.++.||++|++||+++++|||||-..|||+ +.+..|||+|||||+...+...
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y---- 358 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDEY---- 358 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCce----
Confidence 999999985 45669999999999999999999999999999999999999 6888999999999995444332
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
.....-.-...|.|||.+....++.++|||||||+||||+| |+.||.++... +.++.+.....- .-+..|
T Consensus 359 --~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---ev~~~le~GyRl----p~P~~C 429 (468)
T KOG0197|consen 359 --TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---EVLELLERGYRL----PRPEGC 429 (468)
T ss_pred --eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---HHHHHHhccCcC----CCCCCC
Confidence 11112222567999999999999999999999999999999 99999886654 333333332211 123678
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
|+++.++|..||..+|++||||+.+...|++++..
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 99999999999999999999999999999988743
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=341.88 Aligned_cols=253 Identities=20% Similarity=0.278 Sum_probs=204.2
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| +++..+..++...+..||||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999876432 12346678999999987 55666666667788899999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~----- 150 (323)
T cd05571 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCC-----
Confidence 999998874 5679999999999999999999999999999999999999 6788999999999875322111
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+..... .++..+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~-----~~p~~~~~ 220 (323)
T cd05571 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEI-----RFPRTLSP 220 (323)
T ss_pred --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCC-----CCCCCCCH
Confidence 1234679999999999999999999999999999999999999997633 2333443333322 23456889
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 247 EFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
++.++|..||..||++|| ++.++. .++|....+|.....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll----------~h~~f~~~~~~~~~~ 264 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIM----------EHRFFASINWQDVVQ 264 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHH----------cCCCcCCCCHHHHHh
Confidence 999999999999999999 655553 356677778886543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.65 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=207.9
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|+++++||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.| +++..+..++...++.|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS-EWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC-CCCccEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999876432 22356789999999986 5666666667788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--
Confidence 9999 9999999975 4568999999999999999999999999999999999999 6789999999999976543
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc---ccH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS---TSI 237 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~---~~~ 237 (477)
......||+.|+|||++.+..++.++|||||||+||+|++|..||..... .+.+..+...... ...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKYWKETLQRPVY 222 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHhccccccCCCC
Confidence 12356799999999999999999999999999999999999999976433 3333333221110 100
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 293 (477)
......+++++.++|..||..+|++||++.++.+ ++|...++|...
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~----------h~~~~~~~~~~~ 268 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN----------HPFFKEVDWNEL 268 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHh----------CcccCCCCHHHH
Confidence 0011256889999999999999999999776643 455556677654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=338.66 Aligned_cols=267 Identities=20% Similarity=0.263 Sum_probs=215.7
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.|++++..+..++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999876431 12346678888888888899988888888888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCc
Confidence 999 8999999874 4569999999999999999999999999999999999999 6788999999999875432211
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+...... ++
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~-----~p 221 (323)
T cd05615 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVS-----YP 221 (323)
T ss_pred -------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC-----CC
Confidence 1234679999999999999999999999999999999999999997643 33444444443322 33
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~ 298 (477)
..++.++.+++.+||..+|.+|++..+. ..+++ ..++|...++|........
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~--~~~~i---~~h~~f~~~~~~~~~~~~~ 273 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPE--GERDI---REHAFFRRIDWDKLENREI 273 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCC--CHHHH---hcCcccCCCCHHHHhcCCC
Confidence 5678999999999999999999975321 11122 2456777889987665443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=351.42 Aligned_cols=253 Identities=22% Similarity=0.373 Sum_probs=210.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
...|...++||+|..|.||.|....+++.||||.++... ..+-+..|+.+|+.++|.+++..+.-|... +..|+|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEe
Confidence 357889999999999999999999999999999877643 344578999999999997666666555544 77899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ |++|.|++. ...+++.++..++.+++.||+|||.+||||||||-+|||+ ..+|.+||+|||+|..+.....
T Consensus 351 ym~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred ecCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---ccCCcEEEeeeeeeeccccccC-
Confidence 99 999999998 4459999999999999999999999999999999999999 6788999999999998766543
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
...+.+||+.|||||+.....|++++||||||++++||+.|.+||...+ ..+.+..|.....+. -..+.
T Consensus 425 ------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---PlrAlyLIa~ng~P~--lk~~~ 493 (550)
T KOG0578|consen 425 ------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---PLRALYLIATNGTPK--LKNPE 493 (550)
T ss_pred ------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---hHHHHHHHhhcCCCC--cCCcc
Confidence 2467899999999999999999999999999999999999999997633 233333333332221 12345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.++++|++|+.+||..|+++|+++.+| |++.|.+
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eL---L~HpFl~ 527 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKEL---LEHPFLK 527 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHH---hcChhhh
Confidence 689999999999999999999996655 5556543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=339.05 Aligned_cols=266 Identities=18% Similarity=0.254 Sum_probs=208.0
Q ss_pred ceEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
+|+++++||+|+||.||++++. .+++.||+|++.... ....+..|..++..+.+++++..+..++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5999999999999999999864 478999999875421 1234677999999998888888888888888889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 9999999 8999999864 4569999999999999999999999999999999999999 678899999999998654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhhhcccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVST 235 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~ 235 (477)
..... .....+||+.|||||++.+.. ++.++|||||||+||+|++|..||........ ......+.....
T Consensus 157 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 228 (332)
T cd05614 157 SEEKE------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP-- 228 (332)
T ss_pred ccCCC------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--
Confidence 32221 123457999999999998754 78899999999999999999999975433222 222222222211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~--~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
.+...+++.+.+++.+||..||++||++. .+.+++ .++|....+|.....
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l-------~h~~~~~~~~~~~~~ 280 (332)
T cd05614 229 ---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK-------EHPFFKGLDWEALAL 280 (332)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHH-------cCCCcCCCCHHHHHh
Confidence 23356789999999999999999999433 232322 345666667876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=327.59 Aligned_cols=255 Identities=20% Similarity=0.241 Sum_probs=206.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeEEe--eEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWF--GVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~----~~~~E~~il~~L~~~~~i~~~~~~--~~~~~~~~ 79 (477)
.+.|+.+.+|++|+||.||+|+++.+++.||+|.++.+.... .-++|+.++..++| ++|+.+..+ +..-+..|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H-~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARH-PNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCC-CCeeeeEEEEeccccceee
Confidence 457999999999999999999999999999999887765433 35799999999986 777777554 45666789
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||||..+|..+++...++|...++..++.|++.||+|||.+.|+||||||+|+|+ ...|.+||+|||+|+.+...
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL---SHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---ccCCcEEecccchhhhhcCC
Confidence 999999999999999888899999999999999999999999999999999999999 68899999999999998775
Q ss_pred CCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc-----
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (477)
.. ..+..+-|..|.|||.++|. .|+...|+||+|||+.||+++.+-|.+...-+...++.+......
T Consensus 231 ~k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 231 LK-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred cc-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 32 34566789999999999986 489999999999999999999999988544332222222221110
Q ss_pred --------------cccHHHHhcC-----CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 --------------STSIEALCRG-----YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 --------------~~~~~~l~~~-----~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+...+.+. +++.-.+|++.+|.+||.+|.|+.+.++
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0011111111 2366789999999999999999876643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=340.60 Aligned_cols=259 Identities=21% Similarity=0.300 Sum_probs=210.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCC-cEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g-~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.++|++.+.||+|+||.||+|.+..++ ..||||++... .....+..|+.++..+.| ++|+.+..++...+..|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCCcceEEEEEeCCEEE
Confidence 468999999999999999999876654 68999987532 123356789999999987 55556666667778899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 108 lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCC
Confidence 999999 8999999975 4569999999999999999999999999999999999999 6789999999999986543
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
. ....+||+.|||||++.+..++.++|||||||++|+|++|..||.+.. ....+..+......
T Consensus 184 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~~~---- 246 (340)
T PTZ00426 184 R----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKILEGIIY---- 246 (340)
T ss_pred C----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHHhcCCCC----
Confidence 1 124579999999999999999999999999999999999999997643 34445555443321
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~ 297 (477)
++..+++++.++|.+||..+|++|+ ++++++ .++|+..++|.......
T Consensus 247 -~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~----------~hp~f~~~~~~~~~~~~ 299 (340)
T PTZ00426 247 -FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK----------EHPWFGNIDWVSLLHKN 299 (340)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH----------cCCCcCCCCHHHHHhCC
Confidence 3456788999999999999999996 555543 46777778998655443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.80 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=199.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++.++||.|+||.||+|.+..+++.||||++.... ....+..|+.+++.++|+ ++..+..+....+..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA-NIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCC-CEeeEEEEEcCCCeEEEEEe
Confidence 57999999999999999999999999999999876432 233577899999999874 55556555666778899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
|+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCc--
Confidence 99889999987666678999999999999999999999999999999999999 6788999999999976543221
Q ss_pred ccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc---------
Q 011819 164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (477)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+...........+......
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 -----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred -----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 1234578999999999876 5689999999999999999999999976443222221111111000
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 -------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+++++.++|..||..||.+||+++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00111122356788999999999999999999877753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=337.16 Aligned_cols=253 Identities=22% Similarity=0.352 Sum_probs=214.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch-----hHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~-----~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..-+|++.+.||+|+||.|-+|.....|++||||.+.+..... .+.+|++||..|+|+ +|..++.+++..+..+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHP-hII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHP-HIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCC-ceeehhhhhcCCceEE
Confidence 3458999999999999999999998999999999876643222 367899999999985 5555566666788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||. +|.|.|++..++ .+++.++.++++||..|+.|+|+++++|||||.+|||| |.++++||+||||+..+.+
T Consensus 130 ivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhcc
Confidence 999999 999999998754 59999999999999999999999999999999999999 8999999999999988877
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
... ..++||++.|++||++.|.+| ++.+|-|||||+||.|+.|.+||.+. +.+.....|....+..
T Consensus 206 ~kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQIs~GaYrE-- 272 (668)
T KOG0611|consen 206 KKF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQISRGAYRE-- 272 (668)
T ss_pred ccH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHhhcccccC--
Confidence 554 457899999999999999999 59999999999999999999999774 3455566666655533
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~ 282 (477)
+.-|.+..-||.+||..+|+.|.|.+++ -.++|.+.|+
T Consensus 273 ----P~~PSdA~gLIRwmLmVNP~RRATieDi---AsHWWvNwgy 310 (668)
T KOG0611|consen 273 ----PETPSDASGLIRWMLMVNPERRATIEDI---ASHWWVNWGY 310 (668)
T ss_pred ----CCCCchHHHHHHHHHhcCcccchhHHHH---hhhheeeccc
Confidence 2347889999999999999999995554 4566665554
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.36 Aligned_cols=266 Identities=19% Similarity=0.225 Sum_probs=208.9
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+|++.++||+|+||.||++.+..+++.||||++.... ....+..|+.+++.++|+ ++..+...+..++..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCC-CEeeeeeeecCCCeEEEEE
Confidence 5899999999999999999999999999999875432 123456799999999874 5555555556677899999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++ +..+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999 89999887543 3469999999999999999999999999999999999999 677899999999998654322
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||.+.........+...... .....
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05605 157 T--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----DQEEY 224 (285)
T ss_pred c--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----ccccc
Confidence 1 12457899999999999999999999999999999999999999864432222222111111 11123
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhccc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~ 299 (477)
+..++..+.+++..||..||++|| ++++++ .++|....+|..++..+.+
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~----------~~~~~~~~~~~~~~~~~~~ 278 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVK----------AHPFFRTANFKRLEAGMLE 278 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHh----------cCcCccCCCHHHHhhCCCC
Confidence 456789999999999999999999 555553 3466777789977654444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=332.92 Aligned_cols=259 Identities=21% Similarity=0.261 Sum_probs=203.0
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHc--CCCCCCeeEEeeEeCcEEEEE
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lV 81 (477)
|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|.+++..+. .|+++..+..++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999976431 1234566776665443 246666666677788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999 889988886 4569999999999999999999999999999999999999 678999999999987432211
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. .....+|++.|||||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+...... .
T Consensus 156 ~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~~~-----~ 220 (324)
T cd05589 156 D-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSIVNDEVR-----Y 220 (324)
T ss_pred C-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC-----C
Confidence 1 1235679999999999999999999999999999999999999997643 33444444333221 3
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCccccccch
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~--l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
+..+++++.++|.+||..+|.+||+..+ +.+++ .++|...++|....
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~-------~~~~f~~~~~~~~~ 269 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVK-------KQPFFRDINWDDLL 269 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHh-------hCCCcCCCCHHHHH
Confidence 3567899999999999999999995422 22222 24555666776543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.58 Aligned_cols=256 Identities=21% Similarity=0.316 Sum_probs=211.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~---~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
....|+..+.||+|.||.||+|.+..+++.||||+++.+.... .+..|+.++..+++ ++|..++.....+...+++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-PNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-chHHhhhhheeecccHHHH
Confidence 3457889999999999999999999999999999998765443 46789999999887 5555555555677888999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||| ||++.+++.. ...+.+.++..++++++.||.|||.++.+|||||+.|||+. ..|.|||+|||.+..+....
T Consensus 90 Mey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechh
Confidence 9999 9999999984 44458888889999999999999999999999999999994 66999999999998876644
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. ...+++||+.|||||++.+..|+.++||||||++.|||++|.+||..+.+.. +..-......+.+
T Consensus 166 ~-------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-------vlflIpk~~PP~L 231 (467)
T KOG0201|consen 166 K-------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-------VLFLIPKSAPPRL 231 (467)
T ss_pred h-------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-------EEEeccCCCCCcc
Confidence 3 2368899999999999999999999999999999999999999998876621 1111111222334
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~ 282 (477)
...+++.|++||..||.++|+.||++.+| |++.|++...
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~L---LKh~FIk~a~ 270 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKEL---LKHKFIKRAK 270 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHH---hhhHHHHhcC
Confidence 45788999999999999999999996554 6677766644
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=335.74 Aligned_cols=261 Identities=20% Similarity=0.246 Sum_probs=206.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|++..+++.||||++.... ....+..|.+++..+.+|+++..+..++...+..||||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999876431 12345678888887777788888888888888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV----- 151 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc-----
Confidence 899988874 4569999999999999999999999999999999999999 6789999999999976433221
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+...... .+..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~-----~p~~~~~ 221 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVL-----YPVWLSK 221 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCCH
Confidence 1234679999999999999999999999999999999999999997643 34445555443322 2234789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
++.+++..||..+|++||+........+++ ..++|...++|.....
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~---~~hp~~~~~~~~~~~~ 267 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAI---KQHPFFKEIDWVLLEQ 267 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHH---hcCCccCCCCHHHHHh
Confidence 999999999999999999432110011111 2356777789987644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.10 Aligned_cols=254 Identities=20% Similarity=0.230 Sum_probs=196.9
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.++|++ +..+..++...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN-IVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCcc-ccchhhhEecCCEEEEEE
Confidence 57999999999999999999999999999999876532 2345678999999998854 445555556777899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||+.+++.+.+......+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc-
Confidence 999555555555445679999999999999999999999999999999999999 6788999999999987643221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc---------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (477)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||.+............+.....
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 156 -----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred -----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 112345789999999999999999999999999999999999999986443222111111110000
Q ss_pred ---------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 ---------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..........++.++.+|+.+||..+|++||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000111234678899999999999999999987664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.65 Aligned_cols=269 Identities=19% Similarity=0.272 Sum_probs=206.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++++.||+|+||+||+|.+..+++.||||++.... ....+..|+.++..++| +++..+...+.+....|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~-~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS-LWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCeEEEE
Confidence 47999999999999999999999999999999986432 12346778999999877 5566666666677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccc
Confidence 9999 8999999975 4579999999999999999999999999999999999999 678999999999997653211
Q ss_pred CCc-------cc---------------------ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCC
Q 011819 161 THQ-------HI---------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (477)
Q Consensus 161 ~~~-------~~---------------------p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~P 212 (477)
... .. ........+||+.|+|||++.+..++.++|||||||+||||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 000 00 00011245899999999999999999999999999999999999999
Q ss_pred CCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCC---CCCCHHHHHHHHHHHHHHcCCCCCCccc
Q 011819 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD---DKPDYAYLKRIFRDLFIREGFQFDYVFD 289 (477)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~---~RPt~~~l~~~l~~~~~~~~~~~~~~~d 289 (477)
|.+.. ....+.++........... ...+++++.++|.+++. ++. .||++++|+ .++|...++
T Consensus 236 f~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~----------~hp~f~~~~ 300 (363)
T cd05628 236 FCSET---PQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK----------TNPFFEGVD 300 (363)
T ss_pred CCCCC---HHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh----------CCCCCCCCC
Confidence 97643 3444555543221111110 12367889999988654 444 457877664 367888889
Q ss_pred cccchh
Q 011819 290 WTILKY 295 (477)
Q Consensus 290 w~~~~~ 295 (477)
|..+..
T Consensus 301 ~~~~~~ 306 (363)
T cd05628 301 WEHIRE 306 (363)
T ss_pred HHHHHh
Confidence 997644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.26 Aligned_cols=261 Identities=18% Similarity=0.240 Sum_probs=208.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|.+..+++.||||++... .....+..|..++..+.+++++..+..++...+..||||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999987642 122345678888887777788888888888888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~----- 151 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK----- 151 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC-----
Confidence 999998875 4569999999999999999999999999999999999999 6788999999999875432211
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..+...... +...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~~-----~~~~~~~ 221 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVV-----YPTWLSQ 221 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCCC-----CCCCCCH
Confidence 1234679999999999999999999999999999999999999997643 34445544443221 2345789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 011819 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 296 (477)
++.+++..||..||++||++.++. -.+++ ..++|...++|......
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~-~~~~~---~~h~~f~~~~~~~~~~~ 267 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLG-GEEAI---LRHPFFKELDWEKLNRR 267 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCC-CHHHH---HcCCCcCCCCHHHHHhC
Confidence 999999999999999999974321 01111 34677777889865443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.60 Aligned_cols=254 Identities=21% Similarity=0.290 Sum_probs=203.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|++..+++.||||++... .....+..|..++..+.+++++..+..++...+..|+||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999987643 122345677777776666678888777777888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC-----
Confidence 899998875 4569999999999999999999999999999999999999 6788999999999874322111
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+..... .++..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~~~~~~~~-----~~~~~~~~ 221 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFESIRVDTP-----HYPRWITK 221 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC-----CCCCCCCH
Confidence 1235679999999999999999999999999999999999999997643 2333443332211 12345788
Q ss_pred HHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 247 EFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~-~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
++.++|..||..||++||++. ++ ..++|....+|.....
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~----------~~h~~f~~~~~~~~~~ 261 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNI----------RGHPFFKTINWTALEK 261 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHH----------HcCCCcCCCCHHHHHh
Confidence 999999999999999999963 33 2356777778886543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.62 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=203.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.+|++|..+..++..++..|+||||+ |
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999876431 22335567777776666778888777777888999999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~----- 151 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEG----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCC-----
Confidence 999999875 4569999999999999999999999999999999999999 6788999999999976433221
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+..... .+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~-----~~~~~~~~ 221 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDRP-----HFPRWISK 221 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCC-----CCCCCCCH
Confidence 12356799999999999999999999999999999999999999976433 344444433221 13355788
Q ss_pred HHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 247 EFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~-~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
++.+++..||..+|.+||+.. ++. .++|....+|.....
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~----------~h~~~~~~~~~~~~~ 261 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIR----------QHPFFRGIDWERLEK 261 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH----------cCcccCCCCHHHHHh
Confidence 999999999999999999863 332 246666778876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=327.66 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=197.2
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.++|++.++||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.|+ ++..+..+.......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA-NIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCC-CcCeEEEEEecCCeEEEEE
Confidence 4689999999999999999999999999999998765332 23467899999999874 5556666666778899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||++++|.+++......++...+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||++........
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc-
Confidence 999889999887656679999999999999999999999999999999999999 6788999999999975433221
Q ss_pred cccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc--------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (477)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... ....+..+.....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred ------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhcc
Confidence 12345789999999998764 578999999999999999999999987533 1222222211000
Q ss_pred -----------------cccHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 -----------------STSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 -----------------~~~~~~l~--~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
........ ..+++++.+++.+||..||.+||++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 00000001 12457889999999999999999976664
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=334.94 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=202.2
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 15 IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.|+ +|..+..++...+..|+||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCP-FIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCC-cEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999999999999999876421 223467899999999774 4555555566778899999999 999
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccc
Q 011819 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (477)
Q Consensus 89 L~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 168 (477)
|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence 9999875 5579999999999999999999999999999999999999 6789999999999975432211
Q ss_pred cCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHH
Q 011819 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (477)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+..... .+...+++++
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~ 220 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEPL-----RFPDGFDRDA 220 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCC-----CCCCcCCHHH
Confidence 1234679999999999999999999999999999999999999997643 3344444444322 2345688999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 249 ASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
.++|..||..+|.+||++..+.++|.+ +|....+|....
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~h-------p~~~~~~~~~~~ 259 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNH-------PFFSQLSWKKLL 259 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcC-------CCcCCCCHHHHH
Confidence 999999999999999976556555544 444445666543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=333.83 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=196.3
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeE----eCcEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV----EGDYNV 79 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~----~~~~~~ 79 (477)
+|++.++||+|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|++++..+..+.. .....|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5999999999999999999999999999999876421 22357789999999988655544443322 223579
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccccc
Confidence 9999999999999875 4569999999999999999999999999999999999999 67899999999999865332
Q ss_pred CCCcccccccCCCCccCccccccchhcC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH-----------
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE----------- 226 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g--~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~----------- 226 (477)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 157 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 157 TPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 2111 11234579999999999876 578999999999999999999999997643211111110
Q ss_pred -HH-----------hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 227 -KI-----------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 227 -~i-----------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.+ .............+.+++++.+++.+||..+|++||+++++.+
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 0111112222334567889999999999999999999777653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=330.19 Aligned_cols=261 Identities=18% Similarity=0.263 Sum_probs=199.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECC----------------CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGI 65 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~----------------~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i 65 (477)
..++|++.++||+|+||.||+|.+.. ++..||||++..... ...+..|++++..+.| +++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKD-PNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCC-CCe
Confidence 45789999999999999999998532 345799998865432 2357789999999987 455
Q ss_pred CeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 011819 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS------------------RKLSLKTVLMLADQMINRVEFVHSKSFLH 126 (477)
Q Consensus 66 ~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~------------------~~ls~~~~~~i~~qIa~aL~yLHs~giiH 126 (477)
..+..++...+..+|+|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 55655666677789999999 899999986421 23678889999999999999999999999
Q ss_pred CCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHH
Q 011819 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 206 (477)
Q Consensus 127 RDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyel 206 (477)
|||||+|||+ +.++.+||+|||+++....... +.......++..|||||++.+..++.++|||||||++|+|
T Consensus 162 ~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 162 RDLATRNCLV---GENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred cCcchhheEE---cCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 9999999999 6788999999999986543321 1112334567899999999988999999999999999999
Q ss_pred Hc--CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 207 LR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 207 lt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
++ +..||..............................+|..+.+++.+||..+|++||++++|.+.|+
T Consensus 234 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 234 LMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 86 678887654322222211111111111111123457899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=331.94 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=201.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||++.+..+++.||+|++.... ....+..|+++++.+.| +++..+..++...+..||||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCEEEEEEeCCCC
Confidence 47999999999999999999999999876432 12345678899999987 55666666666778899999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCC-----
Confidence 999888874 4569999999999999999999999999999999999999 6788999999999875322211
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+..+...... ++..+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~~-----~p~~~~~ 220 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEIR-----FPRTLSP 220 (323)
T ss_pred --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCC-----CCCCCCH
Confidence 12346799999999999999999999999999999999999999976432 3333333332221 3456889
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 247 EFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
++.++|..||..+|++|| ++.++.+ ++|...++|.....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~----------h~~~~~~~~~~~~~ 264 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME----------HRFFLSINWQDVVQ 264 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc----------CCCcCCCCHHHHHh
Confidence 999999999999999998 5444432 45666678886543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=335.28 Aligned_cols=252 Identities=19% Similarity=0.286 Sum_probs=202.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||++.+..+++.||||++.... ....+..|+.+++.+.| +++..+..++...+..||||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999876432 12346778899998887 56666666677788899999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc-----
Confidence 999888864 4569999999999999999999999999999999999999 6789999999999875332111
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
.....+||+.|+|||++.+..++.++|||||||+||+|++|..||..... .+.+..+..... .++..+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~-----~~p~~~~~ 220 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDI-----KFPRTLSA 220 (328)
T ss_pred --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCCc-----cCCCCCCH
Confidence 12346799999999999999999999999999999999999999976332 233333322221 23456889
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 247 EFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
++.++|.+||..+|++|+ ++.++. .++|....+|....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il----------~h~~~~~~~~~~~~ 263 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIM----------RHSFFTGVNWQDVY 263 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHh----------cCCCcCCCCHHHHH
Confidence 999999999999999997 655553 24666677887644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.72 Aligned_cols=263 Identities=21% Similarity=0.293 Sum_probs=208.9
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| +++..+..++...+..|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~-~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS-PWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCeEEEE
Confidence 47999999999999999999999999999999876532 12346678888877765 6666666666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9999 999999998765779999999999999999999999999999999999999 678999999999998765432
Q ss_pred CCcccccccCCCCccCccccccchhc------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~------g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
.. ......||+.|+|||++. +..++.++|||||||+||+|++|..||..... ...+.++......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~ 227 (330)
T cd05601 157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQRF 227 (330)
T ss_pred ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCCc
Confidence 21 123357899999999987 45678999999999999999999999976432 3344444332211
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
.... ....+++++.+++..||. +|.+||+++++. .++|....+|....
T Consensus 228 ~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~----------~h~~~~~~~~~~~~ 275 (330)
T cd05601 228 LKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLC----------CHPFFSKIDWNNIR 275 (330)
T ss_pred cCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh----------CCCCcCCCCHHHHh
Confidence 1111 123578899999999998 999999987763 35666777887644
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=340.14 Aligned_cols=268 Identities=23% Similarity=0.311 Sum_probs=211.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++++.||+|+||.||+|.+..+++.||||++... .....+..|++++..+.| +++..+..++.+++..|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCC-CCccchhhheecCCeEEEE
Confidence 4799999999999999999999999999999987643 222356788999998886 5555555666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccC
Confidence 9999 89999999753 679999999999999999999999999999999999999 678999999999998665433
Q ss_pred CCc----------------------ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc
Q 011819 161 THQ----------------------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (477)
Q Consensus 161 ~~~----------------------~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~ 218 (477)
... ...........||+.|+|||++.+..++.++|||||||+||+|++|..||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~- 234 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-
Confidence 000 000012234579999999999999999999999999999999999999997644
Q ss_pred ccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt-~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
....+.++.......... ....+++++.++|..||. +|.+||+ ++++++ ++|...++|....
T Consensus 235 --~~~~~~~i~~~~~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~----------hp~~~~~~~~~~~ 297 (350)
T cd05573 235 --LQETYNKIINWKESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS----------HPFFKGIDWENLR 297 (350)
T ss_pred --HHHHHHHHhccCCcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc----------CCCcCCCCHHHHh
Confidence 234444444311111111 112368999999999997 9999999 887754 5667777887544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=330.29 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=206.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++++.||+|+||.||++.+..+++.||||++... .....+..|..++..+.| ++++.+..++..+++.|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR-RWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCceEEEEecCCeEEEE
Confidence 5799999999999999999999999999999997642 122346778888887765 6677777777788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 9999 999999997656679999999999999999999999999999999999999 678899999999997654432
Q ss_pred CCcccccccCCCCccCccccccchhcC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g-----~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
.. ......||+.|||||++.+ ..++.++|||||||++|+|++|..||.... ..+.+.++.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (331)
T cd05597 157 TV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKEHF 227 (331)
T ss_pred Cc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCcc
Confidence 21 1123469999999999873 356889999999999999999999997633 344455554332222
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCC--CCCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFD--DKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~--~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
........+++++.++|..||..+++ .|+++.+++ .++|...++|....
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l----------~hp~~~~~~~~~~~ 278 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFK----------DHPFFEGIDWDNIR 278 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHh----------cCCCCCCCCHHHHh
Confidence 22222345789999999998865333 266755553 35677778888654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=331.91 Aligned_cols=260 Identities=20% Similarity=0.287 Sum_probs=202.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKL-YRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~i-l~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
+.||+|+||+||+|.+..+++.||||++.... ....+..|..+ ++.+.| +++..+...+...+..|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCC-CCCCCeeEEEEeCCEEEEEEcCCC
Confidence 47999999999999999999999999876432 11234455443 455655 56666666667788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCC----
Confidence 8999998875 5579999999999999999999999999999999999999 6789999999999875322211
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCc
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..+...... +...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~ 220 (323)
T cd05575 152 ---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILNKPLR-----LKPNIS 220 (323)
T ss_pred ---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCC
Confidence 1234679999999999999999999999999999999999999997633 34445555443322 345679
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhcc
Q 011819 246 TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (477)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~ 298 (477)
+++.++|..||..+|.+||+... .+.++ ..++|...++|..+.....
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~---~~~~i---l~~~~~~~~~~~~~~~~~~ 267 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKD---DFLEI---KNHVFFSSINWDDLVNKKI 267 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCC---CHHHH---HcCCCcCCCCHHHHhhccC
Confidence 99999999999999999998641 12222 2456777778886654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.68 Aligned_cols=267 Identities=19% Similarity=0.262 Sum_probs=210.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|.+..+++.||||++..... ...+..|..++..+.+++++..+..++...+..|+||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999865321 2236788889989988888888888888888999999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGD----- 151 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCC-----
Confidence 999988864 4579999999999999999999999999999999999999 6788999999999975332211
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc----ccHHHHHHHHhhhcccccHHHHhc
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~----~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
.....+||+.|+|||++.+..++.++|||||||+||+|++|..||..... ......+..+..... .++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~p~ 224 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----RIPR 224 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----CCCC
Confidence 12346799999999999999999999999999999999999999964322 112222333332221 1345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccc
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~ 299 (477)
.++..+.+++.+||..||.+|+++... ..++++ ..++|+..++|......+..
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i---~~h~~f~~~~~~~~~~~~~~ 277 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQ-TGFSDI---KSHTFFRSIDWDLLEKKQVT 277 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHH---HcCCCCCCCCHHHHHhCCCC
Confidence 678899999999999999999985321 011122 35688888899976554443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=320.63 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=213.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.+.+.|++.+.||+|.|+.||++.+..+|+.+|+|+++.+. ..+.+.+|+.|.+.|+| |+|+.+..-.....+.|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH-P~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC-CcEeehhhhhcccceeE
Confidence 45678999999999999999999999999999999877643 34568899999999998 55555555556777899
Q ss_pred EEEecC-CCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 80 LVMDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 80 lVmE~~-g~sL~~li-~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||+|++ |+.|..-| .+ ..+++..+-+++.||+++|.|+|.+||||||+||+|+|+...+...-+||+|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999 88775444 43 458899999999999999999999999999999999999876777789999999999887
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
+... ...++|||.|||||++...+|+..+|||+.|||||-||.|.+||.+ .+....|+.|....+..+-
T Consensus 165 ~g~~--------~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 165 DGEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAYDYPS 233 (355)
T ss_pred Cccc--------cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhccccCCCC
Confidence 4322 3567999999999999999999999999999999999999999977 3446778888877765433
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
. .+..+.++.++||.+||..||.+|.|+.+.
T Consensus 234 ~-~w~~is~~Ak~LvrrML~~dP~kRIta~EA 264 (355)
T KOG0033|consen 234 P-EWDTVTPEAKSLIRRMLTVNPKKRITADEA 264 (355)
T ss_pred c-ccCcCCHHHHHHHHHHhccChhhhccHHHH
Confidence 2 457789999999999999999999996554
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=339.26 Aligned_cols=267 Identities=20% Similarity=0.298 Sum_probs=206.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.| ++|+.+...+..+++.|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN-PWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999999999999999876431 12346679999999986 5666666667778899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.+....
T Consensus 80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence 9999 8999999875 4569999999999999999999999999999999999999 688999999999997653321
Q ss_pred CCccc-----------------c---------c-----ccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcC
Q 011819 161 THQHI-----------------P---------Y-----RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209 (477)
Q Consensus 161 ~~~~~-----------------p---------~-----~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG 209 (477)
..... + + ......+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 10000 0 0 001135799999999999999999999999999999999999
Q ss_pred CCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHHHHHcCCCCCC
Q 011819 210 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRIFRDLFIREGFQFDY 286 (477)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt---~~~l~~~l~~~~~~~~~~~~~ 286 (477)
..||.... ..+.+..+.......... ....+++++.++|..|+. +|.+|++ +.+++ .++|..
T Consensus 236 ~~Pf~~~~---~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll----------~h~~~~ 300 (364)
T cd05599 236 YPPFCSDN---PQETYRKIINWKETLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK----------SHPFFK 300 (364)
T ss_pred CCCCCCCC---HHHHHHHHHcCCCccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh----------cCCCcC
Confidence 99997643 234444443322111111 112468899999999996 9999998 55543 246666
Q ss_pred ccccccc
Q 011819 287 VFDWTIL 293 (477)
Q Consensus 287 ~~dw~~~ 293 (477)
.++|...
T Consensus 301 ~~~~~~~ 307 (364)
T cd05599 301 GVDWEHI 307 (364)
T ss_pred CCCHHHH
Confidence 6788753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=323.57 Aligned_cols=250 Identities=19% Similarity=0.269 Sum_probs=195.6
Q ss_pred CceEEEeeeeecCceEEEEEEECC-CCcEEEEEEecCCCC----chhHHHHHHHHHHHc--CCCCCCeeEEeeE-----e
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK----HPQLLYESKLYRILQ--GGTGIPNVRWFGV-----E 74 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~-~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~--~~~~i~~~~~~~~-----~ 74 (477)
++|++.+.||+|+||.||+|++.. +++.||||.+..... ...+.+|+.++..+. .|+++..+..++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999865 468899998764322 234667888887775 2455555544432 3
Q ss_pred CcEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
....++||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccce
Confidence 4567999999988999998753 3458999999999999999999999999999999999999 67889999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc-
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (477)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... +.+.++....
T Consensus 158 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~ 226 (290)
T cd07862 158 RIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIG 226 (290)
T ss_pred EeccCCc--------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhC
Confidence 8664321 123457899999999999999999999999999999999999999774432 2333322211
Q ss_pred ---------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 ---------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 ---------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.....+.+.+.+++.+.+++.+||..+|++||++.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 11123344456788999999999999999999977765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=338.62 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=204.4
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|++++..+.| ++|+.+..++.+.++.|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS-PWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCeeEEE
Confidence 47999999999999999999999999999999875421 12346779999999877 5666666667788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccc
Confidence 9999 9999999874 4569999999999999999999999999999999999999 678999999999997432211
Q ss_pred CCc-----------ccc------------------------c-----ccCCCCccCccccccchhcCCCCCCcchHHHHH
Q 011819 161 THQ-----------HIP------------------------Y-----RENKNLTGTARYASMNTHLGIEQSRRDDLESLG 200 (477)
Q Consensus 161 ~~~-----------~~p------------------------~-----~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlG 200 (477)
... ..+ + ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 000 0 001135799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHH
Q 011819 201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRIFRDLF 277 (477)
Q Consensus 201 viLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RP---t~~~l~~~l~~~~ 277 (477)
|+||||++|..||..... ...+..+.......... -...++.++.++|.+||. +|.+|+ ++.++.
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l------- 303 (377)
T cd05629 236 AIMFECLIGWPPFCSENS---HETYRKIINWRETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK------- 303 (377)
T ss_pred hhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh-------
Confidence 999999999999976433 33344443211111100 112468899999999997 777764 766553
Q ss_pred HHcCCCCCCccccccch
Q 011819 278 IREGFQFDYVFDWTILK 294 (477)
Q Consensus 278 ~~~~~~~~~~~dw~~~~ 294 (477)
.++|...++|+.+.
T Consensus 304 ---~hp~~~~~~~~~~~ 317 (377)
T cd05629 304 ---SHPFFRGVDWDTIR 317 (377)
T ss_pred ---cCCCcCCCCHHHHc
Confidence 24666667887653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=325.18 Aligned_cols=266 Identities=20% Similarity=0.301 Sum_probs=213.8
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
|.-.+.|++.+.||.|..+.||+|+.+.+++.||||+++.+.. -..+.+|++.+..+.| |||..+.-.++.+...|
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H-PNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH-PNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC-CCcceEEEEEEecceeE
Confidence 3446789999999999999999999999999999999876543 3467899999998887 56666666667788899
Q ss_pred EEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
+||.|| +|++.+++... ...|++..+..++++++.||.|||.+|.||||||+.|||| +.+|.|||+|||....+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeec
Confidence 999999 99999999733 3449999999999999999999999999999999999999 789999999999987776
Q ss_pred cCCCCcccccccCCCCccCccccccchhc--CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc-
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS- 234 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~--g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~- 234 (477)
+..... -++ ..+++||+.|||||++. ...|+.|+||||||++..||.+|..||....+ .+..+.++......
T Consensus 178 ~~G~R~--~~r-f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 178 DSGDRQ--VTR-FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKVLLLTLQNDPPTL 252 (516)
T ss_pred ccCcee--eEe-eccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHHHHHhcCCCCCc
Confidence 654322 122 27889999999999954 34589999999999999999999999987654 23334444433221
Q ss_pred ---ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 235 ---TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 235 ---~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
....+..+.++..|.++|..||.+||.+||++++++ ++.|.+.
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl---kh~FFk~ 298 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL---KHAFFKK 298 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh---ccHHHhh
Confidence 112233356788999999999999999999977664 4444433
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=324.68 Aligned_cols=265 Identities=25% Similarity=0.433 Sum_probs=190.7
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCC---CcEEEEEEecCCCCchh-------------HHHHHHHHHHHcCCCCCC
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKHPQ-------------LLYESKLYRILQGGTGIP 66 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~---g~~vAiKi~~~~~~~~~-------------~~~E~~il~~L~~~~~i~ 66 (477)
...+++|++.++||+|+||.||+|.+..+ +..+|+|+......... ...+...+..+.| .+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h-~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDH-LGIP 86 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCC-CCCC
Confidence 35668999999999999999999998777 67888887544322110 0111112222334 4455
Q ss_pred eeEEeeEeC----cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC
Q 011819 67 NVRWFGVEG----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (477)
Q Consensus 67 ~~~~~~~~~----~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~ 142 (477)
.+..++... .+.+++|+++..++.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+ +..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~~ 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DGN 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCC
Confidence 544443322 25588999998889888875 3346888899999999999999999999999999999999 678
Q ss_pred CcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHH
Q 011819 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222 (477)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~ 222 (477)
+.++|+|||+|+.+..................||+.|+|||++.+..++.++|||||||+||||++|..||.+.......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 89999999999876543221111111123457999999999999999999999999999999999999999876332211
Q ss_pred HHHHHH-hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 223 QKYEKI-SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 223 ~~~~~i-~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
....+. .-..... .......+|+++.+++..||.++|++||+|++|.+.|
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHE-GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhh-hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111100 0000100 1112356789999999999999999999999998875
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=333.08 Aligned_cols=265 Identities=18% Similarity=0.278 Sum_probs=205.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|.+..+++.||+|++..... ...+..|..++..+.+|+++..+..++...+..||||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999998765321 1235678888888766778888877778888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~----- 151 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC-----
Confidence 999888864 4579999999999999999999999999999999999999 6789999999999975322211
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc------ccHHHHHHHHhhhcccccHHHH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~------~~~~~~~~~i~~~~~~~~~~~l 240 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+..+..... .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----~~ 224 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----RI 224 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----CC
Confidence 12346799999999999999999999999999999999999999953211 111122233333222 23
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~ 297 (477)
+..++.++.+++.+||..+|++||++..+.. +.++ ..++|...++|......+
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~-~~~i---~~hp~f~~~~~~~~~~~~ 277 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTG-FADI---QGHPFFRNVDWDLMEQKQ 277 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCC-HHHH---hcCCCCCCCCHHHHHcCC
Confidence 4567889999999999999999998421100 1111 346788888998765443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.04 Aligned_cols=267 Identities=21% Similarity=0.233 Sum_probs=203.9
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.|++++.||+|+||+||+|++..+++.||||++.... ....+..|+++++.+.| ++++.+..++.+.+..|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCC-CCeeeeEEEEecCCEEEEEE
Confidence 6999999999999999999999999999999986532 12346789999999887 56666666667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 81 DYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCcccccccc
Confidence 999 8999999875 4568999999999999999999999999999999999999 6788999999999864421100
Q ss_pred Ccc----------------------------------------cccccCCCCccCccccccchhcCCCCCCcchHHHHHH
Q 011819 162 HQH----------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 201 (477)
Q Consensus 162 ~~~----------------------------------------~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGv 201 (477)
... .........+||+.|||||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000113467999999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHh--cCCCCCCCCHHHHHHHHHHHHHH
Q 011819 202 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR--SLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 202 iLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl--~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+||||++|..||..... .....++.......... ....+++++.++|.+|+ ..++..||++++++.
T Consensus 237 il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~-------- 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTP---TETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA-------- 304 (381)
T ss_pred HHHHHHhCCCCCcCCCH---HHHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc--------
Confidence 99999999999976433 22222232211111111 11247889999999854 445556999877743
Q ss_pred cCCCCCCccccccc
Q 011819 280 EGFQFDYVFDWTIL 293 (477)
Q Consensus 280 ~~~~~~~~~dw~~~ 293 (477)
++|...++|...
T Consensus 305 --hp~f~~~~~~~~ 316 (381)
T cd05626 305 --HPFFSEVDFSSD 316 (381)
T ss_pred --CcccCCCChhHH
Confidence 567777788753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=334.80 Aligned_cols=263 Identities=19% Similarity=0.271 Sum_probs=205.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.+|++|..+..++......||||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999986532 12346788899988877788888888888888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC-----
Confidence 999988864 5679999999999999999999999999999999999999 6788999999999874322111
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc------cHHHHHHHHhhhcccccHHHH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~l 240 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+..+..... .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 224 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-----RI 224 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-----CC
Confidence 123468999999999999999999999999999999999999999642211 11122222333222 23
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
+..++.++.++|..||..+|.+|+++... ..++++ ..++|...++|.....
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i---~~hp~~~~~~~~~~~~ 275 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQ-TGFRDI---KSHPFFRNIDWDLLEQ 275 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHH---hcCCCCCCCCHHHHHh
Confidence 45678999999999999999999984211 001122 2466777788987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=311.09 Aligned_cols=254 Identities=20% Similarity=0.235 Sum_probs=203.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.+|...++||+|.||.||+|++..+|+.||||.+...... -...+|++.++.++|.+ |..+.+++...+...||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~n-Ii~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPN-IIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcc-hhhhhhhccCCCceEEEE
Confidence 5789999999999999999999999999999988765433 35789999999999755 444444555666778999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||+..+|+.+++.....++..++..|+.+++.||+|||++.|+||||||.|+|+ ..+|.+||+|||+|+.+......
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---cCCCcEEeecccchhccCCCCcc
Confidence 999999999999878889999999999999999999999999999999999999 68999999999999988765442
Q ss_pred cccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc--------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (477)
. ...+-|..|.|||.+.|. .|+..+||||.|||+.||+-|.+-|.+.++-+...++.++.-...
T Consensus 158 ~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 158 Q-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred c-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 2 122568899999999875 589999999999999999999888887554322222222221111
Q ss_pred ------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 ------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 ------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
......+....+.++.+|+..+|..||.+|.++.++.+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 11112233445677899999999999999999776643
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=329.74 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=203.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||+||+|++..+++.||||++... ........|..++..+.+|+++..+..++...+..+|||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999987653 122345667777777666678888877777888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDA----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCC-----
Confidence 999999975 4568999999999999999999999999999999999999 6788999999999975422111
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+.+..+..... .+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~-----~~~~~~~~ 221 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDNP-----CYPRWLTR 221 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC-----CCCccCCH
Confidence 12345799999999999999999999999999999999999999976432 333433332221 12345788
Q ss_pred HHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchhh
Q 011819 247 EFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~-~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 296 (477)
++.+++.+||..+|++||++. ++ ..++|....+|......
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l----------~~h~~~~~~~~~~~~~~ 262 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDI----------RQHPFFREIDWSALEER 262 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHH----------HcCcccCCCCHHHHHhC
Confidence 999999999999999999974 33 23566677788765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=334.57 Aligned_cols=254 Identities=20% Similarity=0.259 Sum_probs=202.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----------------chhHHHHHHHHHHHcCCCCCCe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------HPQLLYESKLYRILQGGTGIPN 67 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----------------~~~~~~E~~il~~L~~~~~i~~ 67 (477)
...++|++++.||+|.||.|-+|.+..+++.||||++.+... .+...+|+.||++|.| ++|+.
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H-~nVV~ 172 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH-PNVVK 172 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC-cCeeE
Confidence 456899999999999999999999999999999999765421 1256789999999999 55555
Q ss_pred eEEeeE--eCcEEEEEEecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC
Q 011819 68 VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (477)
Q Consensus 68 ~~~~~~--~~~~~~lVmE~~-g~sL~~li~~~~~~-ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~ 143 (477)
+..+.. ..+..|||+||| .|.+... . +..+ ++..+++.|+..++.||+|||.+|||||||||+|+|| +.+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~-p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl---~~~g 247 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-P-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL---SSDG 247 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC-C-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE---cCCC
Confidence 544432 567789999999 4544322 1 2344 8999999999999999999999999999999999999 5779
Q ss_pred cEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCcc
Q 011819 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (477)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~----~s~ksDIwSlGviLyelltG~~Pf~~~~~~ 219 (477)
+|||+|||.+..+........ ..+....+|||.|||||...+.. .+.+.||||+||+||.|+.|..||.+ .
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~ 322 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---D 322 (576)
T ss_pred cEEeeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---c
Confidence 999999999987744321111 11233478999999999988733 35789999999999999999999965 5
Q ss_pred cHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.....+.+|.......+.. +.+.++++++|.++|.+||+.|.+..+++.
T Consensus 323 ~~~~l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 323 FELELFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred hHHHHHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 5678888888766543322 245788999999999999999999766653
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=336.76 Aligned_cols=268 Identities=22% Similarity=0.264 Sum_probs=204.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|+++++||+|+||.||+|++..+++.||||++... .....+..|+.++..+.|+ ++..+...+..++..|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~-~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE-WVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCC-CcceEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999987542 1234467899999999874 555555666677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++.. ...++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|..+....
T Consensus 80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccc
Confidence 9999 9999999975 4568999999999999999999999999999999999999 678999999999986432110
Q ss_pred CCc------------------------------------ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHH
Q 011819 161 THQ------------------------------------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 204 (477)
Q Consensus 161 ~~~------------------------------------~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLy 204 (477)
... .........++||+.|||||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000 00000112467999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHHHHcC
Q 011819 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRIFRDLFIREG 281 (477)
Q Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RP---t~~~l~~~l~~~~~~~~ 281 (477)
+|++|..||.+... ...+..+......... .....+++++.++|.+|+ .+|.+|+ ++.+++ .
T Consensus 236 ell~G~~Pf~~~~~---~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell----------~ 300 (376)
T cd05598 236 EMLVGQPPFLADTP---AETQLKVINWETTLHI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK----------A 300 (376)
T ss_pred ehhhCCCCCCCCCH---HHHHHHHhccCccccC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh----------C
Confidence 99999999976443 2222233221111111 112357889999999987 4999999 656553 3
Q ss_pred CCCCCccccccch
Q 011819 282 FQFDYVFDWTILK 294 (477)
Q Consensus 282 ~~~~~~~dw~~~~ 294 (477)
++|...++|....
T Consensus 301 h~~~~~~~~~~~~ 313 (376)
T cd05598 301 HPFFKGIDFASLI 313 (376)
T ss_pred CCCcCCCCHHHHh
Confidence 4666667777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=333.13 Aligned_cols=265 Identities=22% Similarity=0.272 Sum_probs=206.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||++++..+++.||||++.... ....+..|..++..+.| +++..+..++...++.|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC-QWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 57999999999999999999999999999999875421 12235667777777665 6777777777788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9999 999999998656679999999999999999999999999999999999999 678899999999998764432
Q ss_pred CCcccccccCCCCccCccccccchhcC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g-----~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
.. ......||+.|||||++.+ ..++.++|||||||+||+|++|..||.... ..+.+.++.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (331)
T cd05624 157 TV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHEERF 227 (331)
T ss_pred ce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHHHHHcCCCcc
Confidence 21 1223579999999999876 457889999999999999999999997633 344455554432222
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~--RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
........+++++.+++.+||..++.. |++++++ ..++|+..++|+...
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~----------~~h~~f~~~~~~~~~ 278 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDF----------KKHAFFEGIDWENIR 278 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHH----------hcCCCcCCCCHHHHh
Confidence 222223457899999999999865433 2354443 245667778898754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=329.15 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=208.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.++||+|+||.||++++..+++.||+|++.... ....+..|..++..+.| +++..+..++...+..|||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-QWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCEEEEE
Confidence 47999999999999999999999999999999875321 12235677778777765 6677777777788889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 9999 999999998656679999999999999999999999999999999999999 678899999999997654322
Q ss_pred CCcccccccCCCCccCccccccchhcC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g-----~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
.. .....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||... ...+.+.++.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~ 227 (332)
T cd05623 157 TV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKERF 227 (332)
T ss_pred cc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC---CHHHHHHHHhCCCccc
Confidence 21 1234579999999999863 45788999999999999999999999764 3345555555443222
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~--RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
........+++++.+++.+|+..+++. |+++++++ .++|...++|....
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~----------~h~~f~~~~~~~~~ 278 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFK----------QHPFFTGIDWDNIR 278 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHh----------CCCCcCCCCHHHHh
Confidence 222233567899999999999765443 56765553 35777778888654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=332.49 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=201.1
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKL-YRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~i-l~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
+.||+|+||.||+|++..+++.||+|++.... ....+..|..+ ++.+.| ++|..+..++...+..|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH-PFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCC-CCCCceeEEEEcCCeEEEEEeCCC
Confidence 47999999999999999999999999876432 11233444443 455655 56666666777788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|.+++.. ...++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC----
Confidence 8899999874 5568899999999999999999999999999999999999 6788999999999975432221
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCc
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (477)
.....+||+.|||||++.+..++.++|||||||++|+|++|..||.... ..+.+..+...... +...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~ 220 (325)
T cd05602 152 ---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKPLQ-----LKPNIT 220 (325)
T ss_pred ---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCcC-----CCCCCC
Confidence 1235679999999999999999999999999999999999999997643 33444444433221 335688
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 246 TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
.++.++|.+||..+|.+||+..+. +.++ .++.|...++|..+..
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~---~~~i---~~~~~~~~~~~~~~~~ 264 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDD---FMEI---KNHIFFSPINWDDLIN 264 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCC---HHHH---hcCcccCCCCHHHHHh
Confidence 999999999999999999986432 2222 2456677789987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=329.30 Aligned_cols=259 Identities=21% Similarity=0.272 Sum_probs=205.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.+|+++..+..++...+..|+||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999876431 22345678888888877788888877778888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV----- 151 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC-----
Confidence 999988875 4579999999999999999999999999999999999999 6788999999999875322211
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
.....+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+...... ++..++.
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~~ 221 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILEDEVR-----YPRWLSK 221 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCC-----CCCcCCH
Confidence 1234579999999999999999999999999999999999999997643 33444444433221 3356789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
++.++|.+||..+|.+||++.. ..+.++ ..++|...++|.....
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~--~~~~~l---l~~~~~~~~~~~~~~~ 265 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLP--TGEQDI---KGHPFFREIDWDKLER 265 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCC--CCHHHH---hcCCCcCCCCHHHHHh
Confidence 9999999999999999999722 111111 2346666678876443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=338.08 Aligned_cols=257 Identities=20% Similarity=0.344 Sum_probs=202.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCCC-----cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g-----~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
++|++++.||+|+||.||+|.+...+ ..||||++..... ...+..|+.+++.+..|++|+.+...+...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 47999999999999999999865443 5799998865432 234778999999995557777777777778889
Q ss_pred EEEEecC-CCCHHHHHHHcC------------------------------------------------------------
Q 011819 79 VLVMDLL-GPSLEDLFNFCS------------------------------------------------------------ 97 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~------------------------------------------------------------ 97 (477)
++||||+ +++|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999 999999885321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccc
Q 011819 98 ---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (477)
Q Consensus 98 ---------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 168 (477)
.++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........ .
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~-----~ 269 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNY-----V 269 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcce-----e
Confidence 247888999999999999999999999999999999999 57789999999999865433211 1
Q ss_pred cCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHH
Q 011819 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (477)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (477)
......++..|||||++.+..++.++|||||||++|+|++ |..||....... .+.......... .....+|++
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~ 343 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQM---SRPDFAPPE 343 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCc---cCCCCCCHH
Confidence 1123345678999999999999999999999999999997 999997643321 222222211111 122346899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 248 FASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
+.+++..||..+|++||++.++.+.|++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=342.49 Aligned_cols=251 Identities=21% Similarity=0.274 Sum_probs=194.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeE-------eCcE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-------EGDY 77 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~-------~~~~ 77 (477)
..++|+++++||+|+||.||+|.+..+++.||||.+.... .....|+.+++.+.|++++....++.. ...+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 3568999999999999999999999999999999875432 335679999999998766665554432 1235
Q ss_pred EEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 78 NVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.++||||++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ ...+.+||+|||+|+
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccch
Confidence 679999998899887753 245699999999999999999999999999999999999993 234579999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
.+..... .....||+.|+|||++.+. .++.++|||||||+||+|++|.+||.+.... +.+.++.....
T Consensus 220 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~ 288 (440)
T PTZ00036 220 NLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV---DQLVRIIQVLG 288 (440)
T ss_pred hccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Confidence 6643221 2245789999999998764 6899999999999999999999999775432 22222211100
Q ss_pred ------------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 ------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 ------------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
......++...|+++.+||.+||..+|.+||++.++.
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0011122345688999999999999999999977664
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=322.36 Aligned_cols=257 Identities=19% Similarity=0.243 Sum_probs=198.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 15 IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
||+|+||+||+|.+..+++.||||++..... ...+..|+++++.+.| +++..+..++......++||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC-CcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 7999999999999999999999998754321 1345678999999866 56666666666778899999999 899
Q ss_pred HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 89 LEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 89 L~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc----
Confidence 9888743 23468999999999999999999999999999999999999 6788999999999976644322
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhhhcccccHHHHhcCC
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ......+.... ..+...+
T Consensus 153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 224 (280)
T cd05608 153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS-----VTYPDKF 224 (280)
T ss_pred ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-----CCCcccC
Confidence 12345789999999999999999999999999999999999999976433211 12222222111 1233568
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCccccccch
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAY--LKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~--l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
++++.+++..||+.+|++||++++ +.++++ ++|...++|..+.
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~-------h~~~~~~~~~~~~ 269 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT-------HPLFRDLNWRQLE 269 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc-------ChhhhcCCHhHHh
Confidence 899999999999999999995432 223333 4555556788643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=332.07 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=200.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|.+..+++.||+|++.... ....+..|.+++..+.| ++|..+..++...+..||||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999876432 12345678888888877 56666666777788899999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
++|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc----
Confidence 899888864 4569999999999999999999997 799999999999999 6788999999999875432211
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCc
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (477)
......||+.|+|||++.+..++.++|||||||+||+|++|..||.+... ...+..+..... .++..++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~-----~~p~~~~ 220 (325)
T cd05594 152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEI-----RFPRTLS 220 (325)
T ss_pred ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCC
Confidence 12345799999999999999999999999999999999999999976432 233333332222 1345678
Q ss_pred HHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 246 TEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 246 ~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
+++.++|..||..||++|+ ++.++.+ ++|...++|....
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~----------h~~~~~~~~~~~~ 264 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ----------HKFFAGIVWQDVY 264 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc----------CCCcCCCCHHHHH
Confidence 9999999999999999997 6555532 4566666777543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.57 Aligned_cols=267 Identities=22% Similarity=0.261 Sum_probs=204.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.+|+++++||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.| ++|+.+...+.+.+..|||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h-~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCC-CcCCeEEEEEEeCCEEEEE
Confidence 36999999999999999999999999999999876432 12356789999999987 5566666666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|..+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 80 MDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccc
Confidence 9999 8899999875 4568999999999999999999999999999999999999 678999999999986432110
Q ss_pred CCcc----------------------------------------cccccCCCCccCccccccchhcCCCCCCcchHHHHH
Q 011819 161 THQH----------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 200 (477)
Q Consensus 161 ~~~~----------------------------------------~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlG 200 (477)
.... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0000 000011235799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHHH
Q 011819 201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRIFRDLF 277 (477)
Q Consensus 201 viLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt---~~~l~~~l~~~~ 277 (477)
|+||||++|..||..... .+...++.......... ....+++++.++|.+|+ .+|.+|++ +++++
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~------- 303 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP---LETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK------- 303 (382)
T ss_pred HHHHHHHhCCCCCCCCCH---HHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh-------
Confidence 999999999999976432 33333333221111111 12356889999998876 49999997 54443
Q ss_pred HHcCCCCCCccccccc
Q 011819 278 IREGFQFDYVFDWTIL 293 (477)
Q Consensus 278 ~~~~~~~~~~~dw~~~ 293 (477)
.++|...++|...
T Consensus 304 ---~hp~f~~~~~~~~ 316 (382)
T cd05625 304 ---AHPFFKTIDFSSD 316 (382)
T ss_pred ---cCCCcCCcChHHH
Confidence 3566677788753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=335.23 Aligned_cols=249 Identities=22% Similarity=0.280 Sum_probs=199.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|++.++||+|+||.||+|++..+++.||||++.... ....+..|+.+++.+.| +++..+..++.+..+.|+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h-~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS-EWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCEEEE
Confidence 468999999999999999999999999999999875421 22346678899988877 556666666677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ |++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCC
Confidence 99999 9999999873 468999999999999999999999999999999999999 67899999999999866432
Q ss_pred CCCcccccccCCCCccCccccccchhcCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~----~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
.. ......+||+.|||||++.+. .++.++|||||||+||+|++|..||.+.. ....+.++.......
T Consensus 196 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~ 266 (370)
T cd05596 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMDHKNSL 266 (370)
T ss_pred Cc------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCCcC
Confidence 21 112346799999999998754 37899999999999999999999997643 344555554432211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLK 270 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~--RPt~~~l~ 270 (477)
... ....++.++.++|..||..+|++ |++++++.
T Consensus 267 ~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell 302 (370)
T cd05596 267 TFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIK 302 (370)
T ss_pred CCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHh
Confidence 111 11247899999999999988987 99977664
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=334.37 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=219.3
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.+...|++.+.||.|.||.||+|+++.+|+.+|+|++.+.... ..+.+|+.+|+.|.+|++++.+...++.....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 3556899999999999999999999999999999998765432 46889999999999778999998888888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC-CCcEEEeecCceeec
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKY 156 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~-~~~vkL~DFGla~~~ 156 (477)
++|||+| |+.|.+.+... .+++..+..++.||+.++.|||+.||+||||||+|+|+...+. .+.+|++|||++...
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999 99999998754 3999999999999999999999999999999999999965433 458999999999987
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
.... .....+||+.|+|||++....|+..+||||+||++|.|+.|..||.+.. ....+.++..... ..
T Consensus 190 ~~~~--------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~---~~~~~~~i~~~~~-~f 257 (382)
T KOG0032|consen 190 KPGE--------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET---EFEIFLAILRGDF-DF 257 (382)
T ss_pred cCCc--------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC---hhHHHHHHHcCCC-CC
Confidence 7621 2456799999999999999999999999999999999999999997743 3455556666665 33
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....+..++..++++|..|+..||..|+++.++++
T Consensus 258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 33456778999999999999999999999877655
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=346.43 Aligned_cols=254 Identities=18% Similarity=0.237 Sum_probs=189.6
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCC-----CCCee-EEeeEeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGT-----GIPNV-RWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~-----~i~~~-~~~~~~~~~~ 78 (477)
.++|+++++||+|+||+||+|.+..+++.||||++.... .......|+.++..+.+.+ ++..+ .++.....+.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 478999999999999999999999999999999986432 2234567888888877643 23333 3444455678
Q ss_pred EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCC-------------CCCc
Q 011819 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGR-------------RANQ 144 (477)
Q Consensus 79 ~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~-------------~~~~ 144 (477)
|||||++|++|.+++.. ...+++..+..++.||+.||+|||+ .|||||||||+|||+..++ ..+.
T Consensus 208 ~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 99999999999998875 4579999999999999999999998 5999999999999995321 1125
Q ss_pred EEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH
Q 011819 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (477)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~ 224 (477)
+||+|||++..... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.........
T Consensus 287 vkl~DfG~~~~~~~----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 287 VRICDLGGCCDERH----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred EEECCCCccccCcc----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 99999998854322 12356899999999999999999999999999999999999999976443222222
Q ss_pred HHHHhhhccc---------------------------ccHHHHh-------cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 225 YEKISEKKVS---------------------------TSIEALC-------RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 225 ~~~i~~~~~~---------------------------~~~~~l~-------~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+.++...... ..+..+. ....+.+.+||..||.+||++||++++++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 2111100000 0000000 00134578999999999999999977664
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=319.27 Aligned_cols=254 Identities=13% Similarity=0.228 Sum_probs=202.6
Q ss_pred CCceEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.++|++.+.||+|+||.||+|.+. ..+..||+|.+..... ...+..|+.++..++| +++..+..++..++..+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH-SNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEecCCCcE
Confidence 357999999999999999999865 3467899998775432 2357789999998877 56666666667778899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||+ +++|.+++......+++..++.++.||+.||+|||++|++||||||+|||+ +.++.++|+|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccccc
Confidence 999999 889999987655679999999999999999999999999999999999999 6788999999998764322
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
... .......++..|+|||++.+..++.++|||||||++||+++ |..||...... .....+......
T Consensus 160 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~~--- 227 (266)
T cd05064 160 EAI------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDGFRL--- 227 (266)
T ss_pred cch------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCCC---
Confidence 111 01112345678999999999999999999999999999775 99999775432 233333322111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
..+..+|..+.+++..||..+|++||++++|.+.|..+
T Consensus 228 -~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 13456899999999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=321.02 Aligned_cols=271 Identities=20% Similarity=0.245 Sum_probs=206.1
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.|++.+.||+|+||+||+|.+..+++.||+|++..... ...+..|+++++.++|+ ++..+.+.+..++..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~-~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCc-CceeEEEEEecCCEEEEEE
Confidence 48899999999999999999999999999998765321 23467899999999874 5555555666778899999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||+ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++ +..+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 999 88998888643 3469999999999999999999999999999999999999 677899999999997654322
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.........+. +... ........
T Consensus 157 ~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~-~~~~~~~~ 224 (285)
T cd05632 157 S--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRR-VLETEEVY 224 (285)
T ss_pred c--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHh-hhcccccc
Confidence 1 1345789999999999999999999999999999999999999976433221111 1111 11111223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~ 299 (477)
...+++++.+|+..||..+|++||+..+. .+.++ ..++|...++|...+..+..
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~--~~~~l---~~~~~~~~~~~~~~~~~~~~ 278 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEE--GAGEV---KRHPFFRNMNFKRLEAGMLD 278 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCccc--ChHHH---HcChhhhcCCHHHHhcCcCC
Confidence 45688999999999999999999994211 01111 22345555577765544443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.12 Aligned_cols=251 Identities=16% Similarity=0.183 Sum_probs=195.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
.++|+++++||+|+||.||+|.+..+++.||||... ...+..|+++++.|+|+ +|..+..++......++|||++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~Hp-nIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHP-SIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCC-CCCCEeEEEEECCeeEEEEecC
Confidence 368999999999999999999999999999999643 34578899999999885 5555555666778899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|+.......
T Consensus 166 ~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~---- 237 (391)
T PHA03212 166 KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINA---- 237 (391)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCcccccccccc----
Confidence 8899888864 4568999999999999999999999999999999999999 6788999999999975432211
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc----cHHHHHHHHhhhc---------
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKK--------- 232 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~----~~~~~~~~i~~~~--------- 232 (477)
......+||+.|+|||++.+..++.++|||||||+||+|++|..||...... .....+..+....
T Consensus 238 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 238 --NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred --cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1123467999999999999999999999999999999999999887542210 0011111111000
Q ss_pred -----------------c----cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 -----------------V----STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 -----------------~----~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. ..+.......+|.++.++|.+||..||.+||++.++.+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000111235778999999999999999999777643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=321.41 Aligned_cols=260 Identities=21% Similarity=0.248 Sum_probs=201.4
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 15 IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
||+|+||.||++.+..+|+.||+|.+.... ....+..|++++..+.| +++..+..++..+...++||||+ |++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCC-CcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999875422 22345679999999976 55666666666778899999999 899
Q ss_pred HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccccc
Q 011819 89 LEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (477)
Q Consensus 89 L~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~ 167 (477)
|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce------
Confidence 98887543 3358899999999999999999999999999999999999 6788999999999986644221
Q ss_pred ccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc-HHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||....... ..+........... .....+++
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 224 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK----FEHQNFTE 224 (277)
T ss_pred --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc----cccccCCH
Confidence 123468999999999999899999999999999999999999997643321 12222222221111 11246789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 011819 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 296 (477)
++.+++.+||..+|++||++.++.+ ++ ..++|+..++|...+..
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~---~~---~~h~~f~~~~~~~~~~~ 268 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKND---DP---RKHEFFKTINFPRLEAG 268 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchh---hh---hcChhhcCCCHHHHhcC
Confidence 9999999999999999999865432 22 13566667788765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=335.79 Aligned_cols=271 Identities=20% Similarity=0.280 Sum_probs=207.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||+|.+..+++.||||++... .....+..|..++..++| ++++.+...+...+..|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999987642 123356778999998877 5555555666677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccc
Confidence 9999 8999999874 4569999999999999999999999999999999999999 678999999999987553221
Q ss_pred CCcc----------------------------cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCC
Q 011819 161 THQH----------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (477)
Q Consensus 161 ~~~~----------------------------~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~P 212 (477)
.... .........+||+.|+|||++.+..++.++|||||||+||+|++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 1000 000011245799999999999999999999999999999999999999
Q ss_pred CCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011819 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 292 (477)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 292 (477)
|..... ...+.++........... ...+++++.++|.+|+. +|.+|++...+.++ ..++|...++|..
T Consensus 236 f~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei-------~~hp~f~~~~~~~ 303 (360)
T cd05627 236 FCSETP---QETYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEI-------KSHPFFEGVDWGH 303 (360)
T ss_pred CCCCCH---HHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHH-------hcCCCCCCCCHHH
Confidence 976433 344444443211111110 11367899999999874 99999864333332 3467888889997
Q ss_pred ch
Q 011819 293 LK 294 (477)
Q Consensus 293 ~~ 294 (477)
+.
T Consensus 304 ~~ 305 (360)
T cd05627 304 IR 305 (360)
T ss_pred Hh
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=330.70 Aligned_cols=286 Identities=21% Similarity=0.237 Sum_probs=232.7
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
.|+..+.|...++||+||||+||-++...||+.||+|.+.++. .....+.|..++..++. +.|+.+.+.++..+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s-~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSS-PFIVSLAYAFETKD 258 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhcc-CcEEEEeeeecCCC
Confidence 4677789999999999999999999999999999999765532 23346789999998887 47777777788888
Q ss_pred EEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
..|+||.+| ||+|.-.|-..+ ..|++..++.|+.+|+.||++||+.+||+|||||+|||| |+.|+|+|+|+|||.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAV 335 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEE
Confidence 999999999 999977664433 459999999999999999999999999999999999999 899999999999999
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
.+..... ....+||.+|||||++....|+...|+|||||+||||+.|+-||..-+... +.+.+ +....
T Consensus 336 ei~~g~~--------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---k~eEv-drr~~ 403 (591)
T KOG0986|consen 336 EIPEGKP--------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---KREEV-DRRTL 403 (591)
T ss_pred ecCCCCc--------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---hHHHH-HHHHh
Confidence 8876554 234589999999999999999999999999999999999999996533322 22222 22233
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCCCccC
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARAL 308 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~~~~ 308 (477)
...+++...+++++++|++.+|..||.+|.....- .......++++..++|..+......++..|++..
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~-----ga~evk~HpfFk~lnw~rleagml~PPfiPdp~a 472 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGE-----GAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGA 472 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhccCCCc-----CcchhhhCcccccCCHhHHhccCCCCCCCCCccc
Confidence 44456778899999999999999999999864210 1111234688888999999888877777765543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=337.34 Aligned_cols=250 Identities=21% Similarity=0.270 Sum_probs=215.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.++|+.+++||+|+||.+++++++..+..|++|.+..... ......|+.++.+++|+++|-..+.|..++.+.+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 4689999999999999999999999999999998776542 225678999999999866666666666677779999
Q ss_pred EecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 82 MDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|+|| |++|.+++.... .-|+++.++.|+.||+.||.|||++.|+|||||+.||++ .+++.|+|.|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---cccCceeecchhhhhhcCCc
Confidence 9999 999999998655 559999999999999999999999999999999999999 68888999999999988765
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. ...+.+||+.||+||++.+.+|+.|+|||||||++|||++=+.+|.+ .+......+|..... ..
T Consensus 160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a---~~m~~Li~ki~~~~~----~P 225 (426)
T KOG0589|consen 160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA---SNMSELILKINRGLY----SP 225 (426)
T ss_pred hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc---cchHHHHHHHhhccC----CC
Confidence 42 24578999999999999999999999999999999999999999966 444566666666553 33
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (477)
++..+..++..+|..|+..+|+.||++.+|+..
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 567789999999999999999999998887654
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.63 Aligned_cols=262 Identities=20% Similarity=0.250 Sum_probs=203.6
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.++..++|++ +..+...+...+..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~-i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF-VVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCC-eeeeeEEEecCCEEEEEE
Confidence 48899999999999999999999999999998754321 134667999999998754 444455555677899999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||+ |++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||++ +..+.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 999 89999988543 2358999999999999999999999999999999999999 678899999999987653322
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||.................. .....
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05630 157 T--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VQEEY 224 (285)
T ss_pred c--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh----hhhhc
Confidence 1 12347899999999999999999999999999999999999999764432222222222111 11223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
...+++++.+++..||..+|++||+ ++++. + ++|...++|.....
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~---~-------h~~~~~~~~~~~~~ 274 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK---E-------HPLFKQINFKRLEA 274 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHH---c-------ChhhhccCHHHHhc
Confidence 4568899999999999999999998 44543 2 34444567775443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=327.97 Aligned_cols=270 Identities=19% Similarity=0.282 Sum_probs=206.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
..++|++.++||+|+||.||+|.+..++..||+|++...... ..+..|+++++.++| ++|+.+..++...+..+||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CcccceeEEEEECCEEEEE
Confidence 357899999999999999999999999999999987654322 357889999999987 4555566666678889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|||+ +++|.+++.. ...++...+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh
Confidence 9999 8999999975 45689999999999999999999975 79999999999999 67788999999999765332
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH-------------
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE------------- 226 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~------------- 226 (477)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.
T Consensus 158 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (333)
T cd06650 158 M---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228 (333)
T ss_pred c---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence 1 134578999999999999899999999999999999999999997543211111100
Q ss_pred ------------------------HHhhhcccccHHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 227 ------------------------KISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 227 ------------------------~i~~~~~~~~~~~l~-~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
.+...........+. ..++.++.+||.+||..||++||++.++ +.+.|.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el---l~h~~~~~~ 305 (333)
T cd06650 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL---MVHAFIKRS 305 (333)
T ss_pred cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH---hhCHHHhcC
Confidence 000000000000011 1357889999999999999999997666 445554443
Q ss_pred -CCCCCccccc
Q 011819 282 -FQFDYVFDWT 291 (477)
Q Consensus 282 -~~~~~~~dw~ 291 (477)
.+..+...|.
T Consensus 306 ~~~~~~~~~~~ 316 (333)
T cd06650 306 EAEEVDFAGWL 316 (333)
T ss_pred ccccccHHHHH
Confidence 3444555665
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=322.24 Aligned_cols=254 Identities=19% Similarity=0.265 Sum_probs=199.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++.++||+|+||.||+|++..+++.||||.+.... ....+..|+.+++.++|+ ++..+..++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA-NIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCC-CcceEEEEEeeCCeEEEEEe
Confidence 67999999999999999999999999999999876432 223567899999999874 55555556667778999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
|+.++|.+++......++...+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCcc--
Confidence 99889999987666668999999999999999999999999999999999999 6788999999999976533221
Q ss_pred ccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc---------
Q 011819 164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (477)
......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.+......
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 160 -----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred -----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 1233467899999999875 4578999999999999999999999976544322222222111000
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 -------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+++++.++|.+||..||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00111223457889999999999999999999776643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=317.21 Aligned_cols=252 Identities=19% Similarity=0.250 Sum_probs=194.8
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHc--CCCCCCeeEEeeE-----eCc
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQ--GGTGIPNVRWFGV-----EGD 76 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~--~~~~i~~~~~~~~-----~~~ 76 (477)
+|++.+.||+|+||.||+|.+..+++.||||.+..... ......|+.+++.+. .|+++..+..++. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 59999999999999999999999999999998765322 224567888888775 2355555443332 235
Q ss_pred EEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..+++|||+.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcccc
Confidence 579999999889999887533 348999999999999999999999999999999999999 6788999999999986
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh----
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---- 231 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~---- 231 (477)
...... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+......
T Consensus 158 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 158 YSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 643221 12356899999999999999999999999999999999999999764432222222111100
Q ss_pred ---------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 232 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 232 ---------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
........+.+.++.++.+++.+||..||++||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 001122334456788999999999999999999987765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=330.99 Aligned_cols=250 Identities=19% Similarity=0.282 Sum_probs=218.6
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
+..|.+=|.+.+.||+|.|..|-+|+|..+|+.||||++.+... ...+..|+..|+.++| ++|+.++.+......
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQH-pNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQH-PNIVRLYEVIDTQTK 91 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcC-cCeeeeeehhcccce
Confidence 34677889999999999999999999999999999999876542 2358899999999998 566666666667788
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.||++|+- +|+|.|+|-.+...+++..+.+|+.||+.||.|+|+..+|||||||+||.+. .+-|.|||.|||++..+
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccC
Confidence 89999999 8899999988888899999999999999999999999999999999999886 67899999999999877
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s-~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
..... ..+.||+..|-|||+++|..|+ +++||||||||||-|++|++||+..++ -+.+..|+++++..
T Consensus 170 ~PG~k--------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---SETLTmImDCKYtv 238 (864)
T KOG4717|consen 170 QPGKK--------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---SETLTMIMDCKYTV 238 (864)
T ss_pred CCcch--------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---hhhhhhhhcccccC
Confidence 65433 4678999999999999999997 789999999999999999999987554 45677788888764
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+..++.++++||+.||..||.+|.+.++|.
T Consensus 239 -----PshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 239 -----PSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred -----chhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 345788999999999999999999977764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=325.57 Aligned_cols=259 Identities=19% Similarity=0.286 Sum_probs=201.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
..++|++.+.||+|+||.||++++..++..||+|++..... ...+..|+++++.++|+ ++..+..++...+..++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP-YIVGFYGAFYSDGEISIC 81 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCC-CCCeEEEEEEECCEEEEE
Confidence 35789999999999999999999999999999998875432 23578899999999874 555555556677789999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred eecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCccccccccc
Confidence 9999 8999999975 45689999999999999999999986 69999999999999 67889999999999765432
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH-----------
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----------- 228 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i----------- 228 (477)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+...
T Consensus 158 ~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 158 M---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred c---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 2 23457899999999999999999999999999999999999999654321111110000
Q ss_pred ----------------------------hhhcccccHHHH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 229 ----------------------------SEKKVSTSIEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 229 ----------------------------~~~~~~~~~~~l-~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
............ ...+++++.+||.+||..||++||++.++ |++.|.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el---l~h~~~~ 305 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML---MNHTFIK 305 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH---hcChHHh
Confidence 000000000000 12467899999999999999999997766 4555544
Q ss_pred c
Q 011819 280 E 280 (477)
Q Consensus 280 ~ 280 (477)
.
T Consensus 306 ~ 306 (331)
T cd06649 306 R 306 (331)
T ss_pred h
Confidence 3
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=329.22 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=199.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHH-HHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKL-YRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~i-l~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
+.||+|+||+||+|.+..+++.||||++.... ....+..|..+ ++.+.| +++..+...+...+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-p~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCC-CCCccEEEEEecCCEEEEEEcCCC
Confidence 46999999999999999999999999876431 12234455544 444555 56666666667788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC----
Confidence 8899888864 5679999999999999999999999999999999999999 6788999999999875322111
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCc
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (477)
.....+||+.|||||++.+..++.++|||||||++|+|++|..||.... ..+.+..+..... .+.+.++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~ 220 (325)
T cd05604 152 ---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNILHKPL-----VLRPGAS 220 (325)
T ss_pred ---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHHcCCc-----cCCCCCC
Confidence 1234679999999999999999999999999999999999999997633 3344444443322 1234678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 246 TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
.++.+++..||..+|.+||++.+. +.++ ..++|...++|.....
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~---~~~i---~~h~~f~~~~~~~~~~ 264 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKED---FLEI---QEHPFFESLSWTDLEQ 264 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCC---HHHH---hcCCCcCCCCHHHHHh
Confidence 899999999999999999986421 2222 2456666778876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.41 Aligned_cols=256 Identities=21% Similarity=0.320 Sum_probs=202.1
Q ss_pred CceEEEeeeeecCceEEEEEEE-----CCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~-----~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
++|+++++||+|+||.||+|++ ..++..||||++..... ...+..|+.++..+.+|++|+.+..++..++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4799999999999999999974 34567899998864332 235778999999996668888887788888889
Q ss_pred EEEEecC-CCCHHHHHHHcC------------------------------------------------------------
Q 011819 79 VLVMDLL-GPSLEDLFNFCS------------------------------------------------------------ 97 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~------------------------------------------------------------ 97 (477)
++||||+ +++|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999 999999886321
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 98 --------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 98 --------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
..+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSNY- 270 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCcccc-
Confidence 147788899999999999999999999999999999999 56788999999999866443221
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..+..+... ... ..+.
T Consensus 271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~-~~~---~~~~ 340 (375)
T cd05104 271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEG-YRM---LSPE 340 (375)
T ss_pred ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhC-ccC---CCCC
Confidence 11123345678999999999999999999999999999998 899997654322 112222211 111 1223
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
..|.++.+++..||..+|++||++.++.+.|++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 4688999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.53 Aligned_cols=246 Identities=21% Similarity=0.260 Sum_probs=191.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
..+|+++++||+|+||.||+|++..+++.||||++..... ...+..|+++++.++|. +|..+..++...+..++||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHP-NVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCC-CcceeeeEeccCCeEEEEE
Confidence 3578999999999999999999999999999998754332 23577899999999875 5555555566777889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+. .......+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 152 e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 152 EFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred ecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccccc
Confidence 999 7887543 235677888999999999999999999999999999999 6789999999999987643221
Q ss_pred CcccccccCCCCccCccccccchhcC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g-----~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
......||..|+|||++.. ...+.++|||||||+||+|++|+.||..............+.....
T Consensus 224 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 293 (353)
T PLN00034 224 -------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--- 293 (353)
T ss_pred -------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC---
Confidence 1234579999999998743 2345689999999999999999999975333332222222221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
......++.++.+||..||..+|++||++.++++
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1133567899999999999999999999777654
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.05 Aligned_cols=253 Identities=22% Similarity=0.246 Sum_probs=201.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEe-----
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVE----- 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~----- 74 (477)
..+++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+.|.+.+.....+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 4568999999999999999999999999999999998654322 2356788888877775555444333221
Q ss_pred --CcEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEe
Q 011819 75 --GDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (477)
Q Consensus 75 --~~~~~lVmE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~ 148 (477)
....++||||+ +++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEE
Confidence 12468999999 89999998632 3468999999999999999999999999999999999999 678899999
Q ss_pred ecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 011819 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (477)
Q Consensus 149 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i 228 (477)
|||+++.+...... ......+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.. ....+.++
T Consensus 186 DFGls~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSD-----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHKT 257 (496)
T ss_pred ecccCeeccccccc-----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence 99999876543221 11235689999999999999999999999999999999999999997633 33344444
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..... ..++..+++++.+++..||..+|++||++.++.+
T Consensus 258 ~~~~~----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LAGRY----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hcCCC----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 33222 2245678999999999999999999999888754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=331.16 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=194.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEe-----
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVE----- 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~----- 74 (477)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.++|++++..+..+...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35689999999999999999999999999999999876432 223567899999999886666665555322
Q ss_pred CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
....|+||||++++|.+.+. ..++...+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCcc
Confidence 23579999999888888775 358899999999999999999999999999999999999 678999999999997
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
....... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+..... .+..+......
T Consensus 172 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~ 240 (359)
T cd07876 172 TACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGT 240 (359)
T ss_pred ccccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCC
Confidence 5432211 234578999999999999999999999999999999999999998654321 11111110000
Q ss_pred -------------------------ccHHHH------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 235 -------------------------TSIEAL------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 235 -------------------------~~~~~l------------~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.....+ ....++++.+||.+||..||++||++.++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 1123567899999999999999999776643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=339.75 Aligned_cols=202 Identities=25% Similarity=0.340 Sum_probs=174.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHc-----CCCCCCeeEEeeEeCcEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQ-----GGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~-----~~~~i~~~~~~~~~~~~~ 78 (477)
+..+|++++.||+|+||.|.+|.+..|++.||||+++.+. ...+...|+.+|..|+ +..+++.+..++...++.
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 4458999999999999999999999999999999987643 3456778999999998 235666777888899999
Q ss_pred EEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|||+|++..+|.++++.. -..|++..++.++.||+.||.+||+.||||+||||+||||.... ...|||+|||.|....
T Consensus 264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~-r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK-RSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC-cCceeEEecccccccC
Confidence 999999999999999853 34589999999999999999999999999999999999996533 3489999999998665
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~ 217 (477)
+... +.+-+..|.|||+++|.+|+.+.||||||||++||++|.+-|.+.+
T Consensus 343 q~vy----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 343 QRVY----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred Ccce----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 4322 4567788999999999999999999999999999999988887743
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=325.53 Aligned_cols=253 Identities=20% Similarity=0.285 Sum_probs=199.3
Q ss_pred EeeeeecCceEEEEEEEC---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+++||+|+||.||++++. .+++.||||++.... ....+..|+.+++.++|++ |..+...+..++..|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF-IVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCc-hhceeeEEecCCeEEEEE
Confidence 368999999999999864 468899999876421 1234567999999998854 555545556677889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+++.. ...+.+..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 999 8899999875 4568899999999999999999999999999999999999 6789999999999875432221
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......||+.|+|||++.+..++.++|||||||+||+|++|..||.... ..+.+..+..... .++
T Consensus 156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~~~~~~-----~~~ 220 (323)
T cd05584 156 -------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKILKGKL-----NLP 220 (323)
T ss_pred -------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCC-----CCC
Confidence 1234579999999999999899999999999999999999999997643 2344444443322 234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
..+++++.++|.+||..+|++|| +++++.+ ++|....+|....
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~----------h~~~~~~~~~~~~ 268 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS----------HPFFRHVNWDDLL 268 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc----------CCCcCCCCHHHHh
Confidence 56789999999999999999999 6555533 4555556776543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=323.94 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=199.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHH-HHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESK-LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~-il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
+.||+|+||.||+|++..+++.||||++.... ....+..|.. +++.+.| ++++.+...+...+..|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH-PFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999876432 1223445544 4556665 56666666677788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCC----
Confidence 8899888864 4568999999999999999999999999999999999999 6789999999999875322211
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCc
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+ ..+.+..+...... +....+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~-----~~~~~~ 220 (321)
T cd05603 152 ---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKPLQ-----LPGGKT 220 (321)
T ss_pred ---ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCCCC-----CCCCCC
Confidence 1234679999999999999999999999999999999999999997643 34445555443321 335578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccch
Q 011819 246 TEFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~-~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
.++.+++..||..+|.+||+.. ++.++ ..++|....+|..+.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~-------~~~~~~~~~~~~~~~ 263 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEI-------KNHVFFSPINWDDLY 263 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHH-------hCCCCcCCCCHHHHh
Confidence 8999999999999999999752 23332 245566667887643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=317.51 Aligned_cols=250 Identities=19% Similarity=0.261 Sum_probs=203.0
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc------E
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGD------Y 77 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~------~ 77 (477)
.|+.+++||+|+||+||+|+++.+|+.||+|.+...... ....+|+.+++.|+|.++|+.+..+....+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 477889999999999999999999999999988765442 246899999999999886766666655544 7
Q ss_pred EEEEEecCCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 78 NVLVMDLLGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~---~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.+||+||+.-+|.++++... ..++...+..++.||+.||+|||+++|+||||||+|||| ++.|.+||+|||+|+
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeeccchHH
Confidence 78999999999999998766 358888999999999999999999999999999999999 679999999999999
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
.+.- |.+.....++|..|.|||++.|. .|+...||||+|||++||++++.-|.+... .+.+.+|.+..-
T Consensus 169 a~~i-------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lG 238 (323)
T KOG0594|consen 169 AFSI-------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLG 238 (323)
T ss_pred HhcC-------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcC
Confidence 6543 33445677899999999999997 789999999999999999999999988554 334433333221
Q ss_pred cc-------------------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 ST-------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 ~~-------------------------~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.+ ......+...++..+++.+||.++|.+|.++..+.
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al 300 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGAL 300 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHh
Confidence 11 00111112234789999999999999999976553
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.20 Aligned_cols=251 Identities=21% Similarity=0.269 Sum_probs=196.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.++..+.| +++..+..++..+.+.|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEE
Confidence 3578999999999999999999999999999999875421 22346678888888877 55666666666788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|.....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceeccc
Confidence 999999 9999999973 468999999999999999999999999999999999999 6789999999999987643
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~----~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
... ......+||+.|||||++.+.. ++.++|||||||+||+|++|..||.... ....+.++......
T Consensus 195 ~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~~i~~~~~~ 265 (370)
T cd05621 195 TGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYSKIMDHKNS 265 (370)
T ss_pred CCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcc
Confidence 221 1123567999999999997653 7889999999999999999999997643 34455555443221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKR 271 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~--RPt~~~l~~ 271 (477)
...+ ....++..+.+++..||..++.. |+++.++++
T Consensus 266 ~~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 266 LNFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred cCCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 1111 01246889999999999854433 778665543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.90 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=208.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~----~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.+.+.+++.||+|.||+||+|.+-. .||||++++....+ .|..|+.+|++-+|.|++....+ +....+ .||
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~-~~~p~~-AIi 465 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA-CMNPPL-AII 465 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh-hcCCce-eee
Confidence 4567789999999999999999644 49999998876443 47889999999888655444444 444444 899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
..+| |.+|..+++....+|...+.+.|+.||++|+.|||.++|||||||..||+| .+++.|||.||||+.......
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeeeec
Confidence 9999 899999998777889999999999999999999999999999999999999 677999999999997654432
Q ss_pred CCcccccccCCCCccCccccccchhcCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~---~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
... ......|...|||||++... +|++.+|||||||++|||++|.+||.. ....+.+..+.........
T Consensus 543 g~~-----q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi---~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 543 GEQ-----QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI---QNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred ccc-----ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC---CChhheEEEecccccCccc
Confidence 211 12445788999999999753 589999999999999999999999974 3344555555554333444
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
-....++|.++++|+..||..++++||.+.+|...|+.++
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 4566789999999999999999999999999998777775
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=319.48 Aligned_cols=273 Identities=20% Similarity=0.276 Sum_probs=224.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.-++|+.++.||+|.||.|.+|+-+.+++.||||+++++.. ...-+.|..++....| |.+..+.+.++..+..|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H-PFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRH-PFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccC-cHHHHhhhhhccCceEE
Confidence 44789999999999999999999999999999998876432 2234568888888777 67777788888889999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||. ||.|.-.+.+ .+.|++..++.|...|+.||.|||+++||+||||.+|.|+ |++|++||+|||||+.-..
T Consensus 245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccc
Confidence 999999 8988887875 5669999999999999999999999999999999999999 8999999999999985332
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
.. ...+++||||.|+|||++....|+..+|+|.+||++|||++|++||...+. ...++-|.-..+.
T Consensus 321 ~g-------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~k---- 386 (516)
T KOG0690|consen 321 YG-------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDLK---- 386 (516)
T ss_pred cc-------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhcc----
Confidence 22 135789999999999999999999999999999999999999999976433 3444444433322
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCC--HHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPD--YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt--~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
++..++++.+.|+..+|.+||.+|.. .+++++++++- |+..+||...-..+..++..|
T Consensus 387 -FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~-------FF~~v~W~~~~~Kki~PPfKP 446 (516)
T KOG0690|consen 387 -FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR-------FFASVDWEATYRKKIEPPFKP 446 (516)
T ss_pred -CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh-------hhccCCHHHHHHhccCCCCCC
Confidence 44668899999999999999999984 46777766554 456679998766666655554
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=360.64 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=220.0
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|+|++.||+|+||.|.+++++.+++.||+|++++- .....|..|..+|.... ..=|..+.+.+.+..+.||
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEE
Confidence 46899999999999999999999999999999998762 22334677777776544 4667777888889999999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ ||+|-.|+.... ++++..+.+|+..|+.||.-||+.|+|||||||+|||| |..|++||+|||.|..+...
T Consensus 153 VMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCC
Confidence 99999 999999998655 79999999999999999999999999999999999999 89999999999999888765
Q ss_pred CCCcccccccCCCCccCccccccchhcC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-----~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
+... ....+|||.|.+||++.. +.|++.+|+||+||++|||++|..||+. +.....|.+|+..+..
T Consensus 229 G~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 229 GTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNHKES 299 (1317)
T ss_pred CcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhchhhh
Confidence 5422 345689999999999863 5689999999999999999999999954 6778899999887543
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt---~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
...+.. ..++++.++||..++. +|+.|.. +++++ .++|+...||..+.
T Consensus 300 l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik----------~HpFF~g~~W~~iR 350 (1317)
T KOG0612|consen 300 LSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIK----------NHPFFEGIDWDNIR 350 (1317)
T ss_pred cCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHH----------hCccccCCChhhhh
Confidence 222211 2388999999999986 7888876 55553 47899999997543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=329.32 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=204.4
Q ss_pred EeeeeecCceEEEEEEEC---CCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
++.||+|+||.||++.+. .+++.||||++.... ....+..|++++..++| ++|..+..++...+..|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH-PFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCC-CCcccEEEEEEcCCEEEEEEcC
Confidence 367999999999999863 578999999876432 22346678999999987 4555566666677889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCC--
Confidence 9 8999999864 4569999999999999999999999999999999999999 6788999999999876543211
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..+...... ++..
T Consensus 154 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~~~-----~p~~ 220 (318)
T cd05582 154 -----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAKLG-----MPQF 220 (318)
T ss_pred -----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCCCC-----CCCC
Confidence 1234679999999999999889999999999999999999999997633 33444444433321 3356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCccccccchhh
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAY--LKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~--l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 296 (477)
+++++.+++..||..||++||++.+ +.+++ .++|...++|......
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~-------~~~~~~~~~~~~~~~~ 268 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIK-------RHPFFSTIDWNKLYRR 268 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHh-------CCCCcCCCCHHHHHhc
Confidence 7899999999999999999999765 44433 3556666788865443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=316.94 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=207.9
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecC----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeE----eCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLLYESKLYRILQGGTGIPNVRWFGV----EGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~----~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~----~~~ 76 (477)
+...|..++.||.|+||.|+.+.+..+|+.||||.+.. ........+|+++++.++|.+++...+.+.. ...
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 55677778999999999999999999999999997652 1223457799999999998777666666544 345
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 77 ~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
..|+|+|+|+.+|.++++. ++.++...+..++.||++||.|+|+.+|+||||||.|+|+ +.+..+||||||+|+..
T Consensus 100 DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence 6799999999999999983 5559999999999999999999999999999999999999 68889999999999988
Q ss_pred ccCCCCcccccccCCCCccCccccccchhc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH-----------
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK----------- 224 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~----------- 224 (477)
...... ...+..+.|..|.|||++. ..+|+...||||+||||.||++|+.-|.+.+.-...+.
T Consensus 176 ~~~~~~-----~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 176 DKFFED-----GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred cccCcc-----cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 543110 1134567899999999875 46799999999999999999999999987433111111
Q ss_pred -HHHH-----------hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 225 -YEKI-----------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 225 -~~~i-----------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+.++ .......+...+.++.++...+|+++||..||.+|+|++++ |++.+..
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA---L~hPYl~ 314 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA---LAHPYLA 314 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH---hcChhhh
Confidence 1111 12223344556667888999999999999999999996655 4555433
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=317.37 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=203.2
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCC-----cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g-----~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+..... ...+..|+.++..+.|+ ++..+..++.....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~-~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP-NIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCc-ccceEEEEEcCCCc
Confidence 467999999999999999999976555 6899998765432 23477899999999875 45555555556677
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 78 NVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+|||+ +.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---cC
Confidence 89999999 899999987531 457889999999999999999999999999999999999 57
Q ss_pred CCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCccc
Q 011819 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~ 220 (477)
++.++|+|||+++....... +.......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-- 232 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-- 232 (283)
T ss_pred CCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 78999999999986543221 111233456889999999998899999999999999999998 9999987543
Q ss_pred HHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
.+.+..+...... ..+..+|+++.+++..||+.+|++||++.++.+.|+.
T Consensus 233 -~~~~~~i~~~~~~----~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 -QEVIEMIRSRQLL----PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHHcCCcC----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 3334444333222 2345789999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=326.76 Aligned_cols=260 Identities=19% Similarity=0.309 Sum_probs=202.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCee-EEeeEeC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNV-RWFGVEG 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~-----~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~-~~~~~~~ 75 (477)
-.++|++++.||.|+||.||+|.... +++.||+|++..... ...+..|+.++..+.+|+++..+ ..+...+
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 45689999999999999999997433 457899998764332 23467899999999555555555 4455566
Q ss_pred cEEEEEEecC-CCCHHHHHHHcC---------------------------------------------------------
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCS--------------------------------------------------------- 97 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~--------------------------------------------------------- 97 (477)
...+++|||+ +++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 7788999999 899999985321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCc
Q 011819 98 ---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174 (477)
Q Consensus 98 ---~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~ 174 (477)
..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.+...... .......
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~ 236 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKGDAR 236 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcch-----hhccCCC
Confidence 257899999999999999999999999999999999999 56789999999999865432211 1122345
Q ss_pred cCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHH
Q 011819 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFH 253 (477)
Q Consensus 175 Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~ 253 (477)
++..|+|||++.+..++.++|||||||+||+|++ |..||.+..... .+.......... .....+++++.+++.
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~~~~l~~ 310 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKEGTRM---RAPEYATPEIYSIML 310 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhccCCC---CCCccCCHHHHHHHH
Confidence 6778999999999999999999999999999997 999997643321 111111111111 122456889999999
Q ss_pred HHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 254 YCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 254 ~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
+||..+|++||++.++.+.|++++.
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=329.00 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=195.6
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|..++..+.| +++..+...+..+.+.|+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEEEE
Confidence 479999999999999999999999999999999875421 12235678888888776 556666666677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ |++|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 121 v~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 121 VMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcC
Confidence 99999 8999999873 458999999999999999999999999999999999999 67899999999999876432
Q ss_pred CCCcccccccCCCCccCccccccchhcCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~----~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
.. ......+||+.|||||++.+.. ++.++|||||||+||+|++|..||... +....+.++.......
T Consensus 196 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~ 266 (371)
T cd05622 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNSL 266 (371)
T ss_pred Cc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCcc
Confidence 21 1123567999999999997643 788999999999999999999999763 3344555555432211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCC---CCCHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDD---KPDYAYLK 270 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~---RPt~~~l~ 270 (477)
... ....++.++.++|..||. ++.. |+++++++
T Consensus 267 ~~~-~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~ 302 (371)
T cd05622 267 TFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIK 302 (371)
T ss_pred cCC-CcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHh
Confidence 111 123578999999999998 5554 56655543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=302.73 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=213.0
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
...++|++++.||+|-||.||+|+...++-.||+|++.+.+ ...++.+|++|...|+|++++..+.+| .+....
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-hd~~ri 97 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-HDSKRI 97 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-ecccee
Confidence 45678999999999999999999999999999999876543 345688999999999996655555554 466678
Q ss_pred EEEEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 79 VLVMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
||++||. .|.|...+.. ...+|++..+..|+.|++.||.|+|.+++|||||||+|+|+ ...+.+||+|||.+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc---CCCCCeeccCCCceeec
Confidence 9999999 7888777762 24569999999999999999999999999999999999999 57899999999998755
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
.. ....++|||..|.+||+..+..++..+|+|++|++.|||+.|..||.... ..+.|.+|.......
T Consensus 175 p~---------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~- 241 (281)
T KOG0580|consen 175 PS---------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKF- 241 (281)
T ss_pred CC---------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccC-
Confidence 42 23467899999999999999999999999999999999999999997643 567787777766543
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
+..++.+++++|.+|+.++|.+|.. +.+.+.+.++..
T Consensus 242 ----p~~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~a 278 (281)
T KOG0580|consen 242 ----PSTISGGAADLISRLLVKNPIERLA---LTEVMDHPWIVA 278 (281)
T ss_pred ----CcccChhHHHHHHHHhccCcccccc---HHHHhhhHHHHh
Confidence 3668999999999999999999998 555566666543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=325.37 Aligned_cols=257 Identities=20% Similarity=0.246 Sum_probs=198.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHc--CCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 15 IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
||+|+||.||+|++..+++.||||++..... ......|..++..+. +++++..+...+......|+||||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999998754321 122345666666554 6788888888788888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~----- 151 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNK----- 151 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCC-----
Confidence 999988874 5679999999999999999999999999999999999999 6788999999999875322211
Q ss_pred cccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCc
Q 011819 167 YRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (477)
.....+||..|||||++.+. .++.++|||||||+||+|++|..||.... ..+.+..+.......+ ...++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~----~~~~~ 222 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIAFGKVRFP----KNVLS 222 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHHcCCCCCC----CccCC
Confidence 12356799999999998764 47899999999999999999999997633 3344444443332211 12468
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchhh
Q 011819 246 TEFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (477)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~-~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 296 (477)
+++.++|..||..+|++||++. .+.++++ ++|....+|......
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~-------h~~~~~~~~~~~~~~ 267 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE-------HPFFADIDWDLLSKK 267 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc-------CccccCCCHHHHHhC
Confidence 8999999999999999999532 2333322 455566678765443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=330.87 Aligned_cols=254 Identities=16% Similarity=0.177 Sum_probs=198.5
Q ss_pred cCCceEEEeeeeecCceEEEEEEEC--CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~--~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+..+|+++++||+|+||.||+|... .+++.||+|.+... ....+|+++++.|+|++++. +..++......|++|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~-~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIIN-LIHAYRWKSTVCMVM 165 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccc-eeeeEeeCCEEEEEe
Confidence 4567999999999999999999754 35678999986543 34578999999998855544 444455677889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.++|+|||++.........
T Consensus 166 e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 166 PKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCccccc
Confidence 9998899998853 5679999999999999999999999999999999999999 67899999999999866543221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc--------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------- 234 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (477)
.......||+.|+|||++.+..++.++|||||||+||+|++|..||.+.........+..+......
T Consensus 242 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 242 -----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred -----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 1123467999999999999999999999999999999999999999875543333333332221100
Q ss_pred -------------------ccHHHH--hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 235 -------------------TSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 235 -------------------~~~~~l--~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...+.+ ...++.++.++|.+||..+|++||++.++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 1245778999999999999999999877754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=327.62 Aligned_cols=250 Identities=20% Similarity=0.264 Sum_probs=194.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeE-----eC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV-----EG 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~-----~~ 75 (477)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.|++++..+..+.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 5689999999999999999999999999999999876432 22356789999999988766666554432 23
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...|+||||++++|.+++. ..++...+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccc
Confidence 4579999999888888875 348899999999999999999999999999999999999 6788999999999976
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... .....||..|+|||++.+..++.++|||||||+||+|++|..||.+... ...+.++.......
T Consensus 176 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~ 244 (364)
T cd07875 176 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTP 244 (364)
T ss_pred cCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 543221 2345789999999999999999999999999999999999999976433 22222222110000
Q ss_pred -------------------------cHHHH------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 -------------------------SIEAL------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 -------------------------~~~~l------------~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+.+ ....+.++.++|.+||..||.+||++.++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 0112457899999999999999999776643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=332.33 Aligned_cols=251 Identities=21% Similarity=0.299 Sum_probs=199.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
+..|+++++||+||.+.||++.. .....||+|.+...... ..+..|+..|.+|+++..|..+.+|...+++.|||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 56799999999999999999996 44455666644332222 34789999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 82 mE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|||-..+|.++++.....++...+..|..||+.|+.++|.+||||.||||.|||| -.|.+||+|||+|.......+
T Consensus 439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcccc
Confidence 9999999999998655555655888999999999999999999999999999999 578999999999998877655
Q ss_pred CcccccccCCCCccCccccccchhcCCC-----------CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIE-----------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-----------~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
... ...-+||+.||+||.+.... .++++||||||||||+|+.|+.||.... +...++..|.+
T Consensus 515 sI~-----kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~ 587 (677)
T KOG0596|consen 515 SIV-----KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITD 587 (677)
T ss_pred cee-----eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcC
Confidence 321 23458999999999987543 4578999999999999999999996532 22344444544
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.........+.+. .++.+++..||.+||.+||+..+|+
T Consensus 588 P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 588 PNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred CCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHh
Confidence 3332222223222 3499999999999999999966553
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.43 Aligned_cols=255 Identities=20% Similarity=0.347 Sum_probs=205.0
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
..+|.+.++||.|+||.||+|.+..+++.||+|++..... ...+..|+++++.+.|++ +..+..++......+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN-LVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCC-hhheEEEEcCCCCcEEEEEe
Confidence 4579999999999999999999999999999998765432 245788999999998854 44454555566778999999
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||+ +.++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccceee
Confidence 9 899999987533 458999999999999999999999999999999999999 67889999999999866543211
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+... ...+..+.... .....
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~----~~~~~ 227 (263)
T cd05052 161 ------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGY----RMERP 227 (263)
T ss_pred ------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCC----CCCCC
Confidence 1112234668999999999999999999999999999998 9999976432 23333332211 11234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+|.++.+++.+||..+|++||++.++.+.|+.+|
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 668999999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=330.94 Aligned_cols=258 Identities=22% Similarity=0.291 Sum_probs=205.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCC-----CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~-----g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
.++|++++.||+|+||.||+|++... +..||||++..... ...+..|++++..+..|++|+.+..++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 45788999999999999999987433 35799998865432 23578899999999856778888777778888
Q ss_pred EEEEEecC-CCCHHHHHHHcC-----------------------------------------------------------
Q 011819 78 NVLVMDLL-GPSLEDLFNFCS----------------------------------------------------------- 97 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~----------------------------------------------------------- 97 (477)
.||||||| +++|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999 999999886421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 98 ------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 98 ------------------------------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
..+++..++.++.||+.||+|||+++|+||||||+|||+ +.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---AQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---eC
Confidence 237788889999999999999999999999999999999 56
Q ss_pred CCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCccc
Q 011819 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~ 220 (477)
++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 788999999999866432221 11233457788999999999999999999999999999997 999997643321
Q ss_pred HHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+..+..... . .....+|.++.+++.+||..+|++||++.+|.+.|+.++
T Consensus 348 --~~~~~~~~~~~-~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 --TFYNKIKSGYR-M---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHHhcCCC-C---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 12222222111 1 123467899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=325.66 Aligned_cols=250 Identities=19% Similarity=0.232 Sum_probs=194.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEe-----C
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE-----G 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~-----~ 75 (477)
+.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.+.|++.+..+..+... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 56899999999999999999999999999999998765322 23466899999999987666666555322 2
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...|+||||++++|.+.+. ..++...+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCccccc
Confidence 3569999999888888775 358899999999999999999999999999999999999 6788999999999976
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+.......
T Consensus 169 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~ 237 (355)
T cd07874 169 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTP 237 (355)
T ss_pred CCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence 543221 23457899999999999999999999999999999999999999764321 1111111100000
Q ss_pred -------------------------c------------HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 -------------------------S------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 -------------------------~------------~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. ........+.++.++|.+||..||++||++.++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0 00011123567899999999999999999777643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.54 Aligned_cols=260 Identities=19% Similarity=0.266 Sum_probs=202.8
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCc----EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeE
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGV 73 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~----~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~ 73 (477)
|+-....+|++.++||+|+||.||+|++..++. .||||++..... ...+..|..++..+.|++ +..+..++.
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~ 79 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY-VCRLLGICL 79 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCC-CceEEEEEc
Confidence 677788999999999999999999999877766 489998765432 234677888888887754 444444443
Q ss_pred eCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCc
Q 011819 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (477)
Q Consensus 74 ~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGl 152 (477)
. ...+++|||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~ 155 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGL 155 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCc
Confidence 3 3467899999 899999987655679999999999999999999999999999999999999 5678899999999
Q ss_pred eeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhh
Q 011819 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 231 (477)
Q Consensus 153 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (477)
++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+...
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~ 227 (279)
T cd05109 156 ARLLDIDETEY-----HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLEKG 227 (279)
T ss_pred eeeccccccee-----ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCC
Confidence 98775432211 0112234678999999999899999999999999999998 99999764432 222222221
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
... .....++.++.+++..||..+|+.||++.++.+.|+++.
T Consensus 228 ~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 228 ERL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CcC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111 122457889999999999999999999999988887764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=325.66 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=196.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeE-----e
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV-----E 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~-----~ 74 (477)
.+.++|++++.||.|+||.||+|.+..+++.||||++..... ...+..|+.+++.++|++++..+..+.. .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 467899999999999999999999999999999998764321 2346689999999998666555544322 2
Q ss_pred CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
....|++|++++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCccce
Confidence 24568999999999999886 4569999999999999999999999999999999999999 678999999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc-
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (477)
...... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.... +.+..+....
T Consensus 167 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~ 233 (343)
T cd07878 167 QADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---DQLKRIMEVVG 233 (343)
T ss_pred ecCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhC
Confidence 654321 24578999999999987 56889999999999999999999999764321 2222111110
Q ss_pred -------------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 -------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 -------------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.......+...+++.+.++|.+||..||++||++.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000111223356677899999999999999999776643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.30 Aligned_cols=247 Identities=20% Similarity=0.317 Sum_probs=201.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
.+|++.+.||+|+||.||++.. .+..||+|.+........+..|+.+++.++|.+.++.+..+...+...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 5799999999999999999985 4788999998766555678899999999988766666655555667789999999
Q ss_pred CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 g~sL~~li~~~~~-~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++..... .+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccC----
Confidence 7899999875333 48899999999999999999999999999999999999 678899999999987654322
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
....++..|+|||++.+..++.++|||||||++|+|++ |..||..... .+....+..... ......
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~ 223 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGYK----MDAPDG 223 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCC----CCCCCC
Confidence 12344568999999999899999999999999999997 9999975332 233333322111 123356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
+|+.+.+++.+||..+|++||++.++.+.|++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 79999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.28 Aligned_cols=243 Identities=21% Similarity=0.193 Sum_probs=195.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeE---eCcEEEEEEec
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGV---EGDYNVLVMDL 84 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~~~~i~~~~~~~~---~~~~~~lVmE~ 84 (477)
..||+|++|.||+|.. +|+.||||.+...... ..+..|+.++..++|++.+..+..+.. ...+.++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999996 7899999987654321 345689999999998644444443322 14577999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++.. ...+++...+.++.|++.||.|||+ .+++||||||+|||+ +.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence 9 8999999975 4569999999999999999999998 499999999999999 678999999999997654322
Q ss_pred cccccccCCCCccCccccccchhcC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g--~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.. ..+.+..+........ +
T Consensus 178 --------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~---~ 243 (283)
T PHA02988 178 --------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLIINKNNSLK---L 243 (283)
T ss_pred --------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcCCCCC---C
Confidence 13468899999999976 678999999999999999999999997643 3344444433222211 2
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
+..+|+++.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 3457899999999999999999999999999988774
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.29 Aligned_cols=258 Identities=20% Similarity=0.266 Sum_probs=199.6
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEE-eeE-----e-CcEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRW-FGV-----E-GDYN 78 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~--~~~~~E~~il~~L~~~~~i~~~~~-~~~-----~-~~~~ 78 (477)
+++|.+.|.+|||+.||+|++...+.+||||.+-...++ ..+.+|+.+|+.|++|++|+.+.+ ... . .-.+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 678889999999999999999888899999976655332 346799999999998888888765 211 1 2345
Q ss_pred EEEEecC-CCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 79 VLVMDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~-~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
+|.|||| |++|-|+++ +....|++.++++|+.|+++||.+||... |||||||-+|||| ..+++.||||||.|.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGSAT 194 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcccccc
Confidence 7999999 799999996 44566999999999999999999999987 9999999999999 578899999999986
Q ss_pred ecccCC-CCccccccc-CCCCccCccccccchh---cCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 155 KYRDTS-THQHIPYRE-NKNLTGTARYASMNTH---LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 155 ~~~~~~-~~~~~p~~~-~~~~~Gt~~Y~APE~~---~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
...... ....+.+-+ .-....|+.|.|||++ .+.+.++|+|||+|||+||.||+...||...-. ..|.
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------laIl 267 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LAIL 267 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------eeEE
Confidence 433222 111111100 1112358999999987 477899999999999999999999999976311 2344
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
...+..+. .+.++..|.+||..||+.+|++||+..++...+..+..
T Consensus 268 ng~Y~~P~---~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 268 NGNYSFPP---FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred eccccCCC---CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 44433222 14678899999999999999999996666655555543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=332.08 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=203.9
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCHH
Q 011819 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~ 90 (477)
+||+|+||+||-|++..+...+|||-+..+.. ...+..|+.+.+.|.|.+++..+.- +.+++++-|.||-+ ||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs-~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGS-VSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhc-cCCCCeEEEEeecCCCCcHH
Confidence 58999999999999999999999998766543 3358889999999999666655555 45666888999998 99999
Q ss_pred HHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccc
Q 011819 91 DLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (477)
Q Consensus 91 ~li~~~~~~l--s~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 168 (477)
+++....+++ ++.++-.|..||++||.|||++.|||||||-+|||++ .-.|.+||+|||.++.+..-..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP------- 731 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP------- 731 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc-------
Confidence 9998777777 7889999999999999999999999999999999996 6789999999999987654322
Q ss_pred cCCCCccCccccccchhcCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 169 ENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~g~~--~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
+..++.||..|||||++..++ |+..+|||||||++.||.||++||..+-. ....+.++.--+..+++ +..++.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs--pqAAMFkVGmyKvHP~i---Peelsa 806 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS--PQAAMFKVGMYKVHPPI---PEELSA 806 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC--hhHhhhhhcceecCCCC---cHHHHH
Confidence 245789999999999998654 88999999999999999999999987533 33344444433333332 344678
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
+.+.||.+|+..+|.+||++.+| |.+.|...+
T Consensus 807 eak~FilrcFepd~~~R~sA~~L---L~DpFlq~~ 838 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDL---LQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHh---ccCcccccC
Confidence 89999999999999999996554 566665544
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=309.42 Aligned_cols=252 Identities=20% Similarity=0.368 Sum_probs=201.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|+++++||+|+||.||+|.+ .++..||+|.+.... ....+..|+.+++.++|.+ +..+.......+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDK-LVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCC-eeeEEEEEcCCCCcEEEEec
Confidence 46899999999999999999996 456789999876433 2346788999999998754 44555555667778999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++... ...+++..++.++.||+.||+|||+.+++||||||+||++ +..+.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCcee
Confidence 9 89999998643 3568899999999999999999999999999999999999 67889999999999876543211
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......+...... ...
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 226 (261)
T cd05072 160 ------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGYRM----PRM 226 (261)
T ss_pred ------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 1123345678999999998889999999999999999998 9999976433 2233333322111 122
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
..+|.++.+++.+||..+|++||+++++.+.|++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 4578999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.16 Aligned_cols=248 Identities=19% Similarity=0.213 Sum_probs=200.9
Q ss_pred CceEEEeeeeecCceEEEEEEECCC-CcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~-g~~vAiKi~~~~~~~--~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..|.+.+.||.|+||.||+|.+..+ ++.||+|.+...... ..+..|+.++..+.| ++|+.+..++..++..|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDH-FGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEEECCEEEEEEE
Confidence 3499999999999999999998877 788999976443322 246679999999987 556666666677888999999
Q ss_pred cC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 84 ~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|+ |++|.+++... ..++++..+..++.||+.||+|||+++|+||||||+|||+ +..+.+||+|||+++.+...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCc
Confidence 99 99999887532 3458999999999999999999999999999999999999 67899999999999876543
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+...... .
T Consensus 223 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~----~ 290 (478)
T PTZ00267 223 VS-----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLYGKYD----P 290 (478)
T ss_pred cc-----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC----C
Confidence 21 112345679999999999999999999999999999999999999997643 23444444333222 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+...++.++.++|..||..+|++||+++++.
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 2345788999999999999999999988774
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.29 Aligned_cols=254 Identities=21% Similarity=0.347 Sum_probs=201.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..++|++.++||+|+||.||+|++..+ ..||||++..... ...+..|++++..+.|.+.+..+ .+. .....++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~-~~~-~~~~~~lv~e 80 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY-AVV-SEEPIYIVTE 80 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEE-EEE-CCCCcEEEEE
Confidence 347899999999999999999998655 4699998875333 34678899999999875544444 333 3455799999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+|+||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeecccccc
Confidence 99 88999999743 3458899999999999999999999999999999999999 5788999999999986654322
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.......++..|+|||+..+..++.++|||||||++|+|++ |..||.+... .+.+..+..... . ..
T Consensus 158 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~~-~---~~ 224 (262)
T cd05071 158 ------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYR-M---PC 224 (262)
T ss_pred ------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhcCCC-C---CC
Confidence 11123456778999999998899999999999999999999 8899976432 333333322211 1 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
...+|..+.+++.+||..+|++||++.++.+.|++.|
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 3457899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=314.37 Aligned_cols=257 Identities=19% Similarity=0.262 Sum_probs=203.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCc--EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~--~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||+|....++. .+++|.+..... ...+..|+.++..+.+|+++..+..++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999877765 468887653221 235778999999997667777777777777888999
Q ss_pred EecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcE
Q 011819 82 MDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~v 145 (477)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeE
Confidence 9999 889999986422 248889999999999999999999999999999999999 678899
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~ 224 (477)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|+|++ |..||..... ...
T Consensus 159 kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~ 227 (297)
T cd05089 159 KIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AEL 227 (297)
T ss_pred EECCcCCCccccceec--------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 9999999864321110 111223557999999999899999999999999999997 9999976443 233
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
+.++..... ......++.++.+|+..||..+|.+||+++++.+.|+.++....
T Consensus 228 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 228 YEKLPQGYR----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 333332211 11234578999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.56 Aligned_cols=255 Identities=18% Similarity=0.265 Sum_probs=199.2
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
+....++|+++++||+|+||.||+|++..+++.||+|++..... ...+..|+.++..++|++.+ .+...+...+..+
T Consensus 4 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii-~~~~~~~~~~~~~ 82 (267)
T cd06646 4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV-AYFGSYLSREKLW 82 (267)
T ss_pred ccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCee-eeeEEEEeCCEEE
Confidence 34456789999999999999999999999999999998865432 23467899999999886554 4555556677889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++.. ..++++..+..++.|++.||.|||+.||+||||||+||++ +..+.++|+|||++.....
T Consensus 83 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecc
Confidence 999999 7899999874 4568999999999999999999999999999999999999 6788899999999986643
Q ss_pred CCCCcccccccCCCCccCccccccchhc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~---g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
... ......|+..|+|||.+. ...++.++|||||||++|+|++|..||...... .....+.......
T Consensus 159 ~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~ 228 (267)
T cd06646 159 TIA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RALFLMSKSNFQP 228 (267)
T ss_pred ccc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---hhheeeecCCCCC
Confidence 221 123456889999999885 344778999999999999999999999654321 1111111111111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
........++.++.++|..||..+|++||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 111122457889999999999999999999887754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=306.10 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=203.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||+|++..+++.||||.+..... ...+..|+.+++.++|++ +..+..++...+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN-VIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcc-eeeeeeeEEECCeEEEE
Confidence 689999999999999999999999999999997654221 234678999999998755 44455455567788999
Q ss_pred EecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 82 mE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|||+ +++|.+++... ...++...+..++.||+.||.|||++|++|+||||+|||+ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 9999 78999988532 3448899999999999999999999999999999999999 577889999999998664
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ........+.....+..
T Consensus 158 ~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~- 228 (267)
T cd08228 158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYPPL- 228 (267)
T ss_pred chhH-------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCCCCC-
Confidence 3221 11235688999999999988899999999999999999999999975432 22233333332222111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
....++..+.+++.+||..+|++||++.++.+.|+.+
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1234678899999999999999999999999888765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.79 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=193.7
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeC----cEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEG----DYNV 79 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~----~~~~ 79 (477)
+|+++++||+|+||.||+|.+..+++.||||.+.... ....+.+|+.+++.++|++++..+..+.... ...|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999999999999999875432 1235778999999998866555554443322 2679
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
+||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecccC
Confidence 9999998899888863 5679999999999999999999999999999999999999 67899999999999865432
Q ss_pred CCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc-----
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (477)
... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.... +.+..+.....
T Consensus 157 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 157 ESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI---QQLDLITDLLGTPSLE 227 (372)
T ss_pred ccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCHH
Confidence 211 12234678999999999875 4789999999999999999999999775432 22222211100
Q ss_pred -------------------cccHH---HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 -------------------STSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 -------------------~~~~~---~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..... .+...+++++.++|.+||..||++||++.++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 00011 12234578899999999999999999976653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=314.59 Aligned_cols=288 Identities=43% Similarity=0.694 Sum_probs=241.0
Q ss_pred cCC-ceEEEeeeeecCceEEEEEEECCCC-cEEEEEEecCCCC--chhHHHHHHHHHHHc---CCCCCCeeEEee-EeCc
Q 011819 5 VGN-KFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKTK--HPQLLYESKLYRILQ---GGTGIPNVRWFG-VEGD 76 (477)
Q Consensus 5 i~~-~y~i~~~IG~G~fG~Vy~a~~~~~g-~~vAiKi~~~~~~--~~~~~~E~~il~~L~---~~~~i~~~~~~~-~~~~ 76 (477)
... +|++.++||+|+||.||+|.+..++ ..+|+|++..... ...+..|..++..+. +..+++.+.+.+ ....
T Consensus 15 ~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 15 KVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 345 8999999999999999999987774 7899998776432 237899999999998 467899999998 5888
Q ss_pred EEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC--CCCcEEEeecCce
Q 011819 77 YNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLA 153 (477)
Q Consensus 77 ~~~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~--~~~~vkL~DFGla 153 (477)
+.||||+++|.+|.++..... +.|+..+++.++.|++.+|++||+.|+|||||||+|++++... ....++|+|||+|
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 999999999999999996554 7899999999999999999999999999999999999997543 1267999999999
Q ss_pred e--ecccCCCCccccccc-CCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 154 K--KYRDTSTHQHIPYRE-NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 154 ~--~~~~~~~~~~~p~~~-~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
+ .+.........+.+. ...+.||..|+++++|.+.++++++|+|||++++.+|+.|.+||.........+.+.+...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 9 443333222234444 3456799999999999999999999999999999999999999988776656666655554
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
...... ++...|.++.+++..+-..++.++|+|..+...|++.+...+..++..+||.....
T Consensus 255 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~ 316 (322)
T KOG1164|consen 255 KLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLR 316 (322)
T ss_pred hhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccccc
Confidence 443322 44557889999999999999999999999999999999999999999999997543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=317.36 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=199.9
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCc----EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~----~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
-..+|++.+.||+|+||.||+|.+..+++ .||||++..... ...+..|+.+++.+.|++.+..+. ++... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g-~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE-EEcCC-C
Confidence 35689999999999999999999766655 489998764332 235778899999998865555444 44333 4
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.++++||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccccc
Confidence 57889988 999999998656678999999999999999999999999999999999999 67789999999999876
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... +. ..+.......
T Consensus 160 ~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~-~~~~~~~~~~ 230 (316)
T cd05108 160 GADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI-SSILEKGERL 230 (316)
T ss_pred cCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH-HHHHhCCCCC
Confidence 5432211 1112334678999999999999999999999999999997 99999764332 22 2222222111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
+ ....++.++.+++..||..+|++||++.++...|.++.
T Consensus 231 ~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 231 P---QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred C---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 22456889999999999999999999999998888775
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=312.38 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=199.6
Q ss_pred CceEEEeeeeecCceEEEEEEEC----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~----~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.+|++.++||+|+||.||+|.+. ..+..||+|.+...... ..+..|+.+++.+.| +++..+..+...+...|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH-PNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCCceE
Confidence 57999999999999999999853 45678999987643322 347789999999987 45555555566677889
Q ss_pred EEEecC-CCCHHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC
Q 011819 80 LVMDLL-GPSLEDLFNFC----------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~----------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~ 142 (477)
++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cCC
Confidence 999999 88999998532 1247888999999999999999999999999999999999 577
Q ss_pred CcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccH
Q 011819 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (477)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~ 221 (477)
+.+||+|||+++........ .......++..|+|||++.+..++.++|||||||+||+|++ |..||.+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--- 232 (283)
T cd05090 161 LHVKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--- 232 (283)
T ss_pred CcEEeccccccccccCCcce-----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 88999999999865432211 11233456778999999998889999999999999999998 9999976433
Q ss_pred HHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
......+..... ...+..+++++.+++.+||..+|++||++.++.+.|+.
T Consensus 233 ~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRKRQL----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 222232222221 12445689999999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=313.92 Aligned_cols=260 Identities=18% Similarity=0.315 Sum_probs=205.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCC-------CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~-------g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
++|.+++.||+|+||.||+|.+... ...||+|++...... ..+..|+.++..+..|+++..+..++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 6899999999999999999986432 357999988754322 246779999999965677777777777788
Q ss_pred EEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~ 140 (477)
..|+||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++|++||||||+|||+ +
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill---~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---T 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE---c
Confidence 899999999 889999997532 248889999999999999999999999999999999999 6
Q ss_pred CCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcc
Q 011819 141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 219 (477)
Q Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~ 219 (477)
.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~- 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 248 (307)
T ss_pred CCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence 77899999999987654322110 0112234568999999999889999999999999999998 8899965332
Q ss_pred cHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
.+....+..... ...+..++.++.+++..||..+|++||++.++.+.|++++....
T Consensus 249 --~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 --EELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred --HHHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 233333322211 12334678999999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=311.15 Aligned_cols=266 Identities=20% Similarity=0.310 Sum_probs=205.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~-----~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
..++|++.++||+|+||.||+|.+.. .+..||+|.+...... ..+..|+.+++.+.| +++..+..++...+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC-HHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCCC
Confidence 35789999999999999999997642 3558999987644322 235678888988876 45666666666777
Q ss_pred EEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEE
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~---------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vk 146 (477)
..|+||||+ +++|.+++.... ..++...+..++.||+.||.|||+++|+||||||+|||+ +.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcEE
Confidence 889999999 899999997432 235677889999999999999999999999999999999 5788999
Q ss_pred EeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHH
Q 011819 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (477)
Q Consensus 147 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~ 225 (477)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.+
T Consensus 160 L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~ 231 (288)
T cd05061 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVL 231 (288)
T ss_pred ECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence 999999986543221 111223345678999999998899999999999999999998 7899976433 2233
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccc
Q 011819 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDW 290 (477)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw 290 (477)
..+...... ..+..+++++.+++.+||..+|++||++.++.+.|++.+ +++...+||
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~----~~~~~~~~~ 288 (288)
T cd05061 232 KFVMDGGYL----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL----HPSFPEVSF 288 (288)
T ss_pred HHHHcCCCC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc----CCCCCCCCC
Confidence 333222211 123457889999999999999999999999988877764 566666677
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=331.73 Aligned_cols=236 Identities=21% Similarity=0.338 Sum_probs=197.7
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCHH
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~ 90 (477)
++.||+|+.|.||+|+ -.++.||||.++ +.-..+++-|+.|+| ++|..+..++...-.+||+|||| .|-|.
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~-----elkETdIKHLRkLkH-~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVR-----ELKETDIKHLRKLKH-PNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHh-----hhhhhhHHHHHhccC-cceeeEeeeecCCceeEEeeeccccccHH
Confidence 6789999999999998 578899999543 223457888999998 56667777888888899999999 89999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccC
Q 011819 91 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170 (477)
Q Consensus 91 ~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~ 170 (477)
.+++. .++++......|..+||.|+.|||.+.|||||||.-|||| ..+..|||+|||.++...+..+ .
T Consensus 201 ~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI---s~~d~VKIsDFGTS~e~~~~ST--------k 268 (904)
T KOG4721|consen 201 EVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI---SYDDVVKISDFGTSKELSDKST--------K 268 (904)
T ss_pred HHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe---eccceEEeccccchHhhhhhhh--------h
Confidence 99984 7789999999999999999999999999999999999999 4778999999999998877654 2
Q ss_pred CCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHH
Q 011819 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFAS 250 (477)
Q Consensus 171 ~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ 250 (477)
-.++||..|||||++...+.+.|+|||||||+|||||||..||...... .++.-+....... ..+..+|.-|+=
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~L---pvPstcP~Gfkl 342 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHL---PVPSTCPDGFKL 342 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccc---cCcccCchHHHH
Confidence 3689999999999999999999999999999999999999999765432 1122222222221 134668999999
Q ss_pred HHHHHhcCCCCCCCCHHHHHHHH
Q 011819 251 YFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 251 li~~cl~~~p~~RPt~~~l~~~l 273 (477)
||.+||.-.|..||+|.+++..|
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHH
Confidence 99999999999999999887665
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.93 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=201.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~-----~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
.++|.+.+.||+|+||.||+|.+.. +++.||||++...... ..+..|++++..+.|. ++..+..++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE-NIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCC-CchheeeEEecCCC
Confidence 4579999999999999999998743 3678999987654333 4678899999999875 55556556666788
Q ss_pred EEEEEecC-CCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC
Q 011819 78 NVLVMDLL-GPSLEDLFNFCS-------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~-------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~ 143 (477)
.++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||+ +.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCCC
Confidence 99999999 999999986432 347888999999999999999999999999999999999 6789
Q ss_pred cEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHH
Q 011819 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (477)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~ 222 (477)
.++|+|||++........ +.......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 160 ~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--- 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--- 231 (280)
T ss_pred eEEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 999999999976533221 111223456788999999999999999999999999999998 99999765432
Q ss_pred HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
.....+....... ....+|.++.+++..||..+|++||++.++.+.|+
T Consensus 232 ~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECITQGRLLQ----RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2333333222211 23467899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=313.55 Aligned_cols=256 Identities=18% Similarity=0.226 Sum_probs=191.1
Q ss_pred EeeeeecCceEEEEEEEC--CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcEEEEEEecCCCC
Q 011819 12 GRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLLGPS 88 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~--~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~lVmE~~g~s 88 (477)
+++||+|+||.||+|.+. .+++.||+|.+........+.+|+.+++.++|++.+..+..+.. .+...|++|||++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 578999999999999965 46789999998766555678899999999998766666655543 456679999999999
Q ss_pred HHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC-CCCCcEEEeecCceeecccC
Q 011819 89 LEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 89 L~~li~~~~--------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~-~~~~~vkL~DFGla~~~~~~ 159 (477)
|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 999886321 248899999999999999999999999999999999999532 35578999999999876433
Q ss_pred CCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCccc------HHHHHHHHhhhc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKK 232 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~------~~~~~~~i~~~~ 232 (477)
.. +........||+.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+.++....
T Consensus 166 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 166 LK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred Cc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 21 11223456789999999999874 58999999999999999999999996533210 011111111100
Q ss_pred -------------cc--------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 -------------VS--------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 -------------~~--------------------~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.. ...+......+.++.++|.+||..||.+|||++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0000011123457889999999999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=311.35 Aligned_cols=259 Identities=22% Similarity=0.313 Sum_probs=207.3
Q ss_pred CCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~~--~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.++|.+.+.||+|+||.||+|.+. .++..|++|.+...... ..+..|+.++..+.| +++..+..++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-EHIVKFYGVCGDGDPL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCce
Confidence 467999999999999999999854 34567999987654332 357889999999987 5666666667777889
Q ss_pred EEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC
Q 011819 79 VLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~ 142 (477)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccC
Confidence 9999999 999999996422 348899999999999999999999999999999999999 678
Q ss_pred CcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccH
Q 011819 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (477)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~ 221 (477)
+.++|+|||++........ ........++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 160 ~~~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--- 231 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--- 231 (291)
T ss_pred CcEEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 8999999999976543221 111233457889999999999999999999999999999998 9999976443
Q ss_pred HHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
...+..+...... .....+|.++.+++.+||..+|++||++.++.+.|+++....
T Consensus 232 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 232 TEVIECITQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred HHHHHHHhCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 2333333332222 123457899999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=309.93 Aligned_cols=255 Identities=20% Similarity=0.309 Sum_probs=199.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~-----~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
+..++|++.+.||+|+||.||+|.+.. ++..||||.+..... ...+..|+.+++.+.|+ ++..+..++..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~-~iv~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEcCC
Confidence 456899999999999999999998642 356899998754322 23467899999998774 555555566677
Q ss_pred cEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcE
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~---------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~v 145 (477)
...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+|||+ +.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCCE
Confidence 7889999999 899999986432 235778899999999999999999999999999999999 578899
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~ 224 (477)
+|+|||+++........ .......++..|||||++.+..++.++|||||||++|+|++ |..||.+... ...
T Consensus 159 ~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQV 230 (277)
T ss_pred EECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 99999999765432221 11123355788999999999899999999999999999999 7899976433 233
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
+..+...... .....++..+.+++.+||..+|++||++.++.+.|+
T Consensus 231 ~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 3323322221 233567889999999999999999999988877664
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=311.62 Aligned_cols=255 Identities=18% Similarity=0.260 Sum_probs=198.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.++|++.++||.|+||.||+|.+..+++.||+|.+..... ...+..|+.+++.++|+ +|..+..++...+..++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA-NIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCC-CcceEEEEEecCCeEEEEE
Confidence 3679999999999999999999999999999998764322 23467899999999885 4555555566778899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||+.++|.+++......+++..+..++.||+.||+|||++||+|+||||+|||+ +.++.++|+|||++........
T Consensus 84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCCC-
Confidence 999889999987666679999999999999999999999999999999999999 6788999999999975433221
Q ss_pred cccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc--------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (477)
......+++.|+|||++.+. .++.++|||||||++|+|++|..||...........+..+.....
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 12234678899999998764 478899999999999999999999976543211111111110000
Q ss_pred --------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 --------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+++++.++|.+||..||.+||+++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00111223457889999999999999999999776643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=314.24 Aligned_cols=256 Identities=19% Similarity=0.261 Sum_probs=202.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcE--EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~--vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||+|.+..++.. +|+|.+.... ....+..|+.++..+.+|++++.+..++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5899999999999999999998777764 5676654322 1235678999999996668888887777888889999
Q ss_pred EecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcE
Q 011819 82 MDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~v 145 (477)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCCcE
Confidence 9999 899999997432 247899999999999999999999999999999999999 678899
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~ 224 (477)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||..... .+.
T Consensus 164 kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~ 232 (303)
T cd05088 164 KIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL 232 (303)
T ss_pred EeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHH
Confidence 999999986332111 0112234668999999988889999999999999999998 9999976443 223
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
+..+..... ......+++++.+++.+||..+|++||+++++...|..++...
T Consensus 233 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 233 YEKLPQGYR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHhcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 333322111 1122357889999999999999999999999999888876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=310.15 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=206.7
Q ss_pred CCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
..+|.+.+.||+|+||.||++... .++..||+|.+..... ...+..|+.++..++| +++..+..++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCcc
Confidence 357999999999999999999852 3456799998765332 2357889999999987 5666666667778889
Q ss_pred EEEEecC-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcE
Q 011819 79 VLVMDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~v 145 (477)
+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||+ +.++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCCcE
Confidence 9999999 899999986432 248999999999999999999999999999999999999 678899
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~ 224 (477)
+|+|||+++....... ........++..|+|||++.+..++.++|||||||++|+|++ |..||..... ...
T Consensus 160 kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~ 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV 231 (288)
T ss_pred EeccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 9999999976533221 111223446788999999999889999999999999999998 9999976443 233
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+..+...... .....++.++.+++.+||..+|.+||++.++...|+++...
T Consensus 232 ~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 IECITQGRVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHcCCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 4444433322 12345789999999999999999999999999999988644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=320.00 Aligned_cols=276 Identities=21% Similarity=0.262 Sum_probs=230.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
..+|.++..||+|+||.|.+|..+.+.+.||||++++... .+--..|-++|.....++.+..+..+++.-+..|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3579999999999999999999999999999998766421 12234577777777778888888888888888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ ||+|--.+++ -++|.+..+..|+.+|+.||-|||++|||+||||.+|||| +..|+|||+|||+++.---.
T Consensus 428 VMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccC
Confidence 99999 9999887875 5679999999999999999999999999999999999999 89999999999999743221
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
. ...++++||+.|+|||++.-.+|+..+|+||+||+|||||.|+.||.+ .++.+.+..|.+....
T Consensus 504 ~-------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG---eDE~elF~aI~ehnvs----- 568 (683)
T KOG0696|consen 504 G-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG---EDEDELFQAIMEHNVS----- 568 (683)
T ss_pred C-------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHHccCc-----
Confidence 1 234689999999999999999999999999999999999999999977 4556777778877664
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchhhccccCCCCCc
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPAR 306 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~-~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~~ 306 (477)
.++.++.+..+++...|.+.|.+|.... +-. +++ ..++|+..+||+.++..+.+++..|..
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge---~di---~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGE---RDI---REHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCccccCCCCccc---cch---hhCcchhhccHHHHhhccCCCCCCCcc
Confidence 5577899999999999999999997431 111 111 346788889999999999998887754
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=309.28 Aligned_cols=257 Identities=20% Similarity=0.321 Sum_probs=200.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~-----~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
-.++|++.+.||+|+||.||+|.+.. ++..||+|....... ...+..|+.+++.+.|. ++..+..++.+.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ-NIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCC-CEeeEEEEEccCC
Confidence 35789999999999999999999877 778999998764332 23578899999999875 5555555555667
Q ss_pred EEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
..++||||+ |++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||+........+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 789999999 999999997543 2488999999999999999999999999999999999995333345799999
Q ss_pred cCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHH
Q 011819 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (477)
Q Consensus 150 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i 228 (477)
||+++........ ........+..|+|||++.+..++.++|||||||++|+|++ |..||..... ......+
T Consensus 163 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~ 234 (277)
T cd05036 163 FGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFV 234 (277)
T ss_pred CccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 9999866332210 11112234568999999999899999999999999999997 9999976433 2222222
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
..... ...+..+|.++.+++.+||..+|++||++.++.+.|+
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGR----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 22111 1234567899999999999999999999998877664
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.93 Aligned_cols=254 Identities=20% Similarity=0.233 Sum_probs=197.3
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..+..|.+.+.||+|+||.||+|.+..+++.||||... ...+..|+++++.|+|. +|+.+..++..++..+||||
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~Hp-nIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHP-AVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCC-CCCcEEEEEEECCEEEEEEE
Confidence 34668999999999999999999999999999999632 23467899999999884 55555566667788999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
++.++|.+++......+++..++.++.||+.||.|||++|||||||||+|||| +..+.+||+|||+++........
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceeccccccc-
Confidence 99889999887555679999999999999999999999999999999999999 67789999999999876432211
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-----cHHHHHHHHhhhccc----
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEKKVS---- 234 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~-----~~~~~~~~i~~~~~~---- 234 (477)
.......||..|||||++.+..++.++|||||||+||||++|..|+...... ...+....+......
T Consensus 317 ----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 317 ----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 0122467999999999999999999999999999999999988766432211 111222222111100
Q ss_pred -c-------------------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 235 -T-------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 235 -~-------------------------~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. ....+ ..++.++.+||.+||..||.+||++.++++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 00000 134568999999999999999999877754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=302.89 Aligned_cols=249 Identities=19% Similarity=0.268 Sum_probs=199.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
++|++.+.||+|+||.||++... .+..+|+|.+.... ....+..|+.+++.++| +++..+..++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH-PKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCC-CCceeEEEEEccCCCEEEEEEcC
Confidence 57999999999999999999864 55689999866433 34568889999999987 45555566666777889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++......+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCce---
Confidence 899999997545568999999999999999999999999999999999999 6788999999999976533221
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||.... ..+.+..+....... .+..
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i~~~~~~~----~~~~ 225 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMISRGFRLY----RPKL 225 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCCCC----CCCC
Confidence 11122345678999999998889999999999999999999 999996643 233444443322111 1234
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
.+.++.+++.+||..+|++||+++++.+.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 678899999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=305.33 Aligned_cols=248 Identities=28% Similarity=0.455 Sum_probs=199.4
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchh----HHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~----~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
|++++.||+|+||.||++.+..+++.||+|++........ ...|+.+++.+.| +++..+..+.......+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRH-PNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTB-TTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccc-cccccccccccccccccccccc
Confidence 8999999999999999999999999999999887653332 2458999999965 6666677777778889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+ +++|.+++.. ...+++..++.++.||+.||.+||++||+|+||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~-- 153 (260)
T PF00069_consen 80 CPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNE-- 153 (260)
T ss_dssp ETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTS--
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc--
Confidence 9 5599999983 5679999999999999999999999999999999999999 6889999999999986522111
Q ss_pred ccccccCCCCccCccccccchhc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh-
Q 011819 164 HIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC- 241 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~-g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~- 241 (477)
......++..|+|||++. +..++.++||||||+++|+|++|..||...........+.+...... .....
T Consensus 154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 225 (260)
T PF00069_consen 154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL---PSSSQQ 225 (260)
T ss_dssp -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH---HHHTTS
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc---cccccc
Confidence 234567899999999998 88899999999999999999999999987533233333333322211 11111
Q ss_pred -cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 -RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 -~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...++++.+++..||+.+|++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122489999999999999999999877653
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=311.82 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=196.3
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeC----cEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG----DYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~----~~~~lVm 82 (477)
=.|+-.+.||.|+||.||+|....++++||||..-.+.. --.+|.++|+.+.|+|++..+..|.... -+..+||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 368889999999999999999999999999996544332 2346899999888866555555554322 2456999
Q ss_pred ecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 83 DLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 83 E~~g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||+..+|.++++. .+.+++...+.-|..||++||.|||+.||+||||||.|+|++ ...|.+||||||.|+.+...
T Consensus 102 eymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 102 EYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccC
Confidence 9999999999874 257799999999999999999999999999999999999995 45699999999999988765
Q ss_pred CCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc------
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 232 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~------ 232 (477)
.. +.+...|..|.|||.+.|. +|+.+.||||.||++.||+-|++-|.+..+.+....+-++....
T Consensus 180 ep--------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 180 EP--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred CC--------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 44 2345668899999999875 68999999999999999999999999855433222222221111
Q ss_pred ---cc-----------ccH-HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 233 ---VS-----------TSI-EALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 233 ---~~-----------~~~-~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
.. ... +.+.+..++++.+|+.++|.++|.+|.++-++
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~ 303 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEA 303 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHH
Confidence 00 000 11334568999999999999999999996554
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=319.55 Aligned_cols=260 Identities=20% Similarity=0.314 Sum_probs=202.1
Q ss_pred CCceEEEeeeeecCceEEEEEEE-----CCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEE-eeEeCc
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRW-FGVEGD 76 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~-----~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~-~~~~~~ 76 (477)
.++|++++.||+|+||.||+|.+ ..+++.||||++...... ..+..|+.++..+.+|+++..+.. +...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999984 346789999998654322 346789999999977666666554 445566
Q ss_pred EEEEEEecC-CCCHHHHHHHcC----------------------------------------------------------
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCS---------------------------------------------------------- 97 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~---------------------------------------------------------- 97 (477)
..+++|||+ +++|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 789999999 999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccccccc
Q 011819 98 --------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169 (477)
Q Consensus 98 --------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~ 169 (477)
..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........ +..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~-----~~~ 237 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPD-----YVR 237 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcc-----hhh
Confidence 236788889999999999999999999999999999999 6788999999999976533221 111
Q ss_pred CCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHH
Q 011819 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (477)
Q Consensus 170 ~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (477)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||...... ......+..... . ..+..+++++
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~-~---~~~~~~~~~~ 311 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTR-M---RAPDYTTPEM 311 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccCC-C---CCCCCCCHHH
Confidence 223345678999999999899999999999999999996 99999764332 112222211111 1 1223467899
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 249 ASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.+++..||..+|++||++.+|.+.|+.++..
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=305.19 Aligned_cols=255 Identities=15% Similarity=0.268 Sum_probs=203.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCC---CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~---g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.++|++.+.||+|+||.||+|.+..+ ...||||++...... ..+..|+.++..++|+ ++..+..+....+..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHP-NIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCC-CcceEeEEEecCCceE
Confidence 36899999999999999999998654 458999987654322 3467899999999875 5555555566777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
++|||+ +++|.+++......+++..++.++.|++.||.|||+++|+|+||||+|||+ +.++.++|+|||+++....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcccc
Confidence 999999 889999997656679999999999999999999999999999999999999 6788999999999987752
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+....+......
T Consensus 159 ~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~--- 227 (266)
T cd05033 159 SEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYRL--- 227 (266)
T ss_pred cccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCC---
Confidence 21110 0112345678999999999899999999999999999998 9999966432 2333333322111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
.....+|+.+.+++..||..+|++||++.++.+.|.++
T Consensus 228 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12245789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=306.77 Aligned_cols=253 Identities=18% Similarity=0.349 Sum_probs=197.9
Q ss_pred eEEEeeeeecCceEEEEEEECCC---CcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeC-----c
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG-----D 76 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~---g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~-----~ 76 (477)
|++++.||+|+||.||+|....+ +..||||.+...... ..+..|+.+++.++|++.+..+..+.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987654 478999987654322 35778999999998865555444333222 2
Q ss_pred EEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 77 YNVLVMDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~-----~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
..+++|||+ +++|..++... ...+++..++.++.||+.||.|||+++|+||||||+||++ ++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECCc
Confidence 468999999 89999888532 2358999999999999999999999999999999999999 67889999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHh
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (477)
|+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+... .+.+..+.
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLR 229 (273)
T ss_pred cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence 999876543321 11122345678999999998889999999999999999999 9999976433 23333333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
..... ..+..++.++.+++.+||..+|++||++.++.+.|+++
T Consensus 230 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNRL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 32211 13456889999999999999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=311.40 Aligned_cols=258 Identities=19% Similarity=0.284 Sum_probs=199.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCC----------------cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN----------------EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGI 65 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g----------------~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i 65 (477)
..++|+++++||+|+||.||+|.+..++ ..||+|++..... ...+..|++++..+.|+ ++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDP-NI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCC-CE
Confidence 3468999999999999999999876543 5689998765432 23567899999999875 45
Q ss_pred CeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCce
Q 011819 66 PNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 134 (477)
Q Consensus 66 ~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~----------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NI 134 (477)
..+..++..++..+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 55555556667889999999 899999987543 2589999999999999999999999999999999999
Q ss_pred EeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc--CCCC
Q 011819 135 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLP 212 (477)
Q Consensus 135 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt--G~~P 212 (477)
++ +..+.++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 162 li---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 162 LV---GKNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred ee---cCCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 99 56799999999999865443221 11234456788999999998889999999999999999998 7788
Q ss_pred CCCCCcccHHHHHHHHhhh---cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 213 WQGLKAGTKKQKYEKISEK---KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~---~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
|..... .+.+..+... ............+|.++.+++..||..+|++||++.+|.+.|+
T Consensus 234 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 234 YEHLTD---QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCcCh---HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 866443 2222222211 0001111123456889999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=303.17 Aligned_cols=246 Identities=21% Similarity=0.257 Sum_probs=200.4
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
+|++.++||.|+||.||++.+..+++.||+|.+.... ....+..|+.+++.++| +++..+...+..++..|++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH-PNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEee
Confidence 5899999999999999999999999999999875432 22456788899999987 5566666666788899999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++... ...++...++.++.||+.||.|||++||+|+||||+||++ +..+.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc-
Confidence 9 88999988642 3458999999999999999999999999999999999999 6788999999999976644221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||.... ....+..+...... .+..
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~ 222 (255)
T cd08219 156 ------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILKVCQGSYK----PLPS 222 (255)
T ss_pred ------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHHHhcCCCC----CCCc
Confidence 1234578899999999999889999999999999999999999997533 22333333322221 1334
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.++.++.++|.+||..+|++||++.++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 57889999999999999999999887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.52 Aligned_cols=253 Identities=20% Similarity=0.252 Sum_probs=200.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~-----g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.+|++.++||+|+||.||+|.+..+ ++.||||++...... ..+..|+.++..++|+ ++..+..++......
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~-~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP-NIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCC-CcCeEEEEEcCCCce
Confidence 4688999999999999999987543 578999998754432 3467888888888875 555555556666778
Q ss_pred EEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC
Q 011819 79 VLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~---------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~ 142 (477)
++++||+ +++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cCC
Confidence 9999999 88999998521 2347888999999999999999999999999999999999 577
Q ss_pred CcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccH
Q 011819 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (477)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~ 221 (477)
+.+||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--- 232 (283)
T cd05091 161 LNVKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 232 (283)
T ss_pred CceEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 8899999999886543221 111233456789999999998889999999999999999998 8889976433
Q ss_pred HHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
.+.+..+...... .....+|.++.+++..||+.+|++||+++++...|+.
T Consensus 233 ~~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 QDVIEMIRNRQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 3444444443322 2345789999999999999999999999999887763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=304.47 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=200.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..++|+++++||+|+||.||+|.. .+++.||+|.+..... ...+..|+.+++.++|++.+..+ .+. ..+..+++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~-~~~-~~~~~~~v~e 80 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY-AVV-TQEPIYIITE 80 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEE-EEE-ccCCcEEEEE
Confidence 457899999999999999999985 5678899998765433 34688899999999876554444 333 3456899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCCCc
Confidence 99 89999998643 3468999999999999999999999999999999999999 6788999999999987653221
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... ..+..+..... . ..
T Consensus 158 ------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~-~---~~ 224 (260)
T cd05067 158 ------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLERGYR-M---PR 224 (260)
T ss_pred ------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHcCCC-C---CC
Confidence 11123356778999999998899999999999999999998 99999765432 22222222111 1 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
...+|.++.+++.+||..+|++||+++++...|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 35578899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=304.09 Aligned_cols=251 Identities=22% Similarity=0.397 Sum_probs=199.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|++.++||+|+||.||+|.+..+ ..||||.+.... ....+..|+++++.+.|++.++.+..+ ..+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~v~e~ 81 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV--SEEPIYIVTEF 81 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCCcEEEEEc
Confidence 47899999999999999999987554 469999876533 234678899999999987766655444 34567899999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++... ...+++..+..++.||+.||.|||+.|++|+||||+||++ ++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCcc-
Confidence 9 78999999743 3348899999999999999999999999999999999999 6788999999999986643221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+... ...+..+..... . ...
T Consensus 158 -----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~-~---~~~ 225 (260)
T cd05069 158 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERGYR-M---PCP 225 (260)
T ss_pred -----cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC-C---CCC
Confidence 11123346778999999998899999999999999999999 9999976443 233333322211 1 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
..+|..+.+++.+||..+|++||+++++.+.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 4678999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.14 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=202.0
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|++.+.||+|+||.||+|.+. .++.||||.+.... ....+..|+.+++.++|+ ++..+..++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP-KLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCC-CccceeEEEecCCCeeeeeec
Confidence 468999999999999999999964 55789999876543 234688899999999875 555555566677788999999
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCCccc
Confidence 9 999999997433 468999999999999999999999999999999999999 67889999999999877532211
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.......+..|+|||++.+..++.++||||||+++|+|++ |..||.+... ...+..+..... . ...
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~-~---~~~ 226 (261)
T cd05068 160 ------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVDQGYR-M---PCP 226 (261)
T ss_pred ------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC-C---CCC
Confidence 0111223457999999999899999999999999999999 9999976443 233333322211 1 122
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
..++..+.+++.+||..+|++||++.++.+.|++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 4578999999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=304.68 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=194.1
Q ss_pred eeeecCceEEEEEEEC--CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CC
Q 011819 14 KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~--~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~ 87 (477)
.||+|+||.||+|.+. ..+..||+|+...... ...+..|+.+++.+.|++.+..+..+ .....++||||+ ++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~--~~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC--EAEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE--cCCCeEEEEEeCCCC
Confidence 4899999999999764 4456799998765432 23477899999999886655555443 345679999999 89
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccccc
Q 011819 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (477)
Q Consensus 88 sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~ 167 (477)
+|.+++......+++..++.++.||+.||.|||++|++||||||+|||+ +.++.+||+|||++......... +
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~----~ 152 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSY----Y 152 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccc----e
Confidence 9999987556679999999999999999999999999999999999999 57789999999999755432211 0
Q ss_pred ccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
.......++..|+|||++.+..++.++|||||||++|++++ |..||...... .....+..... ......+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~ 225 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFIEQGKR----LDCPAECPP 225 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCC----CCCCCCCCH
Confidence 11111233578999999998889999999999999999996 99999875442 22222222211 113356789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
++.+++..||..+|++||++.++.+.|+..|
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.87 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=210.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||++.+..+++.||||++.... ....+..|+++++.+.| +++..+..++..+...+++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH-PFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCeEEEE
Confidence 47999999999999999999999999999999875422 22457789999999986 5566666666777889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++.. ...++...+..++.||+.||.|||++||+|+||+|.|||+ +.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 80 MEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC-
Confidence 9999 9999999975 4679999999999999999999999999999999999999 67889999999999866443
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... ..+.+..+..... .+
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-----~~ 217 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKV-----RF 217 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCc-----cC
Confidence 124578999999999998888999999999999999999999997643 2333434333222 13
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~ 297 (477)
...++..+.+++.+||..+|.+|+ +++++ ..++|...++|..+....
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l----------~~~~~~~~~~~~~~~~~~ 269 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDI----------KNHPWFAGIDWIALLQRK 269 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHH----------HcCcccccCCHHHHhhcc
Confidence 455789999999999999999998 43333 235777778998775433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=300.82 Aligned_cols=255 Identities=23% Similarity=0.335 Sum_probs=203.9
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+..|+++++.++|.+ +..+..++...+..+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~-i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN-VIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCC-eeeeeeeeecCCeEEEE
Confidence 68999999999999999999998899999999765321 2345788999999998754 44444445566788999
Q ss_pred EecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 82 mE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|||+ +++|.+++... ...++...++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 9999 88999998642 3458999999999999999999999999999999999999 678899999999987654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ........+.........
T Consensus 158 ~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08224 158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDYPPLP 229 (267)
T ss_pred CCCc-------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCCCCCC
Confidence 3221 11234688899999999998899999999999999999999999965332 222233333322221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
...++.++.++|.+||..+|++||++.+|.+.|+++
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 125788999999999999999999999999988875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=302.65 Aligned_cols=246 Identities=20% Similarity=0.318 Sum_probs=193.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
+.||+|+||.||+|++..+++.||+|....... ...+..|+++++.+.| +++..+..++......++||||+ +++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 479999999999999989999999998654322 2357889999999987 45555656666777889999999 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccc
Q 011819 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (477)
Q Consensus 89 L~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 168 (477)
|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~----- 151 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS----- 151 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc-----
Confidence 999997555568999999999999999999999999999999999999 577889999999987544321100
Q ss_pred cCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHH
Q 011819 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (477)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (477)
.......+..|+|||.+.+..++.++|||||||++|+|++ |..||...... .....+... ... .....+|..
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~~~-~~~---~~~~~~~~~ 224 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIEQG-VRL---PCPELCPDA 224 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHHcC-CCC---CCcccCCHH
Confidence 0111123457999999999889999999999999999997 99999764432 222222221 111 123457899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 248 FASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
+.+++.+||..+|++||++.++.+.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=311.36 Aligned_cols=260 Identities=19% Similarity=0.290 Sum_probs=197.2
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCC--------------cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCee
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN--------------EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNV 68 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g--------------~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~ 68 (477)
.++|++.++||+|+||.||+|.+..++ ..||||.+..... ...+..|++++..++|+ ++..+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~-~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNP-NIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC-CcCeE
Confidence 368999999999999999999875432 3589998765422 23477899999999885 55555
Q ss_pred EEeeEeCcEEEEEEecC-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEe
Q 011819 69 RWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136 (477)
Q Consensus 69 ~~~~~~~~~~~lVmE~~-g~sL~~li~~~~-----------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl 136 (477)
..++......++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++||||||+|||+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 55566777889999999 899999986422 136788999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc--CCCCCC
Q 011819 137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQ 214 (477)
Q Consensus 137 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt--G~~Pf~ 214 (477)
+.++.+||+|||++........ ........++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 163 ---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 163 ---GNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred ---cCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 5678899999999976543221 111223455778999999998899999999999999999988 678887
Q ss_pred CCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
........+....................+|+.+.+|+.+||..+|++||+++++.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 654322222111111111111111123457899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=309.32 Aligned_cols=256 Identities=17% Similarity=0.315 Sum_probs=200.6
Q ss_pred ceEEEeeeeecCceEEEEEEECC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~-----~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
+|++.+.||+|+||.||+|.+.. ....|++|.+..... ...+..|+.++..+.|+ ++..+...+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHP-HVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCC-CEeeEEEEEecCCCcE
Confidence 58899999999999999998753 235799998765432 23577899999999875 4555555566777889
Q ss_pred EEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceE
Q 011819 80 LVMDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~-----------------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NIL 135 (477)
++|||+ +++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999 899999986421 24788999999999999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCC
Q 011819 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (477)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~ 214 (477)
+ +.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 160 l---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 160 V---AEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred E---cCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9 57789999999999765432221 11123345678999999998889999999999999999998 999997
Q ss_pred CCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+... ...+..+.. .... .....++.++.+++..||+.+|++||++.++.+.|++++.+
T Consensus 232 ~~~~---~~~~~~~~~-~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 232 GIAP---ERLFNLLKT-GYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCH---HHHHHHHhC-CCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 6432 222222221 1111 12356789999999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=319.62 Aligned_cols=249 Identities=18% Similarity=0.232 Sum_probs=191.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
..+|++++.||+|+||.||+|.+..+++.||+|+... .....|+.+++.++|+ +++.+..++......++|||++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~----~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----GTTLIEAMLLQNVNHP-SVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc----cccHHHHHHHHhCCCC-CCcChhheEEeCCeeEEEEEcc
Confidence 3579999999999999999999999999999997433 2345689999999885 5555555666778889999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~---- 212 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPA---- 212 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCcc----
Confidence 889999987666779999999999999999999999999999999999999 6788999999999974332111
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHH-------HHHHHHhhh-c-----
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-------QKYEKISEK-K----- 232 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~-------~~~~~i~~~-~----- 232 (477)
.....||..|+|||++.+..++.++|||||||++|||+++..|+......... ..+.++... .
T Consensus 213 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 213 ----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred ----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 23457999999999999999999999999999999999865555332221100 011111110 0
Q ss_pred cc-----ccHH------------------HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 VS-----TSIE------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 ~~-----~~~~------------------~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.. .... .....++.++.++|.+||..||.+||++.++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l 349 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence 00 0000 00124577788899999999999999977664
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=305.68 Aligned_cols=253 Identities=19% Similarity=0.338 Sum_probs=196.5
Q ss_pred eEEEeeeeecCceEEEEEEECCCCc--EEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeE-----eCcE
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV-----EGDY 77 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~--~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~-----~~~~ 77 (477)
|.++++||+|+||.||+|++..++. .||+|.+.... ....+..|.++++.++|.+.+..+..+.. ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578999999999999999877765 69999876532 22346789999999988655555544322 1224
Q ss_pred EEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 78 NVLVMDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~-----~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
.+++|||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCC
Confidence 68999999 88998887421 2348899999999999999999999999999999999999 678899999999
Q ss_pred ceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhh
Q 011819 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 152 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
+++....... ........+++.|++||++.+..++.++|||||||++|+|++ |..||..... .+.+..+..
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQ 229 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence 9987644321 111223346778999999999999999999999999999999 8999976432 333443333
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
.... .....++..+.+++.+||..+|++||++.++.+.|+++
T Consensus 230 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRL----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2211 12356789999999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=299.82 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=200.5
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.+.||+|+||.||+|.+..+++.|++|.+.... ....+..|+++++.++|++ +..+..++...+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY-IIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCC-eehheeeeccCCEEEEEEE
Confidence 5899999999999999999999999999999876432 2335778899999998754 4444555556778899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++... ...++...+..++.||+.||.|||++||+|+||||+||++ +.++.++|+|||+++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccc
Confidence 99 89999999754 4568999999999999999999999999999999999999 5778999999999987654322
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......|++.|+|||++.+..++.++|+|||||++|+|++|..||.... ......++....... +.
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~----~~ 222 (256)
T cd08529 157 -------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGVFPP----VS 222 (256)
T ss_pred -------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC----Cc
Confidence 1234578899999999999999999999999999999999999997643 233333333332221 22
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..++.++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 357899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=304.19 Aligned_cols=250 Identities=17% Similarity=0.269 Sum_probs=199.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|++.+.||+|+||.||+|.+. .+..||||.+.... ....+..|+.+++.++| +++..+..++......+++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSH-EKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCC-CCeeeEEEEEccCCCcEEEEEc
Confidence 357999999999999999999864 45569999876433 24568889999999987 5666666666677788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+ +++|.+++......+++..++.++.||+.||.|||+.|++|+||||.|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCce--
Confidence 9 889999997655578999999999999999999999999999999999999 6778999999999986544321
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
.......++..|++||++.+..++.++|||||||++|+|++ |..||..... ......+...... ....
T Consensus 156 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 224 (256)
T cd05113 156 ----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRL----YRPH 224 (256)
T ss_pred ----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCC----CCCC
Confidence 11122345678999999998889999999999999999998 9999976443 2233333332221 1223
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
..+..+.+++..||..+|++||++.+|.+.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 4688999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=310.31 Aligned_cols=260 Identities=17% Similarity=0.264 Sum_probs=196.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECC----------------CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIP 66 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~----------------~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~ 66 (477)
.++|++.++||+|+||.||++.+.. ++..||+|++..... ...+..|+.++..++| +++.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKD-PNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcc
Confidence 4679999999999999999986432 345799998765432 2357789999999987 5555
Q ss_pred eeEEeeEeCcEEEEEEecC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceE
Q 011819 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (477)
Q Consensus 67 ~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~----------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NIL 135 (477)
.+..++...+..+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 6666667777889999999 899999987432 23677889999999999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc--CCCCC
Q 011819 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPW 213 (477)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt--G~~Pf 213 (477)
+ +.++.++|+|||+++.+...... .......++..|++||.+.+..++.++|||||||++|||++ |..||
T Consensus 163 i---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 163 V---GKNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred E---cCCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 9 57789999999999865432211 11122344678999999988899999999999999999998 78999
Q ss_pred CCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 214 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
..............................+|+.+.+++..||..+|++||++.++.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7644322111111111110000001122457889999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.14 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=203.3
Q ss_pred cCCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
..++|.+.+.||+|+||.||+|.+. .++..||||++..... ...+..|+++++.+.+|+++..+..++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3458999999999999999999752 3456899998765432 2347789999999965577777766777778
Q ss_pred EEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
..+++|||+ +++|.+++.... ..+++.+++.++.||+.||+|||+++|+|+||||+|||+ +..+.++|+|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCcccc
Confidence 899999999 899999997433 238999999999999999999999999999999999999 577899999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .+.+......
T Consensus 190 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~~~~~~ 261 (302)
T cd05055 190 DIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKLIKEGY 261 (302)
T ss_pred cccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHHHHcCC
Confidence 65433211 11223456788999999999999999999999999999998 999997654322 1222221111
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
.. ......++++.+++.+||..+|++||++.++.+.|+++
T Consensus 262 ~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11 12345688999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.00 Aligned_cols=258 Identities=21% Similarity=0.270 Sum_probs=196.4
Q ss_pred Cce-EEEeeeeecCceEEEEEEE----CCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcE
Q 011819 7 NKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGV-EGDY 77 (477)
Q Consensus 7 ~~y-~i~~~IG~G~fG~Vy~a~~----~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~ 77 (477)
++| ++.+.||+|+||+||++.. ..++..||+|++..... ...+..|+++++.++|++.+..+..+.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 445 9999999999999988653 35678999998765432 3457789999999987555554444333 3456
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.+++|||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++..
T Consensus 83 ~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeeccccccc
Confidence 79999999 8999999974 459999999999999999999999999999999999999 57789999999999866
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH-----------HH
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-----------KY 225 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~-----------~~ 225 (477)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..||.......... ..
T Consensus 158 ~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 158 PEGHEYY----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred CCcchhh----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 5432211 11122345677999999998899999999999999999999999996533210000 00
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
......... ......+|.++.+++..||..+|++||+++++.+.|+++
T Consensus 234 ~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 234 IELLERGMR---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhcCCC---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 000000000 011345789999999999999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=304.75 Aligned_cols=253 Identities=20% Similarity=0.240 Sum_probs=195.5
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+..|+.++..+.| +++..+..+...+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH-PNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCC-CCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999875432 22457789999999987 555555555667788899999
Q ss_pred cCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~g~sL~~li~~~~--~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+.++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcc
Confidence 99889988886432 568999999999999999999999999999999999999 6789999999999976533211
Q ss_pred CcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH------------
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------------ 228 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i------------ 228 (477)
......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.............
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 157 -------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred -------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 12234678899999998764 4688999999999999999999999764321111111000
Q ss_pred ---------hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 229 ---------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 229 ---------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...............+++++.++|.+||..||++||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000011112223457899999999999999999999877753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=303.78 Aligned_cols=247 Identities=21% Similarity=0.354 Sum_probs=193.3
Q ss_pred eeeeecCceEEEEEEE--CCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~--~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
++||+|+||.||+|.+ ..++..||+|++...... ..+..|+.++..+.|.+.+..+ .++ ..+..++||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-~~~-~~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI-GIC-EAESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEE-EEE-cCCCcEEEEecCC
Confidence 3689999999999964 456789999998654432 3567889999999875544444 443 345668999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||.|||+ +.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~--- 151 (257)
T cd05116 79 LGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENY--- 151 (257)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCe---
Confidence 7899999974 4569999999999999999999999999999999999999 57789999999999866443221
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
+.......++..|+|||.+....++.++|||||||++|||++ |..||..... ......+...... ..+..+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~~~ 223 (257)
T cd05116 152 -YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIESGERM----ECPQRC 223 (257)
T ss_pred -eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCCCC----CCCCCC
Confidence 111122344678999999988889999999999999999998 9999976443 2333333332211 234568
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
|+++.++|.+||..+|++||++++|.+.|+..
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 99999999999999999999999998888754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=310.63 Aligned_cols=260 Identities=17% Similarity=0.303 Sum_probs=206.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEEC-------CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~-------~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
..++|++.+.||+|+||.||+|++. ..+..||+|+...... ...+..|+.++..+.+|+++..+..++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3568999999999999999999753 2345799998764322 24578899999999655777777777777
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~ 138 (477)
....+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili-- 170 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV-- 170 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE--
Confidence 78889999999 889999987531 247888899999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCC
Q 011819 139 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (477)
Q Consensus 139 ~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~ 217 (477)
+.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 171 -~~~~~~kl~D~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 171 -TENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred -cCCCcEEECCCccceecccccccc-----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 577899999999998764432211 1122345678999999998889999999999999999998 889996643
Q ss_pred cccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
..+.+..+...... .....++.++.+++..||..+|++||++.++.+.|++++.-
T Consensus 245 ---~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 ---VEELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ---HHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 23334333332211 12346789999999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=345.17 Aligned_cols=253 Identities=21% Similarity=0.310 Sum_probs=199.2
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV-EGDY 77 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~ 77 (477)
+...++|+++++||+|+||.||+|.+..+++.||+|++..... ...+..|+.++..|.|++++..+..|.. ....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3456799999999999999999999999999999998765322 2357889999999999776666665543 4567
Q ss_pred EEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeeCCCCCCceEeecC-------
Q 011819 78 NVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-------SFLHRDIKPDNFLMGLG------- 139 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~-------giiHRDLKP~NILl~~~------- 139 (477)
.||||||+ +++|.+++... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999 89999998643 35699999999999999999999984 49999999999999531
Q ss_pred -------CCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcC--CCCCCcchHHHHHHHHHHHHcCC
Q 011819 140 -------RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGS 210 (477)
Q Consensus 140 -------~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g--~~~s~ksDIwSlGviLyelltG~ 210 (477)
+....+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||+|++|.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 1234689999999986543221 234579999999999865 45789999999999999999999
Q ss_pred CCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.||..... ..+.+..+.... .. ....++.++.+||..||..+|++||++.+++
T Consensus 241 ~PF~~~~~--~~qli~~lk~~p-~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 241 TPFHKANN--FSQLISELKRGP-DL----PIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CCCCcCCc--HHHHHHHHhcCC-CC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 99975432 222332222211 11 1235688999999999999999999977764
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=307.51 Aligned_cols=249 Identities=19% Similarity=0.332 Sum_probs=194.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++.+.||+|+||.||+|.+..+|+.||||.+..... ...+..|..++.+..+++++..+..++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999998765432 23455677765555666777777666667778999999
Q ss_pred cCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 84 LLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 84 ~~g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|+.++|.+++... ...+++..++.++.||+.||+|||++ +++||||||+|||+ +.++.+||+|||++......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 9998998888642 34589999999999999999999997 99999999999999 67899999999999765432
Q ss_pred CCCcccccccCCCCccCccccccchhcC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g----~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
.. .....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||..... ..+.+..+.......
T Consensus 158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 227 (283)
T cd06617 158 VA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSPQ 227 (283)
T ss_pred cc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCCC
Confidence 11 123468889999999865 4568899999999999999999999965322 122222222211111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. ....+|.++.++|..||..+|++||++.++.+
T Consensus 228 ~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 L---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred C---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 11347899999999999999999999877754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.14 Aligned_cols=256 Identities=16% Similarity=0.273 Sum_probs=203.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCc---EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~---~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.++|++.+.||+|+||.||+|.+..++. .||+|.+..... ...+..|+.++..++| +++..+..++..++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCccE
Confidence 4689999999999999999999765543 799998765332 2357789999999987 55666666667778899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
++|||+ +++|.+++......+++.+++.++.||+.||.|||+++++||||||+|||+ +.++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCccccccc
Confidence 999999 889999998655678999999999999999999999999999999999999 6788999999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
..... .......++..|++||++.+..++.++|+|||||++|++++ |..||..... .+.+..+..... .
T Consensus 159 ~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~~~-~-- 228 (267)
T cd05066 159 DPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIEEGYR-L-- 228 (267)
T ss_pred cccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHhCCCc-C--
Confidence 32211 01112234568999999999899999999999999999886 9999976443 223333332211 1
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
.....+|+.+.+++.+||..+|++||++.++.+.|.++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 12245789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=304.12 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=203.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.+.|. ++..+..++...+..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~-~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP-NVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCC-chhhhhheeEeCCeEEEE
Confidence 57999999999999999999999999999999765422 123567899999999774 555555555667788999
Q ss_pred EecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 82 mE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|||+ +++|.+++... ...+++..+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 9999 88999998642 3458999999999999999999999999999999999999 677899999999987664
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.+... ........+........
T Consensus 158 ~~~~-------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~- 228 (267)
T cd08229 158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPPL- 228 (267)
T ss_pred cCCc-------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcCCCCCC-
Confidence 4322 11235688999999999988899999999999999999999999976432 11222222222211111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
....+++++.+++.+||..+|++||++.++.+.++++
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1234788999999999999999999999999988876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=300.53 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=201.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.++|++.+.||.|+||.||+|.+..+++.+++|++.... ....+..|+.+++.++|++ +..+..+.......|++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN-IVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCC-hhceEEEEEeCCEEEEEEe
Confidence 368999999999999999999999899999999876543 2346788999999998754 5555556667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++......++...+..++.|++.||.|||+++|+|+||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhh-
Confidence 99 789999987654679999999999999999999999999999999999999 6788999999999876543221
Q ss_pred cccccccCCCCccCccccccchhcCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~---~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
......++..|+|||.+.+. .++.++|+|||||++|+|++|..||..... .+....+...........
T Consensus 157 ------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 157 ------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP---MRALFLISKSNFPPPKLK 227 (262)
T ss_pred ------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCcccc
Confidence 12345788999999999877 788999999999999999999999976442 222222222211111111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....++.++.+++.+||..+|.+||++.++..
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22346789999999999999999999887753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=303.23 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=198.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
.+|++.+.||+|+||.||+|.+. ++..+|||++.... ....+..|+.+++.++|. ++..+..++...++.++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHP-NLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCC-CEEEEEEEEcCCCceEEEEecC
Confidence 57899999999999999999875 56789999876533 234678899999999874 5555666666777889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++...+....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccccc--
Confidence 899999997555578999999999999999999999999999999999999 67889999999999865432211
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... .+....+..... ......
T Consensus 157 ----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~ 225 (256)
T cd05059 157 ----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGYR----LYRPKL 225 (256)
T ss_pred ----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCCc----CCCCCC
Confidence 1112234567999999999999999999999999999999 8999976433 233333332211 112345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
+|.++.+++.+||..+|++||++.++.+.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 799999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=298.45 Aligned_cols=247 Identities=21% Similarity=0.281 Sum_probs=199.5
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.|++.+.||.|+||.||++.+..+++.||||.+..... ...+..|+.+++.++|.+.+..+..+.......|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 59999999999999999999999999999998765332 23467888999999886655555555445567899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++... ...+++.++..++.||+.||+|||++||+|+||||+||++ +..+.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCC
Confidence 99 88999988643 3458999999999999999999999999999999999999 5788999999999987643221
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......|++.|+|||++.+..++.++|||||||++|+|++|..||..... ......+...... .+.
T Consensus 158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~~~~----~~~ 223 (257)
T cd08223 158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSLVYRIIEGKLP----PMP 223 (257)
T ss_pred -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHhcCCC----CCc
Confidence 12345789999999999999999999999999999999999999975332 2222333332221 133
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+++++.+++.+||..+|++||++.++.+
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 567899999999999999999999777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.41 Aligned_cols=261 Identities=18% Similarity=0.307 Sum_probs=205.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCC-------CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~-------g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
..+|++++.||+|+||.||+|.+... ...||+|++...... ..+..|++++..+.+++++..+..++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 45799999999999999999986432 237999987653322 35778999999996557777777777777
Q ss_pred cEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~---------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~ 139 (477)
+..+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill--- 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV--- 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---
Confidence 8889999999 88999998642 1247888999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCc
Q 011819 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (477)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~ 218 (477)
+.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||+||+|++ |..||.+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred cCCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 57789999999999876543211 11122334568999999999999999999999999999998 8999976432
Q ss_pred ccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
...+..+...... .....++.++.+++..||..+|++||++.++.+.|+.++....
T Consensus 243 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 ---EELFKLLKEGHRM----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 3333333332211 1234678899999999999999999999999999998875554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=308.46 Aligned_cols=257 Identities=19% Similarity=0.325 Sum_probs=202.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~-----g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
.++|++.+.||+|+||.||++.+... ...||+|++...... ..+..|+.++..+..++++..+..++..+..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 36899999999999999999997644 378999987653322 2467899999999555666666666667778
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 78 NVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~---------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
.+++|||+ +++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV---TE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE---cC
Confidence 89999999 88999998632 3458899999999999999999999999999999999999 57
Q ss_pred CCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCccc
Q 011819 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~ 220 (477)
++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred CCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 889999999999876543221 11122335678999999998889999999999999999997 9999976433
Q ss_pred HHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
.+.+..+...... .....++.++.+++..||..+|++||++.++.+.|+++.
T Consensus 241 -~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 -EELFKLLKEGYRM----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2333332222111 123456889999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=307.04 Aligned_cols=251 Identities=20% Similarity=0.253 Sum_probs=196.1
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+..|+++++.++|+ ++..+..+..+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK-NIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCC-CeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999998764322 23567899999999875 45555455566778899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
|++++|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||+++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC--
Confidence 99889998887656679999999999999999999999999999999999999 6788999999999976543221
Q ss_pred ccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc---------
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (477)
......++..|+|||++.+.. ++.++|||||||++|+|++|..||..... ....+..+.....
T Consensus 155 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 155 -----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred -----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHH
Confidence 123346788999999987754 68999999999999999999998754222 2222222211100
Q ss_pred ---------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 ---------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+++++.++|.+||..+|.+||+++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00012223457889999999999999999999877753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=323.42 Aligned_cols=257 Identities=24% Similarity=0.330 Sum_probs=202.7
Q ss_pred CceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
++|.++++||+|+||.||+|++. .+++.||||++...... ..+..|++++..+..|++++.+..++......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46888999999999999999853 34578999998754332 25778999999998557777777777777789
Q ss_pred EEEEecC-CCCHHHHHHHcC------------------------------------------------------------
Q 011819 79 VLVMDLL-GPSLEDLFNFCS------------------------------------------------------------ 97 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~------------------------------------------------------------ 97 (477)
+|||||+ +++|.+++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999 999999986431
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC
Q 011819 98 -------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140 (477)
Q Consensus 98 -------------------------------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~ 140 (477)
..+++..++.++.||+.||+|||+.+|+||||||+|||+ +
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl---~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI---C 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE---e
Confidence 135677888999999999999999999999999999999 5
Q ss_pred CCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcc
Q 011819 141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 219 (477)
Q Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~ 219 (477)
..+.+||+|||+++........ .......++..|||||++.+..++.++|||||||++|||++ |..||......
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred CCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 6789999999999865432211 11223457889999999999889999999999999999998 89999764321
Q ss_pred cHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
......+... ... ..+..++.++.+++.+||..+|++||++.+|.+.|+.++
T Consensus 349 --~~~~~~~~~~-~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 --EQFYNAIKRG-YRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --HHHHHHHHcC-CCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1122222221 111 123457899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.40 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=199.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+++++.+.|+ ++..+..++...+..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE-RIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCC-CeeeeEEEEccCCeEE
Confidence 579999999999999999999999999999998654321 13467799999999874 5555555566677899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
++|||+ +++|.+++.. ...++...+..++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||+++....
T Consensus 81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccc
Confidence 999999 8899999875 4568999999999999999999999999999999999999 6778999999999976543
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
..... .......|+..|+|||++.+..++.++||||||+++|+|++|..||..... ...+..+..... ..
T Consensus 157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~---~~ 226 (263)
T cd06625 157 ICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPT---NP 226 (263)
T ss_pred ccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHHHhccCC---CC
Confidence 21110 011235678899999999999999999999999999999999999976432 222222222211 12
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.+...++.++.+++..||..+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 244568899999999999999999999877754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=304.98 Aligned_cols=251 Identities=20% Similarity=0.279 Sum_probs=197.0
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~--~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.++|++.++||+|+||.||+|.+..+++.||+|++...... ..+..|+.+++.++|+ ++..+.......+..+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~-~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHS-NIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCC-CeeeEEEEEEeCCEEEEEEe
Confidence 36899999999999999999999999999999987654322 3466788899999775 45555555567788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++.. ...+++.+++.++.||+.||.|||++||+|+||||+||++ +..+.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 87 FCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCccc-
Confidence 99 8899999874 4579999999999999999999999999999999999999 6788999999999976543221
Q ss_pred cccccccCCCCccCccccccchhc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 163 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~---g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
......|+..|+|||++. ...++.++|+|||||++|+|++|..||....... ................
T Consensus 162 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 162 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKLK 232 (267)
T ss_pred ------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhccCCCCCccc
Confidence 123457899999999974 4567899999999999999999999997543321 1111111111111111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....++..+.++|.+||..+|++||+++++.+
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11246789999999999999999999877653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=303.90 Aligned_cols=251 Identities=20% Similarity=0.341 Sum_probs=197.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEe------CcE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVE------GDY 77 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~------~~~ 77 (477)
..+.|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.+|+++..+..++.. ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 3578999999999999999999999999999999876543 234577899999998655666665544432 346
Q ss_pred EEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
.|++|||+ +++|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+||++ +.++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCcee
Confidence 79999999 78999998753 3468999999999999999999999999999999999999 6788999999999986
Q ss_pred cccCCCCcccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
...... ......|+..|+|||++. +..++.++|||||||++|+|++|..||...... .....+..
T Consensus 161 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~~~~~ 230 (272)
T cd06637 161 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR 230 (272)
T ss_pred cccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhc
Confidence 543221 123467899999999986 345788999999999999999999999654321 22222211
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.... ......++.++.+++.+||..+|.+||++.++.+
T Consensus 231 ~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111 1122457889999999999999999999877643
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=302.87 Aligned_cols=252 Identities=21% Similarity=0.366 Sum_probs=199.6
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..++|++.++||+|+||.||+|.+. .+..||+|.+..... ...+..|+.+++.++|.+.+..+..+ .....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~--~~~~~~lv~e 80 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV--SEEPIYIVTE 80 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE--CCCCcEEEEE
Confidence 4568999999999999999999864 667799998765433 34688999999999886655555443 3445789999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++... ...+++..++.++.|++.||.|||+++|+||||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV---GDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---eCCceEEeCCceeeeeccCccc
Confidence 99 88999998743 3458999999999999999999999999999999999999 5678999999999987644321
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+... ......+..... . ..
T Consensus 158 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~-~---~~ 224 (260)
T cd05070 158 T------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVERGYR-M---PC 224 (260)
T ss_pred c------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC-C---CC
Confidence 1 1122345678999999998899999999999999999999 8999976443 223333322211 1 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
...++.++.+++.+||..+|++||+++++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 35678999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=340.55 Aligned_cols=262 Identities=26% Similarity=0.361 Sum_probs=203.1
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|++++..++| ++++.+..++.+.+..|++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~H-PNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-PGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCC-cCcCeEEEEEeeCCEEEEE
Confidence 689999999999999999999999999999998765322 2357789999999987 5555556666678889999
Q ss_pred EecC-CCCHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 82 MDLL-GPSLEDLFNFC----------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 82 mE~~-g~sL~~li~~~----------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
|||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +..+.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9999 99999998642 1235677889999999999999999999999999999999 67889999999
Q ss_pred CceeecccCCCCc-----------ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc
Q 011819 151 GLAKKYRDTSTHQ-----------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (477)
Q Consensus 151 Gla~~~~~~~~~~-----------~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~ 219 (477)
|+++......... ..........+||+.|||||++.+..++.++|||||||++|+|++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998762211100 00111223467999999999999999999999999999999999999999763321
Q ss_pred cHHHHHHHHhhhcccccHH-HHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 011819 220 TKKQKYEKISEKKVSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRIFRDLFI 278 (477)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~-~l~~~~p~~l~~li~~cl~~~p~~RP-t~~~l~~~l~~~~~ 278 (477)
.. .+.. ....+.. .....+|+.+.+++.+||..+|++|| +++++.+.|+..+.
T Consensus 238 ki--~~~~----~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KI--SYRD----VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh--hhhh----hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1111 1111111 11246789999999999999999997 45777777777764
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.45 Aligned_cols=244 Identities=20% Similarity=0.312 Sum_probs=192.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|++++..+.|+ ++..+..++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP-YIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCC-CeeeEEEEEEECCEEEEEEe
Confidence 468999999999999999999999999999998765422 23477899999999874 55555555566778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|..+ ..+++..+..++.||+.||+|||+.||+|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceeccccc--
Confidence 99 7777543 247888999999999999999999999999999999999 678999999999998654322
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHH----HHHHHHhhhcccccHH
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK----QKYEKISEKKVSTSIE 238 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~----~~~~~i~~~~~~~~~~ 238 (477)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||......... .....+.......
T Consensus 150 -------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 219 (279)
T cd06619 150 -------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV--- 219 (279)
T ss_pred -------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC---
Confidence 23457899999999999999999999999999999999999999754322111 1111111111111
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.....+++++.+++.+||..+|+.||+++++.+
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 012346789999999999999999999777654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=304.91 Aligned_cols=255 Identities=18% Similarity=0.228 Sum_probs=196.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCc----EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~----~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.++|++.+.||+|+||.||+|.+..+++ .|++|.+...... ..+..|+.++..+.|++ +..+..++. +...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~-iv~~~~~~~-~~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY-IVRLLGICP-GASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCC-cceEEEEEC-CCcc
Confidence 4689999999999999999999877776 4777776433222 23455666777777754 444444443 3456
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
+++|||+ +++|.+++......+++..++.++.||+.||.|||+++++||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceecc
Confidence 7889988 899999998666779999999999999999999999999999999999999 678899999999998664
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
...... ......++..|++||.+.+..++.++|||||||++|||++ |..||.+.... .+..+........
T Consensus 161 ~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~~~~~~~~~ 231 (279)
T cd05111 161 PDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDLLEKGERLA 231 (279)
T ss_pred CCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCCCcCC
Confidence 322110 1223457788999999998899999999999999999998 99999765432 1222222211111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
....++.++.+++..||..+|++||++.++.+.|..+.
T Consensus 232 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 232 ---QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 22346788999999999999999999999988888775
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.53 Aligned_cols=259 Identities=18% Similarity=0.317 Sum_probs=205.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECC-------CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~-------~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
.++|.++++||+|+||.||+|++.. ....||+|++...... ..+..|+.+++.+.+++++..+..++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4689999999999999999998642 3457999987654322 24678999999997667777777777777
Q ss_pred cEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~ 139 (477)
+..+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill--- 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV--- 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE---
Confidence 8889999999 899999996421 348899999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCc
Q 011819 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (477)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~ 218 (477)
+.++.+||+|||+++......... ......++..|||||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred cCCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 577899999999998664322211 1112234568999999999899999999999999999999 8999976433
Q ss_pred ccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
...+..+...... .....++.++.+++..||..+|++||++.++.+.|.++...
T Consensus 243 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 ---EELFKLLREGHRM----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 3333333332211 12356788999999999999999999999999999888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=302.26 Aligned_cols=257 Identities=15% Similarity=0.237 Sum_probs=203.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCc---EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~---~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
..++|+..+.||+|+||.||+|.+..++. .||+|.+..... ...+..|+.++..+.|+ ++..+..++...+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~ 81 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH-NIIRLEGVVTKFKPA 81 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCC-CeeEEEEEEccCCCc
Confidence 34689999999999999999999876654 799998765432 23577899999999875 555566666677788
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++......+++..+..++.|++.||+|||+.|++|+||||+||++ +.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceecc
Confidence 9999999 889999997656679999999999999999999999999999999999999 578899999999997664
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||..... ......+......
T Consensus 159 ~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~~~~-- 229 (268)
T cd05063 159 DDPEGT----YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDGFRL-- 229 (268)
T ss_pred cccccc----eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcCCCC--
Confidence 322211 00111223457999999998889999999999999999997 9999976433 2333333322111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
.....+|.++.+++.+||..+|++||++.++.+.|+++
T Consensus 230 --~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 --PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11235789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=307.54 Aligned_cols=251 Identities=18% Similarity=0.283 Sum_probs=198.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
..+.|+++++||.|+||.||+|++..+++.|++|++..... ...+..|+.++..++|. ++..+...+..+...++||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHP-YIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCC-cEeeeEEEEEeCCeEEEEE
Confidence 45679999999999999999999999999999999865432 23467799999999875 4555555555667889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|..++......+++..++.++.||+.+|.|||++|++||||||+||++ +.++.++|+|||++........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceecccccc
Confidence 999 888988876556679999999999999999999999999999999999999 5788999999999875433211
Q ss_pred CcccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
......++..|+|||++. ...++.++|||||||++|+|++|..||..... ...+.++......
T Consensus 166 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~-- 233 (292)
T cd06644 166 -------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPP-- 233 (292)
T ss_pred -------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCCCc--
Confidence 123456889999999985 34467899999999999999999999976432 2333333222111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.......++.++.++|.+||..+|++||+++++.+
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11123457889999999999999999999877643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=303.23 Aligned_cols=261 Identities=18% Similarity=0.260 Sum_probs=205.8
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCc----EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeE
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGV 73 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~----~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~ 73 (477)
|......+|++++.||+|+||.||+|.+..+++ .||+|........ ..+..|+.++..+.|++.+..+.. +.
T Consensus 1 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~ 79 (279)
T cd05057 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGI-CL 79 (279)
T ss_pred CcccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEE-Ee
Confidence 455677899999999999999999999876665 6899987654332 356789999999987655555444 33
Q ss_pred eCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCc
Q 011819 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (477)
Q Consensus 74 ~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGl 152 (477)
. ...++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~ 155 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGL 155 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcc
Confidence 3 6778999999 899999998666679999999999999999999999999999999999999 6788999999999
Q ss_pred eeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhh
Q 011819 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 231 (477)
Q Consensus 153 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (477)
++......... ......++..|+|||.+....++.++|+|||||++||+++ |..||...... +....+...
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~ 227 (279)
T cd05057 156 AKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLEKG 227 (279)
T ss_pred cccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhCC
Confidence 98765322111 0111224568999999988889999999999999999998 99999775432 222233222
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
... .....++.++.+++.+||..+|+.||++.++.+.|.+++.
T Consensus 228 ~~~----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ERL----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111 1223467889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=299.40 Aligned_cols=248 Identities=21% Similarity=0.240 Sum_probs=210.4
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
+.|+-.+.||.|..+.|-++.++.++.++|+|++..... .+.-..|+.|++++.+||+|..+..+.+...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 467778899999999999999999999999998765321 1124578999999999999999999999999
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
+.++|+|+| .|.|.|++.. .-.++++....++.|+++|++|||.++||||||||+|||+ +++.++||+|||+|..
T Consensus 97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceeec
Confidence 999999999 8999999984 4569999999999999999999999999999999999999 7899999999999998
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCC------CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~------~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
+..... ...+||||+|+|||.+... .|+..+|+|++|||+|.||.|..||...+. ...+..|+
T Consensus 173 l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---mlMLR~Im 241 (411)
T KOG0599|consen 173 LEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---MLMLRMIM 241 (411)
T ss_pred cCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---HHHHHHHH
Confidence 866543 4568999999999998643 478899999999999999999999965322 23455566
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+.++...- ..+.+++.+.+++|.+||..||.+|.++.+++
T Consensus 242 eGkyqF~s-peWadis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 242 EGKYQFRS-PEWADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred hcccccCC-cchhhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 76664332 34567889999999999999999999976654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=304.31 Aligned_cols=259 Identities=20% Similarity=0.314 Sum_probs=205.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECC----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~----~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
-.++|++.+.||+|+||.||+|.+.. ++..|++|.+..... ...+..|..+++.+.|.+.+..+..+...+..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999876 368899998764322 23467899999999876666655555555677
Q ss_pred EEEEEecC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEee
Q 011819 78 NVLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~-------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
.+++++|+ +++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||+ +.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEECC
Confidence 89999999 799999987532 458999999999999999999999999999999999999 5779999999
Q ss_pred cCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHH
Q 011819 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (477)
Q Consensus 150 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i 228 (477)
||+++.+....... ......++..|+|||++.+..++.++|||||||++|++++ |..||..... ......+
T Consensus 161 ~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~ 232 (280)
T cd05043 161 NALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYL 232 (280)
T ss_pred CCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHH
Confidence 99998664332211 0122346778999999999889999999999999999999 9999976433 2222222
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
...... .....+|+++.+++.+||..+|++||++.++.+.|+++..
T Consensus 233 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 233 KDGYRL----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HcCCCC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222111 1123578999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=303.47 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=192.5
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHc--CCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
.||+|+||.||++.+..+++.||||++..... ...+..|..++..+. +++++..+.......+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999998764321 112334444444443 4566777777677778899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~~---- 152 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---- 152 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccCc----
Confidence 8999988874 4569999999999999999999999999999999999999 6788999999999975543221
Q ss_pred ccccCCCCccCccccccchhc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 166 PYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~-g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
....|+..|+|||.+. +..++.++|||||||++|+|++|..||.......... ...... .....++..+
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~----~~~~~~~~~~ 222 (279)
T cd05633 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL----TVNVELPDSF 222 (279)
T ss_pred -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhh----cCCcCCcccc
Confidence 2346899999999986 4568999999999999999999999997654333222 211111 1111244568
Q ss_pred cHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011819 245 PTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 293 (477)
+.++.++|..||..+|.+|| ++++++ .++|+..++|...
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~----------~h~~~~~~~~~~~ 266 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVK----------EHVFFKGIDWQQV 266 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH----------hCccccCCCHhHH
Confidence 89999999999999999999 455443 2455566677754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=301.95 Aligned_cols=258 Identities=15% Similarity=0.257 Sum_probs=201.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCc---EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~---~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.++|++.+.||+|+||.||+|.+..+++ .||||++..... ...+..|+.+++.+.|+ ++..+..++..+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP-NIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCc-CcceEEEEECCCCceE
Confidence 3579999999999999999999877665 699998765432 23577899999999875 5555555566777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++......+++..++.++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence 999999 889999997656679999999999999999999999999999999999999 6788999999999876543
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
..... .+........+..|+|||++.+..++.++|||||||++|||++ |..||..... ......+... ...
T Consensus 159 ~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~-~~~-- 230 (269)
T cd05065 159 DTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQD-YRL-- 230 (269)
T ss_pred Ccccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcC-CcC--
Confidence 22211 0110111112457999999999999999999999999999886 9999976443 2233333221 111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
.....+|.++.+++..||..+|++||++.++...|+.+
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 -PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11245789999999999999999999999998887764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=303.66 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=196.1
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE-----
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY----- 77 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~----- 77 (477)
++|++.+.||+|+||.||+|.+..+++.||||....... ...+..|+.++..+.+++++..+..++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999998654322 24577899999999887777777666554443
Q ss_pred EEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 78 NVLVMDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~----~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.|++|||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++ ...+.+||+|||++
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~ 158 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG 158 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence 7999999977999988643 23589999999999999999999999999999999999994 22789999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
..+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+.++....
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~ 228 (295)
T cd07837 159 RAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---QQLLHIFKLL 228 (295)
T ss_pred eecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHh
Confidence 76533211 1223356889999998865 45789999999999999999999999764332 2222221110
Q ss_pred -----------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 -----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 -----------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.........+.+++++.++|.+||..+|.+||++.++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001112223467899999999999999999999776643
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=306.97 Aligned_cols=251 Identities=19% Similarity=0.274 Sum_probs=195.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++.++||+|+||.||++.+..++..||+|.+...... ..+..|++++..++|+ ++..+..++..++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSP-YIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEeeCCEEEEEee
Confidence 4799999999999999999999999999999987654332 3477899999999875 55555556667888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++.. ...+++..+..++.||+.||.|||+ ++++|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCcccccccc-
Confidence 99 8899999975 3668999999999999999999997 699999999999999 577889999999987553321
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh-----------
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----------- 230 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~----------- 230 (477)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.....
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 1345789999999999988899999999999999999999999965332111111100000
Q ss_pred ------------------hcccccHHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 ------------------KKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 ------------------~~~~~~~~~l~-~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.........++ ..++.++.+++.+||..+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000001 136788999999999999999999766543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=303.41 Aligned_cols=253 Identities=19% Similarity=0.300 Sum_probs=196.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEee-----EeCcE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFG-----VEGDY 77 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~-----~~~~~ 77 (477)
...++|++.+.||+|+||.||+|.+..+++.||||+..... ....+..|..++..+..|+++..+..++ ..+..
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 35679999999999999999999999999999999876433 2345778999999996445665554443 24567
Q ss_pred EEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 78 NVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.+++|||+ +++|.+++.. ....+++..+..++.||+.||.|||+++|+||||||+||++ +..+.++|+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~ 171 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVS 171 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEEEccCCce
Confidence 89999999 8999998752 23468899999999999999999999999999999999999 57788999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-----~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i 228 (477)
........ ......|+..|+|||++.. ..++.++|||||||++|+|++|..||...... ..+.++
T Consensus 172 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~ 241 (286)
T cd06638 172 AQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKI 241 (286)
T ss_pred eecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhc
Confidence 86643221 1233468999999999753 44788999999999999999999999764331 222222
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..... ........++.++.+++.+||..+|++||++.++.+
T Consensus 242 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 242 PRNPP--PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred cccCC--CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11111 111123446789999999999999999999877754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=303.17 Aligned_cols=252 Identities=20% Similarity=0.325 Sum_probs=203.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
-..+|+++++||.|+||.||+|.+.. ++.||+|++..... ...+..|+.+++.++| +++..+..++......++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRH-KHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCC-cchhheeeeEecCCCeEEEE
Confidence 34679999999999999999999876 88999998776543 3567889999999987 45555555566777889999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCcc
Confidence 999 88999999743 3458999999999999999999999999999999999999 678899999999997664322
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
. ......++..|++||++.+..++.++||||||+++|+|++ |..||..... .+.+..+..... . .
T Consensus 159 ~-------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~-~---~ 224 (261)
T cd05148 159 Y-------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITAGYR-M---P 224 (261)
T ss_pred c-------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHhCCc-C---C
Confidence 1 1123345678999999998889999999999999999998 8999976442 333333332211 1 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
....+++++.+++.+||..+|++||++.+|.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 235678999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=303.35 Aligned_cols=254 Identities=20% Similarity=0.326 Sum_probs=200.3
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCC-----CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~-----g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
..++|++.+.||+|+||.||+|.+... +..||+|....... ...+..|+.++..+.|+ ++..+..++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~-~i~~~~~~~~~~~ 82 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSTGQ 82 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCC-ceeEEEEEEcCCC
Confidence 346899999999999999999997644 37899998764432 22467888999998774 5556666666778
Q ss_pred EEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEE
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~---------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vk 146 (477)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|||+ +.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCEE
Confidence 889999999 899999986421 236788999999999999999999999999999999999 6789999
Q ss_pred EeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHH
Q 011819 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (477)
Q Consensus 147 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~ 225 (477)
|+|||+++....... +.......++..|+|||.+.+..++.++|||||||++|++++ |..||..... .+..
T Consensus 160 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVL 231 (277)
T ss_pred ECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHH
Confidence 999999976544321 112234457789999999988889999999999999999998 9999976432 2333
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
..+...... ..+..++.++.+++..||..+|++||++.++.+.|+
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 KFVIDGGHL----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 333322111 133457899999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.80 Aligned_cols=248 Identities=18% Similarity=0.283 Sum_probs=196.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++++.||+|+||.||+|.+..+++.||+|.+..... ...+..|+.+++.++|+ ++..+...+...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~-~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSP-YIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCC-cHHhhhhheecCCeEEEEEe
Confidence 479999999999999999999998999999998765322 24577899999999775 44444445556788999999
Q ss_pred cC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 84 ~~-g~sL~~li~~~--~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|+ +++|..++... ...+++..+..++.||+.||.|||+ ++|+|+||||+||++ +..+.++|+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCC
Confidence 99 88999988743 2368999999999999999999997 599999999999999 56889999999999765432
Q ss_pred CCCcccccccCCCCccCccccccchhcCC------CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~------~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
.. ....|+..|+|||++.+. .++.++|||||||++|+|++|..||...........+..+.....
T Consensus 157 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 157 LA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred cc---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 21 234688899999998654 347899999999999999999999976443322223333333222
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. .+...++.++.++|.+||..+|++||+++++..
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1 234457899999999999999999999877754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=299.86 Aligned_cols=250 Identities=19% Similarity=0.308 Sum_probs=209.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++.+.+..||.|+.|.||+++++.+|..+|||.+...... ..++..++++.....++.|+....++..+...+|+||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 4456677899999999999999999999999988765443 3466777777766678999998888888888899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+|+..+..|+.+..+++++.-+-++...++.||.||-+ +||||||+||.|||+ |..|++||||||++-.+.+...
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeecccc-
Confidence 99999999999888999999999999999999999996 689999999999999 8999999999999987766543
Q ss_pred cccccccCCCCccCccccccchhcCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~---~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
...-.|.+.|||||.+.-. .|+.++||||||++|+||.||..||.+.+ +..+.+.++.....+...
T Consensus 248 -------htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln~ePP~L~-- 316 (391)
T KOG0983|consen 248 -------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLNEEPPLLP-- 316 (391)
T ss_pred -------cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHhcCCCCCC--
Confidence 2355899999999998643 58999999999999999999999998754 345666666664432221
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...++++.|.+|+..||.+|+.+||.|.+|.+
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 12458999999999999999999999987743
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=300.00 Aligned_cols=245 Identities=20% Similarity=0.296 Sum_probs=197.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
.++|++.+.||+|+||.||++. .+++.||+|.+........+..|+.++..++|++.++.+..+. . +..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~-~~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL-H-NGLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEc-C-CCcEEEEECC
Confidence 4689999999999999999987 5788999999876555567889999999998866666555543 3 3468999999
Q ss_pred -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 86 -GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 86 -g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+++|.+++.... ..+++..++.++.|++.||.|||+.|++||||||+|||+ +.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceeccccCC--
Confidence 899999997543 358899999999999999999999999999999999999 6778999999999976543211
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
....+..|+|||++.+..++.++|+|||||++|+|++ |..||..... ......+...... ....
T Consensus 156 --------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 220 (254)
T cd05083 156 --------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEKGYRM----EPPE 220 (254)
T ss_pred --------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhCCCCC----CCCC
Confidence 2234568999999998899999999999999999997 9999976443 2222222222111 1235
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
.+|.++.+++..||..+|+.||+++++.+.|+
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 67899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=305.37 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=198.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
...+|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.+.|. ++..+...+..+...|+||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~-~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP-NIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCC-CEeeEEEEEEeCCEEEEee
Confidence 45689999999999999999999999999999998765432 34577899999988775 4555555555677899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+++. ...+++.++..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 97 e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 97 EYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcccccc
Confidence 999 899999986 3468999999999999999999999999999999999999 5778999999999876533211
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||...... ...+...... .. . ....
T Consensus 172 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~~~~~-~~-~-~~~~ 239 (296)
T cd06654 172 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNG-TP-E-LQNP 239 (296)
T ss_pred -------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHHhcCC-CC-C-CCCc
Confidence 112347889999999999888999999999999999999999999764331 1112111111 11 1 1123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..++..+.+++.+||..+|++||++.++.+
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 457889999999999999999999777654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=304.05 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=199.5
Q ss_pred CCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
..+|.+.++||+|+||.||++... .++..||+|.+..... ...+..|++++..++|. ++..+..++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ-HIVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCC-CCceEEEEEecCCce
Confidence 457899999999999999999742 3467899998654332 23578899999999875 555555666677888
Q ss_pred EEEEecC-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC
Q 011819 79 VLVMDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~--------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~ 143 (477)
+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||+ +.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cCCC
Confidence 9999999 899999987532 247899999999999999999999999999999999999 5788
Q ss_pred cEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHH
Q 011819 144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (477)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~ 222 (477)
.+||+|||++........ +.......+++.|+|||++.+..++.++|||||||++|+|++ |..||..... .
T Consensus 160 ~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~ 231 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---T 231 (280)
T ss_pred CEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---H
Confidence 999999999976543221 112233445788999999999999999999999999999998 9999966433 2
Q ss_pred HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
..+..+...... .....+|+.+.+++..||..+|++||+++++.+.|+
T Consensus 232 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 EAIECITQGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHcCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 233333222111 123467899999999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=300.11 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=200.1
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----------hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----------~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
+|.++..||.|+||.||+|.+..+++.||+|.+...... ..+..|+.++..++| +++..+..++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH-ENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCC
Confidence 588999999999999999999889999999976543211 246788999999987 45555666667778
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
+.+++|||+ +++|.+++.. ...++...+..++.|++.||+|||++|++||||||+||++ +.++.++|+|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK 155 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcc
Confidence 899999999 8899999975 4568999999999999999999999999999999999999 6788999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
........ ..........|+..|+|||.+.+..++.++|+|||||++|+|++|..||..... ...+..+....
T Consensus 156 ~~~~~~~~-~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~--- 228 (267)
T cd06628 156 LEANSLST-KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENA--- 228 (267)
T ss_pred cccccccC-CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHhccC---
Confidence 65322111 011112345688999999999988899999999999999999999999976432 22233322211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...+...++.++.++|.+||+.+|++||++.++.+
T Consensus 229 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 -SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 12234567899999999999999999999877754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=327.07 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=207.9
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.|.-++.||.|+||.||-|++..+.+.||||.++-.. ++..++.|+.++..|.| |+...+..++......||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~H-PntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRH-PNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccC-CCcccccceeeccchHHHHH
Confidence 4666788999999999999999999999999876543 45578999999999998 55666666666777789999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|||-|+..|++..+.+++.+.++..|+.+.+.||.|||+++.||||||.-|||| .+.|.|||+|||.|.....
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---cCCCeeeeccccchhhcCc----
Confidence 999999999999888899999999999999999999999999999999999999 6889999999999976543
Q ss_pred cccccccCCCCccCccccccchhcC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g---~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
..+++|||.|||||+++. +.|+-++||||||++.+||...++|+.++++.. ..|..... ..++.-
T Consensus 179 -------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--ALYHIAQN-esPtLq-- 246 (948)
T KOG0577|consen 179 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQN-ESPTLQ-- 246 (948)
T ss_pred -------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HHHHHHhc-CCCCCC--
Confidence 357899999999999875 468999999999999999999999999887643 33433333 222211
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
...++..|..||..||.+-|.+||+.+++ |++.|...
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~l---l~H~fv~R 283 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEEL---LKHRFVLR 283 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHH---hhcchhcc
Confidence 24568899999999999999999997765 44444433
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=300.11 Aligned_cols=251 Identities=21% Similarity=0.231 Sum_probs=194.2
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeC--cEEEEEEe
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLVMD 83 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~--~~~~lVmE 83 (477)
|++.++||+|+||.||+|.+..+++.||||.+..... ......|+.++..+.+++++..+..++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7899999999999999999999999999998765322 223456888888887566676666665555 78899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
|+.++|.+++......+++..++.++.||+.||+|||+.|++||||||+||++ +. +.+||+|||+++.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---KD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---cC-CCeEEEecccccccccCCC--
Confidence 99888988887545678999999999999999999999999999999999999 45 9999999999986643222
Q ss_pred ccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc----------
Q 011819 164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------- 232 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (477)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...............
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 155 ------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred ------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 123467889999997654 456889999999999999999999997644322111111111000
Q ss_pred -----------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 -----------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 -----------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....+..+...++.++.++|.+||..+|++||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 001122334567899999999999999999999877754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=301.07 Aligned_cols=255 Identities=21% Similarity=0.280 Sum_probs=210.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCH
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~--~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL 89 (477)
+.||+|+|+.|--|.+..++.+||||++.+...+ ..+.+|++++..+++|.+|..+..|++++..+|||||-| ||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 4689999999999999999999999998876544 358899999999999999999999999999999999999 8998
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccccccc
Q 011819 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169 (477)
Q Consensus 90 ~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~ 169 (477)
...|.. ...|++.++..+...|+.||.|||.+||.||||||+|||....+.-.-||||||.|.........-.....-.
T Consensus 164 LshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 164 LSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 888874 5569999999999999999999999999999999999999655555678999999986543332221111223
Q ss_pred CCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc------------cHHHHHHHHhhhc
Q 011819 170 NKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------------TKKQKYEKISEKK 232 (477)
Q Consensus 170 ~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~------------~~~~~~~~i~~~~ 232 (477)
..+.+|+..|||||+.. ..-|+.++|+||||||||-||.|++||.+.-+. -....++.|++.+
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 45678999999999864 235899999999999999999999999874331 1345677888887
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
+..+ ++-+..++.+.+++|..+|..++.+|.++..+
T Consensus 323 YeFP-dkdWahIS~eakdlisnLlvrda~~rlsa~~v 358 (463)
T KOG0607|consen 323 YEFP-DKDWAHISSEAKDLISNLLVRDAKQRLSAAQV 358 (463)
T ss_pred CcCC-hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence 7544 44567889999999999999999999875544
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=298.98 Aligned_cols=252 Identities=18% Similarity=0.272 Sum_probs=193.6
Q ss_pred eeeeecCceEEEEEEECC---CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~---~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
+.||+|+||.||+|.+.. ....||||.+..... ...+..|..+++.++|++.+..+..+...++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998653 346799998754322 2356788899999988666665554555566789999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|.+++......+++..++.++.||+.||.|||+.+++||||||+|||+ +..+.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~-- 155 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYS-- 155 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCccee--
Confidence 899999997655567888889999999999999999999999999999999 577899999999998654322110
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
........++..|+|||++.+..++.++|||||||++|||++| ..||..... ......+...... .....+
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~ 227 (262)
T cd05058 156 -VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQGRRL----LQPEYC 227 (262)
T ss_pred -ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCCCC----CCCCcC
Confidence 1111234567789999999988999999999999999999994 666755332 2222222222111 112346
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
|+.+.+++..||..+|++||++.++.+.|++++
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 889999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=305.76 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=197.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||+|.+..+++.||||.+...... ..+..|++++..++| ++++.+..++......|++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH-PFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCC-CCchhheeeeecCCEEEEE
Confidence 4799999999999999999999999999999987654322 346789999999986 5566666666778889999
Q ss_pred EecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 82 MDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 82 mE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|||+ +++|.+++... ...+++..+..++.||+.||+|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence 9999 88999998743 3568999999999999999999999999999999999999 57789999999998765332
Q ss_pred CCCcc----------------------cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 011819 160 STHQH----------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (477)
Q Consensus 160 ~~~~~----------------------~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~ 217 (477)
..... ........+.|+..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11000 00011224578999999999999999999999999999999999999997643
Q ss_pred cccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011819 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265 (477)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt 265 (477)
. ...+..+........ ....++.++.++|.+||..+|++||+
T Consensus 237 ~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 237 R---DETFSNILKKEVTFP---GSPPVSSSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred h---HHHHHHHhcCCccCC---CccccCHHHHHHHHHHccCCHhHCCC
Confidence 3 333333333222111 11226899999999999999999999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=308.73 Aligned_cols=256 Identities=19% Similarity=0.223 Sum_probs=188.7
Q ss_pred EeeeeecCceEEEEEEECC--CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcEEEEEEecCCCC
Q 011819 12 GRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLLGPS 88 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~--~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~lVmE~~g~s 88 (477)
+.+||+|+||.||+|.+.. ++..||+|.+........+..|+.+++.++|++.+..+..+.. .+...++||||++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 4689999999999999654 5689999988766555678899999999998766665555543 456779999999889
Q ss_pred HHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC-CCCCcEEEeecCceeecccC
Q 011819 89 LEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 89 L~~li~~~--------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~-~~~~~vkL~DFGla~~~~~~ 159 (477)
|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 99887532 1247889999999999999999999999999999999999432 35678999999999876543
Q ss_pred CCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH------HHHHHHHhhhc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEKISEKK 232 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~------~~~~~~i~~~~ 232 (477)
... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ...+.++....
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred ccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 221 1122346789999999999874 578999999999999999999999965322100 00111110000
Q ss_pred c------------------------------cc---cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 V------------------------------ST---SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ~------------------------------~~---~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. .. ..+......+..+.+++.+||..||.+||++.++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00 000011123456889999999999999999877653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=304.49 Aligned_cols=250 Identities=20% Similarity=0.340 Sum_probs=197.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeE------eCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGV------EGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~------~~~~~ 78 (477)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+.++..+.+++++..+..++. .....
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 478999999999999999999999999999999876543 23457788899999976677776655542 35678
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
|++|||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhhh
Confidence 9999999 77999998743 3458888899999999999999999999999999999999 67888999999998755
Q ss_pred ccCCCCcccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (477)
..... ......|+..|+|||.+. ...++.++|||||||++|+|++|..||..... ...+..+...
T Consensus 172 ~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~~ 241 (282)
T cd06636 172 DRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRN 241 (282)
T ss_pred hcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH---HhhhhhHhhC
Confidence 33211 123457899999999976 34578899999999999999999999976432 1222222221
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.. .......++.++.++|.+||..+|.+||++.+|.+
T Consensus 242 ~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 PP---PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CC---CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11 11123468899999999999999999999887743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=298.03 Aligned_cols=254 Identities=22% Similarity=0.372 Sum_probs=203.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
...++|++.++||.|+||.||+|.+. .+..||||.+.... ....+..|+.+++.++|. ++..+..++......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHD-KLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCC-CEeeeeeeeecCCceEEEE
Confidence 45689999999999999999999974 56789999877543 335688899999999874 5555555566667889999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceeccchh
Confidence 999 88999999643 2468999999999999999999999999999999999999 678999999999998765321
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
. .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+... ...+.++..... . .
T Consensus 158 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~-~---~ 224 (261)
T cd05034 158 Y------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGYR-M---P 224 (261)
T ss_pred h------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC-C---C
Confidence 1 11122234568999999999899999999999999999998 9999976433 333333332211 1 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
....+|.++.+++.+||..+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 224568999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.96 Aligned_cols=257 Identities=23% Similarity=0.332 Sum_probs=199.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc-EEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGD-YNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~-~~~lVmE 83 (477)
++|.-...||+|+||.||+|.- .++..||||.+..... ..+|..|+.++..++| +|++.+..||.+.+ ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H-~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRH-PNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCC-cCcccEEEEEecCCceEEEEEE
Confidence 5788888999999999999995 5559999998776554 4669999999999995 66777777777777 5999999
Q ss_pred cC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---CeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~-~ls~~~~~~i~~qIa~aL~yLHs~g---iiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|+ +|+|.+++..... .++|...++|+.++|.||+|||+.. |||||||+.|||| |.+.++||+|||+|+....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence 99 8899999985444 8999999999999999999999854 9999999999999 8999999999999965543
Q ss_pred -CCCCcccccccCCCC-ccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc---cHHHHH-HHHhhhc
Q 011819 159 -TSTHQHIPYRENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---TKKQKY-EKISEKK 232 (477)
Q Consensus 159 -~~~~~~~p~~~~~~~-~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~---~~~~~~-~~i~~~~ 232 (477)
... .... .||..|++||++.....+.|+|||||||+|.|+++|+.|....... ...... ..+.+..
T Consensus 230 ~~~~--------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 230 GDTS--------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cccc--------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 111 1112 7999999999999889999999999999999999999888653211 111111 1111111
Q ss_pred ccccHH-HHh-cCCc-----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 233 VSTSIE-ALC-RGYP-----TEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 233 ~~~~~~-~l~-~~~p-----~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
....++ .+. ..++ ..+..+...|+..+|.+||++.++.+.|+.+
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 111111 111 2233 2366778899999999999999988887554
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.72 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=195.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+..|+.+++.++|. ++..+..++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~-~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP-NLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCC-CEeeeeeEEeeCCEEEEEE
Confidence 57999999999999999999999899999999865432 223467899999999875 4555555566777889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ ++.|..++. ....+++..++.++.||+.+|+|||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 80 EYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred eccCccHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc
Confidence 999 555655554 34569999999999999999999999999999999999999 6778999999999987654321
Q ss_pred CcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh---------
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 231 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (477)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+................
T Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 156 -------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred -------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1123467889999999876 45789999999999999999999999875432222111111100
Q ss_pred --------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 --------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 --------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
......+.....++..+.+|+.+||..+|++||++.++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0001122334567889999999999999999999877643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=297.58 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=194.3
Q ss_pred eeeeecCceEEEEEEECCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g---~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
++||+|+||.||+|.+...+ ..||+|.+..... ...+..|+++++.+.|.+.+ .+..++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV-RLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCee-eEEEEEc-CCceEEEEEeCC
Confidence 47999999999999876655 7999998765443 34577899999999875544 4444433 45679999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|.+++.. ...+++..++.++.||+.||+|||..+++|+||||+|||+ +.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 79 LGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcc---
Confidence 8899999975 3469999999999999999999999999999999999999 67889999999999866443321
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
+.......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... .+....+...... .....+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~~ 223 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGERL----PRPEEC 223 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCcC----CCCCCC
Confidence 111122234568999999999899999999999999999998 9999976543 2233333222111 133567
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
+..+.+++.+||..+|++||++.++.+.|++.
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 89999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.63 Aligned_cols=260 Identities=21% Similarity=0.260 Sum_probs=198.1
Q ss_pred CceEEEeeeeecCceEEEEEEE----CCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEe-CcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~----~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~-~~~~ 78 (477)
..|+++++||+|+||.||+|.. ..++..||+|.+..... ...+.+|+.+++.+.|++.+..+..+... ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4579999999999999999984 45688999998764322 23577899999999886555544444333 3667
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ |++|.+++......+++..++.++.||+.||+|||++|++||||||+|||+ +.++.++|+|||++....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccccc
Confidence 9999999 999999997555568999999999999999999999999999999999999 567899999999998664
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc-----------ccHHHHHH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----------GTKKQKYE 226 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~-----------~~~~~~~~ 226 (477)
..... ........++..|+|||++.+..++.++|||||||++|+|+++..|+..... ........
T Consensus 161 ~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 161 TDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 43221 1112345677889999999988899999999999999999998776532110 00000111
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
........ ......++.++.+|+.+||..+|++||++.++.+.|+++
T Consensus 237 ~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKR---LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCcc---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111110 112345789999999999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=303.08 Aligned_cols=248 Identities=19% Similarity=0.291 Sum_probs=196.4
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
-|++.+.||.|+||.||+|.+..++..+++|.+..... ...+..|+++++.+.|.+ +..+..++..+...++||||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~-ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN-IVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCC-eeeEEEEEeeCCEEEEEEEec
Confidence 46889999999999999999999999999998765432 234677999999998754 555555556677889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|..++......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++........
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccccccc---
Confidence 889988876555679999999999999999999999999999999999999 6788999999999875533211
Q ss_pred cccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 165 IPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
......|+..|+|||++. +..++.++|||||||++|+|++|..||..... .+.+..+....... ..
T Consensus 159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~ 229 (282)
T cd06643 159 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPT--LA 229 (282)
T ss_pred ----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCCCC--CC
Confidence 123457899999999984 45578899999999999999999999976432 33333332221111 11
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....++.++.++|.+||..+|++||+++++.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 23457899999999999999999999877643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=310.16 Aligned_cols=258 Identities=20% Similarity=0.218 Sum_probs=196.3
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeE----eCcE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGV----EGDY 77 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~----~~~~ 77 (477)
++++|++.++||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.++|++.+..+..+.. ....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 6789999999999999999999999999999999875422 22346779999999997655554443322 2245
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
.|++|||++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeecc
Confidence 79999999889988886 4579999999999999999999999999999999999999 678899999999998764
Q ss_pred cCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh------
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE------ 230 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~------ 230 (477)
...... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+............+..
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred cccccc----CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 432211 11234578999999998765 4688999999999999999999999976332111110100000
Q ss_pred -----------------hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 -----------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 -----------------~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.........+.+.+++++.+++.+||..+|++||++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00111122234556788999999999999999999776644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=305.74 Aligned_cols=270 Identities=19% Similarity=0.269 Sum_probs=208.3
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||++.+..+++.||||.+..... ...+..|+.+++.++| +++..+...+..+++.++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN-PFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEecCCEEEEE
Confidence 479999999999999999999999999999998765431 2346688899998877 4555666666677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ |++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +..+.++|+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCc
Confidence 9999 8899999975 4568999999999999999999999999999999999999 678899999999987422111
Q ss_pred CCc--------ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 161 THQ--------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 161 ~~~--------~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
... ...........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.. ..+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~~~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFGQVISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcc
Confidence 100 000011123567889999999998889999999999999999999999997643 233344333322
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011819 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (477)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 293 (477)
...+. ....+|.++.++|.+||..+|++||+...+.++|++ +|+...||...
T Consensus 233 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~-------~~~~~~~~~~~ 284 (305)
T cd05609 233 IEWPE--GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH-------RFFLGLDWNGL 284 (305)
T ss_pred cCCCC--ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC-------ccccCCCHHHH
Confidence 21111 112578999999999999999999997766666554 44455677763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=296.80 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=200.2
Q ss_pred eeeeecCceEEEEEEECCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~---g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
+.||+|+||.||+|.+... +..|++|++..... ...+..|++++..+.| +++..+..+.......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH-PNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCC-CChheeeeeecCCCceEEEEEecc
Confidence 4799999999999998766 88999999876544 3467889999999995 55666655555688899999999
Q ss_pred CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 86 GPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 86 g~sL~~li~~~--------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
+++|.+++... ...+++..+..++.||+.||+|||++||+|+||||+||++ +.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccc
Confidence 99999999865 3679999999999999999999999999999999999999 677999999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
.... +.......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... .+....+.....
T Consensus 157 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~--- 225 (262)
T cd00192 157 DDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGYR--- 225 (262)
T ss_pred cccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC---
Confidence 4331 112334567889999999998889999999999999999999 6999977533 333443333211
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
......+|.++.+++.+||..+|++||++.++.+.|
T Consensus 226 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 226 -LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred -CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 123355789999999999999999999999887765
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=297.13 Aligned_cols=253 Identities=19% Similarity=0.355 Sum_probs=199.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
...++|++.++||+|+||.||++.+ ..+..||+|.+..... ...+..|+.+++.++|.+++.....+. . ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEc-C-CCeEEEE
Confidence 3568999999999999999999985 4556799998765332 345788999999998765555544443 3 6679999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||+ +++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||++ +..+.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeeccCCC
Confidence 999 78999999642 3457888999999999999999999999999999999999 678899999999998664322
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. ......++..|+|||++.+..++.++|+|||||++|++++ |..||...... .....+...... .
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~----~ 223 (260)
T cd05073 157 YT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGYRM----P 223 (260)
T ss_pred cc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCCC----C
Confidence 11 1122345678999999998889999999999999999998 99999765432 222222221111 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
....+|.++.+++.+||..+|++||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 235678999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=297.52 Aligned_cols=250 Identities=21% Similarity=0.336 Sum_probs=202.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
.++|++.++||+|+||.||+|.+..+++.|++|.+........+..|+++++.++| +++..+..++......|+++||+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS-PYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCC-CcEeeeeeeeecCCcEEEEEecC
Confidence 36899999999999999999999888999999998765445678899999999966 45555555555668889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++......+++..+..++.||+.||.|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~--- 154 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMA--- 154 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCcc---
Confidence 889999997666779999999999999999999999999999999999999 6788999999999987654321
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
......|+..|+|||++.+..++.++||||||+++|+|++|..||...... .....+..... ........+
T Consensus 155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~~~~~~~~ 225 (256)
T cd06612 155 ----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM---RAIFMIPNKPP--PTLSDPEKW 225 (256)
T ss_pred ----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh---hhhhhhccCCC--CCCCchhhc
Confidence 123346888999999999999999999999999999999999999764332 11111111111 111122346
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+.++.+++..||..+|++||++.++.+
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 789999999999999999999877654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=310.41 Aligned_cols=259 Identities=20% Similarity=0.294 Sum_probs=216.2
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
-|.++++||+|+||.||+|.|+.+|..||||.+.++....++..|+.++.++..+..+.++..|+. ....||||||| .
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeehhhcCC
Confidence 478899999999999999999999999999999998888899999999999998655555555554 34579999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
|++.+++...++++++.++..++...+.||+|||...-||||||.-|||| +.+|..||+|||.|-.+.+...
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMA----- 184 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMA----- 184 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHH-----
Confidence 99999998778889999999999999999999999999999999999999 7899999999999988766443
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
...++.||+-|||||++....|+.++||||||++..||..|++||....+.. .+.-|..+..++.. -+..++.
T Consensus 185 --KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPPTF~--KPE~WS~ 257 (502)
T KOG0574|consen 185 --KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPPTFK--KPEEWSS 257 (502)
T ss_pred --hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCCCCCC--ChHhhhh
Confidence 2357899999999999999999999999999999999999999998765521 11122222222221 1234678
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Q 011819 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~ 285 (477)
+|.+||..||-+.|++|-+ ..+++++.|+++.-..+
T Consensus 258 ~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNAPGCD 293 (502)
T ss_pred HHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCCCccc
Confidence 9999999999999999988 56678888887765443
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=300.57 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=196.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.++|++.+.||.|+||.||+|.+..+++.||||.+..... ...+..|+.+++.++| +++..+..++...+..++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH-ANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCC-cceeeEEEEEecCCeEEEEE
Confidence 4689999999999999999999988999999998764322 2346689999999987 55666666677788999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||++++|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCCc-
Confidence 999879999987666678999999999999999999999999999999999999 6788999999999875432111
Q ss_pred cccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc---------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (477)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||...... .+.+..+....
T Consensus 159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhh
Confidence 1123356889999999876 45789999999999999999999999764321 11111111000
Q ss_pred ----------------ccccHHHHhcCCc--HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 ----------------VSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ----------------~~~~~~~l~~~~p--~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...........+. .++.+++.+||..+|++||++.++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0011111222334 78899999999999999999877643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.09 Aligned_cols=251 Identities=21% Similarity=0.280 Sum_probs=199.8
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.+.||.|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| +++..+..+...+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-PYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCC-CCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999998765432 3457889999999986 555556555666888899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
|++++|.+++......+++..++.++.||+.||+|||++|++|+||||+||++ +..+.++|+|||++........
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC--
Confidence 99999999997666779999999999999999999999999999999999999 5688999999999986654321
Q ss_pred ccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc----------
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------- 232 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (477)
.......|+..|+|||++.+.. ++.++|||||||++|+|++|..||.+... ...+..+....
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 155 ----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred ----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhh
Confidence 1123457899999999987644 58999999999999999999888865432 22222221110
Q ss_pred ---------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 ---------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ---------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.........+..+.++.++|.+||..+|++||+++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 001122334567889999999999999999999877654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=301.70 Aligned_cols=261 Identities=21% Similarity=0.231 Sum_probs=197.1
Q ss_pred CCceEEEeeeeecCceEEEEEE----ECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEee-EeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFG-VEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~----~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~-~~~~~~ 78 (477)
.++|++.+.||+|+||.||+|. +..+++.||||.+..... ...+..|++++..++|++.+..+..+. ......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 4689999999999999999997 345788999998765432 235778999999998855544444332 334567
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCccccccc
Confidence 9999999 899999997655668999999999999999999999999999999999999 678899999999998764
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHH------------HHH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK------------QKY 225 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~------------~~~ 225 (477)
...... .......++..|+|||++.+..++.++|||||||++|||++|..|+......-.. ..+
T Consensus 160 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 432210 0011123445699999999989999999999999999999998776542211000 000
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
........ .......++.++.+++.+||..+|++||++.++.+.|+.+
T Consensus 236 ~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNG---RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCC---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000 0012245788999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.53 Aligned_cols=254 Identities=19% Similarity=0.199 Sum_probs=198.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~ 79 (477)
..++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....|+.+++.++|.+.+..+..+.. ..+..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 356899999999999999999999999999999987644322 235679999999998665555554432 335679
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
+||||++++|.+++......+++..+..++.||+.||.|||+.|++||||||+||++ +..+.+||+|||++......
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCCc
Confidence 999999889999998666779999999999999999999999999999999999999 67889999999999876543
Q ss_pred CCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc-----
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (477)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|..||..... .+.+..+.....
T Consensus 162 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 162 AK-------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---IEQLDLIIQLLGTPNES 231 (309)
T ss_pred cC-------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChh
Confidence 21 1122345788999999876 4578999999999999999999999976443 233332222100
Q ss_pred --------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 --------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 --------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+++++.++|.+||..||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00011112335788999999999999999999776653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=303.03 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=200.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECC-----CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~-----~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
.++|++.+.||.|+||.||+|.+.. ++..||||++..... ...+..|+.++..+.| +++..+..++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH-PNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCCc
Confidence 4689999999999999999998743 678999998765432 2357789999999987 556666666667778
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceE
Q 011819 78 NVLVMDLL-GPSLEDLFNFCS---------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~---------------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NIL 135 (477)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||+++++||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 89999999 789999986321 23778889999999999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCC
Q 011819 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (477)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~ 214 (477)
+ +.++.++|+|||++........ +........+..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 163 ~---~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 163 V---GENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred e---cCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9 6788999999999876543221 111122344678999999999899999999999999999997 889997
Q ss_pred CCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
+... .+....+...... ..+..+|.++.+++.+||..+|++||++.++.+.|+
T Consensus 235 ~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 235 GMAH---EEVIYYVRDGNVL----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCH---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 6433 2333333332221 123467899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=300.54 Aligned_cols=245 Identities=22% Similarity=0.346 Sum_probs=199.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++.+.||.|+||.||+|.+..+++.||||++..... ...+..|+.+++.++|.+ +..+..++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY-ITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCC-eeeeeEEEEECCeEEEEEE
Confidence 479999999999999999999999999999998765432 235778999999999754 5555555667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++.. .++++..++.++.||+.||.|||+++++|+||+|+||++ +.++.++|+|||+++.......
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc-
Confidence 99 8899999974 379999999999999999999999999999999999999 6789999999999987754321
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
......|+..|+|||++.+..++.++|||||||++|+|++|..||..... ......+....... +..
T Consensus 154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~----~~~ 220 (274)
T cd06609 154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNNPPS----LEG 220 (274)
T ss_pred ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcCCCC----Ccc
Confidence 12345788999999999998899999999999999999999999976442 22222233222211 122
Q ss_pred C-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 243 G-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 243 ~-~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. ++.++.+++..||..+|++||+++++.+
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2 7899999999999999999999776643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=305.01 Aligned_cols=252 Identities=17% Similarity=0.273 Sum_probs=196.3
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.+|+..++||+|+||.||++.+..+++.||||.+..... ...+..|+.++..+..++++..+..+.......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467888999999999999999999999999998765332 23567898899888755677766666666778899999
Q ss_pred cCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 84 LLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 84 ~~g~sL~~li~~----~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|++.+|.++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +..+.++|+|||++.....
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhcc
Confidence 998888776542 23569999999999999999999997 499999999999999 5778999999999976543
Q ss_pred CCCCcccccccCCCCccCccccccchhcCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~---~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
... .....|+..|+|||++.+. .++.++|||||||++|+|++|..||.... ...+...++.....+.
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~ 230 (288)
T cd06616 161 SIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPI 230 (288)
T ss_pred CCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCc
Confidence 221 1234688899999998876 68899999999999999999999997643 1222222222222111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
........++.++.+|+..||..+|++||+++++..
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111122357899999999999999999999877654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=297.03 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=198.3
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEe------Cc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVE------GD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~------~~ 76 (477)
.-.++|++.+.||.|+||.||+|.+..+++.|++|++..... ...+..|+.+++.+.+|+++..+..++.. +.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 346899999999999999999999988999999998765443 34678899999999655666666555433 44
Q ss_pred EEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCc
Q 011819 77 YNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGl 152 (477)
..++||||+ +++|.+++... ...+++..+..++.||+.||.|||+++++|+||+|+||++ +.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCcc
Confidence 579999999 88999998643 3568999999999999999999999999999999999999 6788999999999
Q ss_pred eeecccCCCCcccccccCCCCccCccccccchhcCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 011819 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (477)
Q Consensus 153 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-----~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~ 227 (477)
+........ ......|+..|+|||++.+. .++.++|||||||+||+|++|..||..... ......
T Consensus 160 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~ 229 (275)
T cd06608 160 SAQLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALFK 229 (275)
T ss_pred ceecccchh-------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHHH
Confidence 976543221 12345689999999988643 467889999999999999999999975432 222222
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+......... ....++.++.++|.+||..||++||++.++.+
T Consensus 230 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2222111111 11236789999999999999999999887754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=299.88 Aligned_cols=247 Identities=19% Similarity=0.265 Sum_probs=194.7
Q ss_pred eeeeecCceEEEEEEECCCCc--EEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~--~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|.+..++. .+++|...... ....+..|+.++..+.+|+++..+..++......++||||+ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999888775 46888765322 22357789999999976677877777777778889999999 8
Q ss_pred CCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 87 PSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 87 ~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||+ +.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCC
Confidence 99999986421 247899999999999999999999999999999999999 678899999999
Q ss_pred ceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhh
Q 011819 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 152 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||.+... ...+..+..
T Consensus 158 l~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~ 226 (270)
T cd05047 158 LSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ 226 (270)
T ss_pred Cccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHhC
Confidence 986322110 0111233567999999988889999999999999999997 9999976433 223333322
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
.... .....++.++.+++.+||..+|.+||+++++...|+.++
T Consensus 227 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111 123457889999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=296.11 Aligned_cols=248 Identities=21% Similarity=0.327 Sum_probs=199.6
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
-.++|++.+.||.|+||.||+|.. .++.||||.+..... ...+..|+.++..++|.+.+ .+..+.......++|||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLV-QLLGVVLQGNPLYIVTE 80 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCccee-eeEEEEcCCCCeEEEEE
Confidence 357899999999999999999985 488999998876544 45688899999999885544 44444445778899999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccccc
Confidence 99 789999997533 258999999999999999999999999999999999999 6788999999999986632211
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
...++..|+|||++.+..++.++||||||+++|+|++ |..||..... ......+..... ...
T Consensus 158 ----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~ 220 (256)
T cd05039 158 ----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYR----MEA 220 (256)
T ss_pred ----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCC----CCC
Confidence 2234567999999998889999999999999999997 9999976432 233332222211 112
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
...+|+++.+++.+||..+|++||++.++.+.|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 35678999999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=296.70 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=201.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~---g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.++|.+.++||+|+||.||+|.+... ...||||....... ...+..|+.+++.+.|.+.+..+..+ . ....+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~-~~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-T-ENPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEE-c-CCCcE
Confidence 45799999999999999999987544 35789998765432 23577899999999886555554443 3 34568
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
++|||+ +++|.+++......+++..++.++.||+.||+|||++|++|+||||+|||+ +..+.++|+|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeeccc
Confidence 999999 899999997655568999999999999999999999999999999999999 5778999999999986654
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+......
T Consensus 160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~~~~~--- 227 (270)
T cd05056 160 ESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGRIENGERL--- 227 (270)
T ss_pred ccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCcC---
Confidence 3221 1112234568999999988889999999999999999986 9999976543 2333333322211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
..+..+|.++.++|.+||..+|++||++.++.+.|+++..
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1345688999999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=300.03 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=193.6
Q ss_pred EEEeeeeecCceEEEEEEEC----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 10 RLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 10 ~i~~~IG~G~fG~Vy~a~~~----~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++.+.||.|.||.||+|... ..+..|+||+++.... ...+..|++.+..++| +++..+..++...+..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRH-PNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSB-TTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccc-cccccccccccccccccccc
Confidence 57899999999999999987 3467899999865433 2468889999999965 66666666666667789999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||+ +++|.+++... ...+++.....|+.||+.||.|||+++++|+||+++|||+ +.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 999 78999999865 4679999999999999999999999999999999999999 578899999999998773222
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. .......+...|+|||.+.+..++.++||||||+++|||++ |..||..... .+...++.+.... .
T Consensus 158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~~~~~----~ 225 (259)
T PF07714_consen 158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQGQRL----P 225 (259)
T ss_dssp SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHTTEET----T
T ss_pred cc-----cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccc----e
Confidence 11 11233456788999999998889999999999999999999 7899976533 4444444333221 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
....+|..+.++|..||+.+|++||++.++.+.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 3356899999999999999999999999887754
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=310.72 Aligned_cols=251 Identities=22% Similarity=0.284 Sum_probs=195.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeE-----e
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV-----E 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~-----~ 74 (477)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|.+.+..+..+.. +
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45789999999999999999999999999999999875432 12346689999999988666666555432 2
Q ss_pred CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
....|+||||++++|.+++.. .++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccce
Confidence 245799999998899998863 28999999999999999999999999999999999999 678899999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
....... .....++..|+|||++.+..++.++|||||||++|+|++|..||...+. ...+.++......
T Consensus 167 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~ 235 (353)
T cd07850 167 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGT 235 (353)
T ss_pred eCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCC
Confidence 6543221 2234688999999999999999999999999999999999999976432 2222222110000
Q ss_pred -------------------------ccHHHH-------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 235 -------------------------TSIEAL-------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 235 -------------------------~~~~~l-------------~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.....+ ....++++.++|.+||..||.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 1134667899999999999999999776643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=291.36 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=202.0
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.+.||.|+||.||.+++..+++.|++|.+.... ....+..|+++++.++| +++..+..++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-PNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCC-CCeeEEEeEEecCCeEEEEEE
Confidence 5999999999999999999999999999999866432 22357789999999977 556666666667788999999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++... ...+++..+..++.|++.+|.|||+.|++|+||||+||++ +.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccc
Confidence 99 89999999753 3468999999999999999999999999999999999999 5778999999999987644332
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......|++.|+|||++.+..++.++|||||||++|+|++|..||... ...+....+....... ..
T Consensus 157 -------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~----~~ 222 (256)
T cd08221 157 -------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT---NPLNLVVKIVQGNYTP----VV 222 (256)
T ss_pred -------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCC----Cc
Confidence 123457899999999999888999999999999999999999999653 2334444444333222 22
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..++.++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 567899999999999999999999877754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=309.73 Aligned_cols=254 Identities=16% Similarity=0.206 Sum_probs=189.5
Q ss_pred EEeeeeec--CceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 11 LGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 11 i~~~IG~G--~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
++++||+| +|++||++.+..+|+.||||.+..... ...+..|+.+++.++| ++|..+..++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCEEEEEEec
Confidence 57889999 789999999999999999998865432 2346678899998887 5555566666777889999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccccccc
Confidence 9 89999998643 3458999999999999999999999999999999999999 57789999999876544322111
Q ss_pred cccccccCCCCccCccccccchhcC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc-----
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST----- 235 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g--~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----- 235 (477)
............++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ............
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKLNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH---HHHHHhcCCcccccccc
Confidence 1000001123456788999999976 458999999999999999999999997643311 111111110000
Q ss_pred ------------------------------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 ------------------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ------------------------------------~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
........+++++.+|+..||..||++||+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000112235678999999999999999999876643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.62 Aligned_cols=258 Identities=23% Similarity=0.323 Sum_probs=215.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~-----g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.+-+..+.||+|.||+||+|+-... ...||||.++.+... .+|.+|+.++..|+| ++|+.+..++.+++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H-~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH-PNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEccCCee
Confidence 4566788999999999999985433 357999988765443 569999999999998 6777888888899999
Q ss_pred EEEEecC-CCCHHHHHHHcC---------CC----CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCc
Q 011819 79 VLVMDLL-GPSLEDLFNFCS---------RK----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~---------~~----ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~ 144 (477)
|||+||| .|+|.+++..+. .. ++..+.+.|+.|||.|++||-++.+|||||-..|+|+ .+...
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccceE
Confidence 9999999 999999986442 22 7889999999999999999999999999999999999 58899
Q ss_pred EEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHH
Q 011819 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (477)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~ 223 (477)
|||+||||++......+.. -...-.=..+||+||.++..+++.++|||||||+|||+++ |..||.++.. .+
T Consensus 642 VKIsDfGLsRdiYssDYYk-----~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~E 713 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYK-----VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QE 713 (774)
T ss_pred EEecccccchhhhhhhhhc-----ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HH
Confidence 9999999999766554422 1112233679999999999999999999999999999998 9999998665 45
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.++.+...... ..+.++|.++++||..||..+|.+||+|.+|-..|+++....
T Consensus 714 VIe~i~~g~lL----~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 VIECIRAGQLL----SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHcCCcc----cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 55666665542 245789999999999999999999999999999999886443
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=302.45 Aligned_cols=247 Identities=18% Similarity=0.298 Sum_probs=196.9
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++.++||+|+||+||++.+..+++.||+|++..... ...+..|++++..++| +++..+..++......++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS-PYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCC-CCcceEeeeEecCCEEEEEEe
Confidence 679999999999999999999999999999998764432 3457789999999976 555555555666788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++.. .+.+++..+..++.|++.+|.|||+ ++++||||||+||++ +.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 84 FMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred cCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhhc-
Confidence 99 8899998875 4568999999999999999999997 699999999999999 678899999999986543221
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-----cH---HHHHHHHhhhcc
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TK---KQKYEKISEKKV 233 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~-----~~---~~~~~~i~~~~~ 233 (477)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...... .. ...+..+....
T Consensus 159 --------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 229 (284)
T cd06620 159 --------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP- 229 (284)
T ss_pred --------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-
Confidence 12457899999999999888999999999999999999999999764331 00 11111111111
Q ss_pred cccHHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 STSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 ~~~~~~l~-~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...+. ..+|.++.+++.+||..+|++||++.++.+
T Consensus 230 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~ 265 (284)
T cd06620 230 ---PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCA 265 (284)
T ss_pred ---CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111 137889999999999999999999877754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=301.40 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=198.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..+|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|++.+ .+..++...+..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV-NFLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCcee-eeeeeEecCceEEEEEE
Confidence 357999999999999999999999999999999876533 234577899999999875544 45555566778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++. ...+++.+++.++.|++.||+|||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 97 YLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred ecCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhcccccc-
Confidence 99 999999887 3468999999999999999999999999999999999999 6788999999999876543221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+...... ......
T Consensus 171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---~~~~~~~~~~~~--~~~~~~ 239 (296)
T cd06655 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNGTP--ELQNPE 239 (296)
T ss_pred ------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCc--ccCCcc
Confidence 112346889999999999888999999999999999999999999764331 222222211111 111234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.+++.+.++|.+||..+|++||++.++..
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 57889999999999999999999877653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=302.40 Aligned_cols=250 Identities=20% Similarity=0.319 Sum_probs=200.2
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.++|+++++||.|+||.||+|.+..++..||+|+...... ...+..|+++++.++| +++..+...+..+...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH-PNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEecCCeEEEEee
Confidence 3679999999999999999999988999999998765432 2357789999999996 566666666667888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++......+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccccc-
Confidence 99 889999997666779999999999999999999999999999999999999 6789999999999875533221
Q ss_pred cccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 163 QHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
......|++.|++||.+. +..++.++|||||||++|+|++|..||..... .+.+.++.......
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 227 (280)
T cd06611 159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLKILKSEPPT-- 227 (280)
T ss_pred ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHHHhcCCCCC--
Confidence 123456899999999975 34567899999999999999999999976432 23333333322111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
......++.++.++|..||..+|++||++.++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1122457889999999999999999999776643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=297.77 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=195.6
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHc--CCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
.||+|+||.||+|.+..+++.||||++..+... .....|..++..+. +++++..+.+.+...+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999987653211 12344444444443 3566777777777788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
|++|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+||++ +.++.++|+|||++..+....
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~----- 151 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK----- 151 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccC-----
Confidence 8999998864 4569999999999999999999999999999999999999 678899999999987553321
Q ss_pred ccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 166 PYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.................. ...++..+
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 222 (278)
T cd05606 152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-----AVELPDSF 222 (278)
T ss_pred ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc-----CCCCCCcC
Confidence 124578999999999874 46899999999999999999999999775332222222211111 11234457
Q ss_pred cHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 245 PTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
+.++.+++.+||..+|.+|| ++.++++ ++|...++|.....
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~----------~~~~~~~~~~~~~~ 268 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE----------HPFFRSLDWQMVFL 268 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh----------CccccCCCchHhhh
Confidence 89999999999999999999 7666643 56666678886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=292.13 Aligned_cols=244 Identities=19% Similarity=0.303 Sum_probs=191.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
+.||+|+||.||+|.. .++..||+|++...... ..+..|++++..+.|. ++..+..++...+..++||||+ +++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHP-NIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCC-CcCeEEEEEecCCccEEEEECCCCCc
Confidence 4789999999999985 56889999987654322 2467899999999775 5555555566677889999999 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccc
Q 011819 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (477)
Q Consensus 89 L~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 168 (477)
|.+++......+++..++.++.|++.+|.|||++|++|+||||+||++ +.++.+||+|||++.........
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~------ 149 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYS------ 149 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccc------
Confidence 999987555568999999999999999999999999999999999999 67889999999999754432211
Q ss_pred cCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHH
Q 011819 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (477)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (477)
......++..|+|||++.+..++.++|||||||++|++++ |..||...... .....+..... ......++.+
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~ 222 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEKGYR----MSCPQKCPDD 222 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCCC----CCCCCCCCHH
Confidence 1112244678999999998889999999999999999998 99999765332 22222222111 1123457899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 248 FASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
+.+++.+||..+|++||++.++.+.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=300.05 Aligned_cols=250 Identities=20% Similarity=0.246 Sum_probs=195.4
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-------hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-------~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
+|++.+.||.|+||.||+|.+..+++.||||.+...... ..+..|+++++.++|.+ +..+..++...+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN-IIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCC-ChhhhheeecCCEEEE
Confidence 589999999999999999999999999999987654322 24567899999998755 4445455555788999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||||++++|.+++......+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCCC
Confidence 99999999999997543369999999999999999999999999999999999999 678899999999998765432
Q ss_pred CCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc-------
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------- 232 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~------- 232 (477)
. ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.... ..+.++....
T Consensus 157 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 157 R-------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEEN 226 (298)
T ss_pred c-------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhh
Confidence 1 1123356788999999865 45789999999999999999998888764432 2222221110
Q ss_pred ----------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 ----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ----------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.......+....+.++.++|..||..+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 011122233456788999999999999999999777654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=301.92 Aligned_cols=263 Identities=22% Similarity=0.241 Sum_probs=198.5
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeE-------
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV------- 73 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~------- 73 (477)
..++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++.+..+..+..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 35799999999999999999999999999999998754322 2346789999999998666555544432
Q ss_pred eCcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 74 EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 74 ~~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.....++||||++.+|..++......+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccc
Confidence 234579999999888988887555679999999999999999999999999999999999999 67899999999999
Q ss_pred eecccCCCCccc----ccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 011819 154 KKYRDTSTHQHI----PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (477)
Q Consensus 154 ~~~~~~~~~~~~----p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i 228 (477)
............ .........|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.......+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 865443221110 11122345678899999988754 5789999999999999999999999765443222222211
Q ss_pred hhh----------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 229 SEK----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 229 ~~~----------------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
... ............+.+++.++|.+||..+|.+||++.++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 110 001111122234567899999999999999999977664
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=300.34 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=200.9
Q ss_pred CCceEEEeeeeecCceEEEEEEEC----CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEe--Cc
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE--GD 76 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~----~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~--~~ 76 (477)
..+|++.+.||+|+||.||+|... .+++.||||++..... ...+..|+++++.+.|.+.+. +..++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~-~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK-YKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChhe-EEeeeecCCCC
Confidence 457899999999999999999864 3478999998876544 346888999999998755444 4444443 55
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
+.+++|||+ +++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||+ +.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccccccc
Confidence 789999999 899999998655569999999999999999999999999999999999999 6779999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-----------HHH
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-----------KQK 224 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~-----------~~~ 224 (477)
....... +.......++..|++||.+.+..++.++|||||||++|+|++|..||........ ...
T Consensus 159 ~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 159 LPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 6532211 1111123455679999999988999999999999999999999999865432110 111
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
........... .....+|.++.+++.+||..+|++||++.++.+.|+.+
T Consensus 235 ~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111111111 11245688999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=296.09 Aligned_cols=253 Identities=20% Similarity=0.306 Sum_probs=198.3
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
+|+..+.||+|+||.||+|.+..+++.||||++.... ....+..|+++++.++|.+ +..+..++.+.+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH-IIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCc-eehhhceeccCCeEE
Confidence 5889999999999999999999999999999876432 1245778999999998855 444445556677889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC-CcEEEeecCceeecc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYR 157 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~-~~vkL~DFGla~~~~ 157 (477)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||++ +.. ..++|+|||++....
T Consensus 80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~---~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEcccccccccc
Confidence 999999 8999999975 4568999999999999999999999999999999999999 344 469999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
....... .......|+..|+|||++.+..++.++|||||||++|+|++|..||..............+..... .
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~ 229 (268)
T cd06630 156 AKGTGAG---EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT---A 229 (268)
T ss_pred cccccCC---ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC---C
Confidence 4322110 012345688999999999988999999999999999999999999975443322222222221111 1
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
......+++++.+++.+||..+|++||++.++..
T Consensus 230 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 2233457889999999999999999999877753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.59 Aligned_cols=258 Identities=19% Similarity=0.269 Sum_probs=200.3
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCc----EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~----~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
.-.++|++.+.||+|+||.||+|.+..+++ .||+|++...... ..+..|+.++..+.|++.+..+..+ .. .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-~~-~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVC-LS-P 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE-cC-C
Confidence 345789999999999999999999877776 4788987654322 2467888999999875555555444 33 3
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..++++||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEcccccccc
Confidence 457899999 899999997655578999999999999999999999999999999999999 5678899999999986
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..... +..+......
T Consensus 159 ~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~ 229 (303)
T cd05110 159 LEGDEKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLEKGER 229 (303)
T ss_pred ccCcccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCCC
Confidence 6432211 01122345678999999999999999999999999999997 999997643221 2222221111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
. .....++..+.+++..||..+|++||++.++.+.|+++..
T Consensus 230 ~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 230 L---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 1224567899999999999999999999999998888753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=299.57 Aligned_cols=246 Identities=21% Similarity=0.335 Sum_probs=199.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
...|+..++||.|+||.||+|.+..++..||||++..... ...+..|++++..+.| ++++.+..++......++||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEEEE
Confidence 3568899999999999999999989999999998765432 2356788999999876 56666666777788999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+++. ..+++...+..++.|++.||+|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 82 EYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence 999 889999987 3568999999999999999999999999999999999999 5778999999999976643221
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......++..|+|||++.+..++.++|+|||||++|+|++|..||...... .....+..... ..+.
T Consensus 157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~----~~~~ 222 (277)
T cd06640 157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLFLIPKNNP----PTLT 222 (277)
T ss_pred -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhhhhhcCCC----CCCc
Confidence 122346788999999999988999999999999999999999999764432 22222211111 1233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+|.++.+++.+||..+|++||++.++..
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 457889999999999999999999887754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=293.82 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=201.4
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++++.||.|+||+||+|....++..||+|++.... ....+..|+++++.++|. ++..+......++..+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHP-NVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCC-CEEEEEEEEeeCCEEEEEEe
Confidence 57999999999999999999998899999999876533 234578899999999875 45555555667888999999
Q ss_pred cC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 84 ~~-g~sL~~li~~~~--~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
++ +++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||++ +.++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence 99 899999997532 458999999999999999999999999999999999999 567899999999998765543
Q ss_pred CCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH-
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE- 238 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~- 238 (477)
... ........|+..|++||++... .++.++|+|||||++|+|++|..||...... +.+.+...........
T Consensus 157 ~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (267)
T cd06610 157 DRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETG 230 (267)
T ss_pred ccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCc
Confidence 211 0122345789999999998876 7889999999999999999999999765432 2233332222111111
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.....+++++.+++..||..+|++||++.++.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 112367899999999999999999999777654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=297.27 Aligned_cols=252 Identities=20% Similarity=0.264 Sum_probs=194.6
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+.|. ++..+..++..++..|+||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHA-NIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCC-CEeEEEEEEecCCeEEEEE
Confidence 46899999999999999999999999999999987654322 2467899999999874 5556666667778899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||++++|.+.+......+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCC-
Confidence 999888888776445568888999999999999999999999999999999999 6788999999999975433221
Q ss_pred cccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc--------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (477)
......++..|+|||++.+. .++.++|||||||++|+|++|..||..... ..+.+.++.....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 159 ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred ------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhh
Confidence 11234578899999998764 578899999999999999999999976432 1222222211000
Q ss_pred -----------------cccHHHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 -----------------STSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 -----------------~~~~~~l~~--~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
......... ..+.++.+++.+|+..+|.+||++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 000111111 1256899999999999999999987764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=294.16 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=194.1
Q ss_pred eeeeecCceEEEEEEECC-CC--cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTNIQ-TN--EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~-~g--~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
++||+|+||.||+|.+.. .+ ..||||.+..... ...+..|+.+++.++|++.+..+..+. . ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-T-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-C-CeEEEEEEecC
Confidence 468999999999999755 33 3699998876544 235778999999999866555544443 3 7889999999
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++.... ..+++..+..++.||+.||+|||++|++|+||||+||++ +.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~-- 153 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDH-- 153 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEeccccccccccccccc--
Confidence 899999997543 468999999999999999999999999999999999999 57799999999999876543221
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
+.......++..|+|||++.+..++.++|||||||++|+|++ |..||..... .+....+...... ......
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~~---~~~~~~ 225 (257)
T cd05040 154 --YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDKEGER---LERPEA 225 (257)
T ss_pred --eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhcCCc---CCCCcc
Confidence 112223567789999999999899999999999999999998 9999976443 2333333221111 112345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
+|..+.+++..||..+|++||++.++.+.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7899999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=297.49 Aligned_cols=252 Identities=19% Similarity=0.302 Sum_probs=196.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEe-----CcEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVE-----GDYN 78 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~-----~~~~ 78 (477)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.++..+.+|+++..+..++.. ....
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 3578999999999999999999999999999999876533 234567889999998555666666544432 2467
Q ss_pred EEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 79 VLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
++||||+ +++|.++++. ....+++..++.++.||+.||+|||+.||+|+||||+||++ +.++.+||+|||++.
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccch
Confidence 9999999 8899998863 24568999999999999999999999999999999999999 678889999999987
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-----~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
....... ......|+..|+|||++... .++.++|||||||++|+|++|+.||..... ...+.++.
T Consensus 177 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~~~ 246 (291)
T cd06639 177 QLTSTRL-------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFKIP 246 (291)
T ss_pred hcccccc-------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHHHh
Confidence 6543221 11234688999999997643 367899999999999999999999976433 23333333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....... .....++.++.++|.+||..+|++||++.++.+
T Consensus 247 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2221111 112346778999999999999999999877754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=301.59 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=197.9
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
..++|++++.||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.+.|. ++..+..++..++..++||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~-~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNP-NIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCC-CEeeEEEEEecCCEEEEee
Confidence 34789999999999999999999999999999998765332 23467788898888775 5555555556777899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+++. ...+++..++.++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 96 EYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cccCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCCcc
Confidence 999 999999986 3568999999999999999999999999999999999999 6788999999999976543221
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......|++.|+|||.+.+..++.++|+|||||++|+|++|..||....... ..+ .+.... .......
T Consensus 171 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~~-~~~~~~--~~~~~~~ 238 (297)
T cd06656 171 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY-LIATNG--TPELQNP 238 (297)
T ss_pred -------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--hee-eeccCC--CCCCCCc
Confidence 1123468899999999999889999999999999999999999997643211 111 111111 1111123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..++..+.+++.+||..+|++||++.++.+
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 457889999999999999999999777654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=291.67 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=198.4
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|+ ++..+.......+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~-~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP-NIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCC-chhheeeeEecCCEEEEEEe
Confidence 5999999999999999999999999999999876543 223577899999999875 44445445566778899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++... ...+++..++.++.|++.+|+|||++||+|+||||+||+++ +..+.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCcc
Confidence 99 88999999753 34589999999999999999999999999999999999994 3455789999999987654321
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ......+...... .+.
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~ 222 (256)
T cd08220 158 --------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTFA----PIS 222 (256)
T ss_pred --------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCCC----CCC
Confidence 1235688999999999988889999999999999999999999976432 2233333322211 233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+++++.+++..||..+|++||++.++..
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 567899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=296.41 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=197.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|++.++||+|+||.||+|.+..+++.||||.+.... ....+..|+++++.+.|. ++..+..++..++..+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE-NIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCC-CeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999875432 234678999999999974 5555555666788899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||+++++.+.+......++...+..++.||+.||.|||+.+++|+||+|+||++ +.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence 999556555554445669999999999999999999999999999999999999 67899999999999876543320
Q ss_pred cccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh----------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 231 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~---------- 231 (477)
......++..|+|||++.+. .++.++||||||+++|+|++|..||.+............+...
T Consensus 157 ------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 157 ------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 12345678899999999888 7899999999999999999999999764332111111111000
Q ss_pred -------------cccccHH-HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 -------------KVSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 -------------~~~~~~~-~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
......+ .....+++++.++|..||..+|++||+++++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000011 112235889999999999999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=296.16 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=194.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-------~~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~~ 78 (477)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... ...+..|+.+++.++|++.+..+..+.. .....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 579999999999999999999999999999998754321 1246779999999987655555544433 34678
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
+++|||+ +++|.+++.. ...++...++.++.||+.||+|||+++|+|+||||+||++ +.++.++|+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence 9999999 8899999875 4468999999999999999999999999999999999999 678899999999997654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
...... .......++..|+|||++.+..++.++|||||||++|+|++|..||..... .+....+.... ..
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~~~~~~~---~~ 227 (266)
T cd06651 158 TICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQP---TN 227 (266)
T ss_pred cccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHHHHhcCC---CC
Confidence 321110 111235688999999999998899999999999999999999999976432 22222222111 11
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+...+++.+.+++ .||..+|++||+++++.+
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 223345678889998 688899999999877743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=295.52 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=186.2
Q ss_pred eeeeecCceEEEEEEEC--CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~--~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||+|+||.||+|... .++..+|+|.+..... ...+..|+.+++.++|++ +..+..++.+....++||||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSN-LLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCC-EeeEEEEEcCCCCcEEEEECCCC
Confidence 46899999999999854 3456899998765432 235777999999998855 445555555667789999999 8
Q ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 87 PSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 87 ~sL~~li~~~~----~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
++|.+++.... ..+++..++.++.|++.||+|||+++++||||||+||++ +..+.++|+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~- 155 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDY- 155 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcce-
Confidence 99999986422 235677888999999999999999999999999999999 5788999999999875433221
Q ss_pred cccccccCCCCccCccccccchhcCC-------CCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI-------EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~-------~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
+.......|+..|+|||++.+. .++.++|||||||++|||++ |..||........ ....+......
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~~~~ 229 (269)
T cd05087 156 ----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTVREQQLK 229 (269)
T ss_pred ----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHhhcccCC
Confidence 1112345678899999998642 35789999999999999996 9999976543221 11112222222
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
.....+...+++.+.++++.|| .+|++||++++|...|.
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222333457889999999999 68999999999987653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=319.29 Aligned_cols=272 Identities=20% Similarity=0.287 Sum_probs=222.4
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----C-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----K-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.+++++..||-|+||.|-++........+|+|++++.. + ++.+..|..||..+.. +.|+.++--+.+..|.||.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s-~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRS-DFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCc-hHHHHHHHHhccchhhhhh
Confidence 46677888999999999999976665568999876542 2 2346678889888875 6666665556678899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||.| ||.|+.++.. .+.|...++.+|+..+++|++|||++|||+|||||+|.|| +..|-+||.|||+|+......
T Consensus 499 mEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCC
Confidence 9999 9999999975 5679999999999999999999999999999999999999 789999999999999887755
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. ..++|||+.|.|||+++....+..+|.||||+++||||+|.+||.+.+. ...|..|..... .-.+
T Consensus 575 K--------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGid---~i~~ 640 (732)
T KOG0614|consen 575 K--------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGID---KIEF 640 (732)
T ss_pred c--------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhhh---hhhc
Confidence 4 3478999999999999999999999999999999999999999988655 455665555432 1235
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~--~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
++.++....++|.+++..+|.+|..+ ..+.++ ..+.|+..|||..++....+++..|
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DI-------kkH~Wf~gfdweglr~~~L~pPi~~ 699 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDI-------KKHRWFEGFDWEGLRSRTLPPPIIP 699 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHH-------HhhhhhhcCChhhhhhccCCCCccc
Confidence 57788999999999999999999763 222222 3467889999999988766655544
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=293.72 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=193.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-------~~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~~ 78 (477)
.+|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.++..+.|++.+..+..+.. .....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998653221 1246679999999987555554443332 24567
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
+++|||+ +++|.+++.. ...+++..++.++.||+.||+|||+++|+|+||||+|||+ +..+.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence 8999999 8899999875 3558999999999999999999999999999999999999 678899999999998654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
..... ........|+..|+|||++.+..++.++|||||||++|+|++|..||..... ...+.++......
T Consensus 158 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~--- 227 (265)
T cd06652 158 TICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPTN--- 227 (265)
T ss_pred ccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHHHHHhcCCCC---
Confidence 32111 0112345688999999999988899999999999999999999999976432 2222222221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...+..++..+.+++..|| .+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 1123346778999999999 49999999877754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=294.81 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=196.7
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
+|++.++||.|++|.||+|++..+++.||||++.... ....+..|+.+++.++| +++..+..++...+..+|||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC-CCEeeeeeeEeeCCcEEEEEec
Confidence 5999999999999999999999999999999876543 23456789999999976 5666666666777888999999
Q ss_pred CCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 LGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~g~sL~~li~~~~--~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCcc-
Confidence 9879999886433 458999999999999999999999999999999999999 6788999999999975533211
Q ss_pred cccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc-------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 234 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (477)
......++..|++||++.+. .++.++|||||||++|+|++|..||.+...................
T Consensus 156 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 ------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 12234578899999998764 4688999999999999999999999765432221111111100000
Q ss_pred --------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 235 --------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 235 --------------~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.....+.+.+++++.+++..||..+|++||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111223456788999999999999999999877653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=293.57 Aligned_cols=252 Identities=19% Similarity=0.317 Sum_probs=197.4
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
+|++++.||.|+||.||+|.+ .+++.||||.+..... ...+..|+.+++.++|. ++..+..++...+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV-NIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCC-CEeeEeeEeecCCeEE
Confidence 588999999999999999986 5788999998764321 13467899999999874 5555666666778999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
++|||+ +++|.+++.. ...+++..+..++.||+.||+|||+.+|+|+||||+||++ +..+.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence 999999 8999999975 3568999999999999999999999999999999999999 6789999999999876532
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
...... .........|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.... ....
T Consensus 155 ~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~--~~~~ 228 (265)
T cd06631 155 VGLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL---AAMFYIGAHR--GLMP 228 (265)
T ss_pred cccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH---HHHHHhhhcc--CCCC
Confidence 111100 001123456899999999999988999999999999999999999999764321 1111111110 1122
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.+...++.++.++|++||..+|++||++.++..
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 345678999999999999999999999877643
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=294.25 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=196.3
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
+.||.|+||.||+|.+..+++.||||++..... ...+..|..++....+++++..+..++..++..|++|||+ +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999998764321 1223455555544445577777777777788899999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||++ +..+.++|+|||++.....
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~-------- 149 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE-------- 149 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc--------
Confidence 999999975 4568999999999999999999999999999999999999 5788999999999875433
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
.....|+..|++||.+.+..++.++||||||+++|+|++|..||..... .+.+..+....... .......+++
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~ 222 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRINW-PEEVKEFCSP 222 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccCC-CCcccccCCH
Confidence 1234688899999999988889999999999999999999999976433 33344333322211 1123346789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 247 EFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
++.+++.+||..+|++||++..+.+++.+.+.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 99999999999999999988777777776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=296.63 Aligned_cols=261 Identities=20% Similarity=0.242 Sum_probs=199.8
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 15 IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
||+|+||+||+|.+..+++.||+|++.... ....+..|+++++.++| +++..+.......+..|+||||+ +++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC-CCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 689999999999999999999999875432 12345679999999985 56666655566677889999999 899
Q ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccccc
Q 011819 89 LEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (477)
Q Consensus 89 L~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~ 167 (477)
|.+++.... ..+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~------- 149 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGK------- 149 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCC-------
Confidence 999986433 368999999999999999999999999999999999999 678899999999987654311
Q ss_pred ccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHH
Q 011819 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (477)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (477)
......++..|++||++.+..++.++|||||||++|+|++|..||.............. ... .........++++
T Consensus 150 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~ 224 (277)
T cd05577 150 -KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---RTL-EMAVEYPDKFSPE 224 (277)
T ss_pred -ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---ccc-cccccCCccCCHH
Confidence 12345678899999999988899999999999999999999999976443222222211 111 1111234567899
Q ss_pred HHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCccccccchhhcc
Q 011819 248 FASYFHYCRSLRFDDKPDYAY--LKRIFRDLFIREGFQFDYVFDWTILKYQQS 298 (477)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~--l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~ 298 (477)
+.++|.+||..+|++||++.+ +.+++. ++|...++|........
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~-------h~~~~~~~~~~~~~~~~ 270 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE-------HPLFKDLNWRRLEAGML 270 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh-------ChhhhcCChhhhhcCCC
Confidence 999999999999999995433 222222 45566678887654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=301.51 Aligned_cols=252 Identities=19% Similarity=0.327 Sum_probs=199.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
-.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|..++..+..+++++.+..++......|++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34789999999999999999999988899999999865432 234566777777776567777777777788889999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||++++|.+++......+++..+..++.||+.||.|||+ .||+||||+|+||++ +.++.+||+|||++..+....
T Consensus 93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCCC
Confidence 9999889999987666789999999999999999999997 699999999999999 678899999999987654322
Q ss_pred CCcccccccCCCCccCccccccchhcCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~----~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
. .....++..|+|||++.+.. ++.++||||||+++|+|++|..||..... ..+.+.++........
T Consensus 170 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 170 A--------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPSL 239 (296)
T ss_pred c--------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCCC
Confidence 2 12235788999999987654 78899999999999999999999965322 2233333333221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. ....++.++.+++.+||..+|++||+++++.+
T Consensus 240 -~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 240 -P-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred -C-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 11247889999999999999999999877754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=292.13 Aligned_cols=247 Identities=23% Similarity=0.294 Sum_probs=200.3
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~lVm 82 (477)
+|++.+.||.|+||.||+|.+..+++.||+|++..... ...+..|+++++.+.|++.+..+..+.. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999998764332 2346778999999998665555544433 456679999
Q ss_pred ecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH-----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 83 E~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLH-----s~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
||+ +++|.+++... ..++++..++.++.||+.||.||| +.+++|+||||+||++ +..+.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccccc
Confidence 999 88999998754 456899999999999999999999 8999999999999999 57799999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
........ ......|++.|++||++.+..++.++|+||||+++|+|++|..||.... .......+.....
T Consensus 158 ~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~ 227 (265)
T cd08217 158 KILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGKF 227 (265)
T ss_pred ccccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcCCC
Confidence 87654321 0123468999999999999889999999999999999999999997643 2233333333222
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+...++.++.+++.+||..+|++||++.++.+
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 2244567899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=290.18 Aligned_cols=249 Identities=20% Similarity=0.284 Sum_probs=197.3
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
.+|++.+.||+|+||.||+|.+. .+..+|+|++..... ...+..|+++++.+.|++ +..+..++......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPK-LVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCC-eeeEEEEEccCCceEEEEEcC
Confidence 57999999999999999999874 477899998765432 356888999999998754 555555556667789999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++......++++.+..++.|++.+|+|||+.+++|+||||+||++ +.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~--- 155 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQY--- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCcc---
Confidence 889999997655678999999999999999999999999999999999999 5778999999999986543221
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......+...... .....
T Consensus 156 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~ 225 (256)
T cd05112 156 ---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAGFRL----YKPRL 225 (256)
T ss_pred ---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCCCCC----CCCCC
Confidence 11122345678999999998889999999999999999998 9999965332 2333333221111 01233
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
.+.++.+++.+||..+|++||++.++.+.|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 688999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=298.31 Aligned_cols=259 Identities=21% Similarity=0.241 Sum_probs=194.3
Q ss_pred ceEEEeeeeecCceEEEEEEECC--CCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeC--cEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYN 78 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~--~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~--~~~ 78 (477)
+|++.++||+|+||.||+|.+.. +++.||||++... .....+..|+.++..++|++.+..+.. +... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEV-FLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEE-EeCCCCceE
Confidence 58999999999999999999988 8999999987762 234567789999999988555555544 4444 788
Q ss_pred EEEEecCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec-CCCCCcEEEeecCce
Q 011819 79 VLVMDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLA 153 (477)
Q Consensus 79 ~lVmE~~g~sL~~li~~~~----~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~-~~~~~~vkL~DFGla 153 (477)
++||||++++|.+++.... ..++...+..++.||+.||.|||+++|+||||||+|||++. ++..+.+||+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999999888988876432 25889999999999999999999999999999999999942 112889999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCccc------HHHHHH
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYE 226 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~------~~~~~~ 226 (477)
......... ........++..|+|||++.+. .++.++|||||||++|+|++|..||.+..... ....+.
T Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 160 RLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred cccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 866443221 1123345788999999988764 57899999999999999999999997654322 000111
Q ss_pred HHhhh----------------------------ccc-ccHHH-Hh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 227 KISEK----------------------------KVS-TSIEA-LC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 227 ~i~~~----------------------------~~~-~~~~~-l~--~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
++... ... ..... .. ...+.++.+++.+||..+|++||++.++..
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11000 000 00000 11 146678999999999999999999877753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=296.35 Aligned_cols=248 Identities=19% Similarity=0.332 Sum_probs=199.3
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+..|+++++.+.| +++..+..++......+++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-PYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCC-CchhhhheeeecCCEEEEEEE
Confidence 478999999999999999999999999999998765432 2457789999999986 455555555556688999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++......++...+..++.||+.||+|||+ .|++|+||||+||++ +..+.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHh
Confidence 99 699999998655779999999999999999999999 999999999999999 5688999999999876543221
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc--ccHHHHHHHHhhhcccccHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~~ 239 (477)
....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ....+....+.......
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 223 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR---- 223 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC----
Confidence 125788999999999999999999999999999999999999975421 12222333332222111
Q ss_pred HhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 240 LCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 240 l~~~-~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+... ++.++.++|..||..+|++||++.++..
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1222 7889999999999999999999777643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=295.16 Aligned_cols=252 Identities=20% Similarity=0.250 Sum_probs=194.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|++.+.||.|+||.||+|.+..+++.||||.+..... ...+..|+++++.+.| +++..+..++......|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccC-CCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999998754322 2457789999999987 55666666666778899999
Q ss_pred ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||++++|.+++.... ..+++..+..++.||+.||+|||+++++|+||||+||+++ ...+.+||+|||++........
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCcc
Confidence 999888888876433 2367888899999999999999999999999999999994 2456799999999975533211
Q ss_pred CcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh---c-----
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---K----- 232 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~---~----- 232 (477)
......+++.|+|||++.+. .++.++|||||||++|+|++|..||...... ..+.++... .
T Consensus 159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 159 -------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETW 228 (294)
T ss_pred -------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhc
Confidence 12334678899999998764 5789999999999999999999999764332 122211110 0
Q ss_pred ----------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 ----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ----------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.........+.+++++.+++.+||..+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111223457889999999999999999999877654
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=290.46 Aligned_cols=245 Identities=21% Similarity=0.322 Sum_probs=194.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
++||.|+||.||+|.+.. ++.||+|+...... ...+..|+++++.+.| +++..+..++......++||||+ +++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH-PNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 479999999999999877 99999998765433 2357789999999987 45666666667777889999999 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccc
Q 011819 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (477)
Q Consensus 89 L~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 168 (477)
|.+++......++...++.++.|++.+|.|||+++++||||||+|||+ +.++.++|+|||++..........
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~----- 150 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV----- 150 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee-----
Confidence 999997555678999999999999999999999999999999999999 678899999999997654321110
Q ss_pred cCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHH
Q 011819 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (477)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (477)
......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ....+... .. ......+|.+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~~~~-~~---~~~~~~~~~~ 223 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIESG-YR---MPAPQLCPEE 223 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHHhcC-CC---CCCCccCCHH
Confidence 0112234567999999998899999999999999999998 899997654322 22222211 11 1123457899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 248 FASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
+.+++.+||..+|++||++.++.+.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=291.20 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=198.2
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
+|+..+.||+|+||.||+|.+..+++.|+||.+.... ....+..|+.+++.+.| +++..+..++..+...++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCC-CCchheeeeEecCCeEEE
Confidence 5888999999999999999998899999999876533 22457789999999977 455555556667788899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
+|||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||++ +.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 80 FLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceecccc
Confidence 99999 8899999975 3468999999999999999999999999999999999999 67889999999998865443
Q ss_pred CCCcccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
. ......|+..|++||.+.... ++.++|+|||||++|+|++|..||..... .+...++.... ...
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~---~~~ 221 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRSK---ELP 221 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHHhcc---cCC
Confidence 2 123456889999999998776 89999999999999999999999976432 22222222211 112
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.+...+++++.+++.+||..+|++||++.++..
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 234567899999999999999999999877754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=316.46 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=210.1
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~----~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
+...+.|.+.+.||+|.|+.|.+|++..++.+||||++++..... .+.+|+++++.|.| ++|+.+..+-......
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~H-PnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNH-PNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCC-cceeeeeeeeeeccee
Confidence 344578999999999999999999999999999999987754332 36899999999998 5565666666667788
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|+||||+ ++.+.+++...+ .+...++..++.|+..|++|||+++|||||||.+|+|| +.++++||+|||++..+.
T Consensus 131 ylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeec
Confidence 9999999 999999998644 46669999999999999999999999999999999999 788999999999998876
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
.... ..+++|++.|+|||++.|.+| ++++|+||+|++||-|+.|.+||.+. +.+..-.+....++..+
T Consensus 207 ~~~~--------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~---~lk~Lr~rvl~gk~rIp 275 (596)
T KOG0586|consen 207 YGLM--------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ---NLKELRPRVLRGKYRIP 275 (596)
T ss_pred cccc--------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc---ccccccchheeeeeccc
Confidence 5433 457899999999999999988 58999999999999999999999763 33344444444444322
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
-.+..++.++|.++|.++|.+|++.+++ +++.+...+
T Consensus 276 -----~~ms~dce~lLrk~lvl~Pskr~~~dqi---m~~~W~n~~ 312 (596)
T KOG0586|consen 276 -----FYMSCDCEDLLRKFLVLNPSKRGPCDQI---MKDRWRNDL 312 (596)
T ss_pred -----ceeechhHHHHHHhhccCccccCCHHHh---hhhcccchh
Confidence 2357799999999999999999996554 444444333
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=295.13 Aligned_cols=250 Identities=20% Similarity=0.251 Sum_probs=194.7
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++++.||.|+||.||+|++..+++.||||.+..... ...+..|+++++.++|++ +..+..++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-IVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCC-CcchhhhcccCCcEEEEee
Confidence 58999999999999999999999999999998764322 235788999999998855 5445445567778899999
Q ss_pred cCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+.++|.+++... ...+++..++.++.||+.||+|||+++++|+||+|+||++ +.++.+||+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc-
Confidence 9988899888643 3468999999999999999999999999999999999999 6788999999999875533211
Q ss_pred cccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh----------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 231 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~---------- 231 (477)
......++..|+|||++.+.. ++.++|||||||++|+|++|..||...... ....++...
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCCChhhhh
Confidence 122335688999999887654 588999999999999999999999764321 111111110
Q ss_pred --------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 --------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 --------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+.+++++.++|.+||..||.+||+++++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0011122233457889999999999999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=295.89 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=194.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|++.++||+|+||.||+|.+..+++.||+|.+..... ...+..|++++..+.|. ++..+..++..+...++||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE-NLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCc-chhhHHHhcccCCeEEEEE
Confidence 579999999999999999999988999999998654322 23567899999999875 5555555556778899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|..+... ...+++..++.++.||+.||.|||+.||+|+||+|+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 80 EFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred ecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence 999 6677766653 4459999999999999999999999999999999999999 6788999999999986544221
Q ss_pred CcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh---------
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 231 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (477)
......++..|+|||++.+. .++.++|||||||++|+|++|..||..... ...+.++...
T Consensus 156 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 156 -------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred -------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhH
Confidence 12335688999999998763 467899999999999999999999975432 1111111110
Q ss_pred -----------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 -----------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 -----------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+.++..+.+++..||..+|++||++.++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0011122234577899999999999999999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=296.79 Aligned_cols=267 Identities=18% Similarity=0.260 Sum_probs=207.8
Q ss_pred ceEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
+|++.+.||+|+||.||++++. .+++.||||++.... ....+..|++++..+.+++++..+......+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 467899999875321 1234678999999998778888887777778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++.. ...+++..++.++.|++.+|.|||+.+++|+||||.||++ +.++.++|+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 9999999 8899998864 4568999999999999999999999999999999999999 677899999999987654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhhhccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVS 234 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~--~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 234 (477)
.... .......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||........ ......+....
T Consensus 157 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 228 (288)
T cd05583 157 AEEE------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-- 228 (288)
T ss_pred cccc------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--
Confidence 3321 1122356889999999987765 67899999999999999999999964322111 11111111111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 296 (477)
......++.++.+++.+||+.+|++||++.++.++|++. |...++|..+...
T Consensus 229 ---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~-------~~~~~~~~~~~~~ 280 (288)
T cd05583 229 ---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP-------FFQGIDWDDLAAK 280 (288)
T ss_pred ---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc-------ccccCCHHHHhhh
Confidence 123345788999999999999999999988887776654 4555688765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=289.35 Aligned_cols=246 Identities=21% Similarity=0.235 Sum_probs=200.5
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.++||+|+||.||++.+..+++.||||.+.... ....+..|+.+++.++|. ++..+..+....+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHP-NIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCC-CeeeeEeeecCCCeEEEEEe
Confidence 5999999999999999999999999999999875432 223578899999999884 55556666667788999999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||+|+|||+ +.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchh
Confidence 99 88999998643 3358899999999999999999999999999999999999 5778999999999986644221
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||... .....+..+....... ..
T Consensus 157 -------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~----~~ 222 (256)
T cd08218 157 -------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSYPP----VS 222 (256)
T ss_pred -------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHhcCCCCC----Cc
Confidence 112346888999999999988999999999999999999999999653 2333444443333221 23
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..++.++.++|.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 467899999999999999999999877754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=297.82 Aligned_cols=261 Identities=19% Similarity=0.219 Sum_probs=194.9
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEe------
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE------ 74 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~------ 74 (477)
..++|++.++||+|+||.||+|.+..+++.||||.+..... ...+..|+++++.+.|++++..+..+...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34679999999999999999999999999999998754322 22356799999999886666555543322
Q ss_pred -CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 75 -GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 75 -~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
....++||||++++|.+++......+++.+++.++.||+.||+|||++|++|+||||+||++ +..+.+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCc
Confidence 23569999999889999887655579999999999999999999999999999999999999 67889999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
.......... ........++..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.........+..+....
T Consensus 167 ~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 167 RAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred ccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 8664432211 01123346788999999987643 6889999999999999999999997644322222222221100
Q ss_pred ccc-----------------------cHHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 VST-----------------------SIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ~~~-----------------------~~~~l~-~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
... ....+. ...+..+.++|..||..+|++||+++++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 000000 112466789999999999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=289.57 Aligned_cols=247 Identities=27% Similarity=0.398 Sum_probs=198.3
Q ss_pred eEEEeeeeecCceEEEEEEECCCC----cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g----~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
|++.+.||.|+||.||+|.+...+ ..||+|++..... ...+..|+.++..+.| +++..+..++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDH-PNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCCeeEEE
Confidence 467899999999999999998766 8999999865542 3467889999999965 5666666666666789999
Q ss_pred EecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 82 MDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~-ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|||+ +++|.+++...... +++..+..++.||+.||.|||+.+++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecccc
Confidence 9999 89999999754333 9999999999999999999999999999999999999 67789999999999876554
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ...+..+.......
T Consensus 157 ~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~--- 224 (258)
T smart00219 157 DYYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKKGYRLP--- 224 (258)
T ss_pred cccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCCC---
Confidence 2211 112236789999999988889999999999999999998 8899876332 33333333332221
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (477)
....++.++.+++.+||..+|++||++.++.+.
T Consensus 225 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 225 -KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred -CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 234478999999999999999999999888764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=294.90 Aligned_cols=262 Identities=17% Similarity=0.274 Sum_probs=203.3
Q ss_pred ceEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
+|++.+.||.|+||.||+|.+. .+|+.||+|++.... ....+..|++++..+.++++++.+..++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999874 478999999876422 1234677999999998888898888887788889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 9999999 8899999875 4568999999999999999999999999999999999999 678899999999998654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhhhccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVS 234 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~--~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 234 (477)
..... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||........ ......+.....
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~- 229 (290)
T cd05613 157 EDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP- 229 (290)
T ss_pred ccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC-
Confidence 32211 12245688999999998763 367899999999999999999999964322211 122222211111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
.....+++.+.+++.+||..+|++|| +.+++ ..++|...+.|+...
T Consensus 230 ----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l----------~~~~~~~~~~~~~~~ 280 (290)
T cd05613 230 ----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEI----------KKHPFFQKINWDDLA 280 (290)
T ss_pred ----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH----------HcCcccccCCHHHHh
Confidence 12345788999999999999999998 43333 234556666786553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=294.21 Aligned_cols=252 Identities=18% Similarity=0.310 Sum_probs=199.9
Q ss_pred CceEEEeeeeecCceEEEEEEECC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~-----~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.+|++.+.||.|+||.||+|+... ..+.|++|........ ..+..|++++..+.| +++..+..++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCC-cceeeeEEEECCCCcc
Confidence 679999999999999999999654 3468999987654332 457889999999977 4555666666677788
Q ss_pred EEEEecC-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEee
Q 011819 79 VLVMDLL-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~--------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +..+.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEEcc
Confidence 9999999 899999997433 158999999999999999999999999999999999999 5788999999
Q ss_pred cCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHH
Q 011819 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (477)
Q Consensus 150 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i 228 (477)
||++........ .......++..|++||.+.+..++.++|||||||++|+|++ |..||..... ...+..+
T Consensus 161 ~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~ 231 (275)
T cd05046 161 LSLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRL 231 (275)
T ss_pred cccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHH
Confidence 999875432211 12234466788999999988889999999999999999998 8899965433 2333333
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
........ ....+|..+.+++.+||..+|++||++.++...|.
T Consensus 232 ~~~~~~~~---~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLELP---VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 32222111 23457899999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=294.17 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=195.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~lVm 82 (477)
++|+..++||.|++|.||+|.+..+++.||+|.+..... ...+.+|++++..+.|++++..+..+.. .....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 479999999999999999999999999999998765432 2457889999999987555555544433 345679999
Q ss_pred ecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 83 DLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 83 E~~-g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
||+ +++|.+++.. ....++...+..++.||+.||.|||+.|++|+||+|+||++ +..+.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccccccccc
Confidence 999 8899988753 23558999999999999999999999999999999999999 5778899999999875533
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc--ccHHHHHHHHhhhccccc
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~ 236 (477)
... ....++..|++||.+.+..++.++|||||||++|+|++|..||..... ....+....+........
T Consensus 158 ~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 158 SLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred ccc---------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence 221 234678899999999999999999999999999999999999976422 122222332222111111
Q ss_pred HHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 IEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ~~~l~--~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..... ..+++++.+++.+||..+|.+||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 10001 235678999999999999999999776644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=293.06 Aligned_cols=248 Identities=18% Similarity=0.282 Sum_probs=184.2
Q ss_pred eeeeecCceEEEEEEECC--CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~--~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
++||+|+||.||+|.... ....+|+|.+..... ...+..|+.+++.++|++ +..+...+......++||||+ +
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~n-ii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPN-VLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCC-cceEEEEECCCCceEEEEEeCCC
Confidence 468999999999997533 345788887654322 234678999999888755 555555555677889999999 8
Q ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 87 PSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 87 ~sL~~li~~~~----~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~- 155 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDY- 155 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchh-
Confidence 99999987532 224677889999999999999999999999999999999 6788999999999865432211
Q ss_pred cccccccCCCCccCccccccchhcC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHH-hhhcc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI-SEKKV 233 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g-------~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i-~~~~~ 233 (477)
+.......++..|+|||++.. ..++.++|||||||++|+|++ |..||..... .+.+... .....
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~ 228 (269)
T cd05042 156 ----YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQVVREQDI 228 (269)
T ss_pred ----eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhhccCc
Confidence 011123356778999998743 456889999999999999999 8899976433 2222222 22222
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
......+...+++.+.+++..|| .+|++||+++++.++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 22223345678899999999999 5999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=293.94 Aligned_cols=245 Identities=21% Similarity=0.341 Sum_probs=195.9
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHc--CCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.|++.+.||.|+||.||+|.+..+++.||||++.... ....+..|+.+++.+. .++++..+..++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 5889999999999999999999999999999876532 2345778999999997 2455655555666778899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||++ +..+.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCcc
Confidence 999 8899999863 478999999999999999999999999999999999999 5688999999999987654332
Q ss_pred CcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||..... ......+..... ..+
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~----~~~ 222 (277)
T cd06917 157 -------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA---FRAMMLIPKSKP----PRL 222 (277)
T ss_pred -------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh---hhhhhccccCCC----CCC
Confidence 1233468999999999875 4568999999999999999999999976432 121211111111 112
Q ss_pred hc-CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 241 CR-GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 241 ~~-~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.. .++.++.+++..||..+|++||++.++..
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 22 37889999999999999999999777644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=297.93 Aligned_cols=253 Identities=21% Similarity=0.243 Sum_probs=196.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeC--cEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG--DYN 78 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~--~~~ 78 (477)
..++|++.+.||.|+||.||+|.+..+++.||||.+...... ..+..|+.++..+.| +++..+..+.... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCC-CCEEEEEEEEEecCCCcE
Confidence 346899999999999999999999989999999987654322 235679999999986 5555555444444 789
Q ss_pred EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 79 ~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|+||||++++|.+++......+++..++.++.||+.||+|||++|++|+||||+|||+ +..+.++|+|||++.....
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence 9999999889999998655669999999999999999999999999999999999999 6789999999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc----
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---- 233 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~---- 233 (477)
... ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...... ..+.++.....
T Consensus 159 ~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~ 228 (293)
T cd07843 159 PLK-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTE 228 (293)
T ss_pred Ccc-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCch
Confidence 321 122345788999999987654 688999999999999999999999765432 22222211100
Q ss_pred ---------------------cccHHHHhcC--CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 ---------------------STSIEALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 ---------------------~~~~~~l~~~--~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...+....+. +++.+.++|..||..+|++||++.++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000011111 4778999999999999999999877754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=292.49 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=197.7
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC------------chhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~------------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
+|.+.+.||.|+||.||+|.+..+++.||||.+..... ...+..|+.++..+.| +++..+..++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH-LNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCC-CCcceEEEEeccC
Confidence 68999999999999999999988999999997643211 1235678899999987 5555666667778
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
+..++||||+ +++|.+++... ..++...+..++.||+.||.|||+++++|+||||+||++ +.++.++|+|||+++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISK 156 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccc
Confidence 8889999999 99999999754 569999999999999999999999999999999999999 678999999999997
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh-
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK- 231 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~--~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~- 231 (477)
........ .......|+..|+|||.+.... ++.++|+||||+++|++++|..||..... ...+..+...
T Consensus 157 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~ 228 (272)
T cd06629 157 KSDDIYDN-----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKR 228 (272)
T ss_pred cccccccc-----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHHHhhccc
Confidence 65432111 1123456889999999988755 78999999999999999999999964322 2222222211
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
............++.++.+++..||..+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1112222344567999999999999999999999887754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=304.11 Aligned_cols=256 Identities=21% Similarity=0.224 Sum_probs=196.6
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEe----Cc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVE----GD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~----~~ 76 (477)
+.++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|.+.+..+..+... ..
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 6789999999999999999999999999999999865421 223467899999999886555544433222 13
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 77 ~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
..||+|||++++|.+++.. ...+++..+..++.||+.||.|||+++++||||||+|||+ +.++.+||+|||+++..
T Consensus 83 ~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTT 158 (337)
T ss_pred cEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccccc
Confidence 5799999999999999874 4569999999999999999999999999999999999999 67889999999999866
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh------
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS------ 229 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~------ 229 (477)
..... ......++..|+|||.+.. ..++.++|||||||++|+|++|..||.+..............
T Consensus 159 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 159 SEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred CCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 43221 1234567889999998875 458899999999999999999999997643211111111000
Q ss_pred -----------------hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 230 -----------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 230 -----------------~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
............+.+++++.++|.+||..+|++||+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 000011122334568899999999999999999999776644
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=288.45 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=205.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++.+.||.|++|.||+|++..+++.|+||++..... ...+..|+.++..++| +++..+..+.......+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES-PYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEccCCeEEEEEE
Confidence 479999999999999999999999999999998876543 4567889999999986 566666666667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 99 79999999753 679999999999999999999999 999999999999999 6789999999999986644332
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.........+....+..... ..+.
T Consensus 156 ~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 224 (264)
T cd06623 156 Q-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSLP 224 (264)
T ss_pred c-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----CCCC
Confidence 1 1244688999999999998899999999999999999999999977543233444444443222 1233
Q ss_pred cC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~-~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.. ++..+.++|..||..+|++||++.++.+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 44 7899999999999999999999777654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=295.26 Aligned_cols=249 Identities=20% Similarity=0.322 Sum_probs=190.6
Q ss_pred eeeeecCceEEEEEEECCCC------cEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 13 RKIGSGSFGEIYLGTNIQTN------EEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g------~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+.||+|+||.||+|++.... +.||||.+.... ....+..|+.+++.++|++ +..+..++...+..+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN-IVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCC-eeeEeeeecCCCCeEEEEe
Confidence 46899999999999976544 689999875432 2345778999999998854 4445555566777899999
Q ss_pred cC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC--CCCcEEEeecCcee
Q 011819 84 LL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAK 154 (477)
Q Consensus 84 ~~-g~sL~~li~~~------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~--~~~~vkL~DFGla~ 154 (477)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++++|+||||+|||++.+. ....++|+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99 89999998642 13378899999999999999999999999999999999995321 12389999999997
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||..... .+....+.....
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~ 231 (269)
T cd05044 160 DIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTAGGR 231 (269)
T ss_pred cccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhcCCc
Confidence 65432211 11223355788999999999999999999999999999998 9999976433 222222222111
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
......+|..+.+++.+||..+|++||++.++.+.|+
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 ----LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1123457899999999999999999999999988765
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=303.86 Aligned_cols=260 Identities=19% Similarity=0.245 Sum_probs=199.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEee---EeCcE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFG---VEGDY 77 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~---~~~~~ 77 (477)
++++|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|++.+..+..+. .....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 5689999999999999999999999999999999876532 2234677999999999755444444332 24457
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
.++||||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceeec
Confidence 899999998899998864 4569999999999999999999999999999999999999 678999999999997664
Q ss_pred cCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH---------
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK--------- 227 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~--------- 227 (477)
...... ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 159 SSPTEH---KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred ccCcCC---CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 432211 011234578899999999866 4578999999999999999999999976433211111110
Q ss_pred --------------HhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 228 --------------ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 228 --------------i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
............+.+.+++++.++|..||..+|++||+++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00111112223344667899999999999999999999776543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=316.50 Aligned_cols=253 Identities=26% Similarity=0.354 Sum_probs=204.8
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCc---E-EEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---E-VAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~---~-vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
+-.+.++||+|+||+||+|+....+. . ||||....+. ....+..|++++++++| ++|+.++.+.......
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H-~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH-PNVVRFYGVAVLEEPL 236 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCcc
Confidence 44567899999999999999765422 3 8999866422 22457899999999988 6777777788889999
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
+||||+| ||+|.+++......++..+.+.++.+.+.||+|||++++|||||-..|+|+ ...+.+||+|||+++...
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee---cCCCeEEeCccccccCCc
Confidence 9999999 999999998655569999999999999999999999999999999999999 466778999999987543
Q ss_pred cCCCCcccccccCC-CCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 158 DTSTHQHIPYRENK-NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 158 ~~~~~~~~p~~~~~-~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
.-. ... ...-...|+|||.+...-|+.++|||||||++||+++ |..||.+.... +...++.......
T Consensus 314 ~~~--------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 314 QYV--------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKIVKNGYRM 382 (474)
T ss_pred cee--------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHHHhcCccC
Confidence 111 111 1123578999999999999999999999999999998 89999887653 4444443322222
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
. .+...|.++..++..||..+|++||+|.++.+.|+.+..
T Consensus 383 ~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 383 P---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred C---CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 2 223678999999999999999999999999999998853
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.21 Aligned_cols=257 Identities=20% Similarity=0.234 Sum_probs=184.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCC-cEEEEE------------------EecC-CCCchhHHHHHHHHHHHcCCCC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK------------------LENV-KTKHPQLLYESKLYRILQGGTG 64 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g-~~vAiK------------------i~~~-~~~~~~~~~E~~il~~L~~~~~ 64 (477)
+.++|+++++||+|+||+||+|...... +.+++| .+.. ......+..|+.++..|+|+ +
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp-n 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE-N 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC-C
Confidence 4578999999999999999998754332 222222 1110 01123467899999999874 5
Q ss_pred CCeeEEeeEeCcEEEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC
Q 011819 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140 (477)
Q Consensus 65 i~~~~~~~~~~~~~~lVmE~~g~sL~~li~~~----~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~ 140 (477)
|+.+..++...+..|++|++++++|.+++... ........++.++.||+.||+|||++|||||||||+|||+ +
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl---~ 301 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL---N 301 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---C
Confidence 55566666777888999999988888876532 1224466788899999999999999999999999999999 6
Q ss_pred CCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc
Q 011819 141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (477)
Q Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~ 220 (477)
.++.+||+|||+++.+...... .....+||..|+|||++.+..++.++|||||||+||||++|..++.......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 7889999999999876543221 1234679999999999999999999999999999999999876543322222
Q ss_pred HHHHHHHHhhhc------cc-------------------ccHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 221 KKQKYEKISEKK------VS-------------------TSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 221 ~~~~~~~i~~~~------~~-------------------~~~~~l~--~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....+.++.... ++ ..+..+. ..++.++.++|.+||..||.+||++.++..
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 222222221110 00 0011111 245778889999999999999999877643
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=298.92 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=197.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+.|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+++++.+.| ++++.+..++......++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCC-CccHhhhcccccCCceEEEEE
Confidence 4578889999999999999999889999999987644322 347789999999987 455555555566778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++. ...+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 83 YLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred ccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcch-
Confidence 99 889999886 4568999999999999999999999999999999999999 5778999999999976543221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....+..... ..+..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~----~~~~~ 223 (277)
T cd06642 157 ------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFLIPKNSP----PTLEG 223 (277)
T ss_pred ------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhhhhcCCC----CCCCc
Confidence 1123468889999999999899999999999999999999999997644322 1111211111 12334
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.++.++.+++.+||..+|++||++.++..
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 57889999999999999999999888765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=286.34 Aligned_cols=264 Identities=19% Similarity=0.211 Sum_probs=199.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEe----eEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWF----GVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~----~~~~~~~~ 79 (477)
+++|++.+.||+|||+.||++++..++..||+|.+.... ..+...+|++..+.+++++.+..+.+. .+.....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 579999999999999999999999999999999765443 334578999999999996666655332 22345679
Q ss_pred EEEecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 80 LVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~---~~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
|+++|. .|+|.+.+..+. ..+++.+++.|+.+|++||++||+.. ++||||||.|||++ +.+.++|.|||.+
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLGSA 176 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEeccCc
Confidence 999998 899999987553 35899999999999999999999998 99999999999994 5799999999998
Q ss_pred eecccCCCCc--ccccccCCCCccCccccccchhcC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 011819 154 KKYRDTSTHQ--HIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (477)
Q Consensus 154 ~~~~~~~~~~--~~p~~~~~~~~Gt~~Y~APE~~~g---~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i 228 (477)
....-..... .....+...-..|..|.|||.+.- ...+.++|||||||+||.|+.|.-||......- ......+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-gSlaLAv 255 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-GSLALAV 255 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-CeEEEee
Confidence 7653322111 111112223345889999999864 456899999999999999999999995421100 0000011
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
...++..+. ...+++.+.++|..|+..||.+||+..++...+.++
T Consensus 256 ~n~q~s~P~---~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 256 QNAQISIPN---SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eccccccCC---CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111111111 134889999999999999999999999988877765
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=294.70 Aligned_cols=254 Identities=17% Similarity=0.183 Sum_probs=209.0
Q ss_pred ccCCceEEEe-eeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeE----eCcEE
Q 011819 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV----EGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~-~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~----~~~~~ 78 (477)
-|.++|.+-. +||-|-.|.|-.|.++.+++.+|+|++. ..+...+|+++......|++|+.+..+.. .....
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 3667787754 6899999999999999999999999874 44568889999999998888888765543 33455
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.||||+| ||.|.+.|+.. .+.|++.++..|+.||..||.|||+.+|.||||||+|+|.+....+..+||+|||+|+..
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 7999999 99999998743 456999999999999999999999999999999999999987777888999999999876
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc-HHHHHHHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~ 235 (477)
..... ..+.+-|+.|.|||++-...|+..+|+||+||++|-||.|.+||....... ......+|....+..
T Consensus 215 ~~~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 215 QEPGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred CCCcc--------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 54332 345677999999999999999999999999999999999999997755422 123344555555543
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
+.+ -+..++++.+++|..+|..+|.+|.+.+++
T Consensus 287 P~p-EWs~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 287 PEP-EWSCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred CCh-hHhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 333 456688999999999999999999995544
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=293.27 Aligned_cols=242 Identities=26% Similarity=0.316 Sum_probs=198.1
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+++++.++| +++..+..++......++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH-PFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCC-CChHHHHHhhcCCCeEEEEE
Confidence 5999999999999999999999899999999876532 23457789999999987 45555555556778899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ |++|.+++... ..++...+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCcc
Confidence 999 99999999753 579999999999999999999999999999999999999 6788999999999876644321
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.........+.... ... .....+
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~----~~~~~~ 222 (258)
T cd05578 156 --------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK-QET----ADVLYP 222 (258)
T ss_pred --------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH-hcc----ccccCc
Confidence 1245688899999999988899999999999999999999999987554322222222 111 122234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYA 267 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~ 267 (477)
..+|.++.++|.+||..+|++||++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCcc
Confidence 56789999999999999999999983
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=291.09 Aligned_cols=236 Identities=18% Similarity=0.237 Sum_probs=182.9
Q ss_pred eeeeecCceEEEEEEECCCC----------cEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 13 RKIGSGSFGEIYLGTNIQTN----------EEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g----------~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
+.||+|+||.||+|.+..++ ..|++|+...... ...+..|+.+++.+.|++.+..+.. +.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGV-CVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeE-Eec-CCcEEE
Confidence 47899999999999987776 4588887655433 4567889999999987555544444 434 667999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC-------cEEEeecCce
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-------QVYIIDFGLA 153 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~-------~vkL~DFGla 153 (477)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ..+ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~---~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA---RYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEe---cCccccCCceeEEeCCCCcc
Confidence 9999 8999999976444789999999999999999999999999999999999995 344 7999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCC--CCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhh
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~--~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
...... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||...........+. .
T Consensus 156 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~ 221 (259)
T cd05037 156 ITVLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---D 221 (259)
T ss_pred cccccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---c
Confidence 765431 123567789999999877 78999999999999999999 688887654322222221 1
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
... ........+.+++.+||..+|++||++.++.+.|
T Consensus 222 ~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 QHR------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCC------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 110 0111236899999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=300.94 Aligned_cols=251 Identities=21% Similarity=0.239 Sum_probs=197.5
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
+.++|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|+.++..+.|++.+..+..+.......++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 5789999999999999999999999999999999765322 234577899999999986655555555555677899
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
+|||++++|.+++. ...++...+..++.||+.||.|||++||+||||||.|||+ +..+.++|+|||++......
T Consensus 88 v~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred EeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCCC-
Confidence 99999999999887 4568889999999999999999999999999999999999 67889999999998754321
Q ss_pred CCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH-----------
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----------- 228 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i----------- 228 (477)
.....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.............+.
T Consensus 162 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 162 ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 123467889999998766 56899999999999999999999999764321111111110
Q ss_pred ------------hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 229 ------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 229 ------------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.............+.+++++.++|.+||..+|++||+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000111223334456789999999999999999999977664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=303.50 Aligned_cols=264 Identities=17% Similarity=0.249 Sum_probs=200.2
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHH-cCCCCCCeeEEeeE-e
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRIL-QGGTGIPNVRWFGV-E 74 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~----~~~~~~~~E~~il~~L-~~~~~i~~~~~~~~-~ 74 (477)
.++.+.++|++.+.||+|+||.||+|.+..+++.||||.+... .....+..|+.++..+ +|.+++..+..+.. .
T Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred CCchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 3678889999999999999999999999889999999976432 1223466899999999 66544444444433 3
Q ss_pred CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
....|+||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~ 155 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLAR 155 (337)
T ss_pred CceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchh
Confidence 456799999998899998873 378899999999999999999999999999999999999 688999999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh---
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--- 230 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~--- 230 (477)
......... .........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 156 SLSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred ccccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 664432211 0012234578999999998865 4578899999999999999999999976433221111111100
Q ss_pred --------------------hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 --------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 --------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.........+.+.++.++.++|.+||..+|++||++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00111223344557899999999999999999999776654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=293.08 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=198.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+-|++.++||.|+||.||+|.+..+++.||||+...... ...+..|+.++..+.| +++..+..++..+++.++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCEeEEEEEEEeCCeEEEEEE
Confidence 347889999999999999999988999999998754332 2357788999999987 456666666667888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++. ...+++..+..++.|++.+|.|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 83 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh-
Confidence 99 889999987 4568999999999999999999999999999999999999 6778999999999876543221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||..... ......+..... ..+..
T Consensus 157 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~ 223 (277)
T cd06641 157 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNNP----PTLEG 223 (277)
T ss_pred ------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCCC----CCCCc
Confidence 11235688899999999988889999999999999999999999976432 222222222211 12345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.++.++.+++..||..+|++||++.++..
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 67899999999999999999999887765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.90 Aligned_cols=247 Identities=19% Similarity=0.309 Sum_probs=194.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
+.|.....||+|+||.||++.+..++..||||.+.... ....+..|+.+++.++|++.+ .+...+..+++.++||||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii-~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVV-DMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHH-HHHHheecCCeEEEEEeC
Confidence 45666788999999999999998999999999875432 223577899999999875444 444445567788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+ +++|.+++. ...+++..++.++.||+.||+|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc--
Confidence 9 889999886 3468999999999999999999999999999999999999 6778999999999875433221
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
......|+..|+|||++.+..++.++|||||||++|+|++|..||..... .+.+..+.... .... .....
T Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~-~~~~-~~~~~ 243 (292)
T cd06658 174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDNL-PPRV-KDSHK 243 (292)
T ss_pred -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcC-CCcc-ccccc
Confidence 12345789999999999988999999999999999999999999976432 22222222211 1111 11234
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
++..+.+++..||..+|.+||+++++.+
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 6789999999999999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=296.24 Aligned_cols=240 Identities=18% Similarity=0.233 Sum_probs=181.3
Q ss_pred eeeeecCceEEEEEEECCCCc-------EEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 13 RKIGSGSFGEIYLGTNIQTNE-------EVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~-------~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+.||.|+||.||+|.+...+. .||+|....... ...+..|..+++.+.|++ +..+..++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~-iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH-LVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCC-hhheeeEEEeCCCcEEEEe
Confidence 469999999999999765443 488887654322 234677888888888754 5555555556677899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC-----CCcEEEeecCceeecc
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-----ANQVYIIDFGLAKKYR 157 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~-----~~~vkL~DFGla~~~~ 157 (477)
|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. .+.++++|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99 88999999765556899999999999999999999999999999999999953211 1237999999986543
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCC-CCCCCCCcccHHHHHHHHhhhcccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
. .....++..|+|||++.+. .++.++|||||||++|+|++|. .||........ . ......
T Consensus 160 ~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~-~~~~~~--- 221 (258)
T cd05078 160 P-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L-QFYEDR--- 221 (258)
T ss_pred C-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H-HHHHcc---
Confidence 2 1235678899999999864 5789999999999999999985 66654332111 1 111111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
..++...+.++.+++..||+.+|++||+++++.+.|
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 --HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112334567899999999999999999998887754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=302.34 Aligned_cols=259 Identities=20% Similarity=0.242 Sum_probs=196.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeE---------
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGV--------- 73 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~--------- 73 (477)
++++|++.+.||.|+||.||+|.+..+++.||||.+..... ...+..|+++++.++|++.+..+..+..
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 46899999999999999999999999999999998765432 2357789999999988665555433322
Q ss_pred ----eCcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEee
Q 011819 74 ----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 74 ----~~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
.....|+||||++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++ ..++.++|+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence 124578999999889988886 45699999999999999999999999999999999999994 3456789999
Q ss_pred cCceeecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 011819 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (477)
Q Consensus 150 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i 228 (477)
||++.......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 159 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 159 FGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred cccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99997654322111 01123357889999998754 56788999999999999999999999764432211111100
Q ss_pred ----------------------hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 229 ----------------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 229 ----------------------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...........+.+.++.++.+++.+||..+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0001112223334567889999999999999999999877743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.00 Aligned_cols=241 Identities=20% Similarity=0.265 Sum_probs=190.3
Q ss_pred CceEEEeee--eecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 7 NKFRLGRKI--GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 7 ~~y~i~~~I--G~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
++|++.+.+ |.|+||.||++.+..+++.+|+|+........ .|..+...+.+++++..+...+...+..|+||||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 567777777 99999999999999999999999876543211 2333444455567777777777777899999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC-cEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||++. ..+ .++|+|||++......
T Consensus 91 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 91 IKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCC---
Confidence 9 89999999753 4799999999999999999999999999999999999994 555 8999999998765432
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~ 241 (477)
....|+..|+|||++.+..++.++|||||||++|+|++|..||........ ...+...... .....
T Consensus 164 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~ 230 (267)
T PHA03390 164 --------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-----KLPFI 230 (267)
T ss_pred --------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-----cCCcc
Confidence 234688999999999999999999999999999999999999975433211 1111111111 11233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCC-HHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPD-YAYLK 270 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt-~~~l~ 270 (477)
+.+++.+.++|..||+.+|.+||+ +++++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 468999999999999999999995 46664
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=294.82 Aligned_cols=279 Identities=19% Similarity=0.272 Sum_probs=224.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch-----hHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~-----~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|.+++.||.|+|..|.+++.+.+.+.||+|+++++.... =...|-.++.+..+++.++-+..++......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 468999999999999999999999999999999876643221 245677888888888888888888888888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|.||+ |++|--.+++ +++++++.++.|...|..||.|||++|||+||||.+|+|+ +..|++||.|+|+++.--..
T Consensus 329 vieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCC
Confidence 99999 8888777764 6789999999999999999999999999999999999999 89999999999999854333
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-----CcccHHHHHHHHhhhccc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL-----KAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~-----~~~~~~~~~~~i~~~~~~ 234 (477)
.. ...++|||+.|.|||++.|.+|+..+|+|+|||+++||+.|+.||.-. ...++.-.+.-|.++.+.
T Consensus 405 gd-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 405 GD-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred Cc-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence 22 246799999999999999999999999999999999999999999532 222333344555665554
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
++..++-....++...|.+||.+|.... ...-|.++ .+++|+..+||+.+++.+..++..|
T Consensus 478 -----iprslsvkas~vlkgflnkdp~erlgc~-~~~g~~di---k~h~ffr~idwd~leqk~v~ppf~p 538 (593)
T KOG0695|consen 478 -----IPRSLSVKASHVLKGFLNKDPKERLGCR-PQTGFSDI---KSHAFFRSIDWDLLEQKQVLPPFQP 538 (593)
T ss_pred -----ccceeehhhHHHHHHhhcCCcHHhcCCC-cccchhhh---hcchhhhhCCHHHHhhcccCCCCCC
Confidence 3455677788899999999999986421 11123333 5678888899999887665555444
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=298.48 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=195.1
Q ss_pred ceEEEeeeeecCceEEEEEEECCC--CcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeE----eCcE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQT--NEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV----EGDY 77 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~--g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~----~~~~ 77 (477)
+|++.+.||+|+||.||++.+..+ +..||||.+.... ....+..|+.+++.+.+|++++.+..++. ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999888 8999999875422 23356789999999976666666654322 2345
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
.+++|+|++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.+.
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecc
Confidence 789999999999999864 5569999999999999999999999999999999999999 678899999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH------------
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK------------ 224 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~------------ 224 (477)
...... ........|+..|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 157 ~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGEN---AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccc---cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 432210 111234578999999998876 4689999999999999999999999976432111110
Q ss_pred HHHHhh-----------hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 225 YEKISE-----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 225 ~~~i~~-----------~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+..+.. .........+...++.++.+++.+||..+|.+||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 111100 0011222333455688999999999999999999977764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.61 Aligned_cols=255 Identities=20% Similarity=0.308 Sum_probs=204.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCc-----EEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~-----~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.+-++.+.||+|.||.||.|+...... .||||.+.... ....|..|..+|..++|+|++..+... ......
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~-l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVC-LDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEee-cCCCCc
Confidence 456788999999999999999754432 48888776543 334689999999999996555555444 447788
Q ss_pred EEEEecC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 79 VLVMDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
+|++||| ||+|..++... ...++..+.+.++.|||+|+.||+++++|||||-..|+|| +....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEcccc
Confidence 9999999 99999999876 5569999999999999999999999999999999999999 677999999999
Q ss_pred ceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhh
Q 011819 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 152 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
+|+.+.+... |+....-.-...|||||.+....++.|+|||||||+|||+++ |..||.+... .+.+.-..+
T Consensus 848 lArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---~~v~~~~~~ 919 (1025)
T KOG1095|consen 848 LARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---FEVLLDVLE 919 (1025)
T ss_pred hhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch---HHHHHHHHh
Confidence 9995544433 122222123468999999999999999999999999999999 9999987554 233332333
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
... -..+..||..++++|..||+.+|++||+|..|.+.+.++.
T Consensus 920 ggR----L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 920 GGR----LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred CCc----cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 221 1134679999999999999999999999999988777665
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=288.83 Aligned_cols=248 Identities=21% Similarity=0.273 Sum_probs=191.6
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
+.....||+|+||.||+|.+..++..||+|.+..... ...+..|+.++..++|. ++..+..++..++..+++|||+
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR-NIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCC-CeeeeeeeeccCCEEEEEEecCC
Confidence 4445689999999999999999999999998765432 23577899999999875 4455555666778899999999
Q ss_pred CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 86 GPSLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 86 g~sL~~li~~~~~~l--s~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+++|.+++......+ +...++.++.||+.||.|||++||+||||||+||+++ ...+.++|+|||++........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~-- 164 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP-- 164 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC--
Confidence 899999987544445 7888999999999999999999999999999999994 2367899999999876543221
Q ss_pred ccccccCCCCccCccccccchhcCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~--~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......|+..|+|||++.+.. ++.++||||||+++|+|++|..||....... ........ ......++
T Consensus 165 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~---~~~~~~~~ 234 (268)
T cd06624 165 -----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGM---FKIHPEIP 234 (268)
T ss_pred -----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhh---hccCCCCC
Confidence 112346889999999987644 7889999999999999999999997643211 11111110 01111234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+++++.+++.+||..+|++||++.++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 567889999999999999999999877654
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=289.73 Aligned_cols=248 Identities=22% Similarity=0.285 Sum_probs=193.2
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHc--CCCCCCeeEEeeEeCcE-----
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQ--GGTGIPNVRWFGVEGDY----- 77 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~--~~~~i~~~~~~~~~~~~----- 77 (477)
|++.+.||.|+||.||+|++..+++.||||.+...... ..+..|+.++..+. .++++..+..++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999888999999988643322 24557888887775 24566666555554444
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.+++|||+.++|.+++.... ..+++..++.++.||+.||.|||+++++|+||+|+||++ +.++.+||+|||++..+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceec
Confidence 89999999889999887543 358999999999999999999999999999999999999 57799999999999876
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc----
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---- 232 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~---- 232 (477)
..... .....++..|+|||++.+..++.++|+|||||++|+|++|..||..... .+.+.++....
T Consensus 158 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 226 (287)
T cd07838 158 SFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE---ADQLDKIFDVIGLPS 226 (287)
T ss_pred cCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh---HHHHHHHHHHcCCCC
Confidence 44321 1233578899999999999999999999999999999999999976443 22233222210
Q ss_pred ------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 ------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 ------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
...........+++++.++|..||..+|.+||++.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 01111222234567889999999999999999987764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=299.41 Aligned_cols=248 Identities=18% Similarity=0.302 Sum_probs=197.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
...|+...+||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| +++..+..++..++..+++||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-QNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCC-CchhhhhhheeeCCeEEEEEe
Confidence 345666778999999999999998899999999876433 23457788899998887 455555555667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 99 ~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~- 172 (297)
T cd06659 99 FLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP- 172 (297)
T ss_pred cCCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc-
Confidence 99 889999886 3568999999999999999999999999999999999999 6789999999999875433221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
......|+..|+|||++.+..++.++|||||||++|+|++|..||..... ...+..+....... .....
T Consensus 173 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~~~~ 241 (297)
T cd06659 173 ------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPPK--LKNAH 241 (297)
T ss_pred ------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCCC--ccccC
Confidence 12345789999999999998999999999999999999999999975332 23333332221111 11234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.++.++.+++..||..+|++||++.++.+
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 57889999999999999999999877755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=290.41 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=197.1
Q ss_pred ceEEEeeeeecCceEEEEEEECC-CCcEEEEEEecCCCC------------chhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK------------HPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~-~g~~vAiKi~~~~~~------------~~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
+|++.+.||+|+||.||+|.+.. .++.+|+|.+..... ...+..|+.++.....++++..+..++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999877 678999997653211 12355677777654445666666666677
Q ss_pred CcEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEee
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
++..+++|||+ +++|.+++.. ....+++..++.++.|++.+|.|||+ .+++|+||||+|||+ +..+.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 88999999999 8899998753 24468999999999999999999996 789999999999999 6788999999
Q ss_pred cCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 150 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
||++....... ......|+..|++||++.+..++.++|+||||+++|+|++|..||..... ......+.
T Consensus 158 fg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~ 226 (269)
T cd08528 158 FGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIV 226 (269)
T ss_pred ccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHHh
Confidence 99998654432 12345788999999999998899999999999999999999999965332 22333333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~ 274 (477)
....... ....+++++.++|.+||..+|++||++.++...++
T Consensus 227 ~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYEPL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCCcC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 3222211 11357889999999999999999999999887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=297.44 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=196.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
....|++.++||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.++| +++..+..++...+..+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH-PNTIEYKGCYLREHTAW 91 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEEeCCeEE
Confidence 34679999999999999999999988999999998754322 1346789999999987 55556666666778889
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
+||||+.++|.+++......+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.++|+|||++......
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCCC
Confidence 999999889988887666779999999999999999999999999999999999999 67889999999998754321
Q ss_pred CCCcccccccCCCCccCccccccchhc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~---g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
....|+..|+|||++. ...++.++||||||+++|+|++|..||..... ......+........
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~ 234 (307)
T cd06607 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPTL 234 (307)
T ss_pred -----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCCC
Confidence 2356888999999875 35578899999999999999999999976432 121222222111111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....++.++.+++..||..+|++||++.++..
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 235 ---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred ---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11246789999999999999999999777754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=289.26 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=195.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-------~~~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~~ 78 (477)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+..|+.+++.++|.+.+..+..+.. .....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999864321 11256789999999988665555554433 24567
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence 8999999 8899999874 3458999999999999999999999999999999999999 677899999999998654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
...... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||..... .....++... ...
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~---~~~ 227 (264)
T cd06653 158 TICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQ---PTK 227 (264)
T ss_pred cccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHcC---CCC
Confidence 321100 112345689999999999998899999999999999999999999976432 2222222211 112
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..++..+++++.+++.+||. ++..||+..++.
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 23456788999999999999 579999987664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=292.01 Aligned_cols=249 Identities=19% Similarity=0.244 Sum_probs=194.3
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
|++.++||.|++|.||+|.+..+|..||||++..... ...+..|+++++.++|+ +++.+..++..++..+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHP-NIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCC-CccCHhheeccCCeEEEEEec
Confidence 6789999999999999999999999999998765432 23577899999999875 455554555667889999999
Q ss_pred CCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 LGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
++++|.+++.... ..+++..++.++.||+.||+|||+++++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCcc--
Confidence 9889999987433 368999999999999999999999999999999999999 5688999999999975432211
Q ss_pred ccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh-----------
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 231 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~----------- 231 (477)
......++..|+|||++.+. .++.++|||||||++|+|++|..||...... ..+.++...
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI---DQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhh
Confidence 12233568899999988764 5688999999999999999999999764332 111111110
Q ss_pred -------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 -------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 -------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
............++.++.++|.+||+.+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0011222334567889999999999999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=295.84 Aligned_cols=259 Identities=21% Similarity=0.256 Sum_probs=197.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEe-----
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE----- 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~----- 74 (477)
+..++|++.++||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.++|++.+..+..+...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345789999999999999999999999999999998765322 23466799999999876555544443322
Q ss_pred ----CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 75 ----GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 75 ----~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
.+..+++|||++++|.+++......+++..+..++.||+.||.|||+.||+|+||||+||++ +..+.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeCcc
Confidence 23789999999778888887545579999999999999999999999999999999999999 67889999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
|++........ .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+.+..
T Consensus 161 g~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 161 GLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred cccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99986644321 011233567889999988654 46889999999999999999999997644322222222221
Q ss_pred hhccc----------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 230 EKKVS----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 230 ~~~~~----------------------~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..... ......+..+|..+.+++..||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110 0111233457899999999999999999999877754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.09 Aligned_cols=250 Identities=19% Similarity=0.274 Sum_probs=197.7
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 15 IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
||.|+||.||+|.+..+++.||||++.... ....+..|+++++.+.| +++..+..+...+...+++|||+ +++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNH-PFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCC-CCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999999899999999876532 22457789999999977 45555555666778899999998 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccc
Q 011819 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (477)
Q Consensus 89 L~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 168 (477)
|.+++.. ...++...+..++.||+.||.|||+++++|+||||+||++ +.++.++|+|||++........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~------- 148 (262)
T cd05572 80 LWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQK------- 148 (262)
T ss_pred HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccc-------
Confidence 9999975 4458999999999999999999999999999999999999 6788999999999987654321
Q ss_pred cCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHH
Q 011819 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (477)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (477)
.....|+..|++||.+.+..++.++|+||||+++|+|++|..||..... +....+.++....... ..+..+++++
T Consensus 149 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~ 223 (262)
T cd05572 149 -TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKL---EFPNYIDKAA 223 (262)
T ss_pred -cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCC---CCCcccCHHH
Confidence 1234688999999999888899999999999999999999999976542 2333444433211111 1223457899
Q ss_pred HHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccc
Q 011819 249 ASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWT 291 (477)
Q Consensus 249 ~~li~~cl~~~p~~RPt-----~~~l~~~l~~~~~~~~~~~~~~~dw~ 291 (477)
.++|.+||..+|++||+ +.++.+ ++|+..++|+
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~----------~~~~~~~~~~ 261 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK----------HKWFNGFDWE 261 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc----------ChhhhCCCCC
Confidence 99999999999999999 444432 4556566775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=291.94 Aligned_cols=240 Identities=16% Similarity=0.197 Sum_probs=180.4
Q ss_pred eeeeecCceEEEEEEECC------------CCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 13 RKIGSGSFGEIYLGTNIQ------------TNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~------------~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
+.||+|+||.||+|.... ....|++|++..... ...+..|+.++..++| +++..+..++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~h-p~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH-KHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCC
Confidence 468999999999998432 233689998655332 2246677888888887 5566666666677778
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC----CCCcEEEeecCce
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----RANQVYIIDFGLA 153 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~----~~~~vkL~DFGla 153 (477)
+++|||+ +++|..++......+++..++.++.||+.||+|||+++|+||||||+|||+.... ....++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999 7888888875566799999999999999999999999999999999999995211 1123899999998
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhc-CCCCCCcchHHHHHHHHHHHH-cCCCCCCCCCcccHHHHHHHHhhh
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEK 231 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-g~~~s~ksDIwSlGviLyell-tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (477)
...... ....++..|+|||.+. +..++.++|||||||++|+|+ .|..||........ .+....
T Consensus 160 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~ 224 (262)
T cd05077 160 ITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERFYEG 224 (262)
T ss_pred ccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHHHhc
Confidence 654321 2345788999999886 566899999999999999998 58899865432111 111111
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
... .....+.++.++|.+||..+|++||++.+|.+.|
T Consensus 225 ~~~-----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QCM-----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Ccc-----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 111 1123467899999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=294.23 Aligned_cols=239 Identities=17% Similarity=0.235 Sum_probs=181.1
Q ss_pred eeeecCceEEEEEEECCC------------------------CcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCe
Q 011819 14 KIGSGSFGEIYLGTNIQT------------------------NEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPN 67 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~~~------------------------g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~ 67 (477)
+||+|+||.||+|....+ ...||+|++..... ...+..|+.++..++| ++++.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h-~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH-IHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC-CCeee
Confidence 699999999999974321 23588888754322 2245677788888877 66666
Q ss_pred eEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC----CCC
Q 011819 68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----RRA 142 (477)
Q Consensus 68 ~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~----~~~ 142 (477)
+..++......+|||||+ +++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.. ...
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 667777888899999999 889998887656679999999999999999999999999999999999999531 112
Q ss_pred CcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHH-cCCCCCCCCCccc
Q 011819 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGT 220 (477)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyell-tG~~Pf~~~~~~~ 220 (477)
..++|+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus 161 ~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 161 PFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 35899999988643221 12357788999998875 56899999999999999985 6999997654322
Q ss_pred HHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
....+ ..... ++...++++.++|.+||..+|++||++.++.+.|
T Consensus 230 ~~~~~----~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFY----EKKHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH----HhccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 21111 11111 1223457899999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=287.97 Aligned_cols=247 Identities=23% Similarity=0.291 Sum_probs=196.9
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.+.||+|+||.||+|.+..++..||+|.+... .....+..|+.+++.++|.+ +..+...+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~-i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN-IVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCC-hhhhhheeccCCeEEEEEe
Confidence 589999999999999999999999999999987653 23346778999999998754 4445455567778999999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++.... ..+++..+..++.||+.||.|||+.+++|+||||+||+++ +....++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence 99 899999986433 3588999999999999999999999999999999999994 2234679999999976644221
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||..... .+....+..... ....
T Consensus 158 -------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~ 223 (257)
T cd08225 158 -------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---HQLVLKICQGYF----APIS 223 (257)
T ss_pred -------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhcccC----CCCC
Confidence 11234688999999999888899999999999999999999999965332 233333322221 1233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..++.++.++|.+||..+|++||++.++.+
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 467889999999999999999999887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=299.60 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=195.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeC-----
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEG----- 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~----- 75 (477)
+.++|++++.||+|+||.||+|.+..++..||||.+..... ...+..|+.+++.++|++.+..+..+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 67889999999999999999999999999999998754321 234678999999998866555554443322
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...++||||++++|.+++. ...+++..++.++.||+.||+|||+.||+||||||+|||+ +..+.++|+|||++..
T Consensus 93 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccccc
Confidence 2468999999999999987 4569999999999999999999999999999999999999 5778999999999976
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc-
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV- 233 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (477)
..... ....++..|+|||++.+ ..++.++|+|||||++|+|++|..||...... ..+.++.....
T Consensus 168 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~---~~~~~~~~~~~~ 234 (343)
T cd07880 168 TDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL---DQLMEIMKVTGT 234 (343)
T ss_pred cccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCC
Confidence 53321 23467889999999876 45789999999999999999999999764332 22222111100
Q ss_pred -------------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 -------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 -------------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
......+.+.+++++.++|.+|+..+|.+||++.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0111223356788899999999999999999977664
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=291.02 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=201.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.+.||+|+||.||+|.+..+++.||+|+..... ....+..|..++..+..++++..+..++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999876522 2245678889999998456777666666677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||++ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcc
Confidence 9999 9999999975 4479999999999999999999999999999999999999 678899999999998765433
Q ss_pred CCccc-------------ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 011819 161 THQHI-------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (477)
Q Consensus 161 ~~~~~-------------p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~ 227 (477)
..... .........|+..|++||++.+..++.++||||||+++|++++|..||.... ..+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHH
Confidence 21110 0123345678899999999998889999999999999999999999997643 2333333
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 011819 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 266 (477)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~ 266 (477)
+..... .++..+++.+.+++..||+.+|++||++
T Consensus 234 ~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 234 ILKLEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHhcCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 332211 2335678999999999999999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=298.28 Aligned_cols=263 Identities=21% Similarity=0.279 Sum_probs=200.6
Q ss_pred CCCccCCceEE-EeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----------------hhHHHHHHHHHHHcCCC
Q 011819 1 MEPRVGNKFRL-GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------PQLLYESKLYRILQGGT 63 (477)
Q Consensus 1 m~~~i~~~y~i-~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----------------~~~~~E~~il~~L~~~~ 63 (477)
|...+.++|.. .+.||.|+||.||+|.+..+++.||||++...... ..+..|++++..++|.
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~- 80 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHE- 80 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCc-
Confidence 66778889975 46799999999999999999999999987543221 1467899999999875
Q ss_pred CCCeeEEeeEeCcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC
Q 011819 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (477)
Q Consensus 64 ~i~~~~~~~~~~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~ 143 (477)
++..+..++...++.+++|||+.++|.+++.. ...+++..+..++.||+.||+|||++||+|+||||+||++ +..+
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~ 156 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG 156 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence 55555555667788999999998899999874 4569999999999999999999999999999999999999 6788
Q ss_pred cEEEeecCceeecccCCCCcc-------cccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCC
Q 011819 144 QVYIIDFGLAKKYRDTSTHQH-------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG 215 (477)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~-------~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~ 215 (477)
.++|+|||++........... ..........++..|+|||++.+.. ++.++|||||||++|+|++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999987652211100 0001112335688899999987654 68999999999999999999999976
Q ss_pred CCcccHHHHHHHHhhhc-----------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 216 LKAGTKKQKYEKISEKK-----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 216 ~~~~~~~~~~~~i~~~~-----------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.... ..+..+.... ...........++.++.++|..||..+|++||+++++..
T Consensus 237 ~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 237 ENEI---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCHH---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 5432 2222222110 011112223456788999999999999999999777653
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=294.87 Aligned_cols=245 Identities=23% Similarity=0.330 Sum_probs=196.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
...|+..+.||+|+||.||+|.+..++..||||.+..... ...+..|+++++.++| +++..+..++......++
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH-PNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCeEEE
Confidence 3558899999999999999999999999999998764322 1246789999999987 455556666667778899
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||||+.++|.+++.....++++..+..++.||+.||.|||++||+||||+|+||++ +.++.++|+|||++.....
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCC--
Confidence 99999778988887666779999999999999999999999999999999999999 6788999999999865432
Q ss_pred CCcccccccCCCCccCccccccchhc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~---g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||..... ...+..+........
T Consensus 178 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~- 244 (317)
T cd06635 178 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPTL- 244 (317)
T ss_pred ---------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhccCCCC-
Confidence 12346888999999974 35678999999999999999999999976432 222222322221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....+++.+.+++.+||..+|.+||++.++.+
T Consensus 245 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 245 --QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred --CCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 12346788999999999999999999877754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=282.05 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=200.2
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
+|++.+.||+|++|.||++.+..+++.|++|++.... ....+..|+.++..+.| +++..+..++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH-PNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEEEecC
Confidence 5899999999999999999998899999999987654 44568899999999996 55666666666678889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +..+.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc---
Confidence 799999997644679999999999999999999999999999999999999 5688999999999976654321
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
.....|+..|++||.+.+..++.++||||||+++|+|++|..||..... ................ ....+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~--~~~~~ 223 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIATNGPPGLR--NPEKW 223 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHhcCCCCcC--ccccc
Confidence 2345788999999999988889999999999999999999999976432 2222222221111111 11224
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+.++.++|..||..+|.+||++.++.+
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 889999999999999999999877754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=290.64 Aligned_cols=249 Identities=22% Similarity=0.249 Sum_probs=198.4
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ..+..|+.+++.+.| +++..+..+...+...+++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH-PNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcC-CCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999889999999987654332 457789999999986 5555555555567888999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 85 ~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+.++|.+++......+++..++.++.||+.||.|||+.+|+|+||||+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~--- 153 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVR--- 153 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcc---
Confidence 9889999987656679999999999999999999999999999999999999 6778999999999987755331
Q ss_pred cccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc-----------
Q 011819 165 IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------- 232 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~----------- 232 (477)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ..+.++....
T Consensus 154 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 154 ----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred ----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCchHhcccc
Confidence 11234678899999999876 7889999999999999999999999764332 2222211110
Q ss_pred --------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 --------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 --------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.......+.+.++.++.++|..||..+|.+||++.++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 011122334567889999999999999999999877753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=310.59 Aligned_cols=241 Identities=22% Similarity=0.328 Sum_probs=202.8
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecCCC
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP 87 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~g~ 87 (477)
.+.||+|-||+||-|+++.+|+.||||++++. ....++..|+.|+..+.| ++|+++...++..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~H-PGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHH-PGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCC-CCeeEEEEeecCCceEEEEehhhcc
Confidence 46899999999999999999999999998753 234678899999999877 8999999999999999999999955
Q ss_pred CH-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 88 SL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 88 sL-~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++ +-++....+++++....+++.||+.||.|||-++|+|.||||+|||+...+.-.++||||||+|+...+...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence 54 555565577899999999999999999999999999999999999998766778999999999999887664
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcH
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (477)
...++||+.|+|||++..+.|.+.-|+||.|||+|--|.|..||....+ .-+.|+...+-.+.. -++.+++
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQNAaFMyPp~-PW~eis~ 793 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQNAAFMYPPN-PWSEISP 793 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhccccccCCC-chhhcCH
Confidence 3578999999999999999999999999999999999999999965322 223333332222111 2356788
Q ss_pred HHHHHHHHHhcCCCCCCCCHH
Q 011819 247 EFASYFHYCRSLRFDDKPDYA 267 (477)
Q Consensus 247 ~l~~li~~cl~~~p~~RPt~~ 267 (477)
+..+||+.+|+..-.+|.+.+
T Consensus 794 ~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchH
Confidence 999999999999999998844
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=284.39 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=198.3
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.+.|. ++..+..+....+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHP-NLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCC-ChhheeeeEecCCEEEEEEe
Confidence 58999999999999999999988999999998765433 23577899999999874 55555555667788899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||++ +..+.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence 99 8999999974 4458899999999999999999999999999999999999 57889999999999876543321
Q ss_pred cccccccCCCCccCccccccchhcCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~---~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. .......++..|++||++.+.. ++.++||||||+++|++++|..||..... .......+..... ....
T Consensus 156 ~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~-~~~~- 228 (264)
T cd06626 156 MG---EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGHK-PPIP- 228 (264)
T ss_pred cc---ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhcCCC-CCCC-
Confidence 10 0012356889999999998766 78999999999999999999999976432 1222222222111 1111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....+++.+.++|..||..+|++||++.++..
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11235889999999999999999999887643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=298.99 Aligned_cols=250 Identities=21% Similarity=0.299 Sum_probs=193.7
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeE-----e
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV-----E 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~-----~ 74 (477)
.+.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.++..++|.+.+..+..+.. .
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 356899999999999999999999999999999998764321 2346789999999988665555544432 2
Q ss_pred CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
....|+++++++++|.+++. ...+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecccccc
Confidence 23468999999999999886 3469999999999999999999999999999999999999 678899999999987
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc-
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (477)
..... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ..+..+....
T Consensus 169 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~ 235 (345)
T cd07877 169 HTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVG 235 (345)
T ss_pred ccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhC
Confidence 64332 123467889999999876 56789999999999999999999999764332 1111111110
Q ss_pred -------------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 -------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 -------------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
............++++.++|..||..+|++||++.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000111122245788999999999999999999766543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.23 Aligned_cols=248 Identities=19% Similarity=0.324 Sum_probs=204.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
+.|+|+..||.|+||.||+|.++.++-..|-|++..+.. ...++.|+.||..+.|+.++..+..|+ ..+..+|+.||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-FENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-ccCceEEEEee
Confidence 468899999999999999999999999999998765443 346788999999999755555554444 44567999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
| ||-+..++-..++.+++.++..++.|++.||.|||+++|||||||..|||+ .-+|.|+|+|||.+.......
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~--- 184 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTR--- 184 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE---EecCcEeeecccccccchhHH---
Confidence 9 777777777778899999999999999999999999999999999999999 578999999999876443211
Q ss_pred ccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 164 HIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
....++.|||+|||||++. ..+|+.++||||||++|+||..+.+|.+.++. ...+.+|.....++.+
T Consensus 185 ----qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVllKiaKSePPTLl- 256 (1187)
T KOG0579|consen 185 ----QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLL- 256 (1187)
T ss_pred ----hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHHHHhhcCCCccc-
Confidence 1245789999999999875 46799999999999999999999999987665 3445556555555443
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.+..+...|.+|+.+||.++|+.||++++|.
T Consensus 257 -qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 257 -QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred -CcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 2456888999999999999999999988764
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.54 Aligned_cols=253 Identities=20% Similarity=0.252 Sum_probs=197.8
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeC----cEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEG----DYNV 79 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~----~~~~ 79 (477)
+|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|.+.+..+..+.... ...|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6999999999999999999998899999999876532 2346788999999998755444444333322 3679
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
++|||++++|.+++.. ...+++..++.++.||+.||+|||++||+|+||||+|||+ +.++.++|+|||++......
T Consensus 81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeeccc
Confidence 9999998899998874 4479999999999999999999999999999999999999 67799999999999877554
Q ss_pred CCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc-----
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (477)
.... .......++..|+|||++.+. .++.++|+|||||++|+|++|..||...... +.+..+.....
T Consensus 157 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 157 EDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSEE 229 (330)
T ss_pred cccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCChh
Confidence 3110 112345678899999999888 7899999999999999999999999765432 22222222110
Q ss_pred ---------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 ---------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 ---------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+++++.++|..||..+|++||+++++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11112233457889999999999999999999777653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=289.03 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=194.3
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEe-CcEEEEEEe
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNVLVMD 83 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~-~~~~~lVmE 83 (477)
|++.++||.|+||.||+|.+..+++.||+|.+.... ....+..|+.+++.+.|.+.+..+..+... .+..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999999999999887643 223477899999999975554444444333 278999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
|++++|.+++......+++..++.++.||+.||+|||+.|++|+||||+|||+ +.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~- 156 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSA- 156 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcc-
Confidence 99889999987544579999999999999999999999999999999999999 67899999999999876554310
Q ss_pred ccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc----------
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------- 232 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (477)
......++..|+|||.+.+. .++.++||||||+++|+|++|..||...................
T Consensus 157 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 157 -----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred -----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 11234567889999987753 57899999999999999999999997644322111111110000
Q ss_pred ------------ccccHHHHhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 ------------VSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ------------~~~~~~~l~~~-~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
........... +++++.+++..||..+|++||++.++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00011112223 3889999999999999999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.67 Aligned_cols=272 Identities=22% Similarity=0.261 Sum_probs=207.6
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
-|..++.||-|+||+|+++....|...||+|.+.+... ......|.+||....+ +-++.+++.+.+++..|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn-~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCC-cceEEEEEEeccCCceEEEE
Confidence 48889999999999999999999999999997765431 1235578888877665 66777778788999999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC-
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS- 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~- 160 (477)
||+ ||++-.|+-+. +-|.+..+++|+.++.+||+++|+.|+|||||||+|||| |.+|+|||.|||||.-++-..
T Consensus 709 dYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccc
Confidence 999 99999998763 459999999999999999999999999999999999999 899999999999997542210
Q ss_pred -------CCcc-------------------cccc--------cCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHH
Q 011819 161 -------THQH-------------------IPYR--------ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 206 (477)
Q Consensus 161 -------~~~~-------------------~p~~--------~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyel 206 (477)
.+.. ...+ ..-.++||+.|+|||++....|+..+|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 0000 0000 13347899999999999999999999999999999999
Q ss_pred HcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCC
Q 011819 207 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDY 286 (477)
Q Consensus 207 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~ 286 (477)
+.|+.||..........++..... ..-...+.+++.++.++|.+++. .+++|..-. -.+ ....++|+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~----~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkn-----g~d--~vKaHpfFk 932 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRN----FLHIPYQGNLSKEALDLIQKLCC-SADSRLGKN-----GAD--QVKAHPFFK 932 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhh----ccccccccccCHHHHHHHHHHhc-Chhhhhccc-----chh--hhhcCcccc
Confidence 999999977655433222211111 11112456788999998887654 677886321 111 124679999
Q ss_pred ccccccchhh
Q 011819 287 VFDWTILKYQ 296 (477)
Q Consensus 287 ~~dw~~~~~~ 296 (477)
.+||..+..+
T Consensus 933 gIDfsslRkq 942 (1034)
T KOG0608|consen 933 GIDFSSLRKQ 942 (1034)
T ss_pred ccchHhhhhc
Confidence 9999985544
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=283.08 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=200.7
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.+.||.|+||.||++.+..++..||+|++.... ....+..|+++++.++|++ +..+......+...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN-IIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCC-hhheEEEEecCCEEEEEEE
Confidence 5899999999999999999999899999999876543 2345778999999999754 4444444455688899999
Q ss_pred cC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 84 ~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|+ +++|.+++... ...+++..+..++.||+.||.|||++|++|+||+|+||++ +..+.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeecccC
Confidence 99 78999999754 3679999999999999999999999999999999999999 57789999999999876543
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+......... ...
T Consensus 157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~----~~~ 222 (258)
T cd08215 157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQ----YPP 222 (258)
T ss_pred cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCC----CCC
Confidence 31 1234578899999999999889999999999999999999999996543 233333333322 222
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+...++.++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 34468899999999999999999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.98 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=195.3
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeC----
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEG---- 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~---- 75 (477)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.|++.+..+..+....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 36789999999999999999999999999999999875432 1234667999999998865555544333222
Q ss_pred -cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 76 -DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 76 -~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
...++|+||++++|.+++. ...+++..+..++.||+.||+|||++||+||||||+||++ +.++.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~ 166 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLAR 166 (343)
T ss_pred cccEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEccccccc
Confidence 2479999999999999997 3569999999999999999999999999999999999999 578899999999997
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+... ...+..+.....
T Consensus 167 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~ 233 (343)
T cd07851 167 HTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVG 233 (343)
T ss_pred ccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcC
Confidence 65432 123467889999999865 3678999999999999999999999976433 222222221110
Q ss_pred --------------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 --------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 --------------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
......+...+++++.++|..||..+|++||++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 0011122345688999999999999999999987764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=293.34 Aligned_cols=248 Identities=23% Similarity=0.322 Sum_probs=197.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.++|++.+.||+|+||.||++.+..++..||+|.+.... ....+..|+.+++.+.| +++..+..++...+..|+|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH-PNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCC-CCeeehhheeeeCCcEEEEEe
Confidence 478999999999999999999998899999999875432 22357788999999986 556666666667788899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++.. ..+++..+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceeccccccc-
Confidence 99 8999999873 458899999999999999999999999999999999999 5778999999999876543221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
......|++.|++||.+.+..++.++|+|||||++|++++|..||...... .....+..... .......
T Consensus 171 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~---~~~~~~~~~~~--~~~~~~~ 239 (293)
T cd06647 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNGT--PELQNPE 239 (293)
T ss_pred ------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---hheeehhcCCC--CCCCCcc
Confidence 123356889999999999888999999999999999999999999764321 11111111111 1111223
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.++..+.++|..||..+|++||++.++..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 46788999999999999999999876653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=288.01 Aligned_cols=253 Identities=18% Similarity=0.298 Sum_probs=192.1
Q ss_pred eEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEe--C---c
Q 011819 9 FRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE--G---D 76 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~--~---~ 76 (477)
|++.+.||+|+||.||+|... .+++.||||++..+.. ...+..|+++++.+.|++.+..+..+... . .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 3578999998765432 23467899999999875544444333221 1 1
Q ss_pred EEEEEEecC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~-----~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
..+++++|+ +++|.+++.... ..++...++.++.||+.||+|||++||+||||||+||++ +.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcc
Confidence 347888998 889988874221 247888999999999999999999999999999999999 57889999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHh
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (477)
|+++....... +.......+++.|++||.+.+..++.++|||||||++|+|++ |..||..... ...+..+.
T Consensus 158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI 229 (273)
T ss_pred cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH
Confidence 99986543221 111223345678999999998889999999999999999999 8999976433 22333332
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
..... .....++..+.+++..||..+|++||++.++.+.|+.+
T Consensus 230 ~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22111 11245788999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=292.61 Aligned_cols=245 Identities=25% Similarity=0.348 Sum_probs=195.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.+.|...++||+|+||.||+|.+..+++.|+||++..... ...+..|+.+++.++| +++..+..++......|+
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH-PNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEE
Confidence 3457778899999999999999999999999998764322 1346789999999987 556666666677788999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||||+.++|.+++.....++++..++.++.||+.+|.|||++|++|+||||+||++ +.++.++|+|||++.....
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC--
Confidence 99999889988887666779999999999999999999999999999999999999 6778999999999854321
Q ss_pred CCcccccccCCCCccCccccccchhc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~---g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||...... .....+.....+.
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~~~-- 239 (313)
T cd06633 174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNDSPT-- 239 (313)
T ss_pred ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCC--
Confidence 22457889999999984 356788999999999999999999999765432 2222222221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.....++..+.+++.+||+.+|++||++.++..
T Consensus 240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112456788999999999999999999877653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=297.71 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=192.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEe-----
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVE----- 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~----- 74 (477)
.+.++|.+.+.||+|+||.||+|.+..+++.||||.+.... ....+..|+.++..+.|.+.+..+..+...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 35689999999999999999999999999999999876432 123467899999999886655555444322
Q ss_pred CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
....++||||+..+|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++
T Consensus 92 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEecccccCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCc
Confidence 23458999999878877653 468999999999999999999999999999999999999 678999999999987
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh--
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 231 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~-- 231 (477)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... ..+..+...
T Consensus 166 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~ 232 (342)
T cd07879 166 HADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTG 232 (342)
T ss_pred CCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence 54321 123467889999999876 46889999999999999999999999764321 112111110
Q ss_pred ------------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 ------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 ------------------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
........+.+.++.++.++|..||..+|++||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011112223456788999999999999999999877754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=279.31 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=201.0
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeC--cEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEG--DYNVLV 81 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~--~~~~lV 81 (477)
+|++.+.||+|++|.||+|.+..+++.|++|++..... ...+..|+.+++.+.|++ +..+....... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN-IVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCC-EeeEEEEEecCCCCeEEEE
Confidence 58899999999999999999988999999998766542 446788999999999754 44444444455 788999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||++ +..+.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEeccccc
Confidence 9999 99999999754 379999999999999999999999999999999999999 568899999999998776543
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.. .......++..|++||.+.+..++.++||||||+++|+|++|..||.... ........+... .....+
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~---~~~~~~ 225 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSS---GEPPEI 225 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhcccc---CCCcCC
Confidence 21 01234568899999999998889999999999999999999999997654 222222222221 111224
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+..++.++.+++.+||..+|++||++.++..
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 4556899999999999999999999877754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=287.37 Aligned_cols=252 Identities=23% Similarity=0.291 Sum_probs=194.3
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
|++.+.||.|+||.||+|....+++.|+||.+..... ......|+..+..+.+++++..+..++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7899999999999999999988999999998765432 2234568888888984466666655556688899999999
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++.... ..+++..++.++.||+.+|.|||++|++|+||+|+||++ +..+.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC---
Confidence 999999887543 468999999999999999999999999999999999999 6789999999999986644221
Q ss_pred cccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc-----------
Q 011819 165 IPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------- 232 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~----------- 232 (477)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...................
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 -----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 123568889999998754 457899999999999999999999997654322221111111100
Q ss_pred -----------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 -----------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 -----------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.......+....+.++.+++..||..+|++||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001112223344688999999999999999999877643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=288.27 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=201.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..+.|++.+.||+|+||.||+|.+..++..|++|++..... ...+..|+++++.++| +++..+..++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH-PNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCC-CCeeEEEEEEEECCEEEEEEe
Confidence 45679999999999999999999988899999998875443 4567889999999987 566666666667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++......+++..+..++.||+.||.|||+.||+|+||+|+||++ +.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchh-
Confidence 99 799999998644479999999999999999999999999999999999999 6788999999999865443211
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
......++..|++||++.+..++.++|+|||||++|+|++|..||..... ......+......... ...
T Consensus 172 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~--~~~ 240 (286)
T cd06614 172 ------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPPLK--NPE 240 (286)
T ss_pred ------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCCCc--chh
Confidence 11234578899999999988899999999999999999999999975433 2222222222221111 123
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.++.++.++|.+||+.+|.+||++.++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 4789999999999999999999977664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=280.46 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=200.2
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.+.||+|++|.||++.+..+++.|+||.+..... ...+..|++++..+.|+ ++..+..+.......+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHP-NIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCC-CccEEEEEEEeCCEEEEEEe
Confidence 58999999999999999999998999999998766542 23577899999999875 55555555666788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++... ..+++..+..++.|++.+|.|||++||+|+||||+||++ +.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---CCCCCEEEeccccceecCCCccc
Confidence 99 88999999753 579999999999999999999999999999999999999 56789999999999876543321
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ...+.+...... ..+..
T Consensus 156 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~ 221 (254)
T cd06627 156 -------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQDDH----PPLPE 221 (254)
T ss_pred -------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhccCC----CCCCC
Confidence 2345688999999999888889999999999999999999999976442 222222222222 12345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.++.++.+++.+||..+|++||++.++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence 6789999999999999999999987765
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=287.50 Aligned_cols=246 Identities=21% Similarity=0.303 Sum_probs=196.3
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
.|...+.||+|++|.||++.+..+++.|+||.+.... ....+..|+.+++.+.|+ ++..+..++...+..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~-~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP-NIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCC-ChheEEEEEEcCCeEEEEEecc
Confidence 5667789999999999999998999999999875432 223467888999998875 5555555556778889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++.. .+++...+..++.||+.||+|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc---
Confidence 8999999874 568999999999999999999999999999999999999 6789999999998875433211
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+........ .....+
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~---~~~~~~~~~~~~~~~~--~~~~~~ 241 (285)
T cd06648 171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP---PLQAMKRIRDNLPPKL--KNLHKV 241 (285)
T ss_pred ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHhcCCCCC--cccccC
Confidence 1223568999999999998889999999999999999999999997533 2333333333321111 112347
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+..+.+++.+||..+|++||++.++.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 889999999999999999999776653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=285.59 Aligned_cols=248 Identities=19% Similarity=0.266 Sum_probs=182.0
Q ss_pred eeeeecCceEEEEEEECCC--CcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 13 RKIGSGSFGEIYLGTNIQT--NEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~--g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
++||+|+||.||+|..... ...+++|...... ....+..|+.++..++|++. ..+...+......|+||||+ +
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNI-LQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcch-hheEEEecCCCccEEEEecCCC
Confidence 3699999999999975433 3456777655433 23457788888998887554 44444555667889999999 8
Q ss_pred CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 87 PSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 87 ~sL~~li~~~~---~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
++|.+++.... ..++...++.++.||+.||+|||+++++||||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh--
Confidence 99999987432 336677788999999999999999999999999999999 6788999999999864322111
Q ss_pred ccccccCCCCccCccccccchhcC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhh-ccc
Q 011819 164 HIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK-KVS 234 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g-------~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~-~~~ 234 (477)
........|+..|+|||++.. ..++.++|||||||++|+|++ |..||..... ...+..+... ...
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~~ 228 (268)
T cd05086 155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQQVK 228 (268)
T ss_pred ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhcccc
Confidence 011234578899999998753 345789999999999999997 5778865433 2333332222 221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
.....+...+++.+.+++..|| .+|++||+++++.+.|
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1222334557889999999999 6899999999987765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=318.84 Aligned_cols=144 Identities=23% Similarity=0.417 Sum_probs=125.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..++| ++|..+..++....+.||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS-PFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCC-CCcCeEEEEEEECCEEEE
Confidence 3789999999999999999999999999999999865322 1356788888888877 555666666677889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
||||+ |++|.+++.. ...+++..++.|+.||+.||+|||.++||||||||+|||| +.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 99999 9999999975 4568999999999999999999999999999999999999 577899999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.35 Aligned_cols=249 Identities=20% Similarity=0.371 Sum_probs=206.8
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEE---EEecC---CCCchhHHHHHHHHHHHcCCCCCCeeE-EeeEeCcEEEEEE
Q 011819 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAI---KLENV---KTKHPQLLYESKLYRILQGGTGIPNVR-WFGVEGDYNVLVM 82 (477)
Q Consensus 10 ~i~~~IG~G~fG~Vy~a~~~~~g~~vAi---Ki~~~---~~~~~~~~~E~~il~~L~~~~~i~~~~-~~~~~~~~~~lVm 82 (477)
+...+||+|+|-+||+|.|..+|.+||- |+-+. ......|..|+.+|+.|+|.++|..+. |+........+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4567899999999999999999999983 33222 122346889999999999988777774 5555666778999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|++ .|+|..++++ .++++.+.+..|++||+.||.|||++. |||||||.+||+|+ ...|.|||+|+|||......
T Consensus 123 EL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence 999 9999999986 566999999999999999999999985 99999999999996 56799999999999988765
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. +.++|||.|||||+.. ..|+..+||||||+++.||+|+..||.... ...|.|.++.....+..+.
T Consensus 200 ~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl~- 266 (632)
T KOG0584|consen 200 HA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAALS- 266 (632)
T ss_pred cc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHhh-
Confidence 43 4579999999999988 789999999999999999999999998654 4578898888776654443
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
+--.+++++||.+|+.. ..+||++ +++|.+.|...
T Consensus 267 --kV~dPevr~fIekCl~~-~~~R~sa---~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 267 --KVKDPEVREFIEKCLAT-KSERLSA---KELLKDPFFDE 301 (632)
T ss_pred --ccCCHHHHHHHHHHhcC-chhccCH---HHHhhChhhcc
Confidence 33378999999999998 8999995 55566666443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.49 Aligned_cols=204 Identities=25% Similarity=0.370 Sum_probs=171.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeeEEeeEe------
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVE------ 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~---~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~------ 74 (477)
-....|...+.||+|+||.||+|+++.+|+.||||.++.. ...+...+|++++++|+| ++|+.+....++
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh-~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNH-PNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCc-hhhhhhcccCCccccCcc
Confidence 3456788889999999999999999999999999987763 344567899999999996 555555444332
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC-CcEEEeec
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDF 150 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~--~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~-~~vkL~DF 150 (477)
....++||||| ||+|..+++... ..+++.+++.++..+..||.|||++||+||||||.||++-.+.+. -..||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 34568999999 999999997432 349999999999999999999999999999999999999665433 34589999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCC
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-g~~~s~ksDIwSlGviLyelltG~~Pf~~~ 216 (477)
|.|+.+.+... ..+++||..|.+||+.. ...|+..+|+|||||++|+++||.+||...
T Consensus 169 G~Arel~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 169 GAARELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccccCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999887653 46789999999999998 488999999999999999999999999653
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=282.02 Aligned_cols=244 Identities=19% Similarity=0.295 Sum_probs=198.1
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+|++.++||.|+||.||++.+..+++.||||.+.... ....+..|+++++.++| ++++.+..++......++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC-CCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999876432 22346788899999986 556666555566688999999
Q ss_pred cC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 84 ~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|+ +++|.+++... ...+++..+..++.||+.||.|||+.|++|+||+|+||++ +..+.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhccC
Confidence 99 89999988642 3458999999999999999999999999999999999999 46788999999999776543
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
. .....|+..|++||.+.+..++.++|+||||+++|+|++|..||..... ......+...... .
T Consensus 157 ~---------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~ 220 (256)
T cd08530 157 M---------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGKYP----P 220 (256)
T ss_pred C---------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCC----C
Confidence 1 1234678899999999999999999999999999999999999976432 2222233332222 2
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+...++.++.+++.+||..+|++||++.++.+
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 23457889999999999999999999877754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=283.81 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=195.3
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 15 IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
||.|+||.||++.+..+++.|+||++..... ...+..|.+++..+.| +++..+......+...|++|||+ +++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCC-cchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999988999999998765432 2357788899999986 45555555566778889999999 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc-cccc
Q 011819 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-HIPY 167 (477)
Q Consensus 89 L~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~-~~p~ 167 (477)
|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++.......... ....
T Consensus 80 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCccccccccc
Confidence 99999854 379999999999999999999999999999999999999 678899999999987543321100 0001
Q ss_pred ccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHH
Q 011819 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (477)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (477)
.......++..|++||.+....++.++||||||+++|+|++|..||.... ....+..+........ . ...++..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~-~--~~~~~~~ 229 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNILNGKIEWP-E--DVEVSDE 229 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCcCCC-c--cccCCHH
Confidence 12234567889999999998889999999999999999999999996543 3334444433222211 1 1124899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 248 FASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
+.+++..||..+|++||++..+.++|++.
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 99999999999999999996666665533
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=290.74 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=193.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
...|+..+.||+|+||.||+|.+..+++.||||.+..... ...+..|+++++.++|++.+. +..++......++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ-YRGCYLREHTAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCccc-EEEEEEcCCeeEE
Confidence 4568888999999999999999999999999998754211 234668999999998755444 4455556778899
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||||+.++|.+++......++...+..++.|++.||.|||+++++||||||+|||+ +.++.++|+|||++......
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecCc-
Confidence 99999888988886656679999999999999999999999999999999999999 57789999999998765321
Q ss_pred CCcccccccCCCCccCccccccchhcC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g---~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
....|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+.......
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~-- 233 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPA-- 233 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH---HHHHHHhhcCCCC--
Confidence 23468889999999853 45788999999999999999999999764432 1112222211111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.....++..+.++|.+||..+|++||+++++..
T Consensus 234 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred -cCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 112357889999999999999999999877754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=284.36 Aligned_cols=249 Identities=20% Similarity=0.242 Sum_probs=196.0
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.++| +++..+..+....+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCC-CCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999877543 23456789999999986 4555555555566788999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 85 ~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
++++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~--- 153 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLR--- 153 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCcc---
Confidence 9889999998654579999999999999999999999999999999999999 5789999999999976543221
Q ss_pred cccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc-----------
Q 011819 165 IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------- 232 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~----------- 232 (477)
......++..|+|||.+.+. .++.++|||||||++|+|++|..||..... ...+.++....
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 154 ----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE---IDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred ----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHHHhCCCcHHHHHhh
Confidence 12234567789999998876 788999999999999999999999976432 22222221100
Q ss_pred -------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 -------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 -------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.........+.++.++.++|..||..+|++||++.++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 011111223455789999999999999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.32 Aligned_cols=255 Identities=20% Similarity=0.334 Sum_probs=213.3
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
.....+||-|-||.||.|.++.-.-.||||.++... ...+|+.|..+|+.++| ++++.+..+|...-.+||+.||| .
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikH-pNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcC-ccHHHHhhhhccCCCeEEEEecccC
Confidence 456779999999999999999999999999876654 34679999999999998 66777777777888889999999 9
Q ss_pred CCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 87 PSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 87 ~sL~~li~~~~~~-ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
|+|.+++..|++. ++....+.++.||..|++||..+++|||||-..|+|+ ..+..|||+||||++.+.......+.
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTAHA 424 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTAHA 424 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCceeccc
Confidence 9999999988764 6777788999999999999999999999999999999 57889999999999988765442221
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
...=...|.|||.+.-..++.|+|||+|||+|||+.| |--||.+.+-...+..+++.... .-+.+|
T Consensus 425 ------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM-------~~PeGC 491 (1157)
T KOG4278|consen 425 ------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM-------DGPEGC 491 (1157)
T ss_pred ------CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc-------cCCCCC
Confidence 1112467999999988889999999999999999998 99999886554444444433222 235789
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
|+.+++|+..||.+.|.+||+|+++-+.|+.+|...
T Consensus 492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 999999999999999999999999999999998544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=301.65 Aligned_cols=264 Identities=20% Similarity=0.300 Sum_probs=210.4
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---------CchhHHHHHHHHHHHcCCCCCCeeEEeeE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------KHPQLLYESKLYRILQGGTGIPNVRWFGV 73 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---------~~~~~~~E~~il~~L~~~~~i~~~~~~~~ 73 (477)
|.+.++|-++..||+|||++||+|.+...++.||||+-.... .+....+|..|.+.|.|+.++..+++|..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 566788999999999999999999999999999999844332 23345689999999999988888899989
Q ss_pred eCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 74 ~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~--giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
+.+.+|.|+||| |.+|.-+++. .+-+++++++.|+.||+.||.||.+. .|||=||||.||||-.+...|.+||.||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 999999999999 7788777774 56699999999999999999999976 5999999999999988888999999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCC----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~----~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~ 226 (477)
||++.+.+................||..|++||++.-. ..+.++||||+|||+|+++.|+.||...........+.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 99999988776543333344567899999999998643 35789999999999999999999996532211111111
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
.|.... ..-....+.+..+..+||.+||.++-++|.+..+|
T Consensus 698 TIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 698 TILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred chhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 121110 00001124567899999999999999999885544
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.00 Aligned_cols=252 Identities=14% Similarity=0.200 Sum_probs=185.0
Q ss_pred eeeeec--CceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G--~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
..||.| +||+||++.+..+++.||||+....... ..+..|+.+++.++| ++|..+..++..++..++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRH-PNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999997654322 346778888887887 55666666667788899999999
Q ss_pred CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +..+.++++||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCcccc
Confidence 88999998753 3458999999999999999999999999999999999999 5778999999986644322211111
Q ss_pred cccccCCCCccCccccccchhcCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc--------
Q 011819 165 IPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------- 234 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~--~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (477)
..+.......++..|+|||++.+. .++.++|||||||++|+|++|..||...... +.+.........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT---QMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH---HHHHHHhcCCCCCCcccccc
Confidence 111111223456779999999764 4789999999999999999999999764321 111111110000
Q ss_pred ----------------------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 235 ----------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 235 ----------------------------------~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.........+++.+.+|+.+||..||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000112335678999999999999999999777643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=332.94 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=206.6
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
+.-+|.-+.+||.|.||.||.|.+..+|+..|+|.+.-. ..-+.+..|.+++..|+| ++++.++.+.++.+..+|
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnH-pNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNH-PNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccC-ccccccCceeecHHHHHH
Confidence 345678888999999999999999999999999964432 223457789999999998 667777777788888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
.|||| ||+|.+++.. ++-.++.....|-.|++.||.|||++|||||||||.||+| +.+|.+|+.|||.|+.....
T Consensus 1312 FMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCc
Confidence 99999 9999999973 5557777778899999999999999999999999999999 78899999999999988765
Q ss_pred CCCcccccccCCCCccCccccccchhcCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~---~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
.. .+| .+.....||+.|||||++.+.. ...++|||||||++.||+||+.||..++. ..+.+-++.....+.
T Consensus 1388 ~~--~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy~V~~gh~Pq- 1461 (1509)
T KOG4645|consen 1388 AQ--TMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMYHVAAGHKPQ- 1461 (1509)
T ss_pred hh--cCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHhHHhccCCCC-
Confidence 31 222 3445678999999999998754 46789999999999999999999987643 344444444433333
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
++..++++-.+||.+||..||..|=++. ++|+..|
T Consensus 1462 ---~P~~ls~~g~dFle~Cl~~dP~~Rw~~~---qlle~~f 1496 (1509)
T KOG4645|consen 1462 ---IPERLSSEGRDFLEHCLEQDPKMRWTAS---QLLEHAF 1496 (1509)
T ss_pred ---CchhhhHhHHHHHHHHHhcCchhhhHHH---HHHHhhc
Confidence 3344788999999999999999996644 4455554
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=287.08 Aligned_cols=243 Identities=19% Similarity=0.294 Sum_probs=193.0
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CC
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~ 87 (477)
...+||+|+||.||++.+..+++.||||.+.... ....+..|+.+++.+.| ++++.+..++..++..+++|||+ ++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCC-cchhheeeEEEeCCEEEEEEecCCCC
Confidence 3467999999999999999999999999875433 23357789999999987 55555555666788999999999 88
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccccc
Q 011819 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167 (477)
Q Consensus 88 sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~ 167 (477)
+|.+++. ...+++..+..++.|++.+|+|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 103 ~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~------ 171 (292)
T cd06657 103 ALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP------ 171 (292)
T ss_pred cHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc------
Confidence 9998876 4568999999999999999999999999999999999999 6778999999999876543221
Q ss_pred ccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHH
Q 011819 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (477)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (477)
......|+..|++||.+.+..++.++|+|||||++|+|++|..||..... ......+... ...... ....++++
T Consensus 172 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~-~~~~~~-~~~~~~~~ 245 (292)
T cd06657 172 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDN-LPPKLK-NLHKVSPS 245 (292)
T ss_pred -cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhh-CCcccC-CcccCCHH
Confidence 12345688999999999888899999999999999999999999976432 2222222221 111111 12356889
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 248 FASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+.+++.+||..+|.+||++.++..
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 999999999999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=279.24 Aligned_cols=245 Identities=22% Similarity=0.277 Sum_probs=191.7
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-------~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
+|.+.++||+|+||.||++.+...+..+++|+.... .....+..|+.+++.++|++.+ .+..+.......++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV-KFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHH-HHHHHHhcCCceEE
Confidence 589999999999999999999888777777765431 1222456788889998875544 44444455667899
Q ss_pred EEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 81 VMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 81 VmE~~-g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
||||+ +++|.+++.. ....+++..++.++.|++.||.|||++|++|+||||+||++. .+.++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 99999 8899988863 235689999999999999999999999999999999999993 356999999999876
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
..... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||... ........+......
T Consensus 156 ~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~-- 223 (260)
T cd08222 156 MGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPTP-- 223 (260)
T ss_pred CCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHcCCCC--
Confidence 44322 123456888999999998888999999999999999999999999642 233333333332222
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.+...++.++.++|.+||..+|++||++.++.+
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 233567889999999999999999999877754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=290.72 Aligned_cols=256 Identities=20% Similarity=0.258 Sum_probs=200.0
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCC-----CCCCeeEEeeEeCcE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGG-----TGIPNVRWFGVEGDY 77 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~-----~~i~~~~~~~~~~~~ 77 (477)
.+.++|+++..+|+|+||.|..+.+..++..||||+++.-. ..+....|++++..|.+. .-+.++..+++..+.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 35789999999999999999999999999999999876543 445677899999999532 223344445667788
Q ss_pred EEEEEecCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC----------------
Q 011819 78 NVLVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR---------------- 140 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~---------------- 140 (477)
.|||+|.+|.++.+++.. ...+|+...++.++.|++.+++|||+.+++|-||||+|||+...+
T Consensus 166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 899999999999999974 345699999999999999999999999999999999999995211
Q ss_pred -CCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc
Q 011819 141 -RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (477)
Q Consensus 141 -~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~ 219 (477)
+...|+|+|||.|....+.. ..++.|..|.|||+++|..++..+||||+||||+|+.+|...|+.-.+.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred CCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 23468999999998665543 3568899999999999999999999999999999999999999875543
Q ss_pred cHHHHHHHHhhhcccccHHHH----------------------------h-------cCC---cHHHHHHHHHHhcCCCC
Q 011819 220 TKKQKYEKISEKKVSTSIEAL----------------------------C-------RGY---PTEFASYFHYCRSLRFD 261 (477)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~l----------------------------~-------~~~---p~~l~~li~~cl~~~p~ 261 (477)
.....+++|........+..- | ..- -.+|.+|++.||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 333444444432111111111 0 000 12488999999999999
Q ss_pred CCCCHHHH
Q 011819 262 DKPDYAYL 269 (477)
Q Consensus 262 ~RPt~~~l 269 (477)
+|+|+.|+
T Consensus 396 ~RiTl~EA 403 (415)
T KOG0671|consen 396 RRITLREA 403 (415)
T ss_pred ccccHHHH
Confidence 99996554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.89 Aligned_cols=251 Identities=20% Similarity=0.347 Sum_probs=208.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeE-----eCcE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGV-----EGDY 77 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~-----~~~~ 77 (477)
.-.+.|+|.+.||.|.+|.||+++++.+++.+|+||+.... ...++..|..+++.+.+|++++.+++++. .++.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 44678999999999999999999999999999999987654 44568889999999999999999876654 4667
Q ss_pred EEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
.||||||| ||+..||++.. +.++.++.+..|++.++.||.+||...+||||||-.|||+ ...+.|||+|||.+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeee
Confidence 89999999 99999999743 5669999999999999999999999999999999999999 6889999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-----~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
+...- ....+++||+.|||||++... .|+.++|+||||++.+||..|.+|+..+... ..+..|..
T Consensus 173 ldsT~-------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---raLF~IpR 242 (953)
T KOG0587|consen 173 LDSTV-------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR 242 (953)
T ss_pred eeccc-------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---hhhccCCC
Confidence 75432 234578999999999998754 3678999999999999999999999877652 22333333
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
...+... -++.+..+|.+||..||.+|.+.||...++
T Consensus 243 NPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 243 NPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred CCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 2222211 235678899999999999999999996654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=301.48 Aligned_cols=241 Identities=20% Similarity=0.245 Sum_probs=202.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
.+.|++...+|.|+|+.|-.+.+..+++..++|++... ..+...|..++....+++++..+...+.++...|+|||++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 56799999999999999999999999999999998765 3455667888888888999999999998999999999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
|+-|.+-+.. ...+. .++..|+.||+.||.|||++|+|||||||+|||+. +..++++|+|||.++.....
T Consensus 399 ~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~----- 469 (612)
T KOG0603|consen 399 DGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERS----- 469 (612)
T ss_pred cccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchh-----
Confidence 6655555542 33344 77888999999999999999999999999999994 37889999999999877654
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
..+.+=|..|.|||+....+|++++||||||++||+||+|+.||..-..+ .+.+.++....+. ..+
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~~v 535 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS-------ECV 535 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc-------ccc
Confidence 12335588999999999999999999999999999999999999875544 4455555444333 457
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+.++++|+++||+.+|.+||++.++..
T Consensus 536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 536 SDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CHHHHHHHHHhccCChhhCcChhhhcc
Confidence 899999999999999999999888754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=283.79 Aligned_cols=251 Identities=19% Similarity=0.282 Sum_probs=201.9
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
+.+-+..||.|.||+|++..++.+|+..|||.+..... +.+++.|.+....-..+++|+.++...-..+..||+||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 33445679999999999999999999999998765443 456888988888888888888876655566678999999
Q ss_pred CCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 85 LGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 85 ~g~sL~~li~~~----~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|..+|..+.++. +..+++.-+.++..-.+.||+||-+ ..|||||+||+|||+ +..|.|||||||++-.+.+.
T Consensus 145 Md~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHH
Confidence 999998886532 4568888888888889999999996 589999999999999 78999999999999877654
Q ss_pred CCCcccccccCCCCccCccccccchhcC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g--~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.. .+.-+|...|||||.+.. ..|+.++|+||||++|||+.||..||.+... ..+++..+..+..+...
T Consensus 222 iA--------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 222 IA--------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILL 291 (361)
T ss_pred HH--------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeec
Confidence 32 223478899999999864 3489999999999999999999999987654 34444445544443322
Q ss_pred H-HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 E-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~-~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. .-+-.++..+..+|..||.+|-.+||.|.+|++
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2 222457889999999999999999999988865
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=284.55 Aligned_cols=254 Identities=19% Similarity=0.228 Sum_probs=183.1
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 10 ~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
.+++.+|.| |.||++++..+++.||||++.... ....+..|+.+++.++|++.+. +..++...+..+++|||+
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~-~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhh-hhheeecCCeEEEEEecc
Confidence 344444444 555666666799999999876542 2235788999999998755444 444556677889999999
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 86 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 86 -g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+++|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeeccccccc
Confidence 89999998743 3458999999999999999999999999999999999999 567899999999997664432211
Q ss_pred ccccccCCCCccCccccccchhcC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc--------
Q 011819 164 HIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g--~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (477)
...........++..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....++.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCch
Confidence 111112234567889999999876 35789999999999999999999999764321 111222111000
Q ss_pred --------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 --------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 --------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........++.++.+++..||..+|++||+++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000111234567899999999999999999776643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=295.36 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=205.4
Q ss_pred EEeeeeecCceEEEEEEECCC--C--cEEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 11 LGRKIGSGSFGEIYLGTNIQT--N--EEVAIKLENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~--g--~~vAiKi~~~~---~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+.++||.|-||.||.|..... | --||||..+.. ...+.|+.|..+++.+.|+++|..+.. ++ ....|||||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv-~~-e~P~WivmE 470 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGV-CV-EQPMWIVME 470 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeee-ee-ccceeEEEe
Confidence 345799999999999986433 2 36888876542 234568999999999999655555444 43 345799999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
++ -|.|..+++.....++......|+.||..||.|||+..+|||||-..|||+ .....|||+|||+++-+.+....
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV---SSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee---cCcceeeecccchhhhccccchh
Confidence 99 899999998777779999999999999999999999999999999999999 57788999999999988776542
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
. .....-...|||||.+.-..++.++|||=|||++||++. |..||++.+..+....+++ ...-..+
T Consensus 548 k------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn-------GeRlP~P 614 (974)
T KOG4257|consen 548 K------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN-------GERLPCP 614 (974)
T ss_pred h------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-------CCCCCCC
Confidence 2 222233567999999999999999999999999999987 9999999876543322222 1112255
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
++||+.++.++.+||+++|.+||.+.+|+..|.++++.+.
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 7899999999999999999999999999999999987544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=300.70 Aligned_cols=249 Identities=20% Similarity=0.239 Sum_probs=200.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g---~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
++.++.++||+|.||.|++|.+...+ ..||||++..... -..|++|+.+|..|+|.+.|..+..+.. ....|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhH
Confidence 35667889999999999999986543 4799999876543 3579999999999999665555544432 56689
Q ss_pred EEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 81 VMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 81 VmE~~-g~sL~~li~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||++ +|+|.+.+.. ....|-......|+.||+.||.||.++++|||||-..|+|| .....||||||||.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll---asprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL---ASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee---cccceeeeecccceeccCC
Confidence 99999 9999988875 34558889999999999999999999999999999999999 5688999999999998876
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
....-. ......-...|+|||.+....++.++|||+|||+||||++ |..||.+... .+++.+|-++....
T Consensus 265 ned~Yv----m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---~qIL~~iD~~erLp-- 335 (1039)
T KOG0199|consen 265 NEDMYV----MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---IQILKNIDAGERLP-- 335 (1039)
T ss_pred CCcceE----ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---HHHHHhccccccCC--
Confidence 544211 1112223568999999999999999999999999999998 8999998766 44555444332211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
-++.||+++++++..||..+|++||+|..|.+
T Consensus 336 --RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 336 --RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred --CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 23668999999999999999999999998863
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.48 Aligned_cols=260 Identities=17% Similarity=0.258 Sum_probs=212.9
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
....++++||+|-||+|.+|+- ..+..||+|.+.... ....|..|+++|.+|+| |+|..+..++..++..+|++|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkh-PNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKH-PNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCC-CCeeEEEeeeecCCchHHHHH
Confidence 4567899999999999999994 457899999987643 23468999999999976 778888888888899999999
Q ss_pred cC-CCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~l-s~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ .|+|.+++..+..+. .-+....++.||+.|++||.+.+||||||.+.|+|+ +...++||+|||+++.+.....
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccccCCc
Confidence 99 999999998654443 455667799999999999999999999999999999 7899999999999997765544
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc--CCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
. +.-...+-..+|||+|.+.-.+++.++|+|+||+++||+++ ...||..+.+....+................
T Consensus 693 y-----~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 693 Y-----RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred e-----eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 2 22334556789999999999999999999999999999875 8899988766544444444444444444444
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
.+.-||.++.+++..||..+-.+||+|++|...|.+.
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 4567899999999999999999999999998877654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=272.00 Aligned_cols=234 Identities=23% Similarity=0.302 Sum_probs=190.6
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 15 IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
||.|+||.||++.+..+++.||+|++..... ...+..|+++++.+.|. ++..+...+..+...+++|||+ +++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHP-FIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCC-cHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6999999999999988899999998765432 23577889999999864 5555555566788899999999 999
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccc
Q 011819 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168 (477)
Q Consensus 89 L~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~ 168 (477)
|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||++ +..+.++|+|||++........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~------- 148 (250)
T cd05123 80 LFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGS------- 148 (250)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCC-------
Confidence 9999975 4468999999999999999999999999999999999999 5778999999999987644321
Q ss_pred cCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHH
Q 011819 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (477)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (477)
......++..|++||.+.+...+.++|+||||+++|++++|..||..... .+.+..+..... .+...++.++
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~l 220 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPL-----RFPEFLSPEA 220 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCCHHH
Confidence 12345788999999999988889999999999999999999999965332 333333333211 2344568999
Q ss_pred HHHHHHHhcCCCCCCCCHHH
Q 011819 249 ASYFHYCRSLRFDDKPDYAY 268 (477)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~ 268 (477)
.+++.+||..+|++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 99999999999999999844
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=275.37 Aligned_cols=265 Identities=21% Similarity=0.238 Sum_probs=202.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCC----cEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g----~~vAiKi~~~~----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
...|+++++||+|+||.||+|....++ +++|||.++.+ .......+|+.+++.|+|++.+..+..|...+..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457999999999999999999655543 38999987765 3445688999999999998888888777777888
Q ss_pred EEEEEecCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec-CCCCCcEEEeecCc
Q 011819 78 NVLVMDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGL 152 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~----~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~-~~~~~~vkL~DFGl 152 (477)
.+|++||...+|+++|+.+. +.++...+..++.||+.|+.|||++=|+||||||.|||+.. +...|.|||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999999999999997542 34888899999999999999999999999999999999942 33459999999999
Q ss_pred eeecccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCccc------HHHHH
Q 011819 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKY 225 (477)
Q Consensus 153 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~------~~~~~ 225 (477)
++.+.+.-. |......++-|..|.|||.++|. .|+++.||||+|||+.||++-.+-|.+..... ....+
T Consensus 183 aR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 183 ARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred HHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999877543 33445567789999999999985 58999999999999999999888886532210 11122
Q ss_pred HHHhhhcc-------------cc---cHHH----------------HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 226 EKISEKKV-------------ST---SIEA----------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 226 ~~i~~~~~-------------~~---~~~~----------------l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
.+|.+-.- +. .+.. ..+.-++...+|+.++|.+||-+|.|+++. |
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA---l 335 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA---L 335 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH---h
Confidence 22222110 00 0000 001124447899999999999999996654 4
Q ss_pred HHHH
Q 011819 274 RDLF 277 (477)
Q Consensus 274 ~~~~ 277 (477)
++.+
T Consensus 336 eh~y 339 (438)
T KOG0666|consen 336 EHPY 339 (438)
T ss_pred cccc
Confidence 4443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=253.19 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=199.3
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.+|...++||+|.||+||+|++..+++.||+|........ ....+|+-+++.|+|.+++.. ..+...+...-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl-~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL-HDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeeh-hhhhccCceeEEeH
Confidence 3577889999999999999999999999999987654432 357899999999999655444 44444556678999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|||..+|..+++.+++.++.+.+..++.|++.||.|+|+++++||||||.|.|| +.+|.+||+|||+|+.+.-
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgi---- 153 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGI---- 153 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCC----
Confidence 999999999999999999999999999999999999999999999999999999 7899999999999987753
Q ss_pred cccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccc-----
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST----- 235 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~----- 235 (477)
|.++....+-|..|.+|.++.|.. |+...|+||-|||+.|+.. |.+-|.+.+..+....+.+........
T Consensus 154 ---pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 154 ---PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred ---ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 445566667799999999999865 7889999999999999987 778887754433333332222111100
Q ss_pred ----------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 236 ----------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 236 ----------------~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
....+-+.+...=+++++++|.-+|..|.+++...
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 01111122233457899999999999999976543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=301.59 Aligned_cols=251 Identities=18% Similarity=0.188 Sum_probs=166.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCC----CcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEE----e-eEeCc
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQT----NEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRW----F-GVEGD 76 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~----g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~----~-~~~~~ 76 (477)
.++|++.++||+|+||.||+|.+..+ +..||||.+...........| .+ ....+......+.. . ...+.
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l-~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RV-RRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HH-HhhchhhHHHHHHhhhcccccccCC
Confidence 46899999999999999999999888 899999986543222111111 11 11111111111111 1 24566
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCC-------------------CHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEe
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKL-------------------SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~l-------------------s~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl 136 (477)
..+|||||+ +++|.+++......+ ....+..++.||+.||+|||+++|+||||||+|||+
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl 288 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence 789999999 889999987432111 123456799999999999999999999999999999
Q ss_pred ecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCC----------------------CCCCcc
Q 011819 137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI----------------------EQSRRD 194 (477)
Q Consensus 137 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~----------------------~~s~ks 194 (477)
+ +..+.+||+|||+|+.+..... .....+.|++.|||||.+... .++.++
T Consensus 289 ~--~~~~~~KL~DFGlA~~l~~~~~------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 289 S--EGSGSFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred e--CCCCcEEEEeCCCccccccccc------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 4 3457899999999986543222 112456889999999976432 234567
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH-hhhccc--ccHH--------------HHhcCCcHHHHHHHHHHhc
Q 011819 195 DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI-SEKKVS--TSIE--------------ALCRGYPTEFASYFHYCRS 257 (477)
Q Consensus 195 DIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i-~~~~~~--~~~~--------------~l~~~~p~~l~~li~~cl~ 257 (477)
|||||||+||||+++..|+.. ....+.++ ...... .... .+.........+||..||.
T Consensus 361 DVwSlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999998776532 11111111 111100 0000 0001112345689999999
Q ss_pred CCCCCCCCHHHHHH
Q 011819 258 LRFDDKPDYAYLKR 271 (477)
Q Consensus 258 ~~p~~RPt~~~l~~ 271 (477)
.||.+||++.++.+
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999776643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.95 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=189.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeE-EeeE-------
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVR-WFGV------- 73 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~-~~~~------- 73 (477)
...+|+.++.||+||||.||+++++-+|++||||.+.... ....+.+|++++..|+|++.|.++. |+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4568999999999999999999999999999999877653 2235778999999999966664321 1100
Q ss_pred ---------------------------------------------------------------------eC---------
Q 011819 74 ---------------------------------------------------------------------EG--------- 75 (477)
Q Consensus 74 ---------------------------------------------------------------------~~--------- 75 (477)
++
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 00
Q ss_pred --------------------------------cEEEEEEecCC-CCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHH
Q 011819 76 --------------------------------DYNVLVMDLLG-PSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHS 121 (477)
Q Consensus 76 --------------------------------~~~~lVmE~~g-~sL~~li~~~~~~l-s~~~~~~i~~qIa~aL~yLHs 121 (477)
.+.||=||||. .+|.+++.+ +... ....++++++||++||.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-NHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-cccchhhHHHHHHHHHHHHHHHHHHh
Confidence 13478899995 455555553 3323 477889999999999999999
Q ss_pred CCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc---C-----C--CCcc-cccccCCCCccCccccccchhcCCC-
Q 011819 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---T-----S--THQH-IPYRENKNLTGTARYASMNTHLGIE- 189 (477)
Q Consensus 122 ~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~---~-----~--~~~~-~p~~~~~~~~Gt~~Y~APE~~~g~~- 189 (477)
+|||||||||.||+| +.++.|||+|||+|..... . . .... .+....+..+||.-|+|||++.+..
T Consensus 716 ~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred CceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999 7899999999999987221 0 0 0000 0111345678999999999998765
Q ss_pred --CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 011819 190 --QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 267 (477)
Q Consensus 190 --~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~ 267 (477)
|+.|+|||||||||+||+. ||. +.......+..+....++.+ ..+...--+.-+++|+++++.||.+||++.
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFG--TSMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCC--chHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 9999999999999999995 564 33445555555555544443 222322234568899999999999999988
Q ss_pred HHH
Q 011819 268 YLK 270 (477)
Q Consensus 268 ~l~ 270 (477)
+|+
T Consensus 867 eLL 869 (1351)
T KOG1035|consen 867 ELL 869 (1351)
T ss_pred HHh
Confidence 765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=268.57 Aligned_cols=219 Identities=16% Similarity=0.146 Sum_probs=173.8
Q ss_pred cCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHc
Q 011819 18 GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC 96 (477)
Q Consensus 18 G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~ 96 (477)
|.||.||++.+..+++.||+|.+.... ....|...+....| +++..+..++...+..+++|||+ |++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHCV-PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK- 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcCC-CceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence 899999999999999999999876543 23334444333333 66666666667788899999999 8899999864
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccC
Q 011819 97 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176 (477)
Q Consensus 97 ~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt 176 (477)
...+++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||++....... ....++
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~----------~~~~~~ 145 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSC----------DGEAVE 145 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhcccccc----------ccCCcC
Confidence 3469999999999999999999999999999999999999 678899999999886554321 123456
Q ss_pred ccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHh
Q 011819 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR 256 (477)
Q Consensus 177 ~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl 256 (477)
..|+|||.+.+..++.++|+|||||++|+|++|..||...... +... ....++..+++.+.++|.+||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~~----~~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------INTH----TTLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------cccc----cccCCcccCCHHHHHHHHHHc
Confidence 7899999998888999999999999999999999988542210 0000 001133557889999999999
Q ss_pred cCCCCCCCCH
Q 011819 257 SLRFDDKPDY 266 (477)
Q Consensus 257 ~~~p~~RPt~ 266 (477)
+.||++||++
T Consensus 214 ~~dp~~R~~~ 223 (237)
T cd05576 214 QFNPTERLGA 223 (237)
T ss_pred cCCHHHhcCC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=296.80 Aligned_cols=255 Identities=16% Similarity=0.280 Sum_probs=212.3
Q ss_pred CceEEEeeeeecCceEEEEEEECCCC---cEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g---~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
..-+|.+.||.|.||+||+|+-+..+ ..||||.++... .+..|+.|+.||-++.| ++|..+..+-.......|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH-PNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC-CcEEEEEEEEecCceeEE
Confidence 34568889999999999999987666 479999887643 33469999999999998 566677777778888899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
+.||| +++|..++....+.|++.+..-+++.|+.|+.||-++++|||||-..|||+ +.+-.+|++||||++.+.+.
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecccC
Confidence 99999 999999998878889999999999999999999999999999999999999 78889999999999988776
Q ss_pred CCCcccccccCCCCcc--CccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 160 STHQHIPYRENKNLTG--TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~G--t~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
... ...+.-| ..+|.|||.+....++..+||||+||++||.++ |..||.++...+ .+..| +..+..+
T Consensus 785 ~~~------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---VIkaI-e~gyRLP 854 (996)
T KOG0196|consen 785 PEA------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIKAI-EQGYRLP 854 (996)
T ss_pred CCc------cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---HHHHH-HhccCCC
Confidence 531 1223333 368999999999999999999999999999776 999998876533 23222 2222211
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
. +-+||..|..|+..||++|-..||.|++|+..|.+++.
T Consensus 855 p---PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 855 P---PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred C---CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1 24689999999999999999999999999999998863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=272.39 Aligned_cols=135 Identities=27% Similarity=0.506 Sum_probs=113.5
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCC-------CCCee-EEe--
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGT-------GIPNV-RWF-- 71 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~-------~i~~~-~~~-- 71 (477)
++.+++|.+.++||+|.|++||+|.+.++.+.||+|+.+.... .+..+.|+++|+++..+. .|+.+ ++|
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 4456899999999999999999999999999999999765443 345778999999987432 33333 333
Q ss_pred -eEeCcEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEee
Q 011819 72 -GVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMG 137 (477)
Q Consensus 72 -~~~~~~~~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~ 137 (477)
+..+.+.|||+|++|.+|..+|.++. +.+++..+..|+.||+.||.|||. +||||-||||+||||.
T Consensus 154 sGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 34678899999999999999998764 459999999999999999999996 6999999999999995
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=270.93 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=203.0
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCeeEEeeE---eCcE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRI--LQGGTGIPNVRWFGV---EGDY 77 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~--L~~~~~i~~~~~~~~---~~~~ 77 (477)
..|.++..+.+.||+|.||+||+|. ..|+.||||++... .+..+.+|.+|+.. |+|.|++..+..-.. .-..
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~sr-dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSR-DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred HhhhheeEEEEEecCccccceeecc--ccCCceEEEEeccc-chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 4577889999999999999999998 57899999998764 45678888888875 667655554422211 1234
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeCCCCCCceEeecCCCCCcEEEe
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYII 148 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~--------giiHRDLKP~NILl~~~~~~~~vkL~ 148 (477)
.|||.+|. .|+|.|++.+ ..++.+..++++..++.||++||.. .|.|||||..|||+ .+++.+.|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEe
Confidence 58999999 9999999984 6799999999999999999999952 49999999999999 789999999
Q ss_pred ecCceeecccCCCCcccccccCCCCccCccccccchhcCCC------CCCcchHHHHHHHHHHHHcC----------CCC
Q 011819 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG----------SLP 212 (477)
Q Consensus 149 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~------~s~ksDIwSlGviLyelltG----------~~P 212 (477)
|+|||...........++ ....+||.+|||||++...- .-..+||||||.++||++.. .+|
T Consensus 359 DLGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred eceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999877654433332 34568999999999986531 23578999999999999853 679
Q ss_pred CCCCCcc--cHHHHHHHHhhhcccccHHHHhcCCc--HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 213 WQGLKAG--TKKQKYEKISEKKVSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 213 f~~~~~~--~~~~~~~~i~~~~~~~~~~~l~~~~p--~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
|.+.-+. ...+...-+...+..+.++..++..| ..+.++|..||..+|.-|.++=-+++.|.++.
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 8775432 22333333334444444444444444 45889999999999999999888888888875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=266.98 Aligned_cols=257 Identities=22% Similarity=0.268 Sum_probs=197.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEee-------Ee
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFG-------VE 74 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~-------~~ 74 (477)
.+.|+...+||+|.||+||+|+...+++.||+|+.-.+. .-...++|++++..|+|.+.+..+..+- -+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 457888889999999999999999999999999543322 2235789999999999966554443221 13
Q ss_pred CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
...+||||++|..+|.-++.....+|+..++..++.+++.||.|+|...|+|||+||+|+|| +.++.+||+|||+|+
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGlar 172 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGLAR 172 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeecccccc
Confidence 34579999999999999998666789999999999999999999999999999999999999 788999999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh---
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--- 230 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~--- 230 (477)
.+......... .+.+.+-|..|.+||.++| .+|++..|||.-|||+.+|++|.+-|++... .+.+..|..
T Consensus 173 ~fs~~~n~~kp---rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte---qqql~~Is~LcG 246 (376)
T KOG0669|consen 173 AFSTSKNVVKP---RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE---QQQLHLISQLCG 246 (376)
T ss_pred ceecccccCCC---CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH---HHHHHHHHHHhc
Confidence 77654432221 2455667999999999987 4689999999999999999999999987433 333332221
Q ss_pred hc---ccccH------HH-----Hhc----CC---------cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 KK---VSTSI------EA-----LCR----GY---------PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 ~~---~~~~~------~~-----l~~----~~---------p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.. ..+.. .. +.+ .+ .++..+++++++.+||.+|++++++..
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 10 00000 00 000 00 346889999999999999999877643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=289.80 Aligned_cols=257 Identities=20% Similarity=0.322 Sum_probs=206.6
Q ss_pred ceEEEeeeeecCceEEEEEEECC-------CCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~-------~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
+.++.+.||+|.||.|++|.-.. ....||||.+..... ...+..|+++++.+.+|+++..+...+...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 34567799999999999997321 145899998765433 35688999999999988999998888888889
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 78 NVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
.++|+||+ .|+|.+++..+. ..++..+.+.++.||+.|++||++..+|||||-..|||+ ..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI---TK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe---cC
Confidence 99999999 999999997554 238899999999999999999999999999999999999 57
Q ss_pred CCcEEEeecCceeecccCCCCcccccccCCCCcc--CccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCc
Q 011819 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG--TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~G--t~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~ 218 (477)
+..+||+|||+|+........ . .+.-.| ...|||||.+....|+.++|||||||+||||++ |..||.+...
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y-----~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYY-----R-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred CCEEEEccccceeccCCCCce-----E-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 789999999999865443321 1 111122 345999999999999999999999999999999 9999987442
Q ss_pred ccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
. ...+..+..... .+.+..+++++++++..||..+|++||++.++.+.|...+..
T Consensus 528 ~--~~l~~~l~~G~r----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 T--EELLEFLKEGNR----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred H--HHHHHHHhcCCC----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 2 222333333222 123456799999999999999999999999999999987543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=279.60 Aligned_cols=206 Identities=23% Similarity=0.310 Sum_probs=171.1
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCC-----CCCCeeEEeeEeCc
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLLYESKLYRILQGG-----TGIPNVRWFGVEGD 76 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-~~~~~~~~E~~il~~L~~~-----~~i~~~~~~~~~~~ 76 (477)
..+.++|.+....|+|-|++|..|.+...|.+|||||+... ..+..=+.|+.||+.|+.. .++..+.-.+...+
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 35678999999999999999999999999999999998654 3455667899999999743 22222333345678
Q ss_pred EEEEEEecCCCCHHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 77 YNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 77 ~~~lVmE~~g~sL~~li~~~~~~--ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
+.|||+|-+.-+|.++++..++. |.+..+..|+.|+..||..|-.+||+|.||||+|||+. .....+||||||.|.
T Consensus 508 HLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 508 HLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSAS 585 (752)
T ss_pred eeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCcccc
Confidence 89999999999999999865443 78889999999999999999999999999999999995 456788999999997
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~ 219 (477)
...+... .|| .-+--|.|||+++|.+|+...|+||+||+||||.||+.-|.+....
T Consensus 586 ~~~enei---tPY------LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 586 FASENEI---TPY------LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred ccccccc---cHH------HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 6654332 222 3345699999999999999999999999999999999999885543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=271.83 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=191.8
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHH--cCCCCCCeeEEeeEe----CcEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRIL--QGGTGIPNVRWFGVE----GDYNVLV 81 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L--~~~~~i~~~~~~~~~----~~~~~lV 81 (477)
..++.+.||+|.||.||+|+ -+++.||||++... ....+..|..|+... +| ++|..+.....- .-.++||
T Consensus 211 pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~-~kqs~~~Ek~Iy~lp~m~h-~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ-EKQSFQNEKNIYSLPGMKH-ENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhh--ccCceeEEEecCHH-HHHHHHhHHHHHhccCccc-hhHHHhhchhccCCccccceeEE
Confidence 45678899999999999998 56799999998764 456788898888763 45 444444333322 3367999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---------CCCeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs---------~giiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
++|. .|+|.++++ ...++|....+++..|++||+|||+ ..|+|||||..|||+ ..++++.|+|||
T Consensus 287 t~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccc
Confidence 9999 999999998 4579999999999999999999996 359999999999999 789999999999
Q ss_pred ceeecccCCCCcccccccCCCCccCccccccchhcCCC------CCCcchHHHHHHHHHHHHcC------------CCCC
Q 011819 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG------------SLPW 213 (477)
Q Consensus 152 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~------~s~ksDIwSlGviLyelltG------------~~Pf 213 (477)
||..+..... ....-.-+||.+|||||++.|.- .-.+.||||+|.+||||++. ++||
T Consensus 362 LAl~~~p~~~-----~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 362 LALRLEPGKP-----QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeEEecCCCC-----CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9998864322 22233468999999999998742 12478999999999999975 2344
Q ss_pred CCC--CcccHHHHHHHHhhhcccccHHHHh-c-CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 214 QGL--KAGTKKQKYEKISEKKVSTSIEALC-R-GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 214 ~~~--~~~~~~~~~~~i~~~~~~~~~~~l~-~-~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
+.. ...+..+...-+..++..+.+...+ + ....-+.+.++.||+.|++.|.|+.-+.+.+.++.
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 311 1122333333444444333333222 2 23466899999999999999999998888777763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=307.29 Aligned_cols=248 Identities=14% Similarity=0.161 Sum_probs=185.5
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
.|...+.||+|+||.||+|++..++..||||.+..... ....|++++..++| ++|+.+..++...+..|+||||+ +
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~H-pnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQH-PNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCC-CCcceEEEEEEcCCCCEEEEeCCCC
Confidence 45667789999999999999989999999998754322 23456888888877 55666666667777889999999 9
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLH---s~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
++|.+++. .+++..+..++.||+.||+||| +.+|+||||||+||++ +..+.+++. ||.+.....
T Consensus 768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccccccc-----
Confidence 99999996 3899999999999999999999 6699999999999999 566666664 665543211
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc--cHHHHHHHHhh-hcccccH-HH
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISE-KKVSTSI-EA 239 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~--~~~~~~~~i~~-~~~~~~~-~~ 239 (477)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...... ...+....... ....... +.
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 11236889999999999999999999999999999999999999543221 11111111000 0000000 00
Q ss_pred Hh------cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 240 LC------RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 240 l~------~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
+. .....++.+++.+||..+|++||++.++.+.|+++.
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 00 011335778999999999999999999999988775
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=247.59 Aligned_cols=236 Identities=25% Similarity=0.343 Sum_probs=187.4
Q ss_pred CceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCHHHHHH
Q 011819 19 SFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFN 94 (477)
Q Consensus 19 ~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~ 94 (477)
+||.||+|.+..+++.||+|+...... ...+..|++.++.++| +++..+..++......+++|||+ +++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKH-PNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCC-CcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999988899999999876544 4578899999999965 55666655566667889999999 559999997
Q ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCc
Q 011819 95 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174 (477)
Q Consensus 95 ~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~ 174 (477)
... .++...++.++.+++.+|.|||+.+++|+||+|.||++ +..+.++|+|||.+....... ......
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeecccc--------cccccc
Confidence 533 38999999999999999999999999999999999999 567899999999998765432 123456
Q ss_pred cCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHH
Q 011819 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 254 (477)
Q Consensus 175 Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~ 254 (477)
++..|++||.+.+..++.++||||||+++|+|++|..||..... ....+..+....... ......++.++.+++.+
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPF--PPPEWKISPEAKDLIRK 223 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCC--ccccccCCHHHHHHHHH
Confidence 88899999999988899999999999999999999999976322 122222222221111 11111278899999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 011819 255 CRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 255 cl~~~p~~RPt~~~l~~ 271 (477)
||..+|++||++.++.+
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999877754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=247.96 Aligned_cols=247 Identities=19% Similarity=0.314 Sum_probs=191.6
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeE--eCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~--~~~~~~lVmE 83 (477)
.++|++.+++|.|-|++||.|.+..+++.++||+++.. +...+.+|++|+..|.++++|..+..... ......|++|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 46899999999999999999999999999999998763 45678999999999998888777655432 4455679999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +.+...+.. .++..++..++.|++.||.|+|++||.|||+||.|++|+ -....++|+|+|||..+.....
T Consensus 116 ~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 116 YVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred hhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCce-
Confidence 99 777777665 588899999999999999999999999999999999995 4567899999999988766543
Q ss_pred cccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc---------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (477)
..-.+.+..|--||.+.. ..|+..-|+|||||+|..|+..+-||....+ ...++.+|....
T Consensus 189 -------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d--N~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 189 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred -------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC--CHHHHHHHHHHhChHHHHHHH
Confidence 223456667888998865 4578899999999999999999999964322 122222221111
Q ss_pred ------ccccHHHHh----------------cC-CcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 233 ------VSTSIEALC----------------RG-YPTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 233 ------~~~~~~~l~----------------~~-~p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
.....+.+. .. ..++..+|+.++|..|..+|+|+.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHH
Confidence 011111110 11 25889999999999999999997665
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=241.81 Aligned_cols=212 Identities=22% Similarity=0.282 Sum_probs=172.7
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
...+..||+|+||.|-+.++.++|...|+|-+.... .+..+++|+.+......++.+++++...-.....+|+||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 344678999999999999999999999999766543 23457788888877777777777655444556689999999
Q ss_pred CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 86 GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 86 g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
..+|..+... .++.+++..+-+++..++.||+|||++ .+||||+||.|||+ +..|+||+||||++-.+.+...
T Consensus 128 ~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhhH
Confidence 9999887642 366789999999999999999999975 89999999999999 7999999999999987766442
Q ss_pred CcccccccCCCCccCccccccchhcC----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g----~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
.+.-.|...|||||.+.. ..|+-++||||||++++||.+++.||... .+..+++..+.+...
T Consensus 205 --------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w--~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 205 --------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW--GTPFQQLKQVVEEPS 270 (282)
T ss_pred --------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc--CCHHHHHHHHhcCCC
Confidence 122478899999999864 36899999999999999999999999754 456677766666544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=270.97 Aligned_cols=254 Identities=19% Similarity=0.206 Sum_probs=173.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEEC----------------CCCcEEEEEEecCCCC----------------chhHHHH
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNI----------------QTNEEVAIKLENVKTK----------------HPQLLYE 52 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~----------------~~g~~vAiKi~~~~~~----------------~~~~~~E 52 (477)
-.++|++.++||+|+||.||+|... ..++.||||.+..... ......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4568999999999999999999752 2356799998754321 1123346
Q ss_pred HHHHHHHcCCCCCC----ee-EEee-------EeCcEEEEEEecC-CCCHHHHHHHcC----------------------
Q 011819 53 SKLYRILQGGTGIP----NV-RWFG-------VEGDYNVLVMDLL-GPSLEDLFNFCS---------------------- 97 (477)
Q Consensus 53 ~~il~~L~~~~~i~----~~-~~~~-------~~~~~~~lVmE~~-g~sL~~li~~~~---------------------- 97 (477)
+.++..+.|.+++. .+ .++. ...+..+|||||+ +++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 66777777755421 12 2221 1234579999999 899999986421
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccC
Q 011819 98 -RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176 (477)
Q Consensus 98 -~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt 176 (477)
..+++..+..++.||+.+|.|||+++|+||||||+|||+ +.++.+||+|||++......... ......++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~------~~~~g~~t 373 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINF------NPLYGMLD 373 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCcc------CccccCCC
Confidence 124567788999999999999999999999999999999 67789999999999754332110 01122347
Q ss_pred ccccccchhcCCC--------------------CC--CcchHHHHHHHHHHHHcCCC-CCCCCCccc-HHH-------HH
Q 011819 177 ARYASMNTHLGIE--------------------QS--RRDDLESLGYVLMYFLRGSL-PWQGLKAGT-KKQ-------KY 225 (477)
Q Consensus 177 ~~Y~APE~~~g~~--------------------~s--~ksDIwSlGviLyelltG~~-Pf~~~~~~~-~~~-------~~ 225 (477)
+.|+|||.+.... |+ .+.||||+||+||+|++|.+ ||....... ... .+
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~ 453 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW 453 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence 8999999876432 11 24799999999999999986 775432111 011 11
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCC---CCCCCHHHHH
Q 011819 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF---DDKPDYAYLK 270 (477)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p---~~RPt~~~l~ 270 (477)
..+...... .......++..++++.+||..+| .+|+++++++
T Consensus 454 r~~~~~~~~---~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 454 RMYKGQKYD---FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred HhhcccCCC---cccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 111111111 11234567899999999999876 6799977664
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=276.69 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=204.0
Q ss_pred eEEEeeeeecCceEEEEEEECCCCc----EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~----~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.+..++||+|+||+||+|.+.-.|+ +||||++..... ...++.|+.+|..|.|++.+..+... .... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc-~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVC-MLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhc-ccch-HHHH
Confidence 3457789999999999999876654 789998765432 35688999999999996655554443 3222 6789
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
.+|+ .|+|.|+++....++.....+.|+.||++||.|||+++++||||-..|||+ .....+||.|||+|+.+....
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCccc
Confidence 9999 999999999888889999999999999999999999999999999999999 788999999999999876654
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
..-.. ....-.+.|||-|.+.-..|+.++|||||||++||++| |..||.+....+....+++-.+ -.
T Consensus 853 ~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-------Ls 920 (1177)
T KOG1025|consen 853 KEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-------LS 920 (1177)
T ss_pred ccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-------CC
Confidence 42211 11122467999999999999999999999999999998 9999999776544444432211 11
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
.++-++-+++-++.+||..|++.||+|.++...|.....
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 235578899999999999999999999999988877653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=279.08 Aligned_cols=244 Identities=20% Similarity=0.227 Sum_probs=185.7
Q ss_pred eeeeecCce-EEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecCCCCHHH
Q 011819 13 RKIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLED 91 (477)
Q Consensus 13 ~~IG~G~fG-~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~g~sL~~ 91 (477)
+.+|.|+.| .||+|. -.+++||||-+-. .......+|++.++.-..|++|..+.....+..+.||+.|+|..+|.+
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~d 591 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLLE-EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQD 591 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHhh-HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHH
Confidence 457888888 579998 5788999996533 233457899999998888888777666667888999999999999999
Q ss_pred HHHHcCCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC--CCCcEEEeecCceeecccCCCCcccc
Q 011819 92 LFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 92 li~~~~~~---ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~--~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
++...... ........++.|++.||++||+.+||||||||.||||+..+ ....++|+|||+++.+......
T Consensus 592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS---- 667 (903)
T KOG1027|consen 592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS---- 667 (903)
T ss_pred HHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch----
Confidence 99853111 11145577889999999999999999999999999997532 3357899999999987654432
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCc
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (477)
+.......||.+|+|||++........+|||||||++|+.++| .+||... .+.-..|........ .+.....
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~-----~~R~~NIl~~~~~L~--~L~~~~d 740 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS-----LERQANILTGNYTLV--HLEPLPD 740 (903)
T ss_pred hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch-----HHhhhhhhcCcccee--eeccCch
Confidence 3345678899999999999998888899999999999999995 9999543 222223333322111 0111111
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 246 TEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.+..+||..|++.+|..||++.++.
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHh
Confidence 2889999999999999999987763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=267.10 Aligned_cols=196 Identities=23% Similarity=0.364 Sum_probs=170.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHc--CCCCCCeeEEeeEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLLYESKLYRILQ--GGTGIPNVRWFGVE 74 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----------~~~~~~~E~~il~~L~--~~~~i~~~~~~~~~ 74 (477)
.+|..++.+|+|+||.|++|.++.+..+|+||.+.++. +-..+-.|++||..|+ .|++|..+..|+++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35999999999999999999999999999999876542 1123557999999998 24666677777888
Q ss_pred CcEEEEEEecC--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCc
Q 011819 75 GDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (477)
Q Consensus 75 ~~~~~lVmE~~--g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGl 152 (477)
++++||+||-. |-+|.++|.. ...+++.++..|+.||+.|+++||+.||||||||-+|+++ +.+|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccc
Confidence 99999999998 6788888875 5669999999999999999999999999999999999999 7999999999999
Q ss_pred eeecccCCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCC
Q 011819 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQG 215 (477)
Q Consensus 153 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~ 215 (477)
|....... ...++||..|+|||++.|..| +..-|||+||++||.++....||.+
T Consensus 717 aa~~ksgp---------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKSGP---------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcCCC---------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 87655433 357899999999999999888 5778999999999999999999964
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=242.29 Aligned_cols=261 Identities=20% Similarity=0.318 Sum_probs=198.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCe-eEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPN-VRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~-~~~~~~~~~~~~lVm 82 (477)
+.+.|.|.+.||+|.||.+-+|+|+.++..+++|.+.... ....|.+|...--.|.+|.+|.. +...++..++++++|
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4578999999999999999999999999999999766543 45568888776666776655544 445566777999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ -++|..-+. ...+.+.....++.|++.||+|||++++||||||.+||||-..| ...|||||||+.+.....-
T Consensus 102 E~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~g~tV- 177 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRKVGTTV- 177 (378)
T ss_pred ccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeecccccccCcee-
Confidence 999 888887775 24478888899999999999999999999999999999996543 4599999999987543211
Q ss_pred CcccccccCCCCccCccccccchhcCCC-----CCCcchHHHHHHHHHHHHcCCCCCCCCCc-ccHHHHHHHHhhhcccc
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKYEKISEKKVST 235 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-----~s~ksDIwSlGviLyelltG~~Pf~~~~~-~~~~~~~~~i~~~~~~~ 235 (477)
..+.-+..|.+||...... ..+..|+|.||+++|.+|+|.+||+.... +.....+.+....+..
T Consensus 178 ---------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~- 247 (378)
T KOG1345|consen 178 ---------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP- 247 (378)
T ss_pred ---------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-
Confidence 1223456789999875432 36789999999999999999999984322 2234444444444443
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
..+....-+++.+..++.+-|..+|++|=-..+.++...+.+..
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 33445566788999999999999999995555566655555443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=225.81 Aligned_cols=207 Identities=29% Similarity=0.439 Sum_probs=178.5
Q ss_pred eeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCHH
Q 011819 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (477)
Q Consensus 15 IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~ 90 (477)
||+|.+|.||++.+..+++.++||+....... ..+..|+++++.+.+ +++..+..+.......+++||++ +++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 68999999999999888999999998776553 678899999999988 66777776666678899999999 69999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC-CCcEEEeecCceeecccCCCCccccccc
Q 011819 91 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKKYRDTSTHQHIPYRE 169 (477)
Q Consensus 91 ~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~p~~~ 169 (477)
+++......++...+..++.+++.+|.+||+.|++|+||+|.||++ +. .+.++|+|||.+........ .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcc-------h
Confidence 9998643568999999999999999999999999999999999999 45 68999999999987655321 1
Q ss_pred CCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHH
Q 011819 170 NKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (477)
Q Consensus 170 ~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (477)
.....+...|++||.+... .++.+.|+|+||+++|+| ..+
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~ 190 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL 190 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence 1234678899999999887 788999999999999998 578
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHH
Q 011819 249 ASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.+++..|+..+|++||++.++.+
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhh
Confidence 99999999999999999887764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=252.55 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=200.7
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECC---CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~---~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
|.+.+.|.++++||+|+|+.||++.+.. ..+.||+|-+.....-..+..|..++..+.+..++..+..+...++..+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 4567889999999999999999999877 7889999988877777789999999999999999999988888899999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ .....++.. .++..++..|+..++.||.++|.+|||||||||.|||.+ ...+.-.|+|||||.....
T Consensus 112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHh
Confidence 999999 667777765 478999999999999999999999999999999999997 4567778999999972211
Q ss_pred CC-------------C---Ccc---------------------cccccCCCCccCccccccchhcCCC-CCCcchHHHHH
Q 011819 159 TS-------------T---HQH---------------------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLG 200 (477)
Q Consensus 159 ~~-------------~---~~~---------------------~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlG 200 (477)
.. . ... ..........||++|.|||++...+ ++.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 000 0011233467999999999988754 68999999999
Q ss_pred HHHHHHHcCCCCCCCCCccc--HHHHH--------HH---Hhhh-----------------ccccc-HH-----------
Q 011819 201 YVLMYFLRGSLPWQGLKAGT--KKQKY--------EK---ISEK-----------------KVSTS-IE----------- 238 (477)
Q Consensus 201 viLyelltG~~Pf~~~~~~~--~~~~~--------~~---i~~~-----------------~~~~~-~~----------- 238 (477)
||+.-++++..||....++. ..+.. .+ .... .+... ++
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999997543321 00000 00 0000 00000 11
Q ss_pred --HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 239 --ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 239 --~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.....+|..+.+++.+|++++|.+|.++++.+
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 11123466899999999999999999987654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-31 Score=245.77 Aligned_cols=205 Identities=20% Similarity=0.316 Sum_probs=164.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEe----C
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVE----G 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~----~ 75 (477)
....+.+-.+.||-|.||.||.+++..+|+.||+|.+... .....+.+|.+++..++|.+.+..++..... -
T Consensus 50 qqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 50 QQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred cccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 3444556678899999999999999999999999965322 1234577899999999998877666544321 1
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...|++.|++..+|..+|-. .+.++...+.-++.||++||.|||+.+|+||||||.|.|+ +.+..+||||||+|+.
T Consensus 130 qEiYV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 130 QELYVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccc
Confidence 22478889999999888863 5679999999999999999999999999999999999999 6889999999999986
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~ 218 (477)
....... ..+..+-|..|.|||++.|. .|+...||||.|||+.|+|..+.-|+....
T Consensus 206 ee~d~~~------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 206 WDQRDRL------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred cchhhhh------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 5543221 11223457899999999885 589999999999999999999999976443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=241.63 Aligned_cols=247 Identities=21% Similarity=0.257 Sum_probs=193.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeE-----eC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGV-----EG 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~-----~~ 75 (477)
+..+|.-++.+|.|.- .|..+-+...++.||+|..... ...+...+|..++..++|.+.|..+..|.. +-
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4457888889999998 8899999899999999965432 344567899999999999888888777643 23
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...|+|||+|..+|.+++. -.++-+++..++.|+++|+.|||+.||+||||||+||++ ...+.+||+|||+|+.
T Consensus 94 ~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 94 QEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLART 167 (369)
T ss_pred HhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhcc
Confidence 3469999999999999987 358888999999999999999999999999999999999 7889999999999986
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc-
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS- 234 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~- 234 (477)
..... ..+..+.|..|.|||++.+..|.+.+||||+||++.||++|..-|.+. +....+.++.+..-.
T Consensus 168 e~~~~--------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~---d~idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 168 EDTDF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK---DHIDQWNKIIEQLGTP 236 (369)
T ss_pred cCccc--------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc---hHHHHHHHHHHHhcCC
Confidence 54331 234567889999999999999999999999999999999999999763 223333333222100
Q ss_pred ------------------------ccHHHHhcC--C----------cHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 235 ------------------------TSIEALCRG--Y----------PTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 235 ------------------------~~~~~l~~~--~----------p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
.....+.+. + ..-+.+++.+||..+|++|.+.+++
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da 307 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA 307 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence 001111110 0 2337889999999999999996555
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=240.26 Aligned_cols=258 Identities=19% Similarity=0.268 Sum_probs=198.4
Q ss_pred CceEEEeeeeecCceEEEEEEECCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~-----g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.++++...+-+|.||+||.|.++.. .+.|-+|.++....+ ..++.|.-.+..+.|++.++.......+....
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 4677788899999999999975433 345556654332222 23556766777777766666655555677778
Q ss_pred EEEEecC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 79 VLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~-------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
++++.++ -++|..++..|. +.++..+...++.|++.|++|||++|+||.||-..|.+| ++.-+|||+|=
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltDs 440 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTDS 440 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEeccc
Confidence 8899999 689999998553 336777888999999999999999999999999999999 78899999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHh
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (477)
.+++.+.....+.- ..+.-....||+||.+....|+..+|+|||||+||||++ |+.||...++ .+.+.-+.
T Consensus 441 aLSRDLFP~DYhcL-----GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---fEm~~ylk 512 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCL-----GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---FEMEHYLK 512 (563)
T ss_pred hhccccCccccccc-----CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---HHHHHHHh
Confidence 99987655443211 011223568999999999999999999999999999998 9999977544 34433333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+.... ..+-+||.++..++..||.+.|++||+++++...|.++...
T Consensus 513 dGyRl----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 513 DGYRL----AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred cccee----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 33222 23457999999999999999999999999999999988654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=261.76 Aligned_cols=251 Identities=18% Similarity=0.264 Sum_probs=200.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
-.++|+++..+|+|+||.||+++++.+++..|+|+++.+. ....+..|+-+++.++|++++..+.-|- ..+..+|+|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl-r~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL-RRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh-hhcCcEEEE
Confidence 3578999999999999999999999999999999877643 3445778888899999977776665543 344569999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||| |++|.++.+- .+++++.++.++++..+.+|+|||++|-+|||||-.|||+ .+.+.+||.|||.+..+....
T Consensus 92 EycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---td~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---TDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred EecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceee---cccCceeecccCchhhhhhhh-
Confidence 999 8999998873 6679999999999999999999999999999999999999 688999999999987665432
Q ss_pred CcccccccCCCCccCccccccchhc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~---g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
...+.+.||+.|||||+.. ...|...+|||++|+...|+..=+.|-...... +.+.-.....+..+.-
T Consensus 167 ------~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmTkS~~qpp~l 237 (829)
T KOG0576|consen 167 ------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMTKSGFQPPTL 237 (829)
T ss_pred ------hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhhccCCCCCcc
Confidence 2346789999999999863 456899999999999999999888887665542 2221112222222222
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+-...+.+-|.+|+..||.++|.+||+++.++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 23345678899999999999999999987553
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=219.03 Aligned_cols=197 Identities=29% Similarity=0.440 Sum_probs=164.7
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
|.+.+.||.|++|.||++.+..+++.+|||...... ....+..|++.+..+.+. ++..+..+.......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~-~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHP-NIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCC-ChhhheeeeecCCceEEEEecc
Confidence 678999999999999999998889999999987654 245678899999999774 5555555566667889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++......+++..+..++.|++.+|.+||+++++|+||+|.||++ +..+.++|+|||++.........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~-- 154 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAA-- 154 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccc--
Confidence 669999998533228999999999999999999999999999999999999 56689999999999877554210
Q ss_pred cccccCCCCccCccccccchh-cCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 011819 165 IPYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~-~g~~~s~ksDIwSlGviLyelltG~~Pf~~ 215 (477)
......++..|++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12345678899999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-27 Score=212.93 Aligned_cols=166 Identities=17% Similarity=0.184 Sum_probs=127.3
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 87 ~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
|+|.+++...+..+++.+++.++.||+.||.|||+++ ||+|||+ +.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc------
Confidence 6899999865667999999999999999999999998 9999999 67888998 99998664321
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH--HHhcCC
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE--ALCRGY 244 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--~l~~~~ 244 (477)
..||+.|||||++.+..++.++|||||||++|||++|..||...... ...+..+.......... .....+
T Consensus 64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHH
Confidence 26889999999999999999999999999999999999999654321 12222222111111000 001122
Q ss_pred cH--HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 245 PT--EFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 245 p~--~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
+. ++.+++..||..+|++||++.++.+.+....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 33 6999999999999999999888877665543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=266.25 Aligned_cols=186 Identities=14% Similarity=0.167 Sum_probs=133.1
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec----------------C
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----------------G 139 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~----------------~ 139 (477)
..++++||+++.+|.+++......+++.+++.++.||+.||.|||++||+||||||+||||+. .
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~ 132 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGS 132 (793)
T ss_pred chhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccc
Confidence 456788999999999999755566999999999999999999999999999999999999942 1
Q ss_pred CCCCcEEEeecCceeecccCCC--------Cccccc-ccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCC
Q 011819 140 RRANQVYIIDFGLAKKYRDTST--------HQHIPY-RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 210 (477)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~--------~~~~p~-~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~ 210 (477)
+..+.+||+|||+++....... ....++ ......+||+.|||||++.+..|+.++|||||||+||||++|.
T Consensus 133 ~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~ 212 (793)
T PLN00181 133 DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPV 212 (793)
T ss_pred cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCC
Confidence 2344566777777654321100 000000 0011246899999999999999999999999999999999998
Q ss_pred CCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.||.... ..+..+.....+. ..... .++...++.+||..+|.+||++.++.
T Consensus 213 ~~~~~~~-----~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 213 SSREEKS-----RTMSSLRHRVLPP---QILLN-WPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred CchhhHH-----HHHHHHHHhhcCh---hhhhc-CHHHHHHHHHhCCCChhhCcChHHHh
Confidence 8875311 1122221111111 11111 34567889999999999999988874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=224.40 Aligned_cols=180 Identities=18% Similarity=0.192 Sum_probs=137.0
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECC-CCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKT-------KHPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~-~g~~vAiKi~~~~~-------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
+.+.++|++.+.||+|+||+||+|.+.. +++.||||++.... ....+.+|++++..|.|+++++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4567889999999999999999999876 67888999764321 123478999999999998887766543
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCC-CCCceEeecCCCCCcEEEeecCc
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGL 152 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDL-KP~NILl~~~~~~~~vkL~DFGl 152 (477)
+..||||||+ |++|.. +. ... ...++.|++.+|.|||++||+|||| ||+|||+ +.++.+||+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECcc
Confidence 3469999999 888862 21 111 1467889999999999999999999 9999999 5678899999999
Q ss_pred eeecccCCCCccc-ccccCCCCccCccccccchhcCCC------CCCcchHH
Q 011819 153 AKKYRDTSTHQHI-PYRENKNLTGTARYASMNTHLGIE------QSRRDDLE 197 (477)
Q Consensus 153 a~~~~~~~~~~~~-p~~~~~~~~Gt~~Y~APE~~~g~~------~s~ksDIw 197 (477)
|+.+........+ .+.......+++.|+|||++...+ .+...|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9988765433222 122235678899999999986543 23445665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-23 Score=203.98 Aligned_cols=255 Identities=30% Similarity=0.415 Sum_probs=191.4
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
|.+.+.||.|+||.||++.+. ..+++|.+..... ...+..|..++..+.+++++..+..++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999986 7889998765443 33578899999999988656666555566666799999
Q ss_pred cC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC-cEEEeecCceeecccC
Q 011819 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDT 159 (477)
Q Consensus 84 ~~-g~sL~~li~~~~--~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~-~vkL~DFGla~~~~~~ 159 (477)
++ ++++.+++.... ..+.......++.|++.+|.|+|+.+++||||||+||++ +..+ .++++|||+++.+...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCC
Confidence 99 889997776433 268999999999999999999999999999999999999 5556 7999999999865543
Q ss_pred CCCcccccccCCCCccCccccccchhcC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-cHHHHHHHHhhhcccc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVST 235 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g---~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~ 235 (477)
....... .......|+..|++||.+.+ ..+....|+||+|++++++++|..||...... ...+....+.......
T Consensus 156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 3211000 12356789999999999998 57889999999999999999999998664431 1122222222222110
Q ss_pred cHHHHhcCC----cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 236 SIEALCRGY----PTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 236 ~~~~l~~~~----p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
......... ...+.+++..|+..+|..|.+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 111111111 25789999999999999999865443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=227.05 Aligned_cols=259 Identities=21% Similarity=0.263 Sum_probs=186.3
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEecCC---CC-ch----hHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TK-HP----QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 10 ~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~---~~-~~----~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.....+|.|.+|.|+.+......+.++.|....+ .. .. .+..|.-+-..|.|.+.+..+..+.....+.. +
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~-~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ-S 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh-h
Confidence 4567899999998888887766666666644321 11 11 12334444445666555555544443333333 3
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 82 mE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||||..+|..++.. ..+++..++.-++.|++.||.|||+.||.||||||+|+++ ...+.+||+|||.+..+.-...
T Consensus 400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~---~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV---TENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE---ecCCceEEeecCcceeeccCcc
Confidence 99994499999874 3479999999999999999999999999999999999999 5788999999999987765443
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCC-cchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH-HHhhhcccccHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE-KISEKKVSTSIEA 239 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~-ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~-~i~~~~~~~~~~~ 239 (477)
.. ......++|+..|+|||++.+.+|++ ..||||.|++++.|.+|+.||......+...... .............
T Consensus 476 ~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 476 KN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 21 12345689999999999999999985 4799999999999999999997644332211111 1112222334445
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+...+|.+.+.+|-.+|+.+|.+|.++++| |++-|.+
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i---~~d~W~~ 589 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQI---LNDEWIR 589 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHH---hhChHhh
Confidence 667789999999999999999999996555 4544433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-23 Score=222.17 Aligned_cols=243 Identities=22% Similarity=0.329 Sum_probs=168.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
-.+|+.++.|..|+||.||+++|+.+.+.+|+|+-+... |++. ++.. .+..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l----------ilRn-----ilt~-------a~npfvv---- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL----------ILRN-----ILTF-------AGNPFVV---- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch----------hhhc-----cccc-------cCCccee----
Confidence 468999999999999999999999999999997532211 1111 0000 1111222
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC---
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--- 162 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~--- 162 (477)
++-..+++. -++++. +++.+++|||+.||+|||+||+|.|| ..-|++|+.|||+.++.-.....
T Consensus 136 -gDc~tllk~-~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLKN-IGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhccc-CCCCcc--------hhhHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchhh
Confidence 333344442 223443 23779999999999999999999999 68899999999998753221110
Q ss_pred -----cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 163 -----QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 163 -----~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
........+.++||+.|.|||++.-..|+..+|+|++|+|+|+++.|..||.+... .+.+..+....+..+.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDDIEWPE 279 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhhhccccc
Confidence 00111234668999999999999999999999999999999999999999987543 4444444433332222
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccc
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~ 299 (477)
+ -..+|+|+++++.++|..+|..|---.. .+....+.++..+||+.+..|+.+
T Consensus 280 ~--dea~p~Ea~dli~~LL~qnp~~Rlgt~g-------a~evk~h~ff~~LDw~~llRqkae 332 (1205)
T KOG0606|consen 280 E--DEALPPEAQDLIEQLLRQNPLCRLGTGG-------ALEVKQHGFFQLLDWKSLLRQKAE 332 (1205)
T ss_pred c--CcCCCHHHHHHHHHHHHhChHhhcccch-------hhhhhhccceeecccchhhhhhcc
Confidence 2 2347899999999999999999963221 122234567778899966555444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.3e-22 Score=217.24 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=186.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC---CCeeEEeeEeCcEEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG---IPNVRWFGVEGDYNVL 80 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~---i~~~~~~~~~~~~~~l 80 (477)
+-+..|.|.+.||+|+||.||+|.+.. |+.||||+......++- ..=.+++.+|+ ... +-.+.......+-.+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf-YI~~q~~~RLk-~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF-YICLQVMERLK-PQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee-eehHHHHHhhc-hhhhcchHHHHHHHccCCccee
Confidence 346789999999999999999999866 99999999877665543 22234455555 222 2222222334556689
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec----CCCCCcEEEeecCceee
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----GRRANQVYIIDFGLAKK 155 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~----~~~~~~vkL~DFGla~~ 155 (477)
|+||. .|+|.++++ ..+.+++..++.++.||+.-|+.||.++|||+||||+|+||.+ +.....++|+|||.+..
T Consensus 772 v~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 99999 999999998 5677999999999999999999999999999999999999964 22345789999999875
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
+.-.... ......++|-.+-++|+..|++++..+|.|.|..+++-||.|+.-= ...+... ....
T Consensus 851 m~lfp~~-----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~~~---------~~~~ 914 (974)
T KOG1166|consen 851 MKLFPDG-----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGSSW---------MVKT 914 (974)
T ss_pred eeEcCCC-----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCcce---------eccc
Confidence 5443332 1345678899999999999999999999999999999999985321 0111000 0001
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.+..+++ -.-+.+|+..+|..+-+.=|...+|...|+..+...
T Consensus 915 ~~~Ry~~--~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 915 NFPRYWK--RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred cchhhhh--HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 0111110 123567888889866666678888888888887544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-23 Score=215.52 Aligned_cols=256 Identities=19% Similarity=0.262 Sum_probs=197.6
Q ss_pred eeeecCceEEEEEEEC---CCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 14 KIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
.+|.|.||.|+++... ..+.-+|+|+..+.... .....|..++..++.++.+..+.+.+......++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3699999999997632 34667888876654311 134567888888887788888888777788889999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
|+.|...+.. ...+.......+...++.+++++|+.+|+|||+|++||++ +..|.+++.|||+++..-+...
T Consensus 81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh----
Confidence 7777766653 4568888899999999999999999999999999999999 8999999999999987654332
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCc
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (477)
-|||..|||||++. .....+|+||||++.|||++|..||.. +....|...+... +..+.
T Consensus 153 -------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~-----p~~l~ 211 (612)
T KOG0603|consen 153 -------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEM-----PRELS 211 (612)
T ss_pred -------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCC-----chhhh
Confidence 28999999999998 457789999999999999999999976 3334444433322 23356
Q ss_pred HHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCCC
Q 011819 246 TEFASYFHYCRSLRFDDKPDY--AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPA 305 (477)
Q Consensus 246 ~~l~~li~~cl~~~p~~RPt~--~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~ 305 (477)
.++.+++..++..+|..|... ..+.++ ..+.+....||+.+...+.+++..|.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~ei-------k~h~f~~~i~~~~l~~r~~~~~fkp~ 266 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAGPDGVDEI-------KQHEFFQSIDWNELEARSRPPPFKPG 266 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccCcchhHHH-------hccchheeeeHhhHhhcCCCCCCCCc
Confidence 678899999999999999754 223232 33456677899988887777666553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=189.99 Aligned_cols=231 Identities=23% Similarity=0.263 Sum_probs=146.4
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcC----------CCCCCeeEEe-
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQG----------GTGIPNVRWF- 71 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~----------~~~i~~~~~~- 71 (477)
.+..++.||.|+|+.||.+++..+++++|||+....... +++..|.-....+.+ ...+..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456788999999999999999999999999986544321 123333222211111 0111111111
Q ss_pred -------eEeC---c-----EEEEEEecCCCCHHHHHHHc---CCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCC
Q 011819 72 -------GVEG---D-----YNVLVMDLLGPSLEDLFNFC---SRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130 (477)
Q Consensus 72 -------~~~~---~-----~~~lVmE~~g~sL~~li~~~---~~~---ls~~~~~~i~~qIa~aL~yLHs~giiHRDLK 130 (477)
.... . ..+++|+-+.++|.+++... ... +.....+.+..|++..+++||..|++|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1111 1 12678888899999886521 222 2233345566899999999999999999999
Q ss_pred CCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcC--------CCCCCcchHHHHHHH
Q 011819 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYV 202 (477)
Q Consensus 131 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g--------~~~s~ksDIwSlGvi 202 (477)
|+||++ +.+|.++|.||+.......... . ...+..|.+||.... ..++.+.|.|+||++
T Consensus 173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~---------~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 173 PENFLL---DQDGGVFLGDFSSLVRAGTRYR---------C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp GGGEEE----TTS-EEE--GGGEEETTEEEE---------G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eeeEEE---cCCCCEEEcChHHHeecCceee---------c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999 7899999999998876544221 0 233467899997643 246889999999999
Q ss_pred HHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCC
Q 011819 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 263 (477)
Q Consensus 203 LyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~R 263 (477)
||.|++|..||......... ...-..|.++|+.++.+|..+|..+|++|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~------------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADP------------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTS------------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccc------------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999999999764332111 00223566899999999999999999987
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=187.82 Aligned_cols=171 Identities=13% Similarity=0.205 Sum_probs=127.9
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchh-----------HHHHHHHHHHHcCCCCCCeeEE
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----------LLYESKLYRILQGGTGIPNVRW 70 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~-----------~~~E~~il~~L~~~~~i~~~~~ 70 (477)
+..+.++|++.+.||.|+||.||++.. ++..+|||++..+..... +.+|+..+..|.| ++++.+..
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~-~GI~~~~d 102 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS-EGLASLND 102 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH-CCCCcceE
Confidence 446789999999999999999999764 467899999865432221 4678888999976 56666655
Q ss_pred eeEeC--------cEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 71 FGVEG--------DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 71 ~~~~~--------~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
++... ...+|+|||+ |.+|.++.. ++. ....+|+.+|..||..|++||||||.||++ +.
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili---~~ 170 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIV---SK 170 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEE---eC
Confidence 53322 3478999999 788988743 333 245699999999999999999999999999 45
Q ss_pred CCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHH
Q 011819 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyell 207 (477)
++ ++|+|||.......... .-.+++...|+.++|+|+|||++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 56 99999998865532111 011444456777899999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=182.63 Aligned_cols=136 Identities=23% Similarity=0.238 Sum_probs=102.9
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----------chh-----------------HHHHHHHHHHHcCCC
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQ-----------------LLYESKLYRILQGGT 63 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----------~~~-----------------~~~E~~il~~L~~~~ 63 (477)
.+.||+|+||.||+|.+. +|+.||||++..... ... ...|.+++..|.+.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~- 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA- 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC-
Confidence 568999999999999986 899999998764311 011 13488899999763
Q ss_pred CCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeCCCCCCceEeecCCC
Q 011819 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 64 ~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yL-Hs~giiHRDLKP~NILl~~~~~ 141 (477)
+++....+... ..+|||||+ |+++...... ...++...++.++.||+.+|.|+ |+.||+||||||+|||++
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 33222222222 238999999 5555444322 45799999999999999999999 799999999999999993
Q ss_pred CCcEEEeecCceeec
Q 011819 142 ANQVYIIDFGLAKKY 156 (477)
Q Consensus 142 ~~~vkL~DFGla~~~ 156 (477)
.+.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=180.03 Aligned_cols=192 Identities=16% Similarity=0.107 Sum_probs=139.8
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch------hHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP------QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~------~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+.+...|++|+||+||++. ..+..++.+-+....... .+.+|+++++.|.++++++.+..+ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 3467899999999999887 477788877554433321 367899999999988888888664 3358999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCC-CCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDL-KP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||+ |.+|.+.... ....++.|++.+|+++|++||+|||| ||.|||+ +.++.++|+|||+|.......
T Consensus 78 eyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcc
Confidence 999 8888654321 12357889999999999999999999 7999999 567889999999998655433
Q ss_pred CCccc-cccc-----CCCCccCccccccchhcCC-CCC-CcchHHHHHHHHHHHHcCCCCCCCCC
Q 011819 161 THQHI-PYRE-----NKNLTGTARYASMNTHLGI-EQS-RRDDLESLGYVLMYFLRGSLPWQGLK 217 (477)
Q Consensus 161 ~~~~~-p~~~-----~~~~~Gt~~Y~APE~~~g~-~~s-~ksDIwSlGviLyelltG~~Pf~~~~ 217 (477)
....+ -++. ......++.|++|+...-. ..+ .+.++++.|+.+|.|+|+.+|+.+..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 11000 0000 0012257788888865433 233 56688899999999999999986643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=175.49 Aligned_cols=138 Identities=20% Similarity=0.249 Sum_probs=105.1
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----------------------------hhHHHHHHHHHHHcCC
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------------------PQLLYESKLYRILQGG 62 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----------------------------~~~~~E~~il~~L~~~ 62 (477)
+.+.||+|+||.||+|.+. +|+.||||++...... ..+..|...+..+.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 8999999997754210 0124678888888874
Q ss_pred CCCCeeEEeeEeCcEEEEEEecC-CCCHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecC
Q 011819 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG 139 (477)
Q Consensus 63 ~~i~~~~~~~~~~~~~~lVmE~~-g~sL~-~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~ 139 (477)
. +.....+... ..||||||+ |+++. ..+. ...++...+..++.|++.+|.++|. +||+||||||+|||+
T Consensus 80 ~-i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll--- 151 (190)
T cd05145 80 G-VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY--- 151 (190)
T ss_pred C-CCCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---
Confidence 3 3333222222 248999999 44333 3343 3468888999999999999999999 999999999999999
Q ss_pred CCCCcEEEeecCceeeccc
Q 011819 140 RRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~ 158 (477)
+ ++.++|+|||+|.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 3 68899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=181.28 Aligned_cols=192 Identities=18% Similarity=0.228 Sum_probs=143.5
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC-CCCcEEEeecCcee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAK 154 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~-~~~~vkL~DFGla~ 154 (477)
...|+||.-...+|.+++. .+..+......++.|+++|+.|||++||.|||||.+|||+-.++ ....+.|+|||.|-
T Consensus 316 ~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 3458999999999999997 55678888899999999999999999999999999999997643 33467899999986
Q ss_pred ecccCCCCcccccccC-CCCccCccccccchhcCCCC------CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 011819 155 KYRDTSTHQHIPYREN-KNLTGTARYASMNTHLGIEQ------SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~-~~~~Gt~~Y~APE~~~g~~~------s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~ 227 (477)
.-.... ...||... -..-|+...||||+....+= -.++|.|+.|.+.||++....||...-... -....
T Consensus 394 Ad~~hG--lqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~~r~ 469 (598)
T KOG4158|consen 394 ADDNHG--LQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LDTRT 469 (598)
T ss_pred eccccc--cccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe--echhh
Confidence 544322 22333322 23467889999999876431 258899999999999999999997621110 00111
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+ ..++.++..+|+.+.+++..+|..||.+|++..-....|.-.+
T Consensus 470 Yqe----~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsL 515 (598)
T KOG4158|consen 470 YQE----SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSL 515 (598)
T ss_pred hhh----hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHH
Confidence 122 2334566789999999999999999999998766555554333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-20 Score=200.01 Aligned_cols=249 Identities=16% Similarity=0.098 Sum_probs=170.8
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc------hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~------~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
+|...+.||++.|=+|.+|++ ..|. |+||++-..... .+.+.|++ ...+++ +++..+....+.....|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~-pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKA-PNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcC-CcccchHHHHHhhHHHHHH
Confidence 688899999999999999996 3444 899987654422 23344444 333444 4444444445566777899
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 82 mE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
=+|.-.+|.|.+. ...-+...+...|+.||+.||..+|+.||+|+|||.+|||| ..=+=++|+||..-+...-+..
T Consensus 100 RqyvkhnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI---TSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE---eeechhhhhcccccCCccCCCC
Confidence 9999999999987 23336788889999999999999999999999999999999 4556679999987664322221
Q ss_pred CcccccccCCCCccCccccccchhcCC----------C-CCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGI----------E-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~----------~-~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (477)
....--....+-..-..|.|||.+... . .+++.||||+||++.||++ |++||.- -| +....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQ-L~aYr 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQ-LLAYR 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HH-HHhHh
Confidence 110000011111223469999988642 1 4678999999999999987 8899842 11 11111
Q ss_pred hhcccccHHHHhcCC-cHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011819 230 EKKVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLKRI 272 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~-p~~l~~li~~cl~~~p~~RPt~~~l~~~ 272 (477)
... ....+.+...+ ...++.+|..|++.||..|.++++.++.
T Consensus 249 ~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 249 SGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111 12223233323 3478999999999999999998776553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-19 Score=170.27 Aligned_cols=142 Identities=20% Similarity=0.225 Sum_probs=108.6
Q ss_pred ceEEEeeeeecCceEEEEEE-ECCCCcEEEEEEecCCCC--------------------------chhHHHHHHHHHHHc
Q 011819 8 KFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTK--------------------------HPQLLYESKLYRILQ 60 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~-~~~~g~~vAiKi~~~~~~--------------------------~~~~~~E~~il~~L~ 60 (477)
-|++.+.||+|+||.||+|. +..+|+.||||++..... ...+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999999 778999999998764321 012457999999997
Q ss_pred CCCCCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeCCCCCCceEeec
Q 011819 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGL 138 (477)
Q Consensus 61 ~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g-iiHRDLKP~NILl~~ 138 (477)
+ .++.....+... ..+|||||+ |.+|..+... ...+....+..++.||+.+|.+||++| |+||||||+|||+
T Consensus 109 ~-~~i~~p~~~~~~--~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli-- 182 (237)
T smart00090 109 E-AGVPVPKPIAWR--RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV-- 182 (237)
T ss_pred h-cCCCCCeeeEec--CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE--
Confidence 6 233332222222 248999999 5566555421 344666677899999999999999999 9999999999999
Q ss_pred CCCCCcEEEeecCceeecc
Q 011819 139 GRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 139 ~~~~~~vkL~DFGla~~~~ 157 (477)
+ .+.++|+|||+|....
T Consensus 183 -~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 -H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred -E-CCCEEEEEChhhhccC
Confidence 4 6789999999986443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-19 Score=169.59 Aligned_cols=243 Identities=14% Similarity=0.172 Sum_probs=179.4
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+..++-+|.+...|+.|+|++ .|..++.|++++... ...|..|.-.++.+.|+++++.+..+... ...+++..
T Consensus 191 ~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-pnlv~isq 267 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-PNLVIISQ 267 (448)
T ss_pred hhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-CCceEeee
Confidence 345667889999999999995 455677888776543 34577788888999998777777666544 45678888
Q ss_pred cC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCC-C-eeCCCCCCceEeecCCCCCcEEE--eecCceeecc
Q 011819 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS-F-LHRDIKPDNFLMGLGRRANQVYI--IDFGLAKKYR 157 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~-~ls~~~~~~i~~qIa~aL~yLHs~g-i-iHRDLKP~NILl~~~~~~~~vkL--~DFGla~~~~ 157 (477)
|| -++|..+++.... ..+..++.+++..|++|+.|||+.. + .---|....+++ |++.+.+| +|--++-..
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfqe- 343 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQE- 343 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeeec-
Confidence 88 8999999984322 2667789999999999999999864 3 344578888999 56665554 333222111
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCC---CcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s---~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
....=.+.||+||.+...+-+ +.+|+|||.++|||+.|...||.......-. .++. ..
T Consensus 344 -------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---mkia---le 404 (448)
T KOG0195|consen 344 -------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---MKIA---LE 404 (448)
T ss_pred -------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---hhhh---hc
Confidence 111236789999999877654 5789999999999999999999887653222 1211 12
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
.....+++++++.+..++..|...||.+||.|+.+.-+|++.
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 233345678888999999999999999999999998888765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.8e-18 Score=159.65 Aligned_cols=131 Identities=27% Similarity=0.419 Sum_probs=103.9
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+.||+|++|.||+|.+ .+..|+||+...... ...+..|+.++..+.+. +++....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKA-GVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHC-CCCCCeEEEEeCCCCEEEE
Confidence 6799999999999986 777899997554321 12356788899888864 3444444444556678999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
||+ |.+|.+++.... . ....++.+|+.+|.+||+.|++|+|++|.|||+ + .+.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~---~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL---S-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE---E-CCCEEEEECCcccC
Confidence 999 889999987421 2 788899999999999999999999999999999 3 67899999999864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.4e-18 Score=158.60 Aligned_cols=135 Identities=16% Similarity=0.215 Sum_probs=100.6
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcC----CCCCCeeEEeeEeC---cE-EEEE
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQG----GTGIPNVRWFGVEG---DY-NVLV 81 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~----~~~i~~~~~~~~~~---~~-~~lV 81 (477)
.+.||+|+||.||. +..++.. +||++.... ....+.+|+.+++.|.| +++|+.+..+..++ ++ ..+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 56899999999995 7777766 699876532 34568899999999953 45566655544433 34 3478
Q ss_pred EecCC---CCHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeeCCCCCCceEeecCC-CCCcEEEeecCce
Q 011819 82 MDLLG---PSLEDLFNFCSRKLSLKTVLMLADQMINRV-EFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 153 (477)
Q Consensus 82 mE~~g---~sL~~li~~~~~~ls~~~~~~i~~qIa~aL-~yLHs~giiHRDLKP~NILl~~~~-~~~~vkL~DFGla 153 (477)
|||+| ++|.+++.. ..+++. ..++.|++.++ +|||+++|+||||||+|||++..+ ....++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99964 899999974 346655 35678888888 999999999999999999996432 3458999995544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-19 Score=179.43 Aligned_cols=174 Identities=25% Similarity=0.347 Sum_probs=131.9
Q ss_pred CcEEEEEEecC-CCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
..+.||.|++| -.+|.+++.+ .....++...+.++.|++.+++| ++.+|||+||.||++ ..+..+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhh
Confidence 34679999999 8999999962 23347788899999999999999 999999999999999 456689999999
Q ss_pred ceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhh
Q 011819 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 152 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
+........+. ..++.....-+||..||+||.+.|..|+.++||||||+||+|++. -..+|.. ...+..+..
T Consensus 402 l~ts~~~~~~~-~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~r~ 474 (516)
T KOG1033|consen 402 LVTSQDKDETV-APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATLTDIRD 474 (516)
T ss_pred heeecccCCcc-cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhhhc
Confidence 99877665411 112233445689999999999999999999999999999999997 3333322 122233333
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt 265 (477)
..++ +....++| +-+.|+++++...|.+||+
T Consensus 475 g~ip---~~~~~d~p-~e~~ll~~lls~~p~~RP~ 505 (516)
T KOG1033|consen 475 GIIP---PEFLQDYP-EEYTLLQQLLSPSPEERPS 505 (516)
T ss_pred CCCC---hHHhhcCc-HHHHHHHHhcCCCcccCch
Confidence 3332 12223444 4578999999999999993
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=152.97 Aligned_cols=127 Identities=27% Similarity=0.417 Sum_probs=99.4
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCCCC-c---------hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-H---------PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~---------~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.||+|+||.||+|. .++..|++|....... . ..+..|.+++..+.+. +++....+.......+++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKA-GVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHC-CCCCCEEEEEECCCCEEEEE
Confidence 37999999999998 4678899997543221 1 2356799999999874 33343444445566789999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
|+ |++|.+++.... . .++.|++.+|.+||+.|++|+|++|.|||+ + .+.++|+|||++..
T Consensus 78 ~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcC
Confidence 99 899998876311 1 789999999999999999999999999999 3 68899999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.6e-17 Score=153.20 Aligned_cols=136 Identities=19% Similarity=0.281 Sum_probs=103.6
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC------------------------chhHHHHHHHHHHHcCCC
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------------------HPQLLYESKLYRILQGGT 63 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~------------------------~~~~~~E~~il~~L~~~~ 63 (477)
.|.+.+.||+|+||.||+|.. .+|+.||||++..... ......|..++..+.+..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 488899999999999999986 4899999998654220 012456788888886642
Q ss_pred -CCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 64 -GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 64 -~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
.++.... ....++||||+ |++|.++... .....++.+|+.+|.++|..||+||||||.||++ +.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~ 160 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DD 160 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cC
Confidence 2222222 23458999999 7788765431 3456788999999999999999999999999999 56
Q ss_pred CCcEEEeecCceeeccc
Q 011819 142 ANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~ 158 (477)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 88999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.5e-17 Score=167.63 Aligned_cols=211 Identities=16% Similarity=0.222 Sum_probs=158.0
Q ss_pred HHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eeCCCCCCceE
Q 011819 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-LHRDIKPDNFL 135 (477)
Q Consensus 58 ~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gi-iHRDLKP~NIL 135 (477)
.+.| .++..+.+.+.++...++|-+|| .++|.|++......+++.-...++..|+.||+|+|.-.| .|+.|+..|.+
T Consensus 3 ~l~h-~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl 81 (484)
T KOG1023|consen 3 QLDH-DNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL 81 (484)
T ss_pred ccch-hhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence 4455 55666666666778889999999 899999998767778888899999999999999998765 99999999999
Q ss_pred eecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCC-------CCCcchHHHHHHHHHHHHc
Q 011819 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-------QSRRDDLESLGYVLMYFLR 208 (477)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-------~s~ksDIwSlGviLyellt 208 (477)
+ +....+||.|||+.......... .......-...|.|||.+.+.. .+.+.|+||||+++||+++
T Consensus 82 v---d~~w~lklt~~Gl~~~~~~~~~~-----~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 82 V---DSRWVLKLTDFGLNSLLEETAEP-----EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred e---eeeEEEEechhhhcccccccccc-----cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 9 78999999999998766431110 0011122345799999998742 3567999999999999999
Q ss_pred CCCCCCCCCccc-HHHHHHHHhhhc---ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 209 GSLPWQGLKAGT-KKQKYEKISEKK---VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 209 G~~Pf~~~~~~~-~~~~~~~i~~~~---~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
...||....... ..+...++.... ..+.+.... .+++++..++..||..+|+.||+++.+...++.+..
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccCccccccccCChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999997632221 123333333312 222222222 567789999999999999999999999888877754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.4e-16 Score=169.48 Aligned_cols=133 Identities=24% Similarity=0.409 Sum_probs=102.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-C---------chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-K---------HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~---------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
..|...+.||+|+||.||+|.+... .+++|....+. . ...+..|++++..++++. ++....+.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG-VPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccC-CCeeEEEEEeCC
Confidence 3456688999999999999986433 44444322111 1 124678999999998754 545445555556
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..++||||+ |++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccccc
Confidence 678999999 999998875 346789999999999999999999999999999 356899999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=7e-16 Score=142.59 Aligned_cols=135 Identities=24% Similarity=0.325 Sum_probs=94.0
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hh----------------------HHHHHHHHHHHcCCC-C
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQ----------------------LLYESKLYRILQGGT-G 64 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~----------------------~~~E~~il~~L~~~~-~ 64 (477)
++.||+|+||.||+|.+. ++++||||++...... .. ...|...+..+.+.. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999975 8999999987643211 00 124555555555431 2
Q ss_pred CCeeEEeeEeCcEEEEEEecC-CCCHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCC
Q 011819 65 IPNVRWFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 65 i~~~~~~~~~~~~~~lVmE~~-g~sL~-~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~ 141 (477)
++....+ ...++||||+ ++.+. ..+.... .. ..+..++.+++.++.++|. +||+|+||||+||++ +
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E-
Confidence 2332222 2358999999 42221 1222111 11 6678899999999999999 999999999999999 4
Q ss_pred CCcEEEeecCceeeccc
Q 011819 142 ANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~ 158 (477)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 78899999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.8e-15 Score=130.96 Aligned_cols=131 Identities=21% Similarity=0.331 Sum_probs=105.9
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC-CCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG-TGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~-~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
+++.||.|.++.||++.... ..++||..........+..|..++..+.+. ..++.+..+....+..+++|||+ |..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 46789999999999999643 789999876544345688999999999876 56666666666667889999999 555
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 89 L~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~---giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
+..+ +......++.+++.+|.+||.. +++|+||+|.|||+ +..+.++++|||++.
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~ 137 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKILGIIDWEYAG 137 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE---ECCcEEEEEeccccc
Confidence 5433 4556677899999999999984 79999999999999 456889999999885
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-14 Score=139.56 Aligned_cols=132 Identities=16% Similarity=0.222 Sum_probs=96.4
Q ss_pred eeee-ecCceEEEEEEECCCCcEEEEEEecCCC---------------CchhHHHHHHHHHHHcCCCC-CCeeEEeeE-e
Q 011819 13 RKIG-SGSFGEIYLGTNIQTNEEVAIKLENVKT---------------KHPQLLYESKLYRILQGGTG-IPNVRWFGV-E 74 (477)
Q Consensus 13 ~~IG-~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---------------~~~~~~~E~~il~~L~~~~~-i~~~~~~~~-~ 74 (477)
..|| .||.|+||.+.. .+..++||.+.... ....+.+|+.++..|.+... ++....+.. .
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 889999999874 47789999764311 12346789999999987432 233333322 2
Q ss_pred CcE---EEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEee
Q 011819 75 GDY---NVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 75 ~~~---~~lVmE~~-g-~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
... .+||||++ | .+|.+++.. ..++... +.||+.+|.+||++||+||||||.|||+ +.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCEEEEE
Confidence 222 25999999 5 689998863 4455543 5689999999999999999999999999 4567899999
Q ss_pred cCceee
Q 011819 150 FGLAKK 155 (477)
Q Consensus 150 FGla~~ 155 (477)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.8e-16 Score=171.10 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=187.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCC-CcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~-g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
...|.+.+.||+|+|+.|-+..+..+ ...+|.|.+...... .....|..+-+.+..|.++..+.......+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 35688999999999999999886433 345666655443311 1233466676677756777777777778888899
Q ss_pred EEecC-CCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeCCCCCCceEeecCCCCC-cEEEeecCceeec
Q 011819 81 VMDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKY 156 (477)
Q Consensus 81 VmE~~-g~sL~~li-~~~~~~ls~~~~~~i~~qIa~aL~yLH-s~giiHRDLKP~NILl~~~~~~~-~vkL~DFGla~~~ 156 (477)
+++|. |+++.+.+ .......+...+..++.|+..+|.|+| ..++.||||||+|.++ +..+ .+++.|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhccc
Confidence 99998 88888887 422224677788899999999999999 9999999999999999 5666 8999999999988
Q ss_pred cc-CCCCcccccccCCCCcc-CccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 157 RD-TSTHQHIPYRENKNLTG-TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 157 ~~-~~~~~~~p~~~~~~~~G-t~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
.. .... +.....+| ++.|+|||.+.+..| .+..|+||+|+++.-+++|..||....... +.+........
T Consensus 176 ~~~~g~~-----~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~ 248 (601)
T KOG0590|consen 176 RNKNGAE-----RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG 248 (601)
T ss_pred cccCCcc-----eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc
Confidence 77 2221 22344577 999999999998544 688999999999999999999997643322 22222222211
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
......+..+.....+++.+++..+|..|.+.+++.
T Consensus 249 -~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 -RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 111223466778889999999999999999866554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=3e-13 Score=141.61 Aligned_cols=138 Identities=20% Similarity=0.304 Sum_probs=96.6
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCCch-------------------------------------------hH
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------------------------------------------QL 49 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~-------------------------------------------~~ 49 (477)
+.||+|++|.||+|+. .+|+.||||+..... .. .+
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i-~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGI-EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCc-HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 5699999999999985 589999999865421 11 12
Q ss_pred HHHHHHHHHHc----CCCCCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 011819 50 LYESKLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN-RVEFVHSKS 123 (477)
Q Consensus 50 ~~E~~il~~L~----~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~-aL~yLHs~g 123 (477)
..|...+..+. +.+.+.....+.......+|||||+ |.+|.++.......+. ...++.+++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 33444444443 3344443334433344569999999 8899887653222232 2345556655 478899999
Q ss_pred CeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 124 iiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
++|+|++|.||++ +.++.++|+|||++..+..
T Consensus 278 ~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFV---LKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence 9999999999999 6778999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=1e-12 Score=119.21 Aligned_cols=126 Identities=17% Similarity=0.283 Sum_probs=96.0
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCH
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL 89 (477)
++.|+.|.++.||+++. .+..|+||+..... ....+..|++++..+.+...++.+..+.. ...++||||+ |.++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 46789999999999985 47889999865543 23457889999999987666676665543 2357999999 6666
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 90 ~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gi-----iHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.+. . . ....++.+++.+|..||..++ +|+|++|.|||++ .+.++|+||+.+.
T Consensus 79 ~~~-~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE-D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAG 135 (170)
T ss_pred ccc-c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEeccccc
Confidence 432 0 1 113456789999999999885 9999999999993 5679999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.6e-13 Score=141.16 Aligned_cols=252 Identities=18% Similarity=0.183 Sum_probs=184.7
Q ss_pred CCceEEEeeeee--cCceEEEEEEE--CCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGS--GSFGEIYLGTN--IQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~--G~fG~Vy~a~~--~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
...|.+.+.+|. |.+|.||.+.. ..++..+|+|.-.... ....-.+|..-.+.+..+.+.+.........+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345777889999 99999999987 7888999999632221 112234555555556555555554445567888
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeeCCCCCCceEeecCCCC-CcEEEeecCc
Q 011819 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN----RVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGL 152 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~----aL~yLHs~giiHRDLKP~NILl~~~~~~-~~vkL~DFGl 152 (477)
.++-.|+|+.+|..+......-++...++..+.+... ||..+|+.+|+|-|+||+||++. .+ ..+++.|||+
T Consensus 193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCcce
Confidence 8999999999999988755555788888888889988 99999999999999999999994 55 8899999999
Q ss_pred eeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 153 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
...+.+...... +.......|...|++||...+ -++..+|+|+||.++.+...+..++.........+ +.. .
T Consensus 270 v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~----~r~-~ 341 (524)
T KOG0601|consen 270 VSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ----LRQ-G 341 (524)
T ss_pred eEEccCCccccc--eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc----ccc-c
Confidence 998877654321 122233367788999999886 46889999999999999999877775432211110 111 0
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
....++|.+...++...+..+++.++-.|++.+.+.
T Consensus 342 --~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 342 --YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred --cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 122346667777888889999988888888766553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=7.7e-14 Score=152.01 Aligned_cols=275 Identities=20% Similarity=0.171 Sum_probs=194.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEe---eEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWF---GVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~---~~~~~ 76 (477)
..+.|.+.+-+-+|.++.++.+.-..++-..++|+...... .+....+. .+..++..+.+.-+ +....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s----~~~i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKS----NILITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCcc----CccccCCCCceecccCCCCCCC
Confidence 34678888999999999999988766775566664322111 11111111 11121222333222 23566
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..+|+|+|+ +++|...++. ....+.+-+..+...+..+++|||...++|||++|+|.|+ ...+..++.|||+...
T Consensus 878 P~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSK 953 (1205)
T ss_pred CcchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccc
Confidence 678999999 8889888874 3457777778888889999999999999999999999999 6889999999985432
Q ss_pred cccC------C------------------CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCC
Q 011819 156 YRDT------S------------------THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSL 211 (477)
Q Consensus 156 ~~~~------~------------------~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~ 211 (477)
...- . .......+......||+.|.+||...+......+|+|++|+++++.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2111 0 000001233455789999999999999999999999999999999999999
Q ss_pred CCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 011819 212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291 (477)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~ 291 (477)
||.. .+..+.++.+.....+.+.- ....+.+..+++...+..++.+|..+.-. ....++.++...+|.
T Consensus 1034 p~na---~tpq~~f~ni~~~~~~~p~g--~~~~s~~aq~~~~~ll~~~~~qr~~a~~~-------~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1034 PFNA---ETPQQIFENILNRDIPWPEG--PEEGSYEAQDLINRLLTEEPTQRLGAKGA-------AEVKGHPFFQDVDWE 1101 (1205)
T ss_pred CCCC---cchhhhhhccccCCCCCCCC--ccccChhhhhhhhhhhccCchhccCcccc-------cccccCCccCCCCcc
Confidence 9955 45566777776665543322 23357789999999999999999875311 124678899999999
Q ss_pred cchhhccc
Q 011819 292 ILKYQQSQ 299 (477)
Q Consensus 292 ~~~~~~~~ 299 (477)
.+..+...
T Consensus 1102 ~l~~q~~~ 1109 (1205)
T KOG0606|consen 1102 NLALQKAE 1109 (1205)
T ss_pred ccccccCc
Confidence 87665444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.7e-12 Score=117.82 Aligned_cols=136 Identities=18% Similarity=0.212 Sum_probs=97.0
Q ss_pred EeeeeecCceEEEEEEECC------CCcEEEEEEecCCC------------C------------chhH----HHHHHHHH
Q 011819 12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKT------------K------------HPQL----LYESKLYR 57 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~------~g~~vAiKi~~~~~------------~------------~~~~----~~E~~il~ 57 (477)
...||.|-=+.||.|.... .+..+|||+..... . ...+ .+|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998543 35799999742210 0 0112 37888888
Q ss_pred HHcCC-CCCCeeEEeeEeCcEEEEEEecCCCC-H-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeCCCCCCc
Q 011819 58 ILQGG-TGIPNVRWFGVEGDYNVLVMDLLGPS-L-EDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDN 133 (477)
Q Consensus 58 ~L~~~-~~i~~~~~~~~~~~~~~lVmE~~g~s-L-~~li~~~~~~ls~~~~~~i~~qIa~aL~yL-Hs~giiHRDLKP~N 133 (477)
.|... -.+|.+..+ ...+|||||++++ + ...+. ...++......+..|++.+|..| |+.|+||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 88753 344554443 4568999999653 2 11222 22355566777889999999998 89999999999999
Q ss_pred eEeecCCCCCcEEEeecCceeecc
Q 011819 134 FLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 134 ILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||+. ++.++|+|||.+....
T Consensus 156 IL~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE----CCcEEEEECCCceeCC
Confidence 9993 4789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.8e-12 Score=134.51 Aligned_cols=140 Identities=18% Similarity=0.277 Sum_probs=92.7
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----------------------------------------
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------------------------------- 46 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----------------------------------------- 46 (477)
.|+. +.||+|++|+||+|+...+|++||||+.......
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 7899999999999998877999999987643100
Q ss_pred -hhHHHHHHHHHHHc----CCCCCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCC-----CCHHHHHHHHHHHHHH
Q 011819 47 -PQLLYESKLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMINR 115 (477)
Q Consensus 47 -~~~~~E~~il~~L~----~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~-----ls~~~~~~i~~qIa~a 115 (477)
-.+..|...+..+. +.+.+.....+.......+|||||+ |..+.++-.-.... +....+..++.||
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 01334554444443 3333333333333345578999999 88998753211222 2233333344443
Q ss_pred HHHHHHCCCeeCCCCCCceEeecCCCCC----cEEEeecCceeeccc
Q 011819 116 VEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDFGLAKKYRD 158 (477)
Q Consensus 116 L~yLHs~giiHRDLKP~NILl~~~~~~~----~vkL~DFGla~~~~~ 158 (477)
+..|++|+|++|.||++. .++ .++++|||++..+..
T Consensus 277 ----f~~GffHaDpHPGNIlv~---~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVS---YDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HhCCeeeCCCChHHeEEe---cCCCCCCeEEEEecceEEECCH
Confidence 469999999999999994 444 899999999987644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.5e-11 Score=109.92 Aligned_cols=127 Identities=24% Similarity=0.397 Sum_probs=96.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCC-CCchh---------HHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQ---------LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-~~~~~---------~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
..|++|+=+.||.+.. -|..+++|.=..+ ..++. -..|+.++..+.. .+++....+..+.+...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEcCCCCEEEE
Confidence 3578899999999864 4556888863332 22332 3578888888876 46777677777777789999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
||+ |..|.+++... ...++..|-.-+.-||..||+|+||.+.||+++ .+.++++||||+.
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~ 139 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGE 139 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCccc
Confidence 999 77888888743 144666777778899999999999999999994 4459999999986
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4e-11 Score=108.20 Aligned_cols=142 Identities=20% Similarity=0.257 Sum_probs=107.6
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecC-CCCchh---------HHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQ---------LLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~-~~~~~~---------~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
....|-+|+-+.|+++. ..|+.++||.-.. ...++. ...|++++.++.-- +|+....++.+....+|
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence 67788999999999998 6888889996332 233333 45788888887753 66666666666667789
Q ss_pred EEecCCC--CHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 81 VMDLLGP--SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 81 VmE~~g~--sL~~li~~~~~~-ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
+|||+.+ ++.+++...-.. ...+....++.+|-..|.-||..+|||+||..+||+|..+.....+.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999955 888888643333 33333367889999999999999999999999999997555556679999999853
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=6e-10 Score=105.15 Aligned_cols=139 Identities=22% Similarity=0.276 Sum_probs=99.3
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCC-CCCeeEEeeEeC---cEEEEEEec
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGT-GIPNVRWFGVEG---DYNVLVMDL 84 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~-~i~~~~~~~~~~---~~~~lVmE~ 84 (477)
.+.|+.|.++.||++... +|+.++||+..... ....+..|.+++..+.+.. .++.+..+.... +..+++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 367899999999999863 36889999876543 2456889999999998743 255555554432 356899999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------------------------------ 121 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs------------------------------------------ 121 (477)
+ |.++.+.+. ...++......++.+++..|.+||+
T Consensus 82 i~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 82 VDGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred eCCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9 777765442 1346666666677777777777773
Q ss_pred --------------CCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 122 --------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 122 --------------~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
..++|+|+.|.|||++.+ ..+.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccc
Confidence 236999999999999421 14668999998774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-10 Score=119.80 Aligned_cols=237 Identities=20% Similarity=0.156 Sum_probs=159.1
Q ss_pred CCceEEEeeeeecCceEEEEEEEC-CCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCee--EEeeEeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNV--RWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~-~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~--~~~~~~~~~~ 78 (477)
..+|.++..||.|.|+.|+.+... .++..|++|-....... ..-..|+.+...+.-+.+++.. .|+. ....
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~~ 341 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQG 341 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--cccc
Confidence 457899999999999999998755 56788998854332211 1123466666666544444442 3433 3334
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||-.||| ++++..-+ .....+.....+.+..|++.++.++|++.++|+|+||+||++..+ .+..++.|||++..+.
T Consensus 342 ~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~--~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND--GFFSKLGDFGCWTRLA 418 (524)
T ss_pred cCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc--hhhhhccccccccccc
Confidence 5889999 66665444 445668888899999999999999999999999999999999532 2778999999986422
Q ss_pred cCCCCcccccccCCCCccCcccc--ccchhcCCCCCCcchHHHHHHHHHHHHcCCC-CCCCCCcccHHHHHHHHhhhccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYA--SMNTHLGIEQSRRDDLESLGYVLMYFLRGSL-PWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~--APE~~~g~~~s~ksDIwSlGviLyelltG~~-Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
-.. ....+..+++ +++......+..+.|++|||..+++.+++.. ++.+.. ...+......
T Consensus 419 ~~~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------~~~i~~~~~p 481 (524)
T KOG0601|consen 419 FSS----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------SLTIRSGDTP 481 (524)
T ss_pred eec----------ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------ceeeeccccc
Confidence 111 1223334444 5555566678899999999999999998753 332211 1112222111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
...+...++..+...+...++..||.+.++
T Consensus 482 -----~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l 511 (524)
T KOG0601|consen 482 -----NLPGLKLQLQVLLKVMINPDRKRRPSAVEL 511 (524)
T ss_pred -----CCCchHHhhhhhhhhhcCCccccchhhhhh
Confidence 112334667777788888888888876554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.4e-09 Score=109.45 Aligned_cols=181 Identities=15% Similarity=0.147 Sum_probs=129.0
Q ss_pred eEEEeeeeecCceEEE-EEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 9 FRLGRKIGSGSFGEIY-LGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy-~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
|++ +...-++.+ +| .|..+.++.+|.|...+.... .....+-++-++.|+|++++..+.-+. ..+..|||.|-+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-~~~~~ylvTErV 91 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-EEGTLYLVTERV 91 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-ccCceEEEeecc
Confidence 555 445555554 44 467778899999998776655 344667788899999976666665554 444789999988
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLH-s~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
-+ |..+++. +....+..-+.||+.||.||| +++++|++|.-+.|++ +..|..||.+|.++....+.....
T Consensus 92 ~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~- 162 (690)
T KOG1243|consen 92 RP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPA- 162 (690)
T ss_pred cc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCccc-
Confidence 43 5556653 346677888999999999998 6789999999999999 789999999999987655433200
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG 209 (477)
....--..|..|+.+.... -..|.|-|||++++++.|
T Consensus 163 ------~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 163 ------KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ------ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 1111122355666543222 246999999999999999
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.9e-08 Score=97.26 Aligned_cols=132 Identities=19% Similarity=0.138 Sum_probs=92.2
Q ss_pred eEEEEEEECCCCcEEEEEEecCCCC-----------ch--hHHHHHHHHHHHcCC-CCCCeeEEeeEe-----CcEEEEE
Q 011819 21 GEIYLGTNIQTNEEVAIKLENVKTK-----------HP--QLLYESKLYRILQGG-TGIPNVRWFGVE-----GDYNVLV 81 (477)
Q Consensus 21 G~Vy~a~~~~~g~~vAiKi~~~~~~-----------~~--~~~~E~~il~~L~~~-~~i~~~~~~~~~-----~~~~~lV 81 (477)
..|++.. -.|+.|.||....... .+ ...+|...+..|... -..+.+..+++. ....+||
T Consensus 36 rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3455654 4667889996432220 11 367888888888542 222333334432 2346899
Q ss_pred EecCCC--CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec----CCCCCcEEEeecCcee
Q 011819 82 MDLLGP--SLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----GRRANQVYIIDFGLAK 154 (477)
Q Consensus 82 mE~~g~--sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~----~~~~~~vkL~DFGla~ 154 (477)
||++++ +|.+++... ....+......++.+|+..+.-||..||+|+||++.|||+.. ++....+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999944 799998632 344666777889999999999999999999999999999953 1235789999999875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2e-09 Score=104.79 Aligned_cols=177 Identities=13% Similarity=0.167 Sum_probs=116.3
Q ss_pred EEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 77 YNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
...++.||+ -++|..++++ +...+......+|+.||+.||.|||+.. |+|+++..+-|++ ..++.||+.--
T Consensus 146 rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi---q~ngLIkig~~ 222 (458)
T KOG1266|consen 146 RVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI---QHNGLIKIGSV 222 (458)
T ss_pred ceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee---cCCceEEeccc
Confidence 457889999 8999999863 4556888899999999999999999874 9999999999999 57777776421
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
.... ... .... .-..+.....+.++|.+||.=.....+-.+|||+||....+|..+..--.. .......-..+..
T Consensus 223 ap~s-~h~-s~~~-~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tn--seS~~~~ee~ia~ 297 (458)
T KOG1266|consen 223 APDS-THP-SVNS-TREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTN--SESKVEVEENIAN 297 (458)
T ss_pred Cccc-cch-hhhh-hhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCC--Ccceeehhhhhhh
Confidence 1100 000 0000 001112234567889999986666667789999999999999887543211 1111111111111
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
..+ .+. ..--++++.+|++-.|..||++.++
T Consensus 298 ~i~-----~le---n~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 298 VII-----GLE---NGLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred hee-----ecc---CccccCcCcccccCCCCCCcchhhh
Confidence 111 011 1123568899999999999997765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.2e-08 Score=100.62 Aligned_cols=250 Identities=13% Similarity=0.200 Sum_probs=151.0
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCe-eEE-----eeE-eCcEEEEEE
Q 011819 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN-VRW-----FGV-EGDYNVLVM 82 (477)
Q Consensus 10 ~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~-~~~-----~~~-~~~~~~lVm 82 (477)
..++.||+|+-+.+|-.-. -+. .+-|+......-.+ ...+..|...-.++.+.. +.| ++- .+...-+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d-~VAKIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRD-QVAKIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecch--hhc-hhheeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3567899999999997542 122 24476544321111 111122222222222222 222 122 233356778
Q ss_pred ecC-C-CCHHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 83 DLL-G-PSLEDLFNF-----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 83 E~~-g-~sL~~li~~-----~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..+ | ..+.+++.- .-..+.|...++.++.++.+.+.||+.|.+-+|+.++|||++ +++.|.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcccceee
Confidence 877 3 234444321 112378999999999999999999999999999999999994 678888887543322
Q ss_pred cccCCCCcccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCcc----cHHH-H
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAG----TKKQ-K 224 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG-~~Pf~~~~~~----~~~~-~ 224 (477)
..+ . +.....+|.+.|.+||.-. +-+-+...|.|.||++++++|.| ++||.+.... ...+ .
T Consensus 167 ~~n-g-------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 167 NAN-G-------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred ccC-C-------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 211 1 1233558999999999755 44556788999999999999986 9999874321 1111 0
Q ss_pred H-------H-HHhhhcccccHHHHhcCCcHHHHHHHHHHhcCC--CCCCCCHHHHHHHHH
Q 011819 225 Y-------E-KISEKKVSTSIEALCRGYPTEFASYFHYCRSLR--FDDKPDYAYLKRIFR 274 (477)
Q Consensus 225 ~-------~-~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~--p~~RPt~~~l~~~l~ 274 (477)
+ . +......+.+.+--+.-+|+++..++.+|+..- +.-||+++.....|.
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~ 298 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD 298 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence 0 0 001111122222222346899999999998743 458999865444433
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.5e-09 Score=99.06 Aligned_cols=125 Identities=24% Similarity=0.325 Sum_probs=78.2
Q ss_pred EEEEEEECCCCcEEEEEEecCC--------------C---------Cc-----hhHHHHHHHHHHHcCCC-CCCeeEEee
Q 011819 22 EIYLGTNIQTNEEVAIKLENVK--------------T---------KH-----PQLLYESKLYRILQGGT-GIPNVRWFG 72 (477)
Q Consensus 22 ~Vy~a~~~~~g~~vAiKi~~~~--------------~---------~~-----~~~~~E~~il~~L~~~~-~i~~~~~~~ 72 (477)
.||.|.. ..+.++|||+.... . .. ....+|.+.|..+.... .+|.+..+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899986 67789999974321 0 00 12457899999988643 45555443
Q ss_pred EeCcEEEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeeCCCCCCceEeecCCCCCcEEEee
Q 011819 73 VEGDYNVLVMDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF-VHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 73 ~~~~~~~lVmE~~g--~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~y-LHs~giiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
. ..+|||||++ +.....+.. ..++.+....++.+++..+.. +|+.||+|+||.+.|||++ .+.++|+|
T Consensus 79 -~--~~~ivME~I~~~G~~~~~l~~--~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID 149 (188)
T PF01163_consen 79 -N--RNVIVMEYIGEDGVPLPRLKD--VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID 149 (188)
T ss_dssp -E--TTEEEEE--EETTEEGGCHHH--CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred -e--CCEEEEEecCCCccchhhHHh--ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence 2 3589999996 433333331 112234556677788885555 5799999999999999994 34899999
Q ss_pred cCceeecc
Q 011819 150 FGLAKKYR 157 (477)
Q Consensus 150 FGla~~~~ 157 (477)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.5e-09 Score=115.02 Aligned_cols=153 Identities=13% Similarity=0.222 Sum_probs=106.2
Q ss_pred HHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccC--CCCccCccccccchhc
Q 011819 110 DQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN--KNLTGTARYASMNTHL 186 (477)
Q Consensus 110 ~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~--~~~~Gt~~Y~APE~~~ 186 (477)
.+++.||.|+|. .++||++|.|++|.+ +..+.+||+.|+.+............+|... ....-...|.|||++.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345599999996 589999999999999 7899999999999886655333111111111 1123456799999999
Q ss_pred CCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011819 187 GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265 (477)
Q Consensus 187 g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt 265 (477)
+...+.++|+|||||++|.+.. |+.-+.. ............ ...........++|+++.+-+.+++..+..-||+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~~~~~---~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYSFSRN---LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhc-cCCcchhhhhhc---ccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 9888999999999999999984 4444433 222222111111 1111112223678999999999999999999996
Q ss_pred HHHH
Q 011819 266 YAYL 269 (477)
Q Consensus 266 ~~~l 269 (477)
+..+
T Consensus 259 ~~~l 262 (700)
T KOG2137|consen 259 LDLL 262 (700)
T ss_pred hhhh
Confidence 5544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.4e-07 Score=85.07 Aligned_cols=127 Identities=26% Similarity=0.428 Sum_probs=97.3
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCH
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL 89 (477)
+.+.|++|++|.||+|. ..|.++|+|+-..+.....+..|++++..++....-+.+..++.+ ++.|||+ |..|
T Consensus 26 v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGE--WRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEee--ccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcch
Confidence 35679999999999998 567799999988888888999999999999998888988888644 4569999 7799
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCC-C-CceEeecCCCCCcEEEeecCceee
Q 011819 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK-P-DNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 90 ~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLK-P-~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
.++.... +.+++ ..+++.---|-..||-|..|. | .||++ .++.+.|+||..|..
T Consensus 100 ~~~~~~~----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 8876521 22232 334444344556899998887 3 45555 455899999998863
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.4e-07 Score=85.55 Aligned_cols=110 Identities=20% Similarity=0.291 Sum_probs=81.2
Q ss_pred chhHHHHHHHHHHHcC-CCCCCeeEEeeEeC----cEEEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 011819 46 HPQLLYESKLYRILQG-GTGIPNVRWFGVEG----DYNVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118 (477)
Q Consensus 46 ~~~~~~E~~il~~L~~-~~~i~~~~~~~~~~----~~~~lVmE~~-g-~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~y 118 (477)
.....+|...+..|.. .-..+....++... ...+|++|++ + .+|.+++..... ++......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 3457788888888764 22233344444431 2348999999 4 479999875333 6677788899999999999
Q ss_pred HHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 119 LHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
||..||+|+|+++.|||+..++....+.|+||+.++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999954333448999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2e-07 Score=89.55 Aligned_cols=132 Identities=21% Similarity=0.332 Sum_probs=93.7
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecC----------------CCCc--------hhHHHHHHHHHHHcCC-C
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----------------KTKH--------PQLLYESKLYRILQGG-T 63 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~----------------~~~~--------~~~~~E~~il~~L~~~-~ 63 (477)
+.++.+||.|-=+.||.|.+ ..|.++|||+=.. ...+ ....+|.++|..|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45778999999999999996 5789999996111 0011 1246788899888754 3
Q ss_pred CCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC
Q 011819 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (477)
Q Consensus 64 ~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~ 142 (477)
.+|.... .+..++||||+ |..|..+- ++.+..-.++..|++-+.-+-..|+||+|+.+-|||+ +.+
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~d 238 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TED 238 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecC
Confidence 3444322 35678999999 65554332 2344444556666666666668999999999999999 678
Q ss_pred CcEEEeecCcee
Q 011819 143 NQVYIIDFGLAK 154 (477)
Q Consensus 143 ~~vkL~DFGla~ 154 (477)
|.++++||-.+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 899999996654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.3e-06 Score=80.20 Aligned_cols=134 Identities=10% Similarity=0.092 Sum_probs=96.3
Q ss_pred eecCceEEEEEEECCCCcEEEEEEecC--------CCCchhHHHHHHHHHHHcCCC-CCCeeEEeeEe----CcEEEEEE
Q 011819 16 GSGSFGEIYLGTNIQTNEEVAIKLENV--------KTKHPQLLYESKLYRILQGGT-GIPNVRWFGVE----GDYNVLVM 82 (477)
Q Consensus 16 G~G~fG~Vy~a~~~~~g~~vAiKi~~~--------~~~~~~~~~E~~il~~L~~~~-~i~~~~~~~~~----~~~~~lVm 82 (477)
|.||.+-|+.... .|+.+=||.... ....+.+.+|...+..|.... .++.+.++... .-..+||.
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688888998763 334577885331 224567999999999987532 23444433322 12247999
Q ss_pred ecCC--CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCc--EEEeecCcee
Q 011819 83 DLLG--PSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAK 154 (477)
Q Consensus 83 E~~g--~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~--vkL~DFGla~ 154 (477)
|-++ .+|.+++... -.+.+......++.+|+..|.-||..|+.|+|+-+.|||+ +..+. |+++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll---~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYV---KTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheee---cCCCCeeEEEEEhhccc
Confidence 9885 7999987532 1245677778899999999999999999999999999999 33445 9999997554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.56 E-value=6.1e-07 Score=84.43 Aligned_cols=137 Identities=18% Similarity=0.247 Sum_probs=90.1
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchh-----------HHHHHHHHHHHcC--CCCCCeeE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----------LLYESKLYRILQG--GTGIPNVR 69 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~-----------~~~E~~il~~L~~--~~~i~~~~ 69 (477)
..+.++|++.+.+-......|.+-. .+|+.+++|....+....+ ...++.....+.. ......+.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 4567889999999888877777766 5778899997655432211 1223333333322 12221211
Q ss_pred Eee-----EeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC
Q 011819 70 WFG-----VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (477)
Q Consensus 70 ~~~-----~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~ 143 (477)
.+. ......+|+|||+ |..|.++.. ++. .++..|..+|.-||+.|+.|+|+.|.||+++ ++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~ 171 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NN 171 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CC
Confidence 111 1233457999999 877776643 222 2456677889999999999999999999993 45
Q ss_pred cEEEeecCcee
Q 011819 144 QVYIIDFGLAK 154 (477)
Q Consensus 144 ~vkL~DFGla~ 154 (477)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 69999998664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.7e-06 Score=84.63 Aligned_cols=209 Identities=17% Similarity=0.202 Sum_probs=141.5
Q ss_pred ceEEEEEEECCCCcEEEEEEecCCCC-ch-hHHHHHHHHHHHcCCCCCCeeEEeeE---eCcEEEEEEecC--CCCHHHH
Q 011819 20 FGEIYLGTNIQTNEEVAIKLENVKTK-HP-QLLYESKLYRILQGGTGIPNVRWFGV---EGDYNVLVMDLL--GPSLEDL 92 (477)
Q Consensus 20 fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~-~~~~E~~il~~L~~~~~i~~~~~~~~---~~~~~~lVmE~~--g~sL~~l 92 (477)
..+.|++....+|..|++|.+.-... .. ....-+++++++.|.+.|+.-..|.. .+.-.++|++|. .++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45789999999999999998732211 11 12334677888988666655443331 344568999998 6788887
Q ss_pred HHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 93 FNFC--------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 93 i~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
.-.. +.+.++..++.|+.|+..||.++|+.|+.-+-|.|.+||+ +.+.+++|.-.|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccceeeecC
Confidence 5311 2346788999999999999999999999999999999999 4566888887776654433
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCC-CCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
... |.+.+ -.+-|.=-||.++..|.+|..- |.. +..+.. .+
T Consensus 446 d~~---------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~----d~~~~s----------~~ 487 (655)
T KOG3741|consen 446 DPT---------------------EPLES---QQQNDLRDLGLLLLALATGTENSNRT----DSTQSS----------HL 487 (655)
T ss_pred CCC---------------------cchhH---HhhhhHHHHHHHHHHHhhcccccccc----cchHHH----------HH
Confidence 221 11111 2356999999999999998542 221 111111 01
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..+...++.+++++|.++....+++ -+..++.
T Consensus 488 ~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 488 TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 2233457788899999998888886 3444443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.1e-06 Score=82.20 Aligned_cols=71 Identities=21% Similarity=0.176 Sum_probs=55.4
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEEeeEeCcEEEEEEecC-CC
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL-GP 87 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~-i~~~~~~~~~~~~~~lVmE~~-g~ 87 (477)
..||+|..+.||+. .+..+++|+.........+..|.+++..+..... ++.+..++...+...++||++ |.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999983 2446789987665545568899999999986544 677788877777788999999 54
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1e-06 Score=93.58 Aligned_cols=140 Identities=19% Similarity=0.297 Sum_probs=92.8
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCC---------------------------c---------------hhHH
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------------------H---------------PQLL 50 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---------------------------~---------------~~~~ 50 (477)
+.|+.++-|+||+|+- .+|++||||+...... . -.+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4688999999999995 5699999998533110 0 0123
Q ss_pred HHHHHHHHHc----CCCCCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 011819 51 YESKLYRILQ----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125 (477)
Q Consensus 51 ~E~~il~~L~----~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gii 125 (477)
.|...+..+. +.+.+..-..|.+.....+|+|||+ |..+.++..-....++.+.+.....++. +..+-..|+.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 4544444433 3344433344444445569999999 8888888532234466554444333332 3444458999
Q ss_pred eCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 126 HRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|.|.-|-||++ +.++.+.+.|||+...+..
T Consensus 288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 99999999999 6789999999999876544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4e-06 Score=79.94 Aligned_cols=135 Identities=21% Similarity=0.282 Sum_probs=91.3
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCC---------------------Cchh-----HHHHHHHHHHHcCC-CC
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------------------KHPQ-----LLYESKLYRILQGG-TG 64 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---------------------~~~~-----~~~E~~il~~L~~~-~~ 64 (477)
...|..|--+.||+|.. .++..||+|+..... .... ...|...|+.+... -.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 33566677779999984 678999999864321 0011 23577777777642 22
Q ss_pred CCeeEEeeEeCcEEEEEEecCCCCH--HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCC
Q 011819 65 IPNVRWFGVEGDYNVLVMDLLGPSL--EDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 65 i~~~~~~~~~~~~~~lVmE~~g~sL--~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~ 141 (477)
+|....+ ..++|||||+|... .-.++ .-.+..+++..+..++++.+.-|-. .++||+||..-|||+ .
T Consensus 132 vP~Pi~~----~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~----~ 201 (268)
T COG1718 132 VPEPIAF----RNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV----H 201 (268)
T ss_pred CCCceee----cCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE----E
Confidence 3333322 24589999996541 11122 1224444678888899999888887 899999999999999 3
Q ss_pred CCcEEEeecCceeecc
Q 011819 142 ANQVYIIDFGLAKKYR 157 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~ 157 (477)
++.++|+||+.|....
T Consensus 202 ~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 DGEPYIIDVSQAVTID 217 (268)
T ss_pred CCeEEEEECccccccC
Confidence 7889999999887554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1e-05 Score=77.98 Aligned_cols=75 Identities=20% Similarity=0.270 Sum_probs=53.4
Q ss_pred eeecCc-eEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCHHHH
Q 011819 15 IGSGSF-GEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL 92 (477)
Q Consensus 15 IG~G~f-G~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~~l 92 (477)
|-.|.+ ..||+... .+..+.||+..... ...+..|+++++.+.....++.+..++...+..++|||++ |.+|...
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 334444 78999874 34678899865543 3467889999999987655667777666666679999999 7666543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.1e-06 Score=77.17 Aligned_cols=78 Identities=22% Similarity=0.273 Sum_probs=55.6
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEEee---EeCcEEEEEEecC-C
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWFG---VEGDYNVLVMDLL-G 86 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~-i~~~~~~~---~~~~~~~lVmE~~-g 86 (477)
++.|+.|..+.||++.... ..++||+.........+..|..++..|..... ++.+..++ ......+++|+++ |
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 5789999999999999644 58899986554233567889999999886544 55555533 3444578999999 7
Q ss_pred CCHHH
Q 011819 87 PSLED 91 (477)
Q Consensus 87 ~sL~~ 91 (477)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 66666
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.8e-07 Score=97.17 Aligned_cols=187 Identities=13% Similarity=0.031 Sum_probs=133.6
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecCC-C
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG-P 87 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~g-~ 87 (477)
|...+.+++|+++.+++.+...+...+ .+++... ....-++++|.+++|++-......-++...+.+++|++++ +
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 344556789999999998865554444 6655433 3455678889999987622222222345667899999993 3
Q ss_pred -CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 88 -SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 88 -sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
+.........-.+...+...+++.-+++|+++|+---+||| ||+. ..+..++.||+.+..+....
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~------ 385 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM------ 385 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc------
Confidence 33333322222344555566777778899999998889999 8887 45788999999987765543
Q ss_pred cccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 011819 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~ 215 (477)
......+++.++|||+.....++...|.|++++-..++.-|-.|-..
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 23567899999999999999999999999999888888877776543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00014 Score=67.81 Aligned_cols=124 Identities=18% Similarity=0.280 Sum_probs=84.8
Q ss_pred CceEEEeeeeecCc-eEEEEEEECCCCcEEEEEEecC---C--------------------CCchhHHHHHHHHHHHcCC
Q 011819 7 NKFRLGRKIGSGSF-GEIYLGTNIQTNEEVAIKLENV---K--------------------TKHPQLLYESKLYRILQGG 62 (477)
Q Consensus 7 ~~y~i~~~IG~G~f-G~Vy~a~~~~~g~~vAiKi~~~---~--------------------~~~~~~~~E~~il~~L~~~ 62 (477)
.+++.++.||.|.- |.||+++ -.|+.||||+... . .....+..|...+..|++.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 9999998 5778999998211 0 0112477899999988854
Q ss_pred CC-----CCeeEEeeEeC-----------------cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 011819 63 TG-----IPNVRWFGVEG-----------------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120 (477)
Q Consensus 63 ~~-----i~~~~~~~~~~-----------------~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLH 120 (477)
.. +..+.|+.... ....||.||....- .++.. -+.+|.+-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 33 23333332220 11246777662211 12222 3467788889999
Q ss_pred HCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 121 s~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
+.||+-+|+++.|..= -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC--------CEEEecccC
Confidence 9999999999999873 289999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.6e-05 Score=73.19 Aligned_cols=73 Identities=16% Similarity=0.170 Sum_probs=46.6
Q ss_pred EeeeeecCce-EEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC--CCCCeeEEeeEeC---cEEEEEEecC
Q 011819 12 GRKIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG--TGIPNVRWFGVEG---DYNVLVMDLL 85 (477)
Q Consensus 12 ~~~IG~G~fG-~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~--~~i~~~~~~~~~~---~~~~lVmE~~ 85 (477)
++.|+.|+.. .||+.. ..+++|+.........+..|.+++..|... --++.+...+... ...+++|+++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 3567777766 589752 357889865533445788999999998753 2344444444322 2458899998
Q ss_pred -CCCH
Q 011819 86 -GPSL 89 (477)
Q Consensus 86 -g~sL 89 (477)
|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 6554
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=6.1e-05 Score=80.04 Aligned_cols=141 Identities=21% Similarity=0.306 Sum_probs=91.5
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---------------------------------------hhHHHHH
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------------------------------------PQLLYES 53 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---------------------------------------~~~~~E~ 53 (477)
+.||.-+.|.||+|+- .+|+.||||+....... -.+..|.
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5689999999999995 55999999974332100 0133444
Q ss_pred HHHHH----HcCCC-----CCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011819 54 KLYRI----LQGGT-----GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123 (477)
Q Consensus 54 ~il~~----L~~~~-----~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g 123 (477)
+.... +.+-. .||.+.|. .....+|+|||| |..+.|+-.-....++...+...+.++.. +-+-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 43333 33322 13333333 334469999999 77776664322455777766655555432 3444678
Q ss_pred CeeCCCCCCceEeecC-CCCCcEEEeecCceeeccc
Q 011819 124 FLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 124 iiHRDLKP~NILl~~~-~~~~~vkL~DFGla~~~~~ 158 (477)
++|.|--|-||++..+ ..+..+.+.|||+......
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 9999999999999532 2478899999999876544
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00095 Score=69.05 Aligned_cols=72 Identities=19% Similarity=0.278 Sum_probs=51.0
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCC---------CCchhHHHHHHHHHHHcC--CCCCCeeEEeeEeCcEEEE
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---------TKHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~---------~~~~~~~~E~~il~~L~~--~~~i~~~~~~~~~~~~~~l 80 (477)
.+.||.|.+..||++.....++.|+||..... ........|.+.|..+.. +..+|.+..+.. +..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 46799999999999997543368999974311 122346778888888753 245677777644 55789
Q ss_pred EEecC
Q 011819 81 VMDLL 85 (477)
Q Consensus 81 VmE~~ 85 (477)
|||++
T Consensus 109 VME~L 113 (401)
T PRK09550 109 VMEDL 113 (401)
T ss_pred EEecC
Confidence 99998
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00079 Score=63.02 Aligned_cols=130 Identities=21% Similarity=0.271 Sum_probs=86.9
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCC------------------CchhHHHHHHHHHHHc-C----CCCCCee
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------------------KHPQLLYESKLYRILQ-G----GTGIPNV 68 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~------------------~~~~~~~E~~il~~L~-~----~~~i~~~ 68 (477)
...||+|+.-.||.- ......+||+..... ...+...|+..+..+. . ...++.+
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999999973 233446789876544 2355677888777776 2 2334444
Q ss_pred EEeeEeCcEEEEEEecC-------CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 69 RWFGVEGDYNVLVMDLL-------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 69 ~~~~~~~~~~~lVmE~~-------g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
..+.++..-.-+|+|.+ ..+|.+++. ...++. .....+. +-.+||-+.+|+.+||+|.||++...+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 44444555557777765 457888886 344665 3333333 3456888999999999999999986555
Q ss_pred CC-cEEEeec
Q 011819 142 AN-QVYIIDF 150 (477)
Q Consensus 142 ~~-~vkL~DF 150 (477)
.. .+.|+|-
T Consensus 157 ~~~~lvlIDG 166 (199)
T PF10707_consen 157 GEFRLVLIDG 166 (199)
T ss_pred CceEEEEEeC
Confidence 55 6788883
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00027 Score=80.31 Aligned_cols=77 Identities=16% Similarity=0.204 Sum_probs=51.9
Q ss_pred EEeeeeecCceEEEEEEECCCC--cEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCC--CeeEEeeEeC---cEEEE
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKT---KHPQLLYESKLYRILQGGTGI--PNVRWFGVEG---DYNVL 80 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g--~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i--~~~~~~~~~~---~~~~l 80 (477)
.++.|+.|.++.+|+......+ ..+++|...... ....+.+|.++++.|..+..+ +.+.+++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677899999999998754332 467788754322 223578999999999743444 4455554432 35689
Q ss_pred EEecC-CC
Q 011819 81 VMDLL-GP 87 (477)
Q Consensus 81 VmE~~-g~ 87 (477)
||||+ |.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999 44
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0028 Score=64.48 Aligned_cols=70 Identities=17% Similarity=0.227 Sum_probs=46.8
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEe----cC-----CCCchhHHHHHHHHHHHcC--CCCCCeeEEeeEeCcEEEEEE
Q 011819 14 KIGSGSFGEIYLGTNIQTNEEVAIKLE----NV-----KTKHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~~~g~~vAiKi~----~~-----~~~~~~~~~E~~il~~L~~--~~~i~~~~~~~~~~~~~~lVm 82 (477)
.||.|....||++.+...++.|+||.- .. .........|...|+.+.. +..+|.++.| +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997543468999952 11 1122345678888877654 2345555555 555678999
Q ss_pred ecC
Q 011819 83 DLL 85 (477)
Q Consensus 83 E~~ 85 (477)
|++
T Consensus 80 EdL 82 (370)
T TIGR01767 80 EDL 82 (370)
T ss_pred hhC
Confidence 988
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00065 Score=64.90 Aligned_cols=74 Identities=16% Similarity=0.179 Sum_probs=49.7
Q ss_pred EeeeeecCceEEEEEEECC-CCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 12 GRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH-PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~-~g~~vAiKi~~~~~~~-~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
++.|..|-...+|++.... .++.|++|+....... -....|..++..+......+.+..... ..++|||+ |.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 4667788888999987432 3578899976543221 234578999999876666676654432 24899998 655
Q ss_pred H
Q 011819 89 L 89 (477)
Q Consensus 89 L 89 (477)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00065 Score=68.33 Aligned_cols=138 Identities=22% Similarity=0.266 Sum_probs=92.9
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCC------------------------CCchh----HHHHHHHHHHHcCC
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK------------------------TKHPQ----LLYESKLYRILQGG 62 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~------------------------~~~~~----~~~E~~il~~L~~~ 62 (477)
|-..|..|--+.||.|.. .+|..+|||+.+.. ..... ...|+.-|+.|..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~- 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN- 225 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh-
Confidence 455677888889999984 78889999974321 00011 2457777777765
Q ss_pred CCCCeeEEeeEeCcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeCCCCCCceEeecCCC
Q 011819 63 TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 63 ~~i~~~~~~~~~~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLH-s~giiHRDLKP~NILl~~~~~ 141 (477)
.+||...-... ...+|||+|+|.+-+-.=.-..-.++...+..+-.|++.-+.-|- .+++||.||.--|+|+ .
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----h 299 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----H 299 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----E
Confidence 33544322211 235899999965433221111344777777777778877777664 5799999999999999 5
Q ss_pred CCcEEEeecCceeec
Q 011819 142 ANQVYIIDFGLAKKY 156 (477)
Q Consensus 142 ~~~vkL~DFGla~~~ 156 (477)
.|.++|+|-+.+...
T Consensus 300 dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEH 314 (520)
T ss_pred CCEEEEEEccccccC
Confidence 799999999877543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=7.4e-05 Score=73.78 Aligned_cols=133 Identities=20% Similarity=0.343 Sum_probs=92.4
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecC--------CCC-----------c-----hhHHHHHHHHHHHcCC-C
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--------KTK-----------H-----PQLLYESKLYRILQGG-T 63 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~--------~~~-----------~-----~~~~~E~~il~~L~~~-~ 63 (477)
+.++++||-|--+.||.+-+ ..|.+.++|+=.. +.+ + -...+|...|+.|..+ -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56788999999999999986 6788899995110 000 0 1235788888888752 2
Q ss_pred CCCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC
Q 011819 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (477)
Q Consensus 64 ~i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~ 142 (477)
-+|... +....++|||++ |..|.++-+- .+..+ +...+..-|--|-.+|+||+|..-=||++ +++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd 238 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD 238 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence 233322 234568999999 7777665431 22223 44445555667889999999999999999 578
Q ss_pred CcEEEeecCceeec
Q 011819 143 NQVYIIDFGLAKKY 156 (477)
Q Consensus 143 ~~vkL~DFGla~~~ 156 (477)
+.++++||-.+...
T Consensus 239 ~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 239 DKIVVIDFPQMVST 252 (465)
T ss_pred CCEEEeechHhhcc
Confidence 89999999766543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0012 Score=65.78 Aligned_cols=74 Identities=12% Similarity=0.056 Sum_probs=50.1
Q ss_pred EeeeeecCceEEEEEEECC------CCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~------~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
++.|..|-...||+..... .++.|++|+...... ......|.+++..+......+.+.++... .+||+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 3556667777999987532 257899999665432 24577899999998876566666665532 357888
Q ss_pred C-CCCH
Q 011819 85 L-GPSL 89 (477)
Q Consensus 85 ~-g~sL 89 (477)
+ |..+
T Consensus 79 i~G~~l 84 (302)
T cd05156 79 IPSRTL 84 (302)
T ss_pred eCCCcC
Confidence 7 5544
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.001 Score=65.93 Aligned_cols=138 Identities=16% Similarity=0.171 Sum_probs=80.2
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCC-CCCeeEE------eeEeCcEEEEEEe
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT-GIPNVRW------FGVEGDYNVLVMD 83 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~-~i~~~~~------~~~~~~~~~lVmE 83 (477)
-++.|..|....+|+... .+..+++|+... .....+..|..++..|.+.. .++.+.. +....+..+++++
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 356677788789999863 345788998764 33456778888888886532 1233211 1223445689999
Q ss_pred cC-CCCHHH-----------HH---HHcCCCC----------CHHHHH----------HHHHHHHHHHHHHHH-------
Q 011819 84 LL-GPSLED-----------LF---NFCSRKL----------SLKTVL----------MLADQMINRVEFVHS------- 121 (477)
Q Consensus 84 ~~-g~sL~~-----------li---~~~~~~l----------s~~~~~----------~i~~qIa~aL~yLHs------- 121 (477)
++ |..+.. .+ +.....+ .+.... .....+..++.++..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 98 544311 11 1110001 111100 011112334444443
Q ss_pred CCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 122 ~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.+++|+|+.|.|||+ +.++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~---~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLF---DGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEE---eCCceEEEeehhhhc
Confidence 479999999999999 455556899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0029 Score=61.43 Aligned_cols=131 Identities=18% Similarity=0.161 Sum_probs=77.7
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCHH
Q 011819 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~--~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~ 90 (477)
.+..|-.+.+|+.. .+++.+++|+....... -....|..+++.+......|.+.+++. .++||||+ |..+.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 34567788999887 45678889975443222 246789999999987555666655532 36899998 54432
Q ss_pred H-----------H---HHHc-C-----CCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCCeeCCCCCC
Q 011819 91 D-----------L---FNFC-S-----RKLSLK-TVLMLADQM---------INRVEFVHS--------KSFLHRDIKPD 132 (477)
Q Consensus 91 ~-----------l---i~~~-~-----~~ls~~-~~~~i~~qI---------a~aL~yLHs--------~giiHRDLKP~ 132 (477)
. + +.+. . .+++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1 1 1111 1 112222 122222122 111222221 24899999999
Q ss_pred ceEeecCCCCCcEEEeecCcee
Q 011819 133 NFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 133 NILl~~~~~~~~vkL~DFGla~ 154 (477)
|||++ .++ ++|+||..|.
T Consensus 157 Nil~~---~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVT---PQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEe---CCC-CEEEeccccC
Confidence 99994 334 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0017 Score=64.99 Aligned_cols=138 Identities=17% Similarity=0.265 Sum_probs=78.3
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEE------eeEeCcEEEEEEe
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRW------FGVEGDYNVLVMD 83 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~-i~~~~~------~~~~~~~~~lVmE 83 (477)
.++.|+.|....+|+... . +..+++|+.........+..|..++..|..... ++.+.. +....+..+++|+
T Consensus 26 ~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 356677777789999873 3 335778986553334456678888888864221 223221 1123456789999
Q ss_pred cC-CCCH-----H------HHH---HHcCCCC----------C-HHHHH------------HHHHHHHHHHHHHHH----
Q 011819 84 LL-GPSL-----E------DLF---NFCSRKL----------S-LKTVL------------MLADQMINRVEFVHS---- 121 (477)
Q Consensus 84 ~~-g~sL-----~------~li---~~~~~~l----------s-~~~~~------------~i~~qIa~aL~yLHs---- 121 (477)
|+ |..+ . ..+ +.....+ . |.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 98 4322 1 111 1111111 0 00000 001123334555542
Q ss_pred ---CCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 122 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 122 ---~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.++||+|+.+.||++ +.++.+.|+||+.+
T Consensus 184 ~~~~~l~HgD~~~~Nvl~---~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLF---DGDSVKGVIDFYFA 215 (307)
T ss_pred cCCCccCCCCCCcCcEEE---ECCceEEEeecccc
Confidence 679999999999999 44555689999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0035 Score=62.90 Aligned_cols=73 Identities=16% Similarity=0.172 Sum_probs=44.8
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCC-CCCeeEE------eeEeCcEEEEEEec
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT-GIPNVRW------FGVEGDYNVLVMDL 84 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~-~i~~~~~------~~~~~~~~~lVmE~ 84 (477)
.+.|+.|....+|+... . +..+++|+.. ......+..|..++..|.... .++.+.. +....+..+++|+|
T Consensus 27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEe-C-CCcEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 35566777789999874 3 3368899875 333345666777787776421 1233221 22335567899999
Q ss_pred C-CC
Q 011819 85 L-GP 87 (477)
Q Consensus 85 ~-g~ 87 (477)
+ |.
T Consensus 104 l~G~ 107 (319)
T PRK05231 104 LEGK 107 (319)
T ss_pred cCCC
Confidence 8 44
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00088 Score=62.19 Aligned_cols=97 Identities=24% Similarity=0.278 Sum_probs=73.0
Q ss_pred HHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecCC-CCHHH----HHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 011819 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG-PSLED----LFNFCSRKLSLKTVLMLADQMINRVEFVHS---K 122 (477)
Q Consensus 51 ~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~g-~sL~~----li~~~~~~ls~~~~~~i~~qIa~aL~yLHs---~ 122 (477)
.|.-++..|++..+++.+...+ +. +++.||.+ +++.. +.+ -...+|..+..++.++++.+++|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C--G~--~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC--GR--FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC--CC--EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 4778888898877666665543 43 57888885 44432 111 1237899999999999999999997 3
Q ss_pred CCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 123 giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.+.-.|++|+||-+ +.++.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence 47789999999999 57789999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.027 Score=58.05 Aligned_cols=72 Identities=22% Similarity=0.318 Sum_probs=49.5
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEE----ecCC----CCchhHHHHHHHHHHHcC--CCCCCeeEEeeEeCcEEEEE
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVK----TKHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi----~~~~----~~~~~~~~E~~il~~L~~--~~~i~~~~~~~~~~~~~~lV 81 (477)
.+.||.|.-..||++.+...++.|+||. +... ........|..+|+.+.. +..+|.+.++ +....++|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6788999999999999743456799995 2221 122346678888887653 3456666666 45556788
Q ss_pred EecC
Q 011819 82 MDLL 85 (477)
Q Consensus 82 mE~~ 85 (477)
||++
T Consensus 112 MEdL 115 (409)
T PRK12396 112 MEDL 115 (409)
T ss_pred HHhC
Confidence 8887
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.00018 Score=82.77 Aligned_cols=174 Identities=10% Similarity=-0.025 Sum_probs=114.4
Q ss_pred eCcEEEEEEecC-CCCHHHHHHHcCCCCC--HHHHHHHHHHH-HHHHHHHHHC-----CCeeCCCCCCceEeecCCCCCc
Q 011819 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLS--LKTVLMLADQM-INRVEFVHSK-----SFLHRDIKPDNFLMGLGRRANQ 144 (477)
Q Consensus 74 ~~~~~~lVmE~~-g~sL~~li~~~~~~ls--~~~~~~i~~qI-a~aL~yLHs~-----giiHRDLKP~NILl~~~~~~~~ 144 (477)
.....+.+++|+ +|.+.+.+-....+.+ .........++ +.+..-+|+. --+|++||+-|.+| ..+..
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~ 1378 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYN 1378 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCc
Confidence 444558899999 9999998864433322 22333344444 6667777753 26899999999999 67888
Q ss_pred EEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH
Q 011819 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (477)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~ 224 (477)
+|+.++|+.+...... ...+...+++.|+.+++.....++.++|+|..|+-+|....|..+|- ..
T Consensus 1379 v~~gk~gLdKIknp~~-------sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi--------~f 1443 (2724)
T KOG1826|consen 1379 VKLGKGGLDKIKNPVL-------SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI--------FF 1443 (2724)
T ss_pred ccccccccccccCchH-------hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH--------HH
Confidence 9999999998322211 12355678899999999999999999999999999999999888873 22
Q ss_pred HHHHhhhcccccH-HHHhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011819 225 YEKISEKKVSTSI-EALCRGYPTEFASYFHYCRSLRFDDKPD 265 (477)
Q Consensus 225 ~~~i~~~~~~~~~-~~l~~~~p~~l~~li~~cl~~~p~~RPt 265 (477)
...+.++...... ..+..-.|.+.-......|-+....||.
T Consensus 1444 lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1444 LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcch
Confidence 2333333322111 1122223444444444555556666765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0037 Score=61.68 Aligned_cols=46 Identities=7% Similarity=0.042 Sum_probs=30.0
Q ss_pred eecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC
Q 011819 16 GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG 62 (477)
Q Consensus 16 G~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~ 62 (477)
++|-...||... ...|..+++|.-........+.+|.+++..|...
T Consensus 20 ~~g~~~~v~~i~-~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 20 ESGLDFQVVFAK-DTDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceeEEEEEE-cCCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence 344444555543 2457889999764333345688999999999864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.015 Score=59.17 Aligned_cols=137 Identities=12% Similarity=0.144 Sum_probs=80.5
Q ss_pred EeeeeecCceEEEEEEECC----CCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 12 GRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~----~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
+..|-.|-...+|++.... .++.|++|+...... --....|..+++.+.....-+.+.+++..+ .+++|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 4455558888999987432 246899998755331 123467999999998876777776655332 578887
Q ss_pred CCCHHH-----------H---H---HHcCC---C-CC-HHHHHHHHHHH-----------------HHHHHHH----H--
Q 011819 86 GPSLED-----------L---F---NFCSR---K-LS-LKTVLMLADQM-----------------INRVEFV----H-- 120 (477)
Q Consensus 86 g~sL~~-----------l---i---~~~~~---~-ls-~~~~~~i~~qI-----------------a~aL~yL----H-- 120 (477)
+.+|.. + + +.... + +. +..+..+..++ ...+..| .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 545421 1 1 10010 0 11 22333333221 1111122 1
Q ss_pred --HCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 121 --SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 121 --s~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
...++|+|+++.|||+. +.++.++|+||..|.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 12589999999999994 234689999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.013 Score=66.75 Aligned_cols=203 Identities=14% Similarity=0.065 Sum_probs=123.2
Q ss_pred HHHHHHHHHHHcCCCCCCeeEEeeEeCcEE---EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011819 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYN---VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124 (477)
Q Consensus 49 ~~~E~~il~~L~~~~~i~~~~~~~~~~~~~---~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gi 124 (477)
...|...+..+.|++....+.+-....... .+.-++| ..++..++.. ....+..+.+.+..++++||.|+|+...
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 345666677777765555444332221111 2334466 6777777763 5668999999999999999999999865
Q ss_pred eeCCCCCCceEeecCCCCCcEEEe--ecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCC--cchHHHHH
Q 011819 125 LHRDIKPDNFLMGLGRRANQVYII--DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR--RDDLESLG 200 (477)
Q Consensus 125 iHRDLKP~NILl~~~~~~~~vkL~--DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~--ksDIwSlG 200 (477)
.|.-|...-..-...+..+.+.+. ||+..+.+.+..... ...-...+-++|......+.. ..|+|.+|
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--------~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--------SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccch--------hhcCccccccccccccccchhhhhhHHHHHH
Confidence 555444442222122455566655 888877665543211 112234566777666555543 47999999
Q ss_pred HHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 201 viLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
..+..+..|..+-... . ....-++..+..+..+....|+..+.++|+...++ +...|.+.
T Consensus 380 ll~~~~~~~~~i~~~~--~---------------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l---l~~~f~~~ 439 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKS--A---------------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALEL---LTHPFLRF 439 (1351)
T ss_pred HHHhhhhhcCcccccc--c---------------chhhhhccccchhhhhhhhhhcchhhhhccchhhh---hhchhccc
Confidence 9999998875443210 0 00111122223367888899999999999995554 45555433
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.019 Score=58.08 Aligned_cols=137 Identities=13% Similarity=0.178 Sum_probs=78.5
Q ss_pred EeeeeecCceEEEEEEECCC---CcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-C
Q 011819 12 GRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH-PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~---g~~vAiKi~~~~~~~-~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g 86 (477)
++.|..|=...+|+...... +..|++|+....... -....|..+++.+.....-+.+.+++..+ ++.+|+ |
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 34444477778999875332 347899987553321 13457899999998876667776655322 477777 4
Q ss_pred CCHHH-----------H---HHHc-CCC------CC-HHHHHHHHHHH----------------------HHHHHHHH--
Q 011819 87 PSLED-----------L---FNFC-SRK------LS-LKTVLMLADQM----------------------INRVEFVH-- 120 (477)
Q Consensus 87 ~sL~~-----------l---i~~~-~~~------ls-~~~~~~i~~qI----------------------a~aL~yLH-- 120 (477)
..|.. + +... ..+ ++ +..+..+..++ ..-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 44311 1 1111 111 11 22333333222 11122222
Q ss_pred --HCC----CeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 121 --SKS----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 121 --s~g----iiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
..+ ++|.||.+.|||++ +.++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~--~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLN--EDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEe--CCCCcEEEEcccccC
Confidence 112 79999999999994 345789999998774
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.021 Score=56.94 Aligned_cols=105 Identities=14% Similarity=0.085 Sum_probs=72.8
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCC--CCCeeEEeeEe---CcEEEEEEec
Q 011819 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT--GIPNVRWFGVE---GDYNVLVMDL 84 (477)
Q Consensus 10 ~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~--~i~~~~~~~~~---~~~~~lVmE~ 84 (477)
.-.+.||.|..+.||.... .++ .+.+|+.........+..|...++.|.... .+|.+..++.. .+..+||||+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 17 SRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred heeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3466899999999999863 233 467787433223457899999999998753 45666654432 3567999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~ 122 (477)
+ |.++.+. ..+......++.+++.+|.-||..
T Consensus 95 i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 95 LRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred cCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 9 6666541 123444556778888999999974
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.011 Score=62.13 Aligned_cols=163 Identities=20% Similarity=0.188 Sum_probs=91.0
Q ss_pred CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011819 45 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124 (477)
Q Consensus 45 ~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~gi 124 (477)
...++.-..++++.++|.+....+...........+|||+++.+|+++..... +-... +. .+++
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s-------~~-------~~~~ 88 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDES-------LL-------AHGV 88 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhh-------hc-------cccc
Confidence 33455666778888888544444433333344478999999999999987422 21111 11 1222
Q ss_pred eeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHH
Q 011819 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 204 (477)
Q Consensus 125 iHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLy 204 (477)
.| -|+ ++++| -++.. ..... .+|+||||+|.++.
T Consensus 89 ~~-----~~~----------~~~td-~~~t~--------------~~~~~----------------~pKsdVwsl~~i~~ 122 (725)
T KOG1093|consen 89 LH-----LNI----------IYITD-HFLTK--------------YPSPI----------------GPKSDVWSLGFIIL 122 (725)
T ss_pred ce-----ehh----------hhccc-ccccc--------------CCCCC----------------CcchhhhhHHHHHH
Confidence 22 222 23344 11100 00111 24999999999999
Q ss_pred HHHcCCCCCCCCCcccHHHHHHHHhhhc---ccccHH-HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011819 205 YFLRGSLPWQGLKAGTKKQKYEKISEKK---VSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (477)
Q Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~---~~~~~~-~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l 269 (477)
++.-|..-|...........+.+..... .....+ .+...++..+..+...|+...|..||...++
T Consensus 123 el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 123 ELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 9999988776544322222222221111 001111 1123467788899999999999999966554
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.018 Score=58.11 Aligned_cols=75 Identities=24% Similarity=0.283 Sum_probs=58.7
Q ss_pred EeCcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 73 VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 73 ~~~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
.+..|.|++|++-|++|.-.- ...+++++.++.+.+.-|.-+.++ .+=||||.-+|||| + .|+|-|+||-
T Consensus 296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfk 366 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFK 366 (488)
T ss_pred CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEee
Confidence 466788999999988875321 245778888888877666555543 58899999999999 5 8999999999
Q ss_pred ceeec
Q 011819 152 LAKKY 156 (477)
Q Consensus 152 la~~~ 156 (477)
+++..
T Consensus 367 lsRl~ 371 (488)
T COG5072 367 LSRLS 371 (488)
T ss_pred eeecc
Confidence 99844
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.12 Score=51.50 Aligned_cols=28 Identities=39% Similarity=0.753 Sum_probs=23.9
Q ss_pred CCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 122 ~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.+++|+|+.+.|||++ . +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECccc
Confidence 5789999999999993 3 56899999866
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.25 Score=49.00 Aligned_cols=73 Identities=16% Similarity=0.227 Sum_probs=51.7
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHc--CCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 10 ~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
+-.+.|+.|....+|+.. .+++.+.||+-. ......+..|.+-|+.|. ..-.+|.+..++...+..||+|||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 345678889999999987 778889999876 344567899999999994 5566788888888777789999998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.31 Score=56.77 Aligned_cols=77 Identities=13% Similarity=0.215 Sum_probs=46.0
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC-CCCC--eeE------EeeE----eCc-EE
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG-TGIP--NVR------WFGV----EGD-YN 78 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~-~~i~--~~~------~~~~----~~~-~~ 78 (477)
+.|+ |..-.+|+... .++..+++|+.+.......+..|.+++..|... +.++ .+. .+.. ++. ..
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 45678898873 567789999988654444566677777766542 3332 221 1111 111 45
Q ss_pred EEEEecC-CCCHHH
Q 011819 79 VLVMDLL-GPSLED 91 (477)
Q Consensus 79 ~lVmE~~-g~sL~~ 91 (477)
+-+++|+ |..|.+
T Consensus 109 vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 109 LRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEeccCCCcHHh
Confidence 6789998 666654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.38 Score=48.53 Aligned_cols=65 Identities=14% Similarity=0.135 Sum_probs=40.3
Q ss_pred CceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCe---e----EEeeEeCcEEEEEEecC
Q 011819 19 SFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPN---V----RWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 19 ~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~---~----~~~~~~~~~~~lVmE~~ 85 (477)
.-..||+... .++..+++|+..... ....+..|.+.+..|... .++. + ..+...+++.+.+++++
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~-gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEA-EIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHC-CCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 3457898873 556789999875432 334577888888877652 2221 1 11223356678889888
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.16 Score=51.47 Aligned_cols=135 Identities=16% Similarity=0.200 Sum_probs=78.1
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCee-------EEeeEeCc--EEEEEEec
Q 011819 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNV-------RWFGVEGD--YNVLVMDL 84 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~-------~~~~~~~~--~~~lVmE~ 84 (477)
.|.+ .-..||+... .+|+. ++|+........++..|...+.-|......+.. ........ +.+-+++|
T Consensus 33 ~l~s-~eN~~f~~~~-~~g~~-iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDGRY-ILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEe-cCCCe-EEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3444 4457888884 34444 899987764556677888888887653222221 11222344 77888888
Q ss_pred C-CCCHHH------------HH---HHcCCC-----------CCHH----H---------HHHHHHHHHHHHHHHHH---
Q 011819 85 L-GPSLED------------LF---NFCSRK-----------LSLK----T---------VLMLADQMINRVEFVHS--- 121 (477)
Q Consensus 85 ~-g~sL~~------------li---~~~~~~-----------ls~~----~---------~~~i~~qIa~aL~yLHs--- 121 (477)
+ |..+.. .+ +...+. ..|. . -.....++...+..+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 8 555551 11 111111 1121 0 01123445555555554
Q ss_pred -----CC--CeeCCCCCCceEeecCCCCC-cEEEeecCcee
Q 011819 122 -----KS--FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 154 (477)
Q Consensus 122 -----~g--iiHRDLKP~NILl~~~~~~~-~vkL~DFGla~ 154 (477)
.+ +||.|+.|+||++ +... .+.++||+-|.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~---d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLF---DDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeE---cCCCCeeeEEEccccc
Confidence 23 9999999999999 4444 48899999764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.41 Score=47.79 Aligned_cols=29 Identities=24% Similarity=0.457 Sum_probs=25.7
Q ss_pred CCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 123 giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
++||+|+.++|||+ +.++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhcc
Confidence 69999999999999 567789999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.092 Score=53.98 Aligned_cols=58 Identities=24% Similarity=0.305 Sum_probs=41.3
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeCCCCCCceEee
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMG 137 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLH-s~giiHRDLKP~NILl~ 137 (477)
.+|+.+|. |-++..+++. ...+++....++.-.++||.-|- -.+++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 46888888 8899999873 33444455555555555544333 46899999999999994
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.69 Score=47.87 Aligned_cols=75 Identities=13% Similarity=0.142 Sum_probs=46.8
Q ss_pred EEeeeeecCceEEEEEEECCCC-c-----EEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTN-E-----EVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g-~-----~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.++.|..|-...+|++...... . .|.+.+..... .--.-..|.++++.|.....-+.+...+. .+++.|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 3455655888899999753321 2 24554422111 11124578999999998888888876653 358889
Q ss_pred cC-CCCH
Q 011819 84 LL-GPSL 89 (477)
Q Consensus 84 ~~-g~sL 89 (477)
|+ |.+|
T Consensus 130 fIeGr~l 136 (383)
T PTZ00384 130 WVEGNTM 136 (383)
T ss_pred EeccccC
Confidence 88 5544
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.38 E-value=0.68 Score=46.54 Aligned_cols=141 Identities=16% Similarity=0.251 Sum_probs=75.7
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecC-CC---CchhHHHHHHHHHHHcCCCCCCeeEEee--EeC--cEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KT---KHPQLLYESKLYRILQGGTGIPNVRWFG--VEG--DYNV 79 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~-~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~--~~~--~~~~ 79 (477)
...+++.+-.|..-.+|.... +++.+++. ... .. ......+|..+++.+... .++.-..+. .++ ...|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~-~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDV-DVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCC-CCCCcccccccccCCCCCce
Confidence 344566664455555666553 37788888 332 11 122456777787777653 344433333 222 2458
Q ss_pred EEEecCCC-C------------------HHHHHHHcCC------C-------CCHHHHHHHHHH--------------HH
Q 011819 80 LVMDLLGP-S------------------LEDLFNFCSR------K-------LSLKTVLMLADQ--------------MI 113 (477)
Q Consensus 80 lVmE~~g~-s------------------L~~li~~~~~------~-------ls~~~~~~i~~q--------------Ia 113 (477)
.||+|+.| . |.+++..... . +...++..+..+ +.
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 99999833 1 2222211100 0 011111111111 12
Q ss_pred HHHHHHHHC--------CCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 114 NRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 114 ~aL~yLHs~--------giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
.-..+++.+ .++|+|+.+.|+++. ..+.+-|+||+++..
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~---~~~~~gVlDwe~~~l 228 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIID---PGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEe---CCCeeEEEecccccc
Confidence 234455542 489999999999994 555588999998853
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.54 E-value=1.1 Score=47.35 Aligned_cols=73 Identities=12% Similarity=0.061 Sum_probs=47.4
Q ss_pred EEeeeeecCceEEEEEEECC--------CCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 11 LGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~--------~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
-++.|..|-.-.+|++.... .++.|.+++...... --....|..++..+.....-+.+...+. .+.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 45566667777899987432 156899998654332 1235678889988887666666654332 3467
Q ss_pred EecC-CC
Q 011819 82 MDLL-GP 87 (477)
Q Consensus 82 mE~~-g~ 87 (477)
.+|+ |.
T Consensus 185 ~efi~g~ 191 (442)
T PTZ00296 185 EEWLYGD 191 (442)
T ss_pred EEeeCCc
Confidence 8888 54
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.20 E-value=0.27 Score=49.29 Aligned_cols=62 Identities=23% Similarity=0.246 Sum_probs=38.2
Q ss_pred EEEEEecCCCCHH-----HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH----CCCeeCCCCCCceEeecCC
Q 011819 78 NVLVMDLLGPSLE-----DLFNFCSRKLSLKTVLMLADQMINRVEFVHS----KSFLHRDIKPDNFLMGLGR 140 (477)
Q Consensus 78 ~~lVmE~~g~sL~-----~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs----~giiHRDLKP~NILl~~~~ 140 (477)
..||+.+.-.+-. .... .+-.--.+-+..++.||+.-.-.+-+ ..++|-||||+|||+-..+
T Consensus 250 nIIIfPLArcSadkv~~~~~~e-~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 250 NIIIFPLARCSADKVTEENAAE-LGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred cEEEEehhhcccccCCHHHHHH-cCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 4688887633322 2222 11112345677888998765434433 3589999999999997544
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.45 E-value=3.4 Score=48.12 Aligned_cols=46 Identities=13% Similarity=0.113 Sum_probs=30.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcC
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG 61 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~ 61 (477)
..|+.+ .-.+|+.+. ++..+++|+.+.......+..|..++.-|..
T Consensus 37 ~~L~s~-~d~nf~v~t--~~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~ 82 (972)
T PRK06149 37 TELGSQ-QDRNFRVDS--DGGRFVLKICHAAYAAVELEAQHAALRHLAE 82 (972)
T ss_pred EecCCc-CcceEEEEe--cCCcEEEEeCCccCChHHHHHHHHHHHHHHh
Confidence 455533 346888774 2357889998765555667788888877764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=89.90 E-value=3.8 Score=42.76 Aligned_cols=99 Identities=16% Similarity=0.191 Sum_probs=58.7
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecC-----CC----CchhHHHHHHHHHHHcC--CCCCCeeEEeeEeCcEEE
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KT----KHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~-----~~----~~~~~~~E~~il~~L~~--~~~i~~~~~~~~~~~~~~ 79 (477)
..+.||.|....||+..+ .+..|+||.-.. .. .......|...|+.+.. +..+|.+..++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467889999999999886 345689996431 11 22234556666666542 245677776665 5578
Q ss_pred EEEecCCC---CHHHHHHHcCCCCCHHHHHHHHHHHHHH
Q 011819 80 LVMDLLGP---SLEDLFNFCSRKLSLKTVLMLADQMINR 115 (477)
Q Consensus 80 lVmE~~g~---sL~~li~~~~~~ls~~~~~~i~~qIa~a 115 (477)
++||++.+ .+.+-+- .+......+..+...++..
T Consensus 112 lvME~L~~~~~ilr~~Ll--~G~~~p~~a~~ig~~la~t 148 (418)
T PLN02756 112 IGMRYLEPPHIILRKGLI--AGIEYPLLAEHMSDYMAKT 148 (418)
T ss_pred EEEeecCCcceehhhhhc--cCCCCHHHHHHHHHHHHHH
Confidence 99999933 4544443 1222234444444444443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 477 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 0.0 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-137 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-137 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-137 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 7e-96 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-95 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 4e-95 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 4e-95 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-93 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 7e-93 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 9e-93 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 6e-27 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 3e-26 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 3e-26 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 4e-26 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 2e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 5e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 7e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-04 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-04 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 477 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 0.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 0.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 0.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 0.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 0.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-177 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-173 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-27 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-27 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-27 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-26 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 3e-26 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 6e-26 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 7e-25 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-24 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-24 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-24 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-23 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 5e-23 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-22 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-22 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-22 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-21 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-21 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-21 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-21 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-21 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-21 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 7e-21 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-21 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-20 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-20 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-20 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-20 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-20 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-20 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 6e-20 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 8e-20 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-19 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-19 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-19 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-19 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-19 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-19 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-19 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-19 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-19 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-19 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-19 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-19 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-19 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-19 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 5e-19 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-19 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 6e-19 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-19 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-19 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-18 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-18 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-18 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-18 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-18 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-18 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-18 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-18 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-18 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-18 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-18 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-18 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-18 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-18 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 7e-18 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-18 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 9e-18 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-18 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-17 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-17 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-17 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-17 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-17 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-17 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-17 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-16 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-16 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-16 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-16 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-16 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-16 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-16 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-16 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-16 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-16 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-16 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-16 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-16 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 6e-16 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-16 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 8e-16 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-15 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-15 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-15 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-15 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-15 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-15 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-15 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-15 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-15 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 5e-15 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 7e-15 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-14 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-14 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-14 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-14 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 1e-14 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-14 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-14 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-14 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-14 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 7e-14 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-14 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-13 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-13 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-13 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-13 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-13 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-13 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-13 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 4e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-13 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-12 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-12 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-12 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-12 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-12 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-12 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-12 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-11 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-11 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-11 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-11 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-11 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-11 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-11 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-11 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-04 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 9e-11 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-10 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-10 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-10 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-10 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-10 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-10 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-10 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 3e-10 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-10 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-10 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-10 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-10 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-10 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-10 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-10 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 5e-10 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 7e-10 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-09 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-09 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-09 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-09 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-09 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-09 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-09 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-09 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-09 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-09 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 6e-09 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-08 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-08 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-08 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-08 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 5e-08 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 5e-08 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 9e-07 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 9e-08 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-07 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-07 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-07 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-07 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-07 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-07 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-07 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-07 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-07 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 4e-07 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-07 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-07 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 6e-07 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 6e-07 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 7e-07 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 7e-07 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 7e-07 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-07 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-07 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 9e-07 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-06 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-06 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-06 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-06 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-06 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-06 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-06 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-06 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 4e-06 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-06 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-06 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 8e-06 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-05 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-05 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-05 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-05 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-05 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-05 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 8e-05 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-04 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-04 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 7e-04 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 681 bits (1759), Expect = 0.0
Identities = 383/477 (80%), Positives = 420/477 (88%), Gaps = 5/477 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK+YRILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEAL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
CRGYPTEFASYFHYCRSLRFDDKPDY+YLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 ATPPARALVPGAGTSGAPPAIASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSFS 360
A+ P RA+ GAG SG P DRQ+ G +EGR +G SSMD RRR P+ + G+ +
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQNDRQS-GVDEGRTSGWSSMD--RRRAPPPIASVGTLA 357
Query: 361 KQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAVSSSRDAFVGSETEPQRSRTTEA 420
KQK+PV N+ + +K+ ++S+SNFLGRS G S R AVSSSRD +EP R+R T+A
Sbjct: 358 KQKAPVGNDASFSKEPVISASNFLGRSSGSSRR--PAVSSSRDVMPIDTSEPSRTRATDA 415
Query: 421 SPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYETTLKGIESLHFDTDERVHY 477
SPGA R S + SP+ S++PK SSS R+++++K YE+ LKGIE L+FD DERV Y
Sbjct: 416 SPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 577 bits (1489), Expect = 0.0
Identities = 174/326 (53%), Positives = 227/326 (69%), Gaps = 3/326 (0%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGT 63
VG FR+G+KIG G+FGE+ LG N+ TNE VAIKLE +K++ PQL E + Y+ L G
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
GIP V +FG G YN +V++LLGPSLEDLF+ C R SLKTVLM+A Q+I+R+E+VHSK+
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 124 FLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
++RD+KP+NFL+G + ++IIDF LAK+Y D T +HIPYRE+K+LTGTARY S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
+NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T K++Y+KI + K +T IE LC
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245
Query: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 301
+P E A+Y Y R L F +KPDY YL+++F DLF R+G+ FDY +DW + A
Sbjct: 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGA 304
Query: 302 TPPARALVPGAGTSGAPPAIASGDRQ 327
AL + Q
Sbjct: 305 VQQDPALSSNREAHQHRDKMQQSKNQ 330
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 573 bits (1479), Expect = 0.0
Identities = 231/294 (78%), Positives = 269/294 (91%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 568 bits (1466), Expect = 0.0
Identities = 173/295 (58%), Positives = 214/295 (72%), Gaps = 2/295 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
VG +++GR+IG GSFG I+ GTN+ N++VAIK E ++ PQL E + Y++L
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
G TGIPNV +FG EG +NVLV+DLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 121 SKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
KS ++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238
Y S+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST +
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293
LC G+P EF Y HY R+L FD PDY YL+ +F + R D FDW +L
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 523 bits (1350), Expect = 0.0
Identities = 84/332 (25%), Positives = 148/332 (44%), Gaps = 29/332 (8%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLLYESKL 55
+ +++G IG G FG IYL ++ ++ +K+E + + L E K
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE--PSDNGPLFTELKF 86
Query: 56 YRILQ--------------GGTGIPNVRWFGVEG----DYNVLVMDLLGPSLEDLFNFCS 97
Y+ G+P G+ Y ++MD G L+ ++ +
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
++ S KTVL L+ ++++ +E++H ++H DIK N L+ +QVY++D+GLA +Y
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN-PDQVYLVDYGLAYRYC 205
Query: 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
H+ + GT + S++ H G+ SRR DLE LGY ++ +L G LPW+
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265
Query: 218 AGTKKQKYEKISEKKVSTSIEALC---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFR 274
K + KI ++ S+ C P E A Y + L + +KP Y L+ I
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325
Query: 275 DLFIREGFQFDYVFDWTILKYQQSQLATPPAR 306
G + D D ++++ + T +
Sbjct: 326 QGLKAIGSKDDGKLDLSVVENGGLKAKTITKK 357
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 500 bits (1290), Expect = e-177
Identities = 90/314 (28%), Positives = 141/314 (44%), Gaps = 29/314 (9%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLLYESKLYRIL 59
++ GN++ LG+KIGSG FG IYL E+ A + V+ ++ L E K Y+ +
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 60 QGGT--------------GIPNVRWFGV----EGDYNVLVMDLLGPSLEDLFNFCSRKLS 101
GIP G+ Y +VM+ LG L+ + +
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTFK 149
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
TVL L +M++ +E++H ++H DIK N L+G +QVY+ D+GL+ +Y
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQVYLADYGLSYRYCPNGN 208
Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL---KA 218
H+ K GT + S++ H G+ SRR D+E LGY ++ +L G LPW+
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268
Query: 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278
+ K + E S A E A + SL +D+KP+Y LK+I I
Sbjct: 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328
Query: 279 REGFQFDYVFDWTI 292
G D++
Sbjct: 329 PLGP-----LDFST 337
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 489 bits (1261), Expect = e-173
Identities = 72/316 (22%), Positives = 126/316 (39%), Gaps = 33/316 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT--------NEEVAIKLENVKT------------ 44
G +++L + G +Y T ++ ++KL+
Sbjct: 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA 99
Query: 45 -KHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNVLVMDLLGPSLEDLFNFCSRK-LS 101
K Q+ KLY IP FGV + Y LV+ LG SL+ + + LS
Sbjct: 100 AKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLS 157
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
++VL +A ++++ +EF+H ++H ++ +N + + +QV + +G A +Y +
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCPS-- 214
Query: 162 HQHIPYRENKN--LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
+H+ Y E G + SM+ H G SRR DL+SLGY ++ +L G LPW
Sbjct: 215 GKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274
Query: 220 TKKQKYEKISEKKVSTSIEALCRGY---PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
T+ +K C + Y +L +++KP YA L+ L
Sbjct: 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334
Query: 277 FIREGFQFDYVFDWTI 292
+
Sbjct: 335 LQDLRVSPYDPIGLPM 350
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 54/257 (21%), Positives = 93/257 (36%), Gaps = 47/257 (18%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLYRILQG 61
G + + ++IGSG +++ N + + AIK LE + E LQ
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 62 GTGIPN---VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMIN 114
+ +R + E +VM+ DL ++ +K + M+
Sbjct: 67 ----HSDKIIRLYDYEITDQYIYMVMECGN---IDLNSWLKKKKSIDPWERKSYWKNMLE 119
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
V +H +H D+KP NFL+ G + +IDFG+A + + +T +
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQV 170
Query: 175 GTARYAS-----------MNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQGLKAGT 220
GT Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII--N 225
Query: 221 KKQKYEKISEKKVSTSI 237
+ K I +
Sbjct: 226 QISKLHAIIDPNHEIEF 242
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 53/255 (20%), Positives = 93/255 (36%), Gaps = 43/255 (16%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLYRILQG 61
G + + ++IGSG +++ N + + AIK LE + E LQ
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 62 GTGIPN---VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMIN 114
+ +R + E +VM+ DL ++ +K + M+
Sbjct: 86 ----HSDKIIRLYDYEITDQYIYMVMECGNI---DLNSWLKKKKSIDPWERKSYWKNMLE 138
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
V +H +H D+KP NFL+ G + +IDFG+A + + +T +
Sbjct: 139 AVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQV 189
Query: 175 GTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKK 222
GT Y N + S + D+ SLG ++Y G P+Q + +
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQII--NQI 246
Query: 223 QKYEKISEKKVSTSI 237
K I +
Sbjct: 247 SKLHAIIDPNHEIEF 261
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 62/315 (19%), Positives = 110/315 (34%), Gaps = 55/315 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQGGT 63
+ + L +G G+ ++ G + +T + AIK+ + + E ++ + L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-- 66
Query: 64 GIPN-VRWFGVEGDYN----VLVMDLL--GPSLEDLFNFCSRK-----LSLKTVLMLADQ 111
N V+ F +E + VL+M+ G L+ L L++
Sbjct: 67 --KNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYREN 170
++ + + +HR+IKP N + +G VY + DFG A++ D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-------- 172
Query: 171 KNLTGTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG-T 220
+L GT Y + + DL S+G V Y GSLP++ +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRR 231
Query: 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL---F 277
K+ KI K S +I + + D P L R + L
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRGLQVLLTPV 282
Query: 278 IREGFQFDYVFDWTI 292
+ + D W
Sbjct: 283 LANILEADQEKCWGF 297
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 62/315 (19%), Positives = 110/315 (34%), Gaps = 55/315 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQGGT 63
+ + L +G G+ ++ G + +T + AIK+ + + E ++ + L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-- 66
Query: 64 GIPN-VRWFGVEGDYN----VLVMDLL--GPSLEDLFNFCSRK-----LSLKTVLMLADQ 111
N V+ F +E + VL+M+ G L+ L L++
Sbjct: 67 --KNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTSTHQHIPYREN 170
++ + + +HR+IKP N + +G VY + DFG A++ D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-------- 172
Query: 171 KNLTGTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG-T 220
+L GT Y + + DL S+G V Y GSLP++ +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRR 231
Query: 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL---F 277
K+ KI K S +I + + D P L R + L
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRGLQVLLTPV 282
Query: 278 IREGFQFDYVFDWTI 292
+ + D W
Sbjct: 283 LANILEADQEKCWGF 297
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 41/254 (16%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLYRILQG 61
G + + ++IGSG +++ N + + AIK LE + E LQ
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 62 GTGIPN---VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMIN 114
+ +R + E +VM+ DL ++ +K + M+
Sbjct: 114 ----HSDKIIRLYDYEITDQYIYMVMECGN---IDLNSWLKKKKSIDPWERKSYWKNMLE 166
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
V +H +H D+KP NFL+ G + +IDFG+A + + +T +
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQV 217
Query: 175 GTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
G Y N + S + D+ SLG +L Y G P+Q + +
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQIS 275
Query: 224 KYEKISEKKVSTSI 237
K I +
Sbjct: 276 KLHAIIDPNHEIEF 289
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 38/247 (15%), Positives = 73/247 (29%), Gaps = 53/247 (21%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKLYRILQG- 61
K +L + G ++L +++ E+ A+K+ + ++ +L + L G
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 62 -------------------GTGIPNV-RWFGVEGDYNV----LVMDLLGPSLEDLFNFCS 97
P + + DY V L+M LE LF+
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 98 R------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
+ + +L Q+I + SK +H PDN + ++ + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVS 239
Query: 152 LAKKYRDTSTHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K + YA + + LG + +Y
Sbjct: 240 ALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLG-LSIYRVWC 288
Query: 209 GSLPWQG 215
LP+
Sbjct: 289 LFLPFGL 295
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 40/276 (14%), Positives = 75/276 (27%), Gaps = 47/276 (17%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKLYRILQGG 62
G +G T+ +T E + + Q+ E R+L+G
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 63 ---------------------TGIPNV-RWFGVEGDYN----VLVMDLLGPSLEDLFNF- 95
+ R E D + + +L+
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 96 -----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
+ L L L Q+I + +H +H ++P + ++ + V++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGF 250
Query: 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRG 209
+ E L S + + D +LG +++Y
Sbjct: 251 EHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIWCA 309
Query: 210 SLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 243
LP E I S K + + AL G
Sbjct: 310 DLPITK---DAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 47/235 (20%), Positives = 84/235 (35%), Gaps = 44/235 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------LENVKT--------KHP 47
R + F +G G+FG++ N + AIK L + + H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVL 106
Y + Y + + M+ +L DL + +
Sbjct: 63 ---YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT----STH 162
L Q++ + ++HS+ +HRD+KP N + + V I DFGLAK +
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 163 QHIPYRENKNLT---GTARYAS--MNTHLGIEQSRRDDLE----SLG---YVLMY 205
+ NLT GTA Y + + ++ + + + SLG + ++Y
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEV-----LDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 54/239 (22%), Positives = 93/239 (38%), Gaps = 49/239 (20%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRI--- 58
E +RLG +G G FG ++ G + +VAIK+ + + S
Sbjct: 27 EAFEAE-YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLE 84
Query: 59 ------LQGGTGIPNV----RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL-- 106
+ G G P V WF + + +LV++ P+ +DLF++ + K L
Sbjct: 85 VALLWKVGAGGGHPGVIRLLDWFETQEGF-MLVLERPLPA-QDLFDYITEKGPLGEGPSR 142
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
Q++ ++ HS+ +HRDIK +N L + R +IDFG D
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHDEPYT---- 196
Query: 167 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
GT Y+ S + + + + SLG Y ++ G +P++
Sbjct: 197 -------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVC---GDIPFER 241
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 3e-24
Identities = 54/332 (16%), Positives = 107/332 (32%), Gaps = 73/332 (21%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------LENVKT------ 44
+ + + + ++G+G FG + + T E+VAIK E
Sbjct: 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 45 --KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--- 99
HP ++ + G + D +L M+ DL + ++
Sbjct: 68 KLNHPNVV---SAREVPDGLQKLA-------PNDLPLLAMEYC--EGGDLRKYLNQFENC 115
Query: 100 --LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
L + L + + + ++H +HRD+KP+N ++ G + IID G AK+
Sbjct: 116 CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 158 DTSTHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMYFL-RGSL 211
GT +Y + + +EQ + D S G L + G
Sbjct: 176 QGEL--------CTEFVGTLQYLAPEL-----LEQKKYTVTVDYWSFG-TLAFECITGFR 221
Query: 212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF-DDKPDYAYLK 270
P+ + ++ +K + I Y +++F P +L
Sbjct: 222 PFLP---NWQPVQWHGKVREKSNEHIVV-----------YDDLTGAVKFSSVLPTPNHLS 267
Query: 271 RIFRDL---FIREGFQFDYVFDWTILKYQQSQ 299
I +++ + T +
Sbjct: 268 GILAGKLERWLQCMLMWHQRQRGTDPQNPNVG 299
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 58/261 (22%), Positives = 94/261 (36%), Gaps = 42/261 (16%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG 61
E + N + +G GS G + VA+K L E K +L
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRML-IDFCDIALMEIK---LLTE 64
Query: 62 GTGIPN-VRWFGVEGDYNV--LVMDLLGPSLEDL------FNFCSRKLSLKTVLMLADQM 112
PN +R++ E + ++L +L+DL + + + L Q+
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 113 INRVEFVHSKSFLHRDIKPDNFL----------MGLGRRANQVYIIDFGLAKKYRDTSTH 162
+ V +HS +HRD+KP N L G ++ I DFGL KK
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG--- 181
Query: 163 QHIPYRENKNLTGTARYA-------SMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPW 213
Q N +GT+ + S N +R D+ S+G + Y++ +G P+
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHPF 240
Query: 214 QGLKAGTKKQKYEKISEKKVS 234
G K + I S
Sbjct: 241 -----GDKYSRESNIIRGIFS 256
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 42/222 (18%), Positives = 81/222 (36%), Gaps = 28/222 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGT 63
+ +K+G G F + L + A+K + + E+ ++R+
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-- 85
Query: 64 GIPN-VRWFGV-----EGDYNV-LVMDL-LGPSLEDLFNFCSRK---LSLKTVLMLADQM 112
PN +R + L++ +L + K L+ +L L +
Sbjct: 86 --PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT--STHQHIPYREN 170
+E +H+K + HRD+KP N L+G Q ++D G + + Q + ++
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 171 KNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 206
T Y + + R D+ SLG Y +M+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 57/237 (24%), Positives = 98/237 (41%), Gaps = 47/237 (19%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYR- 57
EP +++G +GSG FG +Y G + N VAIK K + +L +++
Sbjct: 39 EPLESQ-YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPME 96
Query: 58 --ILQG-GTGIPNV----RWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLML 108
+L+ +G V WF + VL+++ P +DLF+F + + L +
Sbjct: 97 VVLLKKVSSGFSGVIRLLDWFERPDSF-VLILERPEPV-QDLFDFITERGALQEELARSF 154
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
Q++ V H+ LHRDIK +N L + ++ +IDFG +DT
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT------ 206
Query: 169 ENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
GT Y+ + + G + SLG Y ++ G +P++
Sbjct: 207 -----DFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVC---GDIPFEH 251
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 39/281 (13%), Positives = 75/281 (26%), Gaps = 60/281 (21%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKLYRILQG-- 61
G +G T+ +T E + + Q+ E R+L+G
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 62 -------------------GTGIPNV-RWFGVEGDYNV----LVMDLLGPSLEDLFNFCS 97
+ R E D V + + +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 98 RK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
L L L Q+I + +H +H ++P + ++ + V++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFE 256
Query: 152 LAKKY-RDTSTHQHIPYRENKNLTGTARYAS-----MNTHLGIEQSRRDDLESLGYVLMY 205
+ + + + H + D +LG + +Y
Sbjct: 257 HLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAFDTWTLG-LAIY 308
Query: 206 F-LRGSLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 243
+ LP E I S K + + AL G
Sbjct: 309 WIWCADLPNTD---DAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 49/223 (21%), Positives = 85/223 (38%), Gaps = 21/223 (9%)
Query: 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG 62
VG F +G G+ G I + N +VA+K E + +L+
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRIL-PECFSFADREVQ---LLRES 74
Query: 63 TGIPN-VRWFGVEGDYNV--LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN +R+F E D + ++L +L++ + L Q + + +
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 120 HSKSFLHRDIKPDNFL--MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
HS + +HRD+KP N L M + I DFGL KK + + GT
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTE 190
Query: 178 RYAS---MNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQG 215
+ + ++ + D+ S G + Y++ GS P+
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 61/248 (24%), Positives = 110/248 (44%), Gaps = 40/248 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---IL 59
++++ R +G GSFGE+ L + T +E A+K+ + K + Q + L R +L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQKTDKESLLREVQLL 80
Query: 60 QGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQM 112
+ PN ++ + E LV ++ G +LF+ SRK S + Q+
Sbjct: 81 K-QLDHPNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIRQV 135
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
++ + ++H +HRD+KP+N L+ + + IIDFGL+ + + K+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--------KD 187
Query: 173 LTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
GTA Y + E D+ S G V++Y L G P+ G + +
Sbjct: 188 KIGTAYYIAP------EVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDILK 237
Query: 227 KISEKKVS 234
K+ + K +
Sbjct: 238 KVEKGKYT 245
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 37/170 (21%), Positives = 61/170 (35%), Gaps = 13/170 (7%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLY 56
E F+ ++G GS+GE++ + + A+K K + L E
Sbjct: 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEV--- 107
Query: 57 RILQGGTGIPN-VRWFG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
+ P VR EG L +L GPSL+ L V +
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
+ +HS+ +H D+KP N +G + + DFGL + +
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGE 214
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 72/245 (29%), Positives = 110/245 (44%), Gaps = 45/245 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRILQ 60
F +GR +G G FG +YL Q+ +A+K LE +H QL E ++ L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLR 67
Query: 61 GGTGIPN-VRWFGV-EGDYNV-LVMDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINR 115
PN +R +G V L+++ L ++ + K + ++ N
Sbjct: 68 H----PNILRLYGYFHDATRVYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+ + HSK +HRDIKP+N L+G A ++ I DFG + H P +L G
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTDLCG 169
Query: 176 TARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKIS 229
T Y M IE D DL SLG VL Y FL G P++ A T ++ Y++IS
Sbjct: 170 TLDYLPPEM-----IEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQETYKRIS 220
Query: 230 EKKVS 234
+ +
Sbjct: 221 RVEFT 225
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 61/248 (24%), Positives = 113/248 (45%), Gaps = 43/248 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLY-ESKLYRIL 59
+ ++ +K+GSG++GE+ L + T+ E AIK +V T L E + ++L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 60 QGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQM 112
PN ++ + E N LVM+ G +LF+ R + ++ Q+
Sbjct: 94 DH----PNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
++ V ++H + +HRD+KP+N L+ + + I+DFGL+ + + K
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--------KE 197
Query: 173 LTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
GTA Y + E R+ D+ S+G V+++ L G P+ G T ++
Sbjct: 198 RLGTAYYIAP------EVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILR 247
Query: 227 KISEKKVS 234
K+ + K +
Sbjct: 248 KVEKGKYT 255
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 59/250 (23%), Positives = 109/250 (43%), Gaps = 43/250 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLY-ESKLYR 57
+ ++ + +G GSFGE+ + T +E A+K + K K + E +L +
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 58 ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSRK-LSLKTVLMLAD 110
L PN ++ F + E + +V +L G +LF+ RK S +
Sbjct: 77 KLDH----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++ +
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------- 180
Query: 171 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 224
K+ GTA Y + E R D+ S G V++Y L G+ P+ G +
Sbjct: 181 KDRIGTAYYIAP------EVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDI 230
Query: 225 YEKISEKKVS 234
+++ K +
Sbjct: 231 LKRVETGKYA 240
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 43/198 (21%), Positives = 69/198 (34%), Gaps = 30/198 (15%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT----------KHP 47
++ R G F+ IGSG FG+++ + + IK N K H
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHV 64
Query: 48 QL--LYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLK 103
+ + + + + M+ +LE KL
Sbjct: 65 NIVHYNGC--WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
L L +Q+ V+++HSK ++RD+KP N + QV I DFGL ++
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRT 179
Query: 164 HIPYRENKNLTGTARYAS 181
GT RY S
Sbjct: 180 RS--------KGTLRYMS 189
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 66/248 (26%), Positives = 114/248 (45%), Gaps = 42/248 (16%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQG 61
+ + F RK+GSG+FG+++L + E IK + + Q+ E ++ + L
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 62 GTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLF------NFCSRKLSLKTVLMLAD 110
PN ++ F V E +N+ +VM+ G +L + LS V L
Sbjct: 80 ----PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMK 131
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
QM+N + + HS+ +H+D+KP+N L + + IIDFGLA+ ++
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------- 183
Query: 171 KNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
N GTA Y + + + D+ S G V+MYF L G LP+ G + ++ +
Sbjct: 184 TNAAGTALYMAPEVFKRDVTFKC----DIWSAG-VVMYFLLTGCLPFTG---TSLEEVQQ 235
Query: 227 KISEKKVS 234
K + K+ +
Sbjct: 236 KATYKEPN 243
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 8e-21
Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 34/236 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRILQ 60
F++G +G GSF +Y +I T EVAIK + ++ E K++ L+
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLK 69
Query: 61 GGTGIPN-VRWFGV-EGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
P+ + + E V LV+++ + + S Q+I +
Sbjct: 70 H----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
++HS LHRD+ N L+ R + I DFGL +T +P+ ++ L GT
Sbjct: 126 LYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGL-------ATQLKMPHEKHYTLCGT 175
Query: 177 ARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKIS 229
Y S + T D+ SLG + Y L G P+ T K K+
Sbjct: 176 PNYISPEIAT--RSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVV 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 57/246 (23%), Positives = 96/246 (39%), Gaps = 43/246 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKL 55
+PR ++ GR +G G F + + ++ T E A K L + ++ E +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 68
Query: 56 YRILQGGTGIPN-VRWFGV-EGDYNV-LVMDLLGPSLEDLFNFCSRK--LSLKTVLMLAD 110
+R L + V + G E + V +V++L L R+ L+
Sbjct: 69 HRSLAH----QHVVGFHGFFEDNDFVFVVLELC--RRRSLLELHKRRKALTEPEARYYLR 122
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q++ +++H +HRD+K N + +V I DFGL +T
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGL-------ATKVEYDGERK 172
Query: 171 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 224
K L GT Y S H S D+ S+G +MY L G P++ K+
Sbjct: 173 KVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKET 223
Query: 225 YEKISE 230
Y +I +
Sbjct: 224 YLRIKK 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 53/242 (21%), Positives = 94/242 (38%), Gaps = 53/242 (21%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQ 60
+ +GSG+FG ++ + + N+EV +K ++ K + + KL ++
Sbjct: 20 GEYSQK-YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 61 GGTGI--------PN-VRWFGV---EGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVL 106
I N ++ + +G + LVM+ G L+ LF F R L
Sbjct: 79 ---EIAILSRVEHANIIKVLDIFENQGFF-QLVMEKHGSGLD-LFAFIDRHPRLDEPLAS 133
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
+ Q+++ V ++ K +HRDIK +N + + + +IDFG A
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLER-------- 182
Query: 167 YRENKNLT---GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
K GT Y N + G E ++ SLG Y L++ P+
Sbjct: 183 ---GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSLGVTLYTLVF---EENPFCE 232
Query: 216 LK 217
L+
Sbjct: 233 LE 234
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 33/187 (17%), Positives = 73/187 (39%), Gaps = 26/187 (13%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGG 62
+ K+ + +G G FG ++ + + K VK + E + I +
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH- 60
Query: 63 TGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMIN 114
N + E + ++ + + D+F + L+ + ++ Q+
Sbjct: 61 ---RNILHLHESFESMEELVMIFEFISGL----DIFERINTSAFELNEREIVSYVHQVCE 113
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
++F+HS + H DI+P+N + RR++ + II+FG A++ + + L
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKPGDNF--------RLLF 164
Query: 175 GTARYAS 181
Y +
Sbjct: 165 TAPEYYA 171
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 39/228 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL----YESKLYRILQ 60
+ ++++ K+G G +YL + N +VAIK + R +
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFEREVH 63
Query: 61 GGT-----GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
+ I ++ E D LVM+ + GP+L + LS+ T + +Q+++
Sbjct: 64 NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILD 122
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
++ H +HRDIKP N L+ + I DFG+AK +TS Q ++
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQ------TNHVL 173
Query: 175 GTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 215
GT +Y S EQ++ D+ S+G +++Y L G P+ G
Sbjct: 174 GTVQYFSP------EQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 35/181 (19%), Positives = 74/181 (40%), Gaps = 26/181 (14%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---ILQGGTGIPN 67
+++G G F + + T +E A K +K + +++ +L+ P
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKF--LKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 68 -VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEF 118
+ V +L+++ G ++F+ C + +S V+ L Q++ V +
Sbjct: 91 VINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
+H + +H D+KP N L+ + I+DFG+++K + + GT
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--------REIMGTPE 198
Query: 179 Y 179
Y
Sbjct: 199 Y 199
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 46/232 (19%), Positives = 85/232 (36%), Gaps = 35/232 (15%)
Query: 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQ 60
+G + R+ R + G F +Y ++ + E A+K + ++ E + L
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 61 GGTGIPN-VRWFGV---------EGDYNVLV-MDLLGPSLEDLFNFCSRK--LSLKTVLM 107
G PN V++ G L+ +L L + + LS TVL
Sbjct: 84 GH---PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 108 LADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-----TS 160
+ Q V+ +H + +HRD+K +N L+ + + DFG A S
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWS 197
Query: 161 THQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 206
+ E T Y + ++ + + D+ +LG Y+L +
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 36/171 (21%), Positives = 67/171 (39%), Gaps = 19/171 (11%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES----KLYRILQG 61
+ +G G+F ++Y T N+ + +K + P +E +L L+
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 62 GT--GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFN----FCSRKLSLKTVLMLADQMIN 114
+ + +VLV +L +L + N + + V+ A +M+
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--------VYIIDFGLAKKYR 157
+E VH +H DIKPDNF++G G + +ID G + +
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 58/246 (23%), Positives = 94/246 (38%), Gaps = 43/246 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKL 55
+PR ++ GR +G G F + + ++ T E A K L + ++ E +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 94
Query: 56 YRILQGGTGIPN-VRWFGV-EGDYNV-LVMDLLGPSLEDLFNFCSR--KLSLKTVLMLAD 110
+R L + V + G E + V +V++L L R L+
Sbjct: 95 HRSLAH----QHVVGFHGFFEDNDFVFVVLELC--RRRSLLELHKRRKALTEPEARYYLR 148
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q++ +++H +HRD+K N L V I DFGL +T
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGL-------ATKVEYDGERK 198
Query: 171 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 224
K L GT Y S H S D+ S+G +MY L G P++ K+
Sbjct: 199 KVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKET 249
Query: 225 YEKISE 230
Y +I +
Sbjct: 250 YLRIKK 255
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 65/281 (23%), Positives = 118/281 (41%), Gaps = 29/281 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKLYRILQGG 62
+ +G++IGSGSFG +Y G + +VA+K+ NV PQ L E + R +
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 79
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
N + + G +V G SL + K +K ++ +A Q +++
Sbjct: 80 ---VNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
+H+KS +HRD+K +N + N V I DFGLA + S + + L+G+
Sbjct: 136 LHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSG-----SHQFEQLSGSIL 187
Query: 179 YAS---MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
+ + + S + D+ + G VL + G LP+ + + Q E + +S
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSP 245
Query: 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
+ + P C + D++P + + +L
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 61/247 (24%), Positives = 102/247 (41%), Gaps = 49/247 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRILQ 60
+ F +GR +G G FG +YL Q +A+K LE +H QL E ++ L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLR 72
Query: 61 GGTGIPN-VRWFGVEGDYN--VLVMDLL--GPSLEDLFNFCSR--KLSLKTVLMLADQMI 113
PN +R + D L+++ G +L+ + + + +++
Sbjct: 73 H----PNILRMYNYFHDRKRIYLMLEFAPRG----ELYKELQKHGRFDEQRSATFMEELA 124
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
+ + + H + +HRDIKP+N LMG ++ I DFG + H P + +
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRRRTM 172
Query: 174 TGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEK 227
GT Y M IE D DL G VL Y FL G P+ + + + + +
Sbjct: 173 CGTLDYLPPEM-----IEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTETHRR 223
Query: 228 ISEKKVS 234
I +
Sbjct: 224 IVNVDLK 230
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 60/258 (23%), Positives = 105/258 (40%), Gaps = 48/258 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---------LENVKTKHPQLLYE 52
E ++G + RK+GSG++GE+ L + E AIK +
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 53 SKLYR---ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSR-KLSL 102
++Y +L+ PN ++ F V E LV + G +LF +R K
Sbjct: 91 EEIYNEISLLK-SLDHPNIIKLFDVFEDKKYFYLVTEFYEGG----ELFEQIINRHKFDE 145
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
+ Q+++ + ++H + +HRDIKP+N L+ + I+DFGL+ +
Sbjct: 146 CDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGL 216
++ GTA Y + E ++ D+ S G V+MY L G P+ G
Sbjct: 206 --------RDRLGTAYYIAP------EVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG- 249
Query: 217 KAGTKKQKYEKISEKKVS 234
+ +K+ + K
Sbjct: 250 --QNDQDIIKKVEKGKYY 265
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 38/168 (22%), Positives = 79/168 (47%), Gaps = 16/168 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG 64
+ +++ + + +GSG+ GE+ L +T ++VAI++ + + E+ ++
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 65 I------PN-VRWFGVEGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
I P ++ + +V++L+ G +LF+ +L T + QM
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQM 248
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
+ V+++H +HRD+KP+N L+ + I DFG +K +TS
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 46/189 (24%), Positives = 87/189 (46%), Gaps = 27/189 (14%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLY-ESKLYR 57
+ ++ + +G GSFGE+ + T +E A+K+ + K K + E +L +
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 58 ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN-FCSR-KLSLKTVLMLAD 110
L PN ++ F + E + +V +L G +LF+ R + S +
Sbjct: 77 KLDH----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++ +
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------- 180
Query: 171 KNLTGTARY 179
K+ GTA Y
Sbjct: 181 KDRIGTAYY 189
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 47/257 (18%), Positives = 95/257 (36%), Gaps = 64/257 (24%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------------LENVKT------ 44
+G K+ +G +G GS+G++ + +T A+K NVK
Sbjct: 3 LIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 45 --KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF-CSRKLS 101
+H ++ +L +L +VM+ ++++ + ++
Sbjct: 62 RLRHKNVI---QLVDVLYNEE-----------KQKMYMVMEYCVCGMQEMLDSVPEKRFP 107
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
+ Q+I+ +E++HS+ +H+DIKP N L L + I G+A+
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVAEALH---- 160
Query: 162 HQHIPYRENKNLT---GTARYAS------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
P+ + G+ + ++T G + D+ S G L G P
Sbjct: 161 ----PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAGVTLYNITTGLYP 212
Query: 213 WQGLKAGTKKQKYEKIS 229
++G + +E I
Sbjct: 213 FEG---DNIYKLFENIG 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 49/218 (22%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG 64
+ +++ + + +GSG+ GE+ L +T ++VAIK+ + + E+ ++
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 65 I------PN-VRWFGVEGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
I P ++ + +V++L+ G +LF+ +L T + QM
Sbjct: 68 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQM 123
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
+ V+++H +HRD+KP+N L+ + I DFG +K +TS +
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--------RT 175
Query: 173 LTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYFL 207
L GT Y + + + +R D SLG V+++
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFIC 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 40/188 (21%), Positives = 81/188 (43%), Gaps = 27/188 (14%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQG 61
V + + + ++G+G+FG ++ T T A K + + E + +L+
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 62 GTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMI 113
P V E D + ++ + + G +LF + + +S + Q+
Sbjct: 214 ----PTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
+ +H +++H D+KP+N + +R+N++ +IDFGL P + K
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKVT 316
Query: 174 TGTARYAS 181
TGTA +A+
Sbjct: 317 TGTAEFAA 324
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 48/226 (21%), Positives = 87/226 (38%), Gaps = 37/226 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR----- 57
+ +G G + + T +E A+K+ +V E + R
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 58 ---ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLM 107
IL+ +G PN ++ E + LV DL+ G +LF++ + LS K
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKETRK 128
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
+ ++ + +H + +HRD+KP+N L L N + + DFG + +
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDPGEKL----- 180
Query: 168 RENKNLTGTARYAS---MNTHLGIEQSRRD---DLESLGYVLMYFL 207
+ + GT Y + + + D+ S G V+MY L
Sbjct: 181 ---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTL 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 64/250 (25%), Positives = 99/250 (39%), Gaps = 40/250 (16%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKLYR 57
P V + L + +G G++GE+ L N T E VA+K+ + + E + +
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINK 60
Query: 58 ILQGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRK--LSLKTVLMLAD 110
+L N V+++G EG+ L ++ G +LF+ +
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPDAQRFFH 112
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + + +
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL----- 164
Query: 171 KNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225
+ GT Y D+ S G VL L G LPW Q+Y
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSCQEY 218
Query: 226 EKISEKKVST 235
EKK
Sbjct: 219 SDWKEKKTYL 228
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 42/174 (24%), Positives = 71/174 (40%), Gaps = 16/174 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ ++G GSFGE++ + QT + A+K ++ + E L P
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE---ELVACAGLSS----P 110
Query: 67 N-VRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
V +G G + + M+LL G SL L L L Q + +E++H++
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTR 169
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
LH D+K DN L L ++ + DFG A + + + + GT
Sbjct: 170 RILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 34/188 (18%), Positives = 72/188 (38%), Gaps = 29/188 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY---------ESKLYR 57
N+ ++IG G FG ++ G ++ VAIK + + E +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 58 ILQGGTGIPN-VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
L PN V+ +G+ + +VM+ + L + + L L +
Sbjct: 79 NLNH----PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 116 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVY--IIDFGLAKKYRDTSTHQHIPYRENK 171
+E++ +++ +HRD++ N + V + DFGL+++ + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS---------- 184
Query: 172 NLTGTARY 179
L G ++
Sbjct: 185 GLLGNFQW 192
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 47/180 (26%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------- 45
+ +G + + +G GSFG++ L T+ +T ++VA+K + +
Sbjct: 5 KRHIGP-YIIRETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISY 62
Query: 46 -----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK- 99
HP ++ KLY ++ T I V+V++ G +LF++ K
Sbjct: 63 LKLLRHPHII---KLYDVITTPTDI-------------VMVIEYAG---GELFDYIVEKK 103
Query: 100 -LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
++ Q+I +E+ H +HRD+KP+N L+ V I DFGL+ D
Sbjct: 104 RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNIMTD 160
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-19
Identities = 49/204 (24%), Positives = 72/204 (35%), Gaps = 33/204 (16%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQ 60
R F + +G G FG ++ N + AIK L N + +++ E K L+
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 61 GGTGIPN-VRWFGVEGDYNV--------------LVMDLL-GPSLEDLFNFCSRKLSL-- 102
P VR+F + N + M L +L+D N
Sbjct: 62 H----PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
L + Q+ VEF+HSK +HRD+KP N + V + DFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEE 174
Query: 163 QHIPYRENKNLT-----GTARYAS 181
Q + GT Y S
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMS 198
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 46/228 (20%), Positives = 86/228 (37%), Gaps = 32/228 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL----YESKLYRILQGG 62
+ +G IG G FG++Y G + EVAI+L +++ + L E YR +
Sbjct: 33 EQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH- 88
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
N V + G + ++ L G +L + L + +A +++ + +
Sbjct: 89 ---ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-KYRDTSTHQHIPYRENKNLTGTA 177
+H+K LH+D+K N G+ V I DFGL + + R G
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQ---NGWL 198
Query: 178 RY---------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
+ + + S+ D+ +LG + P++
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 30/228 (13%)
Query: 2 EPRVGNKF---RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY------- 51
E R G +F RL R +G G G++Y + VA+KL L
Sbjct: 26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKL-----MSETLSSDPVFRTR 80
Query: 52 ---ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLM 107
E++ LQ + + FG + M L+ G L + L+ +
Sbjct: 81 MQREARTAGRLQE-PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVA 138
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
+ Q+ + ++ H+ HRD+KP+N L+ + Y++DFG+A D Q
Sbjct: 139 IVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQ---- 191
Query: 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
N GT Y + + R D+ +L VL L GS P+QG
Sbjct: 192 --LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 40/220 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKLYRIL 59
V + + + ++GSG+FG ++ T K + T +P + E + L
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQL 105
Query: 60 QGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQ 111
P + + VL+++ L G +LF+ + + +S V+ Q
Sbjct: 106 HH----PKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
++ +H S +H DIKP+N + ++A+ V IIDFGLA K K
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIV--------K 208
Query: 172 NLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFL 207
T TA +A+ +G D+ ++G VL Y L
Sbjct: 209 VTTATAEFAAPEIVDREPVGFYT----DMWAIG-VLGYVL 243
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 51/197 (25%), Positives = 89/197 (45%), Gaps = 32/197 (16%)
Query: 1 MEP----RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK-- 54
MEP +V + + +G ++GSG F + T E A K + S+
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 55 LYR---ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSL--KT 104
+ R IL+ N + V E +V L+++L+ G +LF+F ++K SL +
Sbjct: 62 IEREVSILRQVLH-HNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEE 116
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTH 162
Q+++ V ++H+K H D+KP+N ++ L + + +IDFGLA + D
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF 175
Query: 163 QHIPYRENKNLTGTARY 179
KN+ GT +
Sbjct: 176 --------KNIFGTPEF 184
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 60/255 (23%), Positives = 106/255 (41%), Gaps = 61/255 (23%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKT----- 44
+P +GN +RL + IG G+F ++ L +I T EVAIK L+ +
Sbjct: 10 EQPHIGN-YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 45 ---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR--K 99
HP ++ KL+ +++ + L+M+ S ++F++ +
Sbjct: 69 KILNHPNIV---KLFEVIETEKTL-------------YLIMEYA--SGGEVFDYLVAHGR 110
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ K Q+++ V++ H K +HRD+K +N L L N + I DFG + ++
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV- 166
Query: 160 STHQHIPYRENKNLT---GTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG 215
L G YA+ G + D+ SLG +L + GSLP+ G
Sbjct: 167 ----------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
Query: 216 LKAGTKKQKYEKISE 230
K+ E++
Sbjct: 217 ---QNLKELRERVLR 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 45/247 (18%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRI 58
+ + L IG GS+GE+ + T A K +E+V + E ++ +
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD----RFKQEIEIMKS 62
Query: 59 LQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRK--LSLKTVLMLADQ 111
L PN +R + E + ++ LVM+L G +LF K +
Sbjct: 63 LDH----PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKD 114
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
+++ V + H + HRD+KP+NFL + + +IDFGLA +++ +
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--------R 166
Query: 172 NLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEK 227
GT Y S + G E D S G V+MY L G P+ T + K
Sbjct: 167 TKVGTPYYVSPQVLEGLYGPEC----DEWSAG-VMMYVLLCGYPPFSA---PTDSEVMLK 218
Query: 228 ISEKKVS 234
I E +
Sbjct: 219 IREGTFT 225
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 64/253 (25%), Positives = 98/253 (38%), Gaps = 46/253 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY----ESKLYR 57
P V + L + +G G++GE+ L N T E VA+K+ + + E + +
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINK 60
Query: 58 ILQGGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLE-----DLFNFCSRK--LSLKTVLM 107
+L N V+++G EG+ L + E +LF+ +
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYLFL-------EYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + + +
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL-- 164
Query: 168 RENKNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
+ GT Y D+ S G VL L G LPW
Sbjct: 165 ---NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSC 215
Query: 223 QKYEKISEKKVST 235
Q+Y EKK
Sbjct: 216 QEYSDWKEKKTYL 228
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 40/173 (23%), Positives = 75/173 (43%), Gaps = 21/173 (12%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPN-V 68
+G G++G +Y G ++ +AIK + L E L++ L+ N V
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH----KNIV 82
Query: 69 RWFGVEGDYNVL--VMDLL-GPSLEDL--FNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
++ G + + M+ + G SL L + K + +T+ Q++ ++++H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
+HRDIK DN L + + + I DFG +K+ + + TGT
Sbjct: 143 IVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPC-------TETFTGT 186
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 3e-18
Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 27/190 (14%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLY-ESKLYRI 58
+ + + + ++G G+F + + T E A K+ + + + Q L E+++ R
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 59 LQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQ 111
LQ PN VR + + LV DL+ G +LF +R S Q
Sbjct: 62 LQH----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQ 113
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
++ + + HS +HR++KP+N L+ + V + DFGLA + D+
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--------H 165
Query: 172 NLTGTARYAS 181
GT Y S
Sbjct: 166 GFAGTPGYLS 175
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 45/189 (23%), Positives = 82/189 (43%), Gaps = 28/189 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG 64
V + + +G ++GSG F + T +E A K +K + ++
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKF--IKKRRLSSSRRGVSREEIEREVN 60
Query: 65 I------PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQ 111
I PN + + E +V L+++L+ G +LF+F + K SL Q
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGG----ELFDFLAEKESLTEDEATQFLKQ 116
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
+++ V ++HSK H D+KP+N ++ ++ +IDFG+A K +
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-------- 168
Query: 171 KNLTGTARY 179
KN+ GT +
Sbjct: 169 KNIFGTPEF 177
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 21/170 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYR--- 57
K+ IG G + + T E A+K+ V + R
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 58 ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 110
IL+ G P+ + E + LV DL+ G +LF++ + LS K +
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
++ V F+H+ + +HRD+KP+N L L + + DFG +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEPGE 254
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 51/280 (18%), Positives = 100/280 (35%), Gaps = 57/280 (20%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------LENVKT----- 44
+ K+ L IG GS+G + + QT AIK +E +KT
Sbjct: 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 45 ---KHPQLL-----YESK---------------LYRILQGGTGIPNVRWFGVEGDYNVLV 81
HP + YE + L ++ V
Sbjct: 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 82 MDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137
+ ++ + K + + Q+ + + ++H++ HRDIKP+NFL
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF- 201
Query: 138 LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDD 195
++ ++ ++DFGL+K++ + ++ GT + + + + D
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 196 LESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVS 234
S G VL++ L G++P+ G ++ KK+
Sbjct: 259 AWSAG-VLLHLLLMGAVPFPG---VNDADTISQVLNKKLC 294
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 4e-18
Identities = 41/242 (16%), Positives = 76/242 (31%), Gaps = 70/242 (28%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE-EVAIKL------ENVKT------------ 44
V ++ + I G G IYL + N V +K +
Sbjct: 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV 136
Query: 45 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV-----LVMDLL-GPSLEDLFNFCSR 98
HP I + F D + +VM+ + G SL+ +
Sbjct: 137 VHP----------------SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---Q 177
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
KL + + +++ + ++HS ++ D+KP+N ++ Q+ +ID G +
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAVSRINS 233
Query: 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR-----RDDLESLGYVLMYFLRGSLPW 213
L GT + + E R D+ ++G L
Sbjct: 234 FGY-----------LYGTPGFQAP------EIVRTGPTVATDIYTVGRTLAALTLDLPTR 276
Query: 214 QG 215
G
Sbjct: 277 NG 278
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 23/170 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLLYESKLYRILQ 60
FR+ +KIG G F E+Y + VA+K L + K + + E L + L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLN 90
Query: 61 GGTGIPN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL---KTVLMLADQMI 113
PN ++++ +E + +V++L L + ++ L +TV Q+
Sbjct: 91 H----PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 114 NRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
+ +E +HS+ +HRDIKP N F+ V + D GL + + +T
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTA 192
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-18
Identities = 43/208 (20%), Positives = 67/208 (32%), Gaps = 41/208 (19%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-LLYESKLY 56
M+ R +F KIGSG FG ++ AIK + Q L E
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV--- 61
Query: 57 RILQGGTGIPN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL---KTVLMLA 109
+ VR+F E D+ ++ + G SL D + R +S + L
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 110 DQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYII---------------DFGLA 153
Q+ + ++HS S +H DIKP N F+ D G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 154 KKYRDTSTHQHIPYRENKNLTGTARYAS 181
+ G +R+ +
Sbjct: 182 TRISSPQV-----------EEGDSRFLA 198
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 44/189 (23%), Positives = 79/189 (41%), Gaps = 34/189 (17%)
Query: 4 RVGNKFRLGR-----KIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYR 57
G ++ R K+G G F ++L ++ N VA+K + K E KL +
Sbjct: 11 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 58 IL-------QGGTGIPNV----RWF---GVEGDYNVLVMDLLGPSLEDL---FNFCSRKL 100
+ + G ++ F G G + V+V ++LG +L L + R +
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGI 128
Query: 101 SLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRR---ANQVYIIDFGLAKKY 156
L V ++ Q++ ++++H + +H DIKP+N LM + Q+ I D G A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--- 185
Query: 157 RDTSTHQHI 165
+H
Sbjct: 186 --CWYDEHY 192
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 40/173 (23%), Positives = 71/173 (41%), Gaps = 38/173 (21%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVK--------TKHP 47
++ + IGSG+FG L + T E VA+K ENV+ +HP
Sbjct: 18 DSD-RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHP 76
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF-CSR-KLSLKTV 105
++ + ++ T + ++M+ S +L+ C+ + S
Sbjct: 77 NIV---RFKEVILTPTHL-------------AIIMEYA--SGGELYERICNAGRFSEDEA 118
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
Q+++ V + HS HRD+K +N L+ G A ++ I DFG +K
Sbjct: 119 RFFFQQLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 56/267 (20%), Positives = 98/267 (36%), Gaps = 41/267 (15%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLY 56
M R + + IG+GS+G + + K ++ L+ E L
Sbjct: 1 MPSRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 57 RILQGGTGIPNV-----RWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK---LSLKTVLM 107
R L+ PN+ R +VM+ G L + +++ L + VL
Sbjct: 60 RELKH----PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 108 LADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
+ Q+ ++ H +S LHRD+KP N + V + DFGLA+ ++
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSF 172
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQG-----L 216
K GT Y S + + + D+ SLG L+Y L P+ L
Sbjct: 173 -------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPPFTAFSQKEL 224
Query: 217 KAGTKKQKYEKISEKKVSTSIEALCRG 243
++ K+ +I + S + +
Sbjct: 225 AGKIREGKFRRIPY-RYSDELNEIITR 250
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 41/180 (22%), Positives = 72/180 (40%), Gaps = 25/180 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ + +G G+FG + ++VAIK +++ + E + + P
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSRVNH----P 61
Query: 67 N-VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS- 121
N V+ +G + LVM+ G SL ++ + + + Q V ++HS
Sbjct: 62 NIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 122 --KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
K+ +HRD+KP N L L + I DFG A + T N G+A +
Sbjct: 122 QPKALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMT----------NNKGSAAW 169
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 51/248 (20%), Positives = 90/248 (36%), Gaps = 43/248 (17%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKLYR---ILQGGT 63
+ L IG G F + N +T ++ A+K+ +V K L L R I
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH-ML 83
Query: 64 GIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLAD------QM 112
P+ V D + +V + + DL ++ V A Q+
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
+ + + H + +HRD+KP L+ + V + FG+A + +
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLVAGG 192
Query: 173 LTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLP-WQGLKAGTKKQKYE 226
GT + + G D+ G V+++ L G LP + GTK++ +E
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFY-----GTKERLFE 242
Query: 227 KISEKKVS 234
I + K
Sbjct: 243 GIIKGKYK 250
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 49/226 (21%), Positives = 89/226 (39%), Gaps = 35/226 (15%)
Query: 3 PRVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---I 58
R + ++L +G G+ + N+ T++E A+K+ K S+++R +
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIE-KQP---GHIRSRVFREVEM 63
Query: 59 LQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLF-------NFCSRKLSLKTVL 106
L G N + E + LV + + G + +F + S
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEAS----- 114
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166
++ + + ++F+H+K HRD+KP+N L + + V I DF L + I
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYFL 207
E G+A Y + + DL SLG V++Y L
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 9e-18
Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 44/179 (24%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
++G+ + LG +G G+FG++ +G + T +VA+K + +K
Sbjct: 7 RVKIGH-YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 45 ---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK-- 99
+HP ++ KLY+++ T +VM+ + S +LF++ +
Sbjct: 66 KLFRHPHII---KLYQVISTPTDF-------------FMVMEYV--SGGELFDYICKHGR 107
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ L Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 108 VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 47/189 (24%), Positives = 81/189 (42%), Gaps = 28/189 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG 64
V + + G ++GSG F + T + A K +K + + ++
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVS 66
Query: 65 I------PN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQ 111
I PN + V E +V L+++L+ G +LF+F + K SL + Q
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQ 122
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
++N V ++HS H D+KP+N ++ ++ IIDFGLA K +
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-------- 174
Query: 171 KNLTGTARY 179
KN+ GT +
Sbjct: 175 KNIFGTPEF 183
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 24/167 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLLYESKLYRILQGG 62
K+ +KIG GSFG+ L + + + IK + + +K + E + ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82
Query: 63 TGIPN-VRWFG--VEGDYNVLVMDLL--GPSLEDLFNFCSRK----LSLKTVLMLADQMI 113
PN V++ E +VMD G DLF + + +L Q+
Sbjct: 83 ---PNIVQYRESFEENGSLYIVMDYCEGG----DLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
++ VH + LHRDIK N + + V + DFG+A+ T
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTV 179
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 36/194 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK--------- 54
+V + + +G ++GSG F + T E A K + +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSL--KTVLM 107
L ++L PN + V VL+++L+ G +LF+F ++K SL +
Sbjct: 69 LRQVLH-----PNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATS 119
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHI 165
Q+++ V ++H+K H D+KP+N ++ L + + +IDFGLA + D
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 166 PYRENKNLTGTARY 179
KN+ GT +
Sbjct: 176 -----KNIFGTPEF 184
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 53/233 (22%), Positives = 99/233 (42%), Gaps = 41/233 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL----YESKLYRIL 59
+ +++ LG +G G E++L +++ + +VA+K+ L + + R
Sbjct: 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV-----LRADLARDPSFYLRFRREA 63
Query: 60 QGGTGI--PNV-------RWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109
Q + P + G +VM+ + G +L D+ + ++ K + +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVI 122
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
+ F H +HRD+KP N ++ N V ++DFG+A+ D+ +
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGN----SVTQ 175
Query: 170 NKNLTGTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 215
+ GTA+Y S EQ+R R D+ SLG ++Y L G P+ G
Sbjct: 176 TAAVIGTAQYLSP------EQARGDSVDARSDVYSLG-CVLYEVLTGEPPFTG 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 19/166 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---IL 59
+ F +GSG+F E++L T + A+K +K +S L +L
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKC--IKKS--PAFRDSSLENEIAVL 60
Query: 60 QGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
+ N V + E + LVM L+ G +LF+ R + K ++ Q+
Sbjct: 61 KKIKH-ENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQV 115
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
++ V+++H +HRD+KP+N L +++ I DFGL+K ++
Sbjct: 116 LSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 40/166 (24%), Positives = 68/166 (40%), Gaps = 17/166 (10%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR---IL 59
R +++L ++G G+F + + +E A + + TK KL R I
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMI--INTKKLSARDHQKLEREARIC 64
Query: 60 QGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
+ PN VR + + L+ DL+ G +LF +R S Q+
Sbjct: 65 R-LLKHPNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQQI 119
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ V H +HR++KP+N L+ + V + DFGLA +
Sbjct: 120 LEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 39/212 (18%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN-VR 69
+ +G GSF + ++N+ A+K+ + K E ++ +G PN V+
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQKEITALKLCEGH---PNIVK 70
Query: 70 WFGV-EGDYNV-LVMDLL--GPSLEDLF-------NFCSRKLSLKTVLMLADQMINRVEF 118
V + LVM+LL G +LF +F + S + ++++ V
Sbjct: 71 LHEVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEAS-----YIMRKLVSAVSH 121
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT---G 175
+H +HRD+KP+N L ++ IIDFG A+ +N+ L
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPCF 171
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207
T YA+ DL SLG V++Y +
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLG-VILYTM 202
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 43/171 (25%), Positives = 75/171 (43%), Gaps = 19/171 (11%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYR 57
+ + + + ++G G+F + + T E A K+ N K +L E+++ R
Sbjct: 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83
Query: 58 ILQGGTGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 110
LQ PN VR + + LV DL+ G +LF +R S
Sbjct: 84 KLQH----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQ 135
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
Q++ + + HS +HR++KP+N L+ + V + DFGLA + D+
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 40/248 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG 62
+ + + + IG GS+ + TN E A+K+ + E + IL
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI--IDKSKRDPTEEIE---ILLRY 72
Query: 63 TGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFN--FCSRKLSLKTVLMLADQMINR 115
PN + V + V +V +L+ G +L + + S + + +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITKT 128
Query: 116 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
VE++H++ +HRD+KP N L + I DFG AK+ R EN L
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLLM 178
Query: 175 ---GTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
TA + + D+ SLG VL+Y L G P+ T ++
Sbjct: 179 TPCYTANFVAPEVLERQGYDAAC----DIWSLG-VLLYTMLTGYTPFANGPDDTPEEILA 233
Query: 227 KISEKKVS 234
+I K S
Sbjct: 234 RIGSGKFS 241
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 39/194 (20%), Positives = 64/194 (32%), Gaps = 47/194 (24%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL----------------ENVKTKHPQLLYESK 54
L +G G +GE++ G+ E VA+K+ V +H +L
Sbjct: 12 LLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENIL---G 66
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
W L+ SL D L + L + +
Sbjct: 67 FIASDMTSRHSSTQLW---------LITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIA 115
Query: 114 NRVEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
+ + +H + F HRD+K N L+ ++ Q I D GLA + ++ +
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 166 PYRENKNLTGTARY 179
N GT RY
Sbjct: 173 G---NNPRVGTKRY 183
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 52/264 (19%), Positives = 92/264 (34%), Gaps = 54/264 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
N++ L +IG GS+G + L N N A+K+ + K K L+ ++ R P
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLS-KKK---LIRQAGFPRRPPPRGTRP 68
Query: 67 NVRWFGVEGDY-----------------NVL----VMDLLGPS-----LE-----DLFNF 95
NV+ V+D E +
Sbjct: 69 APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 96 CSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ LS +I +E++H + +HRDIKP N L+G + I DFG++
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSN 185
Query: 155 KYRDTSTHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
+++ + N GT + + T + D+ ++G L F+ G
Sbjct: 186 EFKGSDALLS-------NTVGTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQ 237
Query: 211 LPWQGLKAGTKKQKYEKISEKKVS 234
P+ + KI + +
Sbjct: 238 CPFMD---ERIMCLHSKIKSQALE 258
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 40/187 (21%), Positives = 74/187 (39%), Gaps = 22/187 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHP-QLLYESKLYRILQGGTG 64
+ G +G G FG+ T+ +T E + +K L + L E K+ R L+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH--- 66
Query: 65 IPN-VRWFGV---EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN +++ GV + N + + + G +L + + + A + + + ++
Sbjct: 67 -PNVLKFIGVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN------- 172
HS + +HRD+ N L+ V + DFGLA+ D T K
Sbjct: 125 HSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 173 LTGTARY 179
+ G +
Sbjct: 182 VVGNPYW 188
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 44/179 (24%), Positives = 82/179 (45%), Gaps = 44/179 (24%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
++G+ + LG +G G+FG++ +G + T +VA+K + ++
Sbjct: 12 RVKIGH-YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 45 ---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK-- 99
+HP ++ KLY+++ + I +VM+ + S +LF++ +
Sbjct: 71 KLFRHPHII---KLYQVISTPSDI-------------FMVMEYV--SGGELFDYICKNGR 112
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
L K L Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 113 LDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 168
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 39/164 (23%), Positives = 80/164 (48%), Gaps = 12/164 (7%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGT 63
+ ++L RK+G G + E++ NI NE+V +K L+ VK K ++ E K+ L+GG
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKREIKILENLRGGP 91
Query: 64 ---GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
+ ++ V ++ + + L+ + L+ + +++ +++ H
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH 147
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
S +HRD+KP N ++ R ++ +ID+GLA+ Y +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNV 189
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 47/194 (24%), Positives = 76/194 (39%), Gaps = 47/194 (24%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL----------------ENVKTKHPQLLYESK 54
+ ++IG G +GE+++G E+VA+K+ + V +H +L
Sbjct: 41 MVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL---G 95
Query: 55 LYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
GTG + L+ D SL D S L K++L LA +
Sbjct: 96 FIAADIKGTGSWTQLY---------LITDYHENGSLYDYLK--STTLDAKSMLKLAYSSV 144
Query: 114 NRVEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
+ + +H++ F HRD+K N L+ ++ I D GLA K+ + I
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 166 PYRENKNLTGTARY 179
P GT RY
Sbjct: 202 P---PNTRVGTKRY 212
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 30/167 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGT 63
V ++ + + IG GSFG++ + + ++ VA+K + N K H Q E RIL+
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE---IRILE--- 148
Query: 64 GIPNVRWFGVEGDYNV--------------LVMDLLGPSLEDLF---NFCSRKLSLKTVL 106
++R + NV + +LL +L +L F + SL V
Sbjct: 149 ---HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF--QGFSLPLVR 203
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
A ++ ++ +H +H D+KP+N L+ R + + +IDFG +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSS 249
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 47/200 (23%), Positives = 80/200 (40%), Gaps = 53/200 (26%)
Query: 4 RVGNKFRLGRK--IGSGSFGEIYLGTNIQTNEEVAIKL---------ENVKT-------- 44
V + + + + +G G FG+++ T ++A K+ E VK
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 45 KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRK--- 99
H L+ +LY + I VLVM+ + G +LF+ +
Sbjct: 144 DHANLI---QLYDAFESKNDI-------------VLVMEYVDGG----ELFDRIIDESYN 183
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
L+ ++ Q+ + +H LH D+KP+N L + R A Q+ IIDFGLA++Y+
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYKPR 242
Query: 160 STHQHIPYRENKNLTGTARY 179
K GT +
Sbjct: 243 EKL--------KVNFGTPEF 254
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 42/192 (21%), Positives = 79/192 (41%), Gaps = 37/192 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKL------ENVKTKHPQLLYESKLYRIL 59
+ L IG G FG++Y +EVA+K E++ + E+KL+ +L
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 60 QGGTGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
+ PN + GV + LVM+ G L + + +++ ++ A Q+
Sbjct: 64 KH----PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARG 117
Query: 116 VEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY-----IIDFGLAKKYRDTSTHQHIPY 167
+ ++H + +HRD+K N L+ + I DFGLA+++ T+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK------ 171
Query: 168 RENKNLTGTARY 179
+ G +
Sbjct: 172 ---MSAAGAYAW 180
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 38/231 (16%), Positives = 74/231 (32%), Gaps = 52/231 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----------------ENVKTKHPQLL 50
+ +L IG G +G +Y G+ VA+K+ +H +
Sbjct: 13 DNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIA 70
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109
+ + T + + LVM+ SL + + LA
Sbjct: 71 ---RFIVGDERVTADGRMEYL--------LVMEYYPNGSLXKYLS--LHTSDWVSSCRLA 117
Query: 110 DQMINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
+ + ++H+ + HRD+ N L+ + I DFGL+ +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNR 174
Query: 161 THQHIPY-RENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVL 203
+ + GT RY ++N ++ D+ +LG +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 17/167 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQL-LYESKLYRILQGG 62
K+ KIG GS+G ++ N T + VAIK ++ L E ++ + L+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH- 61
Query: 63 TGIPN-VRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN V V LV + ++ + R + V + Q + V F
Sbjct: 62 ---PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQ 163
H + +HRD+KP+N L+ + + + + DFG A+ D +
Sbjct: 119 HKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDE 162
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 29/185 (15%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN-VR 69
L IG G FGE++ G EEVA+K+ + + + E+++Y+ + N +
Sbjct: 46 LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRH--ENILG 100
Query: 70 WFGVEGDYNV------LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ + N LV D SL D N ++++ ++ LA + + +H +
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 123 --------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
+ HRD+K N L+ ++ I D GLA ++ + I +
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA---PNHRV 212
Query: 175 GTARY 179
GT RY
Sbjct: 213 GTKRY 217
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 42/260 (16%), Positives = 93/260 (35%), Gaps = 51/260 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
N +R+ R + G F +I L N+ A+K E + + +S +I
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 66 --------------PN-VRWFGVEGDYN--VLVMDLLGPSLEDLFNF----------CSR 98
+ G+ +Y+ ++ + + + + F +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM--ENDSILKFDEYFFVLDKNYTC 146
Query: 99 KLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
+ ++ + + ++N ++H+ K+ HRD+KP N LM + +V + DFG ++
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESEYMV 203
Query: 158 DTSTHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQ 214
D GT + ++ + D+ SLG + +Y +P+
Sbjct: 204 DKKIK---------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNVVPFS 253
Query: 215 GLKAGTKKQKYEKISEKKVS 234
+ + + I K +
Sbjct: 254 L--KISLVELFNNIRTKNIE 271
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 8e-16
Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 9/151 (5%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYES--KLYRILQGGTGI 65
F R+IG GSFG +Y +++ +E VAIK + K ++ K R LQ
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 113
Query: 66 PN-VRWFG--VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
PN +++ G + LVM+ S DL + L + + + + ++HS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ +HRD+K N L+ V + DFG A
Sbjct: 174 NMIHRDVKAGNILLSE---PGLVKLGDFGSA 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 44/176 (25%), Positives = 77/176 (43%), Gaps = 35/176 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-------QLLYESK-- 54
K+ KIG G++G ++ N +T+E VA+K L++ P LL E K
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 55 ----LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
L+ +L + LV + L+ F+ C+ L + V
Sbjct: 62 NIVRLHDVLHSDKKL-------------TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF 108
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 163
Q++ + F HS++ LHRD+KP N L+ R ++ + +FGLA+ + + +
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYSAE 161
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 39/184 (21%), Positives = 72/184 (39%), Gaps = 23/184 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG 62
+ + F + ++G G+ +Y T + A+K+ + E + L
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH- 107
Query: 63 TGIPN-VRWFGV-EGDYNV-LVMDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMINR 115
PN ++ + E + LV++L+ G +LF+ + S + Q++
Sbjct: 108 ---PNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
V ++H +HRD+KP+N L + I DFGL+K K + G
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--------KTVCG 212
Query: 176 TARY 179
T Y
Sbjct: 213 TPGY 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 39/179 (21%), Positives = 66/179 (36%), Gaps = 41/179 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
K+ +G GS+G + N T VAIK + +K +H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
L+ L + + LV + + ++ D L + V
Sbjct: 85 NLV---NLLEVCKKKKRW-------------YLVFEFVDHTILDDLELFPNGLDYQVVQK 128
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR---DTSTHQ 163
Q+IN + F HS + +HRDIKP+N L+ ++ V + DFG A+ + +
Sbjct: 129 YLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDE 184
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 11/156 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
F + K+G GS+G +Y + +T + VAIK V++ +++ E I+Q P+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKE---ISIMQQCDS-PH 85
Query: 68 -VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
V+++G + +VM+ S+ D+ ++ L+ + + + +E++H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIK N L+ + DFG+A + DT
Sbjct: 146 KIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDT 178
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 48/241 (19%), Positives = 76/241 (31%), Gaps = 56/241 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----------EN-----VKTKHPQLL 50
+L G FG ++ NE VA+K+ E KH +L
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109
+ + GT + W L+ SL D + +S + +A
Sbjct: 82 ---QFIGAEKRGTSVDVDLW---------LITAFHEKGSLSDFLK--ANVVSWNELCHIA 127
Query: 110 DQMINRVEFVHSKSF----------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ M + ++H HRDIK N L+ + I DFGLA K+
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAG 184
Query: 160 STHQHIPYRENKNLTGTARY-----ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
+ + GT RY + + R D+ ++G VL
Sbjct: 185 KSAG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 215 G 215
G
Sbjct: 240 G 240
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 35/153 (22%), Positives = 66/153 (43%), Gaps = 15/153 (9%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN-VR 69
+ +G G G++ N +T E+ A+K + P+ E +L+ P+ VR
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQC---PHIVR 75
Query: 70 WFGV-----EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V G + +VM+ L G + + + + + + + ++++HS
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ HRD+KP+N L R + + DFG AK
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 47/180 (26%), Positives = 72/180 (40%), Gaps = 21/180 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRIL 59
+ + L IGSG+ + E+VAIK LE +T +LL E +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 60 QGGTGIPNV-RWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM--I 113
PN+ ++ V D LVM LL G S+ D+ K K+ ++ + I
Sbjct: 71 HH----PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 114 NR-----VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
R +E++H +HRD+K N L+G V I DFG++ R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR 183
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 43/188 (22%), Positives = 67/188 (35%), Gaps = 48/188 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT--------------- 44
++ +G G F +Y + TN+ VAIK L +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 45 ----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKL 100
HP ++ L + I LV D + LE + S L
Sbjct: 66 LQELSHPNII---GLLDAFGHKSNI-------------SLVFDFMETDLEVIIKDNSLVL 109
Query: 101 SLKTV--LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ + ML + +E++H LHRD+KP+N L+ + + DFGLAK +
Sbjct: 110 TPSHIKAYML--MTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGS 164
Query: 159 ---TSTHQ 163
THQ
Sbjct: 165 PNRAYTHQ 172
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 38/178 (21%), Positives = 72/178 (40%), Gaps = 40/178 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLEN-----------VKT----KHPQ 48
+ K+G G++ +Y G + T+ VA I+LE+ V KH
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLML 108
++ L+ I+ + LV + L L+ + C +++ V +
Sbjct: 62 IV---TLHDIIHTEKSL-------------TLVFEYLDKDLKQYLDDCGNIINMHNVKLF 105
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 163
Q++ + + H + LHRD+KP N L+ ++ + DFGLA+ T ++
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNE 160
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 48/231 (20%), Positives = 94/231 (40%), Gaps = 42/231 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQLL----YESKLYRILQG 61
+ KIG+GSFG ++ + +VA+K+ + H + + E + + L+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 62 GTGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLF--NFCSRKLSLKTVLMLADQMINR 115
PN V + G + +V + L SL L + +L + L +A +
Sbjct: 94 ----PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 116 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
+ ++H+++ +HR++K N L+ + V + DFGL++ T + +K+
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKAST-------FLSSKSA 199
Query: 174 TGTARYASM------NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
GT + M + + + D+ S G +L PW L
Sbjct: 200 AGTPEW--MAPEVLRDEPS----NEKSDVYSFGVILWELATLQQPWGNLNP 244
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-15
Identities = 33/165 (20%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 4 RVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG 62
V + ++L ++ +G G G++ + +T ++ A+K + P+ E + GG
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGG 81
Query: 63 TGIPN-VRWFGV-----EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
P+ V V G + ++M+ + G + + + + + +
Sbjct: 82 ---PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
++F+HS + HRD+KP+N L + + + DFG AK+
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-15
Identities = 37/156 (23%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
+ + ++G G+FG++Y N +T A K+ K++ +L IL P
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDH-PY 77
Query: 68 -VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
V+ G ++++ G +++ + R L+ + ++ QM+ + F+HSK
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRD+K N LM + + DFG++ K T
Sbjct: 138 IIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKT 170
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 30/173 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKLYRIL 59
+ + + IG+GSFG +Y + E VAIK L++ + K E ++ R L
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK----NRELQIMRKL 104
Query: 60 QGGTGIPNV----RWFGVEGD-----YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
N+ +F G+ Y LV+D + E ++ K L +
Sbjct: 105 DH----CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIY 157
Query: 111 ------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
Q+ + ++HS HRDIKP N L L + + DFG AK+
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLV 208
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK----------------TKHP 47
+K+ KIG G+FGE++ + +T ++VA+K +EN K KH
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
++ L I + N + Y LV D L L + K +L +
Sbjct: 77 NVV---NLIEICRTKASPYNRCKGSI---Y--LVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPY 167
+ ++N + ++H LHRD+K N L+ R + + DFGLA+ + Q Y
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY 185
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 36/165 (21%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI 65
F L +G+G++G++Y G +++T + AIK+ +V + + + +L+ +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI--KQEINMLKKYSHH 80
Query: 66 PN-VRWFG--------VEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMIN 114
N ++G D LVM+ S+ DL L + + + +++
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ +H +HRDIK N L+ +V ++DFG++ + T
Sbjct: 141 GLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRT 182
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 35/157 (22%), Positives = 67/157 (42%), Gaps = 15/157 (9%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN-VR 69
+ +G G G++ N +T E+ A+K + P+ E +L+ P+ VR
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQC---PHIVR 119
Query: 70 WFGV-----EGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V G + +VM+ L G + + + + + + + ++++HS
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ HRD+KP+N L R + + DFG AK+
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 38/206 (18%), Positives = 81/206 (39%), Gaps = 14/206 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGG--- 62
++ + RK+G G F ++L +IQ + VA+K +++ + L E +L + ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 63 -TGIPNVR----WF---GVEGDYNVLVMDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMI 113
V F GV G + +V ++LG L + L L V + Q++
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 114 NRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
++++H+K +H DIKP+N L+ + + + + ++
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 173 LTGTARYASMNTHLGIEQSRRDDLES 198
+ + + DL +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 1e-14
Identities = 44/177 (24%), Positives = 69/177 (38%), Gaps = 36/177 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-------QLLYESK-- 54
F+ KIG G++G +Y N T E VA+K L+ P LL E
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 55 ----LYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLA 109
L ++ + LV + L L+ + + + L +
Sbjct: 63 NIVKLLDVIHTENKL-------------YLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 163
Q++ + F HS LHRD+KP N L+ + + DFGLA+ + T TH+
Sbjct: 110 FQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHE 163
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 41/181 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
+++R K+G G++GE+Y + TNE VAIK LE+ V +H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
++ +L ++ + L+ + L+ + +S++ +
Sbjct: 94 NII---ELKSVIHHNHRL-------------HLIFEYAENDLKKYMDKN-PDVSMRVIKS 136
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRD---TSTH 162
Q+IN V F HS+ LHRD+KP N L+ + + + I DFGLA+ + TH
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 163 Q 163
+
Sbjct: 197 E 197
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 41/157 (26%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN- 67
F KIG GSFGE++ G + +T + VAIK+ +++ ++ + +L P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYV 82
Query: 68 VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
+++G ++ ++M+ L G S DL L + + +++ ++++HS+
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKK 140
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
+HRDIK N L+ +V + DFG+A + DT
Sbjct: 141 IHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQI 174
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 22/168 (13%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQL----LYESKLYRILQGGTGIP 66
+IG G++G +Y + + VA +++ N L + E L R L+ P
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH-P 74
Query: 67 N-VRWFGV------EGDYNV-LVMDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVE 117
N VR V + + V LV + + L + L +T+ L Q + ++
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD--TSTHQ 163
F+H+ +HRD+KP+N L+ V + DFGLA+ Y T
Sbjct: 135 FLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMALTPV 179
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 22/164 (13%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGT 63
+++ + IG GSFG++ + E VAIK ++N K Q E +L ++
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 64 G------IPNVRWFGVEGDYN---VLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLADQ 111
+ R F + LV ++L +L DL NF R +SL A Q
Sbjct: 112 TEMKYYIVHLKRHF----MFRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQ 165
Query: 112 MINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
M + F+ + S +H D+KP+N L+ +R + + I+DFG +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSS 208
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 4e-14
Identities = 48/179 (26%), Positives = 73/179 (40%), Gaps = 42/179 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK-----T-----------KHP 47
K+ KIG G++G +Y N E A+K LE T KH
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
++ KLY ++ + VLV + L L+ L + C L T
Sbjct: 61 NIV---KLYDVIHTKKRL-------------VLVFEHLDQDLKKLLDVCEGGLESVTAKS 104
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 163
Q++N + + H + LHRD+KP N L+ R ++ I DFGLA+ + TH+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHE 160
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 57/262 (21%), Positives = 96/262 (36%), Gaps = 74/262 (28%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KH 46
+ F + R IG GSFG++ + T + A+K + NV +H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 47 P---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCS 97
P L Y E ++ +V+DLL G DL
Sbjct: 75 PFLVNLWYSFQDEEDMF-----------------------MVVDLLLGG----DLRYHLQ 107
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
+ +TV + +++ ++++ ++ +HRD+KPDN L+ V+I DF +A
Sbjct: 108 QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAM 164
Query: 156 YRDTSTHQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMY-FLRGSL 211
+ + GT Y + ++ G S D SLG V Y LRG
Sbjct: 165 LPRETQI--------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRR 215
Query: 212 PWQGLKAGTKKQKYEKISEKKV 233
P+ + + K+ V
Sbjct: 216 PYHIRSSTSSKEIVHTFETTVV 237
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 7e-14
Identities = 36/179 (20%), Positives = 67/179 (37%), Gaps = 42/179 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVK-----T-----------KHP 47
K++ K+G G++G +Y + VA I+L+ T HP
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
++ L ++ + LV + + L+ + + L + +
Sbjct: 80 NIV---SLIDVIHSERCL-------------TLVFEFMEKDLKKVLDENKTGLQDSQIKI 123
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TSTHQ 163
Q++ V H LHRD+KP N L+ + + DFGLA+ + + TH+
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPVRSYTHE 179
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLLYESKLYRILQGGTG 64
+ +IG GSF +Y G + +T EVA + K++ + E+++ + LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--- 84
Query: 65 IPN-VRWFGVEGDYN------VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
PN VR++ VLV +L+ +L+ + + +K + Q++ +
Sbjct: 85 -PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGL 142
Query: 117 EFVHSKS--FLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
+F+H+++ +HRD+K DN F+ G V I D GLA R +
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFAK 188
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 42/179 (23%), Positives = 79/179 (44%), Gaps = 35/179 (19%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKLYRILQG 61
+ + + IG+GSFG ++ ++++E VAIK L++ + K E ++ RI++
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK----NRELQIMRIVKH 91
Query: 62 GTGIPNV----------RWFGVEGDYNVLVMDLLGPSLEDL------FNFCSRKLSLKTV 105
PNV E N LV++ + E + + + + + +
Sbjct: 92 ----PNVVDLKAFFYSNGDKKDEVFLN-LVLEYVP---ETVYRASRHYAKLKQTMPMLLI 143
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR--DTSTH 162
+ Q++ + ++HS HRDIKP N L L + + +IDFG AK + +
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAKILIAGEPNVS 200
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRILQGGTGI 65
K+ KIG G+ G +Y ++ T +EVAI+ N++ K ++ E + R +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN---- 76
Query: 66 PN-VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN V + + GD +VM+ L G SL D+ + + + + + +EF+HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIK DN L+G V + DFG +
Sbjct: 135 NQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPE 169
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 41/183 (22%), Positives = 74/183 (40%), Gaps = 45/183 (24%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLEN-----------VKT----KHPQ 48
++F+ K+G+G++ +Y G N T VA +KL++ + KH
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDL-----FNFCSRKLSLK 103
++ +LY ++ + LV + + L+ R L L
Sbjct: 65 IV---RLYDVIHTENKL-------------TLVFEFMDNDLKKYMDSRTVGNTPRGLELN 108
Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD---TS 160
V Q++ + F H LHRD+KP N L+ + Q+ + DFGLA+ + T
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPVNTF 165
Query: 161 THQ 163
+ +
Sbjct: 166 SSE 168
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 21/187 (11%), Positives = 50/187 (26%), Gaps = 36/187 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQLL----YESKLYRILQG 61
+ K+ GE++ G ++ +K+ V+ + E RI
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 62 GTGIPN-VRWFGV----EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMIN 114
PN + G + L+ + SL + L + + + A M
Sbjct: 67 ----PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 115 RVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
+ F+H+ + + ++ I + ++
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSPGR----------- 168
Query: 173 LTGTARY 179
+
Sbjct: 169 -MYAPAW 174
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 33/156 (21%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN 67
KIG GS G + L + +VA+K+ +++ + + L +++ I++ N
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEV-VIMRDYQH-FN 103
Query: 68 -VRWFG--VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
V + + G+ ++M+ L G +L D+ + +L+ + + + + ++ + ++H++
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG 161
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIK D+ L+ +V + DFG +
Sbjct: 162 VIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKD 194
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 40/179 (22%), Positives = 66/179 (36%), Gaps = 38/179 (21%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK-------------- 45
+ ++F++ R G G+FG + LG T VAIK +++ + +
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH 77
Query: 46 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 105
HP ++ +L R Y +VM+ + + L C +
Sbjct: 78 HPNIV---QLQSYFY----TLGERDR--RDIYLNVVMEYVP---DTLHRCCRNYYRRQVA 125
Query: 106 LMLAD------QMINRVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
Q+I + +H S HRDIKP N L + + + DFG AKK
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAKKL 182
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 54/257 (21%), Positives = 94/257 (36%), Gaps = 71/257 (27%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
F+ G+ +G GSF + L + T+ E AIK + V HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
+L + + KLY + G +L + +
Sbjct: 92 FVKLYFTFQDDEKLY-----------------------FGLSYAKNG----ELLKYIRKI 124
Query: 99 -KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
++++ +E++H K +HRD+KP+N L+ + I DFG AK
Sbjct: 125 GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLS 181
Query: 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGL 216
S + GTA+Y S + DL +LG ++Y + G P+
Sbjct: 182 PESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF--- 232
Query: 217 KAGTKKQKYEKISEKKV 233
+AG + ++KI + +
Sbjct: 233 RAGNEYLIFQKIIKLEY 249
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 39/196 (19%), Positives = 74/196 (37%), Gaps = 46/196 (23%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK-----------HP- 47
K+ LG+ +G+GSFG + +I++ + A+K L++ + K H
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN 61
Query: 48 --QLLY------ESKLYRILQGGTGIPNVRWFGVEGDYNV-------------LVMDLLG 86
+L+ + + +++ ++M+ +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 87 PSLEDL------FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140
+ L F R + + + + Q+ V F+HS HRDIKP N L +
Sbjct: 122 ---DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNS 176
Query: 141 RANQVYIIDFGLAKKY 156
+ N + + DFG AKK
Sbjct: 177 KDNTLKLCDFGSAKKL 192
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 21/171 (12%)
Query: 3 PRVGNKF-RLGRKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTKHPQLLYESKLYRIL 59
RV + F G K+G G++G +Y + +++ A+K E L R L
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL 75
Query: 60 QGGTGIPNV----RWFGVEGDYNV-LVMD--------LLGPSLEDLFNFCSRKLSLKTVL 106
+ PNV + F D V L+ D ++ N +L V
Sbjct: 76 KH----PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKKY 156
L Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 38/183 (20%), Positives = 75/183 (40%), Gaps = 44/183 (24%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQ--- 60
+ N F + RK+G G+FG + L +I + A+K + N+K E+ + + +Q
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDD 92
Query: 61 -GGTGIPNVR---WFGVEGDYN---VLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLAD 110
I V+ F Y L+ + LGPSL ++ N+ ++ + +
Sbjct: 93 INNNNI--VKYHGKF----MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCI 144
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLM----------------------GLGRRANQVYII 148
+++ + ++ S H D+KP+N L+ ++ + +I
Sbjct: 145 EILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 149 DFG 151
DFG
Sbjct: 205 DFG 207
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 19/174 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLLYESKLYRILQGGT 63
LG +IG G+FGE++ G N VA+K + L E+++ +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-- 171
Query: 64 GIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN VR GV + +VM+L+ G +L +KT+L + +E++
Sbjct: 172 --PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH-----IPYR 168
SK +HRD+ N L+ N + I DFG++++ D +P +
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 27/181 (14%), Positives = 61/181 (33%), Gaps = 18/181 (9%)
Query: 7 NKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLY-ESKLYRILQ 60
+ L IG G + L T E V ++ LE + L E + ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 61 GGTGIPNV-RWFG--VEGDYNVLVMDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINR 115
PN+ + + + +V + S +DL ++ + + ++
Sbjct: 85 H----PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
++++H ++HR +K + L+ +VY+ Q + + K
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 176 T 176
Sbjct: 198 V 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 31/167 (18%), Positives = 71/167 (42%), Gaps = 38/167 (22%)
Query: 14 KIGSGSFGEIYLGTNIQ-TNEEVA---IKLENVK-------------------TKHPQLL 50
+IG G++G+++ +++ VA ++++ + +HP ++
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 51 YESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK-LSLKTVLMLA 109
+L+ + + LV + + L + + +T+ +
Sbjct: 78 ---RLFDVCTVSRTDRETKLT--------LVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
Q++ ++F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIY 170
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 38/177 (21%), Positives = 70/177 (39%), Gaps = 37/177 (20%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKT--------------K 45
+ + +GSG++G + + ++ E+VAIK ++ +
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 46 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 105
H ++ L + P Y LVM + DL K S + +
Sbjct: 82 HENVI---GLLDVF-----TPASSLRNFYDFY--LVMPFMQ---TDLQKIMGLKFSEEKI 128
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTST 161
L QM+ ++++HS +HRD+KP N + + ++ I+DFGLA+ T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHADAEMT 181
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 33/161 (20%), Positives = 70/161 (43%), Gaps = 15/161 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGT 63
N ++GSG+ G+++ +T +A+K K ++ ++L + ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---LDVVLKSH 81
Query: 64 GIPN-VRWFG---VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P V+ FG D + M+L+G E L + + + + ++ + ++
Sbjct: 82 DCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 120 HSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
K +HRD+KP N L+ Q+ + DFG++ + D
Sbjct: 141 KEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRLVDD 178
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 39/195 (20%), Positives = 75/195 (38%), Gaps = 46/195 (23%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLY-ESKLYRILQG 61
+ + F+L +G G++G + T+ T E VAIK K E K+ + +
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD----------- 110
N+ + + ++ P + FN ++ + LM D
Sbjct: 69 ----ENI----------ITIFNIQRPDSFENFN----EVYIIQELMQTDLHRVISTQMLS 110
Query: 111 ---------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTS 160
Q + V+ +H + +HRD+KP N L+ +N + + DFGLA+ +++
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGLARIIDESA 166
Query: 161 THQHIPYRENKNLTG 175
P + +
Sbjct: 167 ADNSEPTGQQSGMVE 181
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 36/177 (20%), Positives = 65/177 (36%), Gaps = 36/177 (20%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK-LENVKTKHPQLLYESKLYRIL--Q 60
+ ++ + +G G+FG++ + + VA+K ++NV E ++ L
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT 71
Query: 61 GGTGIPNV----RWFGVEGDYN---VLVMDLLGPSLEDL---FNFCSRKLSLKTVLMLAD 110
WF +++ +V +LLG S D F L + +A
Sbjct: 72 DPNSTFRCVQMLEWF----EHHGHICIVFELLGLSTYDFIKENGF--LPFRLDHIRKMAY 125
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIIDFG 151
Q+ V F+HS H D+KP+N L + ++DFG
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 59/261 (22%), Positives = 92/261 (35%), Gaps = 75/261 (28%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
+ + + IG G+FGE+ L + T + A+KL + P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
QL Y + LY +VM+ + G DL N S
Sbjct: 131 VVQLFYAFQDDRYLY-----------------------MVMEYMPGG----DLVNLMSNY 163
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
+ K +++ ++ +HS F+HRD+KPDN L+ ++ + + DFG K
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNK 220
Query: 159 TSTHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPW 213
+ GT Y S + R D S+G V +Y L G P+
Sbjct: 221 EGMVR------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTPF 273
Query: 214 QGLKAGTKKQKYEKISEKKVS 234
A + Y KI K S
Sbjct: 274 ---YADSLVGTYSKIMNHKNS 291
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 34/177 (19%), Positives = 74/177 (41%), Gaps = 25/177 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT--------------KHP 47
+G+++ + +G G G ++ + ++ VAIK L + ++ H
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHD 68
Query: 48 QLLYESKLYRILQGGTGIPNVRWFGVEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVL 106
++ K++ IL + +V +V + + L ++ L +
Sbjct: 69 NIV---KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHAR 123
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
+ Q++ ++++HS + LHRD+KP N + + I DFGLA+ +H+
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLARIMDPHYSHK 178
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 62/298 (20%), Positives = 117/298 (39%), Gaps = 55/298 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
+ K+G G +GE+Y G + + VA+K L+ + + L E+ + + ++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 275
Query: 66 PN-VRWFGV--EGDYNVLVMDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN V+ GV ++ + + G +L D L +++S +L +A Q+ + +E++
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYRENKNLTG 175
K+F+HR++ N L+G + V + DFGL++ P +
Sbjct: 335 EKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW------ 385
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKV 233
TA + S + D+ + G VL++ G P Y I +V
Sbjct: 386 TAPESLAYNKF----SIKSDVWAFG-VLLWEIATYGMSP------------YPGIDLSQV 428
Query: 234 STSIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQ 283
E L + Y P + C D+P +A + + F +F
Sbjct: 429 ---YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 32/182 (17%), Positives = 65/182 (35%), Gaps = 46/182 (25%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGG 62
+ ++ + +G G+FG++ + + +VA+K + NV E +L+
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE---INVLK-- 71
Query: 63 TGIPNVRWFGVEGDYNV--------------LVMDLLGPSLEDL---FNFCSRKLSLKTV 105
++ E + + +LLG + + NF + L V
Sbjct: 72 ----KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF--QPYPLPHV 125
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIID 149
+A Q+ + + F+H H D+KP+N L + + + D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 150 FG 151
FG
Sbjct: 186 FG 187
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 25/221 (11%), Positives = 51/221 (23%), Gaps = 55/221 (24%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKLYRILQ--- 60
++RL G + + + + +VA+ PQ + + L L
Sbjct: 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTF-----VDPQGVLPDDVLQETLSRTL 83
Query: 61 -----GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
G+ V ++V + + G SL+++ S + +
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAA 140
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
+ H P + V +
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA----------------------- 174
Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+DD+ +G L L P
Sbjct: 175 ----TMPDANP-------QDDIRGIGASLYALLVNRWPLPE 204
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 31/110 (28%), Positives = 41/110 (37%), Gaps = 13/110 (11%)
Query: 81 VMDLL-GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLM 136
M L +L+D N L + Q+ VEF+HSK +HRD+KP N F
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT 198
Query: 137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT-----GTARYAS 181
+ V + DFGL Q + T GT Y S
Sbjct: 199 ----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 10/46 (21%), Positives = 17/46 (36%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL 49
R F + +G G FG ++ N + AIK + +
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR 48
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 22/161 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLG----TNIQTNEEVAIKL--ENVKTKHPQ-LLYESKLYRIL 59
+ R +G G FG++ L TN T E VA+K + +H E + R L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 60 QGGTGIPN-VRWFGV---EGDYNV-LVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMI 113
+ +++ G G ++ LVM+ + L L ++ + L +L+ A Q+
Sbjct: 91 YH----EHIIKYKGCCEDAGAASLQLVMEYV--PLGSLRDYLPRHSIGLAQLLLFAQQIC 144
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++H++ ++HRD+ N L+ V I DFGLAK
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 64/290 (22%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
RL K+G G FGE+++GT VAIK L+ L E+++ + L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 238
Query: 66 PN-VRWFGV-EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V+ + V + +V + + SL D L + L L ++ +A Q+ + + +V
Sbjct: 239 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYRENKNLTGTA 177
+++HRD++ N L+G + DFGLA+ D P + TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
A++ + + D+ S G +L+ +G +P Y + ++V
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV-- 390
Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
++ + RGY P C +++P + YL+ D F
Sbjct: 391 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 21/161 (13%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLLY-ESKLYRILQ 60
V +++ + IGSG+ G + + VAIK L H + Y E L + +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 61 --GGTGIPNVRWFGVEGDYNV-----LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
G+ NV F + +VM+L+ +L +L + + L QM+
Sbjct: 83 HKNIIGLLNV--FTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQML 137
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
++ +HS +HRD+KP N ++ +++ + I+DFGLA
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 18/162 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGI 65
++G G++G + ++ + + +A+K + +LL + I
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRTVDC 65
Query: 66 PN-VRWFG---VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA---DQMINRVEF 118
P V ++G EGD + M+L+ SL+ + K +L ++ +E
Sbjct: 66 PFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 119 VHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HSK S +HRD+KP N L+ QV + DFG++ D
Sbjct: 125 LHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGYLVDD 163
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 40/177 (22%), Positives = 72/177 (40%), Gaps = 36/177 (20%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKT--------------K 45
V +R + +GSG++G + + +T +VAIK ++ +
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 46 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 105
H ++ L + P+ Y LVM +G L L KL +
Sbjct: 83 HENVI---GLLDVF-----TPDETLDDFTDFY--LVMPFMGTDLGKLMK--HEKLGEDRI 130
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTST 161
L QM+ + ++H+ +HRD+KP N + + ++ I+DFGLA++ T
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLARQADSEMT 183
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 52/177 (29%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLLY-ESKLYRILQ 60
+ +++ + IG+GS+G + + VAIK + V + + E + L
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------- 110
+V V V+D++ P + F+ +L + + +D
Sbjct: 111 H----DHV----------VKVLDIVIPKDVEKFD----ELYVVLEIADSDFKKLFRTPVY 152
Query: 111 -----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 153
++ V++VHS LHRD+KP N L NQ V + DFGLA
Sbjct: 153 LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL------VNQDCSVKVCDFGLA 203
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 36/177 (20%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKT--------------K 45
V +++ +GSG++G + + +T VA+K +++ K
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 46 HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 105
H ++ L + P Y LV L+G L ++ +KL+ V
Sbjct: 87 HENVI---GLLDVF-----TPARSLEEFNDVY--LVTHLMGADLNNIVK--CQKLTDDHV 134
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTST 161
L Q++ ++++HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLARHTADEMT 187
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 63/279 (22%), Positives = 93/279 (33%), Gaps = 82/279 (29%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
N F + R IG G FGE+Y T + A+K L V T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 45 -KHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFN 94
P + Y KL ++DL+ G DL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLS-----------------------FILDLMNGG----DLHY 281
Query: 95 FCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152
S+ S + A ++I +E +H++ ++RD+KP N L+ V I D GL
Sbjct: 282 HLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGL 338
Query: 153 AKKYRDTSTHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRDDLESLGYVLMY-FLRGS 210
A + H GT Y A G+ D SLG +++ LRG
Sbjct: 339 ACDFSKKKPH---------ASVGTHGYMAPEVLQKGVAYDSSADWFSLG-CMLFKLLRGH 388
Query: 211 LPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
P++ K K + V S + +L G
Sbjct: 389 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 24/163 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQ-LLYESKLYRIL 59
+ R +G G FG++ L T E+VA+K H L E ++ R L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 60 QGGTGIPN-VRWFGV---EGDYNV-LVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQ 111
N V++ G+ +G + L+M+ L L + K++LK L A Q
Sbjct: 81 YH----ENIVKYKGICTEDGGNGIKLIMEFL--PSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++++ S+ ++HRD+ N L+ +QV I DFGL K
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 31/158 (19%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGIPN-VR 69
+IG G++G + + + + +A+K + + QLL + ++ + P V+
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---LDVVMRSSDCPYIVQ 85
Query: 70 WFG---VEGDYNVLVMDLLGPSLEDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
++G EGD + M+L+ S + ++ + + + + + + +
Sbjct: 86 FYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 123 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+HRDIKP N L+ R+ + + DFG++ + D+
Sbjct: 145 LKIIHRDIKPSNILLD---RSGNIKLCDFGISGQLVDS 179
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 58/266 (21%), Positives = 89/266 (33%), Gaps = 80/266 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
F + + IG G+F E+ + QT + A+K+ N V
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
QL + E+ LY LVM+ G DL S+
Sbjct: 123 ITQLHFAFQDENYLY-----------------------LVMEYYVGG----DLLTLLSKF 155
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
++ + +++ ++ VH ++HRDIKPDN L+ R + + DFG K
Sbjct: 156 GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKL 212
Query: 157 RDTSTHQHIPYRENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
R T + + GT Y A D +LG V Y
Sbjct: 213 RADGTVR------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG-VFAYEMFY 265
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKVS 234
G P+ A + + Y KI K
Sbjct: 266 GQTPFY---ADSTAETYGKIVHYKEH 288
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 17/161 (10%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLLY-ESKLYR 57
+ V K+ L +K+G G++G ++ + +T E VA+K + + + Q + E +
Sbjct: 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63
Query: 58 ILQGG---TGIPNVRWFGVEGDYNV-LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
L G + NV + D +V LV D + L + + L + Q+I
Sbjct: 64 ELSGHENIVNLLNV--LRADNDRDVYLVFDYMETDLHAVIR--ANILEPVHKQYVVYQLI 119
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
++++HS LHRD+KP N L+ A V + DFGL+
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 63/264 (23%), Positives = 92/264 (34%), Gaps = 78/264 (29%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
F + + IG G+FGE+ + ++ A+K+ N V
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
L Y ++ LY LVMD G DL S+
Sbjct: 136 ITTLHYAFQDDNNLY-----------------------LVMDYYVGG----DLLTLLSKF 168
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
+L + +M+ ++ VH ++HRDIKPDN LM + + DFG K
Sbjct: 169 EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLKL 225
Query: 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMY-FLRGS 210
+ T Q + GT Y S +E + D SLG V MY L G
Sbjct: 226 MEDGTVQ------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG-VCMYEMLYGE 278
Query: 211 LPWQGLKAGTKKQKYEKISEKKVS 234
P+ A + + Y KI K
Sbjct: 279 TPFY---AESLVETYGKIMNHKER 299
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 64/290 (22%), Positives = 117/290 (40%), Gaps = 53/290 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
RL K+G G FGE+++GT VAIK L+ L E+++ + L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 321
Query: 66 PN-VRWFGV-EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V+ + V + +V + + SL D L + L L ++ +A Q+ + + +V
Sbjct: 322 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYRENKNLTGTA 177
+++HRD++ N L+G + DFGLA+ D P + TA
Sbjct: 382 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 432
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
A++ + + D+ S G +L+ +G +P Y + ++V
Sbjct: 433 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV-- 473
Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
++ + RGY P C +++P + YL+ D F
Sbjct: 474 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 25/166 (15%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLLY-ESKLYRILQ 60
V +++ + IGSG+ G + + + VAIK L H + Y E L + +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 61 GGTGIPNV-------RWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
N+ ++ LVM+L+ +L +L + + L Q
Sbjct: 120 H----KNIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQ 172
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKY 156
M+ ++ +HS +HRD+KP N ++ +++ + I+DFGLA+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA 214
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIK-LENVKTKHPQ-LLYESKLYRILQ 60
+ ++G G+FG + L T VA+K L++ + E ++ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 61 GGTGIPN-VRWFGV---EGDYNV-LVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
V++ GV G ++ LVM+ L L +F +L +L+ + Q+
Sbjct: 83 S----DFIVKYRGVSYGPGRQSLRLVMEYL--PSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ S+ +HRD+ N L+ V I DFGLAK
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 7e-10
Identities = 35/206 (16%), Positives = 62/206 (30%), Gaps = 59/206 (28%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------- 39
K + KIG G FGE++ + VAIK+
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 40 ------------------------ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEG 75
V+ +P LL ++ + G+ +F +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNF 134
+ VL + G LE ++ SL T + Q+ + + F HRD+ N
Sbjct: 137 LFIVLEFEFGGIDLE---QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 135 LMGLGRRANQVYIIDFGLAKKYRDTS 160
L+ ++ + + K S
Sbjct: 194 LL---KKTSLKKLHYTLNGKSSTIPS 216
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGI 65
+ K+G G +GE+Y G + + VA+K T + L E+ + + ++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 68
Query: 66 PN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
PN V+ GV ++ + + G L+ L +++S +L +A Q+ + +E++
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
K+F+HRD+ N L+G + V + DFGL++
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 45/214 (21%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGTGI 65
F ++G+G+ G ++ ++ + +A K LE Q++ E ++L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE---LQVLHECNS- 90
Query: 66 PN-VRWFG---VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
P V ++G +G+ + M+ + G SL+ + R + + + ++ +I + ++
Sbjct: 91 PYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 148
Query: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
K +HRD+KP N L+ ++ + DFG++ + D+ + + GT Y
Sbjct: 149 EKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSY 196
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
S G S + D+ S+G L+ G P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 38/177 (21%), Positives = 66/177 (37%), Gaps = 52/177 (29%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLLY-ESKLYRILQ 60
V + + + IG GS+G +YL + T + VAIK + + + + E + L+
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------- 110
+ + + DL+ P F+ +L + + +D
Sbjct: 84 S----DYI----------IRLYDLIIPDDLLKFD----ELYIVLEIADSDLKKLFKTPIF 125
Query: 111 -----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 153
++ F+H +HRD+KP N L NQ V + DFGLA
Sbjct: 126 LTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL------LNQDCSVKVCDFGLA 176
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 37/173 (21%), Positives = 72/173 (41%), Gaps = 21/173 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGI 65
+++G+G FG + G + +VAIK+ + + E+K+ L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH---- 78
Query: 66 PN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 119
V+ +GV + ++ + + + L N+ + + +L + + +E++
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYM--ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
SK FLHRD+ N L+ V + DFGL++ D +S P R
Sbjct: 137 ESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 37/173 (21%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGI 65
++ ++IGSG FG ++LG ++VAIK + + E+++ L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH---- 62
Query: 66 PN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 119
P V+ +GV E LV + + L ++ + +T+L + + + ++
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFM--EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
+HRD+ N L+G + + DFG+ + D +ST P +
Sbjct: 121 EEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 170
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQ 60
+ +++G G+FG + + T E VA+K + + E ++ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 61 GGTGIPN-VRWFGV---EGDYNV-LVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
N V++ GV G N+ L+M+ L L ++ ++ +L Q+
Sbjct: 101 H----DNIVKYKGVCYSAGRRNLKLIMEYL--PYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ +K ++HRD+ N L+ N+V I DFGL K
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 17/160 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQGGTGI 65
+ L +++GSG FG + LG + +VA+K+ + E++ L
Sbjct: 8 EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH---- 62
Query: 66 PN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 119
P V+++GV + +V + + S L N+ + L +L + + + F+
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYI--SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
S F+HRD+ N L+ R V + DFG+ + D
Sbjct: 121 ESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDD 157
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQ 60
+ +++G G+FG + + T E VA+K + + E ++ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 61 GGTGIPN-VRWFGV---EGDYNV-LVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
N V++ GV G N+ L+M+ L L ++ ++ +L Q+
Sbjct: 70 H----DNIVKYKGVCYSAGRRNLKLIMEYL--PYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ +K ++HRD+ N L+ N+V I DFGL K
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 39/168 (23%), Positives = 69/168 (41%), Gaps = 36/168 (21%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKT--------------KH 46
VG ++ IG G++G + + VAIK E+ +H
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 47 PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVL 106
++ + I++ P + + Y +V DL+ L L ++ LS +
Sbjct: 85 ENII---GINDIIR----APTIEQM--KDVY--IVQDLMETDLYKLLK--TQHLSNDHIC 131
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
Q++ ++++HS + LHRD+KP N L+ + I DFGLA
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLA 175
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 46/177 (25%), Positives = 80/177 (45%), Gaps = 23/177 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LLYESKLYRILQG 61
PR +L ++G+G FGE+++G + +VA+K + P L E+ L + LQ
Sbjct: 11 PR--ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH 67
Query: 62 GTGIPN-VRWFGV---EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINR 115
VR + V E Y ++ + + SL D L KL++ +L +A Q+
Sbjct: 68 ----QRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
+ F+ ++++HRD++ N L+ I DFGLA+ D P +
Sbjct: 122 MAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 39/168 (23%), Positives = 70/168 (41%), Gaps = 15/168 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ +L + IG G FG++ LG +VA+K L E+ + L+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 74
Query: 67 N-VRWFGV---EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
N V+ GV E +V + + G ++ L + L +L + + +E++
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
+F+HRD+ N L+ N + DFGL K+ T +P +
Sbjct: 135 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 17/169 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ +L + IG G FG++ LG +VA+K L E+ + L+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 246
Query: 67 N-VRWFGV---EGDYNVLVMDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
N V+ GV E +V + + G SL D L + L +L + + +E++
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
+F+HRD+ N L+ N + DFGL K+ T +P +
Sbjct: 306 EGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 6e-09
Identities = 55/275 (20%), Positives = 99/275 (36%), Gaps = 99/275 (36%)
Query: 3 PRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
P+ F++ R +G+GSFG ++L + A+K +E+
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 45 ---KHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDL 92
HP ++ +++ ++MD + G +L
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIF-----------------------MIMDYIEGG----EL 93
Query: 93 FNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
F+ + + A ++ +E++HSK ++RD+KP+N L L + + + I DF
Sbjct: 94 FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL--LDKNGH-IKITDF 150
Query: 151 GLAKKYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY-------- 201
G AK D T T L GT Y + E + + Y
Sbjct: 151 GFAKYVPDVTYT-----------LCGTPDY------IAPEV-----VSTKPYNKSIDWWS 188
Query: 202 --VLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKV 233
+L+Y L G P+ + YEKI ++
Sbjct: 189 FGILIYEMLAGYTPFY---DSNTMKTYEKILNAEL 220
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 58/258 (22%), Positives = 97/258 (37%), Gaps = 78/258 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
F + +G+GSFG + L + ++ A+K +E+ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNF--CS 97
+L + S LY +VM+ + G ++F+
Sbjct: 103 LVKLEFSFKDNSNLY-----------------------MVMEYVAGG----EMFSHLRRI 135
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
+ S A Q++ E++HS ++RD+KP+N L+ + + + DFG AK+ +
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVK 192
Query: 158 D-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
T T L GT + L ++ D +LG VL+Y G P+
Sbjct: 193 GRTWT-----------LCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF-- 238
Query: 216 LKAGTKKQKYEKISEKKV 233
A Q YEKI KV
Sbjct: 239 -FADQPIQIYEKIVSGKV 255
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 35/167 (20%), Positives = 65/167 (38%), Gaps = 23/167 (13%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL------------LY 51
+ + + + R I SGS+G + G + VAIK + N + + L
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 52 ESKLYRILQGG--TGIPNVRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLM 107
E +L G+ ++ E + LV +L+ L + + +S + +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY 138
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
++ + +H +HRD+ P N L+ N + I DF LA
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDITICDFNLA 181
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 46/177 (25%), Positives = 79/177 (44%), Gaps = 24/177 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQ---LLYESKLYRILQ 60
+ LGR IG G FG+++ G + VAIK T L E+ R
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINR 115
P+ V+ GV + ++M+L +L +L +F L L ++++ A Q+
Sbjct: 450 H----PHIVKLIGVITENPVWIIMELC--TLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
+ ++ SK F+HRDI N L+ + V + DFGL++ D ++ +P +
Sbjct: 504 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 59/283 (20%), Positives = 90/283 (31%), Gaps = 90/283 (31%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
N FR R +G G FGE+ T + A K LE V
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN- 242
Query: 45 KHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLF-- 93
L Y + L LV+ L+ G DL
Sbjct: 243 -SRFVVSLAYAYETKDALC-----------------------LVLTLMNGG----DLKFH 274
Query: 94 --NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYII 148
+ + A ++ +E +H + ++RD+KP+N L+ G + I
Sbjct: 275 IYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG------HIRIS 328
Query: 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FL 207
D GLA + T K GT Y + + D +LG L+Y +
Sbjct: 329 DLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALG-CLLYEMI 379
Query: 208 RGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 243
G P+Q K K+++ + E S +A LC
Sbjct: 380 AGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 51/284 (17%), Positives = 93/284 (32%), Gaps = 89/284 (31%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
+ F R +G G FGE++ T + A K L K
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA--KV 242
Query: 45 KHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLF-- 93
L Y ++ L LVM ++ G D+
Sbjct: 243 HSRFIVSLAYAFETKTDLC-----------------------LVMTIMNGG----DIRYH 275
Query: 94 ----NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149
+ + + Q+++ +E +H ++ ++RD+KP+N L+ V I D
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISD 332
Query: 150 FGLAKKYRDTSTHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
GLA + + K GT + + LG E D +LG V +Y
Sbjct: 333 LGLAV---------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYEM 382
Query: 207 LRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 243
+ P++ + ++ +++ E+ V S + C
Sbjct: 383 IAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 20/164 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQL---LYESKLYRILQ 60
+ LGR IG G FG+++ G + VAIK T L E+ R
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINR 115
P+ V+ GV + ++M+L +L +L +F L L ++++ A Q+
Sbjct: 75 H----PHIVKLIGVITENPVWIIMELC--TLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
+ ++ SK F+HRDI N L+ + V + DFGL++ D+
Sbjct: 129 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDS 169
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 21/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQ---LLYESKLYRIL 59
+F+ + +GSG+FG +Y G I E+ VAIK T +L E+ + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 60 QGGTGIPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
P+ R G+ L+ L+ L ++ + + +L Q+
Sbjct: 75 DN----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ + +HRD+ N L+ V I DFGLAK
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 38/171 (22%), Positives = 76/171 (44%), Gaps = 17/171 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
+L +K+G+G FGE+++ T + +VA+K ++ L E+ + + LQ
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH---- 242
Query: 66 PN-VRWFGV-EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V+ V + ++ + + SL D L + K L ++ + Q+ + F+
Sbjct: 243 DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD----TSTHQHIPYR 168
++++HRD++ N L+ + I DFGLA+ D P +
Sbjct: 303 RNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 8e-08
Identities = 57/331 (17%), Positives = 99/331 (29%), Gaps = 107/331 (32%)
Query: 24 YLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD------ 76
YL Q L V T +P+ L S + ++ G + W V D
Sbjct: 310 YLDCRPQ-------DLPREVLTTNPRRL--SIIAESIRDGLATWD-NWKHVNCDKLTTII 359
Query: 77 ---YNVLVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINR-----VEFVHSKSFLHR 127
NVL + L F S + + ++ +I V +H S + +
Sbjct: 360 ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEK 419
Query: 128 DIK------PDNFLMGLGRRANQVY----IID----------FGLAKKYRDTSTHQHIPY 167
K P +L + N+ I+D L Y D + HI +
Sbjct: 420 QPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH 479
Query: 168 RENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226
HL IE R L + ++ FL +K +++
Sbjct: 480 -----------------HLKNIEHPERMTLFRMVFLDFRFLE------------QKIRHD 510
Query: 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--------YLKRI------ 272
+ + + L + Y Y D+ P Y +L +I
Sbjct: 511 STAWNASGSILNTL-----QQLKFYKPYI----CDNDPKYERLVNAILDFLPKIEENLIC 561
Query: 273 --FRDLFIREGFQFD--YVFDWTILKYQQSQ 299
+ DL +R + +F+ ++Q Q
Sbjct: 562 SKYTDL-LRIALMAEDEAIFEEA---HKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 9e-07
Identities = 40/379 (10%), Positives = 102/379 (26%), Gaps = 122/379 (32%)
Query: 28 NIQTNEEVAIKLENVKTKHPQLLYESKLYRI----LQGGTGIPNVRWFGVEG----DYNV 79
+I + EE+ + +K S R+ L + V+ F VE +Y
Sbjct: 44 SILSKEEID---HIIMSKDA----VSGTLRLFWTLLSKQEEM--VQKF-VEEVLRINYKF 93
Query: 80 LVMDL----LGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDN 133
L+ + PS+ ++ +L + A ++R++ + L ++P
Sbjct: 94 LMSPIKTEQRQPSMMTRMYIEQRDRLY-NDNQVFAKYNVSRLQPYLKLRQALLE-LRPAK 151
Query: 134 FL----M-GLG----------------RRANQVYIIDFGLAKKYRDTSTH-QHIPYRENK 171
+ + G G + +++ ++ Q + Y+ +
Sbjct: 152 NVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 172 NLTGTARYAS---MNTHLGIEQSRR--------------DDLESLGYVLMYF-------- 206
N T + ++S + H + RR ++++ F
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSCKILL 270
Query: 207 --------------LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL----CRGYP--- 245
+ + + + K + + L P
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL 330
Query: 246 -------TEFASYFHYCRSLRFD----------DKPDYAYLKRIFRDLFIREGFQFD--- 285
+ + + + + D + + A +++F L + F
Sbjct: 331 SIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV---FPPSAHI 387
Query: 286 ----YVFDWTILKYQQSQL 300
W + +
Sbjct: 388 PTILLSLIWFDVIKSDVMV 406
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 28/174 (16%), Positives = 59/174 (33%), Gaps = 26/174 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-------NIQTNEEVAIK-LENVKTKHPQ-LLYESKLYR 57
+G G+F +I+ G EV +K L+ + + + +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 58 ILQGGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQ 111
L + V +GV GD N+LV + + L + +++ L +A Q
Sbjct: 68 KLSH----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 112 MINRVEFVHSKSFLHRDIKPDNFL-----MGLGRRANQVYIIDFGLAKKYRDTS 160
+ + F+ + +H ++ N L + + D G++
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 32/165 (19%), Positives = 66/165 (40%), Gaps = 22/165 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ---LLYESKLYRIL 59
+ + IG+G FGE+Y G + + VAIK Q L E+ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 60 QGGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMI 113
N +R GV + +++ + + L F + S+ ++ + +
Sbjct: 104 SH----HNIIRLEGVISKYKPMMIITEYM--ENGALDKFLREKDGEFSVLQLVGMLRGIA 157
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
++++ + +++HRD+ N L+ + DFGL++ D
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 39/180 (21%), Positives = 70/180 (38%), Gaps = 27/180 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQ---LLYESKLYRILQ 60
++ + + IGSG GE+ G Q + VAIK Q L E+ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 61 GGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
PN +R GV G ++V + + L F + ++ ++ + +
Sbjct: 109 H----PNIIRLEGVVTRGRLAMIVTEYM--ENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD------TSTHQHIPYR 168
+ ++ ++HRD+ N L+ + DFGL++ D T+T IP R
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 22/170 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTKHPQ-LLYESKLY 56
P R IG G FG +Y G I + AIK + + + L E L
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 57 RILQGGTGIPN-VRWFGV---EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLA 109
R L PN + G+ +++ + DL F R ++K ++
Sbjct: 77 RGLNH----PNVLALIGIMLPPEGLPHVLLPYM--CHGDLLQFIRSPQRNPTVKDLISFG 130
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159
Q+ +E++ + F+HRD+ N ++ V + DFGLA+ D
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDES---FTVKVADFGLARDILDR 177
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 40/176 (22%), Positives = 74/176 (42%), Gaps = 34/176 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LLYESK 54
R K + R++G GSFG +Y G + VAIK E + L E+
Sbjct: 23 AR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL------GPSLEDLFNFCSRK 99
+ + + VR GV +G +++M DL P++ + N
Sbjct: 81 VMKEFNC----HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN--NPVLAP 134
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
SL ++ +A ++ + + ++++ F+HRD+ N ++ V I DFG+ +
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMTRD 187
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 37/178 (20%), Positives = 73/178 (41%), Gaps = 23/178 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIKLENVKTKHPQ---LLYESKLYRILQ 60
+ + +G+G FGE+ G + + +E VAIK V Q L E+ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 61 GGTGIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
PN +R GV + ++V + + SL+ + ++ ++ + + + +
Sbjct: 105 H----PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD------TSTHQHIPYR 168
+++ ++HRD+ N L+ + DFGL + D T+ IP R
Sbjct: 161 KYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 19/154 (12%)
Query: 11 LGRKIGSGSFGEIYLGT--NIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGTG 64
+++GSG+FG + G + + VA+K+ N +LL E+ + + L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--- 77
Query: 65 IPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVH 120
P VR G+ E + +LVM++ L L + +R + K ++ L Q+ ++++
Sbjct: 78 -PYIVRMIGICEAESWMLVMEMA--ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+F+HRD+ N L+ + I DFGL+K
Sbjct: 135 ESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 44/185 (23%), Positives = 75/185 (40%), Gaps = 40/185 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQ-LLYESK 54
PR N+ G+ +G+G+FG++ T + ++ VA+K+ + + L+ E K
Sbjct: 21 PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL------------GPSLEDLF 93
+L N V G G +++ DLL + +
Sbjct: 79 ---VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
L L+ +L + Q+ + F+ SK+ +HRD+ N L+ G I DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKICDFGLA 192
Query: 154 KKYRD 158
RD
Sbjct: 193 ---RD 194
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 37/152 (24%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEE--VAIKL---ENVKTKHPQLLYESKLYRILQGGTGI 65
++G G+FG + G ++ VAIK+ K +++ E+++ L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395
Query: 66 PN-VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
P VR GV + + +LVM++ G L ++ + V L Q+ ++++ K
Sbjct: 396 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+F+HR++ N L+ + I DFGL+K
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 34/160 (21%), Positives = 59/160 (36%), Gaps = 21/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQ-LLYESKLYRIL 59
+ R + +GSG FG ++ G V IK+ + + Q + L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 60 QGGTGIPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
+ VR G+ G LV L L L + L + +L Q+
Sbjct: 73 DH----AHIVRLLGLCPGSSLQLVTQYL--PLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ +HR++ N L+ +QV + DFG+A
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 46/193 (23%), Positives = 75/193 (38%), Gaps = 37/193 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LLYESK 54
PR L R +G G+FGE+Y G N + +VA+K E + L E+
Sbjct: 28 PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNF---------CSRKL 100
+ N VR GV + ++M+L+ G DL +F L
Sbjct: 86 IISKFNH----QNIVRCIGVSLQSLPRFILMELMAGG----DLKSFLRETRPRPSQPSSL 137
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK----- 155
++ +L +A + +++ F+HRDI N L+ I DFG+A+
Sbjct: 138 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
Query: 156 YRDTSTHQHIPYR 168
Y +P +
Sbjct: 198 YYRKGGCAMLPVK 210
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 36/181 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIKLENVKTKHPQ---LLYESK 54
PR N + G+ +G+G+FG++ T +E VA+K+ + L+ E K
Sbjct: 44 PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL--------GPSLEDLFNFCS 97
I+ N V G G +++ DLL + F +
Sbjct: 102 ---IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
S + +L + Q+ + F+ SK+ +HRD+ N L+ G + I DFGLA R
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLA---R 212
Query: 158 D 158
D
Sbjct: 213 D 213
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 21/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQ---LLYESKLYRIL 59
+F+ + +GSG+FG +Y G I E+ VAIK T +L E+ + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 60 QGGTGIPN-VRWFGV-EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
P+ R G+ L+ L+ L ++ + + +L Q+
Sbjct: 75 DN----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ + +HRD+ N L+ V I DFGLAK
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 37/163 (22%), Positives = 67/163 (41%), Gaps = 16/163 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQL---LYESKLYRILQ 60
L R +G G FGE+Y G + VA+K + E+ + + L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
P+ V+ G+ E + ++M+L L L + T+++ + Q+ +
Sbjct: 72 H----PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
++ S + +HRDI N L+ V + DFGL++ D
Sbjct: 128 YLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDED 167
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 20/158 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIK-LENVKTKHPQL----LYESKLYRILQ 60
RL K+G GSFG + G + + + VA+K L+ P+ + E L
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
N +R +GV +V +L LG SL D L T+ A Q+ +
Sbjct: 80 H----RNLIRLYGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++ SK F+HRD+ N L+ + V I DFGL +
Sbjct: 135 GYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 6e-07
Identities = 37/181 (20%), Positives = 67/181 (37%), Gaps = 68/181 (37%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L R IG GS+ ++ L +T+ A+K ++ V+T HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
L ES+L+ V++ + G DL R
Sbjct: 71 FLVGLHSCFQTESRLF-----------------------FVIEYVNGG----DLMFHMQR 103
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
KL + + ++ + ++H + ++RD+K DN L+ G + + D+G+
Sbjct: 104 QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGMC 157
Query: 154 K 154
K
Sbjct: 158 K 158
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 59/281 (20%), Positives = 94/281 (33%), Gaps = 94/281 (33%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F +G GSFG++ L T+E A+K +E K P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
QL +LY VM+ + G DL +
Sbjct: 403 FLTQLHSCFQTMDRLY-----------------------FVMEYVNGG----DLMYHIQQ 435
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
+ + A ++ + F+ SK ++RD+K DN ++ G + I DFG+
Sbjct: 436 VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGMC 489
Query: 154 K---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K T T GT Y + + D + G VL+Y L
Sbjct: 490 KENIWDGVTTKT-----------FCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLA 537
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
G P++G + + ++ I E V S A+C+G
Sbjct: 538 GQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 7e-07
Identities = 61/281 (21%), Positives = 99/281 (35%), Gaps = 94/281 (33%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F +G GSFG++ L T+E A+K +E K P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
QL +LY VM+ + G DL +
Sbjct: 82 FLTQLHSCFQTMDRLY-----------------------FVMEYVNGG----DLMYHIQQ 114
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
+ + A ++ + F+ SK ++RD+K DN ++ G + I DFG+
Sbjct: 115 VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGMC 168
Query: 154 KK--YRDTSTHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K+ + +T T GT Y + + D + G VL+Y L
Sbjct: 169 KENIWDGVTTK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLA 216
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKV----STSIEA--LCRG 243
G P++G + + ++ I E V S S EA +C+G
Sbjct: 217 GQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 36/181 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ---LLYESK 54
PR ++ +LG+ +G G+FG++ I VA+K+ H + L+ E K
Sbjct: 25 PR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 55 LYRILQGGTGIPN-VRWFGV---EGDYNVLVM------DLL----------GPSLEDLFN 94
IL N V G G ++++ +L P +
Sbjct: 83 ---ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 95 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLAR 196
Query: 155 K 155
Sbjct: 197 D 197
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 62/281 (22%), Positives = 97/281 (34%), Gaps = 94/281 (33%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L + +G GSFG+++L +TN+ AIK +E +HP
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
+ + L+ VM+ L G DL
Sbjct: 79 FLTHMFCTFQTKENLF-----------------------FVMEYLNGG----DLMYHIQS 111
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
K L A ++I ++F+HSK ++RD+K DN L+ G + I DFG+
Sbjct: 112 CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG------HIKIADFGMC 165
Query: 154 K---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K T+T GT Y + LG + + D S G VL+Y L
Sbjct: 166 KENMLGDAKTNT-----------FCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEMLI 213
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
G P+ G +++ + I + L
Sbjct: 214 GQSPFHG---QDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 45/178 (25%), Positives = 72/178 (40%), Gaps = 35/178 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LLYESK 54
PR L R +G G+FGE+Y G N + +VA+K E + L E+
Sbjct: 69 PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVMDLL--GPSLEDLFNF---------CSRKL 100
+ N VR GV + ++++L+ G DL +F L
Sbjct: 127 IISKFNH----QNIVRCIGVSLQSLPRFILLELMAGG----DLKSFLRETRPRPSQPSSL 178
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158
++ +L +A + +++ F+HRDI N L+ I DFG+A RD
Sbjct: 179 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 233
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 49/182 (26%), Positives = 84/182 (46%), Gaps = 38/182 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ--LLYESKL 55
R L R++G G+FG+++L N+ ++ VA+K T + E++L
Sbjct: 13 KR--RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 56 YRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL------GPSLEDLFNFCSR-- 98
LQ + V+++GV +GD ++V DL GP L + R
Sbjct: 71 LTNLQH----EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
+L L +L +A Q+ + + ++ S+ F+HRD+ N L+G V I DFG++
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMS--- 180
Query: 157 RD 158
RD
Sbjct: 181 RD 182
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 46/181 (25%), Positives = 78/181 (43%), Gaps = 37/181 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ--LLYESKL 55
R L ++G G+FG+++L N+ ++ VA+K ++ + E++L
Sbjct: 39 KR--RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 56 YRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL---------GPSLEDLFNFCS 97
+LQ + VR+FGV EG ++V DL L +
Sbjct: 97 LTMLQH----QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
L L +L +A Q+ + ++ F+HRD+ N L+G G V I DFG++ R
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---R 206
Query: 158 D 158
D
Sbjct: 207 D 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 36/181 (19%), Positives = 67/181 (37%), Gaps = 68/181 (37%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L R IG GS+ ++ L +T+ A++ ++ V+T HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
L ES+L+ V++ + G DL R
Sbjct: 114 FLVGLHSCFQTESRLF-----------------------FVIEYVNGG----DLMFHMQR 146
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
KL + + ++ + ++H + ++RD+K DN L+ G + + D+G+
Sbjct: 147 QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGMC 200
Query: 154 K 154
K
Sbjct: 201 K 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 54/265 (20%), Positives = 93/265 (35%), Gaps = 87/265 (32%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----------------EN---VKTKHP- 47
F + +G G+FG++ L T A+K+ E+ T+HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
L Y +L VM+ G +LF SR
Sbjct: 67 LTALKYAFQTHDRLC-----------------------FVMEYANGG----ELFFHLSRE 99
Query: 99 -KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAK 154
+ + ++++ +E++HS+ ++RDIK +N ++ G + I DFGL K
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG------HIKITDFGLCK 153
Query: 155 ---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRG 209
T GT Y + + R D LG V+MY + G
Sbjct: 154 EGISDGATMKT-----------FCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCG 201
Query: 210 SLPWQGLKAGTKKQKYEKISEKKVS 234
LP+ ++ +E I +++
Sbjct: 202 RLPFYN---QDHERLFELILMEEIR 223
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 37/157 (23%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 7 NKFRLGR-KIGSGSFGEIYLGT-NIQTNE-EVAIKL--ENVKTKHPQ-LLYESKLYRILQ 60
+ + ++G G+FG + G ++ + +VAIK+ + + + ++ E+++ L
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
P VR GV + + +LVM++ G L ++ + V L Q+ ++
Sbjct: 69 N----PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++ K+F+HRD+ N L+ + I DFGL+K
Sbjct: 125 YLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 41/193 (21%), Positives = 66/193 (34%), Gaps = 36/193 (18%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEEVAIKL--ENVKTKHPQ-LLYESKLYR 57
N + IG G+FG++ + AIK E + E
Sbjct: 23 DW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE---LE 77
Query: 58 ILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL----------GPSLEDLFNFCSR 98
+L PN + G Y L + +LL + N +
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--- 155
LS + +L A + ++++ K F+HRD+ N L+G I DFGL++
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEV 194
Query: 156 YRDTSTHQHIPYR 168
Y T +P R
Sbjct: 195 YV-KKTMGRLPVR 206
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 39/171 (22%), Positives = 73/171 (42%), Gaps = 28/171 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYE----SKLYRILQ 60
N F IG G FG++Y G ++ +VA+K ++ + E S
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRH--- 94
Query: 61 GGTGIPN-VRWFG--VEGDYNVLVMDLL--GPSLED-LF--NFCSRKLSLKTVLMLADQM 112
P+ V G E + +L+ + G +L+ L+ + + +S + L +
Sbjct: 95 -----PHLVSLIGFCDERNEMILIYKYMENG-NLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS-TH 162
+ ++H+++ +HRD+K N L+ I DFG++KK + TH
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPK---ITDFGISKKGTELDQTH 196
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 55/281 (19%), Positives = 92/281 (32%), Gaps = 94/281 (33%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F R +G GSFG++ L +T + A+K +E T HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
QL +L+ VM+ + G DL +
Sbjct: 85 FLTQLFCCFQTPDRLF-----------------------FVMEFVNGG----DLMFHIQK 117
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
+ A ++I+ + F+H K ++RD+K DN L+ G + DFG+
Sbjct: 118 SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG------HCKLADFGMC 171
Query: 154 K---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K T+T GT Y + + D ++G VL+Y L
Sbjct: 172 KEGICNGVTTAT-----------FCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYEMLC 219
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
G P++ + +E I +V + +
Sbjct: 220 GHAPFEA---ENEDDLFEAILNDEVVYPTWLHEDATGILKS 257
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 44/189 (23%), Positives = 77/189 (40%), Gaps = 44/189 (23%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQ-LLYESKL 55
R N LG+ +G G FG + G Q + VA+K L+N + + L E+
Sbjct: 32 DR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 56 YRILQGGTGIPN-VRWFGV-------EGDYNVLVMDLL--GPSLEDLFNF--------CS 97
+ PN +R GV ++++ + G DL +
Sbjct: 90 MKDFSH----PNVIRLLGVCIEMSSQGIPKPMVILPFMKYG----DLHTYLLYSRLETGP 141
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK-- 155
+ + L+T+L + +E++ +++FLHRD+ N ++ V + DFGL+KK
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTVCVADFGLSKKIY 198
Query: 156 ----YRDTS 160
YR
Sbjct: 199 SGDYYRQGR 207
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 39/188 (20%), Positives = 73/188 (38%), Gaps = 41/188 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTK--HPQLLYESKL 55
P +F LGR +G G FG + Q + VA+K+ ++ + L E+
Sbjct: 21 PE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 56 YRILQGGTGIPN-VRWFGV--------EGDYNVLVMDLLGPSLEDLFNF--------CSR 98
+ P+ + GV ++++ + DL F
Sbjct: 79 MKEFDH----PHVAKLVGVSLRSRAKGRLPIPMVILPFM--KHGDLHAFLLASRIGENPF 132
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--- 155
L L+T++ + +E++ S++F+HRD+ N ++ V + DFGL++K
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED---MTVCVADFGLSRKIYS 189
Query: 156 ---YRDTS 160
YR
Sbjct: 190 GDYYRQGC 197
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 36/182 (19%), Positives = 76/182 (41%), Gaps = 37/182 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKL--ENVKTKHPQ-LLYE 52
PR +K LG+ +G G+FG++ + I ++ VA+K+ ++ K L+ E
Sbjct: 33 PR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 53 SKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL----------GPSLEDLF 93
+ +++ N + G + +++ +L D+
Sbjct: 91 ME---MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+++ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGLA
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA 204
Query: 154 KK 155
+
Sbjct: 205 RD 206
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 37/182 (20%), Positives = 75/182 (41%), Gaps = 37/182 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKLENVKTKHPQ---LLYE 52
PR ++ LG+ +G G+FG++ L + ++ VA+K+ L+ E
Sbjct: 67 PR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 53 SKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL----------GPSLEDLF 93
++ +++ N + G + +++ +L +
Sbjct: 125 MEMMKMIGKH---KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ +LS K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGLA
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADFGLA 238
Query: 154 KK 155
+
Sbjct: 239 RD 240
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 4e-06
Identities = 58/281 (20%), Positives = 95/281 (33%), Gaps = 94/281 (33%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F + IG GSFG++ L + A+K +++ + KHP
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 48 ---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR 98
L + KLY V+D + G +LF R
Sbjct: 100 FLVGLHFSFQTADKLY-----------------------FVLDYINGG----ELFYHLQR 132
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
A ++ + + ++HS + ++RD+KP+N L+ G + + DFGL
Sbjct: 133 ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG------HIVLTDFGLC 186
Query: 154 K---KYRD-TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
K ++ TST GT Y + R D LG ++Y L
Sbjct: 187 KENIEHNSTTST-----------FCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEMLY 234
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
G P+ + Y+ I K + + S L G
Sbjct: 235 GLPPFYS---RNTAEMYDNILNKPLQLKPNITNSARHLLEG 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 53/261 (20%), Positives = 94/261 (36%), Gaps = 78/261 (29%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
F + +G G+FG++ L T A+K + + T +HP
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 48 --QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR- 98
L Y +L VM+ G +LF SR
Sbjct: 210 LTALKYSFQTHDRLC-----------------------FVMEYANGG----ELFFHLSRE 242
Query: 99 -KLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
S ++++ ++++HS K+ ++RD+K +N ++ + + I DFGL K
Sbjct: 243 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCK-- 297
Query: 157 RDTSTHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPW 213
+ I T GT Y + + R D LG V+MY + G LP+
Sbjct: 298 ------EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPF 349
Query: 214 QGLKAGTKKQKYEKISEKKVS 234
++ +E I +++
Sbjct: 350 YN---QDHEKLFELILMEEIR 367
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 38/179 (21%), Positives = 68/179 (37%), Gaps = 27/179 (15%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTKHPQ-LLYESKLYRILQGGT 63
IG G FG +Y GT + + + A+K L E + +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 85
Query: 64 GIPN-VRWFGV--EGDYNVL-VMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRV 116
PN + G+ + + L V+ + DL NF + ++K ++ Q+ +
Sbjct: 86 --PNVLSLLGICLRSEGSPLVVLPYM--KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 141
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+++ SK F+HRD+ N ++ V + DFGLA+ D Y +
Sbjct: 142 KYLASKKFVHRDLAARNCMLDEK---FTVKVADFGLARDMYDKE-----YYSVHNKTGA 192
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 61/267 (22%), Positives = 104/267 (38%), Gaps = 89/267 (33%)
Query: 9 FRLGRKIGSGSFGEIYL-------GTN------------IQTNEEVAIKLEN---VKTKH 46
F L + +G GSFG+++L ++ + V K+E V+ H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 47 P---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCS 97
P +L Y E KLY L++D L G DLF S
Sbjct: 86 PFIVKLHYAFQTEGKLY-----------------------LILDFLRGG----DLFTRLS 118
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
+ + + V ++ ++ +HS ++RD+KP+N L+ G + + DFGL
Sbjct: 119 KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------HIKLTDFGL 172
Query: 153 AKK--YRDTSTHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FL 207
+K+ + + + GT Y + ++ D S G VLM+ L
Sbjct: 173 SKESIDHEKKAY-----------SFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEML 220
Query: 208 RGSLPWQGLKAGTKKQKYEKISEKKVS 234
G+LP+QG +K+ I + K+
Sbjct: 221 TGTLPFQG---KDRKETMTMILKAKLG 244
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 36/182 (19%), Positives = 75/182 (41%), Gaps = 37/182 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKL--ENVKTKHPQ-LLYE 52
PR +K LG+ +G G FG++ + I ++ VA+K+ ++ K L+ E
Sbjct: 79 PR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 53 SKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL----------GPSLEDLF 93
+ +++ N + G + +++ +L D+
Sbjct: 137 ME---MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+++ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGLA
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA 250
Query: 154 KK 155
+
Sbjct: 251 RD 252
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 40/172 (23%), Positives = 67/172 (38%), Gaps = 25/172 (14%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTKHPQ-LLYESKLYRILQGGT 63
IG G FG +Y GT + + + A+K L E + +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 149
Query: 64 GIPNV-RWFGV--EGDYNVL-VMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRV 116
PNV G+ + + L V+ + DL NF + ++K ++ Q+ +
Sbjct: 150 --PNVLSLLGICLRSEGSPLVVLPYM--KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
+F+ SK F+HRD+ N ++ V + DFGLA RD +
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEK---FTVKVADFGLA---RDMYDKEFDSVH 251
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 40/183 (21%), Positives = 62/183 (33%), Gaps = 39/183 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ---LLYESK 54
+ R ++G FG++Y G E+ VAIK K + P +E+
Sbjct: 7 SL--SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL----------GPSLEDLFNF 95
L LQ PN V GV + ++ DL D
Sbjct: 65 LRARLQH----PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 96 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
L + L Q+ +E++ S +H+D+ N L+ V I D GL
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK---LNVKISDLGLF-- 175
Query: 156 YRD 158
R+
Sbjct: 176 -RE 177
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 37/194 (19%), Positives = 74/194 (38%), Gaps = 56/194 (28%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ-----LLYE 52
PR LG+ +G G FG++ T +++ VA+K+ +K LL E
Sbjct: 21 PR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLSE 76
Query: 53 SKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL------------------ 85
+ + + P+ ++ +G + +L++ L
Sbjct: 77 FNVLKQVNH----PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 86 GPSLEDLFNFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141
+ L + R L++ ++ A Q M +++ +HRD+ N L+ G
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGM----QYLAEMKLVHRDLAARNILVAEG-- 186
Query: 142 ANQVYIIDFGLAKK 155
++ I DFGL++
Sbjct: 187 -RKMKISDFGLSRD 199
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 45/197 (22%), Positives = 68/197 (34%), Gaps = 59/197 (29%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ-----LLYE 52
PR N R IG G+FG ++ + E VA+K+ +K + E
Sbjct: 45 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQRE 100
Query: 53 SKLYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL------------------ 85
+ L PN V+ GV G L+ DL
Sbjct: 101 AALMAEFDN----PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 86 GPSLEDLFNFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141
+ + + LS L +A Q M ++ + F+HRD+ N L+G
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGM----AYLSERKFVHRDLATRNCLVGENM- 211
Query: 142 ANQVYIIDFGLAKKYRD 158
V I DFGL+ R+
Sbjct: 212 --VVKIADFGLS---RN 223
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 3e-05
Identities = 63/269 (23%), Positives = 100/269 (37%), Gaps = 91/269 (33%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-------------LENVKT-------- 44
F L R +G G +G+++ T T + A+K + K
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 45 KHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNF 95
KHP L+Y KLY L+++ L G +LF
Sbjct: 79 KHPFIVDLIYAFQTGGKLY-----------------------LILEYLSGG----ELFMQ 111
Query: 96 CSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDF 150
R T ++ + +H K ++RD+KP+N ++ G V + DF
Sbjct: 112 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG------HVKLTDF 165
Query: 151 GLAKK--YRDTSTHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY- 205
GL K+ + T TH T GT Y + + +R D SLG LMY
Sbjct: 166 GLCKESIHDGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALMYD 213
Query: 206 FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
L G+ P+ G +K+ +KI + K++
Sbjct: 214 MLTGAPPFTG---ENRKKTIDKILKCKLN 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 45/187 (24%), Positives = 68/187 (36%), Gaps = 42/187 (22%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQ-LLYESK 54
PR G+ +GSG+FG++ T I VA+K+ E + + L+ E K
Sbjct: 43 PR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 55 LYRILQGGTGIPN-VRWFGV--EGDYNVLVM------DLL-----------------GPS 88
++ N V G L+ DLL
Sbjct: 101 ---MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
L+ + +L A Q+ +EF+ KS +HRD+ N L+ G V I
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVVKIC 214
Query: 149 DFGLAKK 155
DFGLA+
Sbjct: 215 DFGLARD 221
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 43/185 (23%), Positives = 65/185 (35%), Gaps = 53/185 (28%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-- 64
+ F +G G FG++Y G + VA+K +L E QGG
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVK---------RLKEERT-----QGGELQF 74
Query: 65 ------I-----PN-VRWFG--VEGDYNVLVMDLL--GPSLED-LFNFCSRKLSL----- 102
I N +R G + +LV + G S+ L + L
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG-SVASCLRERPESQPPLDWPKR 133
Query: 103 -KTVLMLADQMINR-VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
+ L A R + ++H +HRD+K N L+ + + DFGLAK
Sbjct: 134 QRIALGSA-----RGLAYLHDHCDPKIIHRDVKAANILLD---EEFEAVVGDFGLAKLMD 185
Query: 158 DTSTH 162
TH
Sbjct: 186 YKDTH 190
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 55/274 (20%), Positives = 106/274 (38%), Gaps = 93/274 (33%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-----------------------LENV 42
F L + +G+G++G+++L + T + A+K LE++
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 43 KTKHP---QLLY----ESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLF 93
+ + P L Y E+KL+ L++D + G +LF
Sbjct: 116 R-QSPFLVTLHYAFQTETKLH-----------------------LILDYINGG----ELF 147
Query: 94 NFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYII 148
S+ + + V + +++ +E +H ++RDIK +N L+ G V +
Sbjct: 148 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVLT 201
Query: 149 DFGLAKKYRDTSTHQHIPYRENKNLT--GTARYAS----MNTHLGIEQSRRDDLESLGYV 202
DFGL+K + + + GT Y + G +++ D SLG V
Sbjct: 202 DFGLSK--------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLG-V 250
Query: 203 LMY-FLRGSLPWQGLKAG-TKKQKYEKISEKKVS 234
LMY L G+ P+ ++ + +I + +
Sbjct: 251 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 8/86 (9%)
Query: 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146
E + L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ V
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 147 IIDFGLAKKYRDTSTHQHIPYRENKN 172
I DFGLA+ Y +
Sbjct: 234 ICDFGLARDIYKDPD-----YVRKGD 254
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 7e-04
Identities = 26/161 (16%), Positives = 60/161 (37%), Gaps = 31/161 (19%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKL-- 55
+G+ +G G ++ + + E +K E +
Sbjct: 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 151
Query: 56 ---YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 112
+R LQ G+ + + EG N ++M+L+ ++L ++ ++ + D +
Sbjct: 152 RNEFRALQKLQGLAVPKVYAWEG--NAVLMELID--AKEL-----YRVRVENPDEVLDMI 202
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ V + + +H D+ N L+ ++IIDF +
Sbjct: 203 LEEVAKFYHRGIVHGDLSQYNVLVSEE----GIWIIDFPQS 239
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 477 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.56 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.61 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.6 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.57 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.44 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.37 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.13 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.98 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.93 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.87 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.78 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.4 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.11 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.86 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-81 Score=659.27 Aligned_cols=472 Identities=82% Similarity=1.281 Sum_probs=278.5
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
|+++++++|+++++||+|+||.||+|++..+++.||||++........+..|+++++.|.|+++++.+.+++...++.+|
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 89999999999999999999999999999999999999988877778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||||++++|.+++..+...+++..++.|+.||+.||+|||++|||||||||+||||+.++..+.+||+|||+++.+....
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999999999878889999999999999999999999999999999999999655578899999999999988777
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.....++.......||+.|+|||++.+..++.++|||||||+||+|++|..||.+.......+.+.++........++.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 66666777777889999999999999999999999999999999999999999998888888999999988888888999
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCCCccCCCCCCCCCCCCC
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPARALVPGAGTSGAPPA 320 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~~~~~~~~~~s~~p~~ 320 (477)
+..+|+++.+||..||..+|++||++++|.+.|++++.+.+++++..+||+.++.++.+.+.+|+++..+..+++..++.
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~~~~~~~~~~s~~~~~ 320 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPP 320 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-------------------------
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCCCCCCCCCCCCCCCCCc
Confidence 99999999999999999999999999999999999999999999999999999988888777777776666666655555
Q ss_pred CCCCCCcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccCCCCCCCCCCccccccCCCcccCCCCCCcccceeecC
Q 011819 321 IASGDRQTGGGEEGRPAGLSSMDSSRRRMSGPVINSGSFSKQKSPVVNEPTMTKDTMLSSSNFLGRSGGGSSRRAAAVSS 400 (477)
Q Consensus 321 ~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (477)
+...++.++ +.+.+..+|+++. +|+.++++.+.|.+.++++|+.++++.+++...+++.+++|+++ ++|| .+||+
T Consensus 321 ~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~ 395 (483)
T 3sv0_A 321 ALQNDRQSG-VDEGRTSGWSSMD--RRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSG-SSRR-PAVSS 395 (483)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccccCc-cccccccCCcccc--cccCCcccccccccccccCCCCCCccccccccccccccccccCC-cccc-ccccc
Confidence 555556555 7778888887765 67778888899999999999999999999999999999999977 6777 77799
Q ss_pred CCCCCCCCCCCCCCCccccCCCCCCCCCCCCCCCCCCCCCCCCccCCCCcCcCCcccccccccccceeccCCCccCC
Q 011819 401 SRDAFVGSETEPQRSRTTEASPGAMHRISSGPRGSPIGSSDPKRSSSGRNTTHIKTYETTLKGIESLHFDTDERVHY 477 (477)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 477 (477)
||++..+...+++++|++++++|+..|+++.||+++..++++|+++++|++++++|||+||||||+|+|++|+|+||
T Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (483)
T 3sv0_A 396 SRDVMPIDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472 (483)
T ss_dssp -----------------------------------------------------------------------------
T ss_pred cccccCCCCCCcccccccccCchhhhcCCCCcccCCCCccccccccccccccccccHHHHhhhhhhcccCCchHHHH
Confidence 99986666667788999999999989999999999999999999999999999999999999999999999999998
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-56 Score=441.80 Aligned_cols=269 Identities=20% Similarity=0.313 Sum_probs=227.0
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|++++.||+|+||+||+|+++.+++.||||++... .....+.+|+++++.|+| ++|+.+..++.+.+..||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999998642 334568899999999987 566666666778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||| |++|.+++.. .+.+++.++..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+...
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence 99999 8999999975 4569999999999999999999999999999999999999 68899999999999987543
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
... ....+++||+.|||||++.+..|+.++|||||||+||+|++|..||.+ .+..+.+.++......
T Consensus 186 ~~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~---~~~~~~~~~i~~~~~~----- 252 (311)
T 4aw0_A 186 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEGLIFAKIIKLEYD----- 252 (311)
T ss_dssp TTC-----CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC---SSHHHHHHHHHHTCCC-----
T ss_pred CCc-----ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCCCC-----
Confidence 321 123567999999999999999999999999999999999999999976 3456667777665543
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 296 (477)
++..+++++.+||.+||..||.+||+++++... .+. ..++|+..+||+.+..+
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~---~~i-~~Hp~F~~idw~~l~~~ 305 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY---GPL-KAHPFFESVTWENLHQQ 305 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH---HHH-HTSGGGTTCCCTTGGGS
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC---HHH-HCCCCcCCCCHHHhcCC
Confidence 345689999999999999999999998765321 111 34788899999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-55 Score=439.64 Aligned_cols=252 Identities=23% Similarity=0.243 Sum_probs=207.1
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+|+++++.|+| ++|+.+..++.+.+..||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-PNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEE
Confidence 6899999999999999999999999999999998764322 357899999999987 56666666777888999999
Q ss_pred ecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||| |++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCc
Confidence 999 899999997533 457999999999999999999999999999999999999 688999999999998664321
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+. +..+.+.++.....+. +
T Consensus 180 ~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~----~ 245 (350)
T 4b9d_A 180 E-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGSFPP----V 245 (350)
T ss_dssp H-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCC----C
T ss_pred c-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCC----C
Confidence 1 123568999999999999999999999999999999999999999763 4456666676655432 3
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
...+++++.+||.+||..||++||+++++ |++.|..
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~---l~hp~~~ 281 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSI---LEKGFIA 281 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHH---HTSHHHH
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHH---hcCHHhh
Confidence 45689999999999999999999997766 4444443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=432.71 Aligned_cols=260 Identities=21% Similarity=0.241 Sum_probs=213.9
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
+.|++.++||+|+||.||+|+++.+|+.||||+++.+.. ..+|+.++..|+| ++|+.+..++.+.+..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSS-PRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCC-TTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeccC
Confidence 579999999999999999999999999999999876433 3469999999987 56666666777888999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC-cEEEeecCceeecccCCCCcc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~~~ 164 (477)
|++|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||| +.++ .+||+|||+|+.+........
T Consensus 134 gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 134 GGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE---CTTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---eCCCCEEEEeeCCCCeEccCCCcccc
Confidence 9999999985 4569999999999999999999999999999999999999 5665 699999999997755332111
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
......++||+.|||||++.+..|+.++|||||||+||||++|..||.+...... +.++..... ....+++.+
T Consensus 210 --~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~~~~--~~~~~~~~~ 282 (336)
T 4g3f_A 210 --LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKIASEPP--PIREIPPSC 282 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHHHHSCC--GGGGSCTTS
T ss_pred --eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHcCCC--CchhcCccC
Confidence 1123456899999999999999999999999999999999999999987554433 333433322 223456789
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
++++.+||.+||..||++||++.+|++.|...+...+
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999998888876544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-55 Score=432.52 Aligned_cols=270 Identities=21% Similarity=0.305 Sum_probs=215.9
Q ss_pred CceEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
++|++++.||+|+||+||+|++. .+++.||||++.... ....+..|+.+++.|+| ++|+.+..++.+.+..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCC-TTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEE
Confidence 68999999999999999999984 467899999876532 22357789999999987 56666666677888999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||| |++|.+++.. .+.+++.++..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+....
T Consensus 103 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred EEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence 999999 9999999985 4569999999999999999999999999999999999999 6889999999999986544
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
... ...+.+||+.|||||++.+..|+.++|||||||+||||++|..||.+. +..+.+.++......
T Consensus 179 ~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~---- 244 (304)
T 3ubd_A 179 HEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLG---- 244 (304)
T ss_dssp --C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred CCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC----
Confidence 322 234678999999999999999999999999999999999999999763 445666666655443
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccchhhccccCCC
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 303 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~--~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 303 (477)
++..+++++.+||.+||..||++||++. .+.+++ .++|+..+||+.+...+.+++..
T Consensus 245 -~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil-------~Hp~f~~idw~~l~~~~~~pP~~ 303 (304)
T 3ubd_A 245 -MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIK-------RHSFFSTIDWNKLYRREIHPPFK 303 (304)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHH-------TSGGGTTCCHHHHHTTCSCCSSC
T ss_pred -CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHH-------cCccccCCCHHHHHhCCCCcCcC
Confidence 3456899999999999999999999852 122222 36777888999887666555443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-54 Score=432.46 Aligned_cols=246 Identities=19% Similarity=0.269 Sum_probs=209.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~--~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
..|+++++||+|+||+||+|+++.+|+.||||++... .....+.+|+.+++.|+| ++|+.+..++.+.+..||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeC
Confidence 5699999999999999999999999999999998643 234568899999999987 5666666777788899999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
| |++|.+++.. .++++.++..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCC--
Confidence 9 8999999974 569999999999999999999999999999999999999 6889999999999997755332
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
.....+||+.|||||++.+..|+.++|||||||+||||++|..||.+. +..+.+..+........ ..+..
T Consensus 226 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~~--~~~~~ 295 (346)
T 4fih_A 226 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPRL--KNLHK 295 (346)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSSCCCC--SCGGG
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCCC--Ccccc
Confidence 235679999999999999999999999999999999999999999764 34455555554322211 12356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+++++.+||.+||..||++||++++++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l 322 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELL 322 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 899999999999999999999977664
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=417.34 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=200.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.|+| ++|+.+..++.+.+..||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-PHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEE
Confidence 368999999999999999999999999999999986532 23458899999999987 566666666677888999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||||+++|.+++.. .+++++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 91 vmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC-------
T ss_pred EEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCC
Confidence 999999999999975 5679999999999999999999999999999999999999 678999999999998665432
Q ss_pred CCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
. ..+.+||+.|||||++.+..| +.++|||||||+||+|++|+.||.+. +..+.+..+......
T Consensus 167 ~--------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~~~~----- 230 (275)
T 3hyh_A 167 F--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNGVYT----- 230 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC-----
T ss_pred c--------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 2 345789999999999999887 58999999999999999999999763 445566666655443
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~ 282 (477)
++..+++++.+||.+||..||++||+++++ |++.|.+...
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~ei---l~hpw~k~~~ 270 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEI---MQDDWFKVDL 270 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHH---HHCHHHHTTC
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHH---HcCcccccCC
Confidence 345689999999999999999999996665 5566655443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=413.41 Aligned_cols=293 Identities=78% Similarity=1.357 Sum_probs=257.9
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
|+..++++|++++.||+|+||.||+|++..+++.||||++........+..|+.++..+.|+++++.+..++...+..++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 67788999999999999999999999999999999999987777777899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||+++......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999999999998777789999999999999999999999999999999999999544567889999999999887766
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.....++.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......+.+.++.........+.+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 55555566667789999999999999999999999999999999999999999887665555666666666666777778
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 293 (477)
+..+|+++.+++..||+.+|++||+++++.+.|++++.+.+..+++.+||+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 88999999999999999999999999999999999999999999999999965
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=410.78 Aligned_cols=293 Identities=78% Similarity=1.357 Sum_probs=263.9
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
|+..++++|++++.||+|+||.||+|++..+++.||||++........+..|+.++..+.|+++++.+..+.......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 67789999999999999999999999999999999999988777777899999999999999999999999899999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999999999998777789999999999999999999999999999999999999544467899999999999887765
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.....++.......||+.|+|||++.+..++.++|||||||++|+|++|..||.........+.+..+.........+.+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 55555555567788999999999999999999999999999999999999999886655555666666666666777778
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 293 (477)
+..+|+++.+++..||+.+|++||+++++.+.|++++.+.+...++.+||+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 88999999999999999999999999999999999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=435.00 Aligned_cols=246 Identities=19% Similarity=0.269 Sum_probs=209.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
+.|+++++||+|+||.||+|+++.+|+.||||++.... ....+.+|+.+++.|+| ++|+.+..++.+.+..||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCCCceEEEEEECCEEEEEEeC
Confidence 56999999999999999999999999999999986543 34468899999999987 5666666667778899999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
| |++|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc--
Confidence 9 8999999974 469999999999999999999999999999999999999 6889999999999997754332
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
....++||+.|||||++.+..|+.++|||||||+||||++|..||.+. ...+.+..+....... ...+..
T Consensus 303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~--~~~~~~ 372 (423)
T 4fie_A 303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPR--LKNLHK 372 (423)
T ss_dssp -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSCCCC--CSCTTS
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCC--Cccccc
Confidence 235679999999999999999999999999999999999999999764 3345555555432221 112356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+++++.+||.+||..||++||++++++
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell 399 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELL 399 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 899999999999999999999977664
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=416.32 Aligned_cols=285 Identities=60% Similarity=1.061 Sum_probs=259.5
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
..++++|++++.||+|+||.||+|++..+++.||||++........+..|+.+++.|.++++++.+..++...+..+|||
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 35788999999999999999999999999999999998877666789999999999977788888888888899999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCc-----EEEeecCceeecc
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-----VYIIDFGLAKKYR 157 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~-----vkL~DFGla~~~~ 157 (477)
||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++. +||+|||+++.+.
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill---~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI---GRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CCGGGTCTTSEEECCCTTCEESB
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---ccCCCCCCceEEEEEcccceeee
Confidence 999999999998777789999999999999999999999999999999999999 45555 9999999999887
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
........+++......||+.|+|||++.+..++.++|||||||+||+|++|..||.+.......+.+..+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 76655555666667889999999999999999999999999999999999999999988777777888888777777777
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~ 291 (477)
+.++..+| ++.+++..||..+|.+||++++|.+.|++++.+.++..+..+||.
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 88888888 999999999999999999999999999999999999999999998
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=416.65 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=212.9
Q ss_pred CCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.++|.+.++||+|+||+||+|++. .++..||||+++.... ...+.+|++++..|+| ++|+.+..++.+.+..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeCCEE
Confidence 468999999999999999999875 3578999999875432 2458899999999987 5666666667777889
Q ss_pred EEEEecC-CCCHHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcE
Q 011819 79 VLVMDLL-GPSLEDLFNFC------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~v 145 (477)
||||||| +|+|.+++... ...+++.+++.++.||+.||+|||+++||||||||+|||| +.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcE
Confidence 9999999 99999999753 2469999999999999999999999999999999999999 678999
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~ 224 (477)
||+|||+|+....... +.......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+... .+.
T Consensus 168 Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~ 239 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV 239 (299)
T ss_dssp EECCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHH
T ss_pred EECCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 9999999986644322 122334579999999999999999999999999999999998 9999987543 455
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+..+....... .+..+|+++.+|+..||+.||++||+++++.+.|+++...
T Consensus 240 ~~~i~~~~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 240 IECITQGRVLQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 55555543322 3467899999999999999999999999999999887644
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=401.86 Aligned_cols=290 Identities=59% Similarity=1.007 Sum_probs=260.4
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
..++++|++++.||+|+||.||+|.+..+++.||||++........+..|+.++..+.++++++.+..++......++||
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 45788999999999999999999999999999999998776667789999999999988899999988889999999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC--CCCCcEEEeecCceeecccCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~--~~~~~vkL~DFGla~~~~~~~ 160 (477)
||++++|.+++.....++++..++.++.||+.||+|||++||+||||||+|||++.+ +..+.+||+|||+++......
T Consensus 86 e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 86 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 999999999998767779999999999999999999999999999999999999421 122349999999999887765
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.....++.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......+.+..+...........+
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence 55555555567788999999999999999999999999999999999999999987777777777777777766777778
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 292 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 292 (477)
+..+|+++.+++..||+.+|++||+++++.+.|++++.+.+...+..+||+.
T Consensus 246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 8899999999999999999999999999999999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=416.10 Aligned_cols=256 Identities=22% Similarity=0.315 Sum_probs=202.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.++|+++++||+|+||+||+|++. ..||||+++..... ..+.+|+.++..|+|++++. +..++.. +..|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~-l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILL-FMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCC-EEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEee-EEEEEEC-CeEEEE
Confidence 357889999999999999999843 36999998654322 35789999999998865554 4445443 457999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||| |++|.+++.....++++.+++.|+.||+.||+|||+++||||||||+|||| +.++.+||+|||+|+......
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceecccCC
Confidence 9999 999999998666789999999999999999999999999999999999999 678999999999998664432
Q ss_pred CCcccccccCCCCccCccccccchhcCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~---~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.. ......+||+.|||||++.+. .|+.++|||||||+||||++|..||.+.... ......+.........
T Consensus 187 ~~-----~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 187 GS-----QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDL 259 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCS
T ss_pred cc-----eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCc
Confidence 21 123457899999999999754 5899999999999999999999999875432 2233333333333333
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
..+...+|+++.+||..||+.+|++||++.++.+.|+.+
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 445678999999999999999999999999999888765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=408.94 Aligned_cols=248 Identities=20% Similarity=0.299 Sum_probs=201.1
Q ss_pred CCce-EEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEe---CcE
Q 011819 6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE---GDY 77 (477)
Q Consensus 6 ~~~y-~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~---~~~ 77 (477)
.++| ++.++||+|+||+||+|.+..+++.||||++..... ...+.+|+.+++.|+|++++..+..+... ...
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 3455 788899999999999999999999999998765432 23578999999999986555555554332 456
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.||||||| |++|.+++.. ...+++..+..|+.||+.||+|||++| ||||||||+||||+ +.++.+||+|||+|+
T Consensus 104 ~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCE
Confidence 79999999 9999999985 457999999999999999999999998 99999999999993 246899999999997
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
..... ...+.+||+.|||||++.+ .|+.++|||||||+||||++|..||.+.. ...+.+..+.....+
T Consensus 181 ~~~~~---------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~~i~~~~~~ 248 (290)
T 3fpq_A 181 LKRAS---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKP 248 (290)
T ss_dssp GCCTT---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCC
T ss_pred eCCCC---------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHHHHHHHHHcCCCC
Confidence 54322 1245789999999999876 69999999999999999999999997643 234445555444332
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. .+...+++++.+||.+||..||++||+++++++
T Consensus 249 ~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 A---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2 244567899999999999999999999777643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=416.83 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=204.5
Q ss_pred CceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.+|.+.++||+|+||+||+|++. .+++.||||++..... ...+.+|++++..|+| ++|+.+..++.+.+..|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH-QHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEE
Confidence 57999999999999999999864 3688999999875432 2458899999999987 56666666677778899
Q ss_pred EEEecC-CCCHHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCc
Q 011819 80 LVMDLL-GPSLEDLFNFC--------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~--------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~ 144 (477)
|||||| +++|.+++... ..++++.+++.|+.||+.||+|||+++||||||||+|||| +.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CCCCc
Confidence 999999 99999999743 2358999999999999999999999999999999999999 67899
Q ss_pred EEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHH
Q 011819 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (477)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~ 223 (477)
+||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+... .+
T Consensus 197 ~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~ 268 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TE 268 (329)
T ss_dssp EEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HH
T ss_pred EEEcccccceeccCCCcc-----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HH
Confidence 999999999876443221 12345689999999999999999999999999999999999 9999987543 44
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
.+..+...... ..+..+|+++.+|+..||+.||++||++++|.+.|+.+.
T Consensus 269 ~~~~i~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 269 AIDCITQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHHHHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 55555443322 134678999999999999999999999999999998875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=410.01 Aligned_cols=254 Identities=19% Similarity=0.239 Sum_probs=209.5
Q ss_pred CCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
..++++.++||+|+||+||+|+.. .+++.||||++.... ....+..|+.++..|+| ++|+.+..++...+.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH-PNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCC-CCCCCcceEEEECCE
Confidence 357899999999999999999853 467899999986543 23568899999999987 556666666667778
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 78 NVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~---------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
.+|||||| +|+|.+++... ...+++.+++.++.||+.||+|||+++||||||||+|||| +.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---YD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---CC
Confidence 89999999 99999999632 1358999999999999999999999999999999999999 67
Q ss_pred CCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCccc
Q 011819 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~ 220 (477)
++.+||+|||+|+....... +......+||+.|||||++.+..|+.++|||||||+||||++ |..||.+...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-- 253 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-- 253 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--
T ss_pred CCCEEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--
Confidence 89999999999987644322 122345689999999999999999999999999999999998 8999987543
Q ss_pred HHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
.+.+..+....... .+..+|+++.+|+..||+.||++||++.+|.+.|+.
T Consensus 254 -~~~~~~i~~~~~~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 254 -QDVVEMIRNRQVLP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -HHHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -HHHHHHHHcCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 45555555443322 346789999999999999999999999999888764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=415.86 Aligned_cols=260 Identities=20% Similarity=0.301 Sum_probs=214.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCC-----CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGV-EGDY 77 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~-----g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~ 77 (477)
++|+++++||+|+||+||+|.+..+ ++.||||.+...... ..+..|++++..+.|+++|+.+..++. .++.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 5899999999999999999997654 368999998765432 357899999999999888887776654 4567
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 78 NVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~---------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
.+|||||| +|+|.+++... ...+++.+++.|+.||+.||+|||+++||||||||+|||+ +.
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee---CC
Confidence 89999999 99999999743 2348999999999999999999999999999999999999 67
Q ss_pred CCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCccc
Q 011819 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~ 220 (477)
++.+||+|||+|+....... +......+||+.|||||++.+..|+.++|||||||+||||++ |..||.+.....
T Consensus 221 ~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred CCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 89999999999987654332 122345689999999999999999999999999999999998 999998765432
Q ss_pred HHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.....+...... ..+..+|+++.++|..||+.||++||++.+|.+.|+.+++.+
T Consensus 296 --~~~~~i~~g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 296 --EFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp --HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --HHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 222233332211 134568999999999999999999999999999999987654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=436.47 Aligned_cols=275 Identities=23% Similarity=0.296 Sum_probs=229.2
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHc--CCCCCCeeEEeeEeC
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEG 75 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~--~~~~i~~~~~~~~~~ 75 (477)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+. ........|..++..+. +|++|+.+...+.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 45568999999999999999999999999999999998642 22334556666666654 457888888888888
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
+..||||||| ||+|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+|||| +.+|.+||+|||+|+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLAC 340 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceee
Confidence 9999999999 9999999975 4569999999999999999999999999999999999999 788999999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
.+.... ..+.+||+.|||||++. +..|+.++|||||||+||||++|..||.+....+..+.+..+.....
T Consensus 341 ~~~~~~---------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~ 411 (689)
T 3v5w_A 341 DFSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 411 (689)
T ss_dssp ECSSCC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC
T ss_pred ecCCCC---------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC
Confidence 775432 24679999999999996 46799999999999999999999999987555555555555554433
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCCC
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPPA 305 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p~ 305 (477)
. ++..+++++.+||..||..||.+|++ ++++ ..++|+..+||..+...+..++..|.
T Consensus 412 ~-----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei----------~~HpfF~~idW~~l~~~~~~pP~~P~ 473 (689)
T 3v5w_A 412 E-----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV----------KESPFFRSLDWQMVFLQKYPPPLIPP 473 (689)
T ss_dssp C-----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH----------TTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred C-----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH----------hcCccccCCCHHHHHcCCCCcCccCC
Confidence 2 34568999999999999999999997 4554 45788999999998877777666553
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=413.07 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=204.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeE-----e
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGV-----E 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~-----~ 74 (477)
.++++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|+|++++..+..+.. +
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 3568899999999999999999999999999999998654332 346789999999988555554444322 3
Q ss_pred CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.+..|||||||+++|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceee
Confidence 456799999998899999974 5679999999999999999999999999999999999999 688999999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc-
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (477)
.+....... .....+.+||+.|||||++.+.. |+.++|||||||+||||++|..||.+.+. ...+..|....
T Consensus 207 ~~~~~~~~~---~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g 280 (398)
T 4b99_A 207 GLCTSPAEH---QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLG 280 (398)
T ss_dssp CC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHC
T ss_pred ecccCcccc---ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcC
Confidence 764432111 12245679999999999998864 69999999999999999999999987443 33344333221
Q ss_pred -------------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 -------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 -------------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.......+.+.+++++.+||.+||..||.+|||+++++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 343 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 11233445567889999999999999999999977653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=399.73 Aligned_cols=264 Identities=22% Similarity=0.254 Sum_probs=189.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeC-------
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG------- 75 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~------- 75 (477)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+|+++++.|+|++++..+..+...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35799999999999999999999999999999988654432 35788999999998866655555554332
Q ss_pred ----cEEEEEEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEe
Q 011819 76 ----DYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (477)
Q Consensus 76 ----~~~~lVmE~~-g~sL~~li~~~~~--~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~ 148 (477)
.+.||||||| |++|.+++..... ......++.++.||+.||+|||++|||||||||+|||| +.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEc
Confidence 3579999999 9999999974321 24566789999999999999999999999999999999 678999999
Q ss_pred ecCceeecccCCCCccc-----ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH
Q 011819 149 DFGLAKKYRDTSTHQHI-----PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (477)
Q Consensus 149 DFGla~~~~~~~~~~~~-----p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~ 223 (477)
|||+|+........... ........+||+.|||||++.+..|+.++|||||||+||||++ ||... .....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH
Confidence 99999877554322110 1122345689999999999999999999999999999999996 88541 11223
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 011819 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291 (477)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~ 291 (477)
.+..+.....+. .....++++.+||..||+.||++||++.++++ ++|...+||.
T Consensus 236 ~~~~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~----------h~~~~~~~~p 289 (299)
T 4g31_A 236 TLTDVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE----------NAVFEDLDFP 289 (299)
T ss_dssp HHHHHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT----------SGGGCCC---
T ss_pred HHHHHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc----------CHhhCCCCCC
Confidence 333333333322 22234567889999999999999999877643 3455556664
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=402.62 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=205.2
Q ss_pred CccCCceEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
|.+.++|+++++||+|+||+||+|++. .+++.||||.+........+.+|++++..+.+|++|+.+..++.+.++.|
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 567889999999999999999999874 46789999988776666678899999999988888888888888899999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||| |++|.+++. .+++.++..++.||+.||+|||++|||||||||+|||++ ...+.+||+|||+|+...+
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCC
Confidence 999999 899999985 499999999999999999999999999999999999995 3448999999999987654
Q ss_pred CCCCcc---------------------cccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCC
Q 011819 159 TSTHQH---------------------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGL 216 (477)
Q Consensus 159 ~~~~~~---------------------~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~ 216 (477)
...... .........+||+.|||||++.+.. |+.++||||+||+||+|++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 322100 0001234568999999999998864 899999999999999999999999654
Q ss_pred CcccHHHHHHHHhhhcc----------------------------------------c---------ccHHHHhcCCcHH
Q 011819 217 KAGTKKQKYEKISEKKV----------------------------------------S---------TSIEALCRGYPTE 247 (477)
Q Consensus 217 ~~~~~~~~~~~i~~~~~----------------------------------------~---------~~~~~l~~~~p~~ 247 (477)
.. ....+..+....- + ......+..++++
T Consensus 251 ~~--~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 251 SD--DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp SS--HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CC--HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 32 2222222211000 0 0001123457889
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHH
Q 011819 248 FASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 248 l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+.+||.+||..||.+|||+++++
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL 351 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEAL 351 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHH
T ss_pred HHHHHHHHCcCChhHCcCHHHHh
Confidence 99999999999999999977664
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=398.67 Aligned_cols=267 Identities=21% Similarity=0.263 Sum_probs=196.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHH--HHHHcCCCCCCeeEEeeEeC---cEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKL--YRILQGGTGIPNVRWFGVEG---DYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~i--l~~L~~~~~i~~~~~~~~~~---~~~~ 79 (477)
|.++|.+.++||+|+||+||+|++ +|+.||||+++... ...+..|.++ +..|+|++++..+..+...+ ...|
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 467899999999999999999986 68999999986543 2334444444 44567755444444444333 2579
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~--------giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
|||||| +++|.++++. .+++++.++.++.|++.||+|||++ +||||||||+|||| +.++.+||+||
T Consensus 78 lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DF 152 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred EEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeC
Confidence 999999 8999999984 5699999999999999999999987 99999999999999 78899999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCC------CCCCcchHHHHHHHHHHHHcCCCCCCC---------
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQG--------- 215 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~------~~s~ksDIwSlGviLyelltG~~Pf~~--------- 215 (477)
|+|+.......... ......+||+.|||||++.+. .++.++|||||||+||||++|..||..
T Consensus 153 Gla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~ 229 (303)
T 3hmm_A 153 GLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp TTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred CCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence 99987755432110 112346899999999999765 367799999999999999999766532
Q ss_pred -CCc--ccHHHHHHHHhhhcccccHHHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011819 216 -LKA--GTKKQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (477)
Q Consensus 216 -~~~--~~~~~~~~~i~~~~~~~~~~~l~~--~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~ 282 (477)
... ....+....+........++.... .+++.+.+|+..||..||++|||+.++.+.|+++...++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 211 122233333333333222221111 2356789999999999999999999999999998766553
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=396.60 Aligned_cols=289 Identities=28% Similarity=0.537 Sum_probs=222.5
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCC-----CcEEEEEEecCCCCchhHHHHHHHHHHHcC--------------CCCC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKHPQLLYESKLYRILQG--------------GTGI 65 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~-----g~~vAiKi~~~~~~~~~~~~E~~il~~L~~--------------~~~i 65 (477)
..++|+++++||+|+||.||+|.+..+ ++.||||++.... ..+..|++++..+.+ |++|
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC--HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc--hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 356999999999999999999998664 5889999976543 356666666666544 5666
Q ss_pred CeeEEeeEeC----cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 66 PNVRWFGVEG----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 66 ~~~~~~~~~~----~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
+.+..++... .+.||||||+|++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++. +.
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SC
T ss_pred CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CC
Confidence 6665554432 567999999999999999876678999999999999999999999999999999999999942 16
Q ss_pred CCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH
Q 011819 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~ 221 (477)
.+.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||+|++|..||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 78999999999987765433222222223456799999999999999999999999999999999999999986333222
Q ss_pred HHHHHHHh-hhcccccHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhh
Q 011819 222 KQKYEKIS-EKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQ 296 (477)
Q Consensus 222 ~~~~~~i~-~~~~~~~~~~l~--~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 296 (477)
........ ............ ..+|+++.+++..||..+|++||++.+|.+.|++++...+...+..+||+.....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~ 347 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENG 347 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC------
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEeccCC
Confidence 21111111 111111111111 6789999999999999999999999999999999999999999999999976543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=415.98 Aligned_cols=253 Identities=18% Similarity=0.269 Sum_probs=213.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+.++|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+|+.+|+.|+| ++|..+..++.+....||||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEE
Confidence 34689999999999999999999999999999998865432 2457889999999987 56666666777888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||| |++|.+++......+++.++..|+.||+.||+|||++||+||||||+|||++. +..+.+||+|||+|+.+.....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc
Confidence 999 89999998654567999999999999999999999999999999999999942 2357999999999998754322
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+. ...+.+..+........ ...+
T Consensus 313 --------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~ 380 (573)
T 3uto_A 313 --------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMD-DSAF 380 (573)
T ss_dssp --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCCCC-SGGG
T ss_pred --------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHhCCCCCC-cccc
Confidence 23568999999999999999999999999999999999999999764 34556666665544322 2345
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+++++.+||.+||..||.+||+++++++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 678999999999999999999999777643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=379.92 Aligned_cols=276 Identities=18% Similarity=0.261 Sum_probs=225.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|+++++||+|+||.||+|++..+++.||||++.... ....+..|..++..+.+|++|+.+..++......||
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999999999999999986532 223478899999998777888888888888899999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccC
Confidence 99999 8899999975 4569999999999999999999999999999999999999 78899999999999853322
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc------ccHHHHHHHHhhhcc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYEKISEKKV 233 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~------~~~~~~~~~i~~~~~ 233 (477)
.. .....+||+.|+|||++.+..++.++|||||||+||+|++|..||..... ......+..+.....
T Consensus 207 ~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 207 GD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp TC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred CC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 21 23467899999999999999999999999999999999999999965321 122234444444333
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~---~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
. ++..+++++.+||..||..||.+||++. .+.+++ .++|+..+||..+...+..++..|
T Consensus 280 ~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~-------~Hpff~~i~w~~l~~~~~~pp~~p 341 (396)
T 4dc2_A 280 R-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ-------GHPFFRNVDWDMMEQKQVVPPFKP 341 (396)
T ss_dssp C-----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHH-------HSTTTTTCCHHHHHTTCSCCSCCC
T ss_pred C-----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHh-------cCccccCCCHHHHHcCCCCCCCcC
Confidence 2 3456899999999999999999999852 233332 367888899998877665555443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=379.78 Aligned_cols=271 Identities=19% Similarity=0.252 Sum_probs=222.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
-.++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.+|++|+.+..++...+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 347899999999999999999999999999999987642 233457789999999877788888888888889999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 101 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeeccc
Confidence 999999 8999999975 4569999999999999999999999999999999999999 6889999999999985432
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +..+.+.++......
T Consensus 177 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~---- 242 (353)
T 3txo_A 177 NGV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILNDEVV---- 242 (353)
T ss_dssp ----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred CCc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC----
Confidence 221 234568999999999999999999999999999999999999999764 345566666655443
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCH------HHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDY------AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~------~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
++..+++++.++|..||..+|.+||++ +++ ..++|+..+||..+...+..++..|
T Consensus 243 -~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~i----------l~hp~f~~~~w~~l~~~~~~~p~~p 303 (353)
T 3txo_A 243 -YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAI----------LRHPFFKEIDWAQLNHRQIEPPFRP 303 (353)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHH----------HTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred -CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHH----------hhCCcccCCCHHHHhcCcCCCCccC
Confidence 234578999999999999999999997 333 2367788889998876665554443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=370.03 Aligned_cols=269 Identities=19% Similarity=0.272 Sum_probs=221.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.| ++|+.+..++...+..|
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCC-CcCcceEEEEEeCCEEE
Confidence 347899999999999999999999999999999987642 234467889999998876 66777777777888899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhccc
Confidence 999999 8899999975 4569999999999999999999999999999999999999 6889999999999985432
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+......
T Consensus 158 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~---- 223 (337)
T 1o6l_A 158 DGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIR---- 223 (337)
T ss_dssp TTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC----
T ss_pred CCC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC----
Confidence 221 2345789999999999999999999999999999999999999997633 34455555544332
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCC
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 303 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 303 (477)
++..+++++.++|..||..||.+|| +++++++ ++|+..+||..+...+..++..
T Consensus 224 -~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~----------h~~f~~~~~~~~~~~~~~pp~~ 282 (337)
T 1o6l_A 224 -FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME----------HRFFLSINWQDVVQKKLLPPFK 282 (337)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT----------SGGGTTCCHHHHHTTCSCCSCC
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc----------CCCcCCCCHHHHHhCCCCCCCC
Confidence 3356899999999999999999999 7666543 5677788999876655444333
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=375.20 Aligned_cols=275 Identities=19% Similarity=0.249 Sum_probs=226.6
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
...++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.++++++.+..++...+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 3457899999999999999999999999999999987642 23345778888888887789999998888888999
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 97 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccc
Confidence 9999999 8999999975 3569999999999999999999999999999999999999 688999999999998543
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. +..+.+..+......
T Consensus 173 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~--- 239 (353)
T 2i0e_A 173 WDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA--- 239 (353)
T ss_dssp CTTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred cCCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC---
Confidence 2221 234578999999999999999999999999999999999999999763 345566666654433
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~--~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
++..+++++.++|..||..+|.+||++. .+.++ ..++|+..+||..+...+.+++..|
T Consensus 240 --~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i-------~~h~~f~~~~w~~l~~~~~~~p~~p 299 (353)
T 2i0e_A 240 --YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI-------KEHAFFRYIDWEKLERKEIQPPYKP 299 (353)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHH-------HTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH-------hcCccccCCCHHHHHhCCCCCCcCC
Confidence 3356899999999999999999999641 12222 2357777889998876666655444
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=370.93 Aligned_cols=278 Identities=19% Similarity=0.268 Sum_probs=224.8
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
|++.-.++|++++.||+|+||.||+|++..+++.||||++..... ...+..|..++..+.+|++|+.+..++...
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 566777899999999999999999999999999999999875432 123678999999886678888888888888
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
...||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCK 158 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCB
T ss_pred CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccc
Confidence 8999999999 8999999975 4569999999999999999999999999999999999999 688999999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc------ccHHHHHHHH
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYEKI 228 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~------~~~~~~~~~i 228 (477)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+..+
T Consensus 159 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 159 EGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp CSCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred cccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 5432221 23456899999999999999999999999999999999999999965321 1222334444
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCCccccccchhhccccC
Q 011819 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 301 (477)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~---~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (477)
...... ++..+++++.++|..||..||.+||++. .+.++ ..++|+..+||..+...+..++
T Consensus 232 ~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i-------~~hp~f~~~~w~~~~~~~~~~p 295 (345)
T 3a8x_A 232 LEKQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADI-------QGHPFFRNVDWDMMEQKQVVPP 295 (345)
T ss_dssp HHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHH-------HTSGGGTTCCHHHHHTTCSCCS
T ss_pred HcCCCC-----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHH-------hcCCccCCCCHHHHHhCCCCCC
Confidence 443322 3456899999999999999999999852 22222 3467788889998766554433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=372.50 Aligned_cols=280 Identities=23% Similarity=0.417 Sum_probs=221.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCC--------CcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCC------------
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQT--------NEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI------------ 65 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~--------g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i------------ 65 (477)
+++|++.+.||+|+||.||+|++..+ ++.||||++... ..+..|+.++..++|++.+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 68999999999999999999999874 889999998654 4688999999999874333
Q ss_pred --CeeEEeeEe-CcEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 66 --PNVRWFGVE-GDYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 66 --~~~~~~~~~-~~~~~lVmE~~g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
+.+..++.. ....||||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~---~~ 194 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV---DP 194 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE---ET
T ss_pred CccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---cC
Confidence 224444444 7888999999999999999854 3679999999999999999999999999999999999999 45
Q ss_pred CC--cEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc
Q 011819 142 AN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (477)
Q Consensus 142 ~~--~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~ 219 (477)
++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||+|++|..||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 66 8999999999876543322111112234568999999999999999999999999999999999999999764322
Q ss_pred cHHHHHHHHh--hhcccccHH--HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011819 220 TKKQKYEKIS--EKKVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 292 (477)
Q Consensus 220 ~~~~~~~~i~--~~~~~~~~~--~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 292 (477)
. ........ ......... .....+++++.++|..||..||++||+++++.+.|++++...+...+..+||+.
T Consensus 275 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~ 350 (352)
T 2jii_A 275 T-EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPM 350 (352)
T ss_dssp H-HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC
T ss_pred H-HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcC
Confidence 1 11111111 111111100 011357899999999999999999999999999999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=372.09 Aligned_cols=271 Identities=21% Similarity=0.270 Sum_probs=223.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
...++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.+|++|+.+..++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3457999999999999999999999999999999987642 23445778999998886678888888888888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence 9999999 8999999975 3569999999999999999999999999999999999999 688999999999998543
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+......
T Consensus 170 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~--- 236 (345)
T 1xjd_A 170 LGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPF--- 236 (345)
T ss_dssp CTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC---
T ss_pred cCCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCCC---
Confidence 2221 1345789999999999999999999999999999999999999997643 34555555544322
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchhhccccCCC
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 303 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~-~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 303 (477)
++..+++++.++|.+||..+|.+||++. ++ ..++|+..+||..+...+..++..
T Consensus 237 --~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i----------~~hp~f~~~~w~~l~~~~~~~p~~ 291 (345)
T 1xjd_A 237 --YPRWLEKEAKDLLVKLFVREPEKRLGVRGDI----------RQHPLFREINWEELERKEIDPPFR 291 (345)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG----------GGSGGGTTCCHHHHHTTCSCC---
T ss_pred --CCcccCHHHHHHHHHHhcCCHhHcCCChHHH----------HcCccccCCCHHHHhhCCCCCCcC
Confidence 2356889999999999999999999975 44 236778888999876655544443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=364.31 Aligned_cols=267 Identities=21% Similarity=0.284 Sum_probs=222.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.| ++|..+..++.+....|
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCC-CCCceEeEEEEeCCEEE
Confidence 357899999999999999999999999999999987642 233456788999988876 56666666677788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS
T ss_pred EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC
Confidence 999999 8999999975 5579999999999999999999999999999999999999 6889999999999987543
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||... .....+.++......
T Consensus 159 ~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~---- 221 (318)
T 1fot_A 159 V----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR---- 221 (318)
T ss_dssp C----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC----
T ss_pred c----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC----
Confidence 2 23568999999999999999999999999999999999999999763 334555565554332
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
++..+++++.++|..||..+|.+|| ++++++ .++|...++|..+......++..|
T Consensus 222 -~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~----------~hp~f~~~~~~~~~~~~~~~p~~p 281 (318)
T 1fot_A 222 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK----------NHPWFKEVVWEKLLSRNIETPYEP 281 (318)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH----------TSGGGSSCCHHHHHTTCSCCSCCC
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh----------cCccccCCCHHHHHhCCCCCCCCC
Confidence 3356889999999999999999999 655553 367788889998776655544433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=367.74 Aligned_cols=267 Identities=19% Similarity=0.292 Sum_probs=223.3
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
...++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.++..+.| ++|+.+..++.+....
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEE
Confidence 3457899999999999999999999999999999987542 233457789999998866 6666777777778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 117 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceecc
Confidence 9999999 89999999753 569999999999999999999999999999999999999 688999999999998764
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+.++......
T Consensus 193 ~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~--- 256 (350)
T 1rdq_E 193 GR----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR--- 256 (350)
T ss_dssp SC----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred CC----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHcCCCC---
Confidence 32 23568999999999999999999999999999999999999999763 345566666655432
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCC
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 303 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 303 (477)
++..+++++.++|..||..||.+||+ +++++ .++|+..+||..+...+..++..
T Consensus 257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~----------~h~~f~~~~w~~~~~~~~~~p~~ 315 (350)
T 1rdq_E 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK----------NHKWFATTDWIAIYQRKVEAPFI 315 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH----------TSGGGTTCCHHHHHTTCSCCSCC
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHH----------hCcCcCCCCHHHHhhccCCCCCC
Confidence 33568999999999999999999998 55553 35777888999876655554443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=358.81 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=212.7
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
...+.++|++++.||+|+||.||+|++..+++.||||++...... ..+..|+.++..++| ++++.+..++...+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH-QNIVSMIDVDEEDD 84 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCB-TTBCCEEEEEECSS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCC-CCCceEEEeeeeCC
Confidence 456788999999999999999999999999999999987543221 346789999999987 56666666777888
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..|+||||+ |++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTT
T ss_pred eEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCccc
Confidence 899999999 8899999975 3569999999999999999999999999999999999999 6788999999999976
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .....+........
T Consensus 161 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~ 231 (294)
T 4eqm_A 161 LSETSL------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA---VSIAIKHIQDSVPN 231 (294)
T ss_dssp C-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---HHHHHHHHSSCCCC
T ss_pred cccccc------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhhccCCC
Confidence 543322 122346799999999999999999999999999999999999999976432 33333444444444
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRIFRDLF 277 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RP-t~~~l~~~l~~~~ 277 (477)
........+|+.+.++|.+||..+|.+|| +++++.+.|+.++
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 44556678999999999999999999999 8888887777664
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=370.09 Aligned_cols=273 Identities=21% Similarity=0.295 Sum_probs=224.9
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
+..++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+.++..++| ++|+.+..++.+....
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH-PFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCEE
Confidence 4457899999999999999999999999999999987542 233567889999999976 6666666777778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|+||||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeecc
Confidence 9999999 9999999974 5579999999999999999999999999999999999999 688999999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g---~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
.... ....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||...........+..+......
T Consensus 167 ~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T 4fr4_A 167 RETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT 238 (384)
T ss_dssp TTCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC
T ss_pred CCCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC
Confidence 4322 346789999999999974 45899999999999999999999999876555555555554443332
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt-~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
++..+++++.+||..||..+|.+||+ ++++ ..++|+..++|..+...+..++..|
T Consensus 239 -----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l----------~~hp~f~~~~w~~~~~~~~~p~~~p 294 (384)
T 4fr4_A 239 -----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV----------QNFPYMNDINWDAVFQKRLIPGFIP 294 (384)
T ss_dssp -----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHH----------HTSGGGTTCCHHHHHTTCSCCCCCC
T ss_pred -----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHH----------HcChhhhcCCHHHHHhCCCCCCCCC
Confidence 23567899999999999999999998 4444 3467888899998766655444433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=365.97 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=219.2
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--------~~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
..+.++|++++.||+|+||.||+|.+..+|+.||||++..... ...+..|+.++..+.| ++|+.+..++..
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH-PNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCC-cCCCcEEEEEEe
Confidence 3567789999999999999999999999999999998865432 2457899999999986 566666666777
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC----cEEEee
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIID 149 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~----~vkL~D 149 (477)
....||||||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+. ..+ .+||+|
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~~~~~vkl~D 162 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID 162 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---CCCCCccCEEEEe
Confidence 88899999999 9999999974 55799999999999999999999999999999999999994 333 799999
Q ss_pred cCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 150 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
||+++....... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+.
T Consensus 163 FG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~ 231 (361)
T 2yab_A 163 FGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANIT 231 (361)
T ss_dssp CSSCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHH
T ss_pred cCCceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Confidence 999987654322 24568999999999999999999999999999999999999999764 3445556665
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 292 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 292 (477)
...... ....+..+++++.+||..||..||.+||++.++++ ++|....+|..
T Consensus 232 ~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~----------hp~~~~~~~~~ 283 (361)
T 2yab_A 232 AVSYDF-DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR----------HPWITPVDTQQ 283 (361)
T ss_dssp TTCCCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT----------STTTSCSSHHH
T ss_pred hcCCCC-CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc----------CcCcCCCchhh
Confidence 554432 23456788999999999999999999999877643 56666667754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=379.20 Aligned_cols=266 Identities=22% Similarity=0.272 Sum_probs=219.6
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|+++++||+|+||+||+|++..+++.||||++... .....+..|..++..+.| ++|+.+..++.+.+..||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS-KWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCEEEE
Confidence 47899999999999999999999999999999987542 233348889999998865 677777777778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ |++|.+++......+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcccC
Confidence 99999 999999998656779999999999999999999999999999999999999 78899999999999876543
Q ss_pred CCCcccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
... .....+||+.|||||++. ...++.++|||||||++|||++|..||.+. +..+.+.++......
T Consensus 229 ~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 229 GTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKER 299 (437)
T ss_dssp SCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHH
T ss_pred CCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHHhhhhcccc
Confidence 321 223468999999999997 456899999999999999999999999764 345556666543322
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~--RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
.........+++++.+||.+||..+|+. ||++++++ .++|+..+||+.+.
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil----------~Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFK----------KHPFFSGIDWDNIR 351 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHH----------TSGGGTTCCTTTGG
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHh----------CCCccCCCCHHHHh
Confidence 2222233558999999999999988887 89977764 36788889999873
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=377.17 Aligned_cols=266 Identities=22% Similarity=0.305 Sum_probs=216.9
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.| ++|+.+..++.+.+..|
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR-RWITQLHFAFQDENYLY 137 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEeeCCEEE
Confidence 357899999999999999999999999999999998642 122347889999988866 67777777778888999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccC
Confidence 999999 999999998666679999999999999999999999999999999999999 7889999999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhc-------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHL-------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-------g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (477)
.... .....+||+.|+|||++. +..|+.++|||||||++|||++|..||.+. +..+.+.++...
T Consensus 215 ~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~ 285 (412)
T 2vd5_A 215 DGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD---STAETYGKIVHY 285 (412)
T ss_dssp TSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTH
T ss_pred CCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC---CHHHHHHHHHhc
Confidence 3321 123568999999999997 456899999999999999999999999764 344555555543
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RP---t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
........+...+++++.+||.+||. +|.+|+ ++++++ .++|+..+||..+.
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~----------~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR----------THPFFFGLDWDGLR 340 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH----------TSGGGTTCCSTTST
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh----------cCCCcCCCCHHHHh
Confidence 22222222346789999999999999 999984 766653 36778888999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=375.31 Aligned_cols=273 Identities=21% Similarity=0.278 Sum_probs=221.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~-----~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..++|+++++||+|+||.||+|++..+++.||||++.. ......+..|..++..++| ++|+.+..++.+....|
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEE
Confidence 34689999999999999999999999999999998754 2233457889999998876 66777777777888999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||+ |++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 146 lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred EEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeecc
Confidence 999999 9999999974 469999999999999999999999999999999999999 7889999999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCC----CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~----~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
... ......+||+.|+|||++.+.. ++.++|||||||+||+|++|..||.+. +....+.++......
T Consensus 221 ~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 221 EGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNS 291 (410)
T ss_dssp TSE------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHH
T ss_pred CCc------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHHHHhcccc
Confidence 321 1234678999999999998766 789999999999999999999999763 345556666543221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCC
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 303 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~--RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 303 (477)
.... ....+++++.+||..||..+|.+ ||+++++++ ++|+..+||......+..++..
T Consensus 292 ~~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~----------Hp~f~~~~w~~~~~~~~~~p~~ 351 (410)
T 3v8s_A 292 LTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR----------HLFFKNDQWAWETLRDTVAPVV 351 (410)
T ss_dssp CCCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT----------SGGGCCSSCCSTTGGGSCCSCC
T ss_pred ccCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc----------CccccCCCHHHHhhcccCCCCC
Confidence 1111 12468999999999999988888 999877743 5777778888766655544443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=395.72 Aligned_cols=274 Identities=19% Similarity=0.252 Sum_probs=230.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.++++|..+..++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 356899999999999999999999999999999987642 334557788999988888899999998888889999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||+ |++|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+....
T Consensus 419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeecccc
Confidence 999999 89999999853 569999999999999999999999999999999999999 6889999999999986433
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
... ....++||+.|||||++.+..|+.++|||||||+||||++|..||.+. +..+.+..+......
T Consensus 495 ~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~---- 560 (674)
T 3pfq_A 495 DGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA---- 560 (674)
T ss_dssp TTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSCCC----
T ss_pred CCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC----
Confidence 222 234678999999999999999999999999999999999999999763 445666667665443
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~--~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
++..+++++.+||..||..||++||++ ..+.++ ..++|+..+||..+...+.+++..|
T Consensus 561 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei-------~~h~ff~~i~w~~l~~~~~~pp~~p 620 (674)
T 3pfq_A 561 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI-------KEHAFFRYIDWEKLERKEIQPPYKP 620 (674)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHH-------HSSGGGSSCCHHHHTTTCSCCSCCC
T ss_pred -CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHH-------hcCccccCCCHHHHHhCCCCCCCCC
Confidence 345689999999999999999999986 111222 3467888899999877766655554
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.69 Aligned_cols=274 Identities=19% Similarity=0.278 Sum_probs=215.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHH-HHHcCCCCCCeeEEeeEeCcEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLY-RILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il-~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
..++|++++.||+|+||.||+|++..+++.||||++.... ....+..|..++ +.+. |++|+.+..++...+..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEE
Confidence 4568999999999999999999999999999999986532 122345555553 3344 57777777777888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence 9999999 8999999975 4569999999999999999999999999999999999999 688999999999998643
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+.++......
T Consensus 191 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~--- 257 (373)
T 2r5t_A 191 EHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNKPLQ--- 257 (373)
T ss_dssp CCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHSCCC---
T ss_pred cCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcccC---
Confidence 3221 234678999999999999999999999999999999999999999763 345566666554332
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
+...+++++.++|..||..||.+||++.+. +.++ ..++|+..+||..+...+..++..|
T Consensus 258 --~~~~~~~~~~~li~~lL~~dp~~R~~~~~~---~~~i---~~h~~f~~~~w~~l~~~~~~pp~~p 316 (373)
T 2r5t_A 258 --LKPNITNSARHLLEGLLQKDRTKRLGAKDD---FMEI---KSHVFFSLINWDDLINKKITPPFNP 316 (373)
T ss_dssp --CCSSSCHHHHHHHHHHTCSSGGGSTTTTTT---HHHH---HTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred --CCCCCCHHHHHHHHHHcccCHHhCCCCCCC---HHHH---hCCccccCCCHHHHHhCCCCCCCCC
Confidence 345689999999999999999999996421 1222 3467788889998776655544443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=359.84 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=206.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
...++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+++++.++| ++|..+..++...+..|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-PNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEE
Confidence 3457899999999999999999999999999999998654322 346789999999987 56666666667788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSS
T ss_pred EEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCC
Confidence 999999 8999999975 3569999999999999999999999999999999999999 6889999999999976543
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s-~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
... ....+||+.|+|||++.+..+. .++|||||||+||+|++|..||.+.. ..+...++......
T Consensus 167 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~--- 232 (328)
T 3fe3_A 167 GGK--------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRGKYR--- 232 (328)
T ss_dssp SCG--------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC---
T ss_pred CCc--------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC---
Confidence 321 2456899999999999998875 79999999999999999999997643 34445555544332
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
++..+++++.+++.+||..||.+||+++++.
T Consensus 233 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 233 --IPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred --CCCCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 2345789999999999999999999977664
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=354.08 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=204.9
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
..++|++.++||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.++| ++|+.+..++...+..|+||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCC-CCCCeEeEEEEECCEEEEEE
Confidence 4568999999999999999999999999999999875432 34557889999999987 55666666666788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc
Confidence 999 9999999974 469999999999999999999999999999999999999 6788999999999987654332
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......+........ ...
T Consensus 172 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~--~~~ 239 (297)
T 3fxz_A 172 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPEL--QNP 239 (297)
T ss_dssp -------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCC--SCG
T ss_pred -------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC--CCc
Confidence 12456899999999999999999999999999999999999999976433 222222222221111 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..+++.+.++|..||..||++||+++++.
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell 268 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELL 268 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 45789999999999999999999977764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=358.16 Aligned_cols=260 Identities=18% Similarity=0.271 Sum_probs=215.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.+.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.++| ++|..+..++.+.+..++||
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCC-CCCCeEeEEEecCCEEEEEE
Confidence 467899999999999999999999999999999998875432 2347789999999987 55666666667888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ |++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCc
Confidence 999 88999999755557999999999999999999999999999999999999942 1268999999999987654321
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+........ ...+
T Consensus 160 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~-~~~~ 227 (321)
T 1tki_A 160 --------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFD-EEAF 227 (321)
T ss_dssp --------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCC-HHHH
T ss_pred --------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHcCCCCCC-hhhh
Confidence 234578999999999999889999999999999999999999997643 3455555655544333 3355
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
..+++++.++|..||..||.+||++.++ |++.|.+.
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~---l~hp~~~~ 263 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLKQ 263 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHH---hcChhhcc
Confidence 7889999999999999999999997665 45555443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=356.82 Aligned_cols=270 Identities=19% Similarity=0.262 Sum_probs=208.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
...++|++++.||+|+||.||+|++. .+++.||||++.... ....+..|+.+++.++| ++|+.+..++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH-PFIVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCC-TTBCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCC-CCccceeEEEEc
Confidence 45678999999999999999999985 689999999986542 22346789999999987 556666666677
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.+..||||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLC 168 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCcc
Confidence 78899999999 8999999975 4569999999999999999999999999999999999999 67899999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+.++.....
T Consensus 169 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~ 238 (327)
T 3a62_A 169 KESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKCKL 238 (327)
T ss_dssp -----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCC
T ss_pred cccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCC
Confidence 75433221 1235689999999999999999999999999999999999999997643 3445555554433
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccchhhcccc
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~--~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~ 300 (477)
. ++..+++++.++|..||..+|.+||++. .+.++++ ++|...++|..+......+
T Consensus 239 ~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~-------hp~f~~~~~~~~~~~~~~~ 295 (327)
T 3a62_A 239 N-----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA-------HPFFRHINWEELLARKVEP 295 (327)
T ss_dssp C-----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH-------SGGGSSCCHHHHHTTCSCC
T ss_pred C-----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc-------CCcccCCCHHHHhhccCCC
Confidence 2 3356789999999999999999999432 2333333 4566677998765544443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=352.40 Aligned_cols=256 Identities=18% Similarity=0.257 Sum_probs=206.0
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.+.++|+++++||+|+||.||+|++. +++.||||++...... ..+.+|+.+++.++| ++|..+..++......+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH-PNIVSLIDVIHSERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCC-TTBCCEEEEECCSSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCC-CCEeeeeeEEccCCEEE
Confidence 46789999999999999999999984 5899999988654322 357789999999987 55666666666777889
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|||||+.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTSC
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCCC
Confidence 999999889999988656679999999999999999999999999999999999999 67889999999999876543
Q ss_pred CCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc-----
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (477)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+.....
T Consensus 173 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 173 VR-------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred cc-------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 22 2234578999999999987 5689999999999999999999999988666554444433322111
Q ss_pred -----------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 -----------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
......+.+.+++++.+||..||..||++||+++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11233445668899999999999999999999877643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=360.71 Aligned_cols=254 Identities=18% Similarity=0.221 Sum_probs=208.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-------~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++| ++|+.+..++...+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH-PHIVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCC
Confidence 4557899999999999999999999999999999987532 134568899999999987 56666666667788
Q ss_pred EEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCc
Q 011819 77 YNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGl 152 (477)
..||||||+ |++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++....+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 899999999 89998887532 33589999999999999999999999999999999999996443445699999999
Q ss_pred eeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 153 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
++....... .....+||+.|+|||++.+..++.++|||||||+||+|++|..||.+. ....+..+....
T Consensus 180 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~~~ 248 (351)
T 3c0i_A 180 AIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGK 248 (351)
T ss_dssp CEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHHTC
T ss_pred eeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHcCC
Confidence 987755322 123467999999999999999999999999999999999999999763 234444454444
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.... ...+..+++++.+||.+||..||++||++.++.
T Consensus 249 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 285 (351)
T 3c0i_A 249 YKMN-PRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285 (351)
T ss_dssp CCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 3322 234567899999999999999999999977664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.43 Aligned_cols=259 Identities=17% Similarity=0.311 Sum_probs=213.0
Q ss_pred CCceEEEeeeeecCceEEEEEEEC-------CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~-------~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
.++|++++.||+|+||.||+|++. .++..||||++...... ..+..|+.+++.+.+|++|+.+..++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999975 34568999998754332 34788999999996567777777777778
Q ss_pred cEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~ 139 (477)
+..||||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--- 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--- 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE---
Confidence 8899999999 889999997543 348999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCc
Q 011819 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (477)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~ 218 (477)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 67899999999999876543321 12234567889999999999999999999999999999999 9999987554
Q ss_pred ccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.. .+..+...... ..+..+++++.++|..||..+|++||++.++.+.|+.++..
T Consensus 312 ~~---~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 312 EE---LFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp GG---HHHHHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---HHHHHhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 32 22233322211 13456889999999999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=361.79 Aligned_cols=256 Identities=20% Similarity=0.229 Sum_probs=214.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.+.++|++++.||+|+||.||+|.+..+++.||||++..... ....|++++..+.+|++|+.+..++.+.+..|||||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 345789999999999999999999999999999999875432 356788899998777888888888888899999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC-CCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~-~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...+ ..+.+||+|||+++.......
T Consensus 97 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 97 LMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99 8999999874 55699999999999999999999999999999999999985321 224699999999987654332
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......+.+..+........ ...+
T Consensus 176 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~~ 247 (342)
T 2qr7_A 176 -------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS-GGYW 247 (342)
T ss_dssp -------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-STTT
T ss_pred -------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-cccc
Confidence 12356899999999999988899999999999999999999999987655566666766666554322 2234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..+++++.+||..||..||++||++.+++
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il 276 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVL 276 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 67899999999999999999999976653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.39 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=208.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.|+| ++|+.+..++.+.+..|+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 446899999999999999999999999999999998765432 357789999999986 566666666777888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.....+.+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999 8899998864 456999999999999999999999999999999999999964444567999999999866543
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+.......+. .
T Consensus 185 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~-~ 252 (362)
T 2bdw_A 185 EA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS-P 252 (362)
T ss_dssp CS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-T
T ss_pred cc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCc-c
Confidence 21 235689999999999999999999999999999999999999997643 34455555544433222 2
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.+..+++++.+||.+||..||++||++.++.
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 3356899999999999999999999977664
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=370.00 Aligned_cols=256 Identities=20% Similarity=0.250 Sum_probs=211.5
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
..+.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.|+| ++|+.+..++.+.+..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-PNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB-TTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-cCCCeEEEEEEECCEE
Confidence 3456789999999999999999999999999999999876543 2347899999999977 5666666667788889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||||||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++....++.+||+|||+++...
T Consensus 86 ~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999 8999999875 5669999999999999999999999999999999999999644467889999999998665
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+.........
T Consensus 165 ~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 165 GEQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp TTCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCCCCCT
T ss_pred CCCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCCCCCc
Confidence 4322 1235689999999999999999999999999999999999999997643 34555555554443222
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+..+++++.+||..||..||.+||++.++++
T Consensus 235 -~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 -PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 234578999999999999999999999877654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=372.39 Aligned_cols=269 Identities=19% Similarity=0.264 Sum_probs=212.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..++|+++++||+|+||.||+|.+..+++.||||++... .....+..|+.++..+.| ++|+.+..++...+..|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSC-TTSCCEEEEEEETTEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCC-CeEeeEEEEEeeCCEEE
Confidence 347899999999999999999999999999999987642 223346678888888876 56777777777888899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|||||+ +++|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||| +.++.+||+|||+|+...
T Consensus 225 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTC
T ss_pred EEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceecc
Confidence 999999 8899999975 4569999999999999999999998 999999999999999 678999999999997543
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... .....+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.. ..+.+..+......
T Consensus 301 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~--- 367 (446)
T 4ejn_A 301 KDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIR--- 367 (446)
T ss_dssp C------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC---
T ss_pred CCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCC---
Confidence 3221 2345789999999999999999999999999999999999999997643 34444544443332
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCC
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 303 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 303 (477)
++..+++++.+||..||..||.+|| +++++++ ++|+..++|..+......++..
T Consensus 368 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~----------hp~f~~~~~~~~~~~~~~pp~~ 426 (446)
T 4ejn_A 368 --FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ----------HRFFAGIVWQHVYEKKLSPPFK 426 (446)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT----------SGGGTTCCHHHHHTTCSCCSCC
T ss_pred --CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh----------CccccCCCHHHHhhCcCCCCcc
Confidence 3356899999999999999999999 8766643 5777788999766555444433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.38 Aligned_cols=263 Identities=18% Similarity=0.246 Sum_probs=211.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.++|+++++||+|+||.||+|.+..+++.||+|++.... ....+..|+.++..++| ++|+.+..++.+.+..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-cCcccEEEEEecCCeeEEEEE
Confidence 478999999999999999999999999999999875432 22357889999999986 566666666778888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccccc
Confidence 99 889999998767789999999999999999999999999999999999999 67899999999999876543321
Q ss_pred ccc-------ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH--HHHHHhhhcc
Q 011819 163 QHI-------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYEKISEKKV 233 (477)
Q Consensus 163 ~~~-------p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~--~~~~i~~~~~ 233 (477)
... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~---- 240 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL---- 240 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH----
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc----
Confidence 100 0011225689999999999999999999999999999999999999997643321100 000000
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
....+..+|+++.+++..||+.||++||++.++.+.|+.+...
T Consensus 241 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 241 ---DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1112456889999999999999999999999999999888643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=352.92 Aligned_cols=251 Identities=20% Similarity=0.261 Sum_probs=209.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.|+| ++|+.+..++...
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~ 86 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENK 86 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 455789999999999999999999999999999998765431 3458899999999987 5666666666778
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC----cEEEeec
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDF 150 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~----~vkL~DF 150 (477)
...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+. ..+ .+||+||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~---~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL---DRNVPKPRIKIIDF 162 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES---CSSSSSCCEEECCC
T ss_pred CEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEe---cCCCCCCCEEEEEC
Confidence 8899999999 8999999974 55699999999999999999999999999999999999994 444 8999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+..
T Consensus 163 g~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~ 231 (326)
T 2y0a_A 163 GLAHKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231 (326)
T ss_dssp TTCEECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHH
T ss_pred CCCeECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHh
Confidence 99987654322 234679999999999999999999999999999999999999997643 3344444444
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.... .....+..+++++.+||..||..||++||++.++.+
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 232 VNYE-FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp TCCC-CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCC-cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3332 223455778999999999999999999999877754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=348.56 Aligned_cols=255 Identities=18% Similarity=0.246 Sum_probs=201.2
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHc--CCCCCCeeEEeeE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLLYESKLYRILQ--GGTGIPNVRWFGV 73 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-------~~~~~~~E~~il~~L~--~~~~i~~~~~~~~ 73 (477)
..+.++|+++++||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+. +|+++..+..++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 356789999999999999999999999999999999876432 2346778888888887 2455555554444
Q ss_pred eCc-----EEEEEEecCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEE
Q 011819 74 EGD-----YNVLVMDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (477)
Q Consensus 74 ~~~-----~~~lVmE~~g~sL~~li~~~~~-~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL 147 (477)
... ..++||||++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl 161 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKL 161 (308)
T ss_dssp ECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEE
T ss_pred ccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEE
Confidence 332 5799999998899999975432 39999999999999999999999999999999999999 67889999
Q ss_pred eecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 011819 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (477)
Q Consensus 148 ~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~ 227 (477)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+.+
T Consensus 162 ~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~ 230 (308)
T 3g33_A 162 ADFGLARIYSYQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGK 230 (308)
T ss_dssp CSCSCTTTSTTCCC--------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHH
T ss_pred eeCccccccCCCcc--------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence 99999976543222 2346799999999999999999999999999999999999999977543 333333
Q ss_pred Hhhhc----------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 228 ISEKK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 228 i~~~~----------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+.... .......+.+.+++++.+||..||..||++||++.++.+
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 32211 112234455678999999999999999999999776643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=348.74 Aligned_cols=245 Identities=18% Similarity=0.205 Sum_probs=201.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.++|+++++||+|+||+||+|.+..+++.||||++...... .....|...+..+.++++++.+..++.+++..|||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36899999999999999999999999999999987654322 23455666666676678888888888889999999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 82 mE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC----
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeecccCCC
Confidence 9999999999998777789999999999999999999999999999999999999 6788999999999987654322
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+. ..+..+..... ...+.
T Consensus 213 --------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~~~---~~~~~ 274 (311)
T 3p1a_A 213 --------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGWQQLRQGYL---PPEFT 274 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHHHHHTTTCC---CHHHH
T ss_pred --------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHhccCC---Ccccc
Confidence 234579999999999887 7999999999999999999997776541 12233333222 23456
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+++++.++|..||..||++||+++++.+
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 778999999999999999999999877754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=360.34 Aligned_cols=268 Identities=31% Similarity=0.519 Sum_probs=198.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECC---CCcEEEEEEecCCCC-------------chhHHHHHHHHHHHcCCCCCCe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTK-------------HPQLLYESKLYRILQGGTGIPN 67 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~---~g~~vAiKi~~~~~~-------------~~~~~~E~~il~~L~~~~~i~~ 67 (477)
..+++|++++.||+|+||.||+|.+.. ++..||||+...... ...+..|+.++..+.| ++|+.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h-~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY-LGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC-CCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc-cCcce
Confidence 456799999999999999999999987 788999998765432 1224455666666666 45555
Q ss_pred eEEeeEe----CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC
Q 011819 68 VRWFGVE----GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (477)
Q Consensus 68 ~~~~~~~----~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~ 143 (477)
+..++.. ....||||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG---YKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---SSS
T ss_pred eecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc---cCC
Confidence 5544444 77889999999999999997533 799999999999999999999999999999999999995 444
Q ss_pred --cEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH
Q 011819 144 --QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (477)
Q Consensus 144 --~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~ 221 (477)
.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||+|++|..||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999987754332211111122456899999999999999999999999999999999999999965322211
Q ss_pred -HHHHHHHhhhcccccHHHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 222 -KQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 222 -~~~~~~i~~~~~~~~~~~l~~--~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
............+........ .+|+++.++|..||..+|++||+++++.+.|+.+
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111112222222222223 7899999999999999999999999998887754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=345.93 Aligned_cols=252 Identities=21% Similarity=0.265 Sum_probs=203.9
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| +++..+..++...+..+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCC-CCEeeEEeEEEeCCEEEEEE
Confidence 6899999999999999999999999999999998654332 457789999999987 56666666677888999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS-
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc-
Confidence 999888888887767889999999999999999999999999999999999999 6789999999999987654322
Q ss_pred cccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc-------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 234 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (477)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... .....+..+......
T Consensus 157 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp ------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCT
T ss_pred ------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhh
Confidence 234567899999999998766 7999999999999999999888864432 223333333221110
Q ss_pred -----------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 235 -----------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 235 -----------------~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.......+.+++++.+||..||..||++||+++++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0111223457899999999999999999999777643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.48 Aligned_cols=260 Identities=17% Similarity=0.258 Sum_probs=210.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCc---EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~---~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
...++|++.+.||+|+||.||+|.+..+++ .||||++...... ..+..|+.++..|+| ++|+.+..++...+.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-PNIIRLEGVVTRGRL 124 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECGGGC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCc
Confidence 345789999999999999999999986554 5999998754332 357889999999986 566666666677788
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.||||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCccccc
Confidence 89999999 889999997666789999999999999999999999999999999999999 67899999999999877
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+... .+....+.......
T Consensus 202 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 202 EDDPDAA----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGYRLP 274 (325)
T ss_dssp C----CC----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCCC
T ss_pred ccCccce----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCCCC
Confidence 5533211 11223456788999999999899999999999999999999 9999977543 33344333332111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
....+|+++.++|..||..+|++||++.++.+.|+.++.
T Consensus 275 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 275 ----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 235689999999999999999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=358.26 Aligned_cols=261 Identities=20% Similarity=0.287 Sum_probs=210.6
Q ss_pred cCCceEEEeeeeecCceEEEEEE-----ECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeE-eC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGV-EG 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~-----~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~-~~ 75 (477)
..++|++++.||+|+||.||+|+ +..+++.||||++...... ..+..|++++..+.+|++|+.+..++. .+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 45789999999999999999999 4566789999998765433 347899999999977777777666554 45
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCC--------------------------------------------------------
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSR-------------------------------------------------------- 98 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~-------------------------------------------------------- 98 (477)
...++||||+ +++|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 5589999999 8899999975322
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccccccc
Q 011819 99 ---------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169 (477)
Q Consensus 99 ---------~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~ 169 (477)
.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........ ..
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~-----~~ 251 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY-----VR 251 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTC-----EE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccc-----hh
Confidence 18999999999999999999999999999999999999 67889999999999866443221 22
Q ss_pred CCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHH
Q 011819 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (477)
Q Consensus 170 ~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (477)
.....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..... .....+...... ..+..+++++
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~l 325 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRM----RAPDYTTPEM 325 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHHTCCC----CCCTTCCHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHcCCCC----CCCCCCCHHH
Confidence 345678999999999999999999999999999999998 999998754332 222222222111 1235678999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 249 ASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.+++..||..+|.+||++.++.+.|+.++..
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=379.03 Aligned_cols=275 Identities=20% Similarity=0.221 Sum_probs=223.0
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
+...++|++++.||+|+||.||+|++..+|+.||||++... .....+..|+.++..++| ++|+.+..++.+.+.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDA 258 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC-CCEeeEEEEEeeCCE
Confidence 45567899999999999999999999999999999987542 233457889999999987 566666666777889
Q ss_pred EEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 78 NVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
.||||||+ |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEeccccee
Confidence 99999999 999999987432 349999999999999999999999999999999999999 6889999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc-HHHHHHHHhhhccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVS 234 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~-~~~~~~~i~~~~~~ 234 (477)
...... ....+||+.|+|||++.+..++.++|||||||+||+|++|..||....... .......+.....
T Consensus 336 ~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~- 406 (576)
T 2acx_A 336 VPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE- 406 (576)
T ss_dssp CCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-
T ss_pred cccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-
Confidence 654322 234589999999999999999999999999999999999999998754332 2333333333222
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
.++..+++++.+||..||..||.+|| ++++++ .++|+..+||..+......++..|
T Consensus 407 ----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil----------~HpfF~~i~w~~l~~~~~~pp~~p 467 (576)
T 2acx_A 407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVK----------EHPLFKKLNFKRLGAGMLEPPFKP 467 (576)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHH----------TSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred ----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHH----------hChhhccCCHHHHhcCCCCCCCCC
Confidence 13356899999999999999999999 555553 357777889998776655544443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=359.70 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=194.4
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEe--C
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE--G 75 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~--~ 75 (477)
+..+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..+.+|++|+.+..++.. .
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 44567899999999999999999999999999999998754322 23467899999999856677666655543 3
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...||||||++++|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRS 158 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccc
Confidence 46899999998899999974 569999999999999999999999999999999999999 6889999999999987
Q ss_pred cccCCCCc--------------ccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc
Q 011819 156 YRDTSTHQ--------------HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (477)
Q Consensus 156 ~~~~~~~~--------------~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~ 220 (477)
+....... ..........+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-- 236 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-- 236 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 64321100 000112345689999999999987 6789999999999999999999999987543
Q ss_pred HHHHHHHHhhhcccccHHH------------------------------------------HhcCCcHHHHHHHHHHhcC
Q 011819 221 KKQKYEKISEKKVSTSIEA------------------------------------------LCRGYPTEFASYFHYCRSL 258 (477)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~------------------------------------------l~~~~p~~l~~li~~cl~~ 258 (477)
...+.++.........+. ....+++++.+|+.+||..
T Consensus 237 -~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 -MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred -HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 333333322111111000 0126788999999999999
Q ss_pred CCCCCCCHHHHH
Q 011819 259 RFDDKPDYAYLK 270 (477)
Q Consensus 259 ~p~~RPt~~~l~ 270 (477)
||++||++++++
T Consensus 316 dP~~R~t~~e~l 327 (388)
T 3oz6_A 316 NPNKRISANDAL 327 (388)
T ss_dssp SGGGSCCHHHHT
T ss_pred CcccCCCHHHHh
Confidence 999999977664
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=348.32 Aligned_cols=267 Identities=21% Similarity=0.265 Sum_probs=205.6
Q ss_pred CccCCceEEE-eeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 3 PRVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 3 ~~i~~~y~i~-~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..+.+.|++. +.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..+.+|++|..+..++...+..|
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4567889996 78999999999999999999999999986543 23568899999999776788888888888889999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++....+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999 8999999975 35699999999999999999999999999999999999995333334599999999986543
Q ss_pred CCCCcccccccCCCCccCccccccchhcC-----CCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc------------H
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------K 221 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-----~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~------------~ 221 (477)
...............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 22211111112234579999999999875 457899999999999999999999997754321 2
Q ss_pred HHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...+..+.......+ ......+++++.+||.+||..||.+||+++++.+
T Consensus 247 ~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGKYEFP-DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHCCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCcccC-chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 233444444433322 2344678999999999999999999999877754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=351.41 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=200.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
..++|++.++||+|+||.||+|++ +++.||||++...... ..+..|+++++.++| ++|+.+..++......++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSTTCCEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCceEE
Confidence 356899999999999999999985 6889999998765432 247789999999987 556666666667777899
Q ss_pred EEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 81 VMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~--~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
||||+ +++|.+++..... .+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCcc
Confidence 99999 8899999974321 2999999999999999999999999 9999999999999 6788999999999975
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+....+......
T Consensus 189 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~~- 257 (309)
T 3p86_A 189 KASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCKR- 257 (309)
T ss_dssp --------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCCC-
T ss_pred cccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCC-
Confidence 443221 12356799999999999999999999999999999999999999976543 3333333221111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..++..+++++.++|..||..+|.+||+++++.+.|+.++
T Consensus 258 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 258 --LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1234678999999999999999999999999999999886
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=357.81 Aligned_cols=271 Identities=18% Similarity=0.262 Sum_probs=215.8
Q ss_pred CCceEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~------~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
.++|+++++||+|+||.||+|++. .+++.||||++... .....+..|+.++..+.++++|+.+..++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 378999999999999999999985 48999999987542 223456789999999987888988888888888
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..+|||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 999999999 8899999975 3569999999999999999999999999999999999999 6789999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCC--CCCCcchHHHHHHHHHHHHcCCCCCCCCCccc-HHHHHHHHhhhc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKK 232 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~--~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~-~~~~~~~i~~~~ 232 (477)
+..... ......+||+.|+|||++.+. .++.++|||||||+||+|++|..||....... .......+....
T Consensus 209 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 209 FVADET------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282 (355)
T ss_dssp CCGGGG------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred cccCCC------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence 643222 112346799999999999863 47899999999999999999999997644322 222333332222
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhccccC
Q 011819 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 301 (477)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (477)
. .++..++..+.+||.+||..||.+|| +++++++ ++|...++|..+..+..+++
T Consensus 283 ~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~----------h~~f~~~~~~~l~~~~~~~p 341 (355)
T 1vzo_A 283 P-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE----------HLFFQKINWDDLAAKKVPAP 341 (355)
T ss_dssp C-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT----------SGGGTTCCHHHHHTTCSCCS
T ss_pred C-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc----------CcchhcCChhHhhhccCCCC
Confidence 1 13456889999999999999999999 7665533 45566678987765544433
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=375.47 Aligned_cols=278 Identities=19% Similarity=0.234 Sum_probs=224.2
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
+...++|++.+.||+|+||.||+|++..+|+.||||++... .....+..|..++..+.| ++|+.+..++.....
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFIVSLAYAFETKTD 259 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC-CCEeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999987543 233457889999999976 666667667777888
Q ss_pred EEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 78 NVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.||||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeeccee
Confidence 99999999 89999998743 2359999999999999999999999999999999999999 68899999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc-cHHHHHHHHhhhc
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKK 232 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~-~~~~~~~~i~~~~ 232 (477)
+....... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.... .....+..+....
T Consensus 337 ~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~ 409 (543)
T 3c4z_A 337 VELKAGQT-------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409 (543)
T ss_dssp EECCTTCC-------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC
T ss_pred eeccCCCc-------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc
Confidence 87654332 123468999999999999999999999999999999999999999875432 3344444444433
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCccccccchhhccccCCC
Q 011819 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATP 303 (477)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~--l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~ 303 (477)
.. ++..+++++.++|..||..||.+||++.+ +.++ ..++|+..++|..+......++..
T Consensus 410 ~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei-------~~Hpff~~i~w~~l~~~~~~pp~~ 470 (543)
T 3c4z_A 410 VT-----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGL-------RTHPLFRDISWRQLEAGMLTPPFV 470 (543)
T ss_dssp CC-----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHH-------HTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred cC-----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHH-------HcCccccCCCHHHHHcCCCCCCCC
Confidence 22 33568999999999999999999997532 1222 246778888999876655544443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=357.64 Aligned_cols=255 Identities=18% Similarity=0.210 Sum_probs=195.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.+.++|++.+.||+|+||.||+|++..+++.||||++........+..|+.++..|.| ++|..+..++......+||||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCC-TTBCCEEEEEECSSEEEEEEC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCC-CCCcceeeeEecCCeEEEEEE
Confidence 4567799999999999999999999999999999998876656678889999999987 556666666677788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++.......
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 206 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence 99 8999999974 45699999999999999999999999999999999999996444578999999999986543221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
....+||+.|+|||++.+..++.++|||||||+||+|++|..||..... ....+..+....... ......
T Consensus 207 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~~~~-~~~~~~ 276 (349)
T 2w4o_A 207 -------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCEYYF-ISPWWD 276 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTCCCC-CTTTTT
T ss_pred -------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCCCcc-CCchhh
Confidence 2346799999999999999999999999999999999999999976433 223444444443322 223446
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.++.++.+||.+||..||++||++.++.+
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 78999999999999999999999776643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=365.17 Aligned_cols=260 Identities=17% Similarity=0.177 Sum_probs=198.6
Q ss_pred cCCceEEE-eeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEe----CcEEE
Q 011819 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYNV 79 (477)
Q Consensus 5 i~~~y~i~-~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~----~~~~~ 79 (477)
+.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+..|+.++..+.+|++|+.+..++.. ....|
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 45678887 789999999999999999999999999853 35678899988777666777776655443 56789
Q ss_pred EEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 80 LVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|||||+ |++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999 889999997432 359999999999999999999999999999999999999533337899999999998654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH-HHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~ 236 (477)
.... ....+||+.|+|||++.+..++.++|||||||+||+|++|..||.+...... ......+........
T Consensus 216 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 216 SHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp -------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred CCCc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 3221 2356899999999999999999999999999999999999999976543221 011222332222211
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
. ..+..+++++.+||..||..||++||++.++ |++.|..
T Consensus 288 ~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~ 326 (400)
T 1nxk_A 288 N-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIM 326 (400)
T ss_dssp T-TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHH
T ss_pred C-cccccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCcccc
Confidence 1 1235689999999999999999999997665 4555443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=354.40 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=206.1
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
|...+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.++| ++|+.+..++...+.
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~ 79 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNI 79 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCe
Confidence 566678999999999999999999999999999999999765432 3468899999999987 566666667778888
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.||||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 155 (323)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeecccee
Confidence 99999999 8899999863 4569999999999999999999999999999999999999 67889999999999876
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... ......+||+.|+|||++.+..+ +.++|||||||+||+|++|..||........ .+..........
T Consensus 156 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~ 228 (323)
T 3tki_A 156 RYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYL 228 (323)
T ss_dssp EETTEE-----CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHHTTCTTS
T ss_pred ccCCcc-----cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHhcccccC
Confidence 543221 12245689999999999988776 7789999999999999999999976544322 222222221111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.....+++++.+||.+||..||.+||++++++
T Consensus 229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ---CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 12345789999999999999999999977764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=345.89 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=199.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|++++.||+|+||.||+|++ .+++.||||++.... ....+.+|+.+++.++| ++|..+..++...+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCC-CCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 789999999876543 23467899999999987 55666666666778899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCcccc-
Confidence 999889999998766789999999999999999999999999999999999999 6789999999999986643221
Q ss_pred cccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc---------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (477)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.+.....
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 12345789999999999764 58999999999999999999999998754322222222211110
Q ss_pred ------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 ------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.....+.....+++++.++|.+||..||++||+++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 001122334568999999999999999999999777643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=355.89 Aligned_cols=257 Identities=20% Similarity=0.274 Sum_probs=204.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHc----CCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQ----GGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~----~~~~i~~~~~~~~~~~~~ 78 (477)
.+.++|+++++||+|+||.||+|++..+++.||||++.... ....+..|..+++.+. .+++|+.+..++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 56789999999999999999999999999999999986432 2235677999999997 357777777777788899
Q ss_pred EEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC------------------
Q 011819 79 VLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG------------------ 139 (477)
Q Consensus 79 ~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~------------------ 139 (477)
+|||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 112 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 112 CLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp EEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 9999999999999997543 359999999999999999999999999999999999999421
Q ss_pred ----CCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCC
Q 011819 140 ----RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (477)
Q Consensus 140 ----~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~ 215 (477)
...+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||+||+|++|..||..
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 127889999999998654322 356799999999999999999999999999999999999999987
Q ss_pred CCcccHHHHHHHHhhhcccccH--------------------------------------HHHhcCCcHHHHHHHHHHhc
Q 011819 216 LKAGTKKQKYEKISEKKVSTSI--------------------------------------EALCRGYPTEFASYFHYCRS 257 (477)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~--------------------------------------~~l~~~~p~~l~~li~~cl~ 257 (477)
.........+..+......... ..+....++.+.+||..||.
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 5443322222222111100000 00111224778899999999
Q ss_pred CCCCCCCCHHHHH
Q 011819 258 LRFDDKPDYAYLK 270 (477)
Q Consensus 258 ~~p~~RPt~~~l~ 270 (477)
.||++||++++++
T Consensus 342 ~dP~~Rpta~elL 354 (360)
T 3llt_A 342 IDPTLRPSPAELL 354 (360)
T ss_dssp SSGGGSCCHHHHT
T ss_pred CChhhCCCHHHHh
Confidence 9999999987764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=366.66 Aligned_cols=276 Identities=17% Similarity=0.195 Sum_probs=192.9
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeE----eC
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGV----EG 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~----~~ 75 (477)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.|+|++++..+..+.. ..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 4668999999999999999999999999999999987653322 357789999999987555555555432 23
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...||||||++++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLART 205 (458)
T ss_dssp CCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBC
T ss_pred ceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccchh
Confidence 56899999999999999974 5669999999999999999999999999999999999999 6789999999999987
Q ss_pred cccCCCCccc--------------------ccccCCCCccCccccccchhc-CCCCCCcchHHHHHHHHHHHHc------
Q 011819 156 YRDTSTHQHI--------------------PYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLR------ 208 (477)
Q Consensus 156 ~~~~~~~~~~--------------------p~~~~~~~~Gt~~Y~APE~~~-g~~~s~ksDIwSlGviLyellt------ 208 (477)
.......... ........+||+.|+|||++. +..|+.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6533211000 001234568899999999864 5679999999999999999999
Q ss_pred -----CCCCCCCCCcc-----------------cHHHHHHHHhhh--------------------------cccccHHHH
Q 011819 209 -----GSLPWQGLKAG-----------------TKKQKYEKISEK--------------------------KVSTSIEAL 240 (477)
Q Consensus 209 -----G~~Pf~~~~~~-----------------~~~~~~~~i~~~--------------------------~~~~~~~~l 240 (477)
|..+|.+.... .....+..+... .........
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 66777553210 001111111111 011112223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 293 (477)
.+.+++++.+||.+||..||++||+++++++ ++|...++|...
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~----------Hp~f~~~~~~~~ 408 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLA----------HPFFKEVRIAEV 408 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHH----------SGGGTTTCCGGG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhc----------CHhhhhcCCCcc
Confidence 4566899999999999999999999776643 355555566543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=358.79 Aligned_cols=262 Identities=18% Similarity=0.283 Sum_probs=208.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEE-----ECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~-----~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
...++|+++++||+|+||.||+|+ +..+++.||||++...... ..+..|+.++..++| ++|+.+..++...
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~ 146 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSLQS 146 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCC-CCCCeEEEEEecC
Confidence 445789999999999999999999 4557889999998654322 247789999999977 5566666666677
Q ss_pred cEEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEe
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~ 148 (477)
...+|||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+.....+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 7789999999 889999997543 358999999999999999999999999999999999999533345569999
Q ss_pred ecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHH
Q 011819 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 227 (477)
Q Consensus 149 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~ 227 (477)
|||+++....... ........||+.|+|||++.+..++.++|||||||+||+|++ |..||..... .+.+..
T Consensus 227 DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~---~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHH
T ss_pred CCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH
Confidence 9999986533221 112234578999999999999999999999999999999998 9999976433 344444
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
+....... .+..+|+++.+|+..||+.+|++||++.++.+.|+.+..
T Consensus 299 i~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 VTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 44332211 235689999999999999999999999999998887753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=352.62 Aligned_cols=268 Identities=18% Similarity=0.260 Sum_probs=215.2
Q ss_pred cCCceEEE-eeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~-~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
+.++|.+. +.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.++++++.+..++......+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 45678888 89999999999999999999999999876532 23468899999999999899999888888889999
Q ss_pred EEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
+||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.....+.+||+|||+++...
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999 88999987532 3569999999999999999999999999999999999999532337899999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+....... .
T Consensus 186 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~-~ 253 (327)
T 3lm5_A 186 HACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQVNVDY-S 253 (327)
T ss_dssp ----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCC-C
T ss_pred Cccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhccccc-C
Confidence 4322 2345799999999999999999999999999999999999999976433 34444444433322 2
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccch
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILK 294 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 294 (477)
......+++.+.++|..||..||++||+++++++ ++|...++|....
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~----------h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS----------HSWLQQWDFENLF 300 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT----------CGGGCCCCTTCC-
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC----------CHhhccccccccc
Confidence 2344678999999999999999999999877643 4566666777543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=346.63 Aligned_cols=265 Identities=20% Similarity=0.264 Sum_probs=202.6
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCeeEEeeE---eC
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRI--LQGGTGIPNVRWFGV---EG 75 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~--L~~~~~i~~~~~~~~---~~ 75 (477)
|+..+.++|++++.||+|+||.||+|++ +++.||||++... ....+..|.+++.. ++|++++..+..+.. ..
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 6778899999999999999999999986 7899999998653 34456678888777 566544444443322 23
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeCCCCCCceEeecCCCCCcEE
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVY 146 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLH--------s~giiHRDLKP~NILl~~~~~~~~vk 146 (477)
...++||||+ +++|.++++ ...+++..++.++.||+.||+||| ++||+||||||+|||+ +.++.+|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~k 153 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCC 153 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred ceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEE
Confidence 5679999999 889999996 457999999999999999999999 9999999999999999 6789999
Q ss_pred EeecCceeecccCCCCcccccccCCCCccCccccccchhcCC------CCCCcchHHHHHHHHHHHHcC----------C
Q 011819 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRG----------S 210 (477)
Q Consensus 147 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~------~~s~ksDIwSlGviLyelltG----------~ 210 (477)
|+|||+++.......... .......||+.|+|||++.+. .++.++|||||||++|+|++| .
T Consensus 154 l~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLD---VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp ECCCTTCEEEETTTTEEE---CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EeeCCCeeeccccccccc---ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 999999987665433211 112345899999999999886 445799999999999999999 8
Q ss_pred CCCCCCCccc-HHHHHHHHhh-hc--ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 211 LPWQGLKAGT-KKQKYEKISE-KK--VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 211 ~Pf~~~~~~~-~~~~~~~i~~-~~--~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
.||....... ....+..... .. ...+.......+++++.+++..||..||++||++.++.+.|+.+
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 8997643321 2222222221 11 11111112233578899999999999999999999999988865
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=354.93 Aligned_cols=263 Identities=19% Similarity=0.302 Sum_probs=216.5
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCC-------CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~-------g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
..++|+++++||+|+||.||+|++..+ +..||||++...... ..+..|++++..+..+++|+.+..++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 457899999999999999999997543 357999998765433 3477899999999666777777777777
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~ 138 (477)
.+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-- 224 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-- 224 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE--
Confidence 88899999999 889999998643 359999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCC
Q 011819 139 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (477)
Q Consensus 139 ~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~ 217 (477)
+.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 225 -~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 225 -TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp -CTTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -cCCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 67889999999999866543221 12234567899999999999999999999999999999999 999997644
Q ss_pred cccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011819 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (477)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~ 282 (477)
. .+....+...... .....+++++.++|..||..+|++||++.++.+.|+.++.....
T Consensus 299 ~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 299 V---EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp H---HHHHHHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred H---HHHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 3 3333333333221 12356899999999999999999999999999999999866543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=356.66 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=207.3
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
.+...++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++| ++|..+..++....
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-PHIIKLYDVITTPT 82 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCC-TTBCCEEEEEECSS
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCC
Confidence 456678999999999999999999999999999999987532 334568899999999987 56666666667778
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 77 ~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
..+|||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 83 ~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTT
T ss_pred EEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceec
Confidence 8999999999999998875 4569999999999999999999999999999999999999 67889999999999765
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
..... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..... .+.++..
T Consensus 159 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~~----- 222 (336)
T 3h4j_B 159 TDGNF--------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---LFKKVNS----- 222 (336)
T ss_dssp TTSBT--------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---CBCCCCS-----
T ss_pred cCCcc--------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---HHHHHHc-----
Confidence 44321 245689999999999998876 789999999999999999999997643221 1111111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
....++..+++++.++|..||..||.+||+++++ +++.|.+.
T Consensus 223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~~ 264 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEI---RRDPWFNV 264 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHH---TTCHHHHT
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHH---HhChhhcc
Confidence 1112345678999999999999999999997665 44454443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=352.55 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=192.5
Q ss_pred CceEEE---eeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLG---RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~---~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|++. +.||+|+||.||+|.+..+++.||||++... ....+..|+.+++.+.+|++|+.+..++.+....|||||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 568886 7899999999999999999999999998653 345678899999999977888888888888889999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++....+||+|||+++.......
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 87 LLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp CCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 99 8899999975 56799999999999999999999999999999999999996433344899999999986644322
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc----ccHHHHHHHHhhhcccccHH
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~----~~~~~~~~~i~~~~~~~~~~ 238 (477)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+.+.++........ .
T Consensus 165 ------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~-~ 237 (325)
T 3kn6_A 165 ------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE-G 237 (325)
T ss_dssp -------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC-S
T ss_pred ------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC-c
Confidence 12345789999999999999999999999999999999999999976432 233445555555444322 2
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..+..+++++.+||..||..||.+||+++++.
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 33457899999999999999999999977664
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=347.63 Aligned_cols=264 Identities=19% Similarity=0.222 Sum_probs=203.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEE----ECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeE-eCc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGV-EGD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~----~~~~g~~vAiKi~~~~~~~--~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~ 76 (477)
...++|+++++||+|+||.||+|+ +..+++.||||++...... ..+..|+.++..++|++++..+..+.. ...
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 457899999999999999999998 5678999999998754322 357889999999987555554444432 345
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCccccc
Confidence 579999999 899999998766669999999999999999999999999999999999999 5678999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc---------HH----
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---------KK---- 222 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~---------~~---- 222 (477)
....... ........++..|+|||++.+..++.++|||||||++|+|++|..||....... ..
T Consensus 164 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 164 LPQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp ----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 6543221 111233457888999999999999999999999999999999999996421100 00
Q ss_pred HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
.....+.... ....+..+|+++.++|..||..+|++||++.++.+.|+++..
T Consensus 240 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 240 HLIELLKNNG----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHTTC----CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhccC----cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 0111111111 111235689999999999999999999999999999998864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=355.11 Aligned_cols=259 Identities=16% Similarity=0.216 Sum_probs=202.2
Q ss_pred cCCceEEEeeeeec--CceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 5 VGNKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 5 i~~~y~i~~~IG~G--~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
-+++|+++++||+| +||.||+|++..+++.||||++...... ..+..|+.+++.++| ++|+.+..++...+..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCCCcEeEEEEECCEE
Confidence 35789999999999 9999999999999999999998754322 346679999999987 5566666666778889
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
||||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence 9999999 89999999753 2569999999999999999999999999999999999999 67899999999998765
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcC--CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g--~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
.................+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......... +......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~ 255 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE---KLNGTVP 255 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH---C------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HhcCCCC
Confidence 4433221111122344589999999999988 6789999999999999999999999987544322211 1110000
Q ss_pred -----------------------------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 235 -----------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 235 -----------------------------------------~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.........+++++.+||.+||..||.+||++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 001123456788999999999999999999987764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=361.72 Aligned_cols=258 Identities=20% Similarity=0.298 Sum_probs=210.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.++|+++++||+|+||.||+|.+..+++.||||++...... ..+..|+++++.++| ++|+.+..++...+..+|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEecCCCcEEEE
Confidence 46899999999999999999999989999999997654322 347789999999987 55666666666777889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCce
Confidence 999 899999998666679999999999999999999999999999999999999 6788999999999986543211
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. .......+++.|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+...... ..
T Consensus 269 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~ 336 (377)
T 3cbl_A 269 A-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVEKGGRL----PC 336 (377)
T ss_dssp E-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHHTTCCC----CC
T ss_pred e-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence 0 01122346778999999998889999999999999999998 9999987543 2233323222111 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+..+|+++.++|..||+.+|++||+++++.+.|+++..+
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 356899999999999999999999999999999988654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=337.37 Aligned_cols=260 Identities=21% Similarity=0.273 Sum_probs=211.6
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+..|+.+++.++| +++..+..++......+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEcCCEEE
Confidence 4678999999999999999999999999999999998654322 346789999999986 56666666667888889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+...+.+||+|||++.....
T Consensus 82 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999 8899888875 45699999999999999999999999999999999999996444455699999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+.........
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~- 228 (284)
T 3kk8_A 161 SEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS- 228 (284)
T ss_dssp SCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-
T ss_pred Ccc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccccCCc-
Confidence 322 234679999999999999999999999999999999999999997643 33444444444332222
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.....+++++.++|..||..+|++||+++++. ++.|...
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l---~h~~~~~ 267 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQAL---KVPWICN 267 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHT---TSHHHHS
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHh---cCccccC
Confidence 23356899999999999999999999977664 4444433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=360.03 Aligned_cols=275 Identities=17% Similarity=0.223 Sum_probs=202.7
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeC----
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG---- 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~---- 75 (477)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.|+|++++..+..+....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 4678999999999999999999999999999999998654322 35779999999998765555555543332
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...||||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCccc
Confidence 56899999999999999974 5569999999999999999999999999999999999999 6789999999999997
Q ss_pred cccCCCCccc---------------ccccCCCCccCccccccchh-cCCCCCCcchHHHHHHHHHHHHcCCCCCC-----
Q 011819 156 YRDTSTHQHI---------------PYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQ----- 214 (477)
Q Consensus 156 ~~~~~~~~~~---------------p~~~~~~~~Gt~~Y~APE~~-~g~~~s~ksDIwSlGviLyelltG~~Pf~----- 214 (477)
.......... ........+||+.|+|||++ .+..++.++|||||||+||||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6543221000 00123567899999999986 45669999999999999999998544443
Q ss_pred ------CCCcc--------------cHHHHHHHHhh--------------------------hcccccHHHHhcCCcHHH
Q 011819 215 ------GLKAG--------------TKKQKYEKISE--------------------------KKVSTSIEALCRGYPTEF 248 (477)
Q Consensus 215 ------~~~~~--------------~~~~~~~~i~~--------------------------~~~~~~~~~l~~~~p~~l 248 (477)
+...- .....+..+.. ...........+.+++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 21100 00111111111 111222333446789999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011819 249 ASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 292 (477)
Q Consensus 249 ~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 292 (477)
.+||.+||..||.+||+++++++ ++|...+.|..
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~----------Hp~f~~~~~~~ 372 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALD----------HPYLKDVRKKK 372 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT----------CGGGTTTCCTT
T ss_pred HHHHHHHhcCCcccCCCHHHHhc----------ChhhhhccCcc
Confidence 99999999999999999776643 45555556654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=349.17 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=194.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeEeC---
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEG--- 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~~~~i~~~~~~~~~~--- 75 (477)
.+.++|++++.||+|+||.||+|++..+++.||||++...... ..+..|+.++..++|++++..+..+....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 4678999999999999999999999999999999998764322 24678888888888755555444443322
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
...||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSCC-
T ss_pred cccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccCcc
Confidence 2459999999 8999999975 4569999999999999999999999999999999999999 577899999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
........ ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ........... .
T Consensus 165 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~-~ 236 (311)
T 3ork_A 165 AIADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVRED-P 236 (311)
T ss_dssp ---------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCC-C
T ss_pred cccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCC-C
Confidence 76543221 1122346799999999999999999999999999999999999999976433 23333333222 2
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 268 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~ 268 (477)
.........+++++.++|.+||..||++||+..+
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~ 270 (311)
T 3ork_A 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270 (311)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence 3344456779999999999999999999997543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=349.24 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=188.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.++|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++| ++|..+..++...+..+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH-ENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCB-TTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCC-CCcceEEEEEEECCeEEEEE
Confidence 478999999999999999999999999999999876543 23467899999999987 56666666666778899999
Q ss_pred ecCCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 83 DLLGPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 83 E~~g~sL~~li~~~~-----~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||+.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETT
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceecC
Confidence 999889999986432 458999999999999999999999999999999999999 678999999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc--
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-- 234 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 234 (477)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.........
T Consensus 160 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 4321 12345789999999999874 6899999999999999999999999875443222222221110000
Q ss_pred -------------------ccH-----HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 235 -------------------TSI-----EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 235 -------------------~~~-----~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
... ......+++++.+||..||..||++||+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 000 011235788999999999999999999977664
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.51 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=208.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
.++|++.++||+|+||.||+|.+ .++.||||++........+..|+.+++.++|++++..+..+.......+|||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 46899999999999999999996 4789999999877667789999999999988665555555555555789999999
Q ss_pred -CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 86 -GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 86 -g~sL~~li~~~~~-~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+++|.+++..... .++...++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc---
Confidence 8899999986544 37999999999999999999999999999999999999 678999999999998543221
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
....++..|+|||++.+..++.++|||||||+||||++ |..||.+......... +...... ..+.
T Consensus 344 -------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~~~~~~----~~p~ 409 (450)
T 1k9a_A 344 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKM----DAPD 409 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH---HHTTCCC----CCCT
T ss_pred -------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCCCC----CCCC
Confidence 12357889999999999999999999999999999998 9999987655433322 2222111 1345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.+|+++.++|..||..+|++||++.++.+.|+++...
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 7899999999999999999999999999999988643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=346.78 Aligned_cols=265 Identities=20% Similarity=0.229 Sum_probs=205.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEe-CcEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNV 79 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~-~~~~~ 79 (477)
...++|++.++||+|+||.||+|.+..+++.||||++.... ....+..|+++++.++|++++..+..+... ....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 46789999999999999999999999999999999976532 334577999999999975544444443332 33779
Q ss_pred EEEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec-CCCCCcEEEeecCceee
Q 011819 80 LVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAKK 155 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~--~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~-~~~~~~vkL~DFGla~~ 155 (477)
|||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+.. ++..+.+||+|||+++.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999 8999999974332 3999999999999999999999999999999999999843 23566799999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhc--------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc-ccHHHHHH
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHL--------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKYE 226 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~--------g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~-~~~~~~~~ 226 (477)
...... .....||+.|+|||++. +..++.++|||||||++|+|++|..||..... ....+.+.
T Consensus 166 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 166 LEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp CCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred cCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 655332 23457999999999987 57789999999999999999999999975433 22333444
Q ss_pred HHhhhcccccH--------------------HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 227 KISEKKVSTSI--------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 227 ~i~~~~~~~~~--------------------~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
++........+ ..+...+++.+.+++..||..||++||+++++.+...+.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 44433221100 011223467899999999999999999988887766544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=340.19 Aligned_cols=255 Identities=19% Similarity=0.272 Sum_probs=210.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|++++.||+|+||.||+|.+. +++.||||++.... ....+..|+++++.++| +++..+..++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCceEEEEEe
Confidence 468999999999999999999985 57789999987643 34568899999999987 5566666666677788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~-- 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY-- 161 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH--
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccccc--
Confidence 9 889999997656679999999999999999999999999999999999999 6778999999999975533211
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... .+....+...... ..+.
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 230 (269)
T 4hcu_A 162 ----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRL----YKPR 230 (269)
T ss_dssp ----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC----CCCT
T ss_pred ----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCccC----CCCC
Confidence 12234567889999999999999999999999999999999 9999976433 3444444332211 1234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
.+++++.+++..||..+|++||++.++.+.|+++..
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 578999999999999999999999999999998863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=344.08 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=209.0
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
.+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.| +++..+..++...
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH-HNVITLHDVYENR 87 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC-CCcceEEEEEecC
Confidence 345689999999999999999999999999999998765432 3458899999999987 4555666666777
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC----cEEEeec
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDF 150 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~----~vkL~DF 150 (477)
...++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++ .+||+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLIDF 163 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEccC
Confidence 8899999999 8999999974 55699999999999999999999999999999999999994 444 7999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+..
T Consensus 164 g~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~ 232 (321)
T 2a2a_A 164 GLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITS 232 (321)
T ss_dssp TTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHT
T ss_pred ccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHh
Confidence 99987654322 234579999999999999999999999999999999999999997643 3444444444
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.... ....+...+++++.++|..||..||++||+++++.+
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VSYD-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TCCC-CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cccc-cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3332 223455788999999999999999999999877754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=344.39 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=197.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----------------------------chhHHHHHHH
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------------------HPQLLYESKL 55 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----------------------------~~~~~~E~~i 55 (477)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 345789999999999999999999999999999998765421 2457889999
Q ss_pred HHHHcCCCCCCeeEEeeE-eCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCc
Q 011819 56 YRILQGGTGIPNVRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (477)
Q Consensus 56 l~~L~~~~~i~~~~~~~~-~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~N 133 (477)
++.++|++++..+..+.. .....||||||+ +++|.+++. ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999987555444444433 367889999999 788887654 4579999999999999999999999999999999999
Q ss_pred eEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCC---CCCcchHHHHHHHHHHHHcCC
Q 011819 134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGS 210 (477)
Q Consensus 134 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~---~s~ksDIwSlGviLyelltG~ 210 (477)
||+ +.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 168 il~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 168 LLV---GEDGHIKIADFGVSNEFKGSDA-------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp EEE---CTTSCEEECCCTTCEECSSSSC-------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred EEE---CCCCCEEEecCCCccccccccc-------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 999 6788999999999987654322 123457999999999998765 378899999999999999999
Q ss_pred CCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.||.... .......+.......+ ....+++++.++|..||..||++||++.++.
T Consensus 238 ~pf~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 238 CPFMDER---IMCLHSKIKSQALEFP---DQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp CSSCCSS---HHHHHHHHHHCCCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCcc---HHHHHHHHhcccCCCC---CccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 9997643 2333333333322211 1246889999999999999999999977764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=341.11 Aligned_cols=259 Identities=21% Similarity=0.298 Sum_probs=198.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~---g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
...++|++++.||+|+||.||+|.+..+ +..||||+...... ...+..|+.+++.++|++++..+.. . ..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~-~~~~ 89 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV-I-TENP 89 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEE-E-CSSS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEE-E-ccCc
Confidence 3467999999999999999999998654 45799998765432 2357789999999987555544444 3 3456
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECcccccccc
Confidence 78999999 789999998666679999999999999999999999999999999999999 56789999999999876
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...... +..+......
T Consensus 167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~~~~~- 236 (281)
T 1mp8_A 167 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGERL- 236 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCCC-
T ss_pred Cccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHcCCCC-
Confidence 543221 1223457889999999999999999999999999999997 9999987654332 3333332221
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.+...+|+++.+++..||..+|++||++.++.+.|++++..+
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 134578999999999999999999999999999999987543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=350.95 Aligned_cols=258 Identities=21% Similarity=0.326 Sum_probs=210.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
..++|++++.||+|+||.||+|++. .+++.||||++...... ..+.+|+.++..++| ++|..+..++...+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAVGK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEccCC
Confidence 4578999999999999999999987 35589999998764432 357889999999976 56666666666777
Q ss_pred EEEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCC
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 132 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~-----------------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~ 132 (477)
..+|||||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 889999999 889999997532 56999999999999999999999999999999999
Q ss_pred ceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCC
Q 011819 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL 211 (477)
Q Consensus 133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~ 211 (477)
|||+ +.++.+||+|||+++....... +.......||+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 204 NIl~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 204 NCLV---GENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp GEEE---CGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEEE---CCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999 6788999999999986543221 112234578999999999999999999999999999999999 999
Q ss_pred CCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
||.+... .+....+...... ..+..+|+++.+++..||..+|++||++.++.+.|+++..
T Consensus 276 p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 276 PYYGMAH---EEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTTTSCH---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCCCCCh---HHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 9976433 3444444443322 2345789999999999999999999999999999988753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.67 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=198.7
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCC-CCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGG-TGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~-~~i~~~~~~~~~~~~~ 78 (477)
..+++|++++.||+|+||.||+|.+ .+++.||||++...... ..+..|+.++..|.|+ ++|..+..++......
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3577899999999999999999997 56899999998755432 3467899999999864 7888888888888999
Q ss_pred EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 79 VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 79 ~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||+.+++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC--
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCc
Confidence 99999889999999985 56799999999999999999999999999999999999993 57899999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhcC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-----------~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~ 227 (477)
.... ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||..... ....+..
T Consensus 160 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~ 232 (343)
T 3dbq_A 160 DTTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA 232 (343)
T ss_dssp ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH
T ss_pred cccc-----ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHH
Confidence 3221 11235679999999999875 6788999999999999999999999976432 2223333
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+...... ..+....+.++.++|..||..||.+||++.+++
T Consensus 233 ~~~~~~~---~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l 272 (343)
T 3dbq_A 233 IIDPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272 (343)
T ss_dssp HHCTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HhcCCcc---cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHH
Confidence 3222111 123345678999999999999999999977664
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=342.24 Aligned_cols=262 Identities=20% Similarity=0.312 Sum_probs=214.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEE-----CCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~-----~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
..++|++++.||+|+||.||+|.+ ..+++.||||++..... ...+..|+.++..+.+|++|..+..++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 357899999999999999999985 45678999999876543 2457899999999965677777777777778
Q ss_pred EEEEEEecC-CCCHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSR-----------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~-----------------~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~ 138 (477)
..++||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~-- 178 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-- 178 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE--
Confidence 889999999 8899999975432 48999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCC
Q 011819 139 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (477)
Q Consensus 139 ~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~ 217 (477)
+.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 179 -~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 179 -THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp -ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -cCCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 57889999999999876554321 12234567889999999999999999999999999999999 999998755
Q ss_pred cccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.... +.......... .....+|+++.+++..||..+|.+||++.++.+.|++++...
T Consensus 253 ~~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 253 VDSK---FYKMIKEGFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp SSHH---HHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred chhH---HHHHhccCCCC---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 4322 12222211111 123567999999999999999999999999999999988654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=341.71 Aligned_cols=257 Identities=17% Similarity=0.277 Sum_probs=209.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|++++.||+|+||.||+|.+. ++..||||++.... ....+..|++++..++| ++|+.+..++......++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCC-CCEeeEEEEEecCCCeEEEEec
Confidence 468999999999999999999874 67889999987643 34568899999999987 5566666666677788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~-- 175 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY-- 175 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHH--
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccccc--
Confidence 9 899999998655679999999999999999999999999999999999999 6788999999999976543211
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ......+....... ...
T Consensus 176 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~----~~~ 244 (283)
T 3gen_A 176 ----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLY----RPH 244 (283)
T ss_dssp ----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCC----CCT
T ss_pred ----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHHHHhcccCCC----CCC
Confidence 12234467889999999999899999999999999999998 9999977543 33334443332211 234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.+++++.+++..||..+|++||++.++.+.|++++.++
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 57899999999999999999999999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=339.01 Aligned_cols=255 Identities=16% Similarity=0.224 Sum_probs=210.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..++|++++.||+|+||.||+|.+. ++..||||++.... ....+..|++++..++| ++++.+..++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH-PKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCceEEEEE
Confidence 4578999999999999999999874 67789999987644 34568899999999987 566666666677778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~- 159 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQY- 159 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCE-
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhhh-
Confidence 99 899999998666679999999999999999999999999999999999999 6789999999999987654332
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+....... .+
T Consensus 160 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~----~~ 227 (268)
T 3sxs_A 160 -----VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQGHRLY----RP 227 (268)
T ss_dssp -----EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCC----CC
T ss_pred -----hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHcCCCCC----CC
Confidence 11234456788999999999899999999999999999999 9999976443 33333333322211 22
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+++++.+++..||..+|.+||++.++.+.|+.+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 456899999999999999999999999998887763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=358.76 Aligned_cols=254 Identities=21% Similarity=0.214 Sum_probs=208.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.+.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+..|+.++..|+| ++|+.+..++.+....+||
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCC-cCCCeEEEEEEeCCEEEEE
Confidence 345789999999999999999999999999999999875432 2357789999999977 5566666666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ |++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++. +..+.+||+|||+++......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTS
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCc
Confidence 9999 89999998754557999999999999999999999999999999999999942 235789999999998765432
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+....... ....
T Consensus 206 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~-~~~~ 273 (387)
T 1kob_A 206 I--------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEF-DEDA 273 (387)
T ss_dssp C--------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCC-CSST
T ss_pred c--------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC-Cccc
Confidence 2 123479999999999999999999999999999999999999997643 334444444433221 1223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
+..+++++.+||..||..||++||++.++++
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 4568999999999999999999999777643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=356.76 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=198.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcC-CCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQG-GTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~-~~~i~~~~~~~~~~~~~~l 80 (477)
+.+|++++.||+|+||.||+|.+.. ++.||||++...... ..+.+|+.++..|.+ +++|..+..++...+..||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4569999999999999999999754 899999998765432 357889999999986 6888888888888889999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+. ++.+||+|||+++.+....
T Consensus 134 v~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC----
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccCCC
Confidence 999779999999985 45799999999999999999999999999999999999993 4789999999998765432
Q ss_pred CCcccccccCCCCccCccccccchhcC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g-----------~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
.. ......+||+.|+|||++.+ ..++.++|||||||+||+|++|..||..... ....+..+.
T Consensus 209 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~ 281 (390)
T 2zmd_A 209 TS-----VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAII 281 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHH
T ss_pred cc-----ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHh
Confidence 21 11235689999999999976 3688999999999999999999999976432 223333333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
...... .++..++.++.+||..||..||.+||++.+++
T Consensus 282 ~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 282 DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 322211 12344578999999999999999999977664
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=334.55 Aligned_cols=252 Identities=21% Similarity=0.239 Sum_probs=210.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~--~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.+.++|++.+.||+|+||.||+|.+..++..||+|++... .....+..|+.+++.++| ++++.+..++......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-PNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCeEEEE
Confidence 4567899999999999999999999999999999987653 334568899999999976 5666666677788889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+..++.++.+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999 8899999875 4569999999999999999999999999999999999999655677899999999998765433
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. .....||+.|+|||++.+. ++.++|||||||++|+|++|..||.... ..+.+..+.......+ ...
T Consensus 164 ~--------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~-~~~ 230 (277)
T 3f3z_A 164 M--------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFP-EKD 230 (277)
T ss_dssp C--------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC-HHH
T ss_pred c--------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCC-chh
Confidence 2 2345799999999998765 8999999999999999999999997643 3444455554444332 334
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
...+++++.++|..||..+|++||++.++.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l 260 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQAL 260 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 457899999999999999999999977664
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=350.93 Aligned_cols=254 Identities=18% Similarity=0.269 Sum_probs=198.1
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++|+++++||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.++| ++|+.+..++...+..+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCC-TTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCC-CCCCeeeeEEeeCCEEEEEec
Confidence 6899999999999999999999999999999987653321 234578999999987 566666666677788999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
|++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCcc--
Confidence 99889999998777779999999999999999999999999999999999999 6788999999999986543221
Q ss_pred ccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc---------
Q 011819 164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (477)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.+......
T Consensus 156 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 -----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 1234578999999999987 5689999999999999999999999987544332222222211111
Q ss_pred -------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 -------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+++++.+||..||..||.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 11122334567899999999999999999999777643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=350.04 Aligned_cols=259 Identities=20% Similarity=0.231 Sum_probs=198.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..++|+++++||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++| ++|+.+..++......+||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCC-CCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999999999999999886543 34568899999999987 566666666677888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCC--cEEEeecCceeecccCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~ 160 (477)
|+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..+ .+||+|||+++......
T Consensus 97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~---~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEEC---SSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCceEEEeecCccccccccC
Confidence 99 8999999975 45699999999999999999999999999999999999993 444 59999999997443222
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCc-chHHHHHHHHHHHHcCCCCCCCCCcc-cHHHHHHHHhhhcccccHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~k-sDIwSlGviLyelltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~ 238 (477)
. ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.... .....+..+.......+
T Consensus 173 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (361)
T 3uc3_A 173 Q--------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP-- 242 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC--
T ss_pred C--------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC--
Confidence 1 234579999999999998888755 89999999999999999999875432 22333344433332211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~ 282 (477)
....+++++.+||.+||..+|.+||++.++ +++.|.....
T Consensus 243 -~~~~~s~~~~~li~~~L~~dP~~Rps~~el---l~hp~f~~~~ 282 (361)
T 3uc3_A 243 -DDIRISPECCHLISRIFVADPATRISIPEI---KTHSWFLKNL 282 (361)
T ss_dssp -TTSCCCHHHHHHHHHHSCSCTTTSCCHHHH---HTSHHHHTTC
T ss_pred -CcCCCCHHHHHHHHHHccCChhHCcCHHHH---HhCcchhcCC
Confidence 123578999999999999999999997665 4555544443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=340.23 Aligned_cols=252 Identities=18% Similarity=0.286 Sum_probs=201.6
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---------hhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------PQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---------~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
...++|++.+.||+|+||.||+|++..+++.||||++...... ..+..|+.++..++|++ +..+..++..
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN-IVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTT-BCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCC-chhhheeecC
Confidence 4568999999999999999999999999999999987553321 45788999999998754 4444444333
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCc-----EE
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQ-----VY 146 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~-----vk 146 (477)
. .++||||+ +++|.+++......+++..++.++.||+.||+|||++| |+||||||+|||++ ..+. +|
T Consensus 95 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~---~~~~~~~~~~k 169 (287)
T 4f0f_A 95 P--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ---SLDENAPVCAK 169 (287)
T ss_dssp T--TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES---CCCTTCSCCEE
T ss_pred C--CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe---ccCCCCceeEE
Confidence 3 37999999 79999988765667999999999999999999999999 99999999999994 4444 99
Q ss_pred EeecCceeecccCCCCcccccccCCCCccCccccccchhc--CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH
Q 011819 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (477)
Q Consensus 147 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~--g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~ 224 (477)
|+|||+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|..||....... ...
T Consensus 170 l~Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~ 238 (287)
T 4f0f_A 170 VADFGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKF 238 (287)
T ss_dssp ECCCTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-HHH
T ss_pred eCCCCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-HHH
Confidence 9999999744321 23467999999999984 4557899999999999999999999998754432 222
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
...+....... .++..+|+++.++|..||..||++||++.++.+.|++
T Consensus 239 ~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 239 INMIREEGLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHhccCCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 33333322221 2345789999999999999999999999999888764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=357.97 Aligned_cols=255 Identities=20% Similarity=0.251 Sum_probs=203.0
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCC-----CCCCeeEEeeEeCcE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGG-----TGIPNVRWFGVEGDY 77 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~-----~~i~~~~~~~~~~~~ 77 (477)
.+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.+. +++..+..++.....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 456789999999999999999999999999999999865322 24577899999998753 466666777778889
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCc--EEEeecCcee
Q 011819 78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAK 154 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~--vkL~DFGla~ 154 (477)
.+|||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++. +||+|||++.
T Consensus 174 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl---~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL---KQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE---SSTTSCCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---ccCCCcceEEeecccce
Confidence 99999999999999997543 359999999999999999999999999999999999999 45555 9999999997
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
...... ...+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.........+.........
T Consensus 251 ~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 251 YEHQRV----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp ETTCCC----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCCcc----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 654322 3468999999999999999999999999999999999999999875443222222211110000
Q ss_pred ---------------------------------------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCC
Q 011819 235 ---------------------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDK 263 (477)
Q Consensus 235 ---------------------------------------------------~~~~~l~~~~p~~l~~li~~cl~~~p~~R 263 (477)
.....+....++++.+||..||..||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 00111223347889999999999999999
Q ss_pred CCHHHHHH
Q 011819 264 PDYAYLKR 271 (477)
Q Consensus 264 Pt~~~l~~ 271 (477)
||++++++
T Consensus 401 pta~e~L~ 408 (429)
T 3kvw_A 401 MTPGQALR 408 (429)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhC
Confidence 99877753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=347.64 Aligned_cols=266 Identities=22% Similarity=0.244 Sum_probs=202.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
...++|+++++||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.++| ++|..+..++...+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-RNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC-TTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC-CCcceEEEEEecCCEEE
Confidence 3557899999999999999999999999999999998654322 346789999999976 56666666777888999
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC--CCCCcEEEeecCceeecc
Q 011819 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~--~~~~~vkL~DFGla~~~~ 157 (477)
|||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +..+.+||+|||+++...
T Consensus 110 lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999998899999975 4569999999999999999999999999999999999999532 234569999999998764
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc---
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 233 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (477)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... .+.+..+.....
T Consensus 189 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 189 IPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLPD 258 (329)
T ss_dssp ------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred Cccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCCc
Confidence 3322 12345789999999999875 489999999999999999999999976443 333333322110
Q ss_pred ----------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 011819 234 ----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291 (477)
Q Consensus 234 ----------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~ 291 (477)
......+...+++++.+||..||..||.+||+++++++ ++|+...+|+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~----------hp~f~~~~~~ 328 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE----------HPYFSHNDFD 328 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT----------SGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC----------CcccCCCCCC
Confidence 00111222337899999999999999999999877643 4566666665
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=363.28 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=192.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEe-----C
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVE-----G 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~-----~ 75 (477)
+.++|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+... .
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4578999999999999999999999999999999986532 123577899999999886655555555332 2
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...||||||++++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 140 ~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeee
Confidence 4679999999888888775 359999999999999999999999999999999999999 6789999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... ....+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+... ...+.++.......
T Consensus 214 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 214 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTP 282 (464)
T ss_dssp ---CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSC
T ss_pred cCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 654321 2456899999999999999999999999999999999999999987443 33333333221111
Q ss_pred c-------------------------HHHHhcC------------CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 S-------------------------IEALCRG------------YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ~-------------------------~~~l~~~------------~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. ...+.+. .++++.+||.+||..||++||+++++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0111110 1567999999999999999999776643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=348.04 Aligned_cols=260 Identities=20% Similarity=0.278 Sum_probs=209.6
Q ss_pred CCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
.++|++++.||+|+||.||+|.+. .++..||||++.... ....+..|+.++..|..|++|+.+..++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 468999999999999999999973 456789999986532 335688999999999656777777777777888
Q ss_pred EEEEEecC-CCCHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCce
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSR----------------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 134 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~----------------------~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NI 134 (477)
.+|||||+ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 99999999 8899999975432 378999999999999999999999999999999999
Q ss_pred EeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCC
Q 011819 135 LMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPW 213 (477)
Q Consensus 135 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf 213 (477)
|+ +.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||+||+|++ |..||
T Consensus 204 ll---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 204 LV---THGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp EE---ETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred EE---cCCCcEEeCCCccCcccccCccc-----eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99 57889999999999876543321 12234567889999999999999999999999999999998 99999
Q ss_pred CCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 214 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.+...... +..+....... ..+..+++++.++|..||..+|.+||++.++.+.|+.++..
T Consensus 276 ~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDAN---FYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSHH---HHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHHH---HHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 87554322 22222222111 12345799999999999999999999999999999988643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=339.25 Aligned_cols=254 Identities=21% Similarity=0.256 Sum_probs=197.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.++|+++++||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.++| ++++.+..++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH-PNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CCccchhheeecCCeEEEE
Confidence 47899999999999999999999999999999987655433 346689999999987 5566666666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 81 FEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence 9999 6677777763 5669999999999999999999999999999999999999 678999999999998765432
Q ss_pred CCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc-------
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------- 232 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~------- 232 (477)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.+.....
T Consensus 157 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 157 D-------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c-------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 2 1234578999999999986 668999999999999999999999998754433222222211110
Q ss_pred ----------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 ----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ----------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.........+.+++++.++|..||..||++||+++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 011122333578899999999999999999999777643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=342.59 Aligned_cols=259 Identities=16% Similarity=0.295 Sum_probs=210.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
..++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+..|+.+++.++| ++|..+..++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH-PHVIKLYGACSQDG 99 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CceeeEEEEEecCC
Confidence 3578999999999999999999983 45589999998754432 346789999999976 55666666666777
Q ss_pred EEEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCC
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 132 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~-----------------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~ 132 (477)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 889999999 899999997532 23899999999999999999999999999999999
Q ss_pred ceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCC
Q 011819 133 NFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL 211 (477)
Q Consensus 133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~ 211 (477)
|||+ +.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 180 NIli---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 180 NILV---AEGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp GEEE---ETTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred eEEE---cCCCCEEEccccccccccccccc-----eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 9999 57789999999999876543321 12234567889999999999889999999999999999999 999
Q ss_pred CCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
||.+...... +..+...... .....+++++.+++..||..||++||++.++.+.|++++.+
T Consensus 252 p~~~~~~~~~---~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 252 PYPGIPPERL---FNLLKTGHRM----ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp SSTTCCGGGH---HHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHH---HHHhhcCCcC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9987554332 2222222211 13356899999999999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=341.57 Aligned_cols=259 Identities=23% Similarity=0.383 Sum_probs=198.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
+..++|++.++||+|+||.||+|.+. ..||||++...... ..+..|+.+++.++|++.+..+ .+. .....+
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~-~~~-~~~~~~ 95 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM-GYS-TAPQLA 95 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEE-EEE-CSSSCE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEE-eec-cCCccE
Confidence 45789999999999999999999853 35999998765433 3477899999999886555444 443 345579
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC-------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceecccccc
Confidence 999999 899999997666779999999999999999999999999999999999999 5778999999999976543
Q ss_pred CCCCcccccccCCCCccCccccccchhc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~---g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
.... .......||+.|+|||++. +..++.++|||||||++|+|++|..||..... .......+.......
T Consensus 173 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 173 WSGS-----HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSP 245 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCCC
T ss_pred cccc-----ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccCc
Confidence 2211 1223467999999999987 66788899999999999999999999976543 233444444444444
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
....+...+|+++.++|..||..+|++||++.++.+.|+++.
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 445556688999999999999999999999999999988763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=341.52 Aligned_cols=246 Identities=18% Similarity=0.294 Sum_probs=203.5
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
.|+..++||+|+||.||+|++..+|+.||||++.... ....+..|+.+++.++| +++..+..++...+..++||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-FNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEecC
Confidence 4889999999999999999999999999999986543 23457899999999987 55556656666778899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 125 ~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~--- 196 (321)
T 2c30_A 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP--- 196 (321)
T ss_dssp CSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC---
T ss_pred CCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc---
Confidence 899999987 4569999999999999999999999999999999999999 6788999999999987654322
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..+........ .....+
T Consensus 197 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~--~~~~~~ 267 (321)
T 2c30_A 197 ----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKRLRDSPPPKL--KNSHKV 267 (321)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCCCC--TTGGGS
T ss_pred ----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCc--CccccC
Confidence 1235689999999999999999999999999999999999999997643 3344444443322211 123457
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
++++.++|..||..||++||++.++.+
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 899999999999999999999777643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=349.14 Aligned_cols=257 Identities=18% Similarity=0.226 Sum_probs=202.7
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcE----EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~----vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
...++|++++.||+|+||.||+|.+..+++. ||+|++.... ....+..|+.++..++|++ |+.+..++. +.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH-IVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTT-BCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCC-cCeEEEEEc-CC
Confidence 3457899999999999999999999888875 7777764432 2245678999999998755 444444443 45
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 578999999 899999997555579999999999999999999999999999999999999 6789999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
........ ......||..|+|||++.+..++.++|||||||++|+|++ |..||.+....... ..+......
T Consensus 165 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~~~ 236 (325)
T 3kex_A 165 LPPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP---DLLEKGERL 236 (325)
T ss_dssp SCCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH---HHHHTTCBC
T ss_pred cCcccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH---HHHHcCCCC
Confidence 65433211 1234568889999999999999999999999999999999 99999875543322 222222111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
.....++.++.+++..||..+|.+||++.++.+.|+.+.
T Consensus 237 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 ----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 122346888999999999999999999999999988874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=338.73 Aligned_cols=254 Identities=25% Similarity=0.350 Sum_probs=201.0
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..+.++|++.++||+|+||.||+|.+..+++.||+|++.... ....+..|+++++.++| ++|..+..++......+
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH-PNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCC-chHHhHHHheecCCeEE
Confidence 356789999999999999999999999999999999876543 23568899999999987 55666666667788899
Q ss_pred EEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 80 LVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
+||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+..++..+.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999 88999988532 46799999999999999999999999999999999999996555568899999999976
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+... ......+.......
T Consensus 177 ~~~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~ 244 (285)
T 3is5_A 177 FKSDEH--------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPNY 244 (285)
T ss_dssp ------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCC
T ss_pred cCCccc--------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCCccc
Confidence 544322 23457999999999986 4689999999999999999999999977443 22333332222211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. ..+..+++++.++|..||..||++||++.++.+
T Consensus 245 ~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 A--VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C--C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c--cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 123457899999999999999999999877643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=347.12 Aligned_cols=257 Identities=19% Similarity=0.277 Sum_probs=200.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcE----EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~----vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
...++|++.++||+|+||.||+|++..+++. ||+|.+.... ....+..|+.++..++| ++|+.+..++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCB-TTBCCEEEEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCC
Confidence 3467899999999999999999999888765 4777664322 33468899999999987 45555555555444
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
.+++|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeE
Confidence 56778887 999999998767789999999999999999999999999999999999999 5778999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......... ......
T Consensus 167 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~~~~~ 238 (327)
T 3poz_A 167 LGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGERL 238 (327)
T ss_dssp HTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTCCC
T ss_pred ccCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH---HcCCCC
Confidence 65433211 1223457889999999999999999999999999999999 99999876554332222 221111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
.....++.++.+++..||..+|++||++.++.+.|+.+.
T Consensus 239 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 239 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 123457899999999999999999999999999888875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=347.98 Aligned_cols=257 Identities=20% Similarity=0.223 Sum_probs=204.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeC----cE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG----DY 77 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~----~~ 77 (477)
++++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|++++..++|++++..+..+.... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 467999999999999999999999999999999998754332 35778999999998866555555543322 46
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
.|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecC
Confidence 799999998899999974 569999999999999999999999999999999999999 678899999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh-----
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----- 231 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~----- 231 (477)
...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 180 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 180 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp GGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred CCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 432211 11245689999999998765 45899999999999999999999999876554433333222111
Q ss_pred ------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 232 ------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 232 ------------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
........+...+++++.+||..||..||++||++.++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 312 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 111223445567889999999999999999999977664
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.06 Aligned_cols=263 Identities=19% Similarity=0.214 Sum_probs=201.2
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeEe---CcEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKLYRILQGGTGIPNVRWFGVE---GDYNVLV 81 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-~~~~~E~~il~~L~~~~~i~~~~~~~~~---~~~~~lV 81 (477)
.++|+++++||+|+||.||+|++. ++.||||++...... .....|+.++..++|++++..+..+... ....++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999864 799999998654322 2345677788888876555555554443 3347999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK----------SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~----------giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
|||+ +++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCC
T ss_pred EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccC
Confidence 9999 8899999974 4599999999999999999999999 99999999999999 67889999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCC-----CCCCcchHHHHHHHHHHHHcCCCCCCCCCcc------
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------ 219 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-----~~s~ksDIwSlGviLyelltG~~Pf~~~~~~------ 219 (477)
|+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....
T Consensus 176 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 176 GLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp TTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred CcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 999877553321 122346799999999999873 4566889999999999999999999764321
Q ss_pred -------cHHHHHHHHhhhcccccHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 220 -------TKKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 220 -------~~~~~~~~i~~~~~~~~~~~l~--~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
........+............+ ...++++.++|..||..||++||++.++.+.|+++....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1112222222222211111111 123567999999999999999999999999999986544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.87 Aligned_cols=260 Identities=18% Similarity=0.326 Sum_probs=214.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.++| +++..+..++......++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCEEEEEE
Confidence 45789999999999999999999999999999999876443 3468899999999987 556566666667778899999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceeccCCcc
Confidence 99 799999997643 459999999999999999999999999999999999999 6778999999999986544322
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.........+. +...... ..
T Consensus 167 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~~~~~~~----~~ 233 (288)
T 3kfa_A 167 ------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRM----ER 233 (288)
T ss_dssp ------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHTTCCC----CC
T ss_pred ------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HhccCCC----CC
Confidence 12234567889999999999999999999999999999999 9999987554333222 2222111 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
...+|+++.+++..||..+|.+||++.++.+.|+.++....
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 35689999999999999999999999999999999986653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=344.80 Aligned_cols=259 Identities=17% Similarity=0.222 Sum_probs=201.9
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCC-cEEEEEEecCCCC-chhHHHHHHHHHHHcCCCC-----CCeeEEeeEe
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKTK-HPQLLYESKLYRILQGGTG-----IPNVRWFGVE 74 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g-~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~-----i~~~~~~~~~ 74 (477)
...+.++|++++.||+|+||.||+|.+..++ +.||||++..... ...+..|+.+++.+.|.+. +..+..++..
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 3457789999999999999999999998777 7999999864322 3457789999999986543 4555666677
Q ss_pred CcEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC--------------
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-------------- 139 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~-------------- 139 (477)
.+..+|||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+...
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 88999999999888888876543 469999999999999999999999999999999999999432
Q ss_pred --CCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC
Q 011819 140 --RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (477)
Q Consensus 140 --~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~ 217 (477)
+..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||+||+|++|..||....
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCCcEEEeecCccccccccc----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 256889999999998654322 34579999999999999999999999999999999999999998754
Q ss_pred cccHHHHHHHHhhhcccccH--------------------------HHHh----------cCCcHHHHHHHHHHhcCCCC
Q 011819 218 AGTKKQKYEKISEKKVSTSI--------------------------EALC----------RGYPTEFASYFHYCRSLRFD 261 (477)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~--------------------------~~l~----------~~~p~~l~~li~~cl~~~p~ 261 (477)
.......+.++......... ...+ ...+.++.+||..||..||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 43322333222211100000 0000 11245899999999999999
Q ss_pred CCCCHHHHH
Q 011819 262 DKPDYAYLK 270 (477)
Q Consensus 262 ~RPt~~~l~ 270 (477)
+||++++++
T Consensus 324 ~Rpt~~e~l 332 (355)
T 2eu9_A 324 QRITLAEAL 332 (355)
T ss_dssp TSCCHHHHT
T ss_pred hCcCHHHHh
Confidence 999987764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=341.53 Aligned_cols=263 Identities=19% Similarity=0.291 Sum_probs=211.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEE-----CCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeE-eC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGV-EG 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~-----~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~-~~ 75 (477)
..++|++++.||+|+||.||+|.+ ..+++.||||++...... ..+..|+.++..+.+|++|..+..++. .+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 457899999999999999999985 356789999998765432 347789999999977677777665544 45
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSRK---------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~~---------------ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~ 139 (477)
...++||||+ +++|.+++...... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~--- 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--- 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---
Confidence 5689999999 78999999753322 8899999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCc
Q 011819 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (477)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~ 218 (477)
+.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCCCCEEECCCccccccccCccc-----eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 67789999999999866443221 12234568899999999999999999999999999999998 9999977543
Q ss_pred ccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
.. .....+...... .....+++++.+++..||..+|.+||++.++.+.|+.++....
T Consensus 257 ~~--~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DE--EFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SH--HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hH--HHHHHhccCccC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 32 222222222111 1234578999999999999999999999999999999986554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=346.31 Aligned_cols=260 Identities=20% Similarity=0.224 Sum_probs=200.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEe-------
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE------- 74 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~------- 74 (477)
.++|+++++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++|++++..+..+...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4789999999999999999999999999999998755432 23577899999999975555554444332
Q ss_pred CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.+..||||||++++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcc
Confidence 45689999999889999887666779999999999999999999999999999999999999 678899999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
......... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+........
T Consensus 173 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSS---CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccccc---ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 765432211 112345678999999999987 4579999999999999999999999987544332222222221111
Q ss_pred cccHHHHh------------------------cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 STSIEALC------------------------RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 ~~~~~~l~------------------------~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
........ ...++++.+||.+||..||.+||+++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11000000 012678999999999999999999776643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.85 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=205.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.++| +++..+..++....
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH-PNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC-CCeeehhheecCCC
Confidence 4578999999999999999999999999999999876532 23468899999999986 56666666667788
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC-CCCcEEEeecCcee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAK 154 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~-~~~~vkL~DFGla~ 154 (477)
..++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+. ....+||+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 899999999 8999999975 45699999999999999999999999999999999999994211 12389999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..+.+..+......
T Consensus 161 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~ 229 (283)
T 3bhy_A 161 KIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNISAVNYD 229 (283)
T ss_dssp ECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCC
T ss_pred eccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhHhcccC
Confidence 7654322 234578999999999999999999999999999999999999997643 33444444443332
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
........+++++.+++..||..+|++||++.++.+
T Consensus 230 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 -FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 223455778999999999999999999999877654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=340.98 Aligned_cols=259 Identities=17% Similarity=0.208 Sum_probs=202.6
Q ss_pred CccCCceEEEeeeeecCceEEEEEEE-CCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCC-----CCCeeEEeeEeC
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTN-IQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGT-----GIPNVRWFGVEG 75 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~-~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~-----~i~~~~~~~~~~ 75 (477)
..+.++|++++.||+|+||.||+|.+ ..+++.||||++..... ...+..|+.++..+.|.+ ++..+..++...
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 45678999999999999999999998 56789999999864322 245778999999998654 356666667788
Q ss_pred cEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC-------------
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR------------- 141 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~------------- 141 (477)
+..+|||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++..+.
T Consensus 90 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 90 GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 8999999999999999997543 36899999999999999999999999999999999999942111
Q ss_pred ---CCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc
Q 011819 142 ---ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (477)
Q Consensus 142 ---~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~ 218 (477)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHH----------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCC----------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccCCCceEeeCcccccCcccc----------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 5679999999998654322 345799999999999999999999999999999999999999987544
Q ss_pred ccHHHHHHHHhhhcccccHH--------------------------H----------HhcCCcHHHHHHHHHHhcCCCCC
Q 011819 219 GTKKQKYEKISEKKVSTSIE--------------------------A----------LCRGYPTEFASYFHYCRSLRFDD 262 (477)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~--------------------------~----------l~~~~p~~l~~li~~cl~~~p~~ 262 (477)
......+.++.......... . ....+++++.+||..||..||.+
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 33333332222111000000 0 00123578999999999999999
Q ss_pred CCCHHHHHH
Q 011819 263 KPDYAYLKR 271 (477)
Q Consensus 263 RPt~~~l~~ 271 (477)
||+++++.+
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999877643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.84 Aligned_cols=260 Identities=21% Similarity=0.319 Sum_probs=211.1
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---------------CchhHHHHHHHHHHHcCCCCCCe
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------------KHPQLLYESKLYRILQGGTGIPN 67 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---------------~~~~~~~E~~il~~L~~~~~i~~ 67 (477)
..+.++|+++++||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.|.| ++|+.
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~ 110 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH-PNIIK 110 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC-TTBCC
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC-CCCCe
Confidence 457789999999999999999999999999999999876532 23457899999999986 56666
Q ss_pred eEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEE
Q 011819 68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (477)
Q Consensus 68 ~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vk 146 (477)
+..++......||||||| |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+.....+|
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 666777888999999999 8899999875 45699999999999999999999999999999999999995433334799
Q ss_pred EeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 011819 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (477)
Q Consensus 147 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~ 226 (477)
|+|||++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+.
T Consensus 190 l~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~ 257 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIK 257 (504)
T ss_dssp ECCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred EEECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHH
Confidence 999999987654322 235679999999999875 68999999999999999999999997643 345555
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.+.......... .+..+++++.+||..||..+|.+||+++++ |++.|.+.
T Consensus 258 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~---l~h~~~~~ 307 (504)
T 3q5i_A 258 KVEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEA---LNSRWIKK 307 (504)
T ss_dssp HHHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHHH
T ss_pred HHHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHH---hcCHhhhh
Confidence 565555433333 456789999999999999999999997665 45555443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=350.38 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=196.0
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeC----
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG---- 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~---- 75 (477)
.+.++|++++.||+|+||.||+|.+..+|+.||||++...... ..+.+|+++++.++|++++..+..+....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 3568899999999999999999999999999999988554322 34678999999999765555555544322
Q ss_pred -cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 76 -DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 76 -~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
...|+||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 102 FTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 176 (367)
T ss_dssp CCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeeccc
Confidence 34599999999999999984 569999999999999999999999999999999999999 678899999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+..+.....
T Consensus 177 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g 243 (367)
T 1cm8_A 177 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTG 243 (367)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHC
T ss_pred ccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcC
Confidence 75432 234578999999999987 6799999999999999999999999987443 233333322111
Q ss_pred --------------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 --------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 --------------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
......+...+++++.+|+.+||..||++||+++++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 11122334567899999999999999999999776643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=362.17 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=210.6
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecC----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~----~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.+.++|+++++||+|+||.||+|.+..+++.||||++.. ......+..|+.+++.|+| ++|+.+..++......|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC-CCcCeEEEEEEcCCEEE
Confidence 356789999999999999999999999999999998753 2334568899999999987 56666666677788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++....
T Consensus 98 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999 8999998865 35699999999999999999999999999999999999996545567899999999976544
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.........+
T Consensus 177 ~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 177 NTK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLP 244 (486)
T ss_dssp C------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSCSG
T ss_pred CCc--------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCc
Confidence 321 234579999999999987 59999999999999999999999997643 345555555554433222
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.+..+++++.+||..||..+|.+||++.++ |++.|.+
T Consensus 245 -~~~~~s~~~~~li~~~L~~dp~~R~t~~~~---l~hp~~~ 281 (486)
T 3mwu_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQC---LEHPWIQ 281 (486)
T ss_dssp -GGGGSCHHHHHHHHHHTCSSTTTSCCHHHH---HHCHHHH
T ss_pred -ccCCCCHHHHHHHHHHcCCChhhCcCHHHH---hcCHhhc
Confidence 345689999999999999999999997665 4455443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=351.90 Aligned_cols=256 Identities=20% Similarity=0.251 Sum_probs=197.1
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcC-------CCCCCeeEEeeE-
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQG-------GTGIPNVRWFGV- 73 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~-------~~~i~~~~~~~~- 73 (477)
..+.++|+++++||+|+||.||+|++..+++.||||++..... ...+..|+.+++.+.+ ++++..+..++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 3456899999999999999999999999999999999865322 2457789999999974 334444444333
Q ss_pred ---eCcEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecCCCCC-----
Q 011819 74 ---EGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRAN----- 143 (477)
Q Consensus 74 ---~~~~~~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~~~~~----- 143 (477)
.....||||||++++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~---~~~~~~~~ 189 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS---VNEQYIRR 189 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC---CCHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe---ccchhhhh
Confidence 456789999999888888876433 5699999999999999999999998 999999999999994 333
Q ss_pred --------------------------------------------cEEEeecCceeecccCCCCcccccccCCCCccCccc
Q 011819 144 --------------------------------------------QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179 (477)
Q Consensus 144 --------------------------------------------~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y 179 (477)
.+||+|||++....... ...+||+.|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----------~~~~gt~~y 259 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----------TEDIQTRQY 259 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------CSCCSCGGG
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------ccCCCCCcc
Confidence 79999999998765432 345799999
Q ss_pred cccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc---HHHHHHHHhhhcccccHH------------------
Q 011819 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKKVSTSIE------------------ 238 (477)
Q Consensus 180 ~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~---~~~~~~~i~~~~~~~~~~------------------ 238 (477)
+|||++.+..++.++|||||||+||+|++|..||....... ....+..+....-..+..
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 99999999999999999999999999999999997654322 112222221111000000
Q ss_pred -------------H------HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 239 -------------A------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 239 -------------~------l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. +....++++.+||.+||..||++||+++++++
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 01123567899999999999999999877653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=346.47 Aligned_cols=244 Identities=22% Similarity=0.315 Sum_probs=202.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.+.|++++.||+|+||.||+|++..+++.||||++...... ..+..|+.++..++| ++|..+..++...+..+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCeEEE
Confidence 35699999999999999999999999999999998654322 347789999999987 556666666677889999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||||+.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS--
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCC--
Confidence 99999889999987667789999999999999999999999999999999999999 5788999999999976532
Q ss_pred CCcccccccCCCCccCccccccchhc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~---g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.....||+.|+|||++. +..++.++|||||||+||+|++|..||.+... ...+..+........
T Consensus 207 ---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~- 273 (348)
T 1u5q_A 207 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPAL- 273 (348)
T ss_dssp ---------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCC-
T ss_pred ---------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCC-
Confidence 13457999999999985 46789999999999999999999999976433 233333333322211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
....+++++.++|..||..+|++||+++++.
T Consensus 274 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 304 (348)
T 1u5q_A 274 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 304 (348)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred --CCCCCCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 1246789999999999999999999977664
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.24 Aligned_cols=261 Identities=16% Similarity=0.312 Sum_probs=212.3
Q ss_pred cCCceEEEeeeeecCceEEEEEEEC-------CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~-------~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
..++|++++.||+|+||.||+|.+. .+++.||||++...... ..+..|+.+++.+..+++|..+..++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999986 45678999998765432 3477899999999666777777777777
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~ 138 (477)
.+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-- 190 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-- 190 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE--
Confidence 88899999999 889999997432 238999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCC
Q 011819 139 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (477)
Q Consensus 139 ~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~ 217 (477)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 191 -~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 191 -TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp -CTTCCEEECCCTTCEECTTTSSE-----ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -cCCCCEEEccccccccccccccc-----cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 67899999999999876543221 12234567889999999998889999999999999999999 999997643
Q ss_pred cccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
. .+.+..+...... ..+..++.++.++|..||..+|.+||++.++.+.|+.++...
T Consensus 265 ~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 265 V---EELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp H---HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H---HHHHHHHhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 3 3333333332211 133568999999999999999999999999999999997654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=342.43 Aligned_cols=255 Identities=22% Similarity=0.251 Sum_probs=194.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEe-------
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE------- 74 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~------- 74 (477)
..++|++++.||+|+||.||+|++..+++.||||++..... ...+..|+++++.|+|++++..+..+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 34689999999999999999999999999999999865332 24578999999999876555555544322
Q ss_pred -------------------------------------------------CcEEEEEEecC-CCCHHHHHHHcCC--CCCH
Q 011819 75 -------------------------------------------------GDYNVLVMDLL-GPSLEDLFNFCSR--KLSL 102 (477)
Q Consensus 75 -------------------------------------------------~~~~~lVmE~~-g~sL~~li~~~~~--~ls~ 102 (477)
..+.++||||+ +++|.+++..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 22479999999 8899999974322 2566
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc-----ccccCCCCccCc
Q 011819 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI-----PYRENKNLTGTA 177 (477)
Q Consensus 103 ~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-----p~~~~~~~~Gt~ 177 (477)
..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........... .+.......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 6789999999999999999999999999999999 67889999999999987654321110 112234567999
Q ss_pred cccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhc
Q 011819 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRS 257 (477)
Q Consensus 178 ~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~ 257 (477)
.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+.....+ .....+++++.++|..||.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP----LLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC----HHHHHHCHHHHHHHHHHHC
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC----cccccCChhHHHHHHHHcc
Confidence 99999999999999999999999999999998777622 12222223332222 2223456788999999999
Q ss_pred CCCCCCCCHHHHHH
Q 011819 258 LRFDDKPDYAYLKR 271 (477)
Q Consensus 258 ~~p~~RPt~~~l~~ 271 (477)
.||++||+++++.+
T Consensus 312 ~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 312 PSPTERPEATDIIE 325 (332)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CCCCcCCCHHHHhh
Confidence 99999999877754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=343.03 Aligned_cols=249 Identities=20% Similarity=0.246 Sum_probs=208.1
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----------chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+..|+.++..+.++++|..+..++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 579999999999999999999998999999999865432 2346789999999966677888877778888
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..||||||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcccc
Confidence 999999999 8899999975 4569999999999999999999999999999999999999 6789999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g------~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ....+..+.
T Consensus 250 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i~ 318 (365)
T 2y7j_A 250 LEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRMIM 318 (365)
T ss_dssp CCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHH
T ss_pred cCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHH
Confidence 654322 235689999999999864 357889999999999999999999997633 344445555
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
......... .+..+++++.++|..||..||++||++.++.+
T Consensus 319 ~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 444433332 34678999999999999999999999877754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=342.68 Aligned_cols=261 Identities=20% Similarity=0.295 Sum_probs=211.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCc-----EEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~-----~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
..++|++++.||+|+||.||+|.+..+++ .||+|++..... ...+..|+.++..+.+|++|+.+..++...+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 35689999999999999999999977664 799999876542 2357899999999955577777777777778
Q ss_pred EEEEEEecC-CCCHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC
Q 011819 77 YNVLVMDLL-GPSLEDLFNFC-------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~-------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~ 142 (477)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---TNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---EGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---CCC
Confidence 899999999 78999998643 3458999999999999999999999999999999999999 567
Q ss_pred CcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccH
Q 011819 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (477)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~ 221 (477)
+.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred CeEEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 89999999999876543321 12234567889999999999999999999999999999998 9999987544322
Q ss_pred HHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
. ..+....... ..+..+|+++.+++..||..+|.+||++.++.+.|+++...
T Consensus 276 ~---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 F---YKLVKDGYQM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp H---HHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---HHHHhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 2 2222221111 12345789999999999999999999999999999988654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=333.99 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=194.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
-.++|++.+.||+|+||.||+|.+ +++.||||++.... ....+..|+++++.++| +++..+..++...+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-PNIIALRGVCLKEPNL 81 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCC-TTBCCEEEEECCC--C
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCC-CCEeeEEEEEecCCce
Confidence 357899999999999999999996 48899999876432 12457889999999987 5666666666677788
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeeCCCCCCceEeecCC-----CCCcEEEee
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGR-----RANQVYIID 149 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g---iiHRDLKP~NILl~~~~-----~~~~vkL~D 149 (477)
++||||+ +++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++... ..+.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999 899999986 567999999999999999999999999 89999999999995211 267899999
Q ss_pred cCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 150 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ......+.
T Consensus 160 fg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~ 227 (271)
T 3dtc_A 160 FGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGVA 227 (271)
T ss_dssp CCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHH
T ss_pred CCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhhh
Confidence 999986544322 245789999999999999999999999999999999999999976443 22222232
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
...... .....+|+++.+++..||..+|++||++.++.+.|++
T Consensus 228 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 MNKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp TSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred cCCCCC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 222211 1345689999999999999999999999999888764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=340.25 Aligned_cols=261 Identities=21% Similarity=0.256 Sum_probs=204.9
Q ss_pred CCceEEEeeeeecCceEEEEEE----ECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEe-CcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVE-GDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~----~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~-~~~ 77 (477)
.++|+++++||+|+||.||+|+ +..+++.||||++.... ....+..|+.++..++|++.+..+..+... ...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4579999999999999999999 56789999999976543 235678999999999875544444444332 356
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.++||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECcccccccc
Confidence 79999999 889999997667789999999999999999999999999999999999999 56789999999999877
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCC-----------cccHHH-H
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----------AGTKKQ-K 224 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~-----------~~~~~~-~ 224 (477)
...... ........||..|+|||++.+..++.++|||||||++|+|++|..||.... ...... .
T Consensus 177 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 177 ETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 554321 122345578899999999999999999999999999999999999874311 011111 1
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
...+.... ....+..+++++.++|..||..||.+||++.++.+.|+.++
T Consensus 253 ~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGK----RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTC----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccC----CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111111 11133568899999999999999999999999999998875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=343.68 Aligned_cols=259 Identities=17% Similarity=0.305 Sum_probs=190.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCc---EEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~---~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
..++|++++.||+|+||.||+|++..++. .||||++.... ....+..|+++++.++|++ |..+..++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH-VAKLVGVSLRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTT-BCCCCEEEECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCc-eehhhceeecccc
Confidence 45789999999999999999999877765 89999886542 1245788999999997754 4444444433333
Q ss_pred E------EEEEecC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcE
Q 011819 78 N------VLVMDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (477)
Q Consensus 78 ~------~lVmE~~-g~sL~~li~~~~-----~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~v 145 (477)
. ++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCCE
Confidence 3 8999999 889999986432 258999999999999999999999999999999999999 678999
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~ 224 (477)
||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+..... .
T Consensus 177 kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~ 248 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I 248 (323)
T ss_dssp EECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H
T ss_pred EEeeccccccccccccc-----cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H
Confidence 99999999866443221 12234457889999999999999999999999999999999 999998755433 2
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+..+...... .....+++++.+++..||..||++||++.++.+.|++++..
T Consensus 249 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 249 YNYLIGGNRL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcCCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 3333332221 12356889999999999999999999999999999998743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=336.87 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=201.0
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.++| +++..+..++...+..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCcE
Confidence 345789999999999999999999999999999998865321 2347789999999976 5566666666678889
Q ss_pred EEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 79 VLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
++||||+ +++|.+++.. ....++...++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEecccee
Confidence 9999999 7899999864 24569999999999999999999999999999999999999 678899999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+... ........+......
T Consensus 185 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 185 FFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYP 256 (310)
T ss_dssp ---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCSC
T ss_pred eecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccCC
Confidence 6544322 12345789999999999999999999999999999999999999976432 223333333333222
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.. ....+++++.++|..||..||++||++.++.+.|+++....
T Consensus 257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11 12467999999999999999999999999999999886444
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.97 Aligned_cols=247 Identities=22% Similarity=0.301 Sum_probs=202.8
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
+...++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+.+++.++| ++|+.+..++.....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATR 83 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC-CCCcchhheEecCCE
Confidence 34568999999999999999999999999999999987542 234457889999999986 566666666777888
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccC
Confidence 99999999 78999999753 569999999999999999999999999999999999999 67899999999998654
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ....+..+......
T Consensus 160 ~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~-- 225 (279)
T 3fdn_A 160 PSSR---------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFT-- 225 (279)
T ss_dssp -----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC--
T ss_pred Cccc---------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHHhCCCC--
Confidence 3321 234578999999999999999999999999999999999999997643 33444444433322
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
++..+++++.++|..||..+|.+||++.++.+
T Consensus 226 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 226 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ---CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 23457899999999999999999999766644
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=344.48 Aligned_cols=257 Identities=19% Similarity=0.270 Sum_probs=198.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEE----EEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEV----AIKLENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~v----AiKi~~~~---~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
...++|+++++||+|+||.||+|.+..+++.| |+|.+... .....+..|+.++..++|++++ .+..++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC-RLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBC-CCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCee-EEEEEEecCC
Confidence 34689999999999999999999998888765 66655432 2345688999999999875544 4444444444
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
.+++|+|+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence 67778887 999999998767789999999999999999999999999999999999999 5678999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......+.+ ......
T Consensus 167 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~~~~~~ 238 (327)
T 3lzb_A 167 LGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGERL 238 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTCCC
T ss_pred ccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCCC
Confidence 65433211 1223457889999999999999999999999999999999 99999876554332222 222111
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+..++.++.++|..||..+|.+||++.++.+.|+.+.
T Consensus 239 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 ----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 123457899999999999999999999999999998885
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=336.38 Aligned_cols=253 Identities=19% Similarity=0.292 Sum_probs=201.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
..++|++.+.||+|+||.||+|.+ +++.||||++........+..|+.++..++|++.+..+..+....+..++||||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 347899999999999999999986 488999999887666677899999999998866666666555555678999999
Q ss_pred C-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~~~-~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccccccc--
Confidence 9 7799999975332 38999999999999999999999999999999999999 678899999999997554322
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
....+++.|+|||++.+..++.++||||||+++|+|++ |..||....... ....+..... ...+
T Consensus 172 --------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~~~----~~~~ 236 (278)
T 1byg_A 172 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYK----MDAP 236 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTTCC----CCCC
T ss_pred --------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCC----CCCc
Confidence 23367889999999999999999999999999999998 999998754432 2233322211 1234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
..+|+++.++|..||..+|++||++.++.+.|+++...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 56899999999999999999999999999999988644
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.16 Aligned_cols=258 Identities=19% Similarity=0.307 Sum_probs=205.3
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
...++|++.+.||+|+||.||+|.+..+++.||||++........+..|+.++..+.| +++..+..++...+..++|||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS-PHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEEEee
Confidence 4567899999999999999999999999999999998877667789999999999977 556666666667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc-
Confidence 99 779999997667789999999999999999999999999999999999999 6788999999999987654322
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+........ ....
T Consensus 181 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~--~~~~ 249 (314)
T 3com_A 181 ------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPPPTF--RKPE 249 (314)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCC--SSGG
T ss_pred ------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCccc--CCcc
Confidence 12345789999999999999999999999999999999999999976433 222222222211111 1234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.++.++.++|..||..+|.+||++.++ |++.|.+.
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~l---l~~~~~~~ 284 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQL---LQHPFVRS 284 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHH---TTSHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHH---HhCHHHhc
Confidence 578999999999999999999997666 44454443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=353.52 Aligned_cols=258 Identities=16% Similarity=0.269 Sum_probs=198.4
Q ss_pred CCceEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.++|++.+.||+|+||.||+|++. .++..||||++...... ..+..|+.++..++| ++|+.+..++...+..+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-PNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCceE
Confidence 458999999999999999999976 46778999998754322 357889999999976 56666666666777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccccc
Confidence 999999 899999998656679999999999999999999999999999999999999 6789999999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
..... .......++..|+|||++.+..++.++|||||||+||||++ |..||..... .+....+.......
T Consensus 200 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~~-- 270 (373)
T 2qol_A 200 DPEAA----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRLP-- 270 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEECC--
T ss_pred CCccc----eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 32211 01122345788999999999999999999999999999998 9999976543 33333333322111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
....+|.++.+++..||..+|.+||++.++.+.|+.++.
T Consensus 271 --~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 271 --PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp --CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 234689999999999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=338.99 Aligned_cols=258 Identities=22% Similarity=0.308 Sum_probs=199.9
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..++| ++|..+..++...+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-PHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCC-CCeeEEEEEEeeCCeE
Confidence 455789999999999999999999999999999999765422 2457789999999977 5666666667778899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccc
Confidence 9999999 7899999975 3569999999999999999999999999999999999999 678899999999997665
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... .......|++.|+|||++.+..++.++|||||||++|+|++|..||..... . .+........ ...
T Consensus 186 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~-~~~~~~~~~~-~~~ 254 (309)
T 2h34_A 186 DEKL------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S-VMGAHINQAI-PRP 254 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H-HHHHHHHSCC-CCG
T ss_pred cccc------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H-HHHHHhccCC-CCc
Confidence 4321 112345799999999999999999999999999999999999999976432 2 2222222222 222
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRIFRDLF 277 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RP-t~~~l~~~l~~~~ 277 (477)
..+...+|+++.++|.+||..+|++|| +++++.+.|+.++
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 345577899999999999999999999 8999988888764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=350.30 Aligned_cols=251 Identities=20% Similarity=0.226 Sum_probs=201.1
Q ss_pred CceEE--EeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRL--GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i--~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
..|.+ .+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..|+| ++|+.+..++...+..+|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~ 165 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-ANLIQLYDAFESKNDIVLVM 165 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEE
Confidence 44555 678999999999999999999999999987643 23457899999999977 56666666677788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+++.......
T Consensus 166 E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 166 EYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp ECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTCB
T ss_pred eCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCccc
Confidence 999 88999988765567999999999999999999999999999999999999943 3467899999999987654322
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
....+||+.|+|||++.+..++.++|||||||+||+|++|..||.+.. ....+..+........ ....
T Consensus 245 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~-~~~~ 312 (373)
T 2x4f_A 245 --------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILACRWDLE-DEEF 312 (373)
T ss_dssp --------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCSC-SGGG
T ss_pred --------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCC-hhhh
Confidence 234579999999999999899999999999999999999999997643 3444555554433222 2234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+++++.+||.+||..+|.+||++.++.+
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 678999999999999999999999776643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=337.45 Aligned_cols=258 Identities=20% Similarity=0.262 Sum_probs=209.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.++| +++..+..++...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-ENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCC-CCeeehhhhcccCCEEEEEE
Confidence 5578999999999999999999999999999999987543 23457899999999987 55666666667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++.......
T Consensus 86 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 86 QLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp CCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred EcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 999 8899999875 4569999999999999999999999999999999999999554567899999999987543211
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+....... .....
T Consensus 164 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~-~~~~~ 231 (304)
T 2jam_A 164 --------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYYEF-ESPFW 231 (304)
T ss_dssp --------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCCCC-CTTTT
T ss_pred --------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCC-Ccccc
Confidence 123468999999999999999999999999999999999999997643 334444554443221 12244
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
..+++++.++|..||..||++||+++++ |++.|...
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~~ 267 (304)
T 2jam_A 232 DDISESAKDFICHLLEKDPNERYTCEKA---LSHPWIDG 267 (304)
T ss_dssp TTSCHHHHHHHHHHHCSSTTTSCCHHHH---HTSHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHH---hcCccccC
Confidence 6789999999999999999999997665 45555444
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=333.59 Aligned_cols=258 Identities=17% Similarity=0.214 Sum_probs=204.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCC---CcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~---g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
...++|++.+.||+|+||.||+|.+... +..||||++..... ...+..|+.+++.++|++.+..+.. .. .+.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~-~~~ 86 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI-IE-EEP 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEE-EC-SSS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEE-Ec-CCC
Confidence 3457899999999999999999986543 45699999876432 2457889999999987555554444 33 344
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.++||||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCccc
Confidence 68999999 899999998766779999999999999999999999999999999999999 56789999999999866
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+ ......
T Consensus 164 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---~~~~~~- 233 (281)
T 3cc6_A 164 EDEDY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---EKGDRL- 233 (281)
T ss_dssp ---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---HHTCCC-
T ss_pred ccccc------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---hcCCCC-
Confidence 54322 11234467889999999999999999999999999999998 99999875544333222 222111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.....+++++.+++..||..+|++||++.++.+.|++++..
T Consensus 234 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 234 ---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 12345789999999999999999999999999999988653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.25 Aligned_cols=249 Identities=21% Similarity=0.214 Sum_probs=195.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEe-----CcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE-----GDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~-----~~~~~lV 81 (477)
.+|++++.||+|+||.||+|++..+++.||||++.... ....+|+++++.|+|++++..+.++... ..+.+||
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 47999999999999999999999999999999876432 2345799999999886666555554332 2346799
Q ss_pred EecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 82 MDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 82 mE~~g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||+.++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ ...+.+||+|||+++....
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCT
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhccc
Confidence 99998888877652 356799999999999999999999999999999999999994 2446789999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc--
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST-- 235 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (477)
... ....+||+.|+|||++.+. .++.++|||||||+||||++|..||.+... ...+.++.......
T Consensus 210 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 210 GEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTR 278 (420)
T ss_dssp TCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCH
T ss_pred CCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 322 2346789999999999875 789999999999999999999999987543 22232222211000
Q ss_pred ----------------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 236 ----------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 236 ----------------------~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
....+...+++++.+||.+||..||.+||++.++.
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 01112345789999999999999999999977664
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.61 Aligned_cols=261 Identities=17% Similarity=0.257 Sum_probs=206.2
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCC---cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g---~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..+|++.+.||+|+||.||+|.+..++ ..||+|.+...... ..+..|+.+++.++|++++..+..+....+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 357999999999999999999975443 46899987754432 347789999999998666666666666677889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence 999999 789999998656679999999999999999999999999999999999999 6788999999999986643
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... .........||+.|+|||++.+..++.++|||||||++|+|++ |.+||......... ..+......
T Consensus 181 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~--- 251 (298)
T 3f66_A 181 KEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQGRRL--- 251 (298)
T ss_dssp GGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHHHTTCCC---
T ss_pred cchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHhcCCCC---
Confidence 2211 1112334567889999999999999999999999999999999 66677654443322 222222211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
..+..+|+++.+++..||..+|++||++.++.+.|+.++..
T Consensus 252 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 252 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 12345789999999999999999999999999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=347.38 Aligned_cols=257 Identities=16% Similarity=0.212 Sum_probs=203.2
Q ss_pred CCceEEEeeeeecCceEEEEE-----EECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcC--CCCCCeeEEeeEeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG--GTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a-----~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~--~~~i~~~~~~~~~~~~~ 78 (477)
.++|++.++||+|+||.||+| .+..+++.||||++... ....+..|..++..+.+ ++++..+..++...+..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 568999999999999999999 46778999999998654 45568889999988873 35566666666677888
Q ss_pred EEEEecC-CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec--------CCCCCcE
Q 011819 79 VLVMDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL--------GRRANQV 145 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~----~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~--------~~~~~~v 145 (477)
||||||+ +++|.+++.. ....+++..++.++.||+.||+|||++|||||||||+|||++. ++..+.+
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence 9999999 8999999975 2456999999999999999999999999999999999999942 1127899
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~ 225 (477)
||+|||+|+.+...... ......+||+.|||||++.+..++.++|||||||+||+|++|..||.......
T Consensus 223 kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKG-----TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp EECCCTTCEEGGGSCTT-----EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred EEeeCchhhhhhccCCC-----ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 99999999876533221 12345689999999999999999999999999999999999999996432211
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCC-CCHHHHHHHHHHHHHHc
Q 011819 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK-PDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~R-Pt~~~l~~~l~~~~~~~ 280 (477)
......... ...++.+.+++..||..+|.+| |+++++.+.|++++...
T Consensus 293 -----~~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 -----CKPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -----EEECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----eeechhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 000010000 1236789999999999999998 57888999999888664
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=362.36 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=209.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.|.| ++|+.+..++......
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH-PNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCEE
Confidence 34578999999999999999999999999999999975432 33468899999999976 5666666667778899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+..+.+||+|||+++.+.
T Consensus 102 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999 8999999874 5679999999999999999999999999999999999999654567899999999998665
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.........
T Consensus 181 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 181 ASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFEL 248 (484)
T ss_dssp CCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCS
T ss_pred cccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCC
Confidence 4322 223579999999999987 69999999999999999999999997643 34555555555443322
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+ .+..+++++.+||..||..+|.+||++.++.
T Consensus 249 ~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 280 (484)
T 3nyv_A 249 P-QWKKVSESAKDLIRKMLTYVPSMRISARDAL 280 (484)
T ss_dssp G-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred c-ccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 2 3456899999999999999999999976664
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=341.33 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=210.6
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
+...++|++++.||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.| ++|..+..++.+.+.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 115 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDNDF 115 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCe
Confidence 456789999999999999999999999999999999876542 12357789999999977 556666666677888
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
.|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 116 ~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceec
Confidence 99999999 7999999875 4569999999999999999999999999999999999999 67889999999999876
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..+......
T Consensus 192 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~-- 259 (335)
T 2owb_A 192 EYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYS-- 259 (335)
T ss_dssp CSTTC-------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC--
T ss_pred ccCcc-------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhcCCCC--
Confidence 54322 1234679999999999999999999999999999999999999997643 33444444433322
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
+...+++++.++|..||..||++||+++++ |++.|...+
T Consensus 260 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~el---l~~~~~~~~ 298 (335)
T 2owb_A 260 ---IPKHINPVAASLIQKMLQTDPTARPTINEL---LNDEFFTSG 298 (335)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHHTS
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHH---hcCccccCC
Confidence 335678999999999999999999997665 455555544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=360.55 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=207.0
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
...++|++++.||+|+||.||+|++..+|+.||||++... .....+.+|+.+++.++| ++|..+..++......
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-PHIIKLYQVISTPSDI 91 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEE
Confidence 4567899999999999999999999999999999997643 223467899999999987 5566666666777889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcc
Confidence 9999999 8999999874 5679999999999999999999999999999999999999 678999999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+... ...+.++......
T Consensus 168 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~-- 234 (476)
T 2y94_A 168 DGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKICDGIFY-- 234 (476)
T ss_dssp TTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHHTTCCC--
T ss_pred cccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCcC--
Confidence 4322 235689999999999998776 6899999999999999999999976433 3445555544332
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.+..+++++.++|..||..||.+||++.++.+
T Consensus 235 ---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 ---TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 23457899999999999999999999776643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=338.36 Aligned_cols=249 Identities=18% Similarity=0.293 Sum_probs=199.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEe--CcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE--GDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~--~~~~~lVmE 83 (477)
.++|+++++||+|+||.||+|.+..+++.||||++.. .....+..|+.+++.|.+++++..+..++.. ....++|||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 5789999999999999999999999999999999864 3456789999999999977778777766665 667899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|+ +++|.+++. .++...+..++.||+.||+|||++||+||||||+|||++ .....+||+|||+++.......
T Consensus 114 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~- 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE- 186 (330)
T ss_dssp CCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC-
T ss_pred ccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCc-
Confidence 99 889998875 389999999999999999999999999999999999994 2334899999999987654332
Q ss_pred cccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc-----
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS----- 236 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~----- 236 (477)
.....||..|+|||++.+ ..++.++|||||||+||+|++|..||..... ....+..+........
T Consensus 187 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 187 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHH
T ss_pred -------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhHH
Confidence 234578999999999987 6689999999999999999999999965332 1222221111100000
Q ss_pred ----------HH-----------------HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 ----------IE-----------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ----------~~-----------------~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.. .....+++++.+||..||..||++||+++++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 011226899999999999999999999777643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=336.65 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=202.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEEC-CCCcEEEEEEecCCC----CchhHHHHHHHHHHHc--CCCCCCeeEEeeE---
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKT----KHPQLLYESKLYRILQ--GGTGIPNVRWFGV--- 73 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~-~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~--~~~~i~~~~~~~~--- 73 (477)
...++|++++.||+|+||.||+|.+. .+++.||||++.... ....+.+|+.+++.+. .|++|..+..++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34578999999999999999999995 678999999875432 2346778999888884 4456666555443
Q ss_pred --eCcEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 74 --EGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 74 --~~~~~~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
.....++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecC
Confidence 456779999999889999997543 349999999999999999999999999999999999999 67889999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+..+..
T Consensus 165 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~ 233 (326)
T 1blx_A 165 GLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILD 233 (326)
T ss_dssp CSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred cccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHH
Confidence 9997654321 12356789999999999999999999999999999999999999977443 333333322
Q ss_pred hc----------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 231 KK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 231 ~~----------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.. .......+...+++++.+||.+||..||++||++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11 01123344567899999999999999999999977664
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=344.97 Aligned_cols=204 Identities=25% Similarity=0.340 Sum_probs=174.3
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCC-----CCeeEEeeEeCcE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTG-----IPNVRWFGVEGDY 77 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~-----i~~~~~~~~~~~~ 77 (477)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.++++ +..+..++...+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 346799999999999999999999999999999999864321 2356778999999986664 6666677778889
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLH--s~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.||||||++++|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+|||++. +..+.+||+|||+++
T Consensus 131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCE
T ss_pred eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCce
Confidence 99999999889999997643 46999999999999999999999 579999999999999942 246789999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~ 218 (477)
...... ....||+.|+|||++.+..++.++|||||||+||+|++|..||.+...
T Consensus 210 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 210 QLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eccccc----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 764422 346899999999999999999999999999999999999999987543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=328.84 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=210.2
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+..|+.+++.++| +++..+..++...+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCeEEEEeC
Confidence 468999999999999999999985 67889999987654 34568899999999986 5566666666667788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~--- 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQ--- 158 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHH---
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEccccccccccccc---
Confidence 9 889999998766679999999999999999999999999999999999999 677899999999997653311
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
........++..|+|||++.+..++.++||||||+++|+|++ |..||..... .+....+...... ..+.
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~ 228 (267)
T 3t9t_A 159 ---YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRL----YKPR 228 (267)
T ss_dssp ---HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC----CCCT
T ss_pred ---ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHHhcCCcC----CCCc
Confidence 112234567889999999998899999999999999999999 8999976432 3344444333211 1234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
.+++++.+++..||..+|++||++.++.+.|+++..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 578999999999999999999999999999998863
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.46 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=198.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeE-----------
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV----------- 73 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~----------- 73 (477)
..++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+++++.++|++++..+..+..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 4678999999999999999999999999999999876443 234479999999988666665555532
Q ss_pred --------------------------eCcEEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011819 74 --------------------------EGDYNVLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSF 124 (477)
Q Consensus 74 --------------------------~~~~~~lVmE~~g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~gi 124 (477)
...+.++||||+.++|.+++.. ....+++..+..++.||+.||.|||++||
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 162 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162 (383)
T ss_dssp ---------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 3445789999998898887753 35679999999999999999999999999
Q ss_pred eeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHH
Q 011819 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVL 203 (477)
Q Consensus 125 iHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviL 203 (477)
+||||||+|||++ ..++.+||+|||+|+....... .....||+.|+|||++.+.. ++.++|||||||++
T Consensus 163 ~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 163 CHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp ECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred ccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9999999999994 2578999999999987654332 23457899999999998754 89999999999999
Q ss_pred HHHHcCCCCCCCCCcccHHHHHHHHhhhcc------------------------cccHHHHhcCCcHHHHHHHHHHhcCC
Q 011819 204 MYFLRGSLPWQGLKAGTKKQKYEKISEKKV------------------------STSIEALCRGYPTEFASYFHYCRSLR 259 (477)
Q Consensus 204 yelltG~~Pf~~~~~~~~~~~~~~i~~~~~------------------------~~~~~~l~~~~p~~l~~li~~cl~~~ 259 (477)
|+|++|..||.+.... +.+..+..... ......+...+|+++.+||.+||..+
T Consensus 233 ~ell~g~~pf~~~~~~---~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSI---DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999875432 33333322111 01112234568899999999999999
Q ss_pred CCCCCCHHHHH
Q 011819 260 FDDKPDYAYLK 270 (477)
Q Consensus 260 p~~RPt~~~l~ 270 (477)
|.+||++.++.
T Consensus 310 P~~R~t~~e~l 320 (383)
T 3eb0_A 310 PDLRINPYEAM 320 (383)
T ss_dssp GGGSCCHHHHH
T ss_pred hhhCCCHHHHh
Confidence 99999987764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=344.40 Aligned_cols=253 Identities=19% Similarity=0.205 Sum_probs=199.6
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
..++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..++| ++|..+..++.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCC-CCCCeEEEEEeeCCc
Confidence 3578999999999999999999999999999999876432 12457889999999987 555555555667778
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 78 ~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
.++||||+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceecc
Confidence 89999999889999997655679999999999999999999999999999999999999 678899999999998664
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc---
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 233 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (477)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... .+.+.++.....
T Consensus 164 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 164 SPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPT 233 (346)
T ss_dssp SCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred CCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCC
Confidence 4322 12356789999999999764 489999999999999999999999977443 333333332211
Q ss_pred --------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 --------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 --------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+...+...+++++.++|..||..||++||+++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 11223344667899999999999999999999877644
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.65 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=204.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
+.++|+++++||+|+||.||+|++..++..||||++.... ....+..|+.+++.+.| ++|+.+..++......||
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH-PNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 3457999999999999999999999999999999876532 34568899999999987 566666666677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||| +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++......
T Consensus 114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999 8899998865 356999999999999999999999999999999999999964445667999999999876543
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+......... .
T Consensus 193 ~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~-~ 259 (494)
T 3lij_A 193 KK--------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEKGKYTFDS-P 259 (494)
T ss_dssp BC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCS-G
T ss_pred cc--------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCc-h
Confidence 22 235679999999999864 69999999999999999999999997643 34555555554443222 2
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.+..+++++.+||..||..+|.+||++.++++
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 34678999999999999999999999877643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=331.01 Aligned_cols=250 Identities=18% Similarity=0.185 Sum_probs=203.1
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
|...+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.+|++|..+..++...+
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 456677899999999999999999999999999999998875422 2356788888888856677888877788888
Q ss_pred EEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC------------
Q 011819 77 YNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR------------ 140 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~------------ 140 (477)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999 88999999743 25699999999999999999999999999999999999994321
Q ss_pred ----CCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCC
Q 011819 141 ----RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQG 215 (477)
Q Consensus 141 ----~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~ 215 (477)
....+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+..
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 44579999999998765422 34689999999999876 566899999999999999999887743
Q ss_pred CCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 216 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. ..+..+...... .++..+++++.++|..||..||++||++.++.+
T Consensus 234 ~------~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 234 G------DQWHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp S------HHHHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h------hHHHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 2 122333333222 234578999999999999999999999877643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=340.94 Aligned_cols=264 Identities=18% Similarity=0.228 Sum_probs=190.6
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEee--------EeC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFG--------VEG 75 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~--------~~~ 75 (477)
..+|++.++||+|+||.||+|++..+++.||||++..... ...+..|+.++..+.+|++|..+..++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 4589999999999999999999999999999998754332 235788999999998556666665444 344
Q ss_pred cEEEEEEecCCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 76 DYNVLVMDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~--~~~~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
...+++|||++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCT
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCc
Confidence 56799999999999999864 3456999999999999999999999999 9999999999999 678899999999
Q ss_pred ceeecccCCCCccc-----ccccCCCCccCccccccchh---cCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH
Q 011819 152 LAKKYRDTSTHQHI-----PYRENKNLTGTARYASMNTH---LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (477)
Q Consensus 152 la~~~~~~~~~~~~-----p~~~~~~~~Gt~~Y~APE~~---~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~ 223 (477)
+++........... .........||+.|+|||++ .+..++.++|||||||++|+|++|..||..... ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~ 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK---LR 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH---HH
Confidence 99876543221100 00112245699999999998 566789999999999999999999999965322 11
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011819 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (477)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~ 282 (477)
+........ ....++..+.+||..||..+|++||++.++.+.|+.+......
T Consensus 261 ----~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 261 ----IVNGKYSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ---------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred ----hhcCcccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 111111111 1245677899999999999999999999999999998765543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=364.87 Aligned_cols=255 Identities=19% Similarity=0.338 Sum_probs=211.0
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
..+|++.++||+|+||.||+|.+..++..||||++.... ....+..|+.+++.|+| ++|+.+..++......+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCC-CCEeeEEEEEecCCcEEEEEEc
Confidence 357999999999999999999999889999999987543 34568899999999987 5566666666677788999999
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCE-
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCCce-
Confidence 9 899999997543 458999999999999999999999999999999999999 6788999999999987643221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+....... ..+...... ..+
T Consensus 374 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~~~----~~~ 441 (495)
T 1opk_A 374 -----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELLEKDYRM----ERP 441 (495)
T ss_dssp -----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHHTTCCC----CCC
T ss_pred -----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCCC----CCC
Confidence 12234456789999999998899999999999999999999 99999876544332 222221111 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+|+++.+||..||..+|++||++.+|.+.|+.++
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 568999999999999999999999999999888764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=355.93 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=195.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.|+|++++..+. ++ .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~-~ 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN-FF-D 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCE-EE-E
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEE-EE-e
Confidence 3578999999999999999999999999999999876431 1224789999999998755555444 44 3
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.+..||||||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++..+....+||+|||++
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 44578999999 8899888863 567999999999999999999999999999999999999965445567999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g---~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
+....... ....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||........ ....+..
T Consensus 290 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~~ 359 (419)
T 3i6u_A 290 KILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS 359 (419)
T ss_dssp TSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHHT
T ss_pred eecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHhc
Confidence 86644221 235689999999999864 5678899999999999999999999976443221 1222233
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
... ......+..+++++.+||..||..||++||+++++.+
T Consensus 360 ~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 222 2334456778999999999999999999999877654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=343.60 Aligned_cols=258 Identities=20% Similarity=0.319 Sum_probs=208.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
...++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+..|+.+++.+.|+ +|..+..++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCT-TBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCC-CEeeeEEEEccC
Confidence 34578999999999999999999876 35789999998754332 2477899999999875 555555566667
Q ss_pred cEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcE
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~---------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~v 145 (477)
+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCCeE
Confidence 7889999999 889999987432 457999999999999999999999999999999999999 678899
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHH
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~ 224 (477)
||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+... .+.
T Consensus 178 kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~ 249 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQV 249 (322)
T ss_dssp EECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHH
T ss_pred EECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHH
Confidence 9999999986544322 112234567899999999999999999999999999999999 8999976433 344
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
...+...... .....+|+++.++|..||..+|.+||++.++.+.|++.+
T Consensus 250 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 LRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 4444433322 133568999999999999999999999999988887664
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=330.57 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=205.6
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeE--------
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-------- 73 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~-------- 73 (477)
+..++++|++++.||+|+||.||+|.+..+++.||||++... ...+..|++++..++|++.+..+..+..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN--NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC--SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 345678999999999999999999999999999999998654 3567899999999988655555544322
Q ss_pred -------eCcEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCc
Q 011819 74 -------EGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (477)
Q Consensus 74 -------~~~~~~lVmE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~ 144 (477)
.....++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---cCCCC
Confidence 245579999999 78999999743 3569999999999999999999999999999999999999 56789
Q ss_pred EEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH
Q 011819 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (477)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~ 224 (477)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.. ....
T Consensus 161 ~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~ 227 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TSKF 227 (284)
T ss_dssp EEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHHH
T ss_pred EEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HHHH
Confidence 99999999987654332 2345789999999999999999999999999999999999998842 1122
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
+..+.... +...+++++.++|..||..||.+||++.++.+.|..+
T Consensus 228 ~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 228 FTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22222221 2345789999999999999999999999998887766
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=329.66 Aligned_cols=250 Identities=18% Similarity=0.207 Sum_probs=207.5
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----------chhHHHHHHHHHHHcCCCCCCeeEEeeE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLLYESKLYRILQGGTGIPNVRWFGV 73 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----------~~~~~~E~~il~~L~~~~~i~~~~~~~~ 73 (477)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.+|+++..+..++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 45799999999999999999999999999999999865431 2346789999999986688888878888
Q ss_pred eCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCc
Q 011819 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (477)
Q Consensus 74 ~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGl 152 (477)
.....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence 888999999999 7899999975 4569999999999999999999999999999999999999 6788999999999
Q ss_pred eeecccCCCCcccccccCCCCccCccccccchhc------CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH
Q 011819 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (477)
Q Consensus 153 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~------g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~ 226 (477)
+........ .....|++.|+|||++. ...++.++|||||||++|+|++|..||..... .....
T Consensus 171 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~ 239 (298)
T 1phk_A 171 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLR 239 (298)
T ss_dssp CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH
T ss_pred hhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHH
Confidence 987654322 23457899999999985 45678999999999999999999999976432 33444
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.+......... .....+++++.++|..||..||++||++.++.
T Consensus 240 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (298)
T 1phk_A 240 MIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282 (298)
T ss_dssp HHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHhcCCcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 44443332221 12346899999999999999999999977764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=332.94 Aligned_cols=260 Identities=20% Similarity=0.310 Sum_probs=209.1
Q ss_pred CCceEEEe-eeeecCceEEEEEEEC--CCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~-~IG~G~fG~Vy~a~~~--~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.++|.+.+ .||+|+||.||+|.+. .+++.||||++..... ...+..|+.++..++|++++..+. ++ ..+..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~-~~~~~~ 85 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VC-QAEALM 85 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE-EE-ESSSEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEE-Ee-cCCCcE
Confidence 46788887 9999999999999864 4678999999876433 235778999999998755444444 44 455689
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceeeecc
Confidence 999999 789999997556679999999999999999999999999999999999999 5678999999999987754
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
..... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..... .+....+......
T Consensus 163 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~~--- 232 (287)
T 1u59_A 163 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRM--- 232 (287)
T ss_dssp CSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCC---
T ss_pred Cccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCcC---
Confidence 33211 11234467899999999998889999999999999999998 9999977543 2333333332221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
.++..+|+++.++|..||..+|++||++.++.+.|+.++...+
T Consensus 233 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 233 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 2345789999999999999999999999999999999986554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=337.51 Aligned_cols=261 Identities=16% Similarity=0.229 Sum_probs=204.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCC----cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g----~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
...++|++.+.||+|+||.||+|.+..++ ..||||++...... ..+..|+.++..++| ++|..+..++...+
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKYK 119 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEecCC
Confidence 34578999999999999999999976553 46999998754332 247789999999987 55666666666777
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..+|||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcchh
Confidence 889999999 789999998766779999999999999999999999999999999999999 6788999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... .+....+......
T Consensus 197 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 197 LEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRL 269 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC
T ss_pred hccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCcC
Confidence 65432211 01123356789999999999999999999999999999999 9999976443 3334444333211
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
. ....+++++.+++..||..+|++||++.++.+.|++++..
T Consensus 270 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 270 P----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp C----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1 2346899999999999999999999999999999998743
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=348.91 Aligned_cols=248 Identities=21% Similarity=0.295 Sum_probs=184.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEe-----C
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVE-----G 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~-----~ 75 (477)
+.++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++|++++..+..+... .
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 56899999999999999999999999999999999865432 23567899999999986655555554322 3
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...|+|||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC------
T ss_pred CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccc
Confidence 55799999999999999873 579999999999999999999999999999999999999 6789999999999986
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh---
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (477)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+..+...
T Consensus 182 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~ 248 (367)
T 2fst_X 182 TADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGT 248 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCS
T ss_pred cccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCC
Confidence 5432 234579999999999987 67899999999999999999999999875432 222222211
Q ss_pred -----------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 232 -----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 232 -----------------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
........+...+++++.+||.+||..||.+||+++++.
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 011223344567789999999999999999999977664
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=334.53 Aligned_cols=258 Identities=20% Similarity=0.340 Sum_probs=205.2
Q ss_pred CCceEEEe-eeeecCceEEEEEEE--CCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 6 GNKFRLGR-KIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~-~IG~G~fG~Vy~a~~--~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.++|++.+ .||+|+||.||+|.+ ..+++.||||++..... ...+..|+.+++.++|++ +..+..++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY-IVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTT-BCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCC-EEEEEEEE-CCCCc
Confidence 45799999 999999999999954 56688999999875432 245788999999998755 44444444 55667
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCcceeec
Confidence 9999999 8999999985 5569999999999999999999999999999999999999 567899999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||..... .+....+......
T Consensus 169 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~-- 239 (291)
T 1xbb_A 169 ADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM-- 239 (291)
T ss_dssp TTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC--
T ss_pred cCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC--
Confidence 433211 11223456789999999998889999999999999999999 9999987543 2333333332211
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
..+..+|+++.++|..||..+|++||++.++.+.|++++...
T Consensus 240 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 240 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 134568999999999999999999999999999999998544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=341.54 Aligned_cols=258 Identities=19% Similarity=0.254 Sum_probs=210.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEE--EEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEV--AIKLENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~v--AiKi~~~~---~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|++.+.||+|+||.||+|++..++..+ |||.+... .....+..|+.++..+.+|++|..+..++...+..+|
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 378999999999999999999998888865 89987642 2334688899999999666788888777888899999
Q ss_pred EEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCc
Q 011819 81 VMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~ 144 (477)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCe
Confidence 99999 889999997432 369999999999999999999999999999999999999 67789
Q ss_pred EEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHH
Q 011819 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (477)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~ 223 (477)
+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+... .+
T Consensus 181 ~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~ 249 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE 249 (327)
T ss_dssp EEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HH
T ss_pred EEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HH
Confidence 9999999997433211 1223457889999999998889999999999999999998 9999976433 34
Q ss_pred HHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011819 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281 (477)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~ 281 (477)
.+..+...... .....+++++.++|..||..+|++||+++++.+.|+.++....
T Consensus 250 ~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 250 LYEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHhhcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 44444332211 1234678999999999999999999999999999999986543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=339.82 Aligned_cols=268 Identities=21% Similarity=0.324 Sum_probs=201.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHc-CCCCCCeeEEeeEeC----cEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ-GGTGIPNVRWFGVEG----DYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~-~~~~i~~~~~~~~~~----~~~ 78 (477)
.+.++|+++++||+|+||.||+|++. ++.||||++... .......|.+++..+. +|++|..+..++... ...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 45678999999999999999999964 899999998543 2344556666665542 446666665555544 678
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeCCCCCCceEeecCCCCCcEEEee
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~--------giiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 111 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~D 185 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 185 (337)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEe
Confidence 9999999 8899999974 4699999999999999999999998 99999999999999 6788999999
Q ss_pred cCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCc------chHHHHHHHHHHHHcC----------CCCC
Q 011819 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRR------DDLESLGYVLMYFLRG----------SLPW 213 (477)
Q Consensus 150 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~k------sDIwSlGviLyelltG----------~~Pf 213 (477)
||+++........... ......||+.|+|||++.+..+... +|||||||++|||++| ..||
T Consensus 186 fg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999876543322111 1235689999999999998777665 9999999999999999 7888
Q ss_pred CCCCccc-HHHHHHH-Hhhhccccc--HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011819 214 QGLKAGT-KKQKYEK-ISEKKVSTS--IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (477)
Q Consensus 214 ~~~~~~~-~~~~~~~-i~~~~~~~~--~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~ 282 (477)
....... ....... +........ .......+++++.++|..||..||++||++.++.+.|+.+......
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 6643322 1122222 211111111 1111234678899999999999999999999999999998765543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=343.17 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=202.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-------~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
+.++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+++++.++| ++|+.+..++.+.+.
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH-PNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC-CCcceeehhhccCCe
Confidence 457899999999999999999999999999999987542 223467889999999986 566666666778889
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 011819 78 NVLVMDLL-GPSLEDLFNFC---------------------------------------SRKLSLKTVLMLADQMINRVE 117 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~---------------------------------------~~~ls~~~~~~i~~qIa~aL~ 117 (477)
.+|||||+ |++|.+++... ...+++..++.++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999 99999988410 112457788899999999999
Q ss_pred HHHHCCCeeCCCCCCceEeecCCCCC--cEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcC--CCCCCc
Q 011819 118 FVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRR 193 (477)
Q Consensus 118 yLHs~giiHRDLKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g--~~~s~k 193 (477)
|||++||+||||||+|||++ .++ .+||+|||+++.+....... ........||+.|+|||++.+ ..++.+
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~---~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFS---TNKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHTTEECCCCCGGGEEES---CSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHCCccccCCChhhEEEe---cCCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999999999999994 444 89999999998765433211 112345679999999999976 678999
Q ss_pred chHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011819 194 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIF 273 (477)
Q Consensus 194 sDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l 273 (477)
+|||||||++|+|++|..||.+... .+....+......... .....+++++.++|..||..+|.+||++.++ |
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~---l 329 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKLCFEN-PNYNVLSPLARDLLSNLLNRNVDERFDAMRA---L 329 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCTTS-GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH---H
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcccccCC-cccccCCHHHHHHHHHHcCCChhHCCCHHHH---h
Confidence 9999999999999999999977543 3444444443332221 2234578999999999999999999997665 4
Q ss_pred HHHHHH
Q 011819 274 RDLFIR 279 (477)
Q Consensus 274 ~~~~~~ 279 (477)
++.|.+
T Consensus 330 ~hp~~~ 335 (345)
T 3hko_A 330 QHPWIS 335 (345)
T ss_dssp HSHHHH
T ss_pred cChhhc
Confidence 555543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=335.87 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=196.5
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
-.++|++.+.||+|+||.||+|++ .++.||||++........+..|+.++..++|++++. +..++. +..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~-~~~~~~--~~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK-LYGACL--NPVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCC-EEEBCT--TTTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCe-EEEEEc--CCcEEEEEc
Confidence 346899999999999999999996 478999999876655667889999999998755444 443333 347899999
Q ss_pred C-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeeCCCCCCceEeecCCCCCc-EEEeecCceeecc
Q 011819 85 L-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAKKYR 157 (477)
Q Consensus 85 ~-g~sL~~li~~~~~--~ls~~~~~~i~~qIa~aL~yLHs---~giiHRDLKP~NILl~~~~~~~~-vkL~DFGla~~~~ 157 (477)
+ +++|.+++..... .++...++.++.||+.||+|||+ +||+||||||+|||++ .++. +||+|||++....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC-----
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEcccccccccc
Confidence 9 8999999974322 37899999999999999999999 8999999999999994 4554 8999999997654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......+......
T Consensus 158 ~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--- 223 (307)
T 2eva_A 158 THM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-AFRIMWAVHNGTRP--- 223 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-HHHHHHHHHTTCCC---
T ss_pred ccc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-HHHHHHHHhcCCCC---
Confidence 321 2346899999999999999999999999999999999999999764332 22222222222221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
.+...+|+++.+++..||..+|++||+++++.+.|+.+.
T Consensus 224 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 224 -PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp -CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred -CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 234578999999999999999999999999999998874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=331.03 Aligned_cols=257 Identities=21% Similarity=0.374 Sum_probs=208.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..++|++++.||+|+||.||+|.+ .++..||||++.... ....+..|+++++.++|++.+..+ .+.. .+..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~-~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY-AVVT-QEPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEE-EEEC-SSSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEE-EEEc-CCCcEEEEe
Confidence 357899999999999999999997 467789999886543 345688999999999875555444 4433 445799999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCccc
Confidence 99 89999998632 2269999999999999999999999999999999999999 6788999999999987654321
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||.+... .+.+..+...... ..
T Consensus 165 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~ 231 (279)
T 1qpc_A 165 ------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRM----VR 231 (279)
T ss_dssp ------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CC
T ss_pred ------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccCC----CC
Confidence 11234467889999999998889999999999999999999 9999976443 3333333332111 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
+..+|+++.+++..||..+|++||++.++.+.|++++...
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 3568999999999999999999999999999999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=339.86 Aligned_cols=263 Identities=18% Similarity=0.201 Sum_probs=201.3
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEe----Cc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVE----GD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~----~~ 76 (477)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.++..++|++++..+..+... ..
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 5678999999999999999999999999999999998643322 3467899999999875555444443322 36
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 77 ~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
..++||||++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 88 ~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccccccc
Confidence 7899999998899999974 569999999999999999999999999999999999999 67889999999999876
Q ss_pred ccCCCCccc---ccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh--
Q 011819 157 RDTSTHQHI---PYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE-- 230 (477)
Q Consensus 157 ~~~~~~~~~---p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~-- 230 (477)
......... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 543221110 0111234679999999998765 6789999999999999999999999987543221111111110
Q ss_pred ----------------------hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 ----------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 ----------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.........+...+++++.++|..||..||++||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00112334455678999999999999999999999777643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=331.55 Aligned_cols=260 Identities=17% Similarity=0.257 Sum_probs=205.9
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCc---EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~---~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.|++.++||+|+||.||+|.+..+++ .||+|++...... ..+..|+.+++.++|++++..+..+.......+++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 57788999999999999999765554 7999998754432 34678999999998866666666655555566999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCc
Confidence 9999 999999998656779999999999999999999999999999999999999 678899999999997654322
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCC-CCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
. ..........+|+.|+|||.+.+..++.++|||||||++|+|++|..| |....... ....+...... .
T Consensus 179 ~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~----~ 248 (298)
T 3pls_A 179 Y---YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQGRRL----P 248 (298)
T ss_dssp G---GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHTTCCC----C
T ss_pred c---cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhcCCCC----C
Confidence 1 011223445788999999999999999999999999999999995555 44433222 22222222211 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
....+++++.+++..||..+|.+||++.++.+.|++++...
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 23567899999999999999999999999999999997654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=360.71 Aligned_cols=255 Identities=20% Similarity=0.380 Sum_probs=205.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|++.++||+|+||.||+|.+. .+..||||++.... ....+..|+.+++.|+|++++. +..++. .+..+|||||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK-LHAVVT-KEPIYIITEF 263 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCC-EEEEEC-SSSCEEEECC
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEee-EEEEEe-CCccEEEEee
Confidence 468999999999999999999974 57889999987543 3456889999999998755544 444443 5567999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~-- 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE-- 338 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHH--
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCc--
Confidence 9 89999999732 2368999999999999999999999999999999999999 678999999999998654321
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
+.......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+...... ..+
T Consensus 339 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~ 407 (454)
T 1qcf_A 339 ----YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRM----PRP 407 (454)
T ss_dssp ----HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCC----CCC
T ss_pred ----eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 111233456789999999998899999999999999999999 9999987543 3333333332111 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
..+|+++.++|..||..+|++||++++|.+.|++++..
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 56899999999999999999999999999999887543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.08 Aligned_cols=252 Identities=18% Similarity=0.258 Sum_probs=200.4
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCC-------cEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGV 73 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g-------~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~ 73 (477)
....++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+..|+.+++.++| ++|..+..++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH-KHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCC-TTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEE
Confidence 455689999999999999999999988777 479999875432 23457889999999986 55666666666
Q ss_pred eCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCc--------
Q 011819 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-------- 144 (477)
Q Consensus 74 ~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~-------- 144 (477)
..+..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~~~ 159 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNPPF 159 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBCCE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCcccccccce
Confidence 777889999999 7999999986555599999999999999999999999999999999999995 3443
Q ss_pred EEEeecCceeecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCC-CCCCCCCcccHH
Q 011819 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKK 222 (477)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~-~Pf~~~~~~~~~ 222 (477)
+||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|. .||..... .
T Consensus 160 ~kl~Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~ 225 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---Q 225 (289)
T ss_dssp EEECCCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---H
T ss_pred eeeccCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---H
Confidence 99999999864422 123468899999999988 67899999999999999999955 45544222 1
Q ss_pred HHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
..... ..... .++..+++++.+++..||..||++||++.++.+.|++++.
T Consensus 226 ~~~~~-~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 226 RKLQF-YEDRH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHH-HHTTC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHHH-hhccC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 11111 1234567889999999999999999999999998887753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.16 Aligned_cols=260 Identities=17% Similarity=0.205 Sum_probs=176.4
Q ss_pred ccCCceEEEe-eeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEe----CcEE
Q 011819 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~-~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~----~~~~ 78 (477)
.+.++|++.+ .||+|+||.||+|.+..+++.||||++... .....|...+..+..+++++.+..++.. ....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4678999966 599999999999999999999999998542 3444555554444445666665544433 4567
Q ss_pred EEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 79 VLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
+|||||+ |++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||+++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999999 889999997533 36999999999999999999999999999999999999965445677999999999866
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH-HHHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YEKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~-~~~i~~~~~~~ 235 (477)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........... ...+.......
T Consensus 182 ~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 182 TQNA---------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp -------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred cccc---------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 5322 2345789999999999888899999999999999999999999976443221111 11111111111
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.......+++++.+||..||..||.+||+++++. ++.|.+
T Consensus 253 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell---~hp~~~ 292 (336)
T 3fhr_A 253 -PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM---NHPWIN 292 (336)
T ss_dssp -CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH---HSHHHH
T ss_pred -CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHh---cCcccc
Confidence 1112356899999999999999999999976664 445443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=338.62 Aligned_cols=264 Identities=19% Similarity=0.273 Sum_probs=206.0
Q ss_pred CCccCCceEEEeeeeecCceEEEEEE-----ECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeE
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGV 73 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~-----~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~ 73 (477)
.....++|++++.||+|+||.||+|+ +..+++.||||++..... ...+..|+.++..+.| ++|..+..++.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~ 103 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSL 103 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCC-CCCCeEEEEEc
Confidence 34567899999999999999999999 556788999999864432 2357789999999976 55666666666
Q ss_pred eCcEEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEE
Q 011819 74 EGDYNVLVMDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (477)
Q Consensus 74 ~~~~~~lVmE~~-g~sL~~li~~~~------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vk 146 (477)
.....||||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+.....+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 677789999999 899999998643 3489999999999999999999999999999999999995433556799
Q ss_pred EeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHH
Q 011819 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (477)
Q Consensus 147 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~ 225 (477)
|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..... ....
T Consensus 184 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVL 255 (327)
T ss_dssp ECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHH
T ss_pred ECcccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHH
Confidence 9999999765443221 12234568899999999999999999999999999999998 9999976432 3333
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
..+...... .....+++++.++|..||..+|.+||++.++.+.|+.+..
T Consensus 256 ~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 256 EFVTSGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 333333221 1235689999999999999999999999999998887753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=335.01 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=196.6
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEee---------
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFG--------- 72 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~--------- 72 (477)
.++++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+++++.++|++.+..+..+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 467899999999999999999999999999999998765432 235778999999998866555555442
Q ss_pred ----EeCcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEe
Q 011819 73 ----VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (477)
Q Consensus 73 ----~~~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~ 148 (477)
......++||||++++|.+++. ..++++..++.++.||+.||+|||++||+||||||+|||++ ..++.+||+
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~ 163 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIG 163 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEEC
T ss_pred cccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEc
Confidence 3456789999999889999997 46799999999999999999999999999999999999994 356799999
Q ss_pred ecCceeecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 011819 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (477)
Q Consensus 149 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~ 227 (477)
|||+++......... .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+..
T Consensus 164 Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~ 236 (320)
T 2i6l_A 164 DFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQL 236 (320)
T ss_dssp CCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH
T ss_pred cCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHH
Confidence 999998664322111 11234467999999999876 6789999999999999999999999987543 222332
Q ss_pred Hhhhc-------------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 228 ISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 228 i~~~~-------------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+.... .......+...+++++.++|..||..||++||+++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHh
Confidence 22211 11223345567899999999999999999999977664
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=331.84 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=210.4
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
++...++|++++.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.+.| ++|..+..++...+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDND 88 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSS
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCC-CCEeeeeeeeccCC
Confidence 35677899999999999999999999999999999998765421 2346789999999976 56666666677788
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCcee
Confidence 899999999 7999999875 4569999999999999999999999999999999999999 6788999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..+.+..+......
T Consensus 165 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~- 233 (294)
T 2rku_A 165 VEYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYS- 233 (294)
T ss_dssp CCSTTC-------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCC-
T ss_pred cccCcc-------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhhccCC-
Confidence 653322 1234579999999999999999999999999999999999999997643 23444444433322
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
++..+++++.+++..||..+|++||+++++. ++.+...
T Consensus 234 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll---~~~~~~~ 271 (294)
T 2rku_A 234 ----IPKHINPVAASLIQKMLQTDPTARPTINELL---NDEFFTS 271 (294)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG---GSHHHHT
T ss_pred ----CccccCHHHHHHHHHHcccChhhCcCHHHHh---hChheec
Confidence 3356789999999999999999999976654 4444443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=345.33 Aligned_cols=240 Identities=20% Similarity=0.237 Sum_probs=199.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCeeEEeeE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLLYESKLYRILQGGTGIPNVRWFGV 73 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----------~~~~~~~E~~il~~L~~~~~i~~~~~~~~ 73 (477)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.++| ++|+.+..++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH-ANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC-TTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe
Confidence 34578999999999999999999999999999999887643 22356789999999976 56666666667
Q ss_pred eCcEEEEEEecC-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 74 EGDYNVLVMDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 74 ~~~~~~lVmE~~-g~-sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
..+..++||||+ ++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg 175 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFG 175 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeecc
Confidence 788899999998 44 99999974 5569999999999999999999999999999999999999 678999999999
Q ss_pred ceeecccCCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 152 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
+++....... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ...
T Consensus 176 ~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~ 238 (335)
T 3dls_A 176 SAAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVE 238 (335)
T ss_dssp TCEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTT
T ss_pred cceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHh
Confidence 9987654332 234579999999999998887 7899999999999999999999965321 111
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
... .....+++++.+||..||..+|++||+++++.
T Consensus 239 ~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell 273 (335)
T 3dls_A 239 AAI-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLV 273 (335)
T ss_dssp TCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hcc-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 111 12234789999999999999999999976654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=329.08 Aligned_cols=246 Identities=18% Similarity=0.258 Sum_probs=205.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
...++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+.++..++| +++..+..++...+..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH-PNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCC-CCEeeEEEEEEcCCEE
Confidence 4457999999999999999999999999999999987532 234568889999999987 5566666666677889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECS
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCc
Confidence 9999999 78999999753 469999999999999999999999999999999999999 678899999999997654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ......+......
T Consensus 166 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~--- 230 (284)
T 2vgo_A 166 SLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETHRRIVNVDLK--- 230 (284)
T ss_dssp SSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTTCCC---
T ss_pred ccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHHHHHhccccC---
Confidence 321 2345799999999999999999999999999999999999999976432 3334444333221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
++..++.++.++|..||..+|.+||+++++.+
T Consensus 231 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 --FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 33567899999999999999999999776643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=341.56 Aligned_cols=255 Identities=20% Similarity=0.279 Sum_probs=191.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeC-----
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG----- 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~----- 75 (477)
+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.++|++++..+..+....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 457899999999999999999999999999999998654322 34678999999998755555555443322
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...||||||+.++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC---
T ss_pred cceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccc
Confidence 3779999999889998886 359999999999999999999999999999999999999 6789999999999986
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+.++.......
T Consensus 177 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 177 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTP 245 (371)
T ss_dssp ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCC
T ss_pred cccccc--------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence 543221 2346799999999999999999999999999999999999999977433 33333333221110
Q ss_pred c-------------------------HHHHh------------cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 236 S-------------------------IEALC------------RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 236 ~-------------------------~~~l~------------~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
. .+.+. ...++++.+||.+||..||.+||+++++ |++.|.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~---l~hp~~ 322 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA---LQHPYI 322 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH---HHSHHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH---hCCcch
Confidence 0 00000 1125689999999999999999996665 555554
Q ss_pred H
Q 011819 279 R 279 (477)
Q Consensus 279 ~ 279 (477)
.
T Consensus 323 ~ 323 (371)
T 2xrw_A 323 N 323 (371)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=345.26 Aligned_cols=262 Identities=20% Similarity=0.213 Sum_probs=206.7
Q ss_pred CCceEEEeeeeecCceEEEEEE----ECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEee-EeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFG-VEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~----~~~~g~~vAiKi~~~~~~~--~~~~~E~~il~~L~~~~~i~~~~~~~-~~~~~~ 78 (477)
.++|++++.||+|+||.||+|+ +..+++.||||++...... ..+..|+++++.+.|++++..+..+. ......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4699999999999999999999 5678999999998764322 34789999999997754444444332 356778
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
+|||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccceecc
Confidence 9999999 999999998656679999999999999999999999999999999999999 577899999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc------------HHHHH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------KKQKY 225 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~------------~~~~~ 225 (477)
...... .......||..|+|||++.+..++.++|||||||++|+|++|..||....... .....
T Consensus 179 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 179 LDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp TTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred cCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 433211 12234568889999999999889999999999999999999999996422110 00111
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
..+.... .......+++++.++|..||..+|++||++.++.+.|+.++.
T Consensus 255 ~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 255 ELLEEGQ----RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHhhccc----CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 111235689999999999999999999999999999988853
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=342.49 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=198.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----------CchhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.|++++. +..+...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~-~~~~~~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDA 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCC-EEEEEES
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCce-EeeEEcC
Confidence 4578999999999999999999999999999999876432 1234788999999998755444 4444444
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.. .|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred Cc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 43 79999999 8899998864 567999999999999999999999999999999999999954334456999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhc---CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~---g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
+....... .....||+.|+|||++. ...++.++|||||||++|+|++|..||........ ....+..
T Consensus 165 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~ 234 (322)
T 2ycf_A 165 KILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS 234 (322)
T ss_dssp EECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH
T ss_pred eecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh
Confidence 87643211 12357899999999974 46688999999999999999999999976543321 1222222
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
... ......+..+++++.++|..||..||++||+++++.+
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Ccc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 222 2234456778999999999999999999999877643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.29 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=182.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..++|++.+.||+|+||.||+|++..+++.||||++... .....+..|+.++..++| +++..+..++...+..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH-PSILELYNYFEDSNYVY 87 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCC-TTBCCEEEEEECSSEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCC-CCeEeEEEEEccCCeEE
Confidence 346899999999999999999999999999999987543 223467889999999987 55666666667788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC-
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccC
Confidence 999999 889999998655679999999999999999999999999999999999999 6788999999999987653
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+.++.....
T Consensus 165 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~----- 229 (278)
T 3cok_A 165 PHE-------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK---NTLNKVVLADY----- 229 (278)
T ss_dssp ----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCC-----
T ss_pred CCC-------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH---HHHHHHhhccc-----
Confidence 322 123457899999999999989999999999999999999999999764432 12222222111
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.++..++.++.++|..||..||++||+++++.+
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 133457899999999999999999999877643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=353.07 Aligned_cols=268 Identities=20% Similarity=0.229 Sum_probs=208.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEe-CcEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVE-GDYNV 79 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~-~~~~~ 79 (477)
...++|++.++||+|+||.||+|.+..+++.||||++.... ....+.+|+++++.++|++++..+..+... ....+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 45789999999999999999999999999999999976532 234577899999999875544444444332 33679
Q ss_pred EEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeec-CCCCCcEEEeecCceee
Q 011819 80 LVMDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAKK 155 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~--~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~-~~~~~~vkL~DFGla~~ 155 (477)
|||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+.. ++..+.+||+|||+++.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 999999 899999997432 23999999999999999999999999999999999999843 23556799999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcC--------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCc-ccHHHHHH
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKYE 226 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g--------~~~s~ksDIwSlGviLyelltG~~Pf~~~~~-~~~~~~~~ 226 (477)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+.+.
T Consensus 166 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 166 LEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp CCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred ccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 654221 235679999999999875 4577899999999999999999999975432 22334444
Q ss_pred HHhhhcccccH--------------------HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 227 KISEKKVSTSI--------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 227 ~i~~~~~~~~~--------------------~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
++........+ ..+...+++.+.+++..||..||++||++.++.+.+.+++.+
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 44433221100 011123467899999999999999999999999999888754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=346.73 Aligned_cols=260 Identities=17% Similarity=0.263 Sum_probs=198.2
Q ss_pred ceEEEeeeeecCceEEEEEEECCCC---cEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g---~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.|++.+.||+|+||.||+|.+..++ ..||||.+..... ...+..|+.+++.++|++++..+..+....+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 5889999999999999999975443 4689998765332 235778999999998766555555555566678999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccccccc
Confidence 9999 889999998656679999999999999999999999999999999999999 678899999999998664432
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||........... +...... .
T Consensus 247 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~---~~~~~~~----~ 316 (373)
T 3c1x_A 247 FDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRRL----L 316 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH---HHTTCCC----C
T ss_pred ccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH---HHcCCCC----C
Confidence 111 111233467889999999999999999999999999999999 7888877554433322 2222211 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.+..+|+++.++|..||..+|++||++.++.+.|++++...
T Consensus 317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 23568999999999999999999999999999999987543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=332.99 Aligned_cols=252 Identities=20% Similarity=0.340 Sum_probs=196.9
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEe------Cc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVE------GD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~------~~ 76 (477)
...++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.+|+++..+..++.. ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 45689999999999999999999999999999999986543 345688999999999666677666555544 56
Q ss_pred EEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCce
Confidence 789999999 77999999753 2569999999999999999999999999999999999999 678899999999997
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||..... ...+..+.
T Consensus 178 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~ 247 (326)
T 2x7f_A 178 QLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIP 247 (326)
T ss_dssp --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH
T ss_pred ecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhh
Confidence 6543221 123457999999999997 56789999999999999999999999976433 23333333
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...... .....+++++.++|..||..+|.+||+++++.+
T Consensus 248 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 222211 123567999999999999999999999776643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=345.49 Aligned_cols=251 Identities=19% Similarity=0.279 Sum_probs=200.4
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
....++|++++.||+|+||.||+|.+..+++.||+|++...... ..+..|+.+++.++| ++|+.+..++...+..+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCC-CCEEEEeEEEEECCEEE
Confidence 34568999999999999999999999999999999998765332 357789999999876 56666666667788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
|||||+ +++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++....
T Consensus 108 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred EEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCcccc
Confidence 999999 8899999975 34699999999999999999999996 99999999999999 678899999999997654
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH------------
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY------------ 225 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~------------ 225 (477)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 184 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 184 DSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp HHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred ccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 322 23457999999999999999999999999999999999999999764432111111
Q ss_pred ---------------------------HHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 226 ---------------------------EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 226 ---------------------------~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..+....... .....++.++.+||..||..||++||+++++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 323 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 1111110000 01124688999999999999999999977664
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=330.15 Aligned_cols=247 Identities=22% Similarity=0.336 Sum_probs=205.6
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
..+.|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| +++..+..++......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEE
Confidence 3467999999999999999999999999999999986543 23567889999999977 5666666666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCccc
Confidence 9999 789999987 4679999999999999999999999999999999999999 678899999999998765432
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+...... .+
T Consensus 174 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~~ 239 (303)
T 3a7i_A 174 I-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKNNPP----TL 239 (303)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCC----CC
T ss_pred c-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcCCCC----CC
Confidence 2 12346799999999999999999999999999999999999999976433 2333333222211 23
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...++.++.++|..||..+|++||++.++.+
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 4578999999999999999999999777654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.70 Aligned_cols=267 Identities=20% Similarity=0.234 Sum_probs=203.8
Q ss_pred ccCCce-EEEeeeeecCceEEEEEEE----CCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEe-
Q 011819 4 RVGNKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVE- 74 (477)
Q Consensus 4 ~i~~~y-~i~~~IG~G~fG~Vy~a~~----~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~- 74 (477)
.+.++| +++++||+|+||.||++.. ..+++.||||++..... ...+..|+++++.++|++++..+..+...
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 455666 9999999999999988764 45789999999876543 23478999999999975544444444333
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
....++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGLA 181 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGC
T ss_pred CceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcccc
Confidence 46789999999 8899999974 459999999999999999999999999999999999999 67889999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc--------HHHHH
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--------KKQKY 225 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~--------~~~~~ 225 (477)
......... ........||..|+|||++.+..++.++|||||||++|+|++|..||....... .....
T Consensus 182 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 3lxp_A 182 KAVPEGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257 (318)
T ss_dssp EECCTTCSE----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred ccccccccc----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence 877553321 112334568889999999999899999999999999999999999996521100 00000
Q ss_pred HHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
..+............+..+++++.++|..||..+|.+||++.++.+.|+.+..+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 011110000111112356899999999999999999999999999999988644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=342.59 Aligned_cols=264 Identities=18% Similarity=0.228 Sum_probs=207.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
..++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+..|+.++..++| ++|..+..++...+..++||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRH-PHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCC-TTBCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEE
Confidence 457899999999999999999995 5789999998765433 2457889999998887 55666666666778889999
Q ss_pred ecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 83 DLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 83 E~~-g~sL~~li~~~~---~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 999 889999886332 248999999999999999999999999999999999999 6789999999999986543
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHH----HHhhhccc
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE----KISEKKVS 234 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~----~i~~~~~~ 234 (477)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............. ........
T Consensus 192 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 192 LDQT-----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp SSCC-----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccc-----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 2221 11234579999999999999899999999999999999999999997644322111111 11111110
Q ss_pred -----ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 235 -----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 235 -----~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
.....+...++.++.+++..||..||++||++.++.+.|+.++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 01111223346789999999999999999999999999998864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=329.27 Aligned_cols=252 Identities=18% Similarity=0.268 Sum_probs=186.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~---~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
...++|++++.||+|+||.||+|.+..+++.||||++....... ....|...+....+|+++..+..++...+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34578999999999999999999999999999999986543322 233333333333345777777777777888999
Q ss_pred EEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 81 VMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 81 VmE~~g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
||||++++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC------
T ss_pred EEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCcccc
Confidence 999998899888753 356799999999999999999999998 99999999999999 67889999999999866
Q ss_pred ccCCCCcccccccCCCCccCccccccchh----cCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~----~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
..... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||..... ....+.......
T Consensus 161 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~ 230 (290)
T 3fme_A 161 VDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVEEP 230 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHHSC
T ss_pred ccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhccC
Confidence 54322 2234799999999996 566789999999999999999999999975322 223333333322
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.... ....+++++.+++..||..+|++||++.++.+
T Consensus 231 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 SPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 2211 12457899999999999999999999877654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=329.58 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=204.7
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
-..+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.++| +++..+..++...+..
T Consensus 2 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 80 (276)
T 2yex_A 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQ 80 (276)
T ss_dssp CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEE
T ss_pred CCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCC-CCceeeeeEEEcCCEE
Confidence 33455789999999999999999999999999999999764332 2457889999999976 5666666667788889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECE
T ss_pred EEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccC
Confidence 9999999 7899998863 4569999999999999999999999999999999999999 678899999999998764
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ .+..+.......
T Consensus 157 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~- 228 (276)
T 2yex_A 157 YNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYL- 228 (276)
T ss_dssp ETTEE-----CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTTCTTS-
T ss_pred CCcch-----hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhccccc-
Confidence 43211 11235679999999999988775 6789999999999999999999977544322 222222221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.....+++++.++|..||..+|.+||+++++.+
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 123467899999999999999999999877643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=366.04 Aligned_cols=265 Identities=20% Similarity=0.301 Sum_probs=207.4
Q ss_pred CceEEEe-eeeecCceEEEEEEEC--CCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 7 NKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 7 ~~y~i~~-~IG~G~fG~Vy~a~~~--~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
++|.+.+ +||+|+||.||+|.+. .++..||||++.... ....+..|+++++.|+|++ |+.+..++.. +..+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpn-iv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY-IVRLIGVCQA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTT-BCCEEEEEES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCC-EeeEEEEecc-CCeEE
Confidence 4566666 8999999999999875 356789999987543 3356889999999998754 5554444444 45899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC--
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCcccccCC
Confidence 99999 899999997556679999999999999999999999999999999999999 56789999999999865432
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
... +.......+++.|+|||++.+..++.++|||||||+||||++ |..||.+.... +.+..+......
T Consensus 490 ~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~~~~~---- 558 (613)
T 2ozo_A 490 DSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRM---- 558 (613)
T ss_dssp ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHHTTCCC----
T ss_pred Cce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCC----
Confidence 211 111123346789999999999999999999999999999998 99999876543 333333332211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCc
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYV 287 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~ 287 (477)
..+..+|+++.++|..||..+|++||++.++.+.|++++...+...+..
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~ 607 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCS
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCc
Confidence 1335689999999999999999999999999999999988777655443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=336.27 Aligned_cols=252 Identities=23% Similarity=0.261 Sum_probs=197.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
..++|++++.||+|+||.||+|++..+++.||||++...... ..+..|+.+++.++| ++|+.+..++...+..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH-ENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC-CCEeeEEEEeecCCEEEE
Confidence 347899999999999999999999999999999987654332 236689999999987 566666666778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ +++|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 102 v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 102 VFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC------
T ss_pred EEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCC
Confidence 99999 566666654 35679999999999999999999999999999999999999 67889999999999865443
Q ss_pred CCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh-------
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------- 231 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~------- 231 (477)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... ..+..+...
T Consensus 178 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 178 GE-------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI---DQLYHIMMCLGNLIPR 247 (331)
T ss_dssp -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHH
T ss_pred cc-------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChh
Confidence 22 12345789999999999875 6899999999999999999999999775432 222222111
Q ss_pred -------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 -------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 -------------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+.+++++.+||..||..||++||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0112233344578999999999999999999999776643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.60 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=200.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|++.++||+|+||.||+|.+.. +..||||++.... ....+..|+.+++.|+|++++..+ .++.. +..+|||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~-~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY-AVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEE-EEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEE-EEEcC-CceEEEehh
Confidence 4679999999999999999999854 5679999987643 335688999999999885555544 44433 567999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCce-
Confidence 9 88999999642 3569999999999999999999999999999999999999 6778999999999987654221
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+...... ..+
T Consensus 336 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~ 403 (452)
T 1fmk_A 336 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCP 403 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCC
T ss_pred -----ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 11223457889999999999999999999999999999999 9999987543 3334333332111 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+|+++.++|..||..+|++||++++|.+.|++++
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 568999999999999999999999999999988775
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=332.58 Aligned_cols=259 Identities=19% Similarity=0.317 Sum_probs=197.4
Q ss_pred CCceEEEeeeeecCceEEEEEEECC---CCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeC---
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG--- 75 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~---~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~--- 75 (477)
.++|++++.||+|+||.||+|.+.. +++.||||++...... ..+..|+.+++.++|++++..+..+....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4689999999999999999998765 4568999998754332 34778999999998766555555544322
Q ss_pred -cEEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEe
Q 011819 76 -DYNVLVMDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (477)
Q Consensus 76 -~~~~lVmE~~-g~sL~~li~~~-----~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~ 148 (477)
...++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEEe
Confidence 2459999999 88999998532 3569999999999999999999999999999999999999 678899999
Q ss_pred ecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHH
Q 011819 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 227 (477)
Q Consensus 149 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~ 227 (477)
|||+++....... +.......+++.|+|||++.+..++.++|||||||++|+|++ |..||....... .+..
T Consensus 190 Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~ 261 (313)
T 3brb_A 190 DFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYDY 261 (313)
T ss_dssp SCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH
T ss_pred ecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHHH
Confidence 9999986644322 112234567889999999999999999999999999999999 999998755433 2233
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+...... ..+..+++++.++|..||..+|.+||++.++.+.|++++..
T Consensus 262 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 262 LLHGHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHTTCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 3332211 13356889999999999999999999999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=344.93 Aligned_cols=250 Identities=18% Similarity=0.218 Sum_probs=192.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEe-----CcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE-----GDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~-----~~~~~ 79 (477)
...+|++++.||+|+||.||+|++..+++ ||+|.+.... ....+|+++++.++|++++..+..+... ..+.+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK--RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc--chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 45689999999999999999999877766 7888664332 2234799999999886655555555432 33478
Q ss_pred EEEecCCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 80 LVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 80 lVmE~~g~sL~~li~---~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
+||||+.+++.+.+. .....+++..+..++.||+.||+|||++||+||||||+|||++ ..++.+||+|||+|+..
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccc
Confidence 999999777766553 2356799999999999999999999999999999999999994 26789999999999876
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc--
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-- 233 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~-- 233 (477)
..... .....||+.|+|||++.+. .++.++|||||||+||+|++|..||.+.... ..+..+.....
T Consensus 193 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p 261 (394)
T 4e7w_A 193 IAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI---DQLVEIIKVLGTP 261 (394)
T ss_dssp CTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCC
T ss_pred cCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence 44332 2346789999999999875 5899999999999999999999999875432 22222222110
Q ss_pred ---------------------c-ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 ---------------------S-TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 ---------------------~-~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
. .....+...+++++.+||.+||..||.+||++.++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 0 111223345889999999999999999999977664
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=341.02 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=195.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc----
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGD---- 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~---- 76 (477)
+.++|.+.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.++|++++..+..+.....
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 568999999999999999999999999999999998754332 356789999999998655555555443322
Q ss_pred -EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 -YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 -~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..|+||||++++|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 120 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC--
T ss_pred eeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccc
Confidence 239999999988888774 459999999999999999999999999999999999999 6789999999999986
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc--
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-- 232 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~-- 232 (477)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .+.+..+....
T Consensus 194 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~ 260 (371)
T 4exu_A 194 ADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGV 260 (371)
T ss_dssp ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred cccC----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Confidence 5432 234578999999999987 7889999999999999999999999977443 22222222111
Q ss_pred ------------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 ------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 ------------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.......+...+++++.+||..||..||++||++++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 11222334456799999999999999999999977664
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=339.31 Aligned_cols=252 Identities=17% Similarity=0.190 Sum_probs=193.6
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-------------hhHHHHHHHHHHHcCCCCCCeeEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------PQLLYESKLYRILQGGTGIPNVRW 70 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-------------~~~~~E~~il~~L~~~~~i~~~~~ 70 (477)
.+.++|++++.||+|+||.||+|.+. +++.||||++...... ..+..|+.+++.++|++++..+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 35689999999999999999999975 4999999987543211 457899999999988666555555
Q ss_pred eeE----eCcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEE
Q 011819 71 FGV----EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (477)
Q Consensus 71 ~~~----~~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vk 146 (477)
+.. .....|+||||++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCEE
Confidence 533 234679999999889999998655679999999999999999999999999999999999999 6788999
Q ss_pred EeecCceeecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH
Q 011819 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (477)
Q Consensus 147 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~ 225 (477)
|+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+
T Consensus 175 l~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~ 243 (362)
T 3pg1_A 175 ICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF---YNQL 243 (362)
T ss_dssp ECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH
T ss_pred EEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH---HHHH
Confidence 999999975443222 234578999999999987 6789999999999999999999999977443 2233
Q ss_pred HHHhhhc---------------------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 226 EKISEKK---------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 226 ~~i~~~~---------------------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..+.... ...........+++.+.+||..||..||.+||++.++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 3222211 11122344566789999999999999999999977664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=350.39 Aligned_cols=250 Identities=16% Similarity=0.137 Sum_probs=185.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-----chhHHHHHHHHHHHc--CCCCCCeeE-------Eee
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKLYRILQ--GGTGIPNVR-------WFG 72 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-----~~~~~~E~~il~~L~--~~~~i~~~~-------~~~ 72 (477)
.+|++++.||+|+||.||+|++..+++.||||++..... ...+..|+.++..|. |++++..+. .+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999877543 224567877777776 444333232 111
Q ss_pred EeC----------------cEEEEEEecCCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHHCCCeeCCCC
Q 011819 73 VEG----------------DYNVLVMDLLGPSLEDLFNFCSRKLSLKTV------LMLADQMINRVEFVHSKSFLHRDIK 130 (477)
Q Consensus 73 ~~~----------------~~~~lVmE~~g~sL~~li~~~~~~ls~~~~------~~i~~qIa~aL~yLHs~giiHRDLK 130 (477)
..+ ...||||||++++|.+++......+..... +.++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 111 347999999999999999865445555555 6778999999999999999999999
Q ss_pred CCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcC--CCCCCcchHHHHHHHHHHHHc
Q 011819 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLR 208 (477)
Q Consensus 131 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g--~~~s~ksDIwSlGviLyellt 208 (477)
|+|||+ +.++.+||+|||+|+...... ....+|+.|+|||++.+ ..++.++|||||||+||+|++
T Consensus 222 p~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFI---MPDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEE---CTTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---CCCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999 678999999999998664311 13456799999999988 779999999999999999999
Q ss_pred CCCCCCCCCcccHHHHHHHHh--hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 209 GSLPWQGLKAGTKKQKYEKIS--EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 209 G~~Pf~~~~~~~~~~~~~~i~--~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
|..||.+....... .+.... ...........+..+++++.+||..||..||++||++.++.
T Consensus 289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999775332110 000000 00000111122357899999999999999999999987764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=324.73 Aligned_cols=248 Identities=20% Similarity=0.291 Sum_probs=199.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeE---eCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV---EGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~---~~~~~ 78 (477)
+..|++.+.||+|+||.||+|.+..++..||+|++..... ...+..|+.+++.++|++++..+..+.. .....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 5579999999999999999999999999999998765432 2347789999999988655555554433 25678
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++ ...+.+||+|||++..
T Consensus 105 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGG
T ss_pred EEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCccc
Confidence 9999999 8899999975 356999999999999999999999999 99999999999993 2678999999999965
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ..+.+..+......
T Consensus 182 ~~~~~---------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~- 248 (290)
T 1t4h_A 182 KRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKP- 248 (290)
T ss_dssp CCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCC-
T ss_pred ccccc---------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCCc-
Confidence 43321 234579999999998875 589999999999999999999999976433 33444444333222
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+...+++++.++|..||..+|.+||+++++.+
T Consensus 249 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2244567899999999999999999999877653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=323.27 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=198.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
...++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+.+++.++| +++..+..++...+..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-PHIIKLYQVISTPTDF 86 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCCeE
Confidence 4568999999999999999999999999999999987542 233467889999999987 5566666666777889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCC
T ss_pred EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccC
Confidence 9999999 8899999975 3569999999999999999999999999999999999999 678899999999997664
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
.... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.... ....+..+......
T Consensus 163 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~-- 229 (276)
T 2h6d_A 163 DGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGGVFY-- 229 (276)
T ss_dssp C---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC--
T ss_pred CCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccc--
Confidence 4221 234578999999999998776 589999999999999999999997643 33444444333221
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
++..++.++.++|..||..+|++||++.++. ++.+.+.
T Consensus 230 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l---~h~~~~~ 267 (276)
T 2h6d_A 230 ---IPEYLNRSVATLLMHMLQVDPLKRATIKDIR---EHEWFKQ 267 (276)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH---HSHHHHT
T ss_pred ---CchhcCHHHHHHHHHHccCChhhCCCHHHHH---hChhhcc
Confidence 2355789999999999999999999977664 4444443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=327.60 Aligned_cols=252 Identities=18% Similarity=0.279 Sum_probs=199.2
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeeEEee-EeCc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK------TKHPQLLYESKLYRILQGGTGIPNVRWFG-VEGD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~------~~~~~~~~E~~il~~L~~~~~i~~~~~~~-~~~~ 76 (477)
.+.++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+.+++.++|++++..+..+. ....
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 3568999999999999999999999999999999987643 22346789999999998755555554442 4556
Q ss_pred EEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..++||||+.++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEA 158 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccccc
Confidence 78999999976688888643 4569999999999999999999999999999999999999 6789999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCC--CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~--s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
........ ......||+.|+|||++.+... +.++|||||||++|+|++|..||.+.. ..+.+..+.....
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKGSY 230 (305)
T ss_dssp CCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCC
T ss_pred cCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcCCC
Confidence 65432211 1234579999999999987544 779999999999999999999997633 3444444444332
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. +...+++++.++|..||..||.+||+++++.+
T Consensus 231 ~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 A-----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp C-----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-----CCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2 34568999999999999999999999776643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=351.86 Aligned_cols=239 Identities=13% Similarity=0.103 Sum_probs=183.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHc--CCCCCCeeE-------Ee
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQ--GGTGIPNVR-------WF 71 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~--~~~~i~~~~-------~~ 71 (477)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+. .|++|..+. .+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999998999999999976432 2245778986666554 234443332 22
Q ss_pred eEeCc-----------------EEEEEEecCCCCHHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHHCCCeeC
Q 011819 72 GVEGD-----------------YNVLVMDLLGPSLEDLFNFCSRKLS-------LKTVLMLADQMINRVEFVHSKSFLHR 127 (477)
Q Consensus 72 ~~~~~-----------------~~~lVmE~~g~sL~~li~~~~~~ls-------~~~~~~i~~qIa~aL~yLHs~giiHR 127 (477)
....+ ..||||||++++|.+++.... .++ +..++.++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 22221 368999999999999997532 243 47888899999999999999999999
Q ss_pred CCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCC-----------CCCCcchH
Q 011819 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-----------EQSRRDDL 196 (477)
Q Consensus 128 DLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-----------~~s~ksDI 196 (477)
||||+|||+ +.++.+||+|||+|+.... .....+| +.|+|||++.+. .++.++||
T Consensus 231 Dikp~NIll---~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 231 YLRPVDIVL---DQRGGVFLTGFEHLVRDGA----------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp CCCGGGEEE---CTTCCEEECCGGGCEETTC----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred CCCHHHEEE---cCCCCEEEEechhheecCC----------cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999 6788999999999986432 1234577 999999999987 89999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 197 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 197 wSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
|||||+||+|++|..||.+..... .+ ..+...+..+|+++.++|..||..||++||++.++.+
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~---~~---------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALG---GS---------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------C---CS---------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCccccccc---ch---------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999999996633211 01 1111123578999999999999999999999887754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=339.02 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=195.0
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcC----------CCCCCeeEEe
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQG----------GTGIPNVRWF 71 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~----------~~~i~~~~~~ 71 (477)
+...++|++++.||+|+||.||+|++..+++.||||++.... ....+..|++++..+.+ ++++..+..+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 345679999999999999999999999999999999986432 23457789999998874 2445544443
Q ss_pred eEeC----cEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecC---CCC
Q 011819 72 GVEG----DYNVLVMDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLG---RRA 142 (477)
Q Consensus 72 ~~~~----~~~~lVmE~~g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~---~~~ 142 (477)
+... ...++||||++++|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.. +..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 3322 278999999999999999753 34599999999999999999999998 99999999999999532 234
Q ss_pred CcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCccc--
Q 011819 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-- 220 (477)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~-- 220 (477)
+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||+||+|++|..||.......
T Consensus 175 ~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ceEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 589999999998765432 24578999999999999999999999999999999999999997643211
Q ss_pred -HHHHHHHHhhhcccccH------------------------------HH-------HhcCCcHHHHHHHHHHhcCCCCC
Q 011819 221 -KKQKYEKISEKKVSTSI------------------------------EA-------LCRGYPTEFASYFHYCRSLRFDD 262 (477)
Q Consensus 221 -~~~~~~~i~~~~~~~~~------------------------------~~-------l~~~~p~~l~~li~~cl~~~p~~ 262 (477)
....+..+.......+. .. +...+++++.+||..||..||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11222222111100000 00 11234678999999999999999
Q ss_pred CCCHHHHHH
Q 011819 263 KPDYAYLKR 271 (477)
Q Consensus 263 RPt~~~l~~ 271 (477)
||+++++.+
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999777643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=327.89 Aligned_cols=251 Identities=22% Similarity=0.256 Sum_probs=201.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEee-EeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFG-VEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~-~~~~~~ 78 (477)
...++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.++|++.+..+..+. ......
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 446799999999999999999999999999999999875432 234778999999998755555544443 346688
Q ss_pred EEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeCCCCCCceEeecCCCCCcEEEee
Q 011819 79 VLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~g-----iiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
++||||+ +++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEec
Confidence 9999999 78999998643 234999999999999999999999999 9999999999999 6788999999
Q ss_pred cCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 150 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+....+.
T Consensus 160 fg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~ 229 (279)
T 2w5a_A 160 FGLARILNHDTS-------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIR 229 (279)
T ss_dssp CCHHHHC---CH-------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred Cchheeeccccc-------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHh
Confidence 999976543221 11234689999999999999999999999999999999999999976432 33444444
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..... .++..+++++.++|..||..+|++||++.++.+
T Consensus 230 ~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 230 EGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp HTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 43322 234568999999999999999999999877754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=324.31 Aligned_cols=249 Identities=11% Similarity=0.156 Sum_probs=200.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeC--cEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG--DYN 78 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~--~~~ 78 (477)
..++|++.+.||+|+||.||+|++ .++.||||++...... ..+..|+.++..++|++ |..+..++... ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN-VLPVLGACQSPPAPHP 84 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTT-EECEEEEECTTTSSSC
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCc-hhheEEEEccCCCCCe
Confidence 357899999999999999999997 4889999998765422 34778888888887754 44444444443 677
Q ss_pred EEEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 79 VLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~-~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
++||||+ +++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKF 161 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCC
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEecccee
Confidence 9999999 8899999985332 4899999999999999999999999 9999999999999 678899999999875
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCC---cchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSR---RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~---ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (477)
.... ....||+.|+|||++.+..++. ++|||||||++|+|++|..||..... ......+...
T Consensus 162 ~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~ 226 (271)
T 3kmu_A 162 SFQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALE 226 (271)
T ss_dssp TTSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHS
T ss_pred eecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhc
Confidence 4322 2347899999999999866554 79999999999999999999976443 2333333322
Q ss_pred cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
.... .++..+++++.+++..||..+|++||+++++.+.|+++.
T Consensus 227 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 227 GLRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 2211 234578999999999999999999999999999988773
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=325.38 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=204.9
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
+.++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.+++.++| +++..+..++......++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccC-CCccEEEEEEeCCCeEEE
Confidence 457899999999999999999999999999999987543 234568899999999976 566666666677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999 8999998864 346999999999999999999999999999999999999964444568999999999765432
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... .+....+..........
T Consensus 178 ~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~- 244 (287)
T 2wei_A 178 TK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYAFDLP- 244 (287)
T ss_dssp SS--------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCSG-
T ss_pred Cc--------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCch-
Confidence 21 234468999999999876 489999999999999999999999976433 34444444443322222
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
....+++++.++|..||..+|++||++.++.+
T Consensus 245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 23568999999999999999999999777654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=329.83 Aligned_cols=250 Identities=20% Similarity=0.292 Sum_probs=196.5
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcC-CCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQG-GTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~-~~~i~~~~~~~~~~~~~~ 79 (477)
.+++|++++.||+|+||.||+|.+ .+++.||||++...... ..+..|+.++..+.+ ++++..+..++......+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 457899999999999999999997 45899999998654332 357789999999986 678888888888888999
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||+++.....
T Consensus 105 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC----
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccccCc
Confidence 9999889999999985 55799999999999999999999999999999999999993 488999999999866543
Q ss_pred CCCcccccccCCCCccCccccccchhcC-----------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-----------~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i 228 (477)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+..+
T Consensus 180 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~ 252 (313)
T 3cek_A 180 TTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAI 252 (313)
T ss_dssp ---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHH
T ss_pred ccc-----ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHHHHH
Confidence 221 11234579999999999976 4678899999999999999999999976432 22223222
Q ss_pred hhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
...... ..+...+++++.++|..||..||.+||++.++.
T Consensus 253 ~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 291 (313)
T 3cek_A 253 IDPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291 (313)
T ss_dssp HCTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred Hhcccc---cCCcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence 222111 112345688999999999999999999976664
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=330.39 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=199.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
...++|++++.||+|+||.||+|.+..+++.||+|++.... ....+..|+.++..+.| +++..+..++...+..++|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH-PYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCC-TTBCCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCC-CCEeeeeeeeeeCCeEEEE
Confidence 45678999999999999999999999999999999876543 33567889999999976 5566666666667788999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccccccc
Confidence 9999 889999987667789999999999999999999999999999999999999 678899999999976432211
Q ss_pred CCcccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
.......||+.|+|||++. +..++.++|||||||++|+|++|..||..... ...+..+.......
T Consensus 172 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 172 -------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSDPPT 241 (302)
T ss_dssp -------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC
T ss_pred -------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhccCCcc
Confidence 1123457899999999984 66789999999999999999999999976443 23333333322211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. .....++.++.++|..||..+|++||++.++.+
T Consensus 242 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 L--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 123457899999999999999999999877643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=335.16 Aligned_cols=268 Identities=19% Similarity=0.197 Sum_probs=205.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEE----ECCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHcCCCCCCeeEEeeE-eCc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIPNVRWFGV-EGD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~----~~~~g~~vAiKi~~~~~~~--~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~ 76 (477)
...++|++++.||+|+||.||+|+ +..+++.||||++...... ..+..|+.+++.++|++++..+..+.. ...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 345689999999999999999998 4568999999998764432 357899999999987555555444433 334
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcchhh
Confidence 679999999 889999998766679999999999999999999999999999999999999 5678999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc---------cHHHHHH
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------TKKQKYE 226 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~---------~~~~~~~ 226 (477)
........ .......++..|+|||++.+..++.++|||||||++|+|++|..||...... .......
T Consensus 195 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 195 LPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp CCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 75433211 1123346788899999999888999999999999999999999998642100 0000000
Q ss_pred HHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
.+............+..+|+++.++|..||..+|++||++.++.+.|+++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0000000000011235689999999999999999999999999999988854
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=335.00 Aligned_cols=252 Identities=20% Similarity=0.210 Sum_probs=184.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeC------cEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEG------DYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~------~~~ 78 (477)
.++|++.+.||+|+||.||+|++..+++.||||++.... .......|++.+..++|++++..+.++.... .+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 468999999999999999999999999999999875433 2345677788888888866666555554322 247
Q ss_pred EEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 79 VLVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 79 ~lVmE~~g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLH--s~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
++||||+.++|.+.+.. ....+++..+..++.||+.||.||| ++||+||||||+|||++ ..++.+||+|||++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCc
Confidence 89999997787766542 3456899999999999999999999 99999999999999994 23789999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
+....... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.... ..+..+....
T Consensus 180 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~ 248 (360)
T 3e3p_A 180 KKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIVRVL 248 (360)
T ss_dssp BCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHH
T ss_pred eecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHHHHc
Confidence 87654332 23457899999999997655 899999999999999999999999875432 3333332211
Q ss_pred cccc-----------------------HHHHh----cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 VSTS-----------------------IEALC----RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 ~~~~-----------------------~~~l~----~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.... ..... ..+++++.+||..||..||.+||++.++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 1110 11111 12578999999999999999999977664
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=347.64 Aligned_cols=264 Identities=19% Similarity=0.233 Sum_probs=187.1
Q ss_pred ccCCceEE-EeeeeecCceEEEEEEEC--CCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcEEE
Q 011819 4 RVGNKFRL-GRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-EGDYNV 79 (477)
Q Consensus 4 ~i~~~y~i-~~~IG~G~fG~Vy~a~~~--~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~~~ 79 (477)
.+.+.|++ +++||+|+||.||+|++. .+++.||||++........+.+|+.+++.|+|++++..+..+.. .....|
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 34567887 558999999999999976 56899999999877667788999999999998655555555433 467889
Q ss_pred EEEecCCCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC-CCCCcEEEeec
Q 011819 80 LVMDLLGPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDF 150 (477)
Q Consensus 80 lVmE~~g~sL~~li~~~~--------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~-~~~~~vkL~DF 150 (477)
|||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+||
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 999999889999886321 249999999999999999999999999999999999999532 45689999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCccc------HHH
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQ 223 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~------~~~ 223 (477)
|+|+....... +.......+||+.|+|||++.+. .++.++|||||||+||+|++|..||.+..... ...
T Consensus 177 g~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 177 GFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp TCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred CCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99987654321 11223456899999999999884 48999999999999999999999997643210 011
Q ss_pred HHHHHhhhcc---cc------------------------------cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 224 KYEKISEKKV---ST------------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 224 ~~~~i~~~~~---~~------------------------------~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.+..+..... .. .........++++.+||..||..||.+||++++++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 2222211100 00 00001112367899999999999999999977664
Q ss_pred H
Q 011819 271 R 271 (477)
Q Consensus 271 ~ 271 (477)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=335.91 Aligned_cols=266 Identities=16% Similarity=0.221 Sum_probs=191.9
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHH--HHcCCCCCCeeEEee----EeCcE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYR--ILQGGTGIPNVRWFG----VEGDY 77 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~--~L~~~~~i~~~~~~~----~~~~~ 77 (477)
.-.++|++++.||+|+||.||+|++ +++.||||++.... ...+..|..++. .+.|++++..+..+. .....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 3457999999999999999999985 78999999986533 334455555544 356655555443322 23346
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeCCCCCCceEeecCCCCCcEEE
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---------SFLHRDIKPDNFLMGLGRRANQVYI 147 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~---------giiHRDLKP~NILl~~~~~~~~vkL 147 (477)
.+|||||+ +++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEE
Confidence 68999999 8999999974 4468999999999999999999999 99999999999999 67889999
Q ss_pred eecCceeecccCCCCcc-cccccCCCCccCccccccchhcC-------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcc
Q 011819 148 IDFGLAKKYRDTSTHQH-IPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (477)
Q Consensus 148 ~DFGla~~~~~~~~~~~-~p~~~~~~~~Gt~~Y~APE~~~g-------~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~ 219 (477)
+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987654322110 01112335679999999999987 35667899999999999999998777442221
Q ss_pred cH---------------HHHHHHHhhhcccccHHHHhc---CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 220 TK---------------KQKYEKISEKKVSTSIEALCR---GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 220 ~~---------------~~~~~~i~~~~~~~~~~~l~~---~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
.. ......+............+. .+++++.++|..||..||++||++.++.+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 10 000011111111111111111 13558999999999999999999999999999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=333.69 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=202.2
Q ss_pred CccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcC-CCCCCeeEEeeE
Q 011819 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLLYESKLYRILQG-GTGIPNVRWFGV 73 (477)
Q Consensus 3 ~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--------~~~~~~~E~~il~~L~~-~~~i~~~~~~~~ 73 (477)
..+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.+ ++++..+..++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 356789999999999999999999999999999999876542 22456789999999985 677777777777
Q ss_pred eCcEEEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 74 EGDYNVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 74 ~~~~~~lVmE~~-g-~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
..+..++|||++ + ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ...+.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeCc
Confidence 888899999999 3 899999975 45699999999999999999999999999999999999994 267899999999
Q ss_pred ceeecccCCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 152 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
+++...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .+..
T Consensus 196 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~~ 257 (320)
T 3a99_A 196 SGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIR 257 (320)
T ss_dssp TCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH
T ss_pred ccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhhc
Confidence 998765432 234579999999999987776 688999999999999999999996421 1111
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
... .+...+++++.++|..||..+|++||+++++.+
T Consensus 258 ~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 GQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 133568999999999999999999999877743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.82 Aligned_cols=266 Identities=22% Similarity=0.313 Sum_probs=205.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHH--HcCCCCCCeeEEeeEeCc----EE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRI--LQGGTGIPNVRWFGVEGD----YN 78 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~--L~~~~~i~~~~~~~~~~~----~~ 78 (477)
+.++|++.+.||+|+||.||+|++ +++.||||++... ....+..|.+++.. +.| +++..+..++.... ..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h-~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCC-TTBCCEEEEEECCCSSCCCE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCC-CcEEEEEeeecccCCcccee
Confidence 457899999999999999999996 5899999998653 34567788898888 455 55555555544443 78
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeCCCCCCceEeecCCCCCcEEEee
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLH--------s~giiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
++||||+ +++|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||+ +.++.+||+|
T Consensus 116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~D 190 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 190 (342)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECC
T ss_pred EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEE
Confidence 9999999 7899999974 46999999999999999999999 8999999999999999 6788999999
Q ss_pred cCceeecccCCCCcccccccCCCCccCccccccchhcCCC------CCCcchHHHHHHHHHHHHcC----------CCCC
Q 011819 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG----------SLPW 213 (477)
Q Consensus 150 FGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~------~s~ksDIwSlGviLyelltG----------~~Pf 213 (477)
||++........... .......||+.|+|||++.+.. ++.++|||||||+||+|++| ..||
T Consensus 191 fg~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 191 LGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp CTTCEEEETTTTEEE---ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCceeccccccccc---cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 999987765432110 1124567999999999998763 33689999999999999999 8899
Q ss_pred CCCCcc--cHHHHHHHHhhhcccccHHH--HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011819 214 QGLKAG--TKKQKYEKISEKKVSTSIEA--LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGF 282 (477)
Q Consensus 214 ~~~~~~--~~~~~~~~i~~~~~~~~~~~--l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~ 282 (477)
...... ........+........... ....++..+.+++..||..+|++||++.++.+.|+++..+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 765332 22233333333222211111 1123457899999999999999999999999999999876653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=334.30 Aligned_cols=264 Identities=16% Similarity=0.190 Sum_probs=199.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeE---eCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGV---EGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~---~~~~~~ 79 (477)
-.++|++++.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.|++++..+..+.. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 3568999999999999999999999999999999875432 23457789999999988665555555542 234679
Q ss_pred EEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 80 LVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~---~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchh
Confidence 999999 78999998752 5669999999999999999999999999999999999999 6788999999999876
Q ss_pred cccCCCCcc--cccccCCCCccCccccccchhcCCC---CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 156 YRDTSTHQH--IPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 156 ~~~~~~~~~--~p~~~~~~~~Gt~~Y~APE~~~g~~---~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
......... ..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ .....+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~ 262 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQN 262 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHHC
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhhc
Confidence 532111000 0000112345799999999988654 68899999999999999999999953211000 00111111
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
... ......+++++.++|..||..+|.+||++.++.+.|+.+
T Consensus 263 -~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 263 -QLS---IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp -C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -cCC---CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 111 112246789999999999999999999999998887765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.94 Aligned_cols=250 Identities=20% Similarity=0.359 Sum_probs=197.6
Q ss_pred eeeeecCceEEEEEEE--CCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~--~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
++||+|+||.||+|.+ ..+++.||||++..... ...+..|++++..|+|++ |+.+..++. .+..+|||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY-IVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTT-BCCEEEEEE-SSSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCC-EeeEEEEEe-cCCEEEEEEccC
Confidence 4799999999999954 45678999999865432 246889999999998755 444444444 34578999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+......
T Consensus 453 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~--- 525 (635)
T 4fl3_A 453 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENY--- 525 (635)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccCccc---
Confidence 8999999975 5679999999999999999999999999999999999999 56789999999999876543221
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
+.......||+.|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+...... ..+..+
T Consensus 526 -~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~~ 597 (635)
T 4fl3_A 526 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM----GCPAGC 597 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCCTTC
T ss_pred -cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCCCC
Confidence 111233457889999999999999999999999999999998 9999987544 3333333332221 134568
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
|+++.+||..||..||++||++++|.+.|++++..
T Consensus 598 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 598 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=360.40 Aligned_cols=253 Identities=22% Similarity=0.370 Sum_probs=205.0
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|++.++||+|+||.||+|.+.. +..||||++.... ....+..|+++++.|+|.+++..+. ++.. +..||||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEE-EECS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEE-EEee-ccceEeeeh
Confidence 4679999999999999999999854 5679999987643 3356899999999999865555544 4433 567999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~-- 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE-- 417 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHH--
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCc--
Confidence 9 88999999642 3569999999999999999999999999999999999999 577899999999997654211
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
+.......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+...... ...
T Consensus 418 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~ 486 (535)
T 2h8h_A 418 ----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCP 486 (535)
T ss_dssp ----HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCC----CCC
T ss_pred ----eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 111233457889999999999899999999999999999999 9999987543 3334333332111 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+|+++.+||..||..+|++||++++|.+.|++++
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 568999999999999999999999999999988775
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=327.88 Aligned_cols=258 Identities=22% Similarity=0.275 Sum_probs=196.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECC-CCc--EEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-TNE--EVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~-~g~--~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
..++|++++.||+|+||.||+|++.. +++ .||||++.... ....+..|+.++..++|++.+..+. +.....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~ 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPP 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEE-EECSSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEE-EEccCC
Confidence 35689999999999999999998643 333 68999876432 1245778999999998755444444 443333
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
.++||||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEcccccccc
Confidence 78999999 899999998656679999999999999999999999999999999999999 5678999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
........ .......+|..|+|||++.+..++.++|||||||++|+|++ |..||..... .+.+..+......
T Consensus 171 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~ 243 (291)
T 1u46_A 171 LPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGER 243 (291)
T ss_dssp CCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCCC
T ss_pred ccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHccCCC
Confidence 75433211 11234567889999999998889999999999999999999 9999976543 3444444333221
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
. .....+|+++.+++..||..+|++||++.++.+.|+++.
T Consensus 244 ~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 L---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1 123568999999999999999999999999999888774
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=337.10 Aligned_cols=261 Identities=17% Similarity=0.216 Sum_probs=200.3
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+..|++++..+.| ++|..+..++......++|
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCC-TTBCCCCEEECCSSCCEEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccC-CCccceEEEEecCCceEEE
Confidence 567899999999999999999984 578999999876543 22368899999999987 5555555566667778999
Q ss_pred EecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 82 MDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~---~~ls~~~~~~i~~qIa~aL~yLHs~---giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 182 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCcccc
Confidence 9999 889999997432 3499999999999999999999999 99999999999999 678899999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCC-----CcccHHHHHHHHh
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL-----KAGTKKQKYEKIS 229 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~-----~~~~~~~~~~~i~ 229 (477)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||... .............
T Consensus 183 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 183 LMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp ECCSSSSC------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred ccCccccc------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 76543321 123456999999999999889999999999999999999999999521 1111111111110
Q ss_pred hhc-cccc-----HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 230 EKK-VSTS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 230 ~~~-~~~~-----~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
... .... ........++++.+++..||..+|.+||++.++.+.|+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 000 0000 0011122357899999999999999999999998887653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=323.90 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=198.1
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 10 ~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
..+++||+|+||.||+|.+ +++.||||++.... ....+..|+.+++.++| +++..+..++...+..++|||
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH-ENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEE
T ss_pred ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC-CCeEEEEEEEecCCceEEEEE
Confidence 3448999999999999984 68899999876432 12457889999999987 566666666667778899999
Q ss_pred cC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 84 ~~-g~sL~~li~~~--~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSCS
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeeccccccccccc
Confidence 99 89999998633 3459999999999999999999999999999999999999 678899999999998765432
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH-
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA- 239 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~- 239 (477)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+........ ..+..
T Consensus 188 ~~-----~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 260 (307)
T 2nru_A 188 QT-----VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE-KTIEDY 260 (307)
T ss_dssp SC-----EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS-CCHHHH
T ss_pred cc-----ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh-hhhhhh
Confidence 21 11234579999999999876 488999999999999999999999987544322212111111111 11111
Q ss_pred -------HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 240 -------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 240 -------l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
....+++.+.+++..||..+|.+||++.++.+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1122457899999999999999999999999998876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=330.59 Aligned_cols=258 Identities=22% Similarity=0.268 Sum_probs=183.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.| ++|..+..++...+..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH-PNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCC-TTBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCC-CCEeeEEEEEeecCCcEEE
Confidence 4578999999999999999999998899999999876532 23456788888888876 5566666666677788999
Q ss_pred EecC-CCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 82 MDLL-GPSLEDLFNF-------CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 82 mE~~-g~sL~~li~~-------~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
|||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccch
Confidence 9999 8999999874 24559999999999999999999999999999999999999 67889999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
.......... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... .......
T Consensus 169 ~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~ 243 (303)
T 2vwi_A 169 AFLATGGDIT--RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQND 243 (303)
T ss_dssp HHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHTSS
T ss_pred heeccCCCcc--chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhccC
Confidence 7654322110 0111234579999999999876 56899999999999999999999999875443221 1111111
Q ss_pred ccc-----cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 VST-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ~~~-----~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
... ........+++++.++|..||..||.+||++.++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111 111233568899999999999999999999877754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=325.94 Aligned_cols=250 Identities=19% Similarity=0.306 Sum_probs=183.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch---hHHHHHH-HHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESK-LYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~---~~~~E~~-il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.++|++++.||+|+||.||+|.+..+++.||||++....... .+..|.. +++.+ +|++|..+..++...+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEE
Confidence 368999999999999999999999999999999987654322 2333433 34444 456777777777778889999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||++..+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++.......
T Consensus 103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCc
Confidence 99998888888876677899999999999999999999995 99999999999999 678899999999997654432
Q ss_pred CCcccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
. .....||+.|+|||++. +..++.++|||||||++|+|++|..||..... ....+..+.......
T Consensus 180 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 180 A--------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPL 249 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCC
T ss_pred c--------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCC
Confidence 2 23457899999999994 55688999999999999999999999976432 233333333332211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. .....+++++.++|..||..||.+||+++++.+
T Consensus 250 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 L--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 112357899999999999999999999877754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=333.79 Aligned_cols=247 Identities=21% Similarity=0.296 Sum_probs=193.7
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc----
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEGD---- 76 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~---- 76 (477)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+..|+.+++.++|++++..+..+.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 457899999999999999999999999999999998654322 346789999999987655555555443322
Q ss_pred -EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 -YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 -~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..|+||||++++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC
T ss_pred eeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeecccccC
Confidence 349999999888887764 459999999999999999999999999999999999999 6788999999999975
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc-
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV- 233 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (477)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+..+.....
T Consensus 176 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~ 242 (353)
T 3coi_A 176 ADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGV 242 (353)
T ss_dssp ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCB
T ss_pred CCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Confidence 4332 134578999999999987 6789999999999999999999999976443 222222221100
Q ss_pred -------------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 -------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 -------------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
......+...+++++.++|.+||..||++||+++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 304 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0111223356789999999999999999999977664
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=323.95 Aligned_cols=259 Identities=19% Similarity=0.211 Sum_probs=193.3
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeE---------
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGV--------- 73 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~--------- 73 (477)
++.++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.++|++.+..+..+..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 35678999999999999999999999999999999875432 22457789999999987655555544432
Q ss_pred ---eCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEee
Q 011819 74 ---EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (477)
Q Consensus 74 ---~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~D 149 (477)
.....|+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEee
Confidence 245679999999 889999998666678899999999999999999999999999999999999 6788999999
Q ss_pred cCceeecccCCCCcc-------cccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH
Q 011819 150 FGLAKKYRDTSTHQH-------IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (477)
Q Consensus 150 FGla~~~~~~~~~~~-------~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~ 221 (477)
||++........... ..........||+.|+|||++.+. .++.++|||||||++|+|++ ||... ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhH
Confidence 999986643211000 001123456799999999999865 68999999999999999998 66431 122
Q ss_pred HHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...+..+..... .....+...+++.+.++|..||..||++||++.++.+
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSI-EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTC-CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccccc-ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 233333332221 1122244567888999999999999999999877754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=330.05 Aligned_cols=254 Identities=17% Similarity=0.280 Sum_probs=178.6
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|...+....++++|..+..++...+..+||
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 457899999999999999999999999999999998765332 23445555333334557777777777778889999
Q ss_pred EecCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 82 MDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 82 mE~~g~sL~~li~~----~~~~ls~~~~~~i~~qIa~aL~yLHs~-giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
|||+.++|.+++.. ....+++..+..++.||+.||.|||+. ||+||||||+|||+ +.++.+||+|||+++..
T Consensus 100 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC-
T ss_pred EeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCceec
Confidence 99998899888863 256799999999999999999999998 99999999999999 57889999999999866
Q ss_pred ccCCCCcccccccCCCCccCccccccchh----cCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~----~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
..... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||...... .+.+..+....
T Consensus 177 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~ 246 (327)
T 3aln_A 177 VDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGD 246 (327)
T ss_dssp -------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSC
T ss_pred ccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCC
Confidence 44322 1234789999999998 4667899999999999999999999999764321 11121122211
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...........+++++.++|..||..||++||++.++.+
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111223468999999999999999999999877754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=320.87 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=192.5
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
...||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| +++..+..++...+..++||||+ +++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSFSENGFIKIFMEQVPGGS 105 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCC-CCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence 3489999999999999999999999998765432 3467889999999977 55556666667788899999999 899
Q ss_pred HHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcccc
Q 011819 89 LEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166 (477)
Q Consensus 89 L~~li~~~~~--~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p 166 (477)
|.+++..... .+++..+..++.||+.||.|||++||+|+||||+|||++ ..++.+||+|||++........
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~----- 178 (295)
T 2clq_A 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP----- 178 (295)
T ss_dssp HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC--------
T ss_pred HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC-----
Confidence 9999976433 467889999999999999999999999999999999994 2378999999999987654221
Q ss_pred cccCCCCccCccccccchhcCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 167 YRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~g~~--~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ............ ...++..+
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~---~~~~~~~~ 251 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKV---HPEIPESM 251 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHHCC---CCCCCTTS
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhhccccc---cccccccC
Confidence 123457899999999997654 789999999999999999999999753321 111111111111 11234568
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
++++.++|..||..+|++||+++++.
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHh
Confidence 99999999999999999999977764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.61 Aligned_cols=271 Identities=18% Similarity=0.253 Sum_probs=198.2
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
..++|++.+.||+|+||.||+|.+.. .||+|++.... ....+..|+.+++.++|+ ++..+..++......++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE-NVVLFMGACMSPPHLAI 106 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCT-TBCCCCEEEECSSCEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCC-CEeEEEEEEecCCceEE
Confidence 45789999999999999999999753 49999876532 223567889999999874 55555555666777899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ + ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY---D-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE---C---CCEECCCSCCC-----
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE---e-CCCEEEeecCCccccccc
Confidence 99999 899999998655579999999999999999999999999999999999999 3 578999999998765332
Q ss_pred CCCcccccccCCCCccCccccccchhcC---------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhh
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLG---------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g---------~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~ 230 (477)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+..
T Consensus 183 ~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~ 257 (319)
T 2y4i_B 183 QAGR--REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMGT 257 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHHHT
T ss_pred cccc--cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhcc
Confidence 2111 1112234569999999999975 3578899999999999999999999976433 333333333
Q ss_pred hcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 011819 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291 (477)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~ 291 (477)
...... ....+|.++.+++..||..+|++||++.++.+.|+++..+..........|.
T Consensus 258 ~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 258 GMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp TCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred CCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 322211 1235788999999999999999999999999999988766655555555554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=324.57 Aligned_cols=242 Identities=21% Similarity=0.310 Sum_probs=191.0
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--------chhHHHHHHHHHHHc---CCCCCCeeEEee
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLLYESKLYRILQ---GGTGIPNVRWFG 72 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--------~~~~~~E~~il~~L~---~~~~i~~~~~~~ 72 (477)
.+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+. .|++|..+..++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 456789999999999999999999999999999999865432 234567999999984 346666666666
Q ss_pred EeCcEEEEEEec-C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 73 VEGDYNVLVMDL-L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 73 ~~~~~~~lVmE~-~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
...+..++|||+ + +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ ..++.+||+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLIDF 184 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEEc
Confidence 667778999998 5 8999999975 45699999999999999999999999999999999999994 26789999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCCCCC-CcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s-~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~ 229 (477)
|++....... .....||..|+|||++.+..+. .++|||||||++|+|++|..||... . .+.
T Consensus 185 g~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~----~~~ 246 (312)
T 2iwi_A 185 GSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----Q----EIL 246 (312)
T ss_dssp SSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H----HHH
T ss_pred chhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----H----HHh
Confidence 9998765432 2345789999999999877664 5899999999999999999999642 1 111
Q ss_pred hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.... .+...+++++.++|..||..+|++||+++++.+
T Consensus 247 ~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 EAEL-----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HTCC-----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhcc-----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 133568899999999999999999999877754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.54 Aligned_cols=238 Identities=14% Similarity=0.129 Sum_probs=185.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCC----------eeEE-
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIP----------NVRW- 70 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~----------~~~~- 70 (477)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+..|+.++..|.|..+.. .+..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35889999999999999999999999999999987432 2345788888888887632211 1111
Q ss_pred ----------eeEe-----CcEEEEEEecCCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCC
Q 011819 71 ----------FGVE-----GDYNVLVMDLLGPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129 (477)
Q Consensus 71 ----------~~~~-----~~~~~lVmE~~g~sL~~li~~~------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDL 129 (477)
+... ....+++|++++++|.+++..+ ...+++..++.++.||+.||+|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 0111 2235888999999999999533 344778899999999999999999999999999
Q ss_pred CCCceEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchh----------cCCCCCCcchHHHH
Q 011819 130 KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH----------LGIEQSRRDDLESL 199 (477)
Q Consensus 130 KP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~----------~g~~~s~ksDIwSl 199 (477)
||+|||+ +.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVL---DQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccceEEE---ecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999 67888999999999865432 234578 999999999 55668889999999
Q ss_pred HHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 200 GviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
||+||+|++|+.||....... .+ ..+...+..+|+++.+||..||..+|++||++.++.
T Consensus 304 Gvil~elltg~~Pf~~~~~~~---~~---------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALG---GS---------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGS---CS---------GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHCCCCCCCcchhh---hH---------HHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999999997643211 01 111112357899999999999999999999977664
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.59 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=205.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCC---CcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~---g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.++|++++.||+|+||.||+|.+..+ +..||||.+...... ..+..|+.++..+.|++++..+. ++. .+..+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~-~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VIT-ENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEE-EEC-SSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE-EEe-cCceE
Confidence 46899999999999999999998654 467999987654322 45788999999998755555544 443 45579
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCeecCC
Confidence 999999 899999998656679999999999999999999999999999999999999 5678999999999987644
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+... .+.+..+......
T Consensus 544 ~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~--- 611 (656)
T 2j0j_A 544 STY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERL--- 611 (656)
T ss_dssp ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHHTCCC---
T ss_pred Ccc------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCC---
Confidence 322 11223467889999999999999999999999999999997 9999987543 3334444333221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.++..+|+++.++|..||..||++||++.++.+.|++++..+
T Consensus 612 -~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 134578999999999999999999999999999999987654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=328.47 Aligned_cols=251 Identities=16% Similarity=0.222 Sum_probs=200.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-------------------hhHHHHHHHHHHHcCCCC
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------------PQLLYESKLYRILQGGTG 64 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-------------------~~~~~E~~il~~L~~~~~ 64 (477)
...++|++++.||+|+||.||+|.+ +++.||||++...... ..+..|+.++..++| ++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN-EY 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC-TT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC-CC
Confidence 3457999999999999999999998 8999999987542110 678899999999986 55
Q ss_pred CCeeEEeeEeCcEEEEEEecC-CCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceE
Q 011819 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDL------FNFC-SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFL 135 (477)
Q Consensus 65 i~~~~~~~~~~~~~~lVmE~~-g~sL~~l------i~~~-~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NIL 135 (477)
+..+..++...+..++||||+ +++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 656656666778899999999 7799988 5421 4569999999999999999999999 99999999999999
Q ss_pred eecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCC-CCCC-cchHHHHHHHHHHHHcCCCCC
Q 011819 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSR-RDDLESLGYVLMYFLRGSLPW 213 (477)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~-ksDIwSlGviLyelltG~~Pf 213 (477)
+ +.++.+||+|||++....... .....||+.|+|||++.+. .++. ++|||||||++|+|++|..||
T Consensus 185 ~---~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 185 M---DKNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp E---CTTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred E---cCCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 9 678899999999998764431 2345799999999999887 5665 999999999999999999999
Q ss_pred CCCCcccHHHHHHHHhhhcccccH--------------HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 214 QGLKAGTKKQKYEKISEKKVSTSI--------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~--------------~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
...... .+.+..+.......+. ......+++++.++|..||..||.+||+++++.+
T Consensus 253 ~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 253 SLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 864432 3344444433222110 1112568999999999999999999999877643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=334.45 Aligned_cols=259 Identities=20% Similarity=0.224 Sum_probs=189.5
Q ss_pred CCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 2 ~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
+..+.+.|.+.+.||+|+||+||.+. ..+|+.||||.+... ....+..|++++..+.+|++|+.+..++......|||
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 44567788888999999999998764 468999999987653 2345788999999886667888887778888899999
Q ss_pred EecCCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC----------CCCCcE
Q 011819 82 MDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----------RRANQV 145 (477)
Q Consensus 82 mE~~g~sL~~li~~~~~~------ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~----------~~~~~v 145 (477)
||||+++|.+++...... .++..++.++.||+.||+|||++||+||||||+|||++.. +..+.+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 999988999999743211 1223457799999999999999999999999999999532 234689
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcC-------CCCCCcchHHHHHHHHHHHHc-CCCCCCCCC
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-------~~~s~ksDIwSlGviLyellt-G~~Pf~~~~ 217 (477)
||+|||+++......... .......+||+.|+|||++.+ ..++.++|||||||++|||++ |..||....
T Consensus 168 kL~DFG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSF---RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEcccccceecCCCCccc---eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 999999999775432211 011234679999999999976 568999999999999999999 999997543
Q ss_pred cccHHHHHHHHhhhcccc-cHHH-HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 218 AGTKKQKYEKISEKKVST-SIEA-LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~-~~~~-l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.. . ..+....... .... ....+++++.++|..||..||.+||++.++.
T Consensus 245 ~~--~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 245 SR--E---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp TH--H---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hh--H---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 21 1 1122211111 0000 0123468899999999999999999987765
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=336.53 Aligned_cols=263 Identities=17% Similarity=0.191 Sum_probs=193.3
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecCCC
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP 87 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~g~ 87 (477)
+|++.+.||+|+||+||.. ...+++.||||++... ....+.+|+++++.+.+|++|+.+..++.+....|||||||++
T Consensus 25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g 102 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPE-CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA 102 (432)
T ss_dssp EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTT-TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC
Confidence 6999999999999997643 3478999999988653 3345778999999996667787777778888999999999988
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC--CCCcEEEeecCceeecccCCCCccc
Q 011819 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 88 sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~--~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+|.+++......+....++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+|+........
T Consensus 103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~--- 179 (432)
T 3p23_A 103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS--- 179 (432)
T ss_dssp EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---------
T ss_pred CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc---
Confidence 99999986555566667789999999999999999999999999999995322 2346789999999876543211
Q ss_pred ccccCCCCccCccccccchhc---CCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 166 PYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~---g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
+......+||+.|+|||++. +..++.++|||||||++|+|++ |..||..... .+ ...+....... .....
T Consensus 180 -~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~-~~~~~~~~~~~-~~~~~ 253 (432)
T 3p23_A 180 -FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQ-ANILLGACSLD-CLHPE 253 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HH-HHHHTTCCCCT-TSCTT
T ss_pred -eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HH-HHHHhccCCcc-ccCcc
Confidence 11234567999999999998 4567889999999999999999 9999965322 11 11111111100 00001
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWT 291 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~ 291 (477)
...+..+.+||..||..||.+||++.++.+ ++|+..++|.
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~----------hp~f~~~~~~ 293 (432)
T 3p23_A 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLK----------HPFFWSLEKQ 293 (432)
T ss_dssp CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT----------STTTCCHHHH
T ss_pred ccccHHHHHHHHHHHhCCHhhCCCHHHHHh----------CccccChHHH
Confidence 223566899999999999999999877753 4555555553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.32 Aligned_cols=235 Identities=17% Similarity=0.199 Sum_probs=181.3
Q ss_pred ccCCceEEE-eeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEe----CcEE
Q 011819 4 RVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYN 78 (477)
Q Consensus 4 ~i~~~y~i~-~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~----~~~~ 78 (477)
.+.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+..|+.++..+.+|++|..+..++.. ....
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 455778887 779999999999999999999999999853 35678899988676666777776655544 6678
Q ss_pred EEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 79 VLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~-~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 170 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence 9999999 889999998643 36999999999999999999999999999999999999954333789999999998643
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHH-HHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~ 235 (477)
.. ..++.++|||||||++|+|++|..||............ ..+..... .
T Consensus 171 ~~-----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~-~ 220 (299)
T 3m2w_A 171 TG-----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-E 220 (299)
T ss_dssp TT-----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC-S
T ss_pred cc-----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc-c
Confidence 21 24677899999999999999999999764321100000 00111111 1
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
........+++++.++|..||..||.+||++.++.+
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 122233678999999999999999999999776643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=313.75 Aligned_cols=231 Identities=11% Similarity=0.080 Sum_probs=186.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
.++++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.++..+.| ++|+.+..++...+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK-PGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCC-CCcceeeEEEEECCcE
Confidence 5678999999999999999999999999999999998765432 457889999988877 5666777777788899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||||||+ |++|.+++.. + ....++..++.||+.||+|||++||+||||||+|||+ +.++.+||++++
T Consensus 107 ~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA------ 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC------
T ss_pred EEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc------
Confidence 9999999 8999999862 3 4666789999999999999999999999999999999 577889987543
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
|++ +++.++|||||||+||+|++|..||.+...........+... ......
T Consensus 175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~ 225 (286)
T 3uqc_A 175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQPIEP 225 (286)
T ss_dssp ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCBCCH
T ss_pred ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCCCCh
Confidence 333 368899999999999999999999987544211100000111 112334
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+...+|+++.++|.+||+.||++| ++.++.+.|+++.
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 45667899999999999999999999 9999999888874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=338.91 Aligned_cols=241 Identities=14% Similarity=0.191 Sum_probs=187.7
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECC-CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCc---
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGD--- 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~-~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~--- 76 (477)
.+.++|+++++||+|+||.||+|.+.. +++.||||++...... ..+..|+.++..++|++++..+.++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 466899999999999999999999976 7899999987654322 346789999999987555554444444333
Q ss_pred -EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 77 -YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 77 -~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
..||||||+ |++|.+++. ..+++..++.++.||+.||.|||++|||||||||+|||++ . +.+||+|||+++
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~ 229 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVS 229 (681)
T ss_dssp EEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCTTCE
T ss_pred ceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEecccch
Confidence 269999999 889988775 2799999999999999999999999999999999999993 3 489999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
..... ....||+.|+|||++.+. ++.++|||||||+||+|++|..||.+..... ..
T Consensus 230 ~~~~~-----------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------~~ 285 (681)
T 2pzi_A 230 RINSF-----------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG------------LP 285 (681)
T ss_dssp ETTCC-----------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS------------CC
T ss_pred hcccC-----------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc------------cc
Confidence 76442 345799999999999875 4889999999999999999999986532110 00
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRIFRDLF 277 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt-~~~l~~~l~~~~ 277 (477)
.... ...+++.+.++|.+||..||.+||+ ++++...|..++
T Consensus 286 ~~~~--~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 EDDP--VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp TTCH--HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccc--ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000 0113578999999999999999995 566666666554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=341.15 Aligned_cols=254 Identities=19% Similarity=0.246 Sum_probs=189.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeE------e
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGV------E 74 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~------~ 74 (477)
...++|++.++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..++|++ |..+..+.. .
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN-VVSAREVPDGLQKLAP 89 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTT-BCCEEECCTTTCCCCT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCC-CCceeeeecccccccC
Confidence 345899999999999999999999999999999998765432 234778999999998754 444444332 2
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~~--~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
.+..+|||||+ |++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 66779999999 9999999975332 58999999999999999999999999999999999999644344569999999
Q ss_pred ceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHH-------
Q 011819 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK------- 224 (477)
Q Consensus 152 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~------- 224 (477)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+.
T Consensus 170 ~a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~--~~~~~~~i~~~ 239 (676)
T 3qa8_A 170 YAKELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ--PVQWHGKVREK 239 (676)
T ss_dssp CCCBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH--HHHSSTTCC--
T ss_pred cccccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc--hhhhhhhhhcc
Confidence 9987654332 2346899999999999999999999999999999999999999965311 0000
Q ss_pred -HHHHh-----hhc-----ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 011819 225 -YEKIS-----EKK-----VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 268 (477)
Q Consensus 225 -~~~i~-----~~~-----~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~ 268 (477)
...+. ... .......+...+++.+.++|..||..||++||++.+
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00000 000 000011123346789999999999999999999866
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.29 Aligned_cols=241 Identities=18% Similarity=0.177 Sum_probs=178.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----------hhHHHHHHHHHHHc--------CCCCCCe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKLYRILQ--------GGTGIPN 67 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----------~~~~~E~~il~~L~--------~~~~i~~ 67 (477)
.++|+++++||+|+||+||+|++ +++.||||++...... ..+..|+.+++.|+ .|+++..
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36799999999999999999997 7899999998754321 56889999999997 3455544
Q ss_pred eEEeeE------------------------------eCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 011819 68 VRWFGV------------------------------EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116 (477)
Q Consensus 68 ~~~~~~------------------------------~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL 116 (477)
+..+.. ..+..||||||+ ++++.+.+. ...+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHH
Confidence 433221 267889999999 775555443 35689999999999999999
Q ss_pred HHHH-HCCCeeCCCCCCceEeecCC-----------------CCCcEEEeecCceeecccCCCCcccccccCCCCccCcc
Q 011819 117 EFVH-SKSFLHRDIKPDNFLMGLGR-----------------RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178 (477)
Q Consensus 117 ~yLH-s~giiHRDLKP~NILl~~~~-----------------~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~ 178 (477)
+||| ++||+||||||+|||++.+. ....+||+|||+|+..... ..+||+.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~gt~~ 242 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVFCDV 242 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEECCCC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEEEeec
Confidence 9999 99999999999999995321 0128999999999876532 3479999
Q ss_pred ccccchhcCCCCCCcchHHHHHHH-HHHHHcCCCCCCCCCcccHHHHHHHHhhhc-c-cccHHHHhcCCcHHHHHHHHHH
Q 011819 179 YASMNTHLGIEQSRRDDLESLGYV-LMYFLRGSLPWQGLKAGTKKQKYEKISEKK-V-STSIEALCRGYPTEFASYFHYC 255 (477)
Q Consensus 179 Y~APE~~~g~~~s~ksDIwSlGvi-LyelltG~~Pf~~~~~~~~~~~~~~i~~~~-~-~~~~~~l~~~~p~~l~~li~~c 255 (477)
|||||++.+.. +.++|||||+++ .++++.|..||..... .......+.... . ..........+++++.+||.+|
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 99999999876 899999998777 7788899999943100 011112222111 1 1111223445789999999999
Q ss_pred hcCCCCCCCCHHHHH
Q 011819 256 RSLRFDDKPDYAYLK 270 (477)
Q Consensus 256 l~~~p~~RPt~~~l~ 270 (477)
|..+ +++++.
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9976 765554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=287.14 Aligned_cols=184 Identities=16% Similarity=0.125 Sum_probs=131.8
Q ss_pred eeeecCceEEEEEEECCCCcEEEEEEecCCCC------------chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 14 ~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~------------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.++.|++|.+..++....|+.||||++..... ...+.+|+++|+.+.++++|+.+..++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45678888888888888899999999865421 234788999999998889999999999999999999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ |++|.+++.. .++++.. .|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCC
Confidence 9999 9999999985 5567764 478999999999999999999999999999 688999999999998765433
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCC
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~P 212 (477)
. ...+.+||+.|||||++.+. +...+|+||+|+++|++.++..+
T Consensus 394 ~-------~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S-------WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C-------CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred c-------cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 2 23457899999999999874 67789999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-27 Score=251.58 Aligned_cols=187 Identities=21% Similarity=0.202 Sum_probs=139.9
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----------hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----------~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
..+.||+|+||.||+|. ..++.+++|....+... ..+.+|+++++.++|+ +|+.+..++...+..||
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~-nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDF-GIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGG-TCCCCCEEEEETTTTEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCC-CcCceEEEEEeCCccEE
Confidence 45689999999999995 66789999976543321 2368999999999875 45544444446667799
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ |++|.+++.. ++.++.||+.||+|||++||+||||||+|||+ +. .+||+|||+|+.....
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl---~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF---DK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE---SS--SEEECCCTTCEECCCH
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE---CC--eEEEEECccCEECCCc
Confidence 99999 8999999873 56899999999999999999999999999999 34 9999999999977542
Q ss_pred CCCcccccccCCCCccCccccccchhcC--CCCCCcchHHHHHHHHHHHHcCCCCCC
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g--~~~s~ksDIwSlGviLyelltG~~Pf~ 214 (477)
.......+.....++||+.|||||++.+ ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2111000111235789999999999987 567788999999999888888877773
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.1e-24 Score=209.94 Aligned_cols=142 Identities=17% Similarity=0.245 Sum_probs=111.7
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--------------------chhHHHHHHHHHHHcCCCCCCe
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------------------HPQLLYESKLYRILQGGTGIPN 67 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--------------------~~~~~~E~~il~~L~~~~~i~~ 67 (477)
.|.+++.||+|+||.||+|.+ .+|+.||||++..... ...+..|+.++..+.| +..
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 455669999999999999999 8899999999754221 2347799999999983 333
Q ss_pred eEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEE
Q 011819 68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (477)
Q Consensus 68 ~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vk 146 (477)
+..+.. +..|+||||+ |++|.+ +. . .....++.||+.||.|||++||+||||||+|||+ + ++.+|
T Consensus 167 ~~~~~~--~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~vk 232 (282)
T 1zar_A 167 PKVYAW--EGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGIW 232 (282)
T ss_dssp CCEEEE--ETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEEE
T ss_pred CeEEec--cceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcEE
Confidence 333322 4459999999 789987 32 1 2345799999999999999999999999999999 5 78999
Q ss_pred EeecCceeecccCCCCcccccccCCCCccCccccccchhcC
Q 011819 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG 187 (477)
Q Consensus 147 L~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g 187 (477)
|+|||+|+. +..|+|||++..
T Consensus 233 l~DFG~a~~--------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 233 IIDFPQSVE--------------------VGEEGWREILER 253 (282)
T ss_dssp ECCCTTCEE--------------------TTSTTHHHHHHH
T ss_pred EEECCCCeE--------------------CCCCCHHHHHHH
Confidence 999999863 345789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-21 Score=185.37 Aligned_cols=136 Identities=20% Similarity=0.292 Sum_probs=106.3
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcE--EEEEEecCCCCc--------------------------hhHHHHHHHHHHH
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKTKH--------------------------PQLLYESKLYRIL 59 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~--vAiKi~~~~~~~--------------------------~~~~~E~~il~~L 59 (477)
-|++.+.||+|+||.||+|.+..+|+. ||||++...... ..+..|+.++..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778999 999986432110 1467899999999
Q ss_pred cCCC-CCCeeEEeeEeCcEEEEEEecCC--C----CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeCCCCC
Q 011819 60 QGGT-GIPNVRWFGVEGDYNVLVMDLLG--P----SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKP 131 (477)
Q Consensus 60 ~~~~-~i~~~~~~~~~~~~~~lVmE~~g--~----sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLH-s~giiHRDLKP 131 (477)
.+.. .++.+..+ ...+|||||++ + +|.++... +++..+..++.||+.+|.||| ++||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8753 23333332 24689999994 2 77776432 234567889999999999999 99999999999
Q ss_pred CceEeecCCCCCcEEEeecCceeec
Q 011819 132 DNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 132 ~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
+|||+ +. .++|+|||+|...
T Consensus 200 ~NILl---~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMY---ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEE---SS--SEEECCCTTCEET
T ss_pred HHEEE---cC--cEEEEECcccccC
Confidence 99999 34 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=168.13 Aligned_cols=137 Identities=17% Similarity=0.270 Sum_probs=98.1
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----------------Cchh--------HHHHHHHHHHHcCCCC
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------------KHPQ--------LLYESKLYRILQGGTG 64 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----------------~~~~--------~~~E~~il~~L~~~~~ 64 (477)
|+++++||.|+||.||+|.+ .+|+.||||++.... .... ...|...+..|.+ .+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~-~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE-EG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh-cC
Confidence 89999999999999999997 579999999864310 0001 1346677777754 34
Q ss_pred CCeeEEeeEeCcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC-
Q 011819 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA- 142 (477)
Q Consensus 65 i~~~~~~~~~~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~- 142 (477)
++....+.... .+|||||+ |.+|.++.. ......++.||+.+|.|||++|||||||||.|||++.+...
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 44433333333 37999999 777754432 22346688999999999999999999999999999532110
Q ss_pred ------CcEEEeecCceeec
Q 011819 143 ------NQVYIIDFGLAKKY 156 (477)
Q Consensus 143 ------~~vkL~DFGla~~~ 156 (477)
..+.|+||+.+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 14899999988653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=4.7e-12 Score=121.64 Aligned_cols=137 Identities=18% Similarity=0.273 Sum_probs=108.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC--CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~--~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
+.|++...++.|+.+.||++.. .+..++||+.... .....+..|..+++.|..+..++.+..++...+..|+|||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 5699999999999999999973 4688999987642 22346899999999997766677888888888889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------------------------------ 121 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs------------------------------------------ 121 (477)
+ |.+|.+.+. +......++.+++.+|..||+
T Consensus 92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9 888876531 112334678899999999998
Q ss_pred -----------------CCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 122 -----------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 122 -----------------~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
..++|+|++|.|||+. ..+.+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4489999999999993 44556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=7.2e-11 Score=112.42 Aligned_cols=134 Identities=15% Similarity=0.066 Sum_probs=97.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEEeeEeCcEEEEEEecC
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~-i~~~~~~~~~~~~~~lVmE~~ 85 (477)
..|.+....+.|..+.||++.. .+|..++||+.... ....+..|..+++.|.+... ++.+..++...+..++||||+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 4566655555666799999963 56778999987654 33568899999999987644 666777776667789999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------------
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS----------------------------------------- 123 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g----------------------------------------- 123 (477)
|.+|. .. ..+. ..++.+++..|..||+..
T Consensus 98 ~G~~l~--~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 76763 21 1222 246677777777777643
Q ss_pred -----------------CeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 124 -----------------FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 124 -----------------iiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
++|+|++|.|||+. ..+.+.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999993 44556799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=7.3e-10 Score=111.53 Aligned_cols=138 Identities=14% Similarity=0.203 Sum_probs=100.4
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEec--CCC---CchhHHHHHHHHHHHcCCC-CCCeeEEeeEeC---cEEEE
Q 011819 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--VKT---KHPQLLYESKLYRILQGGT-GIPNVRWFGVEG---DYNVL 80 (477)
Q Consensus 10 ~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~--~~~---~~~~~~~E~~il~~L~~~~-~i~~~~~~~~~~---~~~~l 80 (477)
..++.|+.|.++.||++.. .+..+++|+.. ... ....+..|..++..|.... .++.+..++.+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3467899999999999884 35678899765 321 1246888999999998632 356666665544 34789
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-------------------------------------- 121 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-------------------------------------- 121 (477)
||||+ |..+.+. ....++......++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999 6665331 12347788888999999999999997
Q ss_pred --------------------CCCeeCCCCCCceEeecCCCC--CcEEEeecCceee
Q 011819 122 --------------------KSFLHRDIKPDNFLMGLGRRA--NQVYIIDFGLAKK 155 (477)
Q Consensus 122 --------------------~giiHRDLKP~NILl~~~~~~--~~vkL~DFGla~~ 155 (477)
..++|+|++|.|||+. .+ ..+.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CCCCcEEEEECcccccc
Confidence 3589999999999994 33 3368999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=2.1e-10 Score=112.92 Aligned_cols=190 Identities=15% Similarity=0.186 Sum_probs=119.8
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCC--CeeEEeeEeCc---EEEEEEecC-
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGI--PNVRWFGVEGD---YNVLVMDLL- 85 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i--~~~~~~~~~~~---~~~lVmE~~- 85 (477)
++.++.|.+..||++. ..+++|+.........+..|..++..|.....+ +.+..++.... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999863 468899865332234688999999998654433 44444433332 348999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-------------------------------------------- 121 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-------------------------------------------- 121 (477)
|.+|.+... ..++..+...++.|++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 777765332 247778888888899998888886
Q ss_pred --------------CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccccccc--------CCCCccCccc
Q 011819 122 --------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE--------NKNLTGTARY 179 (477)
Q Consensus 122 --------------~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~--------~~~~~Gt~~Y 179 (477)
..++|+|++|.|||++.+ ....+.|+||+.+..... ......-... ...+.....+
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 136999999999999521 145678999999875322 1100000000 0000000011
Q ss_pred cc-cchhcCCCCCCcchHHHHHHHHHHHHcCCCCC
Q 011819 180 AS-MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213 (477)
Q Consensus 180 ~A-PE~~~g~~~s~ksDIwSlGviLyelltG~~Pf 213 (477)
.. |+.... .....++|+++.++|.+.+|..+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 222111 012258999999999999998887
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=2.6e-07 Score=90.98 Aligned_cols=136 Identities=24% Similarity=0.258 Sum_probs=91.1
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC--CCeeEEeeE-eCcEEEEEEecC-CC
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG--IPNVRWFGV-EGDYNVLVMDLL-GP 87 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~--i~~~~~~~~-~~~~~~lVmE~~-g~ 87 (477)
++.++.|....||+. +..+++|+.........+..|..++..|.++.. ++.+..++. ..+..+++|+++ |.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456888999999987 567889985322223468899999999987433 455555553 455678999999 77
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 011819 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------------------------------------------- 122 (477)
Q Consensus 88 sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~--------------------------------------------- 122 (477)
.|.+..- ..++......++.++...|..||+.
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 7765321 1244555555555555555555532
Q ss_pred ---------------CCeeCCCCCCceEeecCCCCCc-EEEeecCceee
Q 011819 123 ---------------SFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAKK 155 (477)
Q Consensus 123 ---------------giiHRDLKP~NILl~~~~~~~~-vkL~DFGla~~ 155 (477)
.++|+|+.|.|||+..++..+. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999942111344 58999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=5.1e-07 Score=86.55 Aligned_cols=132 Identities=17% Similarity=0.155 Sum_probs=93.2
Q ss_pred eeeecCce-EEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CCCHHH
Q 011819 14 KIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLED 91 (477)
Q Consensus 14 ~IG~G~fG-~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~sL~~ 91 (477)
.+..|..| .||+......+..+++|+.... ....+..|..+++.|...--++.+..++.+.+..|+|||++ |.++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 34445555 6999886667788999986532 23457889999999987655777888888888999999999 777776
Q ss_pred HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------------------
Q 011819 92 LFNFCSRKLSLKTVLMLADQMINRVEFVHSK------------------------------------------------- 122 (477)
Q Consensus 92 li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~------------------------------------------------- 122 (477)
..... ......++.+++..|..||..
T Consensus 110 ~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 110 VLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred cccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 65421 112233445555555555521
Q ss_pred ---------CCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 123 ---------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 123 ---------giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.++|+|+.+.|||+ +..+.+-|+||+.+.
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVG 222 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCE
T ss_pred hcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECcccc
Confidence 16899999999999 445566799998774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=4.7e-06 Score=84.70 Aligned_cols=74 Identities=18% Similarity=0.170 Sum_probs=49.7
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---------CchhHHHHHHHHHHHcCC--CCCCeeEEeeEeCcEEE
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------KHPQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---------~~~~~~~E~~il~~L~~~--~~i~~~~~~~~~~~~~~ 79 (477)
-.+.||.|.++.||++.....++.|+||...... ....+..|.+++..+... ..++.+..+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3668999999999999765567889999754321 123467899999988653 345555544 344568
Q ss_pred EEEecCC
Q 011819 80 LVMDLLG 86 (477)
Q Consensus 80 lVmE~~g 86 (477)
+|||++.
T Consensus 112 lvmE~l~ 118 (397)
T 2olc_A 112 TVMEDLS 118 (397)
T ss_dssp EEECCCT
T ss_pred EEEEeCC
Confidence 9999994
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=1.8e-06 Score=86.37 Aligned_cols=81 Identities=17% Similarity=0.287 Sum_probs=54.6
Q ss_pred eEEEeee-eecCceEEEEEEEC--C----CCcEEEEEEecCCC-----CchhHHHHHHHHHHHcCC--CCCCeeEEeeEe
Q 011819 9 FRLGRKI-GSGSFGEIYLGTNI--Q----TNEEVAIKLENVKT-----KHPQLLYESKLYRILQGG--TGIPNVRWFGVE 74 (477)
Q Consensus 9 y~i~~~I-G~G~fG~Vy~a~~~--~----~g~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~--~~i~~~~~~~~~ 74 (477)
....+.| +.|....+|+.... . ++..+++|+..... ....+..|..+++.|... -.++.+..++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445778 88989999998742 0 26689999865422 124688999999998764 345666665544
Q ss_pred C---cEEEEEEecC-CCCH
Q 011819 75 G---DYNVLVMDLL-GPSL 89 (477)
Q Consensus 75 ~---~~~~lVmE~~-g~sL 89 (477)
. +..|+|||++ |..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 3 3468999999 5443
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=3e-05 Score=76.41 Aligned_cols=72 Identities=14% Similarity=0.198 Sum_probs=42.8
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC-CCCCeeEE------eeEeCcEEEEEEec
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG-TGIPNVRW------FGVEGDYNVLVMDL 84 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~-~~i~~~~~------~~~~~~~~~lVmE~ 84 (477)
++.|+.|..+.||++.. .+..+++|+... ....+..|..++..|... -.++.+.. +....+..+++|+|
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHR--PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECS--CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCC--CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 44566677889999874 334589998765 234556677777777632 12333322 22356678999999
Q ss_pred C-CC
Q 011819 85 L-GP 87 (477)
Q Consensus 85 ~-g~ 87 (477)
+ |.
T Consensus 113 i~G~ 116 (346)
T 2q83_A 113 IEGR 116 (346)
T ss_dssp CCCB
T ss_pred ecCc
Confidence 9 54
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00014 Score=74.56 Aligned_cols=73 Identities=16% Similarity=0.310 Sum_probs=45.6
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecC-------C--CCchhHHHHHHHHHHHc--CCCCCCeeEEeeEeCcEEE
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-------K--TKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~-------~--~~~~~~~~E~~il~~L~--~~~~i~~~~~~~~~~~~~~ 79 (477)
-.+.||.|..+.||++. .+++.++||.... . ........|.+++..+. .+..++.+..++ .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 46778999999999996 3567899993211 1 01123344555544443 223456665554 45679
Q ss_pred EEEecC-CC
Q 011819 80 LVMDLL-GP 87 (477)
Q Consensus 80 lVmE~~-g~ 87 (477)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 65
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00016 Score=70.73 Aligned_cols=139 Identities=17% Similarity=0.214 Sum_probs=78.1
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEE------eeEeCcEEEEEEe
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRW------FGVEGDYNVLVMD 83 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~-i~~~~~------~~~~~~~~~lVmE 83 (477)
-.+.|+.|....+|+... ..+ .+++|+.........+..|..++..|..... ++.+.. +....+..+++|+
T Consensus 26 ~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred EeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 456678888899999874 333 6889987653334567789999888875322 333321 1123456789999
Q ss_pred cC-CCCH-----H------HH---HHHcCCCC--------C---HHHHHH------------HHHHHHHHHHHHHH----
Q 011819 84 LL-GPSL-----E------DL---FNFCSRKL--------S---LKTVLM------------LADQMINRVEFVHS---- 121 (477)
Q Consensus 84 ~~-g~sL-----~------~l---i~~~~~~l--------s---~~~~~~------------i~~qIa~aL~yLHs---- 121 (477)
++ |..+ . .. ++.....+ . +..... +...+...+++++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 99 5432 1 11 11111111 1 111000 00113444555553
Q ss_pred ---CCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 122 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 122 ---~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.+++|+|+.+.|||+. .++.+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 3689999999999993 44445899998774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00032 Score=68.24 Aligned_cols=68 Identities=13% Similarity=0.097 Sum_probs=47.2
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-CC
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~-g~ 87 (477)
++.|+.|....+|++ ..+++|+...... ......|..+++.+......+.+..++ .+..++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 778989999999998 5688998654321 123567899998887655556665543 33347899998 44
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00044 Score=68.05 Aligned_cols=75 Identities=20% Similarity=0.257 Sum_probs=57.4
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC--CCCCeeEEeeEeCcEEEEEEecC-CC
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNVLVMDLL-GP 87 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~--~~i~~~~~~~~~~~~~~lVmE~~-g~ 87 (477)
-.+.|+.|.+..+|+.. ..+..+++|+.... ....+..|...++.|... ..+|.+..++...+..++|||++ |.
T Consensus 40 ~~~~l~gG~~n~~y~v~--~~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIN--DEVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEEECCSSSSEEEEEE--SSSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eeEEeCCccceeeeEEE--ECCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45678999999999987 35678899986543 245678899999998753 55667777777777899999999 54
Q ss_pred C
Q 011819 88 S 88 (477)
Q Consensus 88 s 88 (477)
.
T Consensus 117 ~ 117 (312)
T 3jr1_A 117 K 117 (312)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00055 Score=67.47 Aligned_cols=78 Identities=8% Similarity=-0.025 Sum_probs=41.7
Q ss_pred EeeeeecCceE-EEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEEeeEeCcEEEEEEecC-CCC
Q 011819 12 GRKIGSGSFGE-IYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL-GPS 88 (477)
Q Consensus 12 ~~~IG~G~fG~-Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~-i~~~~~~~~~~~~~~lVmE~~-g~s 88 (477)
.+.|+.|.... +|+... .++..+++|...... ...+..|..++..|..... ++.+..++...+ +++||++ +..
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 44566565554 667652 236778888654322 1456678888888875432 455555533333 7899998 456
Q ss_pred HHHHH
Q 011819 89 LEDLF 93 (477)
Q Consensus 89 L~~li 93 (477)
+.+.+
T Consensus 99 l~~~l 103 (333)
T 3csv_A 99 FTEVI 103 (333)
T ss_dssp HHHHH
T ss_pred hHHHh
Confidence 65433
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0038 Score=60.05 Aligned_cols=78 Identities=14% Similarity=0.073 Sum_probs=56.9
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.+....-++.+|.|..+.||+.+. .+|+.|++|+...... ...+..|...|+.|.....++....+.... .++||
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~--~~lv~ 89 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD--RTLAM 89 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET--TEEEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC--ceEEE
Confidence 456677889999999999999984 6889999998654322 235788999999997654444443344333 37899
Q ss_pred ecC
Q 011819 83 DLL 85 (477)
Q Consensus 83 E~~ 85 (477)
||+
T Consensus 90 e~l 92 (288)
T 3f7w_A 90 EWV 92 (288)
T ss_dssp ECC
T ss_pred Eee
Confidence 998
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0064 Score=56.24 Aligned_cols=124 Identities=13% Similarity=0.112 Sum_probs=78.1
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
..+|.+++...+.++++++++.++.|.+.+|.-+-. ..-..+=+-|..|+| ..+|.|.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C-------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc----------
Confidence 347999998889999999999999999998876621 111233344678888 5677776653 1110
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
.....+.+||... ...+.+.=|||||++||..+-=.+|=. ....+
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-------------------------eE~eL 142 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-------------------------EEREL 142 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-------------------------EEECC
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-------------------------cchhh
Confidence 1122456777653 234577889999999999886222211 12346
Q ss_pred cHHHHHHHHHHhcC
Q 011819 245 PTEFASYFHYCRSL 258 (477)
Q Consensus 245 p~~l~~li~~cl~~ 258 (477)
+++|.+||..|...
T Consensus 143 S~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 143 SPPLEQLIDHMANT 156 (229)
T ss_dssp CHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhc
Confidence 77888888888655
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0064 Score=59.38 Aligned_cols=73 Identities=12% Similarity=0.101 Sum_probs=46.7
Q ss_pred eeeeecCceEEEEEEECCCCcEEEEEEecCC-CCchhHHHHHHHHHHHcCCCC-CCeeEEe-----eEeCcEEEEEEecC
Q 011819 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLLYESKLYRILQGGTG-IPNVRWF-----GVEGDYNVLVMDLL 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-~~~~~~~~E~~il~~L~~~~~-i~~~~~~-----~~~~~~~~lVmE~~ 85 (477)
..|+ |....||++.. .+|+.+++|+.... .....+..|..++..|..... ++.+... ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77789998763 45667999997643 234567788898888875321 2322221 12355678999999
Q ss_pred CC
Q 011819 86 GP 87 (477)
Q Consensus 86 g~ 87 (477)
.+
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 33
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0059 Score=62.66 Aligned_cols=71 Identities=13% Similarity=0.107 Sum_probs=49.9
Q ss_pred EEeeeeecCceEEEEEEECC-------CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 11 LGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~-------~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
-++.|+.|....||++.... .+..|++|+.........+..|..++..|......+.+...+ .+ .+|||
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~--g~v~e 152 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG--GRLEE 152 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT--EEEEC
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC--CEEEE
Confidence 45678889889999998642 257899998743222156778999999988665556665443 22 38899
Q ss_pred cC
Q 011819 84 LL 85 (477)
Q Consensus 84 ~~ 85 (477)
|+
T Consensus 153 ~l 154 (429)
T 1nw1_A 153 YI 154 (429)
T ss_dssp CC
T ss_pred Ee
Confidence 98
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0042 Score=62.69 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=80.5
Q ss_pred EeeeeecCceEEEEEEECC-------CCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~-------~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
++.|..|-...+|++.... .++.|+||+..... ....+.+|..+++.|......+.+..++.. .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 3567668888999988532 35789999854322 234566899999999876666776555432 28999
Q ss_pred cC-CCCHH--------------HHHH---HcC----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 011819 84 LL-GPSLE--------------DLFN---FCS----RKLS--LKTVLMLADQMIN-------------------RVEFVH 120 (477)
Q Consensus 84 ~~-g~sL~--------------~li~---~~~----~~ls--~~~~~~i~~qIa~-------------------aL~yLH 120 (477)
|+ |.+|. +.+. ... +... +..+..|..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 98 43321 1111 111 1122 3455556554422 233333
Q ss_pred H--------CCCeeCCCCCCceEeecC-CCCCcEEEeecCcee
Q 011819 121 S--------KSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAK 154 (477)
Q Consensus 121 s--------~giiHRDLKP~NILl~~~-~~~~~vkL~DFGla~ 154 (477)
+ ..++|+|+.+.|||+..+ +..+.+.|+||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 248999999999999522 113689999998774
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.019 Score=59.47 Aligned_cols=71 Identities=15% Similarity=0.054 Sum_probs=47.8
Q ss_pred EEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
-++.|+.|-...+|++.....+..|++|+...... .-....|..++..|......+.+..++ .+ .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEee
Confidence 45678889899999998654457899998654321 112368999999998766666666554 22 3599998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0032 Score=62.89 Aligned_cols=71 Identities=11% Similarity=0.055 Sum_probs=43.6
Q ss_pred EEeeeeecCceEEEEEEECC--------CCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 11 LGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTKH-PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~--------~g~~vAiKi~~~~~~~-~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
-.+.|+.|....+|++.... .+..+++|+....... .....|..++..|......+.+.... . .+++
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 35677888888999998543 1368899986542211 13468899999887654455554332 2 3689
Q ss_pred EecC
Q 011819 82 MDLL 85 (477)
Q Consensus 82 mE~~ 85 (477)
|+|+
T Consensus 113 ~e~i 116 (369)
T 3c5i_A 113 EEWL 116 (369)
T ss_dssp EECC
T ss_pred EEEe
Confidence 9998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.40 E-value=0.14 Score=50.32 Aligned_cols=67 Identities=13% Similarity=0.173 Sum_probs=40.6
Q ss_pred ecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCC--CCCCeeEE------eeEeCcEEEEEEecC-CC
Q 011819 17 SGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGG--TGIPNVRW------FGVEGDYNVLVMDLL-GP 87 (477)
Q Consensus 17 ~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~--~~i~~~~~------~~~~~~~~~lVmE~~-g~ 87 (477)
.|....||+... .+| .+++|+...... ..|..++..|... +.++.+.. +....+..+++|+|+ |.
T Consensus 33 ~g~~N~vy~v~~-~~g-~~vLK~~~~~~~----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 33 ADTNAFAYQADS-ESK-SYFIKLKYGYHD----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp SCSSCEEEEEEC-SSC-EEEEEEEECSSC----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred CccccceEEEEe-CCC-CEEEEEecCccc----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 333678999873 345 899998665432 4577777777542 11233221 123457789999999 54
Q ss_pred CH
Q 011819 88 SL 89 (477)
Q Consensus 88 sL 89 (477)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 43
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.11 E-value=0.5 Score=48.15 Aligned_cols=74 Identities=12% Similarity=0.123 Sum_probs=49.9
Q ss_pred EEeeeeecCceEEEEEEECCC-------CcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 11 LGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~-------g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
-++.|..|-...+|++..... ++.|++++...... .-...+|..+++.|......+.+... .. .++||
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~--~~--~~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIAD--FP--EGRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEE--ET--TEEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEE--cC--CCEEE
Confidence 356677788889999986421 57899998654321 12356899999999866666666542 23 37899
Q ss_pred ecC-CCC
Q 011819 83 DLL-GPS 88 (477)
Q Consensus 83 E~~-g~s 88 (477)
+|+ |..
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 999 543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.86 E-value=0.17 Score=50.99 Aligned_cols=31 Identities=26% Similarity=0.472 Sum_probs=25.4
Q ss_pred CeeCCCCCCceEeec---CCCCCcEEEeecCcee
Q 011819 124 FLHRDIKPDNFLMGL---GRRANQVYIIDFGLAK 154 (477)
Q Consensus 124 iiHRDLKP~NILl~~---~~~~~~vkL~DFGla~ 154 (477)
++|.|+.+.|||+.. ++..+.++|+||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 689999999999953 2356789999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 477 | ||||
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-98 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-95 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-31 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-29 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-29 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-28 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-26 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-26 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-25 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-25 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-24 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-24 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-24 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-23 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-23 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-22 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-21 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-20 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-19 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-18 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-17 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 294 bits (754), Expect = 6e-98
Identities = 232/299 (77%), Positives = 272/299 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL ESK+Y+++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+VM+LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAKKYRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL+++FR+LF R+GF +DYVFDW +LK+ S+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 286 bits (733), Expect = 9e-95
Identities = 173/291 (59%), Positives = 214/291 (73%), Gaps = 2/291 (0%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG 64
VG +++GR+IG GSFG I+ GTN+ N++VAIK E ++ PQL E + Y++L G TG
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
IPNV +FG EG +NVLV+DLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H KS
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 125 LHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTARY S+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST + LC
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293
G+P EF Y HY R+L FD PDY YL+ +F + R D FDW +L
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-32
Identities = 61/280 (21%), Positives = 114/280 (40%), Gaps = 27/280 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKLYRILQGG 62
+ +G++IGSGSFG +Y G + + +VA+K+ NV PQ E + R +
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63
Query: 63 TGIPN-VRWFGVEGDYNV-LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
N + + G + +V G SL + K + ++ +A Q ++++
Sbjct: 64 ---VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
H+KS +HRD+K +N + V I DFGLA S + L+G+ +
Sbjct: 121 HAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILW 172
Query: 180 ASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
+ ++ S + D+ + G VL + G LP+ + + Q + +S
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPD 230
Query: 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
+ + P C + D++P + + L
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-31
Identities = 48/233 (20%), Positives = 88/233 (37%), Gaps = 19/233 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQGG 62
F+ G+ +G GSF + L + T+ E AIK + K P + E + L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH- 67
Query: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ + + + + L ++++ +E++H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG 126
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
K +HRD+KP+N L+ + I DFG AK S + GTA+Y S
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
+ DL +LG ++ + G P++ G + ++KI + +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYD 228
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 121 bits (305), Expect = 2e-31
Identities = 50/312 (16%), Positives = 114/312 (36%), Gaps = 31/312 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKLYRILQGGTG 64
+ + + ++G+G+FG ++ T T A K + ++ + E + +L+
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPT 84
Query: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ N+ + + V++ + + G L + K+S + Q+ + +H +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
++H D+KP+N + +R+N++ +IDFGL + + TGTA +A+
Sbjct: 145 YVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPE 195
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
G D+ S+G + L G P+ G + + ++ G
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDW-NMDDSAFSG 251
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG-----------FQFDYVFDWTI 292
+ + + + + + ++ G ++ + D
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 308
Query: 293 LKYQQSQLATPP 304
KY PP
Sbjct: 309 TKYDAWPEPLPP 320
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 6e-31
Identities = 49/274 (17%), Positives = 105/274 (38%), Gaps = 33/274 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGT 63
+ F ++G+G+ G ++ ++ + +A K LE Q++ E ++
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-- 63
Query: 64 GIPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P V ++G + M+ + G SL+ + + ++ + + ++ +I + ++
Sbjct: 64 --PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 120 HSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
K +HRD+KP N L+ ++ + DFG++ + D+ + + GT
Sbjct: 121 REKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRS 168
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238
Y S G S + D+ S+G L+ G P A + + +E
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ--------VE 220
Query: 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI 272
P + S D +P A + +
Sbjct: 221 GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 1e-30
Identities = 57/332 (17%), Positives = 119/332 (35%), Gaps = 33/332 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKLYRILQGGTGIP 66
K+ + +G G FG ++ + + K VK L+ E + I + I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
++ + V++ + + G + + N + +L+ + ++ Q+ ++F+HS +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 185
H DI+P+N + RR++ + II+FG A++ + + + Y + H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175
Query: 186 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245
S D+ SLG ++ L G P+ T +Q E I + T E +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEY-TFDEEAFKEIS 231
Query: 246 TEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG--------------FQFDYVFDWT 291
E + + + ++++ ++ +
Sbjct: 232 IEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 292 ILKYQQSQLATPPARALVPGAGTSGAPPAIAS 323
L S A+ G S A +AS
Sbjct: 289 DLNMVVSAARISCGGAIRSQKGVSVAKVKVAS 320
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 119 bits (298), Expect = 2e-30
Identities = 51/235 (21%), Positives = 91/235 (38%), Gaps = 20/235 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQ 60
V + + + ++GSG+FG ++ T K + T +P + E + L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQLH 84
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
+ N+ + VL+++ L G L D K+S V+ Q ++ +
Sbjct: 85 -HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
H S +H DIKP+N + ++A+ V IIDFGLA K + T TA +
Sbjct: 144 HEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEF 194
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
A+ D+ ++G + L G P+ G + + +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWE 246
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-30
Identities = 42/235 (17%), Positives = 93/235 (39%), Gaps = 28/235 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKLYRILQGGTGIP 66
+ + ++G G+FG++Y N +T+ A K+ + K++ + E + P
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH----P 69
Query: 67 N-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
N V+ + ++++ G +++ + R L+ + ++ Q ++ + ++H
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
+HRD+K N L + + DFG++ K T + + GT + +
Sbjct: 130 KIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAP 179
Query: 183 NTHLGIEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ R D+ SLG L+ P L + KI++ +
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE 231
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 8e-30
Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 21/233 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQG 61
F +GR +G G FG +YL Q+ +A+K QL E ++ L+
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 64
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
I + + + L+++ K + ++ N + + HS
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
K +HRDIKP+N L+G A ++ I DFG + + GT Y
Sbjct: 125 KRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLP 172
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
G + DL SLG + FL G P++ T ++ Y++IS + +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFT 222
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 114 bits (285), Expect = 3e-29
Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 25/225 (11%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRI 58
+ +++ LG +G G E++L +++ + +VA+K L + + + E++
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 59 LQGGTGIPN-VRWFGV------EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 110
L P V + G +VM+ + G +L D+ + ++ K + +
Sbjct: 64 LNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIA 118
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
+ F H +HRD+KP N ++ N V ++DFG+A+ D+ +
Sbjct: 119 DACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QT 171
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ GTA+Y S G R D+ SLG VL L G P+ G
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-29
Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 27/248 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKLYRI 58
+++++G +GSG FG +Y G + N VAIK ++ E L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 59 LQGG-TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINR 115
+ G +G+ + + D VL+++ P DLF+F + + L + Q++
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEA 122
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
V H+ LHRDIK +N L + ++ +IDFG +DT G
Sbjct: 123 VRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYTDFD---------G 171
Query: 176 TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
T Y+ R + SLG +L + G +P++ + + + ++VS
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQRVS 228
Query: 235 TSIEALCR 242
+ + L R
Sbjct: 229 SECQHLIR 236
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 4e-29
Identities = 58/250 (23%), Positives = 100/250 (40%), Gaps = 25/250 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQGGT 63
+ L + +G G++GE+ L N T E VA+K ++ + E + ++L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-- 62
Query: 64 GIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
N V+++G EG+ L ++ + Q++ V ++H
Sbjct: 63 --ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
HRDIKP+N L+ + + I DFGLA +R + + + + GT Y
Sbjct: 121 GIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYV 172
Query: 181 SMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKV 233
+ E + D+ S G VL L G LPW + K++K KK+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 234 STSIEALCRG 243
++ AL
Sbjct: 233 DSAPLALLHK 242
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 8e-29
Identities = 46/235 (19%), Positives = 94/235 (40%), Gaps = 25/235 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQG 61
N F + +G G+FG++ L T A+K + K + + ES++ + +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 62 GTGIPN-VRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEF 118
P ++ L + + +LF SR+ + + ++++ +E+
Sbjct: 65 ----PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
+HS+ ++RDIK +N ++ + + I DFGL K+ GT
Sbjct: 121 LHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPE 170
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
Y + + R D LG V+ + G LP+ ++ +E I +++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEI 222
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-28
Identities = 57/277 (20%), Positives = 114/277 (41%), Gaps = 27/277 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
+L ++G+G FGE+++G + +VA+K L+ L E+ L + LQ
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH---- 67
Query: 66 PN-VRWFGVEGDYNV-LVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
VR + V + ++ + + G ++ L KL++ +L +A Q+ + F+
Sbjct: 68 QRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
++++HRD++ N L+ I DFGLA+ D + ++ +
Sbjct: 128 RNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTA 178
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
+ + D+ S G +L + G +P+ G+ T + + + +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPD-- 233
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
P E C R +D+P + YL+ + D F
Sbjct: 234 --NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-28
Identities = 42/211 (19%), Positives = 83/211 (39%), Gaps = 17/211 (8%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNV-- 68
+ +G G G++ N +T E+ A+K + P+ E +L+ I +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVD 72
Query: 69 --RWFGVEGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
++VM+ L G L + + + + + + + ++++HS +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 132
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 184
HRD+KP+N L R + + DFG AK+ ++ Y T Y +
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TPYYVAPEV 184
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ + D+ SLG ++ L G P+
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 110 bits (275), Expect = 6e-28
Identities = 43/238 (18%), Positives = 81/238 (34%), Gaps = 21/238 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKTKHPQLLYESKLY 56
+ +G G + + T +E A+K E V+ L E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
R + G I ++ + LV DL+ L D LS K + ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEV 122
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+ +H + +HRD+KP+N L+ + + DFG + + + + +
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
+ + H G + D+ S G ++ L GS P+ + I
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNY 232
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 6e-28
Identities = 67/293 (22%), Positives = 108/293 (36%), Gaps = 24/293 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLLYESKLYRILQG- 61
+K+ KIG G+FGE++ + +T ++VA+K +EN K P L E K+ ++L+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 62 ------GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
+ LV D L L + K +L + + ++N
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
+ ++H LHRD+K N L+ R + + DFGLA+ + Q Y N
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVV 183
Query: 176 TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
T Y LG DL G ++ S QG T++ + IS+ S
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGS 240
Query: 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR--IFRDLFIREGFQFD 285
+ E E + + K R DL I + D
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL-IDKLLVLD 292
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (276), Expect = 8e-28
Identities = 51/251 (20%), Positives = 94/251 (37%), Gaps = 34/251 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQGG 62
F R+IG GSFG +Y +++ +E VAIK + K ++ E + + L+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN +++ G LVM+ S DL + L + + + + ++
Sbjct: 75 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
HS + +HRD+K N L+ V + DFG A ++ GT +
Sbjct: 132 HSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF-----------VGTPYW 177
Query: 180 ASMNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGT-----KKQKYEKISEK 231
+ L +++ + D D+ SLG + P + A + + + +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237
Query: 232 KVSTSIEALCR 242
S
Sbjct: 238 HWSEYFRNFVD 248
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (276), Expect = 9e-28
Identities = 59/302 (19%), Positives = 113/302 (37%), Gaps = 29/302 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQG 61
+ + + +G+G+F E+ L + +T + VAIK + ++ K + E + ++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFV 119
I + G + L+M L+ S +LF+ K + + L Q+++ V+++
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
H +HRD+KP+N L +++ I DFGL+K S GT Y
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGY 175
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ S+ D S+G + L G P+ + +E+I + +
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYEFDSP- 231
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRI-FRDLFIREGFQFDYVFDWTILKYQQS 298
+ + + D P+ KR D D I +
Sbjct: 232 YWDDISDSAKDFIRHL--MEKD--PE----KRFTCEQALQHPWIAGDTALDKNIHQSVSE 283
Query: 299 QL 300
Q+
Sbjct: 284 QI 285
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-27
Identities = 55/245 (22%), Positives = 97/245 (39%), Gaps = 22/245 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKLYRILQGGTG 64
K+ KIG G+ G +Y ++ T +EVAI+ N++ K ++ E + R +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPN 78
Query: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I N + GD +VM+ L G SL D+ + + + + + +EF+HS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
+HRDIK DN L+ V + DFG + + + + GT + +
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPE 186
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTSI 237
+ D+ SLG + + + G P+ L E + +K+S
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 238 EALCR 242
Sbjct: 247 RDFLN 251
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 17/215 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQGGTG 64
F L + +G GSFG+++L +TN+ AIK ++V + R+L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 65 IPN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
P F + VM+ L G L C K L A ++I ++F+H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
SK ++RD+K DN L+ + + I DFG+ K+ + GT Y
Sbjct: 121 SKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYI 170
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ LG + + D S G +L L G P+ G
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (270), Expect = 6e-27
Identities = 50/287 (17%), Positives = 108/287 (37%), Gaps = 23/287 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ ++L RK+G G + E++ NI NE+V +K+ K ++ E K+ L+GG I
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-PVKKKKIKREIKILENLRGGPNII 93
Query: 67 NVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
+ + + + D + L+ + +++ +++ HS +H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMH 152
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHL 186
RD+KP N + + ++ +ID+GLA+ Y + + + +
Sbjct: 153 RDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLV 202
Query: 187 GIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245
+ D+ SLG +L + P+ + +I++ + + Y
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 246 TEFASYFH-------YCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
E F+ R RF + + D + + ++D
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF-LDKLLRYD 306
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 108 bits (270), Expect = 1e-26
Identities = 55/235 (23%), Positives = 87/235 (37%), Gaps = 20/235 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKLYRILQG 61
N F + R IG G FGE+Y T + A+K +K L E + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 62 GT--GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
G I + + D ++DL+ S + A ++I +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
H++ ++RD+KP N L+ V I D GLA + H + GT Y
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGY 171
Query: 180 ASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
+ G+ D SLG +L LRG P++ K K + V
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-26
Identities = 58/294 (19%), Positives = 101/294 (34%), Gaps = 30/294 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESKLYRILQG 61
VG ++ IG G++G + + VAIK +T + L E K+ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 62 GTGIPN-VRWFGV-------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
N + + + LV L+G L L ++ LS + Q++
Sbjct: 66 ----ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQIL 119
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
++++HS + LHRD+KP N L+ + I DFGLA+ H
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTE----Y 172
Query: 174 TGTARYASMN-THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
T Y + ++ D+ S+G +L L + G + I
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGIL 229
Query: 233 VSTSIEALCRGYPTEFASY-FHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
S S E L + +Y + + DL + + F+
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL-LDKMLTFN 282
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 4e-26
Identities = 61/280 (21%), Positives = 98/280 (35%), Gaps = 29/280 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTN---EEVAIK-----LENVKTKHPQLLYESKLYRILQ 60
RL K+G GSFG + G + VA+K + + + E L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 61 GGTGIPN-VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
N +R +GV +V +L SL D L T+ A Q+ +
Sbjct: 70 H----RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
++ SK F+HRD+ N L+ + V I DFGL + H Y ++
Sbjct: 126 YLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPF 178
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
+ + + S D G L G PW GL Q KI ++
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGERLP 235
Query: 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
C P + + C + + +D+P + L+ +
Sbjct: 236 RPEDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-26
Identities = 55/275 (20%), Positives = 109/275 (39%), Gaps = 27/275 (9%)
Query: 13 RKIGSGSFGEIYLGTNIQTNE--EVAIK---LENVKTKHPQLLYESKLYRILQGGTGIPN 67
++G G+FG + G + +VAIK K +++ E+++ L P
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70
Query: 68 -VRWFGV-EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
VR GV + + +LVM++ G L ++ + V L Q+ ++++ K+F
Sbjct: 71 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 184
+HRD+ N L+ + I DFGL+K ++ ++ +
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
+ S R D+ S G + L G P++ + + I + K
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGK----RMECPPE 236
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278
P E + C +++D+PD+ +++ R +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 1e-25
Identities = 50/240 (20%), Positives = 90/240 (37%), Gaps = 27/240 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGT 63
+ + IG+GS+G + + K + + L+ E L R L+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 64 GIPNVRWFGVEGDYNV-LVMDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEF 118
+ + + +VM+ G L + +++ L + VL + Q+ ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 119 VHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
H +S LHRD+KP N + V + DFGLA+ ++ K
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KAF 174
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
GT Y S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKF 231
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-25
Identities = 50/249 (20%), Positives = 99/249 (39%), Gaps = 31/249 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQG 61
G + +IG GSF +Y G + +T EVA + K++ + E+++ + LQ
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 67
Query: 62 GTGIPN-VRWFGV------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
PN VR++ VLV +L+ + + + +K + Q++
Sbjct: 68 ----PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 115 RVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
++F+H+++ +HRD+K DN + V I D GLA R + K
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KA 172
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ GT + + + + D+ + G ++ P+ Q Y +++
Sbjct: 173 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGV 229
Query: 233 VSTSIEALC 241
S + +
Sbjct: 230 KPASFDKVA 238
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-25
Identities = 55/295 (18%), Positives = 108/295 (36%), Gaps = 31/295 (10%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHP----QLLYESKLYRI 58
R ++ +IG G++G+++ +++ VA+K V+T + E + R
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 59 LQGGTGIPNVRWFGV--------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
L+ VR F V E ++ + L + +T+ +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Q++ ++F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y +
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV----- 175
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
T Y + L + DL S+G + R ++G + + KI +
Sbjct: 176 ---VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKILD 229
Query: 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
E R ++ D + + +DL + + F+
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD---IDELGKDL-LLKCLTFN 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (256), Expect = 6e-25
Identities = 50/232 (21%), Positives = 94/232 (40%), Gaps = 20/232 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
F++ R +G+GSFG ++L + A+K L+ + + + R++
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 66 PN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
P +R +G + ++MD + S++ A ++ +E++HSK
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
++RD+KP+N L+ + + I DFG AK D + L GT Y +
Sbjct: 124 DIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYIAP 170
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
++ D S G ++ L G P+ + YEKI ++
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELR 219
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 7e-25
Identities = 55/274 (20%), Positives = 108/274 (39%), Gaps = 21/274 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
RL K+G G FGE+++GT T VAIK L+ L E+++ + L+ +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 74
Query: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKSF 124
+ E ++ + SL D + K L ++ +A Q+ + + +V ++
Sbjct: 75 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 184
+HRD++ N L+G + DFGLA+ D + ++ +
Sbjct: 135 VHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR------QGAKFPIKWTAPEA 185
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
L + + D+ S G +L +G +P+ G+ ++ +++
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPP----E 238
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
P C +++P + YL+ D F
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 8e-25
Identities = 62/293 (21%), Positives = 101/293 (34%), Gaps = 40/293 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPN- 67
+ + IG+GSFG +Y + E VAIK V E ++ R L N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKNRELQIMRKLDH----CNI 75
Query: 68 VRWFGV--------EGDYNVLVMDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
VR + Y LV+D + ++ + SR L + V + Q+ +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT----STHQHIPYRENKN 172
++HS HRDIKP N L + + DFG AK+ S YR +
Sbjct: 136 AYIHSFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ G Y + D+ S G VL L G + G + + +I +
Sbjct: 194 IFGATDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEIIKVL 239
Query: 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
+ + E + P F ++ + K L ++
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPW-TKVFRPRTPPEAIAL-CSRLLEYT 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 9e-25
Identities = 56/281 (19%), Positives = 121/281 (43%), Gaps = 30/281 (10%)
Query: 13 RKIGSGSFGEIYLGT--NIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIP 66
+++GSG+FG + G + + VA+K+ + P +LL E+ + + L P
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN----P 68
Query: 67 N-VRWFGV-EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
VR G+ E + +LVM++ + + +R + K ++ L Q+ ++++ +F
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNT 184
+HRD+ N L+ + I DFGL+K R + Y+ + ++ +
Sbjct: 129 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPEC 181
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
+ S + D+ S G ++ G P++G+ + + + + G
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA----G 234
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF---IREG 281
P E + C + +++P +A ++ R+ + + EG
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-24
Identities = 55/280 (19%), Positives = 102/280 (36%), Gaps = 30/280 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQLLYESKLYRILQ 60
+ LGR IG G FG+++ G + VAIK + + L E+ R
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 61 GGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
P+ V+ GV E +++ L L L ++++ A Q+ +
Sbjct: 67 H----PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
++ SK F+HRDI N L+ + V + DFGL++ D++ ++
Sbjct: 123 YLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPI 173
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
++ + + + D+ G + L G P+QG+ +I +
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENGE---- 226
Query: 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
+ P S C + +P + LK +
Sbjct: 227 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 42/232 (18%), Positives = 92/232 (39%), Gaps = 23/232 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
+++G+G FG + G + +VAIK ++ + + E+K+ L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH---- 58
Query: 66 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
V+ +GV + ++ + + L + + + +L + + +E++ S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
K FLHRD+ N L+ V + DFGL++ D + R++
Sbjct: 119 KQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWSP 169
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 232
+ + S + D+ + G ++ G +P++ T + E I++
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGL 218
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (250), Expect = 2e-24
Identities = 55/306 (17%), Positives = 102/306 (33%), Gaps = 49/306 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLLYESKLYR 57
PR N R IG G+FG ++ + VA+K+ + +
Sbjct: 11 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 58 ILQGGTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDL---------------------- 92
++ V+ GV G L+ + + L +
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 93 -FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
+ LS L +A Q+ + ++ + F+HRD+ N L+G V I DFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFG 185
Query: 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGS 210
L++ Y+ + N R+ + + D+ + G VL G
Sbjct: 186 LSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270
P+ G+ ++ + + + E P E + C S D+P + +
Sbjct: 241 QPYYGM---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 271 RIFRDL 276
RI + +
Sbjct: 294 RILQRM 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 100 bits (249), Expect = 2e-24
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 25/218 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGG 62
K+ KIG G++G +Y N E A+K ++ + + E + + L+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59
Query: 63 TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ I + VLV + L L+ L + C L T Q++N + + H +
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH-----QHIPYRENKNLTGTA 177
LHRD+KP N L+ R ++ I DFGLA+ + + YR L G+
Sbjct: 120 RVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+Y S D+ S+G + + G+ + G
Sbjct: 177 KY-----------STTIDIWSVGCIFAEMVNGTPLFPG 203
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.3 bits (247), Expect = 3e-24
Identities = 54/277 (19%), Positives = 100/277 (36%), Gaps = 33/277 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIP 66
+ +L + IG G FG++ LG +VA+K L E+ + L+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 60
Query: 67 N-VRWFGV---EGDYNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120
N V+ GV E +V + + SL D L + L +L + + +E++
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
+F+HRD+ N L+ N + DFGL K+ T ++
Sbjct: 121 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWT 167
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ + S + D+ S G +L G +P+ + K ++ + + +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPD- 223
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
G P C L +P + L+ +
Sbjct: 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.8 bits (248), Expect = 3e-24
Identities = 54/275 (19%), Positives = 115/275 (41%), Gaps = 21/275 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
+ K+G G +GE+Y G + + VA+K L+ + + L E+ + + ++ +
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 75
Query: 66 PNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ ++ + + G L+ L +++S +L +A Q+ + +E++ K+
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMN 183
F+HRD+ N L+G + V + DFGL++ + H + ++ +
Sbjct: 136 FIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAPE 186
Query: 184 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
+ + S + D+ + G +L G P+ G+ Q YE + + E
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKDYRMERPE---- 239
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
G P + C D+P +A + + F +F
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 4e-24
Identities = 50/246 (20%), Positives = 91/246 (36%), Gaps = 27/246 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKLY 56
V + + G ++GSG F + T + A K + E +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 57 RILQGGTGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
+ +Q PN + V +L+++L+ F L+ + Q++
Sbjct: 68 KEIQH----PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123
Query: 114 NRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
N V ++HS H D+KP+N ++ ++ IIDFGLA K + ++I
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI------- 176
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
GT + + D+ S+G + L G+ P+ G TK++ +S
Sbjct: 177 -FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVN 232
Query: 233 VSTSIE 238
E
Sbjct: 233 YEFEDE 238
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (250), Expect = 6e-24
Identities = 46/213 (21%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKLYRILQGGTG 64
++F + +G+GSFG + L + ++ A+K+ + K Q+ + RILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 65 IPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK 122
V+ D + L M + + ++F+ R + S A Q++ E++HS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
++RD+KP+N L+ + + + DFG AK+ + + GT +
Sbjct: 161 DLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLC----------GTPEALAP 207
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
L ++ D +LG ++ G P+
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 1e-23
Identities = 50/267 (18%), Positives = 92/267 (34%), Gaps = 43/267 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKL---ENVKTKHPQLLYESKLYRI 58
G+ +GSG+FG++ T ++ +VA+K+ + ++ L+ E K+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK------------------ 99
L I N+ L+ + L + K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 100 ----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
L+ + +L A Q+ +EF+ KS +HRD+ N L+ V I DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARD 213
Query: 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQ 214
S Y N ++ + + + + D+ S G +L G P+
Sbjct: 214 IMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 215 GLKAGTKKQKYEKISEKKVSTSIEALC 241
G+ + K+ +
Sbjct: 269 GI---PVDANFYKLIQNGFKMDQPFYA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 1e-23
Identities = 56/283 (19%), Positives = 98/283 (34%), Gaps = 20/283 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGGT 63
F+ KIG G++G +Y N T E VA+K + + E L + L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HP 61
Query: 64 GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK 122
I + + LV + L L+ + + L + Q++ + F HS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM 182
LHRD+KP N L+ + + DFGLA+ + + A
Sbjct: 122 RVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPE 172
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
S D+ SLG + + + G ++ + +I + + T E +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRI-FRTLGTPDEVVWP 228
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
G + + + R D L R L + + +D
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL-LSQMLHYD 270
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 2e-23
Identities = 56/296 (18%), Positives = 113/296 (38%), Gaps = 38/296 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQ 60
V +++ +GSG++G + + +T VA+K + + + E +L + ++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 61 GGTGIPN-VRWFGV--------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
N + V E + LV L+G L ++ +KL+ V L Q
Sbjct: 76 H----ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQ 129
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
++ ++++HS +HRD+KP N + ++ I+DFGLA+ D T
Sbjct: 130 ILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVA------ 180
Query: 172 NLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
T Y + L ++ D+ S+G ++ L G + G + + I
Sbjct: 181 ----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILR 233
Query: 231 KKVSTSIEALCRGYPTEFASYFHYCRSL-RFDDKPDYAYLKRIFRDLFIREGFQFD 285
+ E L + +Y + + + + + DL + + D
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL-LEKMLVLD 288
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-23
Identities = 43/227 (18%), Positives = 85/227 (37%), Gaps = 17/227 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLLYESKLYRILQG 61
F+ + +GSG+FG +Y G I E+V I + ++L E+ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ + + ++ + L D + + +L Q+ + ++
Sbjct: 71 -PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+ +HRD+ N L+ V I DFGLAK H + ++ +
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMA 181
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEK 227
+ + L + + D+ S G + + GS P+ G+ A EK
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 3e-23
Identities = 53/276 (19%), Positives = 106/276 (38%), Gaps = 27/276 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQGGTGI 65
++ ++IGSG FG ++LG + ++VAIK + + E+++ L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH---- 59
Query: 66 PN-VRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
P V+ +GV E LV + + L D + +T+L + + + ++
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
+HRD+ N L+ + + DFG+ + D + ++AS
Sbjct: 120 ACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWAS 170
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S + D+ S G ++ G +P++ + + E IS
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR----LYK 223
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276
R T ++C R +D+P ++ L R ++
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 6e-23
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 22/215 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQGG 62
K+ KIG G++G ++ N +T+E VA+K ++ + L E L + L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60
Query: 63 TGIPN-VRWFGV--EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
N VR V LV + L+ F+ C+ L + V Q++ + F
Sbjct: 61 ---KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
HS++ LHRD+KP N L+ R ++ + +FGLA+ + T Y
Sbjct: 118 HSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYS-------AEVVTLWY 167
Query: 180 ASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPW 213
+ G + S D+ S G + P
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (242), Expect = 6e-23
Identities = 50/252 (19%), Positives = 101/252 (40%), Gaps = 26/252 (10%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRIL 59
V +++ + IGSG+ G + + + VAIK + ++ + E L + +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 60 QGGT-----GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
+ + E LVM+L+ +L +L + + L QM+
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLC 130
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
++ +HS +HRD+KP N ++ + + I+DFGLA+ +
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY--------V 179
Query: 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
T Y + LG+ D+ S+G ++ +R + + G ++ K+ E+ +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGT 236
Query: 235 TSIEALCRGYPT 246
E + + PT
Sbjct: 237 PCPEFMKKLQPT 248
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 95.6 bits (237), Expect = 1e-22
Identities = 35/234 (14%), Positives = 88/234 (37%), Gaps = 17/234 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQLLYESKLYRILQ 60
+ ++ + IG+G FGE+ G + VAIK + + L E+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
+ ++ + +++ + + SL+ + ++ ++ + + ++++
Sbjct: 86 H-PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
+++HRD+ N L+ + DFGL++ D ++ Y R+
Sbjct: 145 ADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRW 199
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 232
+ + + D+ S G V+ + G P+ + T + I +
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDY 250
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 1e-22
Identities = 62/283 (21%), Positives = 98/283 (34%), Gaps = 29/283 (10%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLLYESKLYRILQGGTGI 65
+G G F +Y + TN+ VAIK E + L E KL + L I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62
Query: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
+ LV D + LE + S L+ + + +E++H L
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTH 185
HRD+KP+N L+ + + DFGLAK + P R + T Y +
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGS-------PNRAYTHQVVTRWYRAPELL 172
Query: 186 LGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244
G D+ ++G +L L G + + +I E + + E
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQW---- 225
Query: 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL--FIREGFQFD 285
+ S Y F P + DL I+ F F+
Sbjct: 226 -PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.6 bits (239), Expect = 2e-22
Identities = 50/294 (17%), Positives = 109/294 (37%), Gaps = 25/294 (8%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLLYESKLYRILQ 60
EP ++ L RK+G G F ++L ++ N VA+K + K E KL + +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 61 ----------GGTGIPNVRWFGVEGDYNVLVMDLLG-----PSLEDLFNFCSRKLSLKTV 105
G I + N + + ++ L + + R + L V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 106 LMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164
++ Q++ ++++H + +H DIKP+N L + + +I +A +H
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVL--MEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
T Y S LG D+ S ++ + G ++ + + +
Sbjct: 186 YTNS-----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 225 YEKISE-KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277
+ I++ ++ + + ++F+ LR K + L+ + + +
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 5e-22
Identities = 43/233 (18%), Positives = 81/233 (34%), Gaps = 34/233 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL---ENVKTKHPQLLYESKLYRI 58
N+ G+ +G+G+FG++ T VA+K+ T+ L+ E K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 59 LQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL-----------------FNFCSRKL 100
L I N+ G +++ + L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
L+ +L + Q+ + F+ SK+ +HRD+ N L+ I DFGLA+ ++ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDS 199
Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ N ++ + + + D+ S G L
Sbjct: 200 NYVV-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 5e-22
Identities = 55/296 (18%), Positives = 111/296 (37%), Gaps = 38/296 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLLYESKLYRILQ 60
V +R + +GSG++G + + +T +VAIK + + E +L + ++
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 61 GGTGIPN-VRWFGV--------EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
N + V + LVM +G L L KL + L Q
Sbjct: 76 H----ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQ 129
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ--HIPYRE 169
M+ + ++H+ +HRD+KP N + ++ I+DFGLA++ T YR
Sbjct: 130 MLKGLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVTRWYRA 186
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229
+ + RY ++ D+ S+G ++ + G ++G + ++ K++
Sbjct: 187 PEVILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFD 285
+ ++ L + F A + +L + + D
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA--SPLAVNL-LEKMLVLD 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 1e-21
Identities = 49/246 (19%), Positives = 87/246 (35%), Gaps = 36/246 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIK---LENVKTKHPQLLYESKLYRILQG 61
N + IG G+FG++ + + AIK K H E ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDL---------------FNFCSRKLSLKTV 105
I N+ Y L ++ +L D N + LS + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
L A + ++++ K F+HRD+ N L+G I DFGL++
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQK 224
R+ ++ + + D+ S G +L + G P+ G+ T +
Sbjct: 187 --------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL 235
Query: 225 YEKISE 230
YEK+ +
Sbjct: 236 YEKLPQ 241
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 2e-21
Identities = 42/224 (18%), Positives = 90/224 (40%), Gaps = 21/224 (9%)
Query: 4 RVG-NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIK------LENVKTKHPQLLYES 53
+VG F L + +G+G++G+++L I T + A+K + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 54 KLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
++ ++ + + + L++D + + + V + +++
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
+E +H ++RDIK +N L+ V + DFGL+K++ T + +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC----- 191
Query: 174 TGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQG 215
GT Y + + G + + D SLG ++ L G+ P+
Sbjct: 192 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 1e-20
Identities = 45/253 (17%), Positives = 100/253 (39%), Gaps = 38/253 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-------VAIK---LENVKTKHPQLLYESKLY 56
++ LG+ +G G+FG++ L I +++ VA+K + + L+ E ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---------------SRKL 100
+++ I N+ + ++++ +L + +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
S K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 189
Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAG 219
++ N ++ + + + D+ S G +L G P+ G+
Sbjct: 190 YYKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--- 241
Query: 220 TKKQKYEKISEKK 232
++ ++ + E
Sbjct: 242 PVEELFKLLKEGH 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 5e-20
Identities = 33/233 (14%), Positives = 81/233 (34%), Gaps = 16/233 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIK---LENVKTKHPQLLYESKLYRIL 59
+ + IG+G FGE+Y G ++ + VAIK + + L E+ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 60 QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
I ++ + +L+ + S+ ++ + + ++++
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
+ +++HRD+ N L+ + DFGL++ D + R+
Sbjct: 127 ANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRW 179
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ + + D+ S G V+ + + + + I++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGF 230
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 1e-19
Identities = 51/245 (20%), Positives = 96/245 (39%), Gaps = 29/245 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTKHPQLLYESKLYRILQG 61
K + R++G GSFG +Y G + VAIK N + + +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 62 GTGIPNVRWFGV--EGDYNVLVMDLL-GPSLEDLFNFCSR---------KLSLKTVLMLA 109
VR GV +G +++M+L+ L+ SL ++ +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRE 169
++ + + ++++ F+HRD+ N ++ V I DFG+ + +T YR+
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRK 191
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKI 228
R+ S + + D+ S G VL P+QGL + +Q +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFV 248
Query: 229 SEKKV 233
E +
Sbjct: 249 MEGGL 253
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 2e-19
Identities = 26/181 (14%), Positives = 65/181 (35%), Gaps = 32/181 (17%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------------KHPQLLYESKL--- 55
+G+ +G G ++ + + E +K V +
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 56 --YRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
+R LQ G+ + + EG+ ++M E + ++ ++ + D ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNA--VLM-------ELIDAKELYRVRVENPDEVLDMIL 113
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
V + + +H D+ N L+ ++IIDF + + + + + R+ +N+
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWREIL-ERDVRNI 168
Query: 174 T 174
Sbjct: 169 I 169
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 9e-19
Identities = 41/232 (17%), Positives = 82/232 (35%), Gaps = 33/232 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG 61
++ +LG+ +G G+FG++ T VA+K+ H + +IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 62 GTGIPNVR----WFGVEGDYNVLVMDLL-GPSLEDL---------------FNFCSRKLS 101
NV G +++++ +L + L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 189
Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ + ++ + T + + D+ S G +L
Sbjct: 190 YVR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 3e-18
Identities = 44/221 (19%), Positives = 86/221 (38%), Gaps = 22/221 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKHP---QLLYESKLYRILQG 61
IG G FG +Y GT + + A+K N T Q L E + +
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 62 GTGIPN-VRWFGV---EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
PN + G+ ++V+ + L + + ++K ++ Q+ +
Sbjct: 88 ----PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 143
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
+F+ SK F+HRD+ N ++ V + DFGLA+ D
Sbjct: 144 KFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLP 197
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGL 216
++ ++ + + + + D+ S G +L + RG+ P+ +
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 3e-17
Identities = 55/278 (19%), Positives = 89/278 (32%), Gaps = 36/278 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------LENVKTKHPQ 48
+ L IG G FGE++ G EEVA+K + V +H
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHEN 58
Query: 49 LLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLML 108
+L G W + + + D L + + KL+L T L
Sbjct: 59 IL---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGL 113
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
A + V + HRD+K N L+ + I D GLA ++ + I
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP- 169
Query: 169 ENKNLTGTARY------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
+ GT RY E +R D+ ++G V R +
Sbjct: 170 --NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 223 QKYEKISEKKVSTSIEALC-RGYPTEFASYFHYCRSLR 259
S+ V + +C + + + C +LR
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 265
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 477 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.93 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.5 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.7e-60 Score=465.38 Aligned_cols=297 Identities=78% Similarity=1.347 Sum_probs=267.0
Q ss_pred CCCccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 1 m~~~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
||-+++++|+++++||+|+||.||+|++..+|+.||||++........+..|+++++.++|+++++.+..++.+++..++
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 89999999999999999999999999999999999999988877778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 81 VmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
||||++++|.+.+......+++..++.++.||+.||+|||++|||||||||+|||++..+.+..+||+|||+|+.+....
T Consensus 81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99999999999888778889999999999999999999999999999999999999655567789999999999988776
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
.....+++.....+||+.|||||++.+..++.++|||||||++|||++|..||...........+.+........+.+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 66666666777889999999999999999999999999999999999999999887766666666666666666677788
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchhhc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ 297 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~ 297 (477)
++++|+++.++|.+||..+|++||++++|.++|++++.+.++.++..+||+.++...
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~~ 297 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGA 297 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGTC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCCC
Confidence 899999999999999999999999999999999999999999999999999877543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.6e-58 Score=450.57 Aligned_cols=290 Identities=60% Similarity=1.013 Sum_probs=266.4
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
+++++|+++++||+|+||+||+|++..+|+.||||++........+..|++++..|+|+++++.+..++..+...++|||
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57899999999999999999999999999999999988777777899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC--CCCCcEEEeecCceeecccCCC
Q 011819 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 84 ~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~--~~~~~vkL~DFGla~~~~~~~~ 161 (477)
|++++|.+++......++..++..++.|++.||+|||++|||||||||+|||++.. ...+.+||+|||+|+.+.+...
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 99999999998777789999999999999999999999999999999999999532 1357899999999999887666
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
....+.+....++||+.|||||++.+..++.++|||||||++|||++|..||.+.......+.+.++.........+.++
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhc
Confidence 66666666778899999999999999999999999999999999999999999877777777887777777777788899
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTIL 293 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 293 (477)
+++|+++.++++.|+..+|++||+|+.+.++|++++.+.++..++.+||+.+
T Consensus 242 ~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 9999999999999999999999999999999999999999999999999853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=412.99 Aligned_cols=268 Identities=19% Similarity=0.297 Sum_probs=220.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~-----~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|++++.||+|+||+||+|+++.+++.||||++.. ......+.+|+++++.|+| ++|..+..++.+.+..||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCS-TTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCC-CCeeEEEEEEEECCEEEE
Confidence 3589999999999999999999999999999998753 2334568899999999987 556666666677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||| |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccC
Confidence 99999 8999999875 4579999999999999999999999999999999999999 67899999999999876543
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
... ......+||+.|||||++.+..|+.++|||||||+||+|++|..||.+. +..+.+.++......
T Consensus 162 ~~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~----- 228 (288)
T d1uu3a_ 162 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLEYD----- 228 (288)
T ss_dssp -------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCC-----
T ss_pred Ccc-----cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCCCC-----
Confidence 321 1234568999999999999999999999999999999999999999763 445666666655432
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccchh
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKY 295 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 295 (477)
++..+++++.+||.+||..||.+|||++++... .+. ..++|+..+||..+..
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~---~~i-~~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY---GPL-KAHPFFESVTWENLHQ 280 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH---HHH-HTSGGGTTCCCTTGGG
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC---HHH-HcCCccCCCCHHHhhc
Confidence 345689999999999999999999998876442 111 2478888899998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=403.71 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=209.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~-----~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
..++|++++.||+|+||+||+|++..+++.||||++.. ......+.+|+++++.++| ++|..+..++.+.+..|
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRVY 82 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCC-CCCCeEEEEEEECCEEE
Confidence 45789999999999999999999999999999998753 2334567899999999987 55666667777888899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||| +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 83 ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 83 LILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCC
T ss_pred EEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCC
Confidence 999999 8999999975 4569999999999999999999999999999999999999 6789999999999976543
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
.. ....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+. +..+.+.++......
T Consensus 159 ~~---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~---- 222 (263)
T d2j4za1 159 SR---------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFT---- 222 (263)
T ss_dssp CC---------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTTCCC----
T ss_pred Cc---------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCC----
Confidence 22 23468999999999999999999999999999999999999999763 345566666555433
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
++..+++++.+||..||..||++||+++++++
T Consensus 223 -~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 33568999999999999999999999776643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=412.09 Aligned_cols=265 Identities=19% Similarity=0.272 Sum_probs=222.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|++++.||+|+||.||+|++..+|+.||||++... .....+.+|+.+++.++| ++|+.+..++.+.+..||
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC-CCEEEEEeeecccccccc
Confidence 46899999999999999999999999999999997642 234567899999999986 677777777778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||| |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 v~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCT
T ss_pred ceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccC
Confidence 99999 9999999975 4569999999999999999999999999999999999999 68899999999999865443
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.+ ..+.+..+......
T Consensus 159 ~~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~~~~----- 223 (337)
T d1o6la_ 159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIR----- 223 (337)
T ss_dssp TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----
T ss_pred Cc-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHHhcCCCC-----
Confidence 22 1345789999999999999999999999999999999999999997743 44555555554432
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhcccc
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~ 300 (477)
+++.+++++.+||.+||..||.+|++ +++++ .++|+..++|..+...+..+
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil----------~Hp~f~~i~~~~l~~~~~~~ 279 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM----------EHRFFLSINWQDVVQKKLLP 279 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHH----------TSGGGTTCCHHHHHTTCSCC
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHH----------cCcccccCCHHHHHhCCCCC
Confidence 34678999999999999999999995 44442 35677778998876655443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=405.82 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=206.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE 83 (477)
.++|+++++||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.++| ++|+.+..++.+.+..|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCC-CCEeeEeEEEEECCEEEEEEE
Confidence 358999999999999999999999999999999876432 34568899999999988 556666666677888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|| |++|.+++.. ..+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+.....
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccccc-
Confidence 99 8999998874 569999999999999999999999999999999999999 6788999999999987754332
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
.....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+... .+.+..+........ ..+.
T Consensus 172 ------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~~~~~~~--~~~~ 240 (293)
T d1yhwa1 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPEL--QNPE 240 (293)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCC--SSGG
T ss_pred ------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCCC--CCcc
Confidence 12456899999999999999999999999999999999999999976432 333333333322111 1335
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.+++++.+||.+||..||++||++++++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 6899999999999999999999987764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=404.18 Aligned_cols=250 Identities=24% Similarity=0.335 Sum_probs=204.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.++|+++++||+|+||+||+|+++.+|+.||||++.... ....+.+|+.+++.|+| ++|..+..++.+.+..||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCC-CCEeeEeeeeccCceeEEEE
Confidence 468999999999999999999999999999999986543 23458899999999987 55666666677888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||| |++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCCc
Confidence 999 8899999863 5579999999999999999999999999999999999999 6788999999999987654332
Q ss_pred CcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. ......+||+.|||||++.+..+ +.++|||||||+||+|++|..||....... +.+..+...... ...
T Consensus 159 ~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~~~~---~~~ 228 (271)
T d1nvra_ 159 E-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTY---LNP 228 (271)
T ss_dssp E-----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTTCTT---STT
T ss_pred c-----ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCCC---CCc
Confidence 1 12345789999999999998886 578999999999999999999997654332 222222222211 112
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
...+++++.+||.+||..||++||++++++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 356789999999999999999999987763
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=408.71 Aligned_cols=253 Identities=20% Similarity=0.244 Sum_probs=199.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.+.+.|++++.||+|+||+||+|++..+++.||||++.... ....+.+|++++..|+| ++|+.+..++.+.+..||
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH-PNIVALDDIYESGGHLYL 84 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCC-TTBCCEEEEEECSSEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEE
Confidence 35677999999999999999999999999999999986543 23456789999999987 566666667778888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||| |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+...+.++.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp EECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999 8999999974 567999999999999999999999999999999999999975556789999999999866443
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
.. ....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+.. ..+.+..+......... .
T Consensus 164 ~~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~-~ 231 (307)
T d1a06a_ 164 SV--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQILKAEYEFDS-P 231 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHTTCCCCCT-T
T ss_pred Ce--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCCCCC-c
Confidence 22 235689999999999999999999999999999999999999997643 34555666655443222 2
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..+.+|+++.+||.+||..||++||++++++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 4467899999999999999999999977664
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=402.83 Aligned_cols=248 Identities=18% Similarity=0.293 Sum_probs=206.4
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
+.|+++++||+|+||+||+|++..+++.||||++..... ...+.+|+++++.|+| ++|+.+..++.+.+..||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCeEEEEEec
Confidence 469999999999999999999999999999999876433 2468899999999987 5666666666778889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
| |++|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc--
Confidence 9 899999987667789999999999999999999999999999999999999 6789999999999976543211
Q ss_pred ccccccCCCCccCccccccchhc-----CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 164 HIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~-----g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
.....+||+.|||||++. +..|+.++|||||||+||+|++|..||.+.... +.+.++........
T Consensus 166 -----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~~~~~~~-- 235 (288)
T d2jfla1 166 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAKSEPPTL-- 235 (288)
T ss_dssp -----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHHSCCCCC--
T ss_pred -----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCCCC--
Confidence 123568999999999984 456889999999999999999999999875543 33444444332211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.....+++++.+||.+||..||++||+++++.
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 12356899999999999999999999987764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-51 Score=404.94 Aligned_cols=262 Identities=21% Similarity=0.285 Sum_probs=220.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|++++.||+|+||+||+|++..+|+.||||++... .....+..|+.+++.++| ++|+.+..++.+.+..|+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccC-cChhheeeeEeeCCeeee
Confidence 46899999999999999999999999999999997532 234567899999999987 566666667778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||| |++|..++.. ...++...+..++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+...+.
T Consensus 82 vmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC
T ss_pred EeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc
Confidence 99999 8899998875 5678999999999999999999999999999999999999 68899999999999876543
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
. ...+||+.|||||++.+..|+.++|||||||+||+|++|..||.+. +..+.+.++......
T Consensus 158 ~----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~----- 219 (316)
T d1fota_ 158 T----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR----- 219 (316)
T ss_dssp B----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC-----
T ss_pred c----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC-----
Confidence 2 3568999999999999999999999999999999999999999763 345556666554432
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhcccc
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~ 300 (477)
++..+++++.+++.+||..||.+|+ ++++++ .++|...++|..+.....++
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il----------~Hp~f~~i~~~~l~~~~~~~ 275 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK----------NHPWFKEVVWEKLLSRNIET 275 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH----------TSGGGSSCCHHHHHTTCSCC
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHH----------cCcccccCCHHHHHhCCCCc
Confidence 3356899999999999999999996 665553 36777888999765554443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-50 Score=410.20 Aligned_cols=267 Identities=24% Similarity=0.306 Sum_probs=217.7
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHc--CCCCCCeeEEeeEeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQ--GGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~--~~~~i~~~~~~~~~~~~~ 78 (477)
.++|++++.||+|+||.||+|++..+|+.||||++... .....+..|..++..+. +|++|+.+..++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46899999999999999999999999999999987532 22334566666666665 357777777777888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
||||||| |++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecC
Confidence 9999999 8999999975 4569999999999999999999999999999999999999 688999999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
... ....+||+.|||||++. +..|+.++|||||||+||+|++|..||.+............+.....
T Consensus 159 ~~~---------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 226 (364)
T d1omwa3 159 KKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--- 226 (364)
T ss_dssp SSC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC---
T ss_pred CCc---------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC---
Confidence 432 23568999999999997 45689999999999999999999999987655444443333322222
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhcccc
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~ 300 (477)
.++..+++++.+||.+||..||.+||+ +++++ .++|+..+||..+..++.++
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil----------~Hp~f~~i~~~~~~~~~~~~ 283 (364)
T d1omwa3 227 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK----------ESPFFRSLDWQMVFLQKYPP 283 (364)
T ss_dssp --CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHH----------TSGGGTTCCHHHHHTTCSCC
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHH----------cCccccCCCHHHHhcCCCCc
Confidence 234578999999999999999999998 45443 36778888999876655543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=398.38 Aligned_cols=248 Identities=22% Similarity=0.260 Sum_probs=195.3
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEee-EeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFG-VEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~-~~~~~~~lV 81 (477)
++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+|+++++.|+|++++..+..+. ...+..|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999999999999999998765432 24778999999998865555555443 345667999
Q ss_pred EecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeCCCCCCceEeecCCCCCcEEEeecCc
Q 011819 82 MDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (477)
Q Consensus 82 mE~~-g~sL~~li~~---~~~~ls~~~~~~i~~qIa~aL~yLHs~g-----iiHRDLKP~NILl~~~~~~~~vkL~DFGl 152 (477)
|||| |++|.+++.. ....+++..++.++.||+.||+|||++| ||||||||+|||+ +.++.+||+|||+
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~ 160 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGL 160 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccc
Confidence 9999 8999999863 2567999999999999999999999976 9999999999999 6789999999999
Q ss_pred eeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 153 AKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 153 a~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
|+....... .....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.. ..+.+.++....
T Consensus 161 a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~~~ 230 (269)
T d2java1 161 ARILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGK 230 (269)
T ss_dssp HHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTC
T ss_pred eeecccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHcCC
Confidence 987654322 1245789999999999999999999999999999999999999997643 445556665544
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.. .++..+++++.+||.+||..||++||+++++.+
T Consensus 231 ~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 43 234578999999999999999999999887743
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=395.82 Aligned_cols=265 Identities=19% Similarity=0.232 Sum_probs=215.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--------~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
-+.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.|+| ++|+.+..++.+.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~ 85 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENK 85 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEEC
Confidence 35678999999999999999999999999999999876432 13458899999999987 5666666777788
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCC-CCCcEEEeecCce
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 153 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~-~~~~vkL~DFGla 153 (477)
+..||||||| |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+..++ ....+||+|||+|
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 8999999999 8999999975 45699999999999999999999999999999999999994321 2236999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
+....... .....||+.|||||++.+..++.++|||||||+||+|++|..||.+. +..+.+..+.....
T Consensus 165 ~~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 165 HKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNY 233 (293)
T ss_dssp EECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCC
T ss_pred hhcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCC
Confidence 87654322 34568999999999999999999999999999999999999999764 34555666665544
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTI 292 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 292 (477)
... ....+.+++++.+||.+||..||++||+++++++ ++|....+|..
T Consensus 234 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~----------hp~~~~~~~~~ 281 (293)
T d1jksa_ 234 EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ----------HPWIKPKDTQQ 281 (293)
T ss_dssp CCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH----------STTTCC-----
T ss_pred CCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc----------CcccCCCChhH
Confidence 332 3456788999999999999999999999877643 45555556654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-50 Score=408.76 Aligned_cols=263 Identities=19% Similarity=0.306 Sum_probs=221.0
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCC-----CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~-----~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
.++|+++++||+|+||.||+|+++.+|+.||||++... .....+.+|+++++.++| ++|+.+..++......++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCC-CcEeeccccccccccccc
Confidence 36899999999999999999999999999999987532 233457899999999987 556666666677788899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ |++|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 119 v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC
T ss_pred ccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc
Confidence 99999 9999999875 4569999999999999999999999999999999999999 67899999999999876542
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (477)
. ...+||+.|||||++.+..|+.++|||||||+||+|++|..||.+. +..+.+.++......
T Consensus 195 ~----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~----- 256 (350)
T d1rdqe_ 195 T----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR----- 256 (350)
T ss_dssp B----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----
T ss_pred c----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCCCC-----
Confidence 2 3568999999999999999999999999999999999999999764 445666666655443
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccchhhccccC
Q 011819 240 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLA 301 (477)
Q Consensus 240 l~~~~p~~l~~li~~cl~~~p~~RP-----t~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (477)
.+..+++++.++|..||..||.+|+ ++++++ .++|+...||..+..++.+++
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell----------~Hp~f~~~~~~~~~~~~~~~p 313 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK----------NHKWFATTDWIAIYQRKVEAP 313 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH----------TSGGGTTCCHHHHHTTCSCCS
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHH----------cCccccCCCHHHHHhcCCCcC
Confidence 2356899999999999999999995 666663 367888889998765554433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-50 Score=408.16 Aligned_cols=253 Identities=18% Similarity=0.269 Sum_probs=212.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+.++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|+.++..|+| ++|+.+..++.+.+..||||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEE
Confidence 44689999999999999999999999999999999865432 2357789999999987 56666666677888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||| |++|.+++.....++++..++.++.||+.||+|||++|||||||||+|||+.. +.++.+||+|||+|+.+.....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSC
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheecccccc
Confidence 999 89999999655667999999999999999999999999999999999999952 2357899999999987754332
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....||+.|||||++.+..|+.++|||||||++|+|++|..||.+. +..+.+..+........ ....
T Consensus 182 --------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~ 249 (350)
T d1koaa2 182 --------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMD-DSAF 249 (350)
T ss_dssp --------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSC-CGGG
T ss_pred --------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-cccc
Confidence 23568999999999999999999999999999999999999999764 34555666655544322 2344
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..+++++.+||.+||..||++|||++++++
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 678999999999999999999999777643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=398.34 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=204.5
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
.++|+++++||+|+||+||+|+. +..||||++..... ...+.+|+.++..++|++ |..+..++. ....+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~~~~~-~~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN-ILLFMGYST-APQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTT-BCCEEEEEC-SSSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCC-EeeeeEEEe-ccEEEEE
Confidence 46899999999999999999974 33699999865432 235778999999998755 545555544 3457999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||| +++|.+++.....++++..++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeeccccC
Confidence 9999 899999998666779999999999999999999999999999999999999 578999999999998664432
Q ss_pred CCcccccccCCCCccCccccccchhcCC---CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~---~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
.. .......||+.|||||++.+. .|+.++|||||||+||||++|..||.+... ..+....+.........
T Consensus 159 ~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 159 GS-----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDL 231 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHHTSCCCCG
T ss_pred Cc-----ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCcc
Confidence 21 123457899999999999753 478999999999999999999999987543 22333334444444445
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+...+|+++.+||.+||+.+|++||++++|.+.|+.+.
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 5566789999999999999999999999999999988774
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=402.68 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=219.2
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecC-----CCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~-----~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|+++++||+|+||+||+|+++.+++.||||++.. ......+..|..++....+|++|..+..++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 679999999999999999999999999999999853 223345677877776544557788887788888999999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (477)
|||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 9999 8999999975 4569999999999999999999999999999999999999 688999999999998654432
Q ss_pred CCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHH
Q 011819 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (477)
Q Consensus 161 ~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (477)
. .....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+. +..+.+.++...... +
T Consensus 158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~-----~ 222 (320)
T d1xjda_ 158 A-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRMDNPF-----Y 222 (320)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----C
T ss_pred c-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC-----C
Confidence 2 234568999999999999999999999999999999999999999764 345556666554332 3
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccchhhccc
Q 011819 241 CRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRIFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (477)
Q Consensus 241 ~~~~p~~l~~li~~cl~~~p~~RPt~~-~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~ 299 (477)
++.+++++.+||.+||..||++||++. +++ .++|...++|+.+..++..
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~----------~hpff~~~~~~~l~~~~~~ 272 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR----------QHPLFREINWEELERKEID 272 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG----------GSGGGTTCCHHHHHTTCSC
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHH----------hCchhccCCHHHHHhcCCC
Confidence 456899999999999999999999974 442 2567777899876555443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=389.50 Aligned_cols=248 Identities=20% Similarity=0.299 Sum_probs=201.3
Q ss_pred CCce-EEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeE---eCcE
Q 011819 6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGV---EGDY 77 (477)
Q Consensus 6 ~~~y-~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~---~~~~ 77 (477)
.++| ++.++||+|+||+||+|++..+++.||+|++..... ...+.+|+++++.|+|++++..+..+.. ....
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 4455 788899999999999999999999999998765432 2347889999999998665555555433 2456
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~g--iiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.||||||+ +++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++ +.++.+||+|||+|+
T Consensus 87 ~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcce
Confidence 79999999 8999999975 456999999999999999999999998 99999999999994 356899999999997
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
...... ....+||+.|||||++.+ .++.++|||||||+||||++|..||.+.. ...+.+..+.....+
T Consensus 164 ~~~~~~---------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i~~~~~~ 231 (270)
T d1t4ha_ 164 LKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKP 231 (270)
T ss_dssp GCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCC
T ss_pred eccCCc---------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHHHcCCCC
Confidence 543321 235689999999999876 59999999999999999999999997643 334455555544332
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
. .+...+++++.+||.+||+.||++||+++++++
T Consensus 232 ~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 A---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2 244668899999999999999999999877743
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-50 Score=407.90 Aligned_cols=252 Identities=21% Similarity=0.216 Sum_probs=211.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+.++|+++++||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.|+| ++|..+..++.+.+..||||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEE
Confidence 44679999999999999999999999999999999876432 2356789999999987 55666666667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||| |++|.+++.....++++.+++.++.||+.||+|||++|||||||||+||||.. ...+.+||+|||+|+.......
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCCc
Confidence 999 89999988655667999999999999999999999999999999999999942 2568999999999988765332
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....||+.|||||++.+..|+.++|||||||+||+|++|..||.+.. ..+.+..+....... ....+
T Consensus 185 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~-~~~~~ 252 (352)
T d1koba_ 185 --------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEF-DEDAF 252 (352)
T ss_dssp --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCC-CSSTT
T ss_pred --------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC-Ccccc
Confidence 234679999999999999999999999999999999999999997643 345555555544322 22345
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..+++++.+||.+||..||.+||++++++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 67899999999999999999999977764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=404.64 Aligned_cols=253 Identities=19% Similarity=0.276 Sum_probs=200.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC---chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~---~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
..++|+++++||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.|+| ++|+.+..++.+.+..|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCC-TTBCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEE
Confidence 35789999999999999999999999999999999875432 2357889999999987 5566666666777889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 82 mE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
|||+ |++|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||| +.++.+||+|||+|+...+.
T Consensus 83 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp EECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH
T ss_pred EEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCC
Confidence 9999 8899999975 4569999999999999999999997 599999999999999 67899999999999876542
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc-------
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------- 232 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~------- 232 (477)
. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+...............
T Consensus 159 ~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 159 M---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp T---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred c---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 2 245689999999999999999999999999999999999999997644321111100000000
Q ss_pred ----------------cccc----HHH--------Hh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 233 ----------------VSTS----IEA--------LC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 233 ----------------~~~~----~~~--------l~-~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
.... ... +. ..++.++.+||.+||..||++|||++++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000 000 00 125689999999999999999999777644
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=386.96 Aligned_cols=254 Identities=19% Similarity=0.269 Sum_probs=201.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
++|+++++||+|+||.||+|.+. +++.||||++.... ....+.+|++++..++| ++|..+..++...+..+|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCC-CCcccccceeccCCceEEEEEec
Confidence 68999999999999999999974 67889999987543 34568999999999987 56666666666777889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~-- 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT-- 157 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCce--
Confidence 999999987666779999999999999999999999999999999999999 67899999999999876543321
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
......||+.|||||++.+..|+.++|||||||+||||+++ .+||... ...+.+..+....... .+..
T Consensus 158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~~----~p~~ 226 (263)
T d1sm2a_ 158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFRLY----KPRL 226 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---CHHHHHHHHHHTCCCC----CCTT
T ss_pred ----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---CHHHHHHHHHhcCCCC----Cccc
Confidence 12345789999999999999999999999999999999995 5555442 3344555554432221 2356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
+++++.+++..||+.||++||+++++.+.|+++.+
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 78999999999999999999999999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-50 Score=397.67 Aligned_cols=255 Identities=19% Similarity=0.300 Sum_probs=210.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
++|++.++||+|+||+||+|++..+++.||||++..... ...+.+|++++..|+| ++|..+..++.+.+..+||||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCC-CCEecCCccEeeCCeeEEEeecc
Confidence 479999999999999999999999999999999865443 3568899999999987 55666666666777889999999
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 86 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 86 -g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.......
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~-- 170 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTY-- 170 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSS--
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCCc--
Confidence 89999998653 4568999999999999999999999999999999999999 6789999999999986654322
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
.......||+.|||||++.+..|+.++|||||||+||||++|..||.... +..+.+..+..... ...+..
T Consensus 171 ----~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i~~~~~----~~~~~~ 240 (287)
T d1opja_ 171 ----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYR----MERPEG 240 (287)
T ss_dssp ----EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTCC----CCCCTT
T ss_pred ----eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHHhcCCC----CCCCcc
Confidence 11234568999999999999999999999999999999999777764422 22333333333221 123467
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
+|+++.+||..||..||++||+++++.+.|+.++
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 8999999999999999999999999988887764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.7e-50 Score=394.22 Aligned_cols=260 Identities=14% Similarity=0.249 Sum_probs=201.0
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCc---EEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~---~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.++|++.++||+|+||+||+|.+..+++ .||||.+...... ..+.+|+++++.|+| ++|+.+..++...+..+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeCCEEE
Confidence 4689999999999999999999877664 6889987654332 357899999999977 55666666667778889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
|||||| +++|.+++......+++.+++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+|+....
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEccC
Confidence 999999 899999988666679999999999999999999999999999999999999 6889999999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
...... ........||+.|||||++.+..++.++|||||||+||||++ |..||.+... .+.+..+.......
T Consensus 181 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~-- 253 (299)
T d1jpaa_ 181 DTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQDYRLP-- 253 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCC--
T ss_pred CCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 332111 111223468999999999999999999999999999999998 8999977543 34444444432221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
.+..+|+++.+|+..||+.+|++||++.++.+.|++++.
T Consensus 254 --~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 --PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 235689999999999999999999999999999988864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=403.44 Aligned_cols=255 Identities=17% Similarity=0.175 Sum_probs=202.9
Q ss_pred ccCCceEEEe-eeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEe----CcEE
Q 011819 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVE----GDYN 78 (477)
Q Consensus 4 ~i~~~y~i~~-~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~----~~~~ 78 (477)
.+.++|++++ .||+|+||.||+|++..+++.||||++.. ...+.+|+.++..+.+|++|+.+..++.+ ..+.
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4567899876 59999999999999999999999999853 45688899998777656666666554432 4678
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 79 VLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
||||||| |++|.+++... ...+++.++..|+.||+.||+|||++||+||||||+|||++..+..+.+||+|||+|+..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 9999999 89999999743 346999999999999999999999999999999999999965455678999999999877
Q ss_pred ccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHH-HHHHHhhhcccc
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ-KYEKISEKKVST 235 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~-~~~~i~~~~~~~ 235 (477)
..... ....+||+.|||||++.+..|+.++|||||||+||+|++|..||.+........ ....+.......
T Consensus 165 ~~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 165 TSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CCCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred cCCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 65432 245689999999999999999999999999999999999999997654332222 222222222211
Q ss_pred cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+ ......+++++.+||..||..||++||++.++.
T Consensus 237 ~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 270 (335)
T d2ozaa1 237 P-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270 (335)
T ss_dssp C-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred C-CcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 1 122345789999999999999999999977664
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-49 Score=387.77 Aligned_cols=261 Identities=20% Similarity=0.319 Sum_probs=206.1
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeEeC---
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEG--- 75 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~~~~i~~~~~~~~~~--- 75 (477)
.+.++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++|++++..+..+....
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 5778999999999999999999999999999999998754321 24778999999999876666666655433
Q ss_pred cEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
...||||||+ |++|.+++.. .+.+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.++|+|||++.
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTCE
T ss_pred ceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhhh
Confidence 3579999999 8999998875 4569999999999999999999999999999999999999 578999999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (477)
......... ......+||+.|||||++.+..++.++|||||||+||+|++|..||.+.. ..+.+.++......
T Consensus 160 ~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 160 AIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVREDPI 232 (277)
T ss_dssp ECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCCC
T ss_pred hhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcCCC
Confidence 664433211 12345689999999999999999999999999999999999999997643 33444444443332
Q ss_pred ccHHHHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHH
Q 011819 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRIFRDL 276 (477)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~~p~~RP-t~~~l~~~l~~~ 276 (477)
........+|+++.++|.+||..||++|| +++++.+.|..+
T Consensus 233 -~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 -PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 22334578999999999999999999999 888887766654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=388.96 Aligned_cols=257 Identities=20% Similarity=0.312 Sum_probs=209.3
Q ss_pred CceEEEe-eeeecCceEEEEEEECC--CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 7 NKFRLGR-KIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 7 ~~y~i~~-~IG~G~fG~Vy~a~~~~--~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
++|.+.+ +||+|+||.||+|.+.. ++..||||++...... ..+.+|++++..|+|++ |+.+..++.. +..||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY-IVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTT-BCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCC-EeeEeeeecc-CeEEE
Confidence 4688888 49999999999998754 4558999998754433 35789999999998755 4455445543 45789
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||| +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhccccc
Confidence 99999 899999987556679999999999999999999999999999999999999 57889999999999977553
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
.... .......||+.|||||++.+..++.++|||||||+||||++ |..||.+... .+.+..+......
T Consensus 163 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~~~~~---- 231 (285)
T d1u59a_ 163 DSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRM---- 231 (285)
T ss_dssp SCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCC----
T ss_pred cccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----
Confidence 3211 12234578999999999999999999999999999999998 9999987554 3344444443322
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
..++.+|+++.+||..||+.+|++||++.++.+.|++.+..
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 23467899999999999999999999999999999988754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-49 Score=393.47 Aligned_cols=241 Identities=21% Similarity=0.311 Sum_probs=200.2
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+++++.|+| ++|+.+..++.+.+..||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEECCEEEEEE
Confidence 599999999999999999999999999999998764432 247789999999987 56666666677788999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||| +++|..++. ...++++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp ECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---
T ss_pred EecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC---
Confidence 999 666655554 46779999999999999999999999999999999999999 5789999999999975433
Q ss_pred CcccccccCCCCccCccccccchhcC---CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g---~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
....+||+.|||||++.+ ..|+.++|||||||+||||++|..||.+.. ..+.+.++........
T Consensus 168 --------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~~i~~~~~~~~-- 234 (309)
T d1u5ra_ 168 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPAL-- 234 (309)
T ss_dssp --------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCC--
T ss_pred --------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCC--
Confidence 234689999999999975 358899999999999999999999997643 3444555554433322
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
....+++++.+||..||..||++||++++++
T Consensus 235 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 265 (309)
T d1u5ra_ 235 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (309)
T ss_dssp -SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred -CCCCCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 1246899999999999999999999987764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=385.58 Aligned_cols=256 Identities=20% Similarity=0.324 Sum_probs=206.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
.++|+++++||+|+||.||+|++ .++..||||++.... ....+.+|+.++..++|++++. +..++.+ +..+|||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR-LYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCC-EEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeE-EEeeecc-CCeEEEEEe
Confidence 36899999999999999999997 467899999987543 3456899999999998755554 4445443 456899999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 85 ~-g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
+ +++|.+++... ..++++..++.++.||+.||.|||+++|+||||||+|||| +.++.+||+|||+|+.......
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCcc-
Confidence 9 99999877422 3359999999999999999999999999999999999999 6889999999999997754322
Q ss_pred cccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
.......||+.|||||++.+..++.++|||||||+||||++|..||... ....+.+..+....... .+.
T Consensus 165 -----~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i~~~~~~~----~p~ 233 (272)
T d1qpca_ 165 -----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLERGYRMV----RPD 233 (272)
T ss_dssp -----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCCC----CCT
T ss_pred -----ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCCC----Ccc
Confidence 1234567899999999999889999999999999999999965554332 22344444444432221 235
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.+|+++.+|+..||+.+|++||+++++.+.|+++|..
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 6899999999999999999999999999999998854
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=394.07 Aligned_cols=259 Identities=19% Similarity=0.271 Sum_probs=216.5
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
.+-++|++++.||+|+||+||+|.+..+++.||||++..+... ..+.+|+++++.++| ++|+.+..++.+.+..||||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEE
Confidence 4668999999999999999999999999999999998765433 346799999999987 55666666667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||| |++|.+++......+++.++..|+.||+.||+|||++||+||||||+|||++. +....+||+|||+++.......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCCc
Confidence 999 88999999755557999999999999999999999999999999999999942 2456899999999987654322
Q ss_pred CcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHh
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (477)
.....||+.|+|||.+.+..|+.++|||||||+||+|++|..||.+. +..+.+..+........ ....
T Consensus 160 --------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~ 227 (321)
T d1tkia_ 160 --------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTFD-EEAF 227 (321)
T ss_dssp --------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCC-HHHH
T ss_pred --------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-hhhc
Confidence 23457899999999999999999999999999999999999999764 44566666666555433 3455
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 242 ~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
+.+++++.+||.+||..||.+||+++++ |++.|.+
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~ei---l~hp~~~ 262 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLK 262 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHH---hcCHhhc
Confidence 7799999999999999999999997766 4444443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=396.10 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=208.5
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCc-----EEEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~-----~vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
++|+++++||+|+||+||+|++..+++ .||+|.+.... ....+..|+.++..+.+|++|+.+..++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 689999999999999999999876543 69999875432 3346889999999997678888888888888889
Q ss_pred EEEEecC-CCCHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceE
Q 011819 79 VLVMDLL-GPSLEDLFNFCS----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~----------------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NIL 135 (477)
||||||| +++|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 9999999 999999997432 24889999999999999999999999999999999999
Q ss_pred eecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCC
Q 011819 136 MGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (477)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~ 214 (477)
+ +.++.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||++ |..||.
T Consensus 197 l---~~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 197 V---THGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp E---ETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred c---ccCCeEEEeeccccccccCCCce-----eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9 67899999999999876554332 12235678999999999999999999999999999999997 899998
Q ss_pred CCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
+.... +.+.++....... ..+..+|+++.+||..||+.+|++|||+++|.+.|..
T Consensus 269 ~~~~~---~~~~~~~~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 269 GIPVD---ANFYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TCCCS---HHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHH---HHHHHHHhcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 75543 2233333332221 1345689999999999999999999999999887753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-48 Score=381.99 Aligned_cols=249 Identities=18% Similarity=0.206 Sum_probs=210.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc-----------hhHHHHHHHHHHHcCCCCCCeeEEeeEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLLYESKLYRILQGGTGIPNVRWFGVE 74 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~-----------~~~~~E~~il~~L~~~~~i~~~~~~~~~ 74 (477)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+.++..|..|++|..+..++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999999999999999998654321 2467899999999966888888888888
Q ss_pred CcEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 75 GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 75 ~~~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
.+..||||||| |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchhe
Confidence 99999999999 8999999975 4579999999999999999999999999999999999999 68899999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcC------CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHH
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g------~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~ 227 (477)
+....... ....+||+.|+|||.+.+ ..++.++|||||||+||+|++|+.||.+.+ ....+..
T Consensus 158 ~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~~ 226 (277)
T d1phka_ 158 CQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRM 226 (277)
T ss_dssp EECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH
T ss_pred eEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHHH
Confidence 87754332 245689999999999864 346889999999999999999999997643 3445555
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
+.......... ...++++++.+||.+||..+|.+||++++++
T Consensus 227 i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 227 IMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 55554332222 3356899999999999999999999977764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=383.53 Aligned_cols=249 Identities=20% Similarity=0.343 Sum_probs=199.3
Q ss_pred eeeeecCceEEEEEEEC--CCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC-
Q 011819 13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (477)
Q Consensus 13 ~~IG~G~fG~Vy~a~~~--~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~- 85 (477)
++||+|+||+||+|.+. .+++.||||++..... ...+.+|+++++.|+|++++ .+..++.. +..+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv-~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV-RMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBC-CEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCc-eEEEEecc-CCEEEEEEcCC
Confidence 46999999999999864 4567899999865432 23588999999999875544 44445544 4468999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCccc
Q 011819 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165 (477)
Q Consensus 86 g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (477)
+++|.+++.. ...+++..++.++.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+.........
T Consensus 91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEE--
T ss_pred CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccc--
Confidence 8999999975 5679999999999999999999999999999999999999 578999999999998765433221
Q ss_pred ccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcCC
Q 011819 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (477)
Q Consensus 166 p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (477)
.......||+.|||||++.+..++.++|||||||++|||++ |..||.+... .+....+...... ..+..+
T Consensus 165 --~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~~ 235 (277)
T d1xbba_ 165 --KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM----GCPAGC 235 (277)
T ss_dssp --EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCCTTC
T ss_pred --ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCccc
Confidence 12334679999999999999999999999999999999998 9999987543 3444444443222 234678
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 245 PTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 245 p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
|+++.+||..||+.||++||+++++.+.|++.|.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999999999999999988863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=379.76 Aligned_cols=251 Identities=17% Similarity=0.286 Sum_probs=210.4
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
++|+++++||+|+||+||+|++ .++++||||+++... ....+.+|+.++..++| ++|..+..++.+.+..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~H-pnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCceEEEEEcc
Confidence 6899999999999999999997 578899999987644 44678999999999987 45555555666677889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCcc
Q 011819 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQH 164 (477)
Q Consensus 86 -g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (477)
+++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~--- 155 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY--- 155 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSC---
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCc---
Confidence 899999987666779999999999999999999999999999999999999 6789999999999986654332
Q ss_pred cccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 165 ~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+... .+...++...... ..+..
T Consensus 156 ---~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~ 225 (258)
T d1k2pa_ 156 ---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRL----YRPHL 225 (258)
T ss_dssp ---CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCC----CCCTT
T ss_pred ---eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHhCCCC----CCccc
Confidence 12334679999999999999999999999999999999998 8999977543 4445555443222 13356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRD 275 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~ 275 (477)
+|+++.+||.+||+.||++||+++++.+.|.+
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 89999999999999999999999988877643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=383.68 Aligned_cols=260 Identities=19% Similarity=0.278 Sum_probs=201.6
Q ss_pred CceEEEeeeeecCceEEEEEEECC-----CCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeE-eCcE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGV-EGDY 77 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~-----~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~-~~~~ 77 (477)
++|+++++||+|+||.||+|++.. +++.||||++...... ..+..|..++..+.||++++.+..+.. .+..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 689999999999999999999754 4578999998654332 346788888999988888877766544 4556
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCC
Q 011819 78 NVLVMDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~---------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~ 141 (477)
.++||||| +++|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||| +.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE---CC
Confidence 89999999 99999999642 2348899999999999999999999999999999999999 67
Q ss_pred CCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCccc
Q 011819 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGT 220 (477)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG-~~Pf~~~~~~~ 220 (477)
++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||++| ..||.+.....
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp GGCEEECC------CCSCTTS-----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCcEEEccCcchhhccccccc-----cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 899999999999876543321 123456899999999999999999999999999999999986 56787654322
Q ss_pred HHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011819 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIRE 280 (477)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~ 280 (477)
.....+...... ..+..+++++.++|.+||+.||++||+++++.+.|+++++.+
T Consensus 245 --~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 245 --EFCRRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp --HHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHHhcCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 222222222211 234568999999999999999999999999999999987543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=378.91 Aligned_cols=259 Identities=15% Similarity=0.187 Sum_probs=202.3
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCC----cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g----~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
...|++.+.||+|+||.||+|.+..++ ..||||.+...... ..+.+|+.++..|+| ++|+.+..++...+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCC-CCEeeeeEEEecCCce
Confidence 357999999999999999999976654 47999998654332 247789999999987 5666666666677788
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||| +.++.+||+|||+|+...
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-----
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhccc
Confidence 9999999 888999887667789999999999999999999999999999999999999 688999999999998765
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
...... .......||+.|||||++.+..++.++|||||||+||||++|..||... ....+.+..+......
T Consensus 162 ~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~~~~--- 232 (283)
T d1mqba_ 162 DDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKAINDGFRL--- 232 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTTCCC---
T ss_pred CCCccc----eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc--CCHHHHHHHHhccCCC---
Confidence 433211 1123456899999999999999999999999999999999966665432 2234445544443322
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
..+..+|.++.++|..||+.+|++||++.++.+.|+.++.
T Consensus 233 -~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 233 -PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1335689999999999999999999999999999988764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=379.72 Aligned_cols=255 Identities=21% Similarity=0.311 Sum_probs=198.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCC---cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g---~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~l 80 (477)
++|++++.||+|+||.||+|++..++ ..||||.+...... ..+..|+.+++.++|++++..+. ++. .+..||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG-VIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEE-EEC-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEE-EEe-cCeEEE
Confidence 68999999999999999999987553 56889987654332 35789999999998755555444 443 456799
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccC
Q 011819 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (477)
Q Consensus 81 VmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (477)
||||+ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheeccCC
Confidence 99999 899999887667789999999999999999999999999999999999999 57789999999999876543
Q ss_pred CCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHH
Q 011819 160 STHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (477)
Q Consensus 160 ~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (477)
.. .......||+.|||||++.+..++.++|||||||+||||++ |..||.+.... +.+.++......
T Consensus 162 ~~------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i~~~~~~---- 228 (273)
T d1mp8a_ 162 TY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENGERL---- 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTCCC----
T ss_pred cc------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCC----
Confidence 22 12234578999999999999999999999999999999998 89999876553 334444443322
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.+++++|+++.+||..||..||++||++++|.+.|+.++..
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 24567899999999999999999999999999999888754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=379.69 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=200.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC--------CchhHHHHHHHHHHHcC-CCCCCeeEEeeEeC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLLYESKLYRILQG-GTGIPNVRWFGVEG 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~--------~~~~~~~E~~il~~L~~-~~~i~~~~~~~~~~ 75 (477)
+.++|++++.||+|+||.||+|++..+|+.||||++.... ....+.+|+.+++.+++ |++|+.+..++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4678999999999999999999999999999999876432 12336789999999984 57788888888888
Q ss_pred cEEEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCce
Q 011819 76 DYNVLVMDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (477)
Q Consensus 76 ~~~~lVmE~~-g-~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla 153 (477)
+..|+||||+ + +++.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++ .+.+.+||+|||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence 8999999999 4 578888865 45699999999999999999999999999999999999994 24578999999999
Q ss_pred eecccCCCCcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc
Q 011819 154 KKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (477)
Q Consensus 154 ~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (477)
+...... ....+||+.|||||++.+..+ +.++|||||||+||+|++|..||... ..+....
T Consensus 159 ~~~~~~~---------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~~i~~~~ 220 (273)
T d1xwsa_ 159 ALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EEIIRGQ 220 (273)
T ss_dssp EECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHHHHCC
T ss_pred eeccccc---------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---------hHHhhcc
Confidence 8654322 245789999999999988776 57799999999999999999999652 1122222
Q ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
. .+...+|+++.+||.+||..||++|||+++++
T Consensus 221 ~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 221 V-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp C-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred c-----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 2 13467899999999999999999999987764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=380.53 Aligned_cols=254 Identities=19% Similarity=0.283 Sum_probs=199.6
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCc----EEEEEEecCC---CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVK---TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNV 79 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~----~vAiKi~~~~---~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~ 79 (477)
.+|+++++||+|+||+||+|.+..+|+ .||+|.+... .....+.+|+++++.|+| ++|+.+..++.++.. +
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~-~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTSTV-Q 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCC-TTBCCEEEEEESSSE-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCe-e
Confidence 579999999999999999999988876 5888876542 233468899999999987 455555555555554 5
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeeccc
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (477)
++|||+ +++|.+++......+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTT
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceeccc
Confidence 556666 999999988777789999999999999999999999999999999999999 5788999999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccH
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (477)
..... ......||+.|||||++.+..|+.++|||||||+||||++ |..||.+...... ...+......
T Consensus 164 ~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~i~~~~~~--- 232 (317)
T d1xkka_ 164 EEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEKGERL--- 232 (317)
T ss_dssp TCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHHHHHTCCC---
T ss_pred ccccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHcCCCC---
Confidence 33211 1234568999999999999999999999999999999998 8999987655433 2233222211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
..+..+|+++.+++..||..+|.+||++.++.+.|..+.
T Consensus 233 -~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 -PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 123568999999999999999999999999988877664
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=377.35 Aligned_cols=247 Identities=20% Similarity=0.205 Sum_probs=195.7
Q ss_pred EEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 10 ~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-------~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
+.+++||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.++| ++|+.+..++...+..||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTCCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCC-CCEeEEEeeeccCCceeehh
Confidence 357899999999999999999999999998764321 2357899999999987 45555556666777889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||+.+.+...+......+++..+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|+.......
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC-
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcc-
Confidence 999555555554446679999999999999999999999999999999999999 6889999999999986654332
Q ss_pred cccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc---------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (477)
.....+||+.|||||++.+. .|+.++|||||||++|||++|..||.+... .+.+.++.+..
T Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 156 ------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp ------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSS
T ss_pred ------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhcc
Confidence 22356899999999998754 579999999999999999999999976443 33333332210
Q ss_pred --------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 --------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 --------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.......+.+.+++++.+||.+||..||++|||+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11223445567889999999999999999999987764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=373.52 Aligned_cols=251 Identities=21% Similarity=0.255 Sum_probs=201.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|+++++||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.++| ++|+.+..++.+.+..||||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-p~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEEeccccccccceeEEE
Confidence 58999999999999999999999999999999886533 24568899999999987 56666666667888999999
Q ss_pred ecCCCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~g~sL~~li~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
||+++++.+++.. ....+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc
Confidence 9997777776643 34569999999999999999999999999999999999999 6788999999999987654322
Q ss_pred CcccccccCCCCccCccccccchhcCCCC-CCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh---------
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 231 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~-s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (477)
......||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+. ...+.++...
T Consensus 158 -------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 158 -------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp -------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTS
T ss_pred -------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhc
Confidence 2345689999999999877664 7899999999999999999999976433 2222222111
Q ss_pred ---------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 ---------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
............+++++.+|+.+||..||++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0112223344567889999999999999999999887743
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=374.64 Aligned_cols=252 Identities=19% Similarity=0.280 Sum_probs=197.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCC-CcEEEEEEecCC----CCchhHHHHHHHHHHHc--CCCCCCeeE-EeeE---
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVK----TKHPQLLYESKLYRILQ--GGTGIPNVR-WFGV--- 73 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~-g~~vAiKi~~~~----~~~~~~~~E~~il~~L~--~~~~i~~~~-~~~~--- 73 (477)
..++|+++++||+|+||+||+|++..+ ++.||||++... .....+.+|+.+++.|. +|++|..+. .+..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 457899999999999999999999766 678999987543 22345778999888874 345555544 4322
Q ss_pred -eCcEEEEEEecCCCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecC
Q 011819 74 -EGDYNVLVMDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (477)
Q Consensus 74 -~~~~~~lVmE~~g~sL~~li-~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFG 151 (477)
.....+++|||+.+.+..+. ......+++..++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence 23567999999955544443 4445669999999999999999999999999999999999999 688999999999
Q ss_pred ceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh
Q 011819 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (477)
Q Consensus 152 la~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (477)
+++...... ......||+.|||||++.+..|+.++|||||||+||||++|..||.+.+. .+.+.++...
T Consensus 162 ~~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~ 230 (305)
T d1blxa_ 162 LARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDV 230 (305)
T ss_dssp SCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHH
T ss_pred hhhhhcccc--------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHh
Confidence 987554322 23467899999999999999999999999999999999999999977543 3333333221
Q ss_pred ----------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 232 ----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 232 ----------------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
......+.+...+++++.+||.+||..||++|||+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 111223344566789999999999999999999987764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-47 Score=376.74 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=207.7
Q ss_pred CCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
.++|+++++||+|+||+||+|++. .+++.||||+++..... ..+.+|+.+++.++|++ +..+..++...+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~n-iv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN-IVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTT-BCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCC-cccceeeeccCCc
Confidence 367999999999999999999975 35679999998754433 35789999999998755 5555555556778
Q ss_pred EEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCc
Q 011819 78 NVLVMDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~-----------------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~N 133 (477)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 89999999 899999986421 248899999999999999999999999999999999
Q ss_pred eEeecCCCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCC-CC
Q 011819 134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LP 212 (477)
Q Consensus 134 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~-~P 212 (477)
||| +.++.+||+|||+|+........ .......||+.|||||.+.+..|+.++|||||||+||||++|. .|
T Consensus 171 ILl---d~~~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 171 CLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp EEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEE---CCCCcEEEccchhheeccCCccc-----cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999 67899999999999866443221 1234567899999999999999999999999999999999985 57
Q ss_pred CCCCCcccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
|.+. ...+.+..+...... ..+..+|+++.+|+..||+.+|++||++.+|.+.|+++
T Consensus 243 ~~~~---~~~e~~~~v~~~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYGM---AHEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTS---CHHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCC---CHHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 7654 334555666555432 23467899999999999999999999999999988875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=378.46 Aligned_cols=275 Identities=17% Similarity=0.247 Sum_probs=221.1
Q ss_pred CCceEEEeeeeecCceEEEEEEEC---CCCcEEEEEEecCC------CCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCc
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK------TKHPQLLYESKLYRILQGGTGIPNVRWFGVEGD 76 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~---~~g~~vAiKi~~~~------~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~ 76 (477)
.++|+++++||+|+||+||+|.+. .+|+.||||+++.. .....+..|++++..++|+++|..+..+..+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 368999999999999999999974 46899999987542 233457789999999999999999988888999
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 77 YNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 77 ~~~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
..+++|||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhh
Confidence 999999999 8999999975 4568899999999999999999999999999999999999 6789999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCC--CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~--~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
+...... ......|++.|++||.+.+.. ++.++|||||||+||+|++|..||.+.........+.+......
T Consensus 179 ~~~~~~~------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 179 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252 (322)
T ss_dssp CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred hcccccc------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence 6543321 233567999999999998654 67899999999999999999999987655444433333221111
Q ss_pred cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccchhhccccCCCC
Q 011819 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQLATPP 304 (477)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt-----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~p 304 (477)
. .++..+++++.+||.+||..||++||+ ++++ | .++|...++|..+..++.+++..|
T Consensus 253 ~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~ei---l-------~Hpff~~i~~~~l~~~~~~~p~~p 314 (322)
T d1vzoa_ 253 P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI---K-------EHLFFQKINWDDLAAKKVPAPFKP 314 (322)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH---H-------TSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHH---H-------cCHhhcCCCHHHHHhCCCCcCCCC
Confidence 1 134568999999999999999999995 4444 2 356667789987776666644443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=373.17 Aligned_cols=258 Identities=19% Similarity=0.323 Sum_probs=210.1
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCC-------cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeC
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEG 75 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g-------~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~ 75 (477)
.++|++++.||+|+||.||+|++..++ ..||||++...... ..+..|...+..+.+|++|+.+..++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 478999999999999999999976554 47999998765433 34678889999997778888888877788
Q ss_pred cEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC
Q 011819 76 DYNVLVMDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (477)
Q Consensus 76 ~~~~lVmE~~-g~sL~~li~~~~---------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~ 139 (477)
+..++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||+++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl--- 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--- 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee---
Confidence 8899999999 999999996432 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCc
Q 011819 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (477)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~ 218 (477)
+.++.+||+|||+++........ .......||+.|+|||++.+..|+.++|||||||+||||++ |..||.+...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTT-----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCeEeccchhhccccccccc-----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 68899999999999977654432 12345679999999999999999999999999999999998 7899976443
Q ss_pred ccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
.+.+..+...... ..+..+|+++.+||.+||+.+|.+||++.++.+.|+.++.
T Consensus 244 ---~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 ---EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHHHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHcCCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 3444444443222 2346789999999999999999999999999999988864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=370.96 Aligned_cols=248 Identities=19% Similarity=0.302 Sum_probs=199.1
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEee-EeCcEEEEEEecC
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFG-VEGDYNVLVMDLL 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~-~~~~~~~lVmE~~ 85 (477)
++|+++++||+|+||.||+|++ .|..||||++........+.+|+++++.++|+ +|..+..++ ...+..+|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~Hp-nIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHS-NLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCT-TBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCC-CEeeEEEEEEecCCcEEEEEecc
Confidence 5799999999999999999996 57899999998776677899999999999875 555554444 4455679999999
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 86 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 86 -g~sL~~li~~~-~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC---
Confidence 99999998642 2358999999999999999999999999999999999999 688999999999998654322
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhcccccHHHHhc
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (477)
....+|..|+|||++.+..++.++|||||||++|||++ |.+||...... +.+..+....... ++.
T Consensus 158 -------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~~~~~~----~~~ 223 (262)
T d1byga_ 158 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYKMD----APD 223 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTTTCCCC----CCT
T ss_pred -------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCCC----CCc
Confidence 24468899999999999999999999999999999998 78888775443 3444444433222 345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 243 ~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
.+++++.++|.+||..||.+||++.++.+.|+++-
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 68899999999999999999999999999988874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=372.82 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=198.3
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEecC
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~~ 85 (477)
++|+++++||+|+||+||+|++..+ +.||||++.... ....+.+|+.++..++|++++..+. ++.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g-~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEE-EECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEE-EEec-CCeEEEEEec
Confidence 6899999999999999999998544 679999986544 3456899999999999866555544 4443 4468999999
Q ss_pred -CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 86 -GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 86 -g~sL~~li~~-~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
+++|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.......
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~-- 168 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNEY-- 168 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCCc--
Confidence 8899988753 34569999999999999999999999999999999999999 6789999999999987644322
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
.......||+.|+|||++....++.++|||||||+||||++|..||... ....+.+..+...... .....
T Consensus 169 ----~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~~----~~~~~ 238 (285)
T d1fmka3 169 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYRM----PCPPE 238 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCC----CCCTT
T ss_pred ----eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCC----CCCcc
Confidence 1123457899999999999999999999999999999999966555432 2334445554443221 13467
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLF 277 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~ 277 (477)
+|+++.++|.+||+.||++||+++++.+.|++.+
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 8999999999999999999999999988777654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=372.07 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=196.8
Q ss_pred CceEEEeeeeecCceEEEEEEECCC-C--cEEEEEEecCCC-----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQT-N--EEVAIKLENVKT-----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~-g--~~vAiKi~~~~~-----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
++|++.+.||+|+||.||+|++... + ..||||++.... ....+.+|+.++..++|+ +|..+..++.+ ...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~-nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR-NLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCT-TBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCC-CEEEEEEEEee-cch
Confidence 5799999999999999999986433 2 478999876432 123578999999999875 45454444444 356
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecc
Q 011819 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (477)
++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhcc
Confidence 8999999 899999887666779999999999999999999999999999999999999 567899999999999875
Q ss_pred cCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCcccHHHHHHHHhhhccccc
Q 011819 158 DTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (477)
Q Consensus 158 ~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (477)
...... .......|+..|+|||++.+..++.++|||||||++|||++ |..||.+.+. .+.+.++.......
T Consensus 163 ~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~i~~~~~~~- 234 (273)
T d1u46a_ 163 QNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGERL- 234 (273)
T ss_dssp C-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCCCC-
T ss_pred cCCCcc----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---HHHHHHHHhCCCCC-
Confidence 544322 12234568889999999999999999999999999999998 8999977543 44455554443322
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
.....+|+++.++|.+||..||++||++++|.+.|++.
T Consensus 235 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 --PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 13467899999999999999999999999998888764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=373.01 Aligned_cols=254 Identities=19% Similarity=0.247 Sum_probs=209.7
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcE--EEEEEecCCC---CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKT---KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLV 81 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~--vAiKi~~~~~---~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lV 81 (477)
++|++.++||+|+||.||+|++..++.. ||||.+.... ....+.+|++++..+.+|++|..+..++.+.+..+||
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5899999999999999999999888864 6777654322 3346889999999997668888888888888999999
Q ss_pred EecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcE
Q 011819 82 MDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (477)
Q Consensus 82 mE~~-g~sL~~li~~~---------------~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~v 145 (477)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +..+.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCce
Confidence 9999 99999998632 3569999999999999999999999999999999999999 678999
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCC-CCCCCCCcccHHHH
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQK 224 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~-~Pf~~~~~~~~~~~ 224 (477)
||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|. +||.+. +..+.
T Consensus 167 kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL 235 (309)
T ss_dssp EECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH
T ss_pred EEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHH
Confidence 9999999986544332 23457899999999999999999999999999999999975 567553 34555
Q ss_pred HHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
+..+...... ..+..+|+++.+||.+||+.||++||++.++.+.|++++.
T Consensus 236 ~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 236 YEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 6655543322 2345689999999999999999999999999999998874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=369.47 Aligned_cols=260 Identities=20% Similarity=0.311 Sum_probs=213.1
Q ss_pred CCceEEEeeeeecCceEEEEEEEC-----CCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcE
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDY 77 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~-----~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~ 77 (477)
.++|+++++||+|+||.||+|++. .+++.||||++...... ..+.+|+.++..+.+|++|..+..++...+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 378999999999999999999863 45679999998764432 2477899999999877888888888888888
Q ss_pred EEEEEecC-CCCHHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecC
Q 011819 78 NVLVMDLL-GPSLEDLFNFCS-----------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (477)
Q Consensus 78 ~~lVmE~~-g~sL~~li~~~~-----------------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~ 139 (477)
.+|+|||| +++|.+++.... ..+++..++.++.||+.||+|||+++||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~--- 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--- 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc---
Confidence 99999999 899999986432 258999999999999999999999999999999999999
Q ss_pred CCCCcEEEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHc-CCCCCCCCCc
Q 011819 140 RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (477)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyellt-G~~Pf~~~~~ 218 (477)
+..+.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++ |.+||.....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 57899999999999876554332 23345789999999999999999999999999999999999 5666655443
Q ss_pred ccHHHHHHHHhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011819 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIR 279 (477)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~ 279 (477)
.. .+.++........ ....+|+++.+||..||+.||++||++++|.+.|+..+..
T Consensus 254 ~~---~~~~~i~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DS---KFYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SH---HHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---HHHHHHhcCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 32 2222322222221 2345789999999999999999999999999999887643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=373.94 Aligned_cols=259 Identities=20% Similarity=0.224 Sum_probs=199.8
Q ss_pred ccCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEe----Cc
Q 011819 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVE----GD 76 (477)
Q Consensus 4 ~i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~----~~ 76 (477)
.++.+|+++++||+|+||+||+|.+..+|+.||||++...... ..+.+|+.+++.|+|++.+..+..+... ..
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 3678999999999999999999999999999999998754432 3567899999999886666555554332 23
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeec
Q 011819 77 YNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (477)
Q Consensus 77 ~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (477)
+.||+|++++++|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+..
T Consensus 85 ~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVA 159 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred eEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeec
Confidence 4677777779999999974 469999999999999999999999999999999999999 67899999999999876
Q ss_pred ccCCCCcccccccCCCCccCccccccchhc-CCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHh------
Q 011819 157 RDTSTHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS------ 229 (477)
Q Consensus 157 ~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~-g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~------ 229 (477)
....... ......+||+.|+|||++. +..++.++||||+||++|+|++|..||.+..............
T Consensus 160 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 160 DPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CGGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cCCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 5433211 1234568999999999985 4567899999999999999999999997644322211111110
Q ss_pred -----------------hhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 230 -----------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 230 -----------------~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
..........+...+++++.+|+.+||..||.+||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001112334455677889999999999999999999777743
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=373.49 Aligned_cols=252 Identities=19% Similarity=0.282 Sum_probs=196.1
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeEeC-----
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGVEG----- 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~~~----- 75 (477)
+.++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|+|++++..+..|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 678999999999999999999999999999999998754332 34778999999998866665555554322
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...||||||++.+|..+++. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceec
Confidence 35699999999999998873 569999999999999999999999999999999999999 7889999999999987
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhh---
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (477)
..... ....||+.|+|||++.+. .++.++|||||||+||+|++|..||.+.........+......
T Consensus 171 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 171 ADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 65432 356899999999999875 4689999999999999999999999775432222222111110
Q ss_pred --------------------cccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011819 232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (477)
Q Consensus 232 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~ 271 (477)
........+...+++++.+||.+||..||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0111222334567889999999999999999999777644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.3e-46 Score=363.67 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=197.0
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|+++++||+|+||+||+|++. +++.||||++.... ....+.+|+.+++.++| ++|+.+...+...+..+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEeeeeecccCCceeEEE
Confidence 68999999999999999999984 88999999986543 23468899999999987 55566666666777889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 83 E~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
||+++.+...+....+.+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc-
Confidence 999777766666567789999999999999999999999999999999999999 6889999999999987654332
Q ss_pred cccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc---------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (477)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+. .+.+.++....
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWP 226 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTST
T ss_pred ------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhcc
Confidence 12345789999999999765 468999999999999999999999976443 33333322110
Q ss_pred ---------------ccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 233 ---------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 233 ---------------~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
...........+++++.+||.+||..||++||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 01111233456788999999999999999999987764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-45 Score=368.67 Aligned_cols=259 Identities=18% Similarity=0.283 Sum_probs=202.6
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeE--eCcEEEEEEe
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV--EGDYNVLVMD 83 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~--~~~~~~lVmE 83 (477)
.++|+++++||+|+||+||+|++..+|+.||||++... ....+.+|+.+++.+.+|++|..+..++. .....++|||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 46899999999999999999999999999999998653 45678899999999987777777766554 3456899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCC
Q 011819 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (477)
Q Consensus 84 ~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (477)
|| +++|.++. +.+++..++.++.||+.||+|||++||+||||||+|||++ ...+.+||+|||+|+.......
T Consensus 113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~- 185 (328)
T d3bqca1 113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE- 185 (328)
T ss_dssp CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCC-
T ss_pred ecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCc-
Confidence 99 77876553 4699999999999999999999999999999999999995 3445799999999987654332
Q ss_pred cccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhc---------
Q 011819 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (477)
Q Consensus 163 ~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (477)
....+||+.|+|||.+.+.. ++.++|||||||++|+|++|..||...... ......+....
T Consensus 186 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~--~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 186 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHH
T ss_pred -------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh--HHHHHHHHHHHCCchhhhhh
Confidence 34568999999999988754 799999999999999999999999764432 11111111100
Q ss_pred ----c--c------------c-----cHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccc
Q 011819 233 ----V--S------------T-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFD 289 (477)
Q Consensus 233 ----~--~------------~-----~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~~~~~~d 289 (477)
. . . ........+++++.+||.+||..||.+|||++++++ ++|+..+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~----------Hp~F~~v~ 326 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME----------HPYFYTVV 326 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT----------SGGGTTSC
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc----------CcccCCCC
Confidence 0 0 0 000111236789999999999999999999877643 45665556
Q ss_pred cc
Q 011819 290 WT 291 (477)
Q Consensus 290 w~ 291 (477)
|+
T Consensus 327 ~~ 328 (328)
T d3bqca1 327 KD 328 (328)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=371.02 Aligned_cols=247 Identities=21% Similarity=0.217 Sum_probs=194.0
Q ss_pred ceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeE-----eCcEEEEEE
Q 011819 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGV-----EGDYNVLVM 82 (477)
Q Consensus 8 ~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~-----~~~~~~lVm 82 (477)
+|+.+++||+|+||+||+|++..+|+.||||++.... ....+|+++++.|+|++++..+..|.. ...+.||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 6999999999999999999999999999999986543 234579999999988666666555532 334679999
Q ss_pred ecCCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCC-CcEEEeecCceeeccc
Q 011819 83 DLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRD 158 (477)
Q Consensus 83 E~~g~sL~~li~---~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~-~~vkL~DFGla~~~~~ 158 (477)
|||++++.+.+. .....+++..++.++.||+.||+|||++||+||||||+|||+ +.+ ..+||+|||+++....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl---~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE---ecCCCceeEecccchhhccC
Confidence 999776655543 235579999999999999999999999999999999999999 444 5899999999987654
Q ss_pred CCCCcccccccCCCCccCccccccchhcC-CCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhccc---
Q 011819 159 TSTHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--- 234 (477)
Q Consensus 159 ~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g-~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~--- 234 (477)
... ....+||+.|+|||.+.+ ..|+.++|||||||++|||++|..||..... ...+..+......
T Consensus 176 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~---~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 176 GEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTR 244 (350)
T ss_dssp TSC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred Ccc--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH---HHHHHHHHHHhCCChH
Confidence 332 235689999999998875 4689999999999999999999999976443 2333332211000
Q ss_pred ---------------------ccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 235 ---------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 235 ---------------------~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.........+++++.+||.+||..||++|||+.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 001112235688999999999999999999987764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=362.81 Aligned_cols=256 Identities=17% Similarity=0.237 Sum_probs=203.0
Q ss_pred EEeeeeecCceEEEEEEECCCC---cEEEEEEecCCCCc---hhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 11 LGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 11 i~~~IG~G~fG~Vy~a~~~~~g---~~vAiKi~~~~~~~---~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
+.++||+|+||+||+|++..++ ..||||.++..... ..+..|++++..|+|++++..+..+.......++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3678999999999999986653 36899988643322 35889999999998855555555544556688999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCCCc
Q 011819 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (477)
Q Consensus 85 ~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (477)
| +++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||| +.++.+||+|||+++.........
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccccc
Confidence 9 899999998656678899999999999999999999999999999999999 688999999999998765543322
Q ss_pred ccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccccHHHHhcC
Q 011819 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (477)
Q Consensus 164 ~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (477)
........||+.|+|||.+.+..++.++||||||++||||++|..||..... ..+....+....... .++.
T Consensus 188 ---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~~~----~p~~ 258 (311)
T d1r0pa_ 188 ---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRLL----QPEY 258 (311)
T ss_dssp ---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCC----CCTT
T ss_pred ---ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCCC----Cccc
Confidence 1123346789999999999999999999999999999999998888865322 223333333332221 3356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011819 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFI 278 (477)
Q Consensus 244 ~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~ 278 (477)
+|+++.+||..||..||++||++.++.+.|+.++.
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999999999998864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=363.54 Aligned_cols=259 Identities=20% Similarity=0.230 Sum_probs=195.9
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCC----CchhHHHHHHHHHHHcCCCCCCeeEEeeE-------e
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLLYESKLYRILQGGTGIPNVRWFGV-------E 74 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~----~~~~~~~E~~il~~L~~~~~i~~~~~~~~-------~ 74 (477)
.++|+++++||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.++|++++..+..+.. .
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 378999999999999999999999999999999875432 23457899999999998666666555432 2
Q ss_pred CcEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCcee
Q 011819 75 GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (477)
Q Consensus 75 ~~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~ 154 (477)
.+..|+||||+++.+...+......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceee
Confidence 44579999999777777766556779999999999999999999999999999999999999 688999999999998
Q ss_pred ecccCCCCcccccccCCCCccCccccccchhcCC-CCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc
Q 011819 155 KYRDTSTHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (477)
Q Consensus 155 ~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~-~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (477)
......... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.........+.++.....
T Consensus 166 ~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp ECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ecccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 765433221 1223456899999999999865 689999999999999999999999987544333233222221110
Q ss_pred ccc----------------------H-HHH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 STS----------------------I-EAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 ~~~----------------------~-~~l-~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
... . +.+ ....++++.+||.+||..||++|||++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 000 0 000 001256788999999999999999977664
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=363.76 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=207.6
Q ss_pred CceEEEeeeeecCceEEEEEEECC-----CCcEEEEEEecCCCCch---hHHHHHHHHHHHcCCCCCCeeEEeeEeCcEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKHP---QLLYESKLYRILQGGTGIPNVRWFGVEGDYN 78 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~-----~g~~vAiKi~~~~~~~~---~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~ 78 (477)
++|+++++||+|+||.||+|.+.. ++..||||++....... .+.+|+.+++.++|+ +|..+..++...+..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~-nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCT-TBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCC-CEeeeeeEEecCCce
Confidence 789999999999999999998753 35789999987544332 377999999999875 555555555667778
Q ss_pred EEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEe
Q 011819 79 VLVMDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (477)
Q Consensus 79 ~lVmE~~-g~sL~~li~~~~---------~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~ 148 (477)
++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceEEEe
Confidence 9999999 999999986431 347899999999999999999999999999999999999 788999999
Q ss_pred ecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcC-CCCCCCCCcccHHHHHHH
Q 011819 149 DFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEK 227 (477)
Q Consensus 149 DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG-~~Pf~~~~~~~~~~~~~~ 227 (477)
|||+|+........ .......||+.|+|||.+.+..++.++|||||||+||||++| ..||.+. ...+.+..
T Consensus 176 DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~~ 247 (308)
T d1p4oa_ 176 DFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRF 247 (308)
T ss_dssp CTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHHH
T ss_pred ecccceeccCCcce-----eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHHHH
Confidence 99999876553321 123445789999999999999999999999999999999998 5778664 34455655
Q ss_pred HhhhcccccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011819 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDL 276 (477)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~ 276 (477)
+....... .+..+|+.+.++|..||+.+|++||++.+|.+.|++.
T Consensus 248 i~~~~~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 248 VMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHhCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 55544322 3456899999999999999999999999998877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=361.26 Aligned_cols=268 Identities=21% Similarity=0.258 Sum_probs=198.4
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHH--HHHcCCCCCCeeEEeeEeC---cEEE
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLY--RILQGGTGIPNVRWFGVEG---DYNV 79 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il--~~L~~~~~i~~~~~~~~~~---~~~~ 79 (477)
|..+|.+.++||+|+||.||+|++ +|+.||||++.... ......|.+++ ..++|++++..+..+.... ...|
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 457899999999999999999985 68999999986543 23444555544 3456644444444433333 2579
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeeCCCCCCceEeecCCCCCcEEEeec
Q 011819 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (477)
Q Consensus 80 lVmE~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs--------~giiHRDLKP~NILl~~~~~~~~vkL~DF 150 (477)
|||||+ +++|.++++. .++++...+.++.|++.||.|||+ +|||||||||+|||| +.++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEec
Confidence 999999 8999999984 469999999999999999999996 599999999999999 68899999999
Q ss_pred CceeecccCCCCcccccccCCCCccCccccccchhcCCC------CCCcchHHHHHHHHHHHHcCCCCCCCCCc------
Q 011819 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKA------ 218 (477)
Q Consensus 151 Gla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~------~s~ksDIwSlGviLyelltG~~Pf~~~~~------ 218 (477)
|+++.......... .......||+.|||||++.+.. ++.++|||||||+||||++|..||.....
T Consensus 153 Gl~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 153 GLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp TTCEEEETTTTEEC---C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred CccccccCCCccee---ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 99998765443211 1234568999999999987653 56789999999999999999887743211
Q ss_pred ------ccHHHHHHHHhhhcccccHHHH--hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 011819 219 ------GTKKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQ 283 (477)
Q Consensus 219 ------~~~~~~~~~i~~~~~~~~~~~l--~~~~p~~l~~li~~cl~~~p~~RPt~~~l~~~l~~~~~~~~~~ 283 (477)
.........+........+... ....+.++.+++.+||..||.+||++.++.+.|+++...++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 1122222222222221111111 1223567999999999999999999999999999998777653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=364.57 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=195.0
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCc----hhHHHHHHHHHHHcCCCCCCeeEEeeE-----eC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKLYRILQGGTGIPNVRWFGV-----EG 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~----~~~~~E~~il~~L~~~~~i~~~~~~~~-----~~ 75 (477)
+.++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.|+|++++..+..+.. +.
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 357899999999999999999999999999999998754332 246789999999998666655555532 23
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...+++|+++|++|.+++. .+++++.++..++.||+.||+|||++||+||||||+|||+ +.++.+|++|||++..
T Consensus 96 ~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----C
T ss_pred ceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhcc
Confidence 3456666666999999996 4679999999999999999999999999999999999999 6889999999999975
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc-
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV- 233 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (477)
.... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+. ......+.....
T Consensus 171 ~~~~----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 171 TDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGT 237 (348)
T ss_dssp CTGG----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred cCcc----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCC
Confidence 5432 24568999999999987765 58999999999999999999999977443 222222222111
Q ss_pred -------------------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 -------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 -------------------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.........++++++.+||.+||..||.+|||+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence 1122333456789999999999999999999977664
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-44 Score=348.58 Aligned_cols=250 Identities=20% Similarity=0.235 Sum_probs=199.9
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC----chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEE
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~----~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVm 82 (477)
++|+++++||+|+||+||+|++..+++.||||+++.... ...+.+|+.+++.++|+ +|..+..++......++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~-niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK-NIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCT-TBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcC-CEEeeccccccccceeEEe
Confidence 589999999999999999999999999999999865432 23578999999999874 5666667777888889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceeecccCCC
Q 011819 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (477)
Q Consensus 83 E~~-g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (477)
+++ +++|..++. ..+.+++..+..++.|++.||+|||++||+||||||+|||+ +..+.+||+|||.|+.......
T Consensus 81 ~~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 81 EFCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp ECCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred eeccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence 999 666666554 57789999999999999999999999999999999999999 6788999999999988765433
Q ss_pred CcccccccCCCCccCccccccchhcCCC-CCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcc-------
Q 011819 162 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 233 (477)
Q Consensus 162 ~~~~p~~~~~~~~Gt~~Y~APE~~~g~~-~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 233 (477)
. .....+++.|+|||++.+.. ++.++|||||||++|||++|..||.... +..+.+.++.....
T Consensus 157 ~-------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 157 C-------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp C-------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTC
T ss_pred c-------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhh
Confidence 1 23446788999999988765 5899999999999999999999985432 23333333322111
Q ss_pred -----------------cccHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 234 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 234 -----------------~~~~~~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
..........+++++.+|+.+||..||.+|||+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0111223345678999999999999999999987763
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=361.96 Aligned_cols=249 Identities=20% Similarity=0.239 Sum_probs=186.8
Q ss_pred cCCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCCch----hHHHHHHHHHHHcCCCCCCeeEEeeE-----eC
Q 011819 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKLYRILQGGTGIPNVRWFGV-----EG 75 (477)
Q Consensus 5 i~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~----~~~~E~~il~~L~~~~~i~~~~~~~~-----~~ 75 (477)
+.++|+++++||+|+||+||+|.+..+|+.||||++....... .+.+|+.+++.++|++++..+..|.. ..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 3468999999999999999999999999999999987654322 46789999999987555555555532 34
Q ss_pred cEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEEeecCceee
Q 011819 76 DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (477)
Q Consensus 76 ~~~~lVmE~~g~sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL~DFGla~~ 155 (477)
...|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|++|||+++.
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 168 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred ceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhc
Confidence 6789999999777766654 469999999999999999999999999999999999999 6788999999999886
Q ss_pred cccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccHHHHHHHHhhhcccc
Q 011819 156 YRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (477)
Q Consensus 156 ~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (477)
...... ....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+... .....++.......
T Consensus 169 ~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 169 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTP 237 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCC
T ss_pred cccccc--------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---HHHHHHHHHhccCC
Confidence 654332 3456899999999999999999999999999999999999999976543 22222222111100
Q ss_pred cH-------------------------H------------HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011819 236 SI-------------------------E------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (477)
Q Consensus 236 ~~-------------------------~------------~l~~~~p~~l~~li~~cl~~~p~~RPt~~~l~ 270 (477)
.. . ......++++.+||.+||..||++|||+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 00 0 00112366899999999999999999987764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-40 Score=331.59 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=182.8
Q ss_pred CCceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC-chhHHHHHHHHHHHcCCC----------CCCeeEEee--
Q 011819 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKLYRILQGGT----------GIPNVRWFG-- 72 (477)
Q Consensus 6 ~~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~-~~~~~~E~~il~~L~~~~----------~i~~~~~~~-- 72 (477)
.++|+++++||+|+||+||+|++..+|+.||||+++.... ...+..|+++++.+.|.+ ++..+..+.
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4579999999999999999999999999999999875432 245678999999887643 344433332
Q ss_pred EeCcEEEEEEecC--CCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeCCCCCCceEeecCCC---CCcE
Q 011819 73 VEGDYNVLVMDLL--GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRR---ANQV 145 (477)
Q Consensus 73 ~~~~~~~lVmE~~--g~sL~~li~-~~~~~ls~~~~~~i~~qIa~aL~yLHs-~giiHRDLKP~NILl~~~~~---~~~v 145 (477)
......+++|+++ +........ .....+++..+..++.||+.||+|||+ +||+||||||+||||...+. ...+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 2445666666666 444444443 234568999999999999999999998 89999999999999953211 1258
Q ss_pred EEeecCceeecccCCCCcccccccCCCCccCccccccchhcCCCCCCcchHHHHHHHHHHHHcCCCCCCCCCcccH---H
Q 011819 146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---K 222 (477)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~APE~~~g~~~s~ksDIwSlGviLyelltG~~Pf~~~~~~~~---~ 222 (477)
+|+|||.+....... ...+||+.|+|||++.+..|+.++|||||||++++|++|+.||........ .
T Consensus 172 kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred eEeeccccccccccc----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 999999998665432 356899999999999999999999999999999999999999975432111 1
Q ss_pred HHHHHHhhhccc------------------------------ccHHH-------HhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011819 223 QKYEKISEKKVS------------------------------TSIEA-------LCRGYPTEFASYFHYCRSLRFDDKPD 265 (477)
Q Consensus 223 ~~~~~i~~~~~~------------------------------~~~~~-------l~~~~p~~l~~li~~cl~~~p~~RPt 265 (477)
..+......... ..... .....++++.+||.+||..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111111000000 00000 01123578999999999999999999
Q ss_pred HHHHH
Q 011819 266 YAYLK 270 (477)
Q Consensus 266 ~~~l~ 270 (477)
+++++
T Consensus 322 a~e~L 326 (362)
T d1q8ya_ 322 AGGLV 326 (362)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 77663
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=6.8e-24 Score=193.97 Aligned_cols=162 Identities=19% Similarity=0.265 Sum_probs=112.3
Q ss_pred eEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--------------------chhHHHHHHHHHHHcCCCCCCee
Q 011819 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------------------HPQLLYESKLYRILQGGTGIPNV 68 (477)
Q Consensus 9 y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--------------------~~~~~~E~~il~~L~~~~~i~~~ 68 (477)
+.++++||+|+||+||+|++ .+|++||||++..... ......|...+..+.+.+ ++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA-VPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS-SCCE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC-cceE
Confidence 56899999999999999998 5789999998643110 011235667777776643 3333
Q ss_pred EEeeEeCcEEEEEEecCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeCCCCCCceEeecCCCCCcEEE
Q 011819 69 RWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (477)
Q Consensus 69 ~~~~~~~~~~~lVmE~~g~-sL~~li~~~~~~ls~~~~~~i~~qIa~aL~yLHs~giiHRDLKP~NILl~~~~~~~~vkL 147 (477)
.. ... .+|+|||+++ .+. .++...+..++.||+.+|.|||++||+||||||+|||++ ++.++|
T Consensus 80 ~~--~~~--~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~l 143 (191)
T d1zara2 80 YA--WEG--NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWI 143 (191)
T ss_dssp EE--EET--TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEE
T ss_pred EE--ecC--CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEE
Confidence 22 222 3799999954 322 245556778999999999999999999999999999994 355999
Q ss_pred eecCceeecccCCCCcccccccCCCCccCcccccc-----chhcCCCCCCcchHHHHHHHH
Q 011819 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASM-----NTHLGIEQSRRDDLESLGYVL 203 (477)
Q Consensus 148 ~DFGla~~~~~~~~~~~~p~~~~~~~~Gt~~Y~AP-----E~~~g~~~s~ksDIwSlGviL 203 (477)
+|||+|+....... ..|... -.+....|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999986543221 011111 012345688899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=9.5e-07 Score=81.86 Aligned_cols=84 Identities=20% Similarity=0.264 Sum_probs=62.3
Q ss_pred CceEEEeeeeecCceEEEEEEECCCCcEEEEEEecCCCC--chhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 7 ~~y~i~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~--~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
..|++++..+.++.+.||+.. ..++.++||+...... ...+..|...+..|...--++.+.+++..++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 567877776656667999986 5666778897654322 235788999999888665578888888888889999999
Q ss_pred C-CCCHHHH
Q 011819 85 L-GPSLEDL 92 (477)
Q Consensus 85 ~-g~sL~~l 92 (477)
+ |.++.+.
T Consensus 92 l~G~~~~~~ 100 (263)
T d1j7la_ 92 ADGVLCSEE 100 (263)
T ss_dssp CSSEEHHHH
T ss_pred ccccccccc
Confidence 9 6666543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.93 E-value=1.7e-05 Score=78.35 Aligned_cols=73 Identities=18% Similarity=0.169 Sum_probs=47.6
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCC---------CCchhHHHHHHHHHHHcCC--CCCCeeEEeeEeCcEEEE
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---------TKHPQLLYESKLYRILQGG--TGIPNVRWFGVEGDYNVL 80 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~---------~~~~~~~~E~~il~~L~~~--~~i~~~~~~~~~~~~~~l 80 (477)
.+.||.|....||++.+..+++.|+||.-... ........|..++..+... ..+|.+..+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999987777889999963221 1112356788888887643 334555544 4555689
Q ss_pred EEecCC
Q 011819 81 VMDLLG 86 (477)
Q Consensus 81 VmE~~g 86 (477)
+||+++
T Consensus 109 vmE~L~ 114 (392)
T d2pula1 109 VMEDLS 114 (392)
T ss_dssp EECCCT
T ss_pred EEeccC
Confidence 999993
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=2.4e-05 Score=71.66 Aligned_cols=74 Identities=15% Similarity=0.054 Sum_probs=52.3
Q ss_pred eeeecC-ceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCC-CCeeEEeeEeCcEEEEEEecC-CCCH
Q 011819 14 KIGSGS-FGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQGGTG-IPNVRWFGVEGDYNVLVMDLL-GPSL 89 (477)
Q Consensus 14 ~IG~G~-fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~-i~~~~~~~~~~~~~~lVmE~~-g~sL 89 (477)
.+..|. -+.||+... ..+..+++|+.... ....+..|...++.|..... ++.+..+..+.+..++||+++ |.++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344444 368999873 55667889976543 34568899999998876533 566677777778889999999 5443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.13 E-value=0.00075 Score=66.00 Aligned_cols=70 Identities=13% Similarity=0.114 Sum_probs=51.6
Q ss_pred EeeeeecCceEEEEEEECC-------CCcEEEEEEecCCCCchhHHHHHHHHHHHcCCCCCCeeEEeeEeCcEEEEEEec
Q 011819 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKHPQLLYESKLYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~-------~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~~~~i~~~~~~~~~~~~~~lVmE~ 84 (477)
++.|+.|-.-.+|++.... ..+.|.+++.......-...+|..+++.+......+.+.+++. ..+||||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 4678888889999998643 2467888886643333456789999999987777788877653 2688998
Q ss_pred C
Q 011819 85 L 85 (477)
Q Consensus 85 ~ 85 (477)
+
T Consensus 123 i 123 (395)
T d1nw1a_ 123 I 123 (395)
T ss_dssp C
T ss_pred e
Confidence 8
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.85 E-value=0.0012 Score=62.18 Aligned_cols=48 Identities=15% Similarity=0.172 Sum_probs=30.2
Q ss_pred EeeeeecCceEEEEEEECCCCcEEEEEEecCCCCchhHHHHHHHHHHHcC
Q 011819 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQG 61 (477)
Q Consensus 12 ~~~IG~G~fG~Vy~a~~~~~g~~vAiKi~~~~~~~~~~~~E~~il~~L~~ 61 (477)
.+.|..|---+.|+.+. ..| .+++|+.........+..|.+++..|..
T Consensus 23 ~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~ 70 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAA 70 (316)
T ss_dssp EEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHH
T ss_pred eecCCCCcccCeEEEEE-CCC-cEEEEEcCCCCCHHHHHHHHHHHHhhhh
Confidence 34455676678899874 334 5889997654445667888888888865
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.50 E-value=0.01 Score=55.87 Aligned_cols=64 Identities=14% Similarity=0.204 Sum_probs=43.5
Q ss_pred eEEEEEEECCCCcEEEEEEecCCC-CchhHHHHHHHHHHHcCCCCCCee-------EEeeEeCcEEEEEEecCC
Q 011819 21 GEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKLYRILQGGTGIPNV-------RWFGVEGDYNVLVMDLLG 86 (477)
Q Consensus 21 G~Vy~a~~~~~g~~vAiKi~~~~~-~~~~~~~E~~il~~L~~~~~i~~~-------~~~~~~~~~~~lVmE~~g 86 (477)
-.||+++. .+|..|++|+..... ...++..|...+..|.... ++.. ......++..+.++++++
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~g-ipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDE-VPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTT-CSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcC-CCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 48999984 678889999976543 3456788999888887532 2221 122345677788999883
|